Psyllid ID: psy3686

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290------
Protein Sequence
MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNILGIREPPPKKEKKRKKKQFGDDPQASSKTLYQDLGSDSEVEDQSSHPAGGKIFRTHDLSEEEEDVEPDCETLSAAIQLDVKN
Secondary Structure (PSIPRED)
cccccccccEEEEEccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHHHccccccccccccHHHHHHHHHHcccccccHHHHHccccccccHHHHHHHcccccccccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHHcccccccccccHHHHHHHHHHHHHHHcccccccccccccEEEEEEcccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHcccHHcccccHHHHHHccccccccccHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHcccHccccccc
Coil and Loop (DISEMBL)
mspqskesDVWICMELMATCFDRLLKRLhvsvpepicgkiTLSTVKALHYLKEthgvihrdvkpsnilldergniklcdfgisgrlvdskartknagcaaymaperieppnpqkpdydiraDVWSLGITLVElatgefpykdckcdfEVLSRvlndappclpndplfgrtIKASiakdngrsTEFIRKrsyedkstcyecgaeghlsyacpqnilgirepppkkekkrkkkqfgddpqassktlyqdlgsdsevedqsshpaggkifrthdlseeeedvepdcETLSAAIQLDVKN
Flexible Loop (DISEMBL)
mspqskesdVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKEthgvihrdvkpsnilldergniKLCDfgisgrlvdskARTKNAGCAaymaperieppnpqKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKasiakdngrstefirkrsyedKSTCYECGAEghlsyacpqnilgirepppkkekkrkkkqfgddpqassKTLYQDLGSDsevedqsshpagGKIFRTHDLseeeedvepdcetlsaaiqldvkn
Low Complexity Region (SEG)
MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNILGIrepppkkekkrkkkQFGDDPQASSKTLYQDLGSDSEVEDQSSHPAGGKIFRTHdlseeeedvepdceTLSAAIQLDVKN
Disordered region (IsUnstruct)
*********VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYM**************YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK*****TEFIRKRSYEDKSTCYECGAEGHLSYACPQNILGI*******************************************************************************
Disordered Region (DISOPRED)
*****KE*DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP*****PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNI***************************************************************************I******
Disordered Region (DISEMBL)
********DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNILGIREPP******************SSKTLYQD*************PAGGKIFRTHD************ETLSAAIQLDVKN
Disordered Region (DISPRO)
*****KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNILGIRE*****************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNILGIREPPPKKEKKRKKKQFGDDPQASSKTLYQDLGSDSEVEDQSSHPAGGKIFRTHDLSEEEEDVEPDCETLSAAIQLDVKN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	296	2.2.26 [Sep-21-2011]
O14733	419	Dual specificity mitogen-	yes	N/A	0.540	0.381	0.737	1e-67
Q4KSH7	419	Dual specificity mitogen-	yes	N/A	0.540	0.381	0.737	1e-67
Q8CE90	535	Dual specificity mitogen-	no	N/A	0.527	0.291	0.75	6e-67
Q23977	1178	Dual specificity mitogen-	yes	N/A	0.520	0.130	0.732	4e-65
Q07192	446	Dual specificity mitogen-	N/A	N/A	0.604	0.401	0.536	6e-52
P47809	397	Dual specificity mitogen-	no	N/A	0.655	0.488	0.5	9e-51
P45985	399	Dual specificity mitogen-	no	N/A	0.655	0.486	0.5	1e-50
Q9DGE0	361	Dual specificity mitogen-	no	N/A	0.533	0.437	0.537	2e-45
P46734	347	Dual specificity mitogen-	no	N/A	0.533	0.455	0.506	1e-43
O09110	347	Dual specificity mitogen-	no	N/A	0.533	0.455	0.506	3e-43

>sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2

 Score =  256 bits (655), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 118/160 (73%), Positives = 139/160 (86%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct: 190 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 249

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct: 250 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 309

Query: 128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF 167
           I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F
Sbjct: 310 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 349

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q4KSH7|MP2K7_RAT Dual specificity mitogen-activated protein kinase kinase 7 OS=Rattus norvegicus GN=Map2k7 PE=1 SV=1

 Score =  256 bits (655), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 118/160 (73%), Positives = 139/160 (86%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct: 190 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 249

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct: 250 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 309

Query: 128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF 167
           I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F
Sbjct: 310 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 349

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q8CE90|MP2K7_MOUSE Dual specificity mitogen-activated protein kinase kinase 7 OS=Mus musculus GN=Map2k7 PE=1 SV=1

 Score =  254 bits (648), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 117/156 (75%), Positives = 138/156 (88%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct: 206 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 265

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct: 266 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 325

Query: 128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           I+LVELATG+FPYK+CK DFEVL++VL + PP LP 
Sbjct: 326 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 361

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q23977|HEP_DROME Dual specificity mitogen-activated protein kinase kinase hemipterous OS=Drosophila melanogaster GN=hep PE=1 SV=2

 Score =  248 bits (633), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 115/157 (73%), Positives = 132/157 (84%), Gaps = 3/157 (1%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++ DVWICMELM+ CFD+LLK     VPE I GK+T++TV AL YLK+ HGVIHRDVKPS
Sbjct: 265 RDPDVWICMELMSMCFDKLLKLSKKPVPEQILGKVTVATVNALSYLKDKHGVIHRDVKPS 324

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL+DERGNIKLCDFGISGRLVDSKA T++AGCAAYMAPERI+   P+KP YDIRADVWS
Sbjct: 325 NILIDERGNIKLCDFGISGRLVDSKANTRSAGCAAYMAPERID---PKKPKYDIRADVWS 381

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP 162
           LGITLVELAT   PY+ C  DFEVL++VL+  PPCLP
Sbjct: 382 LGITLVELATARSPYEGCNTDFEVLTKVLDSEPPCLP 418

Required for the epithelial cell sheet movement called dorsal closure (DC), which allows establishment of the dorsal epidermis. Controls the expression in the dorsal epithelium edges of another dorsal closure gene, puckered (puc). Phosphorylates and activates the MAP kinase bsk; bsk signal transduction pathway mediates an immune response and morphogenesis.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q07192|MP2K2_XENLA Dual specificity mitogen-activated protein kinase kinase 2 (Fragment) OS=Xenopus laevis GN=map2k2 PE=1 SV=1

 Score =  204 bits (519), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 102/190 (53%), Positives = 130/190 (68%), Gaps = 11/190 (5%)

Query: 6   KESDVWICMELMATCFDRLLKRLHV----SVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +E D WICMELMAT FD+  K ++      +PE I GKITL+TVKAL++LKE   +IHRD
Sbjct: 217 REGDCWICMELMATSFDKFYKYVYSFLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 276

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+ P+  +  YD+R+
Sbjct: 277 IKPSNILLDTNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID-PSASRQGYDVRS 335

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN------DPLFGRTIKASI 175
           DVWSLGITL ELATG FPY      F+ L++V+   PP L N       P F   +   +
Sbjct: 336 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFTSFVNQCL 395

Query: 176 AKDNGRSTEF 185
            KD  +  ++
Sbjct: 396 TKDESKRPKY 405

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P47809|MP2K4_MOUSE Dual specificity mitogen-activated protein kinase kinase 4 OS=Mus musculus GN=Map2k4 PE=1 SV=2

 Score =  200 bits (509), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 107/214 (50%), Positives = 140/214 (65%), Gaps = 20/214 (9%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVS----VPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +E D WICMELM+T FD+  K ++      +PE I GKITL+TVKAL++LKE   +IHRD
Sbjct: 168 REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 227

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+ P+  +  YD+R+
Sbjct: 228 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID-PSASRQGYDVRS 286

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN------DPLFGRTIKASI 175
           DVWSLGITL ELATG FPY      F+ L++V+   PP L N       P F   +   +
Sbjct: 287 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL 346

Query: 176 AKDNGRSTEF--IRKR----SYEDKST---CYEC 200
            KD  +  ++  + K      YE+++    CY C
Sbjct: 347 TKDESKRPKYKELLKHPFILMYEERTVEVACYVC 380

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P45985|MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1

 Score =  200 bits (508), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 107/214 (50%), Positives = 140/214 (65%), Gaps = 20/214 (9%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVS----VPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +E D WICMELM+T FD+  K ++      +PE I GKITL+TVKAL++LKE   +IHRD
Sbjct: 170 REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 229

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+ P+  +  YD+R+
Sbjct: 230 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID-PSASRQGYDVRS 288

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN------DPLFGRTIKASI 175
           DVWSLGITL ELATG FPY      F+ L++V+   PP L N       P F   +   +
Sbjct: 289 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL 348

Query: 176 AKDNGRSTEF--IRKR----SYEDKST---CYEC 200
            KD  +  ++  + K      YE+++    CY C
Sbjct: 349 TKDESKRPKYKELLKHPFILMYEERAVEVACYVC 382

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9DGE0|MP2K6_DANRE Dual specificity mitogen-activated protein kinase kinase 6 OS=Danio rerio GN=map2k6 PE=1 SV=2

 Score =  182 bits (463), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 87/162 (53%), Positives = 114/162 (70%), Gaps = 4/162 (2%)

Query: 6   KESDVWICMELMATCFDRLLKRLH---VSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICMELM T  D+  K++H    ++PE I GKIT+S VKAL +L     VIHRDV
Sbjct: 148 REGDVWICMELMDTSLDKFYKQVHEKGKTIPEDILGKITVSIVKALEHLHSNLSVIHRDV 207

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L++ +G +K+CDFGISG LVDS A+T +AGC  YMAPERI P   QK  Y++++D
Sbjct: 208 KPSNVLINMQGQVKMCDFGISGYLVDSVAKTMDAGCKPYMAPERINPETNQK-GYNVKSD 266

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +WSLGIT++ELA   FPY      F+ L +V+ +  P LP D
Sbjct: 267 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 308

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Phosphorylation by MAP2K6 asymmetrically activates p38 on one side of the blastodisc, an event which is necessary for blastomere cleavage.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P46734|MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2

 Score =  176 bits (447), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 82/162 (50%), Positives = 116/162 (71%), Gaps = 4/162 (2%)

Query: 6   KESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICMELM T  D+  +++   ++++PE I G+I +S V+AL +L     VIHRDV
Sbjct: 132 REGDVWICMELMDTSLDKFYRKVLDKNMTIPEDILGEIAVSIVRALEHLHSKLSVIHRDV 191

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L+++ G++K+CDFGISG LVDS A+T +AGC  YMAPERI P   QK  Y++++D
Sbjct: 192 KPSNVLINKEGHVKMCDFGISGYLVDSVAKTMDAGCKPYMAPERINPELNQK-GYNVKSD 250

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           VWSLGIT++E+A   FPY+     F+ L +V+ +  P LP D
Sbjct: 251 VWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPAD 292

Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|O09110|MP2K3_MOUSE Dual specificity mitogen-activated protein kinase kinase 3 OS=Mus musculus GN=Map2k3 PE=1 SV=2

 Score =  175 bits (444), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 82/162 (50%), Positives = 115/162 (70%), Gaps = 4/162 (2%)

Query: 6   KESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICMELM T  D+  +++   ++ +PE I G+I +S V+AL +L     VIHRDV
Sbjct: 132 REGDVWICMELMDTSLDKFYRKVLEKNMKIPEDILGEIAVSIVRALEHLHSKLSVIHRDV 191

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L+++ G++K+CDFGISG LVDS A+T +AGC  YMAPERI P   QK  Y++++D
Sbjct: 192 KPSNVLINKEGHVKMCDFGISGYLVDSVAKTMDAGCKPYMAPERINPELNQK-GYNVKSD 250

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           VWSLGIT++E+A   FPY+     F+ L +V+ +  P LP D
Sbjct: 251 VWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPAD 292

Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	296
340711560	762	PREDICTED: dual specificity mitogen-acti	0.560	0.217	0.777	2e-73
350416005	762	PREDICTED: dual specificity mitogen-acti	0.574	0.223	0.758	2e-73
332019684	825	Dual specificity mitogen-activated prote	0.574	0.206	0.752	3e-73
383848442	773	PREDICTED: dual specificity mitogen-acti	0.574	0.219	0.752	5e-73
307202793	803	Dual specificity mitogen-activated prote	0.560	0.206	0.771	5e-73
383848440	763	PREDICTED: dual specificity mitogen-acti	0.574	0.222	0.752	5e-73
380029921	762	PREDICTED: dual specificity mitogen-acti	0.574	0.223	0.747	7e-73
242020398	772	dual specificity mitogen-activated prote	0.543	0.208	0.801	2e-72
48137940	762	PREDICTED: dual specificity mitogen-acti	0.574	0.223	0.747	2e-72
345479963	776	PREDICTED: dual specificity mitogen-acti	0.574	0.219	0.747	4e-72

>gi|340711560|ref|XP_003394343.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase hemipterous [Bombus terrestris]

 Score =  281 bits (720), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 129/166 (77%), Positives = 145/166 (87%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 169 ESDVWICMELMATCLDKLLKRTRQAMPEEFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 228

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERG +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 229 ILLDERGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 288

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIK 172
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D LF +  +
Sbjct: 289 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPPDALFSKEFR 334

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350416005|ref|XP_003490816.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase hemipterous-like [Bombus impatiens]

 Score =  281 bits (720), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 129/170 (75%), Positives = 147/170 (86%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 169 ESDVWICMELMATCLDKLLKRTRQAMPEEFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 228

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERG +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 229 ILLDERGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 288

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D LF +  +  ++
Sbjct: 289 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPPDVLFSKEFRNFVS 338

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332019684|gb|EGI60158.1| Dual specificity mitogen-activated protein kinase kinase 7 [Acromyrmex echinatior]

 Score =  281 bits (718), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 128/170 (75%), Positives = 147/170 (86%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 196 ESDVWICMELMATCLDKLLKRSRQAIPEDFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 255

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDE G +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 256 ILLDETGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 315

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D LF +  ++ ++
Sbjct: 316 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPADALFSKEFRSFVS 365

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383848442|ref|XP_003699859.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase hemipterous-like isoform 2 [Megachile rotundata]

 Score =  280 bits (717), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 128/170 (75%), Positives = 147/170 (86%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 179 ESDVWICMELMATCLDKLLKRTRQAMPEEFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 238

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERG +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 239 ILLDERGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 298

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D  F +  ++ ++
Sbjct: 299 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPPDAPFSKEFRSFVS 348

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307202793|gb|EFN82078.1| Dual specificity mitogen-activated protein kinase kinase 7 [Harpegnathos saltator]

 Score =  280 bits (716), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 128/166 (77%), Positives = 144/166 (86%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 188 ESDVWICMELMATCLDKLLKRSRQAIPEDFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 247

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDE G +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 248 ILLDESGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 307

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIK 172
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D LF +  +
Sbjct: 308 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPQDALFSKEFR 353

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383848440|ref|XP_003699858.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase hemipterous-like isoform 1 [Megachile rotundata]

 Score =  280 bits (716), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 128/170 (75%), Positives = 147/170 (86%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 169 ESDVWICMELMATCLDKLLKRTRQAMPEEFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 228

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERG +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 229 ILLDERGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 288

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D  F +  ++ ++
Sbjct: 289 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPPDAPFSKEFRSFVS 338

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380029921|ref|XP_003698612.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase hemipterous-like [Apis florea]

 Score =  280 bits (715), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 127/170 (74%), Positives = 147/170 (86%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLK+   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 169 ESDVWICMELMATCLDKLLKKTRQAMPEEFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 228

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERG +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 229 ILLDERGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 288

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP+D  F +  +  ++
Sbjct: 289 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPSDASFSKEFRNFVS 338

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242020398|ref|XP_002430642.1| dual specificity mitogen-activated protein kinase kinase, putative [Pediculus humanus corporis] gi|212515814|gb|EEB17904.1| dual specificity mitogen-activated protein kinase kinase, putative [Pediculus humanus corporis]

 Score =  278 bits (712), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 129/161 (80%), Positives = 142/161 (88%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATCFD+LLKRL +S+PE I GK+T +TVKAL YLKE HGVIHRDVKPSN
Sbjct: 185 ESDVWICMELMATCFDKLLKRLKISIPEDILGKVTYATVKALDYLKEKHGVIHRDVKPSN 244

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERGN+KLCDFGISGRLVDSK +T +AGCAAY+APERI P NP KPDYDIRADVWSL
Sbjct: 245 ILLDERGNVKLCDFGISGRLVDSKPQTTSAGCAAYLAPERIAPQNPSKPDYDIRADVWSL 304

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF 167
           GITLVELATGEFPYK+CK DFEVL+ V++  PP LP D  F
Sbjct: 305 GITLVELATGEFPYKNCKSDFEVLAEVVDGEPPKLPQDRNF 345

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|48137940|ref|XP_396834.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase hemipterous [Apis mellifera]

 Score =  278 bits (712), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 127/170 (74%), Positives = 146/170 (85%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELMATC D+LLK+   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 169 ESDVWICMELMATCLDKLLKKTRQAMPEEFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 228

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDERG +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 229 ILLDERGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 288

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP D  F +  +  ++
Sbjct: 289 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPPDASFSKEFRNFVS 338

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345479963|ref|XP_001604642.2| PREDICTED: dual specificity mitogen-activated protein kinase kinase 7-like isoform 1 [Nasonia vitripennis]

 Score =  277 bits (709), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 127/170 (74%), Positives = 146/170 (85%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ESDVWICMELM TC D+LLKR   ++PE   GK+T++TVKAL YLKE HGVIHRDVKPSN
Sbjct: 186 ESDVWICMELMVTCLDKLLKRSRQAIPEDFLGKVTVATVKALSYLKEKHGVIHRDVKPSN 245

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDE G +KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSL
Sbjct: 246 ILLDETGGVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 305

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
           GITLVELATG FPY+DCK DFEVLSRV+ D PP LP+D LF +  +  ++
Sbjct: 306 GITLVELATGVFPYRDCKTDFEVLSRVVQDDPPSLPSDALFSKEFQNFVS 355

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	296
UNIPROTKB|F1N664	497	F1N664 "Uncharacterized protei	0.574	0.342	0.707	1.4e-62
UNIPROTKB|F6WCX7	461	MAP2K7 "Dual-specificity mitog	0.574	0.368	0.707	1.4e-62
UNIPROTKB|O14733	419	MAP2K7 "Dual specificity mitog	0.574	0.405	0.707	1.4e-62
UNIPROTKB|F1SA79	536	MAP2K7 "Uncharacterized protei	0.574	0.317	0.707	1.4e-62
MGI|MGI:1346871	535	Map2k7 "mitogen-activated prot	0.574	0.317	0.707	1.4e-62
RGD|1560043	419	Map2k7 "mitogen activated prot	0.574	0.405	0.707	1.4e-62
UNIPROTKB|J9P3J3	435	MAP2K7 "Uncharacterized protei	0.574	0.390	0.707	1.8e-62
ZFIN|ZDB-GENE-090312-186	438	map2k7 "mitogen-activated prot	0.601	0.406	0.653	4.3e-61
FB|FBgn0010303	1178	hep "hemipterous" [Drosophila	0.520	0.130	0.732	8.5e-59
UNIPROTKB|A5PJP8	412	MAP2K4 "Uncharacterized protei	0.655	0.470	0.5	4.7e-48

UNIPROTKB|F1N664 F1N664 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   168 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 227

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   228 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 287

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   288 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 337

GO:0019903 "protein phosphatase binding" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0007257 "activation of JUN kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F6WCX7 MAP2K7 "Dual-specificity mitogen-activated protein kinase kinase 7" [Homo sapiens (taxid:9606)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   232 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 291

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   292 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 351

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   352 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 401

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|O14733 MAP2K7 "Dual specificity mitogen-activated protein kinase kinase 7" [Homo sapiens (taxid:9606)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   190 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 249

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   250 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 309

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   310 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 359

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=IEA

GO:0008545 "JUN kinase kinase activity" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0043525 "positive regulation of neuron apoptotic process" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0006950 "response to stress" evidence=IDA

GO:0000287 "magnesium ion binding" evidence=IDA

GO:0051403 "stress-activated MAPK cascade" evidence=IDA;TAS

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0007165 "signal transduction" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007254 "JNK cascade" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0007257 "activation of JUN kinase activity" evidence=ISS

GO:0019903 "protein phosphatase binding" evidence=ISS

UNIPROTKB|F1SA79 MAP2K7 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   206 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 265

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   266 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 325

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   326 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 375

GO:0019903 "protein phosphatase binding" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0007257 "activation of JUN kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1346871 Map2k7 "mitogen-activated protein kinase kinase 7" [Mus musculus (taxid:10090)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   206 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 265

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   266 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 325

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   326 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 375

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=ISO;IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006915 "apoptotic process" evidence=IEA

GO:0006950 "response to stress" evidence=ISO;IDA

GO:0007254 "JNK cascade" evidence=ISO

GO:0007257 "activation of JUN kinase activity" evidence=ISO;IDA

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008545 "JUN kinase kinase activity" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0019903 "protein phosphatase binding" evidence=IPI

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0051403 "stress-activated MAPK cascade" evidence=ISO;IDA

RGD|1560043 Map2k7 "mitogen activated protein kinase kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   190 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 249

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   250 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 309

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   310 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 359

GO:0000287 "magnesium ion binding" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA;IDA

GO:0005634 "nucleus" evidence=ISO;ISS;IDA

GO:0005737 "cytoplasm" evidence=ISO;ISS

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0006950 "response to stress" evidence=ISO;IDA

GO:0007254 "JNK cascade" evidence=IDA

GO:0007257 "activation of JUN kinase activity" evidence=ISO;IDA

GO:0008022 "protein C-terminus binding" evidence=IPI

GO:0008545 "JUN kinase kinase activity" evidence=IDA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0019903 "protein phosphatase binding" evidence=IEA;ISO

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IPI

GO:0043525 "positive regulation of neuron apoptotic process" evidence=IMP

GO:0051403 "stress-activated MAPK cascade" evidence=ISO;IDA

UNIPROTKB|J9P3J3 MAP2K7 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 638 (229.6 bits), Expect = 1.8e-62, P = 1.8e-62
 Identities = 121/171 (70%), Positives = 143/171 (83%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct:   206 TDVFIAMELMGTCAEKLKKRVQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 265

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLDERG IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   266 LLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 325

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F    + S  KD
Sbjct:   326 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ-SFVKD 375

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

ZFIN|ZDB-GENE-090312-186 map2k7 "mitogen-activated protein kinase kinase 7" [Danio rerio (taxid:7955)]

 Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
 Identities = 119/182 (65%), Positives = 146/182 (80%)

Query:     8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             +DV+I MELM TC ++L KR+   +PE I GK+T++ V AL YLKE HGVIHRDVKPSNI
Sbjct:   207 TDVFIAMELMGTCAEKLKKRIQGPIPEAILGKMTVAIVNALLYLKEKHGVIHRDVKPSNI 266

Query:    68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
             LLD +G IKLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct:   267 LLDAKGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPSKPDYDIRADVWSLG 326

Query:   128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND----PLFGRTIKASIAKDNGRST 183
             I+LVELATG+FPYK+CK DFEVL++VL + PP LP      P F   +K  + KD+ +  
Sbjct:   327 ISLVELATGQFPYKNCKTDFEVLTKVLQEDPPVLPLSMGFSPDFQSFVKDCLTKDHRKRP 386

Query:   184 EF 185
             ++
Sbjct:   387 KY 388

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0001756 "somitogenesis" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

FB|FBgn0010303 hep "hemipterous" [Drosophila melanogaster (taxid:7227)]

 Score = 613 (220.8 bits), Expect = 8.5e-59, P = 8.5e-59
 Identities = 115/157 (73%), Positives = 132/157 (84%)

Query:     6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
             ++ DVWICMELM+ CFD+LLK     VPE I GK+T++TV AL YLK+ HGVIHRDVKPS
Sbjct:   265 RDPDVWICMELMSMCFDKLLKLSKKPVPEQILGKVTVATVNALSYLKDKHGVIHRDVKPS 324

Query:    66 NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
             NIL+DERGNIKLCDFGISGRLVDSKA T++AGCAAYMAPERI+P   +KP YDIRADVWS
Sbjct:   325 NILIDERGNIKLCDFGISGRLVDSKANTRSAGCAAYMAPERIDP---KKPKYDIRADVWS 381

Query:   126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP 162
             LGITLVELAT   PY+ C  DFEVL++VL+  PPCLP
Sbjct:   382 LGITLVELATARSPYEGCNTDFEVLTKVLDSEPPCLP 418

GO:0007395 "dorsal closure, spreading of leading edge cells" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IDA

GO:0008545 "JUN kinase kinase activity" evidence=ISS;TAS

GO:0007254 "JNK cascade" evidence=TAS

GO:0007391 "dorsal closure" evidence=IMP;NAS;TAS

GO:0004708 "MAP kinase kinase activity" evidence=ISS;NAS;TAS

GO:0006468 "protein phosphorylation" evidence=NAS;TAS

GO:0006357 "regulation of transcription from RNA polymerase II promoter" evidence=NAS

GO:0030707 "ovarian follicle cell development" evidence=IMP;TAS

GO:0000165 "MAPK cascade" evidence=NAS

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0046529 "imaginal disc fusion, thorax closure" evidence=TAS

GO:0030381 "chorion-containing eggshell pattern formation" evidence=IMP

GO:0046844 "micropyle formation" evidence=IMP

GO:0046843 "dorsal appendage formation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0030032 "lamellipodium assembly" evidence=IMP

GO:0046847 "filopodium assembly" evidence=IMP

GO:0051017 "actin filament bundle assembly" evidence=IMP

GO:0001736 "establishment of planar polarity" evidence=NAS

GO:0008340 "determination of adult lifespan" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046528 "imaginal disc fusion" evidence=IMP

GO:0007561 "imaginal disc eversion" evidence=IMP

GO:0045610 "regulation of hemocyte differentiation" evidence=IMP

GO:0042060 "wound healing" evidence=IMP

GO:0043507 "positive regulation of JUN kinase activity" evidence=IMP

GO:0071276 "cellular response to cadmium ion" evidence=IMP

GO:0071243 "cellular response to arsenic-containing substance" evidence=IMP

GO:0046330 "positive regulation of JNK cascade" evidence=IMP

GO:0034769 "basement membrane disassembly" evidence=IMP

GO:0048675 "axon extension" evidence=IMP

GO:0035006 "melanization defense response" evidence=IMP

GO:0007298 "border follicle cell migration" evidence=IGI

GO:0033500 "carbohydrate homeostasis" evidence=IMP

GO:0070328 "triglyceride homeostasis" evidence=IMP

GO:0009408 "response to heat" evidence=IMP

GO:0030424 "axon" evidence=IDA

GO:0048666 "neuron development" evidence=IMP

UNIPROTKB|A5PJP8 MAP2K4 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 502 (181.8 bits), Expect = 4.7e-48, P = 4.7e-48
 Identities = 107/214 (50%), Positives = 140/214 (65%)

Query:     6 KESDVWICMELMATCFDRLLKRLHVS----VPEPICGKITLSTVKALHYLKETHGVIHRD 61
             +E D WICMELM+T FD+  K ++      +PE I GKITL+TVKAL++LKE   +IHRD
Sbjct:   183 REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 242

Query:    62 VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
             +KPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+P +  +  YD+R+
Sbjct:   243 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP-SASRQGYDVRS 301

Query:   122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND------PLFGRTIKASI 175
             DVWSLGITL ELATG FPY      F+ L++V+   PP L N       P F   +   +
Sbjct:   302 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL 361

Query:   176 AKDNGRSTEF--IRKRS----YEDKST---CYEC 200
              KD  +  ++  + K      YE+++    CY C
Sbjct:   362 TKDESKRPKYKELLKHPFILMYEERAVEVACYVC 395

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O14733	MP2K7_HUMAN	2, ., 7, ., 1, 2, ., 2	0.7375	0.5405	0.3818	yes	N/A
Q4KSH7	MP2K7_RAT	2, ., 7, ., 1, 2, ., 2	0.7375	0.5405	0.3818	yes	N/A
Q23977	HEP_DROME	2, ., 7, ., 1, 2, ., 2	0.7324	0.5202	0.1307	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	296
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-108
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-80
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-76
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-75
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-47
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-43
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-42
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-37
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-36
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-35
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-34
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-32
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-20
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-19
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-12
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-12
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-04
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	7e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	0.001
TIGR01982	437	TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase	0.001
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.002
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.003
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.004

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  315 bits (810), Expect = e-108
 Identities = 120/176 (68%), Positives = 146/176 (82%), Gaps = 5/176 (2%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +SDV+ICMELM+TC D+LLKR+   +PE I GK+T++ VKALHYLKE HGVIHRDVKPSN
Sbjct: 86  DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLD  GN+KLCDFGISGRLVDSKA+T++AGCAAYMAPERI+PP+P  P YDIRADVWSL
Sbjct: 146 ILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSL 204

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND----PLFGRTIKASIAKD 178
           GI+LVELATG+FPYK+CK +FEVL+++L + PP LP +    P F   +   + KD
Sbjct: 205 GISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKD 260

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  244 bits (626), Expect = 1e-80
 Identities = 94/170 (55%), Positives = 117/170 (68%), Gaps = 6/170 (3%)

Query: 6   KESDVWICMELMATCFDRLLKRLH----VSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +E D WICMELM    D+  K ++      +PE I GKI ++TVKAL+YLKE   +IHRD
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           VKPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+P       YD+R+
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG--YDVRS 191

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTI 171
           DVWSLGITL E+ATG+FPY      F+ L++V+   PP L N      + 
Sbjct: 192 DVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  233 bits (597), Expect = 3e-76
 Identities = 90/163 (55%), Positives = 116/163 (71%), Gaps = 4/163 (2%)

Query: 6   KESDVWICMELMATCFDRLLKRLH---VSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICME+M T  D+  K+++   +++PE I GKI +S VKAL YL     VIHRDV
Sbjct: 71  REGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L++  G +KLCDFGISG LVDS A+T +AGC  YMAPERI P   QK  YD+++D
Sbjct: 131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK-GYDVKSD 189

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           VWSLGIT++ELATG FPY   K  F+ L +V+ +  P LP + 
Sbjct: 190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  230 bits (588), Expect = 5e-75
 Identities = 80/164 (48%), Positives = 110/164 (67%), Gaps = 11/164 (6%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
             D+ ICME M     D++LK +   +PE I GKI ++ +K L YL E H +IHRDVKPS
Sbjct: 71  NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS 130

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+LV+S A+T   G ++YMAPERI+       DY +++D+WS
Sbjct: 131 NILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQG-----NDYSVKSDIWS 184

Query: 126 LGITLVELATGEFPYKDC----KCDFEVLSRVLNDAPPCLPNDP 165
           LG++L+ELATG FPY          FE+L  ++N+ PP LP+  
Sbjct: 185 LGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK 228

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  160 bits (407), Expect = 1e-47
 Identities = 70/169 (41%), Positives = 105/169 (62%), Gaps = 18/169 (10%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+++ +CME M     DR+ K+    +P  I GKI ++ V+ L YL   H ++HRD+KPS
Sbjct: 75  ENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPS 133

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG L++S A T   G + YM+PERI     Q   Y +++DVWS
Sbjct: 134 NILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPERI-----QGGKYTVKSDVWS 187

Query: 126 LGITLVELATGEFPYKDCKCD----------FEVLSRVLNDAPPCLPND 164
           LGI+++ELA G+FP+     D           ++L +++ + PP LP+ 
Sbjct: 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  157 bits (398), Expect = 2e-46
 Identities = 75/164 (45%), Positives = 106/164 (64%), Gaps = 7/164 (4%)

Query: 7   ESDVWICMELM-ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E  V++CME M A   D+L         +PE +  +IT + VK L +LKE H +IHRDVK
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK 130

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
           P+N+L++  G +KLCDFG+SG LV S A+T N GC +YMAPERI+   P Q P Y +++D
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGPNQNPTYTVQSD 189

Query: 123 VWSLGITLVELATGEFPYKDCKCD--FEVLSRVLNDAPPCLPND 164
           VWSLG++++E+A G +PY        F  LS +++  PP LP+ 
Sbjct: 190 VWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  149 bits (378), Expect = 1e-43
 Identities = 64/159 (40%), Positives = 90/159 (56%), Gaps = 8/159 (5%)

Query: 6   KESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           K+ ++WI ME         LLK  + ++ E     +    +K L YL   +G+IHRD+K 
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKA 126

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NILL   G +KL DFG+S +L D+KAR    G   +MAPE I      KP YD +AD+W
Sbjct: 127 ANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN----GKP-YDYKADIW 181

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           SLGIT +ELA G+ PY +     + L ++  + PP L N
Sbjct: 182 SLGITAIELAEGKPPYSELP-PMKALFKIATNGPPGLRN 219

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  147 bits (374), Expect = 4e-43
 Identities = 61/184 (33%), Positives = 84/184 (45%), Gaps = 21/184 (11%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME       FD L KR    + E          + AL YL    G++HRD+KP
Sbjct: 69  EDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHS-KGIVHRDLKP 125

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            NILLDE G++KL DFG++ +L   +  T   G   YMAPE +         Y    D+W
Sbjct: 126 ENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL-----LGKGYGKAVDIW 180

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTE 184
           SLG+ L EL TG+ P+       E+  ++    PP  P +           AKD      
Sbjct: 181 SLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPE-----AKD------ 229

Query: 185 FIRK 188
            IRK
Sbjct: 230 LIRK 233

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  148 bits (375), Expect = 9e-43
 Identities = 63/132 (47%), Positives = 94/132 (71%), Gaps = 8/132 (6%)

Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++ ICME M     D++LK+    +PE I GKI+++ ++ L YL+E H ++HRDVKPSNI
Sbjct: 73  EISICMEHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI 131

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           L++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WSLG
Sbjct: 132 LVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYTVQSDIWSLG 185

Query: 128 ITLVELATGEFP 139
           ++LVE+A G +P
Sbjct: 186 LSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  145 bits (367), Expect = 7e-42
 Identities = 70/200 (35%), Positives = 103/200 (51%), Gaps = 21/200 (10%)

Query: 6   KESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           KE ++ I +E M       LLK+    +PEP+   I    +K L YL     +IHRD+KP
Sbjct: 70  KEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKP 128

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADV 123
           SN+L++ +G +K+ DFGIS  L ++  +     G   YM+PERI     +   Y   AD+
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI---QGESYSYA--ADI 183

Query: 124 WSLGITLVELATGEFPYK--DCKCDFEVLSRVLNDAPPCLPND---PLFGRTIKASIAKD 178
           WSLG+TL+E A G+FP+        FE++  + +  PP LP +   P F   I A + KD
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKD 243

Query: 179 -NGRST-------EFIRKRS 190
              R +        FI+K  
Sbjct: 244 PKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  142 bits (360), Expect = 9e-41
 Identities = 70/168 (41%), Positives = 94/168 (55%), Gaps = 15/168 (8%)

Query: 6   KESDVWICMELM-ATCFDRLLKRLHVS---VPEPICGKITLSTVKALHYLKETHGVIHRD 61
             S + I ME       D + K++      + E + GKI  S +K L YL     +IHRD
Sbjct: 72  SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-IIHRD 130

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNILL  +G +KLCDFG+SG LV+S A T   G + YMAPERI     Q   Y I +
Sbjct: 131 IKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERI-----QGKPYSITS 184

Query: 122 DVWSLGITLVELATGEFPYKDCKCD----FEVLSRVLNDAPPCLPNDP 165
           DVWSLG+TL+E+A   FP+           E+LS ++N   P L ++P
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  133 bits (337), Expect = 1e-37
 Identities = 52/141 (36%), Positives = 75/141 (53%), Gaps = 10/141 (7%)

Query: 7   ESDVWICMELMATC--FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +  +++ ME       FD L +     + E    KI L  ++ L YL   +G+IHRD+KP
Sbjct: 70  KDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHS-NGIIHRDLKP 126

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADV 123
            NILLDE G +K+ DFG++ +L+ S +      G   YMAPE +   N     Y  + DV
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG----YGPKVDV 182

Query: 124 WSLGITLVELATGEFPYKDCK 144
           WSLG+ L EL TG+ P+    
Sbjct: 183 WSLGVILYELLTGKPPFSGEN 203

Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  133 bits (335), Expect = 3e-37
 Identities = 68/162 (41%), Positives = 98/162 (60%), Gaps = 17/162 (10%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           E+ + IC E M    D     ++  +PE + G+I ++ VK L YL     ++HRDVKPSN
Sbjct: 71  ENRISICTEFM----DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK-ILHRDVKPSN 125

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           +L++ RG +KLCDFG+S +LV+S A+T   G  AYMAPERI         Y I +DVWSL
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNSIAKTY-VGTNAYMAPERI-----SGEQYGIHSDVWSL 179

Query: 127 GITLVELATGEFPYKDCKCD------FEVLSRVLNDAPPCLP 162
           GI+ +ELA G FPY   + +       ++L  ++++ PP LP
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  130 bits (329), Expect = 2e-36
 Identities = 59/162 (36%), Positives = 80/162 (49%), Gaps = 14/162 (8%)

Query: 11  WICMELMA--TCFDRLLKRLHVSV-PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           W+ M  ++  +  D +          E I   +    +K L YL  ++G IHRD+K  NI
Sbjct: 75  WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL-HSNGQIHRDIKAGNI 133

Query: 68  LLDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           LL E G++K+ DFG+S  L D      K R    G   +MAPE +E    Q   YD +AD
Sbjct: 134 LLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME----QVHGYDFKAD 189

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +WS GIT +ELATG  PY       +VL   L + PP L   
Sbjct: 190 IWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETG 230

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  130 bits (327), Expect = 2e-35
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 75  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 187

Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 188 MGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  129 bits (324), Expect = 4e-35
 Identities = 62/134 (46%), Positives = 94/134 (70%), Gaps = 8/134 (5%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK     +PE I GK++++ ++ L YL+E H ++HRDVKPS
Sbjct: 75  DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 133

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 187

Query: 126 LGITLVELATGEFP 139
           +G++LVELA G +P
Sbjct: 188 MGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  123 bits (311), Expect = 9e-34
 Identities = 58/139 (41%), Positives = 82/139 (58%), Gaps = 8/139 (5%)

Query: 6   KESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           K +D+WI ME   A     ++K  + ++ E     I   T+K L YL  ++  IHRD+K 
Sbjct: 69  KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL-HSNKKIHRDIKA 127

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADV 123
            NILL+E G  KL DFG+SG+L D+ A+     G   +MAPE I     Q+  Y+ +AD+
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI-----QEIGYNNKADI 182

Query: 124 WSLGITLVELATGEFPYKD 142
           WSLGIT +E+A G+ PY D
Sbjct: 183 WSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 8e-32
 Identities = 73/198 (36%), Positives = 100/198 (50%), Gaps = 26/198 (13%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           K S +WI ME     +C D LLK     + E     I    +  L YL E  G IHRD+K
Sbjct: 70  KGSKLWIIMEYCGGGSCLD-LLKP--GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIK 125

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRAD 122
            +NILL E G++KL DFG+SG+L  + ++     G   +MAPE I     ++  YD +AD
Sbjct: 126 AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI-----KQSGYDEKAD 180

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA----KD 178
           +WSLGIT +ELA GE P  D      VL  +  + PP L     F +  K  ++    KD
Sbjct: 181 IWSLGITAIELAKGEPPLSD-LHPMRVLFLIPKNNPPSLE-GNKFSKPFKDFVSLCLNKD 238

Query: 179 -NGRST-------EFIRK 188
              R +       +FI+K
Sbjct: 239 PKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  115 bits (290), Expect = 3e-31
 Identities = 52/131 (39%), Positives = 71/131 (54%), Gaps = 10/131 (7%)

Query: 7   ESDVWICMELMATC--FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E+ +++ ME        D LLK     + E    +I L  ++ L YL   +G+IHRD+KP
Sbjct: 63  ENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKP 120

Query: 65  SNILLDER-GNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRAD 122
            NILLD   G +KL DFG+S  L   K+  K   G  AYMAPE +      K  Y  ++D
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL----GKGYYSEKSD 176

Query: 123 VWSLGITLVEL 133
           +WSLG+ L EL
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-29
 Identities = 58/148 (39%), Positives = 77/148 (52%), Gaps = 10/148 (6%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHG 56
           +P   +  +W+ MEL    +  D L+K L      + E     I   T++ L YL E   
Sbjct: 76  NPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK- 133

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAPERIEPPNPQK 114
           VIHRD+K  NILL +   +KL DFG+S   +DS    +N   G   +MAPE I       
Sbjct: 134 VIHRDIKGQNILLTKNAEVKLVDFGVS-AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD 192

Query: 115 PDYDIRADVWSLGITLVELATGEFPYKD 142
             YD R+DVWSLGIT +ELA G+ P  D
Sbjct: 193 ASYDARSDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 2e-29
 Identities = 65/189 (34%), Positives = 93/189 (49%), Gaps = 28/189 (14%)

Query: 6   KESDVWICMELMATC----FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +   +WI ME    C       + +     + E     +   T+K L YL ET G IHRD
Sbjct: 71  RRDKLWIVMEY---CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET-GKIHRD 126

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIR 120
           +K +NILL E G++KL DFG+S +L  + A+ K+  G   +MAPE       +K  YD +
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA--VERKGGYDGK 184

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEV-LSRVL------NDAPPCLPN----DPLFGR 169
            D+W+LGIT +ELA  + P       F++   R L      N  PP L +     P+F  
Sbjct: 185 CDIWALGITAIELAELQPPM------FDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238

Query: 170 TIKASIAKD 178
            IK  + KD
Sbjct: 239 FIKKCLTKD 247

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 8e-29
 Identities = 59/157 (37%), Positives = 83/157 (52%), Gaps = 10/157 (6%)

Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           +WI ME       R L +    + E     I    + AL Y+ +  GVIHRD+K +NIL+
Sbjct: 77  LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILV 134

Query: 70  DERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
              GN+KLCDFG++  L  +S  R+   G   +MAPE I     +   YD +AD+WSLGI
Sbjct: 135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT----EGKYYDTKADIWSLGI 190

Query: 129 TLVELATGEFPYKDCKCD-FEVLSRVLNDAPPCLPND 164
           T+ E+ATG  PY     D F  +  +    PP L ++
Sbjct: 191 TIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDN 225

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (274), Expect = 2e-28
 Identities = 49/138 (35%), Positives = 76/138 (55%), Gaps = 10/138 (7%)

Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-- 88
            +PEP+  K T   ++ L YL   +G++HRD+K +NIL+D  G +KL DFG + RL D  
Sbjct: 97  KLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155

Query: 89  -SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF 147
             +      G   +MAPE I     +  +Y   AD+WSLG T++E+ATG+ P+ +     
Sbjct: 156 TGEGTGSVRGTPYWMAPEVI-----RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM 210

Query: 148 EVLSRVLN-DAPPCLPND 164
             L ++ +   PP +P  
Sbjct: 211 AALYKIGSSGEPPEIPEH 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (267), Expect = 4e-27
 Identities = 49/136 (36%), Positives = 74/136 (54%), Gaps = 8/136 (5%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
             ++W+ ME M       ++ +  V + EP    +    ++ L YL  +  VIHRD+K  
Sbjct: 87  GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL-HSQNVIHRDIKSD 145

Query: 66  NILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NILL + G++KL DFG + +L   K+ R    G   +MAPE I     ++ DY  + D+W
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI-----KRKDYGPKVDIW 200

Query: 125 SLGITLVELATGEFPY 140
           SLGI  +E+A GE PY
Sbjct: 201 SLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 8e-26
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 10/156 (6%)

Query: 11  WICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           +I +E        +++K+     PE +        ++ L YL E  GVIHRD+K +NIL 
Sbjct: 75  YIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILT 132

Query: 70  DERGNIKLCDFGISGRLVDSKARTKNAGCAAY-MAPERIEPPNPQKPDYDIRADVWSLGI 128
            + G +KL DFG++ +L D      +     Y MAPE IE            +D+WSLG 
Sbjct: 133 TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-----STASDIWSLGC 187

Query: 129 TLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           T++EL TG  PY D       L R++ D  P LP  
Sbjct: 188 TVIELLTGNPPYYDLN-PMAALFRIVQDDHPPLPEG 222

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (253), Expect = 3e-25
 Identities = 58/167 (34%), Positives = 85/167 (50%), Gaps = 18/167 (10%)

Query: 8   SDVWICMELMATC----FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
             V+I ME    C     + LL      + E +    TL  ++ L YL   HG++HRD+K
Sbjct: 72  EKVYIFMEY---CSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIK 126

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKN-----AGCAAYMAPERIEPPNPQKPDYD 118
           P+NI LD  G IKL DFG + +L ++           AG  AYMAPE I      K    
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI---TGGKGKGH 183

Query: 119 IRA-DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
            RA D+WSLG  ++E+ATG+ P+ +   +F+++  V     P +P+ 
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDS 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 4e-25
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 4/173 (2%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +WI +E       D ++  L   + EP    +    ++AL++L   H VIHRD+K  
Sbjct: 74  ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAG 132

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NILL   G++KL DFG+S +   +  +     G   +MAPE +     +   YD +AD+W
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIW 192

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           SLGITL+ELA  E P+ +      VL ++L   PP L     +  +    +  
Sbjct: 193 SLGITLIELAQMEPPHHELN-PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 5e-25
 Identities = 42/99 (42%), Positives = 55/99 (55%), Gaps = 7/99 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL    G+I+RD+KP NILLD  G+IKL DFG++  L    +RT    G   Y+A
Sbjct: 103 VLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLA 161

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           PE +         Y    D WSLG+ L E+ TG+ P+  
Sbjct: 162 PEVL-----LGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 98.5 bits (246), Expect = 2e-24
 Identities = 40/97 (41%), Positives = 56/97 (57%), Gaps = 6/97 (6%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           V AL YL    G+IHRD+KP NILLDE+G++ + DF I+ ++      T  +G   YMAP
Sbjct: 110 VLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           E +      +  Y +  D WSLG+T  E   G+ PY+
Sbjct: 169 EVL-----CRQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 99.0 bits (245), Expect = 1e-23
 Identities = 56/173 (32%), Positives = 81/173 (46%), Gaps = 17/173 (9%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLH--VSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E  +++ ME +     + LLK++     + E     I    + AL YL    G+IHRD+K
Sbjct: 70  EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIK 128

Query: 64  PSNILLDERGN-IKLCDFGISGRLVDSKARTKNA-------GCAAYMAPERIEPPNPQKP 115
           P NILLD  G  +KL DFG++  L D  + +          G   YMAPE +   +    
Sbjct: 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY- 187

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLNDAPPCLPNDP 165
                +D+WSLGITL EL TG  P++  K      + L  +L    P L +  
Sbjct: 188 -ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Length = 384

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.7 bits (240), Expect = 2e-23
 Identities = 62/159 (38%), Positives = 89/159 (55%), Gaps = 13/159 (8%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           K + +WI ME +   +  D LLK     + E     I    +K L YL  +   IHRD+K
Sbjct: 73  KGTKLWIIMEYLGGGSALD-LLKP--GPLEETYIATILREILKGLDYL-HSERKIHRDIK 128

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            +N+LL E+G++KL DFG++G+L D++  R    G   +MAPE I     ++  YD +AD
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDFKAD 183

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           +WSLGIT +ELA GE P  D      VL  +  ++PP L
Sbjct: 184 IWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNSPPTL 221

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 94.1 bits (235), Expect = 9e-23
 Identities = 43/117 (36%), Positives = 61/117 (52%), Gaps = 11/117 (9%)

Query: 26  KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR 85
           K+     PE       +    AL YL     ++HRD+KP NI L   G +KL DFGIS +
Sbjct: 94  KKEGKPFPEEQILDWFVQLCLALKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGIS-K 151

Query: 86  LVDS---KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFP 139
           ++ S    A+T   G   Y++PE  +     KP Y+ ++D+WSLG  L EL T + P
Sbjct: 152 VLSSTVDLAKTV-VGTPYYLSPELCQ----NKP-YNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 93.3 bits (232), Expect = 3e-22
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 13/158 (8%)

Query: 9   DVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ++W+ ME +      D +    H  + E     + L+ +KAL +L    GVIHRD+K  +
Sbjct: 90  ELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLAVLKALSFL-HAQGVIHRDIKSDS 145

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           ILL   G +KL DFG   ++     R K+  G   +MAPE I     + P Y    D+WS
Sbjct: 146 ILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS----RLP-YGTEVDIWS 200

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           LGI ++E+  GE PY + +   + + R+ ++ PP L N
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKN 237

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.4 bits (229), Expect = 7e-22
 Identities = 58/157 (36%), Positives = 86/157 (54%), Gaps = 4/157 (2%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+++WI +E  A    D ++  L   + EP    +   T++AL+YL E   +IHRD+K  
Sbjct: 74  ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK-IIHRDLKAG 132

Query: 66  NILLDERGNIKLCDFGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NIL    G+IKL DFG+S +   + + R    G   +MAPE +     +   YD +ADVW
Sbjct: 133 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 192

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           SLGITL+E+A  E P+ +      VL ++    PP L
Sbjct: 193 SLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTL 228

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.7 bits (228), Expect = 8e-22
 Identities = 49/141 (34%), Positives = 78/141 (55%), Gaps = 7/141 (4%)

Query: 4   QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           + +E +++I +EL+      +LLK+   S PEP+    T   +  L YL      +HRD+
Sbjct: 71  EREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL-HDRNTVHRDI 128

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           K +NIL+D  G +KL DFG++ ++V+        G   +MAPE I         Y + AD
Sbjct: 129 KGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG----YGLAAD 184

Query: 123 VWSLGITLVELATGEFPYKDC 143
           +WSLG T++E+ATG+ P+   
Sbjct: 185 IWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 91.7 bits (227), Expect = 1e-21
 Identities = 54/129 (41%), Positives = 76/129 (58%), Gaps = 10/129 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMA 103
           +K L YL  +   IHRD+K +N+LL E+G++KL DFG++G+L D++  R    G   +MA
Sbjct: 111 LKGLDYL-HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           PE I     Q+  YD +AD+WSLGIT +ELA GE P  D      VL  +  + PP L  
Sbjct: 170 PEVI-----QQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNNPPTLTG 223

Query: 164 DPLFGRTIK 172
           +  F +  K
Sbjct: 224 E--FSKPFK 230

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 90.3 bits (224), Expect = 3e-21
 Identities = 48/141 (34%), Positives = 78/141 (55%), Gaps = 14/141 (9%)

Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---- 86
           +  E +        +K L+YL    G+IHRD+K +NIL+D +G IK+ DFGIS +L    
Sbjct: 102 AFEETLVRNFVRQILKGLNYL-HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160

Query: 87  ---VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                + AR    G   +MAPE +     ++  Y  +AD+WSLG  +VE+ TG+ P+ DC
Sbjct: 161 LSTKTNGARPSLQGSVFWMAPEVV-----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Query: 144 KCDFEVLSRVLNDAPPCLPND 164
               + + ++  +A P +P++
Sbjct: 216 T-QLQAIFKIGENASPEIPSN 235

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.4 bits (221), Expect = 8e-21
 Identities = 59/161 (36%), Positives = 87/161 (54%), Gaps = 17/161 (10%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPI----CGKITLSTVKALHYLKETHGVIHRD 61
           K++ +WI ME +          L +  P P+       I    +K L YL  +   IHRD
Sbjct: 73  KDTKLWIIMEYLGGG-----SALDLLEPGPLDETQIATILREILKGLDYL-HSEKKIHRD 126

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +K +N+LL E G +KL DFG++G+L D++  R    G   +MAPE I     ++  YD +
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDSK 181

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           AD+WSLGIT +ELA GE P+ +     +VL  +  + PP L
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELH-PMKVLFLIPKNNPPTL 221

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.3 bits (221), Expect = 1e-20
 Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 4/157 (2%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +  +WI +E       D ++  L   + EP    I    ++AL YL  +  +IHRD+K  
Sbjct: 81  DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL-HSMKIIHRDLKAG 139

Query: 66  NILLDERGNIKLCDFGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+LL   G+IKL DFG+S + V + + R    G   +MAPE +     +   YD +AD+W
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 199

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           SLGITL+E+A  E P+ +      VL ++    PP L
Sbjct: 200 SLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTL 235

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 48/130 (36%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 14  MELMATC--FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE 71
           ME       +  L  R      E          V A  YL    G+I+RD+KP N+LLD 
Sbjct: 72  MEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS 128

Query: 72  RGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITL 130
            G +KL DFG + + + S  +T    G   Y+APE I      K  YD   D WSLGI L
Sbjct: 129 NGYVKLVDFGFA-KKLKSGQKTWTFCGTPEYVAPEIIL----NK-GYDFSVDYWSLGILL 182

Query: 131 VELATGEFPY 140
            EL TG  P+
Sbjct: 183 YELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 88.1 bits (218), Expect = 3e-20
 Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 7/159 (4%)

Query: 10  VWICMELM----ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +W+ +EL      T   + L      + E +   I    +  L +L     +IHRDVK +
Sbjct: 99  LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGN 157

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NILL   G +KL DFG+S +L  ++ R   + G   +MAPE I         YD R DVW
Sbjct: 158 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           SLGIT +EL  G+ P  D     + L ++  + PP L +
Sbjct: 218 SLGITAIELGDGDPPLFDMH-PVKTLFKIPRNPPPTLLH 255

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 86.0 bits (214), Expect = 1e-19
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 21/171 (12%)

Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLS----TVKALHYLKETHGVIHR 60
           ++   ++I  E M      LL  L     E +  K  L       K + YL E+   +HR
Sbjct: 71  TQGEPLYIVTEYM--PGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYL-ESKNFVHR 126

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA----AYMAPERIEPPNPQKPD 116
           D+   N L+ E   +K+ DFG+S R +      +  G       +MAPE +     +   
Sbjct: 127 DLAARNCLVTENLVVKISDFGLS-RDIYEDDYYRKRGGGKLPIKWMAPESL-----KDGK 180

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           +  ++DVWS G+ L E+ T GE PY     + EVL  + +    P   N P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLEDGYRLPRPENCP 230

Length = 258

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 56/150 (37%), Positives = 73/150 (48%), Gaps = 7/150 (4%)

Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-AR 92
           EPI   I    +  L +L      IHRDVK +NILL   G +KL DFG+S +L  ++  R
Sbjct: 123 EPIIAYILHEALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 93  TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR 152
             + G   +MAPE I         YD R DVWSLGIT +EL  G+ P  D       L +
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFK 240

Query: 153 VLNDAPPCLPNDPL----FGRTIKASIAKD 178
           +  + PP L    L    F   I+  + KD
Sbjct: 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKD 270

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 42/121 (34%), Positives = 55/121 (45%), Gaps = 15/121 (12%)

Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS------- 83
           S+ E +        V AL YL   +G+IHRD+KP NIL+D  G++KL DFG+S       
Sbjct: 89  SLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147

Query: 84  --GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
                 D K   +  G   Y+APE I         +    D WSLG  L E   G  P+ 
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVIL-----GQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Query: 142 D 142
            
Sbjct: 203 G 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 84.9 bits (211), Expect = 3e-19
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 14/167 (8%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           ++E  ++I ME M        L++    +         L   + + YL E+   IHRD+ 
Sbjct: 71  TEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL-ESKNFIHRDLA 129

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDIR 120
             N L+ E   +K+ DFG+S R +      +  G      +MAPE +     ++  +  +
Sbjct: 130 ARNCLVGENLVVKISDFGLS-RDLYDDDYYRKRGGKLPIRWMAPESL-----KEGKFTSK 183

Query: 121 ADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND-APPCLPNDP 165
           +DVWS G+ L E+ T GE PY     + EVL  + N    P  PN P
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLKNGYRLPQPPNCP 229

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 84.1 bits (209), Expect = 4e-19
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 19/170 (11%)

Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E  + I ME M      LL  L  + P+ +     LS      + + YL E+   IHR
Sbjct: 71  TEEEPLMIVMEYM--PGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL-ESKNFIHR 127

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S R +      K  G      +MAPE +     ++  +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLS-RDLYDDDYYKVKGGKLPIRWMAPESL-----KEGKF 181

Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
             ++DVWS G+ L E+ T GE PY     + EVL  +      P  PN P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLKKGYRLPKPPNCP 230

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 84.2 bits (209), Expect = 4e-19
 Identities = 39/120 (32%), Positives = 60/120 (50%), Gaps = 10/120 (8%)

Query: 26  KRLHVSVPEPICGKITLSTVKALHY----LKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           K+    + E    +I    + AL+         + V+HRD+KP+NI LD   N+KL DFG
Sbjct: 96  KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155

Query: 82  ISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           ++  L    +  K   G   YM+PE++   N     YD ++D+WSLG  + EL     P+
Sbjct: 156 LAKILGHDSSFAKTYVGTPYYMSPEQL---NHMS--YDEKSDIWSLGCLIYELCALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 4e-19
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 22/163 (13%)

Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME M   +  D+L  + + ++ E +  K T   ++ + YL  ++ ++HRD+K +NIL 
Sbjct: 81  IFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYL-HSNMIVHRDIKGANILR 137

Query: 70  DERGNIKLCDFGISGRLVDSKARTKNA----GCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           D  GN+KL DFG S RL    +         G   +M+PE I         Y  +ADVWS
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-----YGRKADVWS 192

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAP----PCLPND 164
           +G T+VE+ T + P+     +FE ++ +   A     P LP+ 
Sbjct: 193 VGCTVVEMLTEKPPWA----EFEAMAAIFKIATQPTNPQLPSH 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 28/160 (17%)

Query: 27  RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG----- 81
           R + S+ E          + AL YL  + G+IHRD+KP NILLD+  +IK+ DFG     
Sbjct: 94  RKYGSLDEKCTRFYAAEILLALEYL-HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152

Query: 82  ---------------ISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
                          I  ++  ++ R  +  G A Y++PE +   N +       +D+W+
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL---NEKPAGKS--SDLWA 207

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           LG  + ++ TG+ P++    ++    ++L       PN P
Sbjct: 208 LGCIIYQMLTGKPPFRG-SNEYLTFQKILKLEYSFPPNFP 246

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.9 bits (208), Expect = 9e-19
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 14/152 (9%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           S   + ME M +    +L+     +PE          +K + Y+    G++HRD+KP+N+
Sbjct: 72  SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANL 130

Query: 68  LLDERGNIKLCDFGISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L+   G +K+ DFG++ RL   +     +       Y APE +         YD   D+W
Sbjct: 131 LISADGVLKIADFGLA-RLFSEEEPRLYSHQVATRWYRAPELLY----GARKYDPGVDLW 185

Query: 125 SLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
           ++G    EL  G   FP ++   D E L+ V 
Sbjct: 186 AVGCIFAELLNGSPLFPGEN---DIEQLAIVF 214

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 13/152 (8%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           + D+++  E M T   +L+K     +PE +        ++ L +   +HG++HRD+KP N
Sbjct: 70  KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC-HSHGILHRDLKPEN 128

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVW 124
           +L++  G +KL DFG++ R   S  R          Y APE +         Y    D+W
Sbjct: 129 LLINTEGVLKLADFGLA-RSFGSPVRPYTHYVVTRWYRAPELLL----GDKGYSTPVDIW 183

Query: 125 SLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
           S+G    EL +    FP K    + + L ++ 
Sbjct: 184 SVGCIFAELLSRRPLFPGKS---EIDQLFKIF 212

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 50/135 (37%), Positives = 66/135 (48%), Gaps = 6/135 (4%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +E   W+ ME        +L+     + E     I    ++ L YL  +H  IHRD+K  
Sbjct: 86  REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYL-HSHERIHRDIKAG 144

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NILL E G +KL DFG S  LV         G   +MAPE I   +  +  YD + DVWS
Sbjct: 145 NILLTEPGTVKLADFG-SASLVSPA--NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWS 199

Query: 126 LGITLVELATGEFPY 140
           LGIT +ELA  + P 
Sbjct: 200 LGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 50/144 (34%), Positives = 71/144 (49%), Gaps = 4/144 (2%)

Query: 2   SPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           SP   +  +W+ ME     +  D +      ++ E     I    ++ L +L   H VIH
Sbjct: 86  SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL-HAHKVIH 144

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYD 118
           RD+K  N+LL E   +KL DFG+S +L  +  R     G   +MAPE I         YD
Sbjct: 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 204

Query: 119 IRADVWSLGITLVELATGEFPYKD 142
            R+D+WSLGIT +E+A G  P  D
Sbjct: 205 YRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 81.8 bits (203), Expect = 4e-18
 Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 22/166 (13%)

Query: 5   SKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETH 55
           ++E  +++ +E M        L++     P P    ++L  +        K + YL  + 
Sbjct: 66  TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL-ASK 124

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPERIEPPN 111
             +HRD+   N L+ E   +K+ DFG+S R V      +          +MAPE ++   
Sbjct: 125 KFVHRDLAARNCLVGEDLVVKISDFGLS-RDVYDDDYYRKKTGGKLPIRWMAPESLK--- 180

Query: 112 PQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND 156
                +  ++DVWS G+ L E+ T G  PY     + EVL  +   
Sbjct: 181 --DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLRKG 223

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.6 bits (201), Expect = 7e-18
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 11/153 (7%)

Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + LS ++AL YL    GVIHRD+K  +I
Sbjct: 93  ELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYL-HNQGVIHRDIKSDSI 149

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G IKL DFG   ++     + K+  G   +MAPE I      +  Y    D+WSL
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-----SRLPYGTEVDIWSL 204

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
           GI ++E+  GE PY + +   + + R+ ++ PP
Sbjct: 205 GIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPP 236

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 10/95 (10%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPER 106
           LH L    G+I+RD+KP NILLDE G+IKL DFG+S   +D + +  +  G   YMAPE 
Sbjct: 114 LHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           +      +  +   AD WS G+ + E+ TG  P++
Sbjct: 170 V-----NRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.8 bits (198), Expect = 2e-17
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 10/134 (7%)

Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           +++  E       + L +    +   +   I    ++ L Y   +H ++HRD+KP NIL+
Sbjct: 73  LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILI 131

Query: 70  DERGNIKLCDFGISGRL--VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           +  G +KL DFG++ R   +  +  T       Y APE +         Y    D+WS+G
Sbjct: 132 NRDGVLKLADFGLA-RAFGIPLRTYTHEVVTLWYRAPEILL----GSKHYSTAVDIWSVG 186

Query: 128 ITLVELATGE--FP 139
               E+ TG+  FP
Sbjct: 187 CIFAEMITGKPLFP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 3e-17
 Identities = 43/136 (31%), Positives = 61/136 (44%), Gaps = 12/136 (8%)

Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL+     +P           ++A+ Y   +H +IHRD+KP NIL+ E G +KLCDFG +
Sbjct: 89  LLEASPGGLPPDAVRSYIWQLLQAIAYC-HSHNIIHRDIKPENILVSESGVLKLCDFGFA 147

Query: 84  GRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
             L    A   T       Y APE +        +Y    DVW++G  + EL  GE  FP
Sbjct: 148 RALRARPASPLTDYVATRWYRAPELLVGD----TNYGKPVDVWAIGCIMAELLDGEPLFP 203

Query: 140 YKDCKCDFEVLSRVLN 155
                 D + L  +  
Sbjct: 204 ---GDSDIDQLYLIQK 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 79.0 bits (194), Expect = 4e-17
 Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 4/144 (2%)

Query: 2   SPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +P   +  +W+ ME     +  D +      ++ E     I    ++ L +L + H VIH
Sbjct: 76  NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIH 134

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYD 118
           RD+K  N+LL E   +KL DFG+S +L  +  R     G   +MAPE I         YD
Sbjct: 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 194

Query: 119 IRADVWSLGITLVELATGEFPYKD 142
            ++D+WSLGIT +E+A G  P  D
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.5 bits (196), Expect = 5e-17
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 15/158 (9%)

Query: 5   SKESDVWICMELMATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           S   D++   EL+ T   RLL  + L     +    +I L  +K +H    + GV+HRD+
Sbjct: 80  SPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI-LRGLKYVH----SAGVVHRDL 134

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSNIL++E  ++K+CDFG++ R+ D +  T       Y APE +     QK  YD+  D
Sbjct: 135 KPSNILINENCDLKICDFGLA-RIQDPQM-TGYVSTRYYRAPEIML--TWQK--YDVEVD 188

Query: 123 VWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAP 158
           +WS G    E+  G+  FP KD    F +++ +L   P
Sbjct: 189 IWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 10/129 (7%)

Query: 33  PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR 92
           PEP     T   +  L +L +   +I+RD+KP N+LLD  GN+++ D G++  L D +++
Sbjct: 95  PEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153

Query: 93  TKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL--ATGEFPYKDCKCDF-E 148
           TK  AG   +MAPE +     Q  +YD   D ++LG+TL E+  A G F  +  K +  E
Sbjct: 154 TKGYAGTPGFMAPELL-----QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208

Query: 149 VLSRVLNDA 157
           +  R+LND+
Sbjct: 209 LKQRILNDS 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 51/143 (35%), Positives = 83/143 (58%), Gaps = 14/143 (9%)

Query: 6   KESDVWICMELMATCFDRLLKRL-HVSVP--EPICGKITLSTVKALHYLKETHGVIHRDV 62
           +   +WICME    C    L+ + HV+ P  E     ++  T++ L+YL  + G +HRD+
Sbjct: 77  RRDKLWICMEF---CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL-HSKGKMHRDI 132

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE--RIEPPNPQKPDYDI 119
           K +NILL + G++KL DFG+S ++  + A+ K+  G   +MAPE   +E    +K  Y+ 
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE----RKGGYNQ 188

Query: 120 RADVWSLGITLVELATGEFPYKD 142
             D+W++GIT +ELA  + P  D
Sbjct: 189 LCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 8/105 (7%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
            +++RD+KP N+LLD+ GN+++ D G++  L   K     AG   YMAPE +     Q  
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL-----QGE 169

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLNDA 157
            YD   D ++LG TL E+  G  P++  K      E+  R L  A
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 76.4 bits (188), Expect = 4e-16
 Identities = 44/122 (36%), Positives = 61/122 (50%), Gaps = 13/122 (10%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN-AGCAAYMAPE 105
           LH L    G+I+RD+K  NILLD  G++ L DFG+S   + + + R  +  G   YMAPE
Sbjct: 121 LHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK---DCKCDFEVLSRVLNDAPPCLP 162
            I   +     +D   D WSLG+   EL TG  P+    +     E+  R+L   PP  P
Sbjct: 177 VIRGGS---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-FP 232

Query: 163 ND 164
             
Sbjct: 233 KT 234

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 4e-16
 Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 20/151 (13%)

Query: 3   PQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--GVI 58
           P S E   DV+I  ELM T   +++K       + I        ++ L YL   H   VI
Sbjct: 70  PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQ-YFLYQILRGLKYL---HSANVI 125

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA---GCAA--YMAPERIEPPNPQ 113
           HRD+KPSNIL++   ++K+CDFG++ R VD     K           Y APE +   +  
Sbjct: 126 HRDLKPSNILVNSNCDLKICDFGLA-RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-- 182

Query: 114 KPDYDIRADVWSLGITLVELATGE--FPYKD 142
              Y    D+WS+G    EL T +  FP +D
Sbjct: 183 --RYTKAIDIWSVGCIFAELLTRKPLFPGRD 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 39/96 (40%), Positives = 60/96 (62%), Gaps = 6/96 (6%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAPE 105
           + YL   H ++HRD+KPSN+L++   N+K+ DFG+S R++       N+  G  AYM+PE
Sbjct: 181 IAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVS-RILAQTMDPCNSSVGTIAYMSPE 238

Query: 106 RIEPPNPQKPDYDIRA-DVWSLGITLVELATGEFPY 140
           RI   +     YD  A D+WSLG++++E   G FP+
Sbjct: 239 RIN-TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.2 bits (187), Expect = 5e-16
 Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 11/157 (7%)

Query: 9   DVWICME-LMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME L       ++ +  ++  E     +  S ++AL YL  + GVIHRD+K  +I
Sbjct: 92  ELWVLMEFLQGGALTDIVSQTRLN--EEQIATVCESVLQALCYL-HSQGVIHRDIKSDSI 148

Query: 68  LLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++  D   R    G   +MAPE I      +  Y    D+WSL
Sbjct: 149 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-----SRTPYGTEVDIWSL 203

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY       + + R+ +  PP L N
Sbjct: 204 GIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKN 239

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.0 bits (188), Expect = 5e-16
 Identities = 38/99 (38%), Positives = 51/99 (51%), Gaps = 14/99 (14%)

Query: 47  ALHYLKETH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           AL YL   H   +++RD+KP N+LLD  G IK+ DFG + R+     RT    G   Y+A
Sbjct: 113 ALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLCGTPEYLA 166

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           PE I         Y    D W+LGI + E+  G  P+ D
Sbjct: 167 PEII-----LSKGYGKAVDWWALGILIYEMLAGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.8 bits (186), Expect = 7e-16
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 11/157 (7%)

Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ +KAL  L    GVIHRD+K  +I
Sbjct: 91  ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVL-HAQGVIHRDIKSDSI 147

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K+  G   +MAPE I      +  Y    D+WSL
Sbjct: 148 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-----SRLPYGPEVDIWSL 202

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 203 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKN 238

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 57/161 (35%), Positives = 79/161 (49%), Gaps = 10/161 (6%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           KE   W+ ME        LL+     + E     IT   ++ L YL  +H +IHRD+K  
Sbjct: 92  KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL-HSHNMIHRDIKAG 150

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAPERIEPPNPQKPDYDIRADV 123
           NILL E G +KL DFG +     SK+   N+  G   +MAPE I   +  +  YD + DV
Sbjct: 151 NILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDV 203

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           WSLGIT +ELA  + P  +      +     ND+P    N+
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.7 bits (186), Expect = 9e-16
 Identities = 45/143 (31%), Positives = 67/143 (46%), Gaps = 28/143 (19%)

Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L     VI
Sbjct: 90  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFLHSNQ-VI 137

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++  +   R+   G   +MAPE +      +  Y
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAY 192

Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 1e-15
 Identities = 38/104 (36%), Positives = 61/104 (58%), Gaps = 8/104 (7%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
            +++RD+KP N+LLD++GN +L D G++  L D K  T+ AG   YMAPE ++    ++P
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK----EEP 170

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLND 156
            Y    D +++G ++ E+  G  P+KD K      E+  R L D
Sbjct: 171 -YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 38/119 (31%), Positives = 59/119 (49%), Gaps = 7/119 (5%)

Query: 27  RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR- 85
           R +    E +    T   ++ L YL  + G++HRD+K  N+L+D  G  K+ DFGIS + 
Sbjct: 100 RTYGRFEEQLVRFFTEQVLEGLAYL-HSKGILHRDLKADNLLVDADGICKISDFGISKKS 158

Query: 86  --LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             + D+       G   +MAPE I         Y  + D+WSLG  ++E+  G  P+ D
Sbjct: 159 DDIYDNDQNMSMQGSVFWMAPEVIH---SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 42/96 (43%), Positives = 51/96 (53%), Gaps = 11/96 (11%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           V ALH L    G IHRD+KP N L+D  G+IKL DFG+S  +V + A +   G   YMAP
Sbjct: 114 VDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-TYANSV-VGSPDYMAP 167

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           E +         YD   D WSLG  L E   G  P+
Sbjct: 168 EVLRGKG-----YDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.9 bits (179), Expect = 4e-15
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 11/133 (8%)

Query: 12  ICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME          L  +    +PE    +  +  +  L +L  +  ++HRD+K  N+ L
Sbjct: 76  IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL-HSKKILHRDIKSLNLFL 134

Query: 70  DERGNIKLCDFGISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           D   N+K+ D G++  L D+   A T   G   Y++PE  E     KP Y+ ++DVW+LG
Sbjct: 135 DAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCE----DKP-YNEKSDVWALG 188

Query: 128 ITLVELATGEFPY 140
           + L E  TG+ P+
Sbjct: 189 VVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 48/139 (34%), Positives = 78/139 (56%), Gaps = 14/139 (10%)

Query: 10  VWICMELMATCFDRLLKRL-HVSVPEPIC--GKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +WICME    C    L+ + HV+ P        +   T++ L YL  + G +HRD+K +N
Sbjct: 81  LWICMEY---CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL-HSKGKMHRDIKGAN 136

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE--RIEPPNPQKPDYDIRADV 123
           ILL + G++KL DFG++ ++  + A+ K+  G   +MAPE   +E    +   Y+   D+
Sbjct: 137 ILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE----KNGGYNQLCDI 192

Query: 124 WSLGITLVELATGEFPYKD 142
           W++GIT +ELA  + P  D
Sbjct: 193 WAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 5e-15
 Identities = 42/117 (35%), Positives = 62/117 (52%), Gaps = 10/117 (8%)

Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           L+K L   +PE    +     V  +  L +  G+IHRD+KP N+L+D+ G++KL DFG+S
Sbjct: 87  LIKTLGG-LPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
              +++K   K  G   Y+APE I        D D  +D WSLG  + E   G  P+
Sbjct: 145 RNGLENK---KFVGTPDYLAPETIL----GVGD-DKMSDWWSLGCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.6 bits (180), Expect = 5e-15
 Identities = 52/136 (38%), Positives = 70/136 (51%), Gaps = 10/136 (7%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +E   W+ ME        LL+     + E     IT   ++ L YL  +H +IHRD+K  
Sbjct: 96  REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL-HSHNMIHRDIKAG 154

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAPERIEPPNPQKPDYDIRADV 123
           NILL E G +KL DFG +     S A   N+  G   +MAPE I   +  +  YD + DV
Sbjct: 155 NILLTEPGQVKLADFGSA-----SIASPANSFVGTPYWMAPEVILAMDEGQ--YDGKVDV 207

Query: 124 WSLGITLVELATGEFP 139
           WSLGIT +ELA  + P
Sbjct: 208 WSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 73.3 bits (180), Expect = 7e-15
 Identities = 38/99 (38%), Positives = 55/99 (55%), Gaps = 4/99 (4%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKN-AGCAAYM 102
           V A+H + +  G +HRD+KP N+L+D  G+IKL DFG + RL  +    +K   G   Y+
Sbjct: 112 VLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170

Query: 103 APERIEPPN-PQKPDYDIRADVWSLGITLVELATGEFPY 140
           APE +   N   K  Y +  D WSLG+   E+  G  P+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.2 bits (179), Expect = 8e-15
 Identities = 49/134 (36%), Positives = 68/134 (50%), Gaps = 6/134 (4%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +E   W+ ME        LL+     + E     +T   ++ L YL  +H +IHRDVK  
Sbjct: 86  REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKAG 144

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NILL E G +KL DFG +  +  +       G   +MAPE I   +  +  YD + DVWS
Sbjct: 145 NILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAPEVILAMDEGQ--YDGKVDVWS 199

Query: 126 LGITLVELATGEFP 139
           LGIT +ELA  + P
Sbjct: 200 LGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 43/111 (38%), Positives = 62/111 (55%), Gaps = 11/111 (9%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL  +  +++RD+KP NILLD+ G+IKL DFG + +L D   RT    G   Y+A
Sbjct: 111 VCALEYL-HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLA 166

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           PE I     Q   ++   D W+LGI + E+  G  P+ D    F +  ++L
Sbjct: 167 PEVI-----QSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKIL 211

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 49/143 (34%), Positives = 73/143 (51%), Gaps = 15/143 (10%)

Query: 26  KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR 85
           KRL   +PE    K  +    AL ++     ++HRD+KP+N+ +   G +KL D G+ GR
Sbjct: 100 KRL---IPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGL-GR 154

Query: 86  LVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
              SK  A     G   YM+PERI      +  Y+ ++D+WSLG  L E+A  + P+   
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Query: 144 KCDFEVLSRVLN--DAPPCLPND 164
           K +   L + +   D PP LP D
Sbjct: 210 KMNLYSLCKKIEKCDYPP-LPAD 231

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 12/146 (8%)

Query: 23  RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI 82
           +  K+    +PE    K  +    AL ++  +  V+HRD+KP+N+ +   G +KL D G+
Sbjct: 94  KHFKKQKRLIPEKTVWKYFVQLCSALEHM-HSRRVMHRDIKPANVFITATGVVKLGDLGL 152

Query: 83  SGRLVDSKARTKNA--GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            GR   SK    ++  G   YM+PERI      +  Y+ ++D+WSLG  L E+A  + P+
Sbjct: 153 -GRFFSSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 141 KDCKCDFEVLSRVLN--DAPPCLPND 164
              K +   L + +   D PP LP+D
Sbjct: 207 YGDKMNLYSLCKKIEQCDYPP-LPSD 231

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 40/111 (36%), Positives = 60/111 (54%), Gaps = 11/111 (9%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           +PE    +I +  ++ L  L E   ++HRD+K +NILL     +K+ D GIS  L  + A
Sbjct: 100 IPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158

Query: 92  RTKNAGCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           +T+  G   YMAPE  +  P       Y  ++D+WSLG  L E+AT   P+
Sbjct: 159 KTQ-IGTPHYMAPEVWKGRP-------YSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 3e-14
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 16/115 (13%)

Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN-IKLCDFGISGRLVDSKAR 92
           E +    T   ++ L YL E   +IHRDVK +N+L+D  G  +++ DFG + RL      
Sbjct: 102 EAVIINYTEQLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160

Query: 93  T-----KNAGCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
                 +  G  A+MAPE  R E        Y    DVWS+G  ++E+AT + P+
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQ-------YGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 55/146 (37%), Positives = 75/146 (51%), Gaps = 16/146 (10%)

Query: 21  FDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC 78
           F  L +R + S  E     G+I L+ ++ LH L    G+++RD+K  NILLD  G++ L 
Sbjct: 93  FTHLYQRDNFSEDEVRFYSGEIILA-LEHLHKL----GIVYRDIKLENILLDSEGHVVLT 147

Query: 79  DFGISGR-LVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           DFG+S   L + K RT +  G   YMAPE I      K  +    D WSLGI + EL TG
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR----GKGGHGKAVDWWSLGILIFELLTG 203

Query: 137 EFPYK---DCKCDFEVLSRVLNDAPP 159
             P+    +     EV  R+L   PP
Sbjct: 204 ASPFTLEGERNTQSEVSRRILKCDPP 229

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 21/151 (13%)

Query: 3   PQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKI--TLSTVKALHYLKETHGVI 58
           P S ES  DV+I  ELM T   +L+K  H+S  + I   +   L  +K +H    +  V+
Sbjct: 74  PPSFESFNDVYIVQELMETDLYKLIKTQHLS-NDHIQYFLYQILRGLKYIH----SANVL 128

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-----TKNAGCAAYMAPERIEPPNPQ 113
           HRD+KPSN+LL+   ++K+CDFG++ R+ D +       T+      Y APE +   N +
Sbjct: 129 HRDLKPSNLLLNTNCDLKICDFGLA-RIADPEHDHTGFLTEYVATRWYRAPEIML--NSK 185

Query: 114 KPDYDIRADVWSLGITLVELATGE--FPYKD 142
              Y    D+WS+G  L E+ +    FP KD
Sbjct: 186 G--YTKAIDIWSVGCILAEMLSNRPLFPGKD 214

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
            L +L E  G+I+RD+K  N+LLD  G+IK+ DFG+    +     T    G   Y+APE
Sbjct: 108 GLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +         Y    D W+LG+ L E+  G+ P+
Sbjct: 167 IL-----SYQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 38/97 (39%), Positives = 55/97 (56%), Gaps = 6/97 (6%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMA 103
           V AL +L + + +++RD+KP NILLD  G+I LCDFG+S   L D+K      G   Y+A
Sbjct: 106 VLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +      +  Y    D WSLG+ + E+  G  P+
Sbjct: 165 PEVLL----DEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 6e-14
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 22/166 (13%)

Query: 7   ESDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  + I ME M   +  D+L  + + ++ E +  K T   ++ + YL  ++ ++HRD+K 
Sbjct: 78  ERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL-HSNMIVHRDIKG 134

Query: 65  SNILLDERGNIKLCDFGISGRL----VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +NIL D  GN+KL DFG S RL    +         G   +M+PE I         Y  +
Sbjct: 135 ANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-----YGRK 189

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP----PCLP 162
           AD+WS+G T+VE+ T + P+     +FE ++ +   A     P LP
Sbjct: 190 ADIWSVGCTVVEMLTEKPPW----AEFEAMAAIFKIATQPTNPVLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.5 bits (171), Expect = 8e-14
 Identities = 41/123 (33%), Positives = 67/123 (54%), Gaps = 12/123 (9%)

Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCD 79
           FD LLK+    + E    KI    V+AL+ L   H +IH D+K  N+L D  +  I LCD
Sbjct: 97  FD-LLKK-EGKLSEAEVKKIIRQLVEALNDL-HKHNIIHNDIKLENVLYDRAKDRIYLCD 153

Query: 80  FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFP 139
           +G+  +++ +   +   G   Y +PE+I+       +YD+  D W++G+   EL TG+ P
Sbjct: 154 YGLC-KIIGTP--SCYDGTLDYFSPEKIK-----GHNYDVSFDWWAVGVLTYELLTGKHP 205

Query: 140 YKD 142
           +K+
Sbjct: 206 FKE 208

Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 9e-14
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 28/143 (19%)

Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFL-HSNQVI 138

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++   ++ R+   G   +MAPE +      +  Y
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAY 193

Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 13/115 (11%)

Query: 33  PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR 92
           PEP+  K T   +  + YL   + V+HRD+K +N++L   G IKL DFG + RL      
Sbjct: 100 PEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158

Query: 93  TKNA-------GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
             ++       G   +MAPE I      +  Y  ++D+WS+G T+ E+ATG+ P 
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVI-----NESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.7 bits (168), Expect = 1e-13
 Identities = 43/127 (33%), Positives = 65/127 (51%), Gaps = 9/127 (7%)

Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME     T  + + KR +  + E       +  + ALH++  T  ++HRD+K  NILL
Sbjct: 76  IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV-HTKLILHRDLKTQNILL 134

Query: 70  DERGNI-KLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           D+   + K+ DFGIS  L          G   Y++PE  E     KP Y+ ++D+W+LG 
Sbjct: 135 DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE----GKP-YNQKSDIWALGC 189

Query: 129 TLVELAT 135
            L ELA+
Sbjct: 190 VLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 1e-13
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 28/143 (19%)

Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 90  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALDFL-HSNQVI 137

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++   ++ R+   G   +MAPE +      +  Y
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAY 192

Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 42/121 (34%), Positives = 56/121 (46%), Gaps = 34/121 (28%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           VPE +  KI   T++A+++  + H  IHRDVKP NIL+ ++G IKLCDFG         A
Sbjct: 97  VPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGF--------A 147

Query: 92  RTKNAGCAAYM---------APERI------EPPNPQKPDYDIRADVWSLGITLVELATG 136
           R        Y          APE +       PP           DVW++G    EL TG
Sbjct: 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP----------VDVWAIGCVFAELLTG 197

Query: 137 E 137
           +
Sbjct: 198 Q 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 10/99 (10%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V A  YL     +I+RD+KP N+LLD +G++K+ DFG + ++ D   RT    G   Y+A
Sbjct: 128 VLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCGTPEYLA 183

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           PE I     Q   +    D W++G+ L E   G  P+ D
Sbjct: 184 PEVI-----QSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217

Length = 329

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.6 bits (167), Expect = 2e-13
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 14/163 (8%)

Query: 7   ESDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  + I ME M   +  D+L  + + ++ E +  K T   ++ + YL  ++ ++HRD+K 
Sbjct: 78  EKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYL-HSNMIVHRDIKG 134

Query: 65  SNILLDERGNIKLCDFGISGRL----VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +NIL D  GN+KL DFG S RL    +         G   +M+PE I         Y  +
Sbjct: 135 ANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-----YGRK 189

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           ADVWSLG T+VE+ T + P+ + +    +         P LP+
Sbjct: 190 ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 41/130 (31%), Positives = 54/130 (41%), Gaps = 44/130 (33%)

Query: 45  VKALHYLKETH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA------ 96
           V AL  +   H  G IHRD+KP NIL+D  G+IKL DFG+  ++  +K R          
Sbjct: 111 VLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 97  ------------------------GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITL 130
                                   G   Y+APE  R  P       Y +  D WSLG+ L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-------YGLECDWWSLGVIL 220

Query: 131 VELATGEFPY 140
            E+  G  P+
Sbjct: 221 YEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 25/144 (17%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETH--GVIHR 60
            DV++   LM    + ++K          C K++   ++ L Y     LK  H  G+IHR
Sbjct: 93  QDVYLVTHLMGADLNNIVK----------CQKLSDDHIQFLVYQILRGLKYIHSAGIIHR 142

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSNI ++E   +K+ DFG++ R  D +  T       Y APE +         Y+  
Sbjct: 143 DLKPSNIAVNEDCELKILDFGLA-RHTDDEM-TGYVATRWYRAPEIML----NWMHYNQT 196

Query: 121 ADVWSLGITLVELATGE--FPYKD 142
            D+WS+G  + EL TG+  FP  D
Sbjct: 197 VDIWSVGCIMAELLTGKTLFPGSD 220

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.5 bits (165), Expect = 4e-13
 Identities = 42/110 (38%), Positives = 61/110 (55%), Gaps = 8/110 (7%)

Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRLVDSKAR 92
           E      T   ++ L YL +   ++HRD+K  N+L++   G +K+ DFG S RL      
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165

Query: 93  TKN-AGCAAYMAPERIEPPNPQKP-DYDIRADVWSLGITLVELATGEFPY 140
           T+   G   YMAPE I+    + P  Y   AD+WSLG T+VE+ATG+ P+
Sbjct: 166 TETFTGTLQYMAPEVID----KGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.5 bits (165), Expect = 4e-13
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 7/118 (5%)

Query: 19  TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC 78
           T +D+++++      E +        V A+ Y+ +  G++HRD+K  NI L + G IKL 
Sbjct: 85  TLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLG 143

Query: 79  DFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           DFGIS  L    +  +   G   YM+PE       Q   Y+ ++D+W+LG  L EL T
Sbjct: 144 DFGISKILGSEYSMAETVVGTPYYMSPELC-----QGVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.4 bits (164), Expect = 5e-13
 Identities = 47/143 (32%), Positives = 75/143 (52%), Gaps = 15/143 (10%)

Query: 26  KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR 85
           KRL   +PE    K  +    A+ ++  +  V+HRD+KP+N+ +   G +KL D G+ GR
Sbjct: 100 KRL---IPERTVWKYFVQLCSAVEHM-HSRRVMHRDIKPANVFITATGVVKLGDLGL-GR 154

Query: 86  LVDSKARTKNA--GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
              SK    ++  G   YM+PERI      +  Y+ ++D+WSLG  L E+A  + P+   
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Query: 144 KCDFEVLSRVLN--DAPPCLPND 164
           K +   L + +   D PP LP +
Sbjct: 210 KMNLFSLCQKIEQCDYPP-LPTE 231

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.3 bits (164), Expect = 6e-13
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 16/148 (10%)

Query: 38  GKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAG 97
           G+I L+ ++ LH L    G+I+RD+K  NILLD  G++ L DFG+S    + +     + 
Sbjct: 112 GEIVLA-LEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF 166

Query: 98  CAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK---DCKCDFEVLSR 152
           C    YMAP+ +   +     +D   D WS+G+ + EL TG  P+    +     E+  R
Sbjct: 167 CGTIEYMAPDIVRGGD---GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223

Query: 153 VLNDAPPCLPND--PLFGRTIKASIAKD 178
           +L   PP  P +   L    I+  + KD
Sbjct: 224 ILKSEPP-YPQEMSALAKDIIQRLLMKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.9 bits (164), Expect = 8e-13
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 26/147 (17%)

Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKAL--------HYLKETHG 56
           S    +++ ME +    +  LK L  ++ +P       S VK L         +L + + 
Sbjct: 76  SNLDKIYMVMEYV----EHDLKSLMETMKQPF----LQSEVKCLMLQLLSGVAHLHD-NW 126

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KARTKNAGCAAYMAPERIEPPNPQK 114
           ++HRD+K SN+LL+ RG +K+CDFG+  R   S  K  T+      Y APE +       
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGL-AREYGSPLKPYTQLVVTLWYRAPELLLGA---- 181

Query: 115 PDYDIRADVWSLGITLVELATGE--FP 139
            +Y    D+WS+G    EL T +  FP
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFP 208

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.1 bits (163), Expect = 8e-13
 Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMA 103
           ++AL +L     VIHRD+K  N+LL   G++KL DFG   ++   ++ R+   G   +MA
Sbjct: 125 LQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +      +  Y  + D+WSLGI  +E+  GE PY
Sbjct: 184 PEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.2 bits (164), Expect = 8e-13
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 7/96 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL +L   HGVI+RD+K  NILLD  G+ KL DFG+    +++    T   G   Y+APE
Sbjct: 108 ALMFL-HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            +     Q+ +Y    D W+LG+ + E+  G+ P++
Sbjct: 167 IL-----QELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 9/103 (8%)

Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNA-G 97
           I + +V  LHY       +HRD+KP NIL+D  G+I+L DFG   +L+ D   ++  A G
Sbjct: 113 IAIDSVHQLHY-------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 165

Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
              Y++PE ++     K  Y    D WSLG+ + E+  GE P+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 40/119 (33%), Positives = 60/119 (50%), Gaps = 3/119 (2%)

Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL +    +PE +        V A+  + +   V HRD+KP N+LLD+ G+I+L DFG  
Sbjct: 91  LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV-HRDIKPDNVLLDKNGHIRLADFGSC 149

Query: 84  GRLVDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            RL+       N   G   Y++PE ++     K  Y    D WSLG+ + E+  GE P+
Sbjct: 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 3/119 (2%)

Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL +    +PE +        V A+H + + H  +HRD+KP N+LLD  G+I+L DFG  
Sbjct: 91  LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH-YVHRDIKPDNVLLDMNGHIRLADFGSC 149

Query: 84  GRLVDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            ++        +   G   Y++PE ++        Y    D WSLG+ + E+  GE P+
Sbjct: 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 39/98 (39%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA--YMAP 104
           AL  L + + VI+RD+KP NILLD +G+I LCDFG+  +L        N  C    Y+AP
Sbjct: 105 ALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLC-KLNMKDDDKTNTFCGTPEYLAP 162

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           E +         Y    D W+LG+ L E+ TG  P+ D
Sbjct: 163 ELL-----LGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 2e-12
 Identities = 36/133 (27%), Positives = 49/133 (36%), Gaps = 51/133 (38%)

Query: 39  KITLSTVK--------ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 90
           K T S +K         L YL  ++G++HRD+K SNIL++  G +KL DFG+        
Sbjct: 96  KFTESQIKCYMKQLLEGLQYL-HSNGILHRDIKGSNILINNDGVLKLADFGL-------- 146

Query: 91  ARTKNAGCAAYMAPERIEPPNPQK------------P-------DYDIRADVWSLGITLV 131
           AR                  N               P        Y    D+WS+G  L 
Sbjct: 147 ARP-------------YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILA 193

Query: 132 ELATGE--FPYKD 142
           EL  G+  F    
Sbjct: 194 ELFLGKPIFQGST 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 47/136 (34%), Positives = 69/136 (50%), Gaps = 19/136 (13%)

Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG 84
             R      E ICG      ++ LH      G+I+RD+K  N+LLD+ G+IK+ DFG+  
Sbjct: 95  EARARFYAAEIICG------LQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Query: 85  RLV--DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             +  + KA T   G   Y+APE ++    QK  Y+   D WS G+ L E+  G+ P+  
Sbjct: 145 ENMNGEGKAST-FCGTPDYIAPEILK---GQK--YNESVDWWSFGVLLYEMLIGQSPFHG 198

Query: 143 CKCDFEVLSRVLNDAP 158
              D E+   +LND P
Sbjct: 199 EDED-ELFDSILNDRP 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 27/156 (17%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           M P  +E+  DV+I  ELM T   ++++     + +  C       ++ L Y+  +  V+
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYI-HSANVL 130

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPERIEP 109
           HRD+KPSN+LL+   ++K+CDFG+        ART +              Y APE +  
Sbjct: 131 HRDLKPSNLLLNANCDLKICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 110 PNPQKPDYDIRADVWSLGITLVELATGE--FPYKDC 143
            +    +Y    DVWS+G    EL   +  FP KD 
Sbjct: 183 CS----EYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL YL   + +I+RD+KP NILLD +G++ L DFG+    ++    T    G   Y+APE
Sbjct: 108 ALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +K  YD   D W LG  L E+  G  P+
Sbjct: 167 VL-----RKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 16/144 (11%)

Query: 10  VWICMELMATCFDRLLKRLHV--SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +W+    MA      L + +    + E + G I    ++ L+YL + +G IHR++K S+I
Sbjct: 74  LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHI 132

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPE---RIEP---PNPQKPD---YD 118
           L+   G + L        LV +  + K      Y  P+    + P   P   + D   Y+
Sbjct: 133 LISGDGLVSLSGLSHLYSLVRNGQKAK----VVYDFPQFSTSVLPWLSPELLRQDLYGYN 188

Query: 119 IRADVWSLGITLVELATGEFPYKD 142
           +++D++S+GIT  ELATG  P++D
Sbjct: 189 VKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 6e-12
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +E       DY    D W LG+ + E+  G  P+
Sbjct: 165 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 39/111 (35%), Positives = 58/111 (52%), Gaps = 4/111 (3%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +PE      T   V AL  +  + G IHRDVKP N+LLD+ G++KL DFG   ++  +  
Sbjct: 139 IPEKWARFYTAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197

Query: 91  ARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            R   A G   Y++PE ++        Y    D WS+G+ L E+  G+ P+
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 64.2 bits (156), Expect = 8e-12
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVS--VPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++++W+    MA    + L   H    + E     I    +KAL Y+    G +HR VK 
Sbjct: 71  DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKA 129

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTK--------NAGCAAYMAPERIEPPNPQKPD 116
           S+IL+   G + L     +  +++   R +        +     +++PE ++  N Q   
Sbjct: 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ-NLQ--G 186

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL------PNDPLFGRT 170
           YD ++D++S+GIT  ELA G  P+KD     ++L   LN   PCL      P + L  + 
Sbjct: 187 YDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNGTVPCLLDTTTIPAEELTMKP 245

Query: 171 IKASIAKDNGRSTEFIRKRSYEDKSTCY 198
            ++      G ST     R    +S+ +
Sbjct: 246 SRSGANSGLGESTTVSTPRPSNGESSSH 273

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 63.7 bits (156), Expect = 9e-12
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 17/155 (10%)

Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
             +S++ +  E M T  ++++K   + +         L T++ L YL   + ++HRD+KP
Sbjct: 72  GHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKP 130

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKAR-TKNAGCAAYMAPE-----RIEPPNPQKPDYD 118
           +N+L+   G +KL DFG++        + T       Y APE     R          Y 
Sbjct: 131 NNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH---------YG 181

Query: 119 IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           +  D+WS+G    EL     P+     D + L ++
Sbjct: 182 VGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 8/103 (7%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           +++RD+KP NILLD+RG+I++ D G++ ++ + +      G   YMAPE I         
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-----NNEK 177

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLND 156
           Y    D W LG  + E+  G+ P++  K      EV  RV  D
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL++L E  G+I+RD+K  N+LLD  G+IKL D+G+    +      +   G   Y+APE
Sbjct: 108 ALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  DY    D W+LG+ + E+  G  P+
Sbjct: 167 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 9/135 (6%)

Query: 10  VWICMELMATCFDR----LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++I M+L+           LK       E     I +  V AL YL +   ++HRD+ P+
Sbjct: 84  LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NI+L E   + + DFG++ +       T   G   Y  PE +     +   Y  +ADVW+
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV-----KNEPYGEKADVWA 198

Query: 126 LGITLVELATGEFPY 140
            G  L ++ T + P+
Sbjct: 199 FGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 38/108 (35%), Positives = 52/108 (48%), Gaps = 23/108 (21%)

Query: 45  VKALHYLKETH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-- 100
           +KAL Y+   H   VIHRD+KPSNILL+    +KL DFG++ R +      +N       
Sbjct: 117 LKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLA-RSLSE--LEENPENPVLT 170

Query: 101 -------YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
                  Y APE +         Y    D+WS+G  L E+  G+  FP
Sbjct: 171 DYVATRWYRAPEILLGST----RYTKGVDMWSVGCILGEMLLGKPLFP 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 6/110 (5%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
            V++RD+KP+NILLDE G++++ D G++      K    + G   YMAPE ++    +  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ----KGV 171

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLNDAPPCLPND 164
            YD  AD +SLG  L +L  G  P++  K  D   + R+       LP+ 
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 17/165 (10%)

Query: 8   SDVWICMELMA--TCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           S++++   LMA  +C D LLK      +PE     I    + AL Y+  + G IHR VK 
Sbjct: 72  SELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYI-HSKGFIHRSVKA 129

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA--------YMAPERIEPPNPQKPD 116
           S+ILL   G + L     S  ++    R +              +++PE ++  N Q   
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ-NLQ--G 186

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           Y+ ++D++S+GIT  ELA G  P+KD      +L +V     PCL
Sbjct: 187 YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVPCL 230

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 16/137 (11%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAP 104
           AL YL E H ++HRD+K  N+ L     IK+ D GI+ R+++++    +   G   YM+P
Sbjct: 114 ALQYLHEKH-ILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLENQCDMASTLIGTPYYMSP 171

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELAT--GEFPYKDCKCDFEVLSRVLNDAPPCLP 162
           E        KP Y+ ++DVW+LG  + E+AT    F  KD      ++ R++    P +P
Sbjct: 172 ELFS----NKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRIIEGKLPPMP 223

Query: 163 ND--PLFGRTIKASIAK 177
            D  P  G  I   ++K
Sbjct: 224 KDYSPELGELIATMLSK 240

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 40/113 (35%), Positives = 56/113 (49%), Gaps = 22/113 (19%)

Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS--GRL----------VDSKA 91
           TV AL YL   +G++HRD+KP N+L+   G+IKL DFG+S  G +          ++   
Sbjct: 110 TVLALEYL-HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168

Query: 92  R----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           R     +  G   Y+APE I      KP      D W++GI L E   G  P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKP-----VDWWAMGIILYEFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL +L    G+I+RD+KP NILLD +G++KL DFG+    +     T    G   YMAPE
Sbjct: 112 ALEHL-HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +      +  +    D WSLG  + ++ TG  P+
Sbjct: 171 IL-----MRSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 10/137 (7%)

Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---- 86
           ++ E +  + T   ++ + YL  ++ ++HRD+K +NIL D  GN+KL DFG S R+    
Sbjct: 102 ALTENVTRRYTRQILQGVSYL-HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160

Query: 87  VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD 146
           +         G   +M+PE I         Y  +ADVWS+  T+VE+ T + P+ + +  
Sbjct: 161 MSGTGIKSVTGTPYWMSPEVISGEG-----YGRKADVWSVACTVVEMLTEKPPWAEYEAM 215

Query: 147 FEVLSRVLNDAPPCLPN 163
             +         P LP+
Sbjct: 216 AAIFKIATQPTKPMLPD 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 41/111 (36%), Positives = 55/111 (49%), Gaps = 7/111 (6%)

Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDS 89
           S PEP           AL YL   + +++RD+KP NILLD +G++ L DFG+    +  S
Sbjct: 92  SFPEPRARFYAAEIASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150

Query: 90  KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
              T   G   Y+APE I     +K  YD   D W LG  L E+  G  P+
Sbjct: 151 DTTTTFCGTPEYLAPEVI-----RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 7/97 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 105 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +E       DY    D W LG+ + E+  G  P+
Sbjct: 164 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 18/150 (12%)

Query: 14  MELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG 73
           M  + +C    L R      E ICG      ++ LH    + G+++RD+K  NILLD  G
Sbjct: 84  MFHIQSCHKFDLPRATFYAAEIICG------LQFLH----SKGIVYRDLKLDNILLDTDG 133

Query: 74  NIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE 132
           +IK+ DFG+    +   A+T    G   Y+APE +     QK  Y+   D WS G+ L E
Sbjct: 134 HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL---GQK--YNTSVDWWSFGVLLYE 188

Query: 133 LATGEFPYKDCKCDFEVLSRVLNDAPPCLP 162
           +  G+ P+     D E L + +    PC P
Sbjct: 189 MLIGQSPFHG--HDEEELFQSIRMDNPCYP 216

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 35/96 (36%), Positives = 46/96 (47%), Gaps = 23/96 (23%)

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYM---------APE 105
           H +IHRD+KP NIL+ + G +KLCDFG         ART  A    Y          APE
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGF--------ARTLAAPGEVYTDYVATRWYRAPE 170

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
            +         Y    D+W++G  + E+ TGE  FP
Sbjct: 171 LL----VGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 7/97 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 105 VSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +E       DY    D W LG+ + E+  G  P+
Sbjct: 164 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 8/104 (7%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
             ++RD+KP NILLD+ G+I++ D G++ ++ + ++     G   YMAPE +   N Q+ 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL---NNQR- 177

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLND 156
            Y +  D W LG  + E+  G+ P++  K      EV  RVL  
Sbjct: 178 -YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 8/103 (7%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           +++RD+KP NILLD+ G+I++ D G++  + + +      G   YMAPE +     ++  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV---KNER-- 177

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLND 156
           Y    D W LG  + E+  G+ P++  K      EV  RV  D
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 42/113 (37%), Positives = 62/113 (54%), Gaps = 8/113 (7%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-K 90
           VPE      T   V AL  +  + G+IHRDVKP N+LLD+ G++KL DFG   ++ ++  
Sbjct: 139 VPEKWAKFYTAEVVLALDAI-HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197

Query: 91  ARTKNA-GCAAYMAPERIEPPNPQKPD--YDIRADVWSLGITLVELATGEFPY 140
            R   A G   Y++PE ++    Q  D  Y    D WS+G+ L E+  G+ P+
Sbjct: 198 VRCDTAVGTPDYISPEVLK---SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 45/118 (38%), Positives = 60/118 (50%), Gaps = 14/118 (11%)

Query: 51  LKETHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KARTKNAGCAAYMAPE 105
           L E H   ++HRD+K +NI L   G IKL DFG S +  DS      +   G   Y+APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL---NDAPPC 160
             E     +  Y  +AD+WSLG+ L EL T   P+K      E++ +VL    D  PC
Sbjct: 242 LWE-----RKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYDPFPC 293

Length = 478

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 37/122 (30%), Positives = 57/122 (46%), Gaps = 8/122 (6%)

Query: 23  RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI 82
            LL  +     E     + L  ++ L YL E + +IHRD+K SN+LL ++G +K+ DFG+
Sbjct: 96  SLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGL 154

Query: 83  SGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           +      +K  T       Y APE +         Y    D+W++G  L EL   +   P
Sbjct: 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCT----TYTTAIDMWAVGCILAELLAHKPLLP 210

Query: 140 YK 141
            K
Sbjct: 211 GK 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 5/88 (5%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V++RD+KP+NILLDE G++++ D G++      K    + G   YMAPE ++    +   
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ----KGTA 172

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCK 144
           YD  AD +SLG  L +L  G  P++  K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 42/113 (37%), Positives = 60/113 (53%), Gaps = 8/113 (7%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           VPE      T   V AL  +  + G IHRDVKP N+LLD+ G++KL DFG   ++  +  
Sbjct: 139 VPEKWARFYTAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197

Query: 91  ARTKNA-GCAAYMAPERIEPPNPQKPD--YDIRADVWSLGITLVELATGEFPY 140
            R   A G   Y++PE ++    Q  D  Y    D WS+G+ L E+  G+ P+
Sbjct: 198 VRCDTAVGTPDYISPEVLK---SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 31/195 (15%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETH--GVIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 95  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 144

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 145 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIML----NWMHYNQT 198

Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
            D+WS+G  + EL TG   FP  D     +++ R++      L       + I +  A++
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL------KKISSESARN 252

Query: 179 NGRSTEFIRKRSYED 193
             +S   + K ++ +
Sbjct: 253 YIQSLTQMPKMNFAN 267

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 9e-11
 Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 11/102 (10%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDS---KARTKNAGCAAYMA 103
           + YL+  H V HRD+   N+LL  R   K+ DFG+S  L   S   +A T       + A
Sbjct: 108 MAYLESKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCK 144
           PE I   N  K  +  ++DVWS G+TL E  + G  PY + K
Sbjct: 167 PECI---NYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    L      +   G   Y+APE
Sbjct: 108 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  DY    D W+LG+ + E+  G  P+
Sbjct: 167 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 41/145 (28%), Positives = 59/145 (40%), Gaps = 43/145 (29%)

Query: 39  KITLSTVKALHYLKET---------HGVIHRDVKPSNILLDERGNIKLCDFGISGRL--- 86
           K T +  +   Y+ ET          G IHRD+KP N+LLD +G+IKL DFG+   L   
Sbjct: 95  KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154

Query: 87  ------------------------VDSKART----KNAGCAAYMA---PERIEPPNPQKP 115
                                   + SK +     +N    AY     P+ I P    + 
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214

Query: 116 DYDIRADVWSLGITLVELATGEFPY 140
            Y+   D WSLG+ + E+  G  P+
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 12/136 (8%)

Query: 51  LKETHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPE 105
           LK  H   ++HRD+K  NI L + G IKL DFGI+ R+++S    ART   G   Y++PE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA-RVLNSTVELART-CIGTPYYLSPE 171

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
             E     +P Y+ ++D+W+LG  L E+ T +  ++       VL  +    PP   +  
Sbjct: 172 ICE----NRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYS 226

Query: 166 LFGRTIKASIAKDNGR 181
              R + + + K N R
Sbjct: 227 YDLRNLVSQLFKRNPR 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 5/88 (5%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           +++RD+KP NILLD+ G+I++ D G++  + + +      G   YMAPE +     +   
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-----KNER 177

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCK 144
           Y    D W+LG  L E+  G+ P++  K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 41/118 (34%), Positives = 58/118 (49%), Gaps = 8/118 (6%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL YL   + +++RD+KP NILLD +G+I L DFG+    ++    T    G   Y+APE
Sbjct: 108 ALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
            +      K  YD   D W LG  L E+  G  P+   +   E+   +LN      PN
Sbjct: 167 VL-----HKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPN 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 21/171 (12%)

Query: 5   SKESDVWICMELMATCFDRLLKRL------HVSVPEPICGKITLSTVKALHYLKETHGVI 58
           + E  ++I  ELM   +  LL+ L       + +P+ I   +       + YL E    I
Sbjct: 71  TLEEPIYIVTELMK--YGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYL-EAQNYI 125

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDS--KARTKNAGCAAYMAPERIEPPNPQKPD 116
           HRD+   N+L+ E    K+ DFG++  + +   +AR        + APE        +  
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA---LYNR-- 180

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV-LNDAPPCLPNDP 165
           + I++DVWS GI L E+ T G  PY     + EVL +V      PC P  P
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMT-NAEVLQQVDQGYRMPCPPGCP 230

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 36/130 (27%), Positives = 57/130 (43%), Gaps = 10/130 (7%)

Query: 14  MELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER 72
            E M    +  +  R      E +   I    ++ L ++   HG  HRD+KP N+L+   
Sbjct: 77  FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI-HKHGFFHRDLKPENLLVSGP 135

Query: 73  GNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLV 131
             +K+ DFG++ R + S+   T       Y APE +     +   Y    D+W+LG  + 
Sbjct: 136 EVVKIADFGLA-REIRSRPPYTDYVSTRWYRAPEILL----RSTSYSSPVDIWALGCIMA 190

Query: 132 ELATGE--FP 139
           EL T    FP
Sbjct: 191 ELYTLRPLFP 200

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 38/96 (39%), Positives = 55/96 (57%), Gaps = 11/96 (11%)

Query: 51  LKETHG--VIHRDVKPSNILLDERGNI-KLCDFGISGRLVDSK--ARTKNAGCAAYMAPE 105
           LK  H   ++HRD+K  NI L + G + KL DFGI+ +L DS   A T   G   Y++PE
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
             +     +P Y+ + D+WSLG  L EL T + P++
Sbjct: 173 ICQ----NRP-YNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 7/97 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL  +  +++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 105 VSALDYL-HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +E       DY    D W LG+ + E+  G  P+
Sbjct: 164 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 8/113 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMA 103
             AL +L +  G+I+RD+K  N+LLD  G+ KL DFG+    + + K  +   G   Y+A
Sbjct: 106 TSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND 156
           PE +     Q+  Y    D W++G+ L E+  G  P++    D ++   +LND
Sbjct: 165 PEIL-----QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILND 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 10/107 (9%)

Query: 35  PICGKITL--STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR 92
            IC  + +  S ++A+ YL E + +IHRD+K  NI ++  G++ L DFG +   VD  A 
Sbjct: 180 AICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238

Query: 93  TKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
                AG  A  APE +      +  Y    D+WS GI L E+AT  
Sbjct: 239 KYYGWAGTIATNAPELL-----ARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 12/102 (11%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----Y 101
           K + YL+E   ++HRD+   N+L+    ++K+ DFG++ +L+D   +  +A        +
Sbjct: 120 KGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLA-KLLDVDEKEYHAEGGKVPIKW 177

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD 142
           MA E I         Y  ++DVWS G+T+ EL T G  PY+ 
Sbjct: 178 MALESI-----LHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.8 bits (142), Expect = 4e-10
 Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 4/85 (4%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V+HRD+K  NI L + G +KL DFG S RL+ S        C     P  + P   +   
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSPG---AYACTYVGTPYYVPPEIWENMP 176

Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           Y+ ++D+WSLG  L EL T + P++
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 46/151 (30%), Positives = 66/151 (43%), Gaps = 39/151 (25%)

Query: 8   SDVWICMELMAT--C--FDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM    C      L  +R+   + + +CG      +K LH    + G+IHRD
Sbjct: 94  QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 143

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA--------YMAPERIEPPNPQ 113
           +KPSNI++     +K+ DFG+        ART               Y APE I      
Sbjct: 144 LKPSNIVVKSDCTLKILDFGL--------ARTAGTSFMMTPYVVTRYYRAPEVI-----L 190

Query: 114 KPDYDIRADVWSLGITLVELATGE--FPYKD 142
              Y    D+WS+G  + E+  G   FP  D
Sbjct: 191 GMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           A+ YL  +  +I+RD+KP NILLD +G++ L DFG+    V+ +  T    G   Y+APE
Sbjct: 108 AIGYL-HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +K  YD   D W LG  L E+  G  P+
Sbjct: 167 VL-----RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 8/116 (6%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V  L YL E + +++RD+K  N+LLD  G +K+ DFG+    +    RT    G   ++A
Sbjct: 111 VLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
           PE +      +  Y    D W LG+ + E+  GE P+     + EV   ++ND   
Sbjct: 170 PEVL-----TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSIVNDEVR 219

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 19/127 (14%)

Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKA 91
           E +CG      ++ LH    + G+I+RD+K  N++LD  G+IK+ DFG+    V  D++A
Sbjct: 104 EIVCG------LQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153

Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS 151
            T   G   Y+APE +     Q   Y    D WS G+ L E+  G+ P+     D E+  
Sbjct: 154 ST-FCGTPDYIAPEIL-----QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFE 206

Query: 152 RVLNDAP 158
            +  D P
Sbjct: 207 SIRVDTP 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.5 bits (141), Expect = 7e-10
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL++L E  G+I+RD+K  N+LLD  G+IKL D+G+    +     T    G   Y+APE
Sbjct: 108 ALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  +Y    D W+LG+ + E+  G  P+
Sbjct: 167 IL-----RGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 18/144 (12%)

Query: 1   MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG--VI 58
           +   ++ + V+I  E M T    +L+     + E       L   + L  LK  H   V+
Sbjct: 82  VGSLTELNSVYIVQEYMETDLANVLE--QGPLSEE---HARLFMYQLLRGLKYIHSANVL 136

Query: 59  HRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTK-----NAGCAAYMAPERIEPPNP 112
           HRD+KP+N+ ++ E   +K+ DFG++ R+VD     K           Y +P  +  PN 
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLA-RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN- 194

Query: 113 QKPDYDIRADVWSLGITLVELATG 136
              +Y    D+W+ G    E+ TG
Sbjct: 195 ---NYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 20/95 (21%)

Query: 56  GVIHRDVKPSNILLDERG---NIKLCDFGISGRLVDSK--------ARTKNAGCAAYMAP 104
           G++HRD+KP NI++ + G   + K+ DFGI   L   +          T+  G   Y AP
Sbjct: 99  GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

Query: 105 E--RIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           E  R EP  P        +D+++ G+  +E  TG+
Sbjct: 159 EQLRGEPVTPN-------SDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 32/81 (39%), Positives = 42/81 (51%), Gaps = 7/81 (8%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR--TKNAGCAAYMAPERIEPPNPQK 114
           V+HRD+KP N+L+D +G IKL DFG+  R      R  T       Y APE +       
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGL-ARAFGIPVRVYTHEVVTLWYRAPEVLL----GS 176

Query: 115 PDYDIRADVWSLGITLVELAT 135
           P Y    D+WS+G    E+AT
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 41/109 (37%), Positives = 60/109 (55%), Gaps = 15/109 (13%)

Query: 38  GKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS----GRLVDSKART 93
           G + +  + A+H++   H +IHRD+K +NILL   G +KL DFG S      + D   RT
Sbjct: 146 GLLFIQVLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 94  KNAGCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
              G   Y+APE  R +P       Y  +AD++SLG+ L EL T + P+
Sbjct: 205 -FCGTPYYVAPEIWRRKP-------YSKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 35/127 (27%), Positives = 52/127 (40%), Gaps = 30/127 (23%)

Query: 35  PICGKITLST----------VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG 84
                  LST             + YL    GVIH+D+   N ++DE   +K+ D  +S 
Sbjct: 107 EANNPQALSTQQLVHMAIQIACGMSYL-HKRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Query: 85  RLV--------DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT- 135
            L         D++ R        +MA E +        +Y   +DVWS G+ L EL T 
Sbjct: 166 DLFPMDYHCLGDNENRP-----VKWMALESL-----VNKEYSSASDVWSFGVLLWELMTL 215

Query: 136 GEFPYKD 142
           G+ PY +
Sbjct: 216 GQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 11/95 (11%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPER 106
           YL E+   IHRD+   NIL+ E    K+ DFG++ RL++    T   G      + APE 
Sbjct: 118 YL-ESRNYIHRDLAARNILVGENLVCKIADFGLA-RLIEDDEYTAREGAKFPIKWTAPEA 175

Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                     + I++DVWS GI L E+ T G  PY
Sbjct: 176 ANYGR-----FTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 31/180 (17%)

Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALH----------YLKET 54
           S      + MELMA    +   R      E   G    +  K +           YL   
Sbjct: 79  STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK 138

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPERIEPP 110
              +HRD+   N ++ E   +K+ DFG++ R +      +  G       +MAPE ++  
Sbjct: 139 K-FVHRDLAARNCMVAEDLTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMAPESLK-- 194

Query: 111 NPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPN 163
                D  +  ++DVWS G+ L E+AT  E PY+    + EVL  V++    D P   P+
Sbjct: 195 -----DGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGHLDLPENCPD 248

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 7/101 (6%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           ++HRD+KP N+L++E+G +KL DFG++  + V +K  +       Y  P+ +        
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST---- 179

Query: 116 DYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
           +Y    D+W +G  L E+ATG   FP    K +  ++ R+L
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 11/96 (11%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPER 106
           L +L  + G+I+RD+K  N++LD  G+IK+ DFG+    +     T+   G   Y+APE 
Sbjct: 114 LFFL-HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172

Query: 107 I--EPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           I  +P       Y    D W+ G+ L E+  G+ P+
Sbjct: 173 IAYQP-------YGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 9/134 (6%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
            D ++ M  M T   +L+K  H  + E     +    +K L Y+    G+IHRD+KP N+
Sbjct: 93  HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYI-HAAGIIHRDLKPGNL 149

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
            ++E   +K+ DFG++ R  DS+  T       Y APE I         Y    D+WS+G
Sbjct: 150 AVNEDCELKILDFGLA-RQTDSEM-TGYVVTRWYRAPEVIL----NWMHYTQTVDIWSVG 203

Query: 128 ITLVELATGEFPYK 141
             + E+ TG+  +K
Sbjct: 204 CIMAEMLTGKPLFK 217

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.6 bits (134), Expect = 5e-09
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 10/92 (10%)

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ E    K+ DFG++ RL++    T   G      + APE I  
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 175

Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 176 ---NYGTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 5/91 (5%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++AL YL    G+IHRDVK  NI LDE  N  L DFG + +L       +  G +  +  
Sbjct: 195 LEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL-- 251

Query: 105 ERIEPPNPQKPD-YDIRADVWSLGITLVELA 134
                P     D Y  + D+WS G+ L E++
Sbjct: 252 -ETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 55.2 bits (133), Expect = 7e-09
 Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 5/83 (6%)

Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNP 112
           +H V+HRD+KP N+L++  G IKL DFG++    V  +  T       Y APE +     
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 113 QKPDYDIRADVWSLGITLVELAT 135
               Y    D+WSLG    E+ T
Sbjct: 178 ----YSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.2 bits (133), Expect = 7e-09
 Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 9/122 (7%)

Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDF 80
           D   +     +P           +K + +    HGV+HRD+KP N+L+D ++G +K+ D 
Sbjct: 97  DSNGRGPGRPLPAKTIKSFMYQLLKGVAHC-HKHGVMHRDLKPQNLLVDKQKGLLKIADL 155

Query: 81  GISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE-- 137
           G+     +  K+ T       Y APE +         Y    D+WS+G    E++  +  
Sbjct: 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST----HYSTPVDIWSVGCIFAEMSRKQPL 211

Query: 138 FP 139
           FP
Sbjct: 212 FP 213

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 7/101 (6%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           V+HRD+KP N+L++ERG +KL DFG++  + V +K  +       Y  P+ +   +    
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS---- 180

Query: 116 DYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
           +Y  + D+W +G    E+A+G   FP    + +  ++ R+L
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 8e-09
 Identities = 38/131 (29%), Positives = 57/131 (43%), Gaps = 14/131 (10%)

Query: 29  HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-V 87
              +  P+        ++ + Y   +H V+HRD+KP N+L+D  G +KL DFG++    V
Sbjct: 93  LTGLDPPLIKSYLYQLLQGIAYC-HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151

Query: 88  DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FPYKDCKC 145
             +  T       Y APE I   + Q   Y    D+WS+G    E+      FP  D + 
Sbjct: 152 PVRTYTHEVVTLWYRAPE-ILLGSRQ---YSTPVDIWSIGCIFAEMVNRRPLFP-GDSEI 206

Query: 146 D-----FEVLS 151
           D     F  L 
Sbjct: 207 DQLFRIFRTLG 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 7/101 (6%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           V+HRD+KP N+L++ERG +KL DFG++  + + +K  +       Y  P+ +        
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST---- 180

Query: 116 DYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
           DY  + D+W +G    E++TG   FP    +     + R+L
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 54.6 bits (131), Expect = 9e-09
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 13/142 (9%)

Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +KE  ++I  E MA  +  D L       V  P     +    + + Y+ E    IHRD+
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI-ERKNYIHRDL 129

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDI 119
           + +N+L+ E    K+ DFG++ R+++    T   G      + APE I         + I
Sbjct: 130 RAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAI-----NFGSFTI 183

Query: 120 RADVWSLGITLVELAT-GEFPY 140
           ++DVWS GI L E+ T G+ PY
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 54.8 bits (132), Expect = 9e-09
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 11/154 (7%)

Query: 5   SKESDVWICMELMAT-CF-DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +K+  ++I  E MA  C  + L +R      E +   +     +A+ YL E++G IHRD+
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD-MCSDVCEAMEYL-ESNGFIHRDL 126

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRA 121
              N L+ E   +K+ DFG++ R V     T + G      P +  PP       +  ++
Sbjct: 127 AARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSSQGTK---FPVKWAPPEVFDYSRFSSKS 182

Query: 122 DVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVL 154
           DVWS G+ + E+ + G+ PY +   + EV+  V 
Sbjct: 183 DVWSFGVLMWEVFSEGKMPY-ERFSNSEVVESVS 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPN 111
            + G+I+RD+K  N++LD  G+IK+ DFG+    +     TK   G   Y+APE I    
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA--- 174

Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYK 141
             +P Y    D W+ G+ L E+  G+ P++
Sbjct: 175 -YQP-YGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 8/96 (8%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           V    YL+  + +++RD+KP N+LLD+ G IK+ DFG + ++VD++  T   G   Y+AP
Sbjct: 141 VLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTYTL-CGTPEYIAP 197

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           E +      K      AD W+LGI + E+  G  P+
Sbjct: 198 EILLNVGHGKA-----ADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 41/131 (31%), Positives = 58/131 (44%), Gaps = 35/131 (26%)

Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----------- 89
           T+  + A+H L    G IHRD+KP N+LLD +G++KL DFG+   L  +           
Sbjct: 110 TVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165

Query: 90  ---------------KART--KNAGCAAYMA---PERIEPPNPQKPDYDIRADVWSLGIT 129
                          KA T  KN    AY     P+ I P    +  Y+   D WSLG+ 
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 130 LVELATGEFPY 140
           + E+  G  P+
Sbjct: 226 MYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 34/127 (26%), Positives = 51/127 (40%), Gaps = 11/127 (8%)

Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           DRL K               +     + YL+     IHRD+   NILL     +K+ DFG
Sbjct: 84  DRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-FIHRDLAARNILLASDDKVKIGDFG 142

Query: 82  ISGRLVDSKARTKNAGCA----AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-G 136
           +   L  ++             A+ APE +     +   +   +DVW  G+TL E+ T G
Sbjct: 143 LMRALPQNEDHYVMEEHLKVPFAWCAPESL-----RTRTFSHASDVWMFGVTLWEMFTYG 197

Query: 137 EFPYKDC 143
           E P+   
Sbjct: 198 EEPWAGL 204

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 27/146 (18%)

Query: 1   MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETH 55
             P +   DV++ M+LM +    ++   H   P      +T   ++   Y     LK  H
Sbjct: 74  RPPGADFKDVYVVMDLMESDLHHII---HSDQP------LTEEHIRYFLYQLLRGLKYIH 124

Query: 56  --GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR------TKNAGCAAYMAPERI 107
              VIHRD+KPSN+L++E   +++ DFG++ R + S         T+      Y APE +
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMA-RGLSSSPTEHKYFMTEYVATRWYRAPELL 183

Query: 108 EPPNPQKPDYDIRADVWSLGITLVEL 133
                  P+Y    D+WS+G    E+
Sbjct: 184 L----SLPEYTTAIDMWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 38/133 (28%), Positives = 56/133 (42%), Gaps = 18/133 (13%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++ L YL     +IHRDVK  NI +++   + + D G +   V + A    AG     AP
Sbjct: 167 LEGLRYL-HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVEL------------ATGEFPYKDCKCDFEVLSR 152
           E +      +  Y+ +AD+WS GI L E+            +T E   K C      +  
Sbjct: 226 EVL-----ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280

Query: 153 VLNDAPPCLPNDP 165
            L   P   P DP
Sbjct: 281 TLKVHPEEFPRDP 293

Length = 357

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 175

Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMPCPPECP 229

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 17/144 (11%)

Query: 5   SKESDVWICMELMATCFDRLLKRLH----VSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           ++E   +I  E M   +  LL  L       V   +   +      A+ YL++ +  IHR
Sbjct: 72  TREPPFYIITEFM--TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-FIHR 128

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 182

Query: 118 DIRADVWSLGITLVELAT-GEFPY 140
            I++DVW+ G+ L E+AT G  PY
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 23/142 (16%)

Query: 9   DVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD+
Sbjct: 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRDL 152

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSNI++     +K+ DFG++     S   T       Y APE I         Y    D
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVD 207

Query: 123 VWSLGITLVELATGE--FPYKD 142
           +WS+G  + E+  G   FP  D
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 16/115 (13%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++ L Y+   H ++HRD+KP N+L+   G +KL DFG+        AR K+     Y + 
Sbjct: 113 LRGLAYIHGQH-ILHRDLKPQNLLISYLGELKLADFGL--------ARAKSIPSQTYSS- 162

Query: 105 ERI----EPPNP--QKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           E +     PP+      DY    D+W  G   +E+  G+  +      FE L ++
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 8/139 (5%)

Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL+ +   VP           +KA+H+  +   ++HRD+KP N+L+     +KLCDFG +
Sbjct: 89  LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFA 147

Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPN-PQKPDYDIRADVWSLGITLVELATGE--FPY 140
             L +      NA    Y+A      P       Y    D+WS+G  L EL+ G+  FP 
Sbjct: 148 RNLSEG----SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203

Query: 141 KDCKCDFEVLSRVLNDAPP 159
           +        + +VL   P 
Sbjct: 204 ESEIDQLFTIQKVLGPLPA 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 37/126 (29%), Positives = 57/126 (45%), Gaps = 25/126 (19%)

Query: 30  VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERGNIKLCDFGISGR 85
           VS+P  +   +    +  +HYL     V+HRD+KP+NIL+     ERG +K+ D G++ R
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLA-R 160

Query: 86  LVDSKARTKNAGCAA-----YMAPE-----RIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           L ++  +             Y APE     R          Y    D+W++G    EL T
Sbjct: 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGAR---------HYTKAIDIWAIGCIFAELLT 211

Query: 136 GEFPYK 141
            E  +K
Sbjct: 212 LEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 41/155 (26%)

Query: 10  VWICMELMATCFDRLLKRLHV--SVPE--PICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           VW          + L K L    SV     I  KI  +T++ +H    + GV+HRD+KP 
Sbjct: 96  VWQK--------ESLSKELAEKTSVGAFLSIFHKIC-ATIEYVH----SKGVLHRDLKPD 142

Query: 66  NILLDERGNIKLCDFGIS-------GRLVDSKARTKNA------------GCAAYMAPER 106
           NILL   G + + D+G +         L+D     +N             G   YMAPER
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202

Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           +    P         D+++LG+ L ++ T  FPY+
Sbjct: 203 LL-GVPAS----ESTDIYALGVILYQMLTLSFPYR 232

Length = 932

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 24/50 (48%), Positives = 31/50 (62%), Gaps = 1/50 (2%)

Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           E +  K       AL YL   HG+IHRD+KP N+L+   G+IKL DFG+S
Sbjct: 103 EEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 46/124 (37%), Positives = 64/124 (51%), Gaps = 16/124 (12%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DS--KARTKNAGCAAYMA 103
           + YL+  + V HRD+   N+LL  +   K+ DFG+S  L   DS  KAR+       + A
Sbjct: 108 MKYLEGKNFV-HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA 166

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN----DAP 158
           PE I   N +K  +  R+DVWS GIT+ E  + G+ PYK  K   EV+S +      D P
Sbjct: 167 PECI---NFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIEQGKRLDCP 220

Query: 159 PCLP 162
              P
Sbjct: 221 AECP 224

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 22/39 (56%), Positives = 29/39 (74%), Gaps = 4/39 (10%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           ++A+H L    G IHRD+KP NIL+D  G+IKL DFG+S
Sbjct: 114 IEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 15/136 (11%)

Query: 10  VWICMELMA----TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++I MELM+      F R   R  VSV + +  + +L   + + YL E+  ++HRD+   
Sbjct: 73  LYIVMELMSKGNLVNFLRTRGRALVSVIQLL--QFSLDVAEGMEYL-ESKKLVHRDLAAR 129

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL+ E G  K+ DFG++   V S     +     + APE +     +   +  ++DVWS
Sbjct: 130 NILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKWTAPEAL-----KHKKFSSKSDVWS 182

Query: 126 LGITLVEL-ATGEFPY 140
            G+ L E+ + G  PY
Sbjct: 183 YGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 6/86 (6%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           G+I+RD+K  N++LD  G+IK+ DFG+    +VD        G   Y+APE I      +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII----AYQ 176

Query: 115 PDYDIRADVWSLGITLVELATGEFPY 140
           P Y    D W+ G+ L E+  G+ P+
Sbjct: 177 P-YGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 18/145 (12%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEP-----ICGKITLSTVKALHYLKETHGVI 58
           +K+  ++I  E M+  C    L R H    +P     +C  +     + + YL E+   I
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVC----EGMAYL-ESKQFI 122

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDY 117
           HRD+   N L+D++G +K+ DFG+S R V     T + G      P R  PP       +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLS-RYVLDDEYTSSVGSK---FPVRWSPPEVLLYSKF 178

Query: 118 DIRADVWSLGITLVELAT-GEFPYK 141
             ++DVW+ G+ + E+ + G+ PY+
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 9/100 (9%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQK 114
           IHRD+   NILL E   +K+CDFG++  +       +         +MAPE I       
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FD 255

Query: 115 PDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
             Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 9/92 (9%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L  V  LH    +H ++HRD+KP NIL+   G +K+ DFG++       A T       Y
Sbjct: 117 LRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWY 172

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            APE +     Q   Y    D+WS+G    EL
Sbjct: 173 RAPEVLL----QSS-YATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 10/99 (10%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCA--AYM 102
           K ++YL+E   ++HRD+   N+L+    ++K+ DFG++  L  D K      G     +M
Sbjct: 120 KGMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           A E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 179 ALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 12/125 (9%)

Query: 14  MELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG 73
            ELM      L+K     +PE          +K+L ++   +G+ HRD+KP NIL+ +  
Sbjct: 79  FELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D 136

Query: 74  NIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPD--YDIRADVWSLGITL 130
            +KL DFG S R + SK   T+      Y APE +        D  Y  + D+W++G   
Sbjct: 137 ILKLADFG-SCRGIYSKPPYTEYISTRWYRAPECL------LTDGYYGPKMDIWAVGCVF 189

Query: 131 VELAT 135
            E+ +
Sbjct: 190 FEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 39/144 (27%), Positives = 52/144 (36%), Gaps = 28/144 (19%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
           AL YL    G+++RD+KP NILL E G+I L DF +S +          A          
Sbjct: 115 ALEYL-HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 107 IEPPNPQKPDYD------------------IRA-------DVWSLGITLVELATGEFPYK 141
              P+    +                    I         D W+LGI L E+  G  P+K
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233

Query: 142 DCKCDFEVLSRVLNDAPPCLPNDP 165
               D E  S +L       P  P
Sbjct: 234 GSNRD-ETFSNILKK-EVTFPGSP 255

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 11/100 (11%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA----AYMAPERIEPPNPQ 113
           IHRD+   NILL E   +K+CDFG++  +       +  G A     +MAPE I      
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GDARLPLKWMAPESI-----F 248

Query: 114 KPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSR 152
              Y  ++DVWS G+ L E+ + G  PY   + D E   R
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITL-STVKALHYLKETHGV 57
           M P S+    D+++  ELM +   +++K      PE    +  L   ++AL Y+  T  V
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH--QFFLYQLLRALKYI-HTANV 124

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-----TKNAGCAAYMAPERIEPPNP 112
            HRD+KP NIL +    +K+CDFG++ R+  +        T       Y APE       
Sbjct: 125 FHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELC---GS 180

Query: 113 QKPDYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPP 159
               Y    D+WS+G    E+ TG+  FP K+     ++++ +L    P
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 14/108 (12%)

Query: 38  GKITLSTVKALHY--LKET-----HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 90
           G +  +TVK+  Y  LK       + V+HRD+KP N+L+++RG +KL DFG+  R     
Sbjct: 95  GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGL-ARAFGIP 153

Query: 91  ARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
             T +       Y AP+ +         Y    D+WS+G  + E+ TG
Sbjct: 154 VNTFSNEVVTLWYRAPDVLLGSRT----YSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 21/139 (15%)

Query: 9   DVWICMELMATCFDRLL------KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           DV++ MELM     +++      +R+   + + +CG      +K LH    + G+IHRD+
Sbjct: 100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRDL 149

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSNI++     +K+ DFG++     +   T       Y APE I         Y    D
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI-----LGMGYKENVD 204

Query: 123 VWSLGITLVELATGEFPYK 141
           +WS+G  + EL  G   ++
Sbjct: 205 IWSVGCIMGELVKGSVIFQ 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 10/101 (9%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAG---CAAYM 102
             + YL E    +HRD+   NIL++     K+ DFG+S RL DS+A     G      + 
Sbjct: 117 SGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT 175

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKD 142
           APE I         +   +DVWS GI + E ++ GE PY D
Sbjct: 176 APEAI-----AYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.4 bits (125), Expect = 9e-08
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 23/142 (16%)

Query: 9   DVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD+
Sbjct: 96  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRDL 145

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSNI++     +K+ DFG++     S   T       Y APE I         Y    D
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVD 200

Query: 123 VWSLGITLVELATGE--FPYKD 142
           +WS+G  + E+   +  FP +D
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRD 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 36/131 (27%), Positives = 48/131 (36%), Gaps = 49/131 (37%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKARTKN----------------- 95
           G IHRD+KP NIL+D  G+IKL DFG+        DSK   K                  
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 96  ------------------------AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLV 131
                                    G   Y+APE +      +  Y    D WS+G+ L 
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQLCDWWSVGVILY 235

Query: 132 ELATGEFPYKD 142
           E+  G+ P+  
Sbjct: 236 EMLVGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 17/91 (18%)

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI----EPPNP 112
           V+HRD+KP N+L+ ERG +KL DFG+        AR K+     Y + E +     PP+ 
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGL--------ARAKSVPSKTY-SNEVVTLWYRPPDV 174

Query: 113 --QKPDYDIRADVWSLGITLVELATGE--FP 139
                +Y    D+W +G    E+ATG   FP
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 18/118 (15%)

Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           D++  +  +     IC        K + YL  +   IHRD+   NIL++    +K+ DFG
Sbjct: 104 DQINLKRLLLFSSQIC--------KGMDYL-GSQRYIHRDLAARNILVESEDLVKISDFG 154

Query: 82  ISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           ++  L + K     +        + APE +     +   +   +DVWS G+TL EL T
Sbjct: 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECL-----RTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 10/113 (8%)

Query: 23  RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNI-KLCDFG 81
             LK    ++ E    +  +  +  +HY+ +   ++HRD+K  NI L  + N+ K+ DFG
Sbjct: 94  EELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-ILHRDLKAKNIFL--KNNLLKIGDFG 150

Query: 82  ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
           +S  L+ S    T   G   YM+PE +     +   YD ++D+WSLG  L E+
Sbjct: 151 VSRLLMGSCDLATTFTGTPYYMSPEAL-----KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 6/102 (5%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           VP      +    ++ L +L  +H V+HRD+KP NIL+   G IKL DFG++       A
Sbjct: 107 VPTETIKDMMFQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 165

Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            T       Y APE +      +  Y    D+WS+G    E+
Sbjct: 166 LTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 12/107 (11%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD----SKARTKNAG 97
           L   K + YL     V HRD+   N +LDE   +K+ DFG++  + D    S      A 
Sbjct: 105 LQVAKGMEYLASKKFV-HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 98  C-AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD 142
               +MA E +     Q   +  ++DVWS G+ L EL T G  PY D
Sbjct: 164 LPVKWMALESL-----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 36/131 (27%), Positives = 56/131 (42%), Gaps = 35/131 (26%)

Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----------- 89
           T+  + ++H L    G IHRD+KP N+LLD +G++KL DFG+   L  +           
Sbjct: 110 TVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165

Query: 90  ---------------KART-----KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGIT 129
                          KA T     +    +    P+ I P    +  Y+   D WSLG+ 
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 130 LVELATGEFPY 140
           + E+  G  P+
Sbjct: 226 MYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 28/112 (25%), Positives = 54/112 (48%), Gaps = 4/112 (3%)

Query: 30  VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 89
            ++P     +  +     + YL  +   IHRD+   N +L+E   + + DFG+S ++   
Sbjct: 108 FTLPLQTLVRFMIDIASGMEYL-SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166

Query: 90  KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
               +  GCA+ +  + +   +     Y   +DVW+ G+T+ E+ T G+ PY
Sbjct: 167 DYYRQ--GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 25/144 (17%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETH--GVIHR 60
           ++V++   LM    + ++K          C K++   V+ L Y     LK  H  G+IHR
Sbjct: 93  NEVYLVTNLMGADLNNIVK----------CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +++ DFG++ R  D +  T       Y APE +         Y+  
Sbjct: 143 DLKPSNVAVNEDCELRILDFGLA-RQADDEM-TGYVATRWYRAPEIML----NWMHYNQT 196

Query: 121 ADVWSLGITLVELATGE--FPYKD 142
            D+WS+G  + EL  G+  FP  D
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 4/110 (3%)

Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           +P  +  K        + YL  +   IHRD+   N +L+E  N+ + DFG+S ++ +   
Sbjct: 109 LPTQMLVKFMTDIASGMEYL-SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167

Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +  G  A M  + I   +     Y  ++DVWS G+T+ E+AT G+ PY
Sbjct: 168 YRQ--GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 51  LKETHG--VIHRDVKPSNILLDERGNIKLCDFGIS-----GRLVDSKARTKNAGCAAYMA 103
           LK  H   V+HRD+KP N+L++    +K+CDFG++         ++   T+      Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPPCL 161
           PE +         Y    DVWS+G  L EL   +  F  KD       + +VL       
Sbjct: 178 PEIMLSFQS----YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT----- 228

Query: 162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYE 192
           P++    R I +  A++  RS   I K+ +E
Sbjct: 229 PDEETLSR-IGSPKAQNYIRSLPNIPKKPFE 258

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 13/137 (9%)

Query: 10  VWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++I  E M   +  D L        P P     +    + + ++ E    IHRD++ +NI
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRNYIHRDLRAANI 133

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDIRADVW 124
           L+      K+ DFG++ R+++    T   G      + APE I         + I++DVW
Sbjct: 134 LVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAI-----NFGSFTIKSDVW 187

Query: 125 SLGITLVELAT-GEFPY 140
           S GI L+E+ T G  PY
Sbjct: 188 SFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 22/100 (22%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--------DSKARTKNAGCAAY 101
           YL+E +  IHRD+   NIL+ E    K+ DFG++ RL+        D K   K      +
Sbjct: 119 YLEEQN-SIHRDLAARNILVGEDLVCKVADFGLA-RLIKEDVYLSSDKKIPYK------W 170

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            APE     +     +  ++DVWS GI L E+ T G+ PY
Sbjct: 171 TAPEAA---SHGT--FSTKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 9/100 (9%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCA-AYMAPERIEPPNPQK 114
           IHRD+   NILL E   +K+CDFG++  +       R  +A     +MAPE I       
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI-----FD 250

Query: 115 PDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
             Y  ++DVWS G+ L E+ + G  PY   + + E   R+
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 5/102 (4%)

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    IHRD++ +NIL+ +    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 175

Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
               + I++DVWS GI L EL T G  PY     + EVL +V
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKARTKNAGC 98
           L  +K LH    + G++HRD+KP N+L++    +K+CDFG++ R+ +   SK  T+    
Sbjct: 113 LRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLA-RVEEPDESKHMTQEVVT 167

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
             Y APE +         Y    D+WS+G    EL
Sbjct: 168 QYYRAPEILM----GSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 14/165 (8%)

Query: 7   ESDVWICMELMATCFDR-LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ VWI MEL      R  L+    S+        +     AL YL E+   +HRD+   
Sbjct: 78  ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL-ESKRFVHRDIAAR 136

Query: 66  NILLDERGNIKLCDFGISGRLVDS---KARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           N+L+     +KL DFG+S  L D    KA +K      +MAPE I   N ++  +   +D
Sbjct: 137 NVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESI---NFRR--FTSASD 190

Query: 123 VWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           VW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 191 VWMFGVCMWEILMLGVKPFQGVK-NNDVIGRIENGERLPMPPNCP 234

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 21/93 (22%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRDV   N+LL +    K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP----VKWMAPESIF-- 287

Query: 111 NPQKPD--YDIRADVWSLGITLVEL-ATGEFPY 140
                D  Y +++DVWS GI L E+ + G+ PY
Sbjct: 288 -----DCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 17/129 (13%)

Query: 38  GKITLSTVKALHY--LK-----ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 90
           G I    VK+  +  LK      +H V+HRD+KP N+L+++ G +KL DFG++ R     
Sbjct: 94  GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIP 152

Query: 91  ARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE---FPYKDCKC 145
            R  +A      Y  P+ +         Y    D+WS G    ELA      FP  D   
Sbjct: 153 VRCYSAEVVTLWYRPPDVLFGAKL----YSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208

Query: 146 DFEVLSRVL 154
             + + R+L
Sbjct: 209 QLKRIFRLL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.1 bits (119), Expect = 3e-07
 Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    IHRD++ +NIL+ +    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 175

Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPY 140
               + I++DVWS GI L EL T G  PY
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 14/129 (10%)

Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC 98
           K +L   +A+ YL E +  +HRD+   N+L+ E    K+ DFG++     ++   K    
Sbjct: 106 KFSLDVCEAMEYL-EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-- 162

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN-- 155
             + APE +     ++  +  ++DVWS GI L E+ + G  PY       +V+ RV    
Sbjct: 163 VKWTAPEAL-----REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGY 216

Query: 156 --DAPPCLP 162
             DAP   P
Sbjct: 217 KMDAPDGCP 225

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 17/93 (18%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   N+LL     +K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP----VKWMAPESI--- 215

Query: 111 NPQKPDYDIRADVWSLGITLVELAT-GEFPYKD 142
                 Y   +DVWS GI L E+ + G  PY  
Sbjct: 216 --FNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)

Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
            +  L Y+    G+IHRD+KP N+ ++E   +K+ DFG++ R  D++  T       Y A
Sbjct: 126 MLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLA-RHADAEM-TGYVVTRWYRA 182

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           PE I         Y+   D+WS+G  + E+ TG+  +K
Sbjct: 183 PEVIL----NWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 49.2 bits (117), Expect = 6e-07
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 11/105 (10%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--- 98
           L   + + YL E+  VIHRD+   N L+ E   +K+ DFG++ R V     T + G    
Sbjct: 107 LDVCEGMAYL-ESSNVIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFP 164

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKD 142
             + +PE           Y  ++DVWS G+ + E+ + G+ PY++
Sbjct: 165 VKWSSPEVFSFSK-----YSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 10/99 (10%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYM 102
           + + YL E   ++HRD+   N+L+ E   +K+ DFG+S  + +  +   R+K      +M
Sbjct: 138 RGMQYLAEMK-LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM 196

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           A E +         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 197 AIESL-----FDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 25/146 (17%)

Query: 12  ICMELMATCFDRLL-KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
           + M++MA+   +++ +++ ++  +  C  I L  +  L+ L + +  +HRD+ P+NI ++
Sbjct: 97  LVMDIMASDLKKVVDRKIRLTESQVKC--ILLQILNGLNVLHKWY-FMHRDLSPANIFIN 153

Query: 71  ERGNIKLCDFGISGR-----LVDSKARTKNAGCAA----------YMAPERIEPPNPQKP 115
            +G  K+ DFG++ R       D+ ++ +                Y APE +        
Sbjct: 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE---- 209

Query: 116 DYDIRADVWSLGITLVELATGE--FP 139
            Y    D+WS+G    EL TG+  FP
Sbjct: 210 KYHFAVDMWSVGCIFAELLTGKPLFP 235

Length = 335

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 44/150 (29%), Positives = 58/150 (38%), Gaps = 38/150 (25%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   NILL      K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP----VKWMAPESI--- 288

Query: 111 NPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
                 Y   +DVWS GI L E+ + G  PY                  P +P D  F +
Sbjct: 289 --FNCVYTFESDVWSYGILLWEIFSLGSSPY------------------PGMPVDSKFYK 328

Query: 170 TIKASIAKDNGRSTEFIRKRSYEDKSTCYE 199
            IK         S E      Y+   +C++
Sbjct: 329 MIKEGYRML---SPECAPSEMYDIMKSCWD 355

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 7/110 (6%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGN-IKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           +AL Y+  +  + HRD+KP N+L+D   + +KLCDFG +  L+  +          Y AP
Sbjct: 181 RALAYI-HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           E +        +Y    D+WSLG  + E+  G +P    +   + L R++
Sbjct: 240 ELMLGAT----NYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 25/155 (16%)

Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
           +I +E +      + KR+     + +   I    +  L Y+ E HG+ H D+KP NI++D
Sbjct: 103 FILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVD 160

Query: 71  ERGNIKLCDFGIS------GRLVDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRAD 122
                 + D+GI+      G+ ++     K+   G   Y     ++  N        R D
Sbjct: 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAG---LDAHNGACVTR--RGD 215

Query: 123 VWSLGITLVELATGEFPYKD----------CKCDF 147
           + SLG  +++ A  + P+K            KCDF
Sbjct: 216 LESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF 250

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 33/83 (39%), Positives = 43/83 (51%), Gaps = 8/83 (9%)

Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKARTKNAGCAAYMAPERIEPPNP 112
             +HRD+K SNILL+ +G IKL DFG++ RL    +S+  T       Y  PE +     
Sbjct: 136 NFLHRDIKCSNILLNNKGQIKLADFGLA-RLYNSEESRPYTNKVITLWYRPPELLL---- 190

Query: 113 QKPDYDIRADVWSLGITLVELAT 135
            +  Y    DVWS G  L EL T
Sbjct: 191 GEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 16/144 (11%)

Query: 1   MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
            SP+++ S         ++     L  L +S  E +C  I       + YL E    +HR
Sbjct: 102 RSPRAQCSLS----HSTSSARKCGLNPLPLSCTEQLC--IAKQVAAGMAYLSERK-FVHR 154

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDS---KARTKNAGCAAYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S  +  +   KA   +A    +M PE I         Y
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-----FYNRY 209

Query: 118 DIRADVWSLGITLVEL-ATGEFPY 140
              +DVW+ G+ L E+ + G  PY
Sbjct: 210 TTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 50/170 (29%), Positives = 70/170 (41%), Gaps = 23/170 (13%)

Query: 11  WICMELMA----TCFDRLLKRLHVSVPEPICGK----ITLSTVKALHYLKETHGVIHRDV 62
           +I +ELMA      F R   R     P  +  K          K   YL+E H  IHRD+
Sbjct: 85  FILLELMAGGDLKSFLRE-NRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-FIHRDI 142

Query: 63  KPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYD 118
              N LL  +G     K+ DFG++  +  +    K  G A  M P +  PP       + 
Sbjct: 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-GRA--MLPIKWMPPEAFLDGIFT 199

Query: 119 IRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLN----DAPPCLPN 163
            + DVWS G+ L E+ + G  PY   + + EV+  V      D P   P 
Sbjct: 200 SKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTGGGRLDPPKGCPG 248

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 18/103 (17%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG-------RLVDSKARTKNAGC 98
           K ++YL+E H ++HR++   NILL     +++ DFG++        +   S+ +T     
Sbjct: 120 KGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP---- 174

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ E+ + G  PY
Sbjct: 175 IKWMALESI-----LFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 17/104 (16%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           L   + + YL E    +HRD+   N+L+ E    K+ DFG+      +K  ++       
Sbjct: 109 LDVCEGMEYL-EEKNFVHRDLAARNVLVSEDLVAKVSDFGL------AKEASQGQDSGKL 161

Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPY 140
              + APE +      +  +  ++DVWS GI L E+ + G  PY
Sbjct: 162 PVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 55/163 (33%)

Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           F  +L R +++       ++TL+ ++++H +    G IHRD+KP NIL+D  G+IKL DF
Sbjct: 98  FPEVLARFYIA-------ELTLA-IESVHKM----GFIHRDIKPDNILIDLDGHIKLTDF 145

Query: 81  GI--------------------------------------SGRL--VDSKARTKNAGCAA 100
           G+                                        RL  ++ +A  ++  C A
Sbjct: 146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205

Query: 101 YM---APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           +     P  I P    +  Y    D WS+G+ L E+  G+ P+
Sbjct: 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 30/122 (24%), Positives = 53/122 (43%), Gaps = 19/122 (15%)

Query: 27  RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 86
            + ++  +  C    L  ++ ++YL E H ++HRD+K +NIL+D +G +K+ DFG++   
Sbjct: 109 SVKLTESQIKC--YMLQLLEGINYLHENH-ILHRDIKAANILIDNQGILKIADFGLARPY 165

Query: 87  VDSKARTKNAGCAA------------YMAPERIEPPNPQKPDYDIRADVWSLGITLVELA 134
                  K  G               Y  PE +      +  Y    D+W +G    E+ 
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL----GERRYTTAVDIWGIGCVFAEMF 221

Query: 135 TG 136
           T 
Sbjct: 222 TR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.8 bits (113), Expect = 2e-06
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 9/114 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMA 103
           ++ L Y+ + + ++HRD+KP N+L+ + G +KL DFG++  + V S   +       Y  
Sbjct: 113 LRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATG--EFP-YKDCKCDFEVLSRVL 154
           P+ +        +Y    D+W +G   VE+  G   FP  KD +   E +  VL
Sbjct: 172 PDVLLGST----EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 9/92 (9%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L  +  LH     + ++HRD+KP NIL+   G +KL DFG++       A T       Y
Sbjct: 118 LRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWY 173

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            APE +      +  Y    D+WS+G    E+
Sbjct: 174 RAPEVL-----LQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)

Query: 54  THGVIHRDVKPSNILLDERGN-IKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPN 111
           +H V+HRD+KP N+L+D R N +KL DFG++    +  +  T       Y APE +    
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 112 PQKPDYDIRADVWSLGITLVELATGE--FP 139
                Y    D+WS+G    E+   +  FP
Sbjct: 180 ----HYSTPVDIWSVGCIFAEMVNQKPLFP 205

Length = 294

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 4/103 (3%)

Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC 98
           K  +     + YL      IHRD+   N +L E   + + DFG+S + + S    +  G 
Sbjct: 117 KFMVDIALGMEYL-SNRNFIHRDLAARNCMLREDMTVCVADFGLS-KKIYSGDYYRQ-GR 173

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            A M  + I   +     Y  ++DVW+ G+T+ E+AT G+ PY
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 41/135 (30%), Positives = 72/135 (53%), Gaps = 20/135 (14%)

Query: 23  RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI 82
           +L K + +S+ + +C        + + YL E +  IHRD+   N L+   G +K+ DFG+
Sbjct: 96  KLSKDMLLSMCQDVC--------EGMEYL-ERNSFIHRDLAARNCLVSSTGVVKVSDFGM 146

Query: 83  SGRLVDSKARTKNAGCAAYMAPERIEPP---NPQKPDYDIRADVWSLGITLVELAT-GEF 138
           + R V     T ++G A +  P +  PP   N  K  Y  ++DVWS G+ + E+ T G+ 
Sbjct: 147 T-RYVLDDEYTSSSG-AKF--PVKWSPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKM 200

Query: 139 PYKDCKCDFEVLSRV 153
           P++  K ++EV+  +
Sbjct: 201 PFEK-KSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 11/102 (10%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYMA 103
           + YL+E    +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + A
Sbjct: 108 MKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           PE +   N  K  +  ++DVWS G+ + E  + G+ PYK  K
Sbjct: 167 PECM---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 20/138 (14%)

Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN-----IKLCDFGISGRLVDS---KA 91
           I L   K   YL++ H  IHRD+   N L+ E+G      +K+ DFG++  +  S   + 
Sbjct: 111 ICLDVAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVL 150
             +      +MAPE +         +  ++DVWS G+ + E+ T G+ PY     + EVL
Sbjct: 170 EGEGLLPVRWMAPESL-----LDGKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVL 223

Query: 151 SRVLN----DAPPCLPND 164
             V        P   P+ 
Sbjct: 224 QHVTAGGRLQKPENCPDK 241

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 40/115 (34%), Positives = 52/115 (45%), Gaps = 14/115 (12%)

Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           + K L++  PE    +     V AL  L    G++ RD+ P+NILLD+RG+I+L  F   
Sbjct: 76  ISKFLNI--PEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRW 132

Query: 84  GRLVDSKARTKNAGCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATG 136
             + DS      A    Y APE   I              D WSLG  L EL TG
Sbjct: 133 SEVEDSCDG--EAVENMYCAPEVGGISEETEA-------CDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 9/89 (10%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGC--AAYMAPERIEPPNPQK 114
           +HRD+   N+L+ E   +K+CDFG++  ++ DS   +K +      +MAPE I       
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-----FN 315

Query: 115 PDYDIRADVWSLGITLVELAT-GEFPYKD 142
             Y   +DVWS GI L E+ T G  PY +
Sbjct: 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPE 344

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 17/139 (12%)

Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKA---LHYLKETHGVIHRDVKPSN 66
           ++I MEL+      LL  L          K+   ++ A   + YL E+   IHRD+   N
Sbjct: 67  IYIVMELVPG--GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNCIHRDLAARN 123

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCA----AYMAPERIEPPNPQKPDYDIRAD 122
            L+ E   +K+ DFG+S R  +    T + G       + APE +   N  +  Y   +D
Sbjct: 124 CLVGENNVLKISDFGMS-REEEGGIYTVSDGLKQIPIKWTAPEAL---NYGR--YTSESD 177

Query: 123 VWSLGITLVELAT-GEFPY 140
           VWS GI L E  + G+ PY
Sbjct: 178 VWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 53/155 (34%)

Query: 29  HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI------ 82
              + E  C       V+++H +    G IHRD+KP NIL+D  G+IKL DFG+      
Sbjct: 104 RFYIAELTCA------VESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153

Query: 83  --------SG------------------------RL--VDSKARTKNAGCAAYM---APE 105
                   SG                        RL  ++ +A  ++  C A+     P 
Sbjct: 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            I P    +  Y    D WS+G+ L E+  G+ P+
Sbjct: 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 34/140 (24%), Positives = 54/140 (38%), Gaps = 24/140 (17%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
              ++  E        LL   +V        K+    +  L+Y+   + ++HRD+K +NI
Sbjct: 92  GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI-HRNKILHRDMKAANI 150

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-------YMAPE-----RIEPPNPQKP 115
           L+ + G +KL DFG++     SK    N            Y  PE     R         
Sbjct: 151 LITKDGILKLADFGLARAFSLSKNSKPN--RYTNRVVTLWYRPPELLLGER--------- 199

Query: 116 DYDIRADVWSLGITLVELAT 135
           DY    D+W  G  + E+ T
Sbjct: 200 DYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 10/99 (10%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCA--AYM 102
           K + YL+E   ++HRD+   N+L+    ++K+ DFG++  L +D      + G     +M
Sbjct: 120 KGMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           A E I         +  ++DVWS G+T+ EL T G  PY
Sbjct: 179 ALESI-----LHRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 12/100 (12%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA----AY 101
           K + YL+E   ++HRD+   N+L+    ++K+ DFG++ RL++   +  NA        +
Sbjct: 120 KGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIKW 177

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           MA E I         +  ++DVWS G+T+ EL T G  PY
Sbjct: 178 MALECI-----HYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 16/124 (12%)

Query: 30  VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERGNIKLCDFGISGR 85
           V +P  +   +    +  +HYL   + V+HRD+KP+NIL+     ERG +K+ D G + R
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYL-HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-R 160

Query: 86  LVDSKAR-----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           L +S  +             Y APE +         Y    D+W++G    EL T E P 
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSE-PI 215

Query: 141 KDCK 144
             C+
Sbjct: 216 FHCR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 10/104 (9%)

Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGC- 98
           T    + + +L  +   +HRD+   N+LL +   +K+CDFG++  ++ DS   +K +   
Sbjct: 243 TYQVARGMEFLA-SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPY 140
              +MAPE I         Y   +DVWS GI L E+ + G  PY
Sbjct: 302 PVKWMAPESI-----FDNLYTTLSDVWSYGILLWEIFSLGGTPY 340

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 5   SKESDVWICMELM-ATCFDRLLKR--LHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +++  ++I MEL+    F   L+     + V E I  ++  +    + YL+  H  IHRD
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI--QMVENAAAGMEYLESKH-CIHRD 119

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD----- 116
           +   N L+ E+  +K+ DFG+S        R +  G  A     +  P     P+     
Sbjct: 120 LAARNCLVTEKNVLKISDFGMS--------REEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 117 -YDIRADVWSLGITLVE-LATGEFPY 140
            Y   +DVWS GI L E  + G  PY
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPY 197

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 36/124 (29%), Positives = 57/124 (45%), Gaps = 16/124 (12%)

Query: 30  VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERGNIKLCDFGISGR 85
           + +P  +   +    +  +HYL   + V+HRD+KP+NIL+     ERG +K+ D G + R
Sbjct: 103 MQLPRSMVKSLLYQILDGIHYL-HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-R 160

Query: 86  LVDSKAR-----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           L +S  +             Y APE +         Y    D+W++G    EL T E P 
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSE-PI 215

Query: 141 KDCK 144
             C+
Sbjct: 216 FHCR 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 22/119 (18%)

Query: 34  EPICGKITLSTV----KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--V 87
           E +  K  +S      + + YL E+   IHRD+   N+L+ E   +K+ DFG++  +  +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYL-ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187

Query: 88  DSKARTKNAGC-AAYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           D   +T N      +MAPE    R+         Y  ++DVWS GI + E+ T G  PY
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 3/97 (3%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI 107
           + YL E + V HRD+   NIL++     K+ DFG+S  L D  +            P R 
Sbjct: 119 MKYLSEMNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 108 EPPNP-QKPDYDIRADVWSLGITLVE-LATGEFPYKD 142
             P       +   +DVWS GI + E ++ GE PY D
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 19/92 (20%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYMAPE----RIEP 109
           IHRD+   N+L+ E   +K+ DFG++ R +      +  T       +MAPE    R+  
Sbjct: 154 IHRDLAARNVLVTEDHVMKIADFGLA-RDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-- 210

Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  Y  ++DVWS G+ L E+ T G  PY
Sbjct: 211 -------YTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 6/104 (5%)

Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC 98
           +I +     + YL   H V HRD+   N L+     +K+ DFG+S R V +    +  G 
Sbjct: 126 QIAVQIASGMVYLASQHFV-HRDLATRNCLVGYDLVVKIGDFGMS-RDVYTTDYYRVGGH 183

Query: 99  AAYMAPERIEPPNPQK-PDYDIRADVWSLGITLVELAT-GEFPY 140
              M P R  PP       +   +DVWS G+ L E+ T G+ P+
Sbjct: 184 T--MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 9/101 (8%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAPE 105
            + YL E    IHRD+   N+L+ E    K+ DFG+S G  V  K +T       +MA E
Sbjct: 131 GMQYLSEKQ-FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIE 188

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC 145
            +         Y  ++DVWS G+ L E+ + G  PY    C
Sbjct: 189 SL-----NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 12/106 (11%)

Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKN 95
           I +     + YL  +H  +HRD+   N L+ E   +K+ DFG+S R + S    + ++K+
Sbjct: 129 IAIQIAAGMEYL-SSHHFVHRDLAARNCLVGEGLTVKISDFGLS-RDIYSADYYRVQSKS 186

Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPY 140
                +M PE I         +   +D+WS G+ L E+ + G  PY
Sbjct: 187 LLPVRWMPPEAI-----LYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)

Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 143 TYQVARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 202 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 10/105 (9%)

Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KARTKNA 96
           I +     + YL  +H  +H+D+   NIL+ E+ ++K+ D G+S  +  +   + + K+ 
Sbjct: 129 IAIQIAAGMEYLS-SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 97  GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
               +M PE I         +   +D+WS G+ L E+ + G  PY
Sbjct: 188 LPIRWMPPEAI-----MYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 13/115 (11%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMA 103
           + YL + + V HRD+   NIL++     K+ DFG+S  L D    T           + A
Sbjct: 120 MKYLSDMNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA 157
           PE I         +   +DVWS GI + E+ + GE PY D   + EV+ + +ND 
Sbjct: 179 PEAI-----AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVM-KAINDG 226

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 34/93 (36%), Positives = 47/93 (50%), Gaps = 6/93 (6%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEP 109
           YL   H  +HRD+   N L+ E   +K+ DFG+S R V S    +  G    M P R  P
Sbjct: 135 YLASQH-FVHRDLATRNCLVGENLLVKIGDFGMS-RDVYSTDYYRVGGHT--MLPIRWMP 190

Query: 110 PNP-QKPDYDIRADVWSLGITLVELAT-GEFPY 140
           P       +   +DVWSLG+ L E+ T G+ P+
Sbjct: 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 43.0 bits (101), Expect = 7e-05
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 11/100 (11%)

Query: 48  LHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGCAA--YMA 103
           + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + A
Sbjct: 119 MKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKD 142
           PE I         +   +DVWS GI + E ++ GE PY +
Sbjct: 178 PEAI-----AYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 17/91 (18%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-AAYMAPE----RIEPP 110
           IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N      +MAPE    RI   
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--- 218

Query: 111 NPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                 Y  ++DVWS G+ L E+ T G  PY
Sbjct: 219 ------YTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 9e-05
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 22/102 (21%)

Query: 57  VIHRDVKPSNILL-----------------DERGNIKLCDFGISGRL-VDSKARTKNAGC 98
           V+HRD+KP NI L                 + R   K+ DFG+S  + ++S A +   G 
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGT 204

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
             Y +PE +     +   YD ++D+W+LG  + EL +G+ P+
Sbjct: 205 PYYWSPELLLH---ETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 9/101 (8%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAPE 105
            + YL +    IHRD+   NIL+ E    K+ DFG+S G+ V  K +T       +MA E
Sbjct: 124 GMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIE 181

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC 145
            +         Y   +DVWS G+ L E+ + G  PY    C
Sbjct: 182 SL-----NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 14/104 (13%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--RTKNAGCAA--Y 101
           K + YL      +HRD+   NIL++    +K+ DFG++  L   K   + +  G +   +
Sbjct: 119 KGMEYLGSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC 145
            APE +      +  + + +DVWS G+ L EL    F Y D  C
Sbjct: 178 YAPESL-----TESKFSVASDVWSFGVVLYEL----FTYSDKSC 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 3/85 (3%)

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    + P + +   +
Sbjct: 141 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVF 198

Query: 118 DIRADVWSLGITLVELAT-GEFPYK 141
              +DVWS G+ L E+AT  E PY+
Sbjct: 199 TTYSDVWSFGVVLWEIATLAEQPYQ 223

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----ARTKNAGCAAY 101
           K + YL  +   +HRD+   N+L++    +K+ DFG++  +   K     +        +
Sbjct: 120 KGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
            APE +      +  + I +DVWS G+TL EL T
Sbjct: 179 YAPECL-----IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 10/109 (9%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAY 101
           + + YL   H  IHRD+   N+LLD    +K+ DFG++  + +     + R        +
Sbjct: 118 EGMAYLHSQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVL 150
            A E +     ++  +   +DVWS G+TL EL T     +     FE +
Sbjct: 177 YAVECL-----KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 10/99 (10%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-AAYM 102
           + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N      +M
Sbjct: 145 RGMEYLA-SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM 203

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           APE +         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 204 APEAL-----FDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 20/115 (17%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILL----DERGN---IKLCDFGISGRLVDSKARTKNAG 97
             ALHYL E   ++H +V   NIL+       G    IKL D GI   ++  + R +   
Sbjct: 111 ASALHYL-EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI- 168

Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR 152
              ++APE I   N Q     I AD WS G TL+E+ +      + +     LS 
Sbjct: 169 --PWIAPECI--RNGQA-SLTIAADKWSFGTTLLEICS------NGEEPLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 14/114 (12%)

Query: 37  CGKITLSTVKALH--------YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 88
            G++TL  + A+         YL   H  +HRD+   N L+ +   +K+ DFG+S R + 
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDFGMS-RDIY 173

Query: 89  SKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRADVWSLGITLVELAT-GEFPY 140
           S    +  G    M P R  PP       +   +D+WS G+ L E+ T G+ P+
Sbjct: 174 STDYYRVGG--RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 9/102 (8%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAP 104
           + + YL +    IHRD+   NIL+ E    K+ DFG+S G+ V  K +T       +MA 
Sbjct: 135 RGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAI 192

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC 145
           E +         Y   +DVWS G+ L E+ + G  PY    C
Sbjct: 193 ESL-----NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 20/39 (51%), Positives = 21/39 (53%), Gaps = 1/39 (2%)

Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR 92
             G  H D  P NIL+   G I L DFGI GRL D K R
Sbjct: 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL-DPKFR 320

Length = 517

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 18/144 (12%)

Query: 5   SKESDVWICMELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           ++   ++I MEL+    F   L++    +      K  L     + YL E+   IHRD+ 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL-ESKNCIHRDLA 120

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD------Y 117
             N L+ E   +K+ DFG+S        R ++ G  +    ++I P     P+      Y
Sbjct: 121 ARNCLVGENNVLKISDFGMS--------RQEDDGIYSSSGLKQI-PIKWTAPEALNYGRY 171

Query: 118 DIRADVWSLGITLVE-LATGEFPY 140
              +DVWS GI L E  + G  PY
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 20/47 (42%), Positives = 26/47 (55%), Gaps = 2/47 (4%)

Query: 36  ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFG 81
           I   I    + AL  L  T G++HRDVKP NI+  E  G+ K+ D G
Sbjct: 256 IIQTIMRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 39.0 bits (92), Expect = 0.001
 Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 9/70 (12%)

Query: 12  ICMELMATCFDRLLKRLHV-SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
           + ME +       L R+ V   PE +  +I    VKA       HG+IH D+   NIL+D
Sbjct: 108 VVMEYID---GVELYRVRVLEDPEEVLDEILEEIVKAYK-----HGIIHGDLSEFNILVD 159

Query: 71  ERGNIKLCDF 80
           +   I + D+
Sbjct: 160 DDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 15/32 (46%), Positives = 18/32 (56%)

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRL 86
            G  H D+ P NI + + G I   DFGI GRL
Sbjct: 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.4 bits (92), Expect = 0.001
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 16/98 (16%)

Query: 47  ALHYLKETHGVIHRDVKPSNILL-----DERGN---IKLCDFGISGRLVDSKARTKNAGC 98
           ALH+L E  G+ H +V   N+LL      + GN   IKL D GIS  ++  +   +    
Sbjct: 112 ALHFL-EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI-- 168

Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
             ++ PE IE  NPQ  +  + AD WS G TL E+ +G
Sbjct: 169 -PWVPPECIE--NPQ--NLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 33/113 (29%), Positives = 50/113 (44%), Gaps = 17/113 (15%)

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAA--YMAPE------ 105
           H  +H D+   N  L     +K+ D+GI   R  +    T++  C    ++APE      
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 106 -RIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLND 156
             +      KP     ++VW+LG+TL EL      PY     D EVL+ V+ D
Sbjct: 178 GGLITAEQTKP-----SNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKD 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEP 109
           YL   H  +HRD+   N L+     +K+ DFG+S R V S    +  G    M P R  P
Sbjct: 138 YLASQH-FVHRDLATRNCLVGANLLVKIGDFGMS-RDVYSTDYYRVGGHT--MLPIRWMP 193

Query: 110 PNP-QKPDYDIRADVWSLGITLVELAT-GEFPY 140
           P       +   +DVWS G+ L E+ T G+ P+
Sbjct: 194 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 40/127 (31%), Positives = 58/127 (45%), Gaps = 22/127 (17%)

Query: 26  KRLHVSVPEPICGKITLST--VKALHYLKETHGVIHRDVKPSNILLDERG-------NIK 76
           ++  V    P+  KIT++     AL YL E   ++H +V   NILL   G        IK
Sbjct: 110 EKGRV----PVAWKITVAQQLASALSYL-EDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELA-T 135
           L D G+S   +  + R +      ++APE +   N         AD WS G TL+E+   
Sbjct: 165 LSDPGVSFTALSREERVERI---PWIAPECVPGGNSLST----AADKWSFGTTLLEICFD 217

Query: 136 GEFPYKD 142
           GE P K+
Sbjct: 218 GEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 21/68 (30%), Positives = 29/68 (42%), Gaps = 8/68 (11%)

Query: 81  GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKP-------DYDIRADVWSLGITLVE 132
             SG ++ +     K  G  A+  PE+  P              Y  +AD++SLGITL E
Sbjct: 37  AKSGNILLTWDGLLKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYE 96

Query: 133 LATGEFPY 140
               E PY
Sbjct: 97  ALDYELPY 104

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 4/40 (10%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           L+ ++ LH +    G++HRD+KP N+L+   G +K+ DFG
Sbjct: 319 LTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFG 354

Length = 507

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 36/104 (34%), Positives = 48/104 (46%), Gaps = 16/104 (15%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERG-------NIKLCDFGISGRLVDSKARTKNAGCA 99
           AL YL E   ++H +V   NILL   G        IKL D GI   ++  +   +     
Sbjct: 117 ALSYL-EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172

Query: 100 AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELA-TGEFPYKD 142
            ++APE +E       +  I AD WS G TL E+   GE P KD
Sbjct: 173 PWIAPECVE----DSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 11/103 (10%)

Query: 39  KITLSTVKALHYL--KETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA 96
           KI +   KAL +L  + +  V+  ++ P  I++D +    L    + G L      TK  
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---TDTKCF 839

Query: 97  GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFP 139
             +AY+APE  E       D   ++D++  G+ L+EL TG+ P
Sbjct: 840 ISSAYVAPETRE-----TKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 11/92 (11%)

Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPERIEP 109
           +H V+H+D+   N+L+ ++ N+K+ D G+  R V +    K  G +     +M+PE I  
Sbjct: 142 SHHVVHKDLATRNVLVFDKLNVKISDLGLF-REVYAADYYKLMGNSLLPIRWMSPEAI-- 198

Query: 110 PNPQKPDYDIRADVWSLGITLVEL-ATGEFPY 140
                  + I +D+WS G+ L E+ + G  PY
Sbjct: 199 ---MYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 12/96 (12%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           LS +  +H      G+IHRD+K  N+L++   +I L DFG +     S +   + G A  
Sbjct: 270 LSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325

Query: 102 M---APERIEPPNPQKPDYDIRADVWSLGITLVELA 134
           +   APE +   +P  P  DI    WS G+ + E A
Sbjct: 326 VDTNAPE-VLAGDPYTPSVDI----WSAGLVIFEAA 356

Length = 461

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 37.7 bits (88), Expect = 0.004
 Identities = 19/54 (35%), Positives = 27/54 (50%), Gaps = 5/54 (9%)

Query: 27  RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           RL V  P+ I  KI     KA        G++H D+   NIL+ E G+I + D+
Sbjct: 198 RLDVENPDEILDKILEEVRKAYRR-----GIVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	296
KOG0581|consensus	364		100.0
KOG0578|consensus	550		100.0
KOG0983|consensus	391		100.0
KOG0598|consensus	357		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0592|consensus	604		100.0
KOG0591|consensus	375		100.0
KOG0616|consensus	355		100.0
KOG0574|consensus	502		100.0
KOG0595|consensus	429		100.0
KOG0599|consensus	411		100.0
KOG0583|consensus	370		100.0
KOG0198|consensus	313		100.0
KOG0593|consensus	396		100.0
KOG0661|consensus	538		100.0
KOG0582|consensus	516		100.0
KOG0192|consensus	362		100.0
KOG0605|consensus	550		100.0
KOG0588|consensus	786		100.0
KOG0597|consensus	808		100.0
KOG0579|consensus	1187		100.0
KOG0201|consensus	467		100.0
KOG0694|consensus	694		100.0
KOG0033|consensus	355		100.0
KOG0610|consensus	459		100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0197|consensus	468		100.0
KOG0984|consensus	282		100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0612|consensus	1317		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0663|consensus	419		100.0
KOG0585|consensus	576		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1006|consensus	361		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0600|consensus	560		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0659|consensus	318		100.0
KOG0577|consensus	948		100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0596|consensus	677		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589|consensus	426		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4721|consensus	904		100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0611|consensus	668		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
PTZ00267	478	NIMA-related protein kinase; Provisional	99.98
KOG0660|consensus	359		99.98
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.98
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.98
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.98
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.98
KOG4279|consensus	1226		99.98
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.98
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.98
KOG0604|consensus	400		99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
KOG0594|consensus	323		99.97
KOG4645|consensus	1509		99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
KOG0032|consensus	382		99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
KOG0658|consensus	364		99.97
KOG0193|consensus	678		99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
KOG4717|consensus	864		99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
KOG0690|consensus	516		99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
KOG0580|consensus	281		99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
KOG0667|consensus	586		99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
KOG2345|consensus	302		99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
KOG0986|consensus	591		99.97
KOG1026|consensus	774		99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
KOG1989|consensus	738		99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
KOG0584|consensus	632		99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
KOG0607|consensus	463		99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
KOG0603|consensus	612		99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
KOG0587|consensus	953		99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
KOG0614|consensus	732		99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
KOG0696|consensus	683		99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
KOG1095|consensus	1025		99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
KOG0608|consensus	1034		99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
KOG4257|consensus	974		99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
KOG0194|consensus	474		99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
KOG1151|consensus	775		99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG0695|consensus	593		99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
KOG1187|consensus	361		99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
KOG4236|consensus	888		99.95
KOG0586|consensus	596		99.95
KOG0671|consensus	415		99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
KOG4278|consensus	1157		99.94
KOG0662|consensus	292		99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
KOG0200|consensus	609		99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG0666|consensus	438		99.94
KOG0669|consensus	376		99.94
KOG0196|consensus	996		99.94
KOG1035|consensus	1351		99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
KOG4250|consensus	732		99.93
KOG0665|consensus	369		99.93
KOG0199|consensus	1039		99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG1345|consensus	378		99.93
KOG0670|consensus	752		99.92
KOG3653|consensus	534		99.92
KOG1094|consensus	807		99.92
KOG2052|consensus	513		99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
KOG1027|consensus	903		99.91
KOG1025|consensus	1177		99.9
KOG0664|consensus	449		99.9
KOG1024|consensus	563		99.9
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.9
KOG0576|consensus	829		99.9
KOG1152|consensus	772		99.89
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0668|consensus	338		99.87
KOG1290|consensus	590		99.85
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.84
KOG4158|consensus	598		99.84
KOG1167|consensus	418		99.83
KOG0590|consensus	601		99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG1164|consensus	322		99.78
KOG1163|consensus	341		99.78
KOG0603|consensus	612		99.77
KOG1165|consensus	449		99.76
KOG1023|consensus	484		99.75
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.75
KOG1033|consensus	516		99.73
KOG0606|consensus	1205		99.71
KOG1240|consensus	1431		99.7
KOG0195|consensus	448		99.61
PRK12274	218	serine/threonine protein kinase; Provisional	99.58
PRK09188	365	serine/threonine protein kinase; Provisional	99.55
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.55
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.54
KOG1166|consensus	974		99.53
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.49
KOG0590|consensus	601		99.38
smart00090	237	RIO RIO-like kinase.	99.35
PRK10345	210	hypothetical protein; Provisional	99.29
PRK14879	211	serine/threonine protein kinase; Provisional	99.27
KOG1266|consensus	458		99.24
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.24
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.22
KOG0606|consensus	1205		99.22
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.22
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.16
KOG0601|consensus	524		99.13
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.05
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.92
KOG2137|consensus	700		98.92
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.92
KOG1243|consensus	690		98.92
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.87
KOG3087|consensus	229		98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.68
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.63
KOG0601|consensus	524		98.6
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.59
PRK09902	216	hypothetical protein; Provisional	98.42
KOG3741|consensus	655		98.4
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.16
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.95
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.87
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.67
KOG1235|consensus	538		97.65
KOG1035|consensus	1351		97.13
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.92
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.91
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.86
KOG2268|consensus	465		96.8
KOG0576|consensus	829		96.74
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.63
KOG1826|consensus	2724		96.17
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.35
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.31
PLN02876	822	acyl-CoA dehydrogenase	95.15
KOG2270|consensus	520		94.95
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.8
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.64
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.54
PRK05231	319	homoserine kinase; Provisional	94.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	94.09
PRK10271	188	thiK thiamine kinase; Provisional	94.06
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.03
PF01636	239	APH: Phosphotransferase enzyme family This family	94.0
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.86
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.61
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.23
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.03
PHA03111	444	Ser/Thr kinase; Provisional	93.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	92.46
KOG1236|consensus	565		92.22
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.21
COG2334	331	Putative homoserine kinase type II (protein kinase	91.76
PLN02236	344	choline kinase	91.6
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.42
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.19
KOG1093|consensus	725		90.63
PRK06148	1013	hypothetical protein; Provisional	89.59
PRK11768	325	serine/threonine protein kinase; Provisional	89.3
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	88.51
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	88.17
KOG2464|consensus	246		86.78
COG4499	434	Predicted membrane protein [Function unknown]	86.77
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	86.48
PRK12396	409	5-methylribose kinase; Reviewed	86.32

>KOG0581|consensus

Probab=100.00  E-value=1.2e-42  Score=297.35  Aligned_cols=192  Identities=36%  Similarity=0.700  Sum_probs=172.6

Q ss_pred             CCCccCC-eEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKES-DVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~-~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +.|+.++ .++|+||||+ |||+.++.. .+.++|..+.+++.+|++||.|||..++||||||||.|||++..|.|||||
T Consensus       144 gaF~~~~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  144 GAFYSNGEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             EEEEeCCceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecc
Confidence            3577778 5999999999 599999987 578999999999999999999999656999999999999999999999999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CCcHHHHHHHHc
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC----KCDFEVLSRVLN  155 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~----~~~~~~~~~i~~  155 (296)
                      ||.++.+... ......||..|||||.+.+.     .|+.++||||||++++|+++|++||...    ....+.+..|+.
T Consensus       223 FGVS~~lvnS-~a~tfvGT~~YMsPERi~g~-----~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  223 FGVSGILVNS-IANTFVGTSAYMSPERISGE-----SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             ccccHHhhhh-hcccccccccccChhhhcCC-----cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence            9999988766 55677999999999999653     8999999999999999999999999873    356788899999


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +.+|.+|.. .+|+++++||..||++||.        +|.+..+++.|+|+...
T Consensus       297 ~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~--------~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  297 EPPPRLPEG-EFSPEFRSFVSCCLRKDPS--------ERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             CCCCCCCcc-cCCHHHHHHHHHHhcCCcc--------cCCCHHHHhcCHHHhhc
Confidence            999999987 4999999999999999998        78888899999987543

>KOG0578|consensus

Probab=100.00  E-value=5.5e-39  Score=287.53  Aligned_cols=197  Identities=27%  Similarity=0.494  Sum_probs=179.1

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ..|-..+.+|+|||||+| +|.+++.  ...++|.++..|+++++.||+|||.+ ||+|||||.+|||++.+|.+||+||
T Consensus       337 ~Sylv~deLWVVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  337 DSYLVGDELWVVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             HHhcccceeEEEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeee
Confidence            356667899999999995 9999998  46799999999999999999999994 9999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..+.... .+....||+.|||||++     ....|++++||||||++++||+-|.+||.. ......+..|.....|
T Consensus       414 GFcaqi~~~~~KR~TmVGTPYWMAPEVv-----trk~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P  487 (550)
T KOG0578|consen  414 GFCAQISEEQSKRSTMVGTPYWMAPEVV-----TRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP  487 (550)
T ss_pred             eeeeccccccCccccccCCCCccchhhh-----hhcccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCC
Confidence            9998887664 56667999999999999     555899999999999999999999999998 6778888899999999


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNIL  215 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (296)
                      .+.....+|+.+++|+.+||..|++        .+..+.+++.|+|+..+|+..-+
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~--------~RasA~eLL~HpFl~~a~p~ssL  535 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVE--------QRASAKELLEHPFLKMAKPESSL  535 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchh--------cCCCHHHHhcChhhhhcCCHHHh
Confidence            9998888999999999999999998        88889999999999888876644

>KOG0983|consensus

Probab=100.00  E-value=2.9e-39  Score=266.23  Aligned_cols=197  Identities=61%  Similarity=1.014  Sum_probs=180.1

Q ss_pred             CCCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           1 MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++||..+..++|.||.|...+..++.+..++++|..+-++...+++||.||..+|||+|||+||+|||++..|++|||||
T Consensus       157 ~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  157 FGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             eeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence            47899999999999999999999999888999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++.++.+....+...|++.|||||.+...  ....|..++||||||+++++|.||+.||.+.+.+.+.+.++++..+|.
T Consensus       237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~--~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~  314 (391)
T KOG0983|consen  237 GISGRLVDSKAHTRSAGCAAYMAPERIDPP--DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL  314 (391)
T ss_pred             cccceeecccccccccCCccccCccccCCC--CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC
Confidence            999999988888888999999999999655  355899999999999999999999999999999999999999999999


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ++....+|+.+.+|+..||.+|+.        ++..-.++++++|+.
T Consensus       315 L~~~~gFSp~F~~fv~~CL~kd~r--------~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  315 LPGHMGFSPDFQSFVKDCLTKDHR--------KRPKYNKLLEHPFIK  353 (391)
T ss_pred             CCcccCcCHHHHHHHHHHhhcCcc--------cCcchHHHhcCccee
Confidence            998878999999999999999996        444445556666653

>KOG0598|consensus

Probab=100.00  E-value=4.2e-38  Score=269.43  Aligned_cols=191  Identities=28%  Similarity=0.397  Sum_probs=163.1

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ..|++.+.+|+|+||+.| .|...|++ .+.+++..++.++..|+.||.|||+ .|||||||||+|||++.+|+++|+||
T Consensus        92 ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   92 YSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             EecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEecc
Confidence            468999999999999995 99999987 7899999999999999999999999 49999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |+++..... ......+||+.|||||++.+     ..|+..+|+||||+++|+|++|.+||.+ .+......+|.++..+
T Consensus       170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~-----~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~  243 (357)
T KOG0598|consen  170 GLCKEDLKDGDATRTFCGTPEYMAPEILLG-----KGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP  243 (357)
T ss_pred             ccchhcccCCCccccccCCccccChHHHhc-----CCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC
Confidence            999854433 44555799999999999954     4899999999999999999999999999 5666888888888755


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ..|..  ++.+.+++|+++|.++|+.|-.    ......++..|++.
T Consensus       244 ~~p~~--ls~~ardll~~LL~rdp~~RLg----~~~d~~~ik~HpfF  284 (357)
T KOG0598|consen  244 LPPGY--LSEEARDLLKKLLKRDPRQRLG----GPGDAEEIKRHPFF  284 (357)
T ss_pred             CCCcc--CCHHHHHHHHHHhccCHHHhcC----CCCChHHhhcCccc
Confidence            55554  7999999999999999985543    22344445566654

>KOG0575|consensus

Probab=100.00  E-value=2.1e-38  Score=285.95  Aligned_cols=186  Identities=27%  Similarity=0.439  Sum_probs=165.0

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|++.+++|||+|+|. |+|..++++ .+.++|.+++.++.||+.||.|||+ ++|+|||||..|+|++.+.+|||+||
T Consensus        85 ~~FEDs~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   85 HFFEDSNNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             eEeecCCceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcCcEEeccc
Confidence            68999999999999999 799999985 7899999999999999999999999 69999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |+|..+... ....+.+||+.|+|||++.     +...+..+||||+||++|.|+.|++||.. ..-.+.+.+|.... .
T Consensus       163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~-----k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~-Y  235 (592)
T KOG0575|consen  163 GLATQLEYDGERKKTLCGTPNYIAPEVLN-----KSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNE-Y  235 (592)
T ss_pred             ceeeeecCcccccceecCCCcccChhHhc-----cCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcC-c
Confidence            999988755 6667789999999999994     44788999999999999999999999998 55667777776554 3


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+|..  +|.+.++||.++|.++|.        ++.++.+++.+.|+
T Consensus       236 ~~P~~--ls~~A~dLI~~lL~~~P~--------~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  236 SMPSH--LSAEAKDLIRKLLRPNPS--------ERPSLDEVLDHPFF  272 (592)
T ss_pred             ccccc--cCHHHHHHHHHHhcCCcc--------cCCCHHHHhcCHhh
Confidence            55553  899999999999999998        66777777777776

>KOG0615|consensus

Probab=100.00  E-value=4.4e-39  Score=278.08  Aligned_cols=196  Identities=20%  Similarity=0.261  Sum_probs=171.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC---CCEEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~---~~~kl   77 (296)
                      +.|...+++||||||++ |.|.+.+-. ++.+.+..-+.+++||+.||.|||+ +||+||||||+|||+..+   -.+||
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEe
Confidence            35677888899999999 599988876 7889999999999999999999999 599999999999999876   67999


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      +|||+|+..+......+.+||+.|.|||++....  ...+..++|+||+||++|.+++|.+||.+...+.....+|.+|.
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg--~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG--VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCC--eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence            9999999888777778889999999999997642  22344589999999999999999999999777777888999988


Q ss_pred             CCCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 PPCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ~p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .+.- +.+.++|.+..+||.+||..||+        .+.+..+.++++|+.-.
T Consensus       399 y~f~p~~w~~Iseea~dlI~~mL~VdP~--------~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINWMLVVDPE--------NRPSADEALNHPWFKDA  443 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHHhhEeCcc--------cCcCHHHHhcChhhhcc
Confidence            7766 46677999999999999999998        88888999999998654

>KOG0592|consensus

Probab=100.00  E-value=1.8e-37  Score=276.24  Aligned_cols=189  Identities=27%  Similarity=0.431  Sum_probs=164.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ..|.|+..+|+|+||++ |+|.++|.+ -+.|++...+.++.||+.||+|||+ +|||||||||+|||++.+++++|.||
T Consensus       141 ~TFQD~~sLYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  141 FTFQDEESLYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             EEeecccceEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCCcEEEeec
Confidence            36899999999999999 799999988 5899999999999999999999999 69999999999999999999999999


Q ss_pred             CCcccccCCcc--------------ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q psy3686          81 GISGRLVDSKA--------------RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD  146 (296)
Q Consensus        81 g~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~  146 (296)
                      |.++.+.....              ...++||..|.+||++.     ....++.+|||+|||++|+|+.|.+||.+ .+.
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-----~~~~~~~sDiWAlGCilyQmlaG~PPFra-~Ne  292 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-----DSPAGPSSDLWALGCILYQMLAGQPPFRA-ANE  292 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-----CCCCCcccchHHHHHHHHHHhcCCCCCcc-ccH
Confidence            99987753211              13468999999999994     44778899999999999999999999999 567


Q ss_pred             HHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         147 FEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       147 ~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .-++++|+.-.. .+|.  .+++.+++||++.|..||.        ++.++.++.+|+|+.-.
T Consensus       293 yliFqkI~~l~y-~fp~--~fp~~a~dLv~KLLv~dp~--------~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  293 YLIFQKIQALDY-EFPE--GFPEDARDLIKKLLVRDPS--------DRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             HHHHHHHHHhcc-cCCC--CCCHHHHHHHHHHHccCcc--------ccccHHHHhhCcccccC
Confidence            778888877543 3333  3799999999999999998        78888888899887544

>KOG0591|consensus

Probab=100.00  E-value=3.1e-38  Score=261.06  Aligned_cols=178  Identities=26%  Similarity=0.447  Sum_probs=155.8

Q ss_pred             CccCCe-EEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHH--h-CCceeCCCCCCcEEECCCCCE
Q psy3686           4 QSKESD-VWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKE--T-HGVIHRDVKPSNILLDERGNI   75 (296)
Q Consensus         4 ~~~~~~-~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~-~~ivH~dlkp~Nil~~~~~~~   75 (296)
                      |.+++. ++||||||+ |+|.+++++.   ...++|..||+++.|++.||..+|.  . .-|+||||||.||+++.+|.+
T Consensus        88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv  167 (375)
T KOG0591|consen   88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV  167 (375)
T ss_pred             hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence            445555 899999999 7999999765   6789999999999999999999998  3 138999999999999999999


Q ss_pred             EEeccCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH
Q psy3686          76 KLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        76 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~  154 (296)
                      ||+|||+++.+..... .....||+.||+||.+.     ...|++++||||+||++|||+.-+.||.+ ++-.+...+|.
T Consensus       168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~-----~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~  241 (375)
T KOG0591|consen  168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIH-----ESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIE  241 (375)
T ss_pred             eeccchhHhHhcchhHHHHhhcCCCcccCHHHHh-----cCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHH
Confidence            9999999998865543 34568999999999995     44899999999999999999999999999 57777888899


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      ++..|.+|..- +|.++..+|..|+..||+.||.
T Consensus       242 qgd~~~~p~~~-YS~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  242 QGDYPPLPDEH-YSTDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             cCCCCCCcHHH-hhhHHHHHHHHHccCCcccCCC
Confidence            99888888543 9999999999999999997774

>KOG0616|consensus

Probab=100.00  E-value=1e-36  Score=253.53  Aligned_cols=172  Identities=27%  Similarity=0.457  Sum_probs=154.6

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+.+++||||||.+| -|..++++ .+++++..++.++.||+.||+|||+ ++|++|||||+|||++.+|.+||+||
T Consensus       111 ~t~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  111 GTFKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             EeeccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEec
Confidence            367899999999999995 99999987 6799999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |+++.....  .-+.+||+.|+|||++.     ...++.++|.|+||+++|||+.|.+||.. .+...++.+|+.+.. .
T Consensus       189 GFAK~v~~r--T~TlCGTPeYLAPEii~-----sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v-~  259 (355)
T KOG0616|consen  189 GFAKRVSGR--TWTLCGTPEYLAPEIIQ-----SKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV-K  259 (355)
T ss_pred             cceEEecCc--EEEecCCccccChHHhh-----cCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc-c
Confidence            999887654  45569999999999994     45889999999999999999999999998 566899999998874 4


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      +|..  +++++++||+++|+.|-..|
T Consensus       260 fP~~--fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 FPSY--FSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CCcc--cCHHHHHHHHHHHhhhhHhh
Confidence            4443  89999999999999998844

>KOG0574|consensus

Probab=100.00  E-value=3.3e-38  Score=263.27  Aligned_cols=199  Identities=31%  Similarity=0.513  Sum_probs=181.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|+.+..+|||||||+ |++.++++.++.+|++.++..+++..++||+|||. ..-+|||||..|||++.+|..||+||
T Consensus        95 GSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen   95 GSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             hhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhc
Confidence            46888999999999999 89999999889999999999999999999999999 58999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..+.+. ..++...||+.|||||++     ....|+.++||||||++..+|..|++||.+ ..++..+..|-..++|
T Consensus       174 GVAGQLTDTMAKRNTVIGTPFWMAPEVI-----~EIGY~~~ADIWSLGITaIEMAEG~PPYsD-IHPMRAIFMIPT~PPP  247 (502)
T KOG0574|consen  174 GVAGQLTDTMAKRNTVIGTPFWMAPEVI-----EEIGYDTKADIWSLGITAIEMAEGRPPYSD-IHPMRAIFMIPTKPPP  247 (502)
T ss_pred             cccchhhhhHHhhCccccCcccccHHHH-----HHhccchhhhHhhhcchhhhhhcCCCCccc-ccccceeEeccCCCCC
Confidence            999988766 355667999999999999     444789999999999999999999999998 5777888888889999


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNIL  215 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (296)
                      .+.....||.++.+||++||.++|+        ++.+++++.+|.|+..+....++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE--------~R~TA~~L~~H~FiknA~g~~I~  295 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPE--------ERKTALRLCEHTFIKNAPGCDIM  295 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHH--------HHHHHHHHhhhhhhcCCCcccHH
Confidence            9998888999999999999999998        77889999999999887666664

>KOG0595|consensus

Probab=100.00  E-value=1.1e-36  Score=263.14  Aligned_cols=173  Identities=28%  Similarity=0.484  Sum_probs=148.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC------CC
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER------GN   74 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~------~~   74 (296)
                      ++..+++++|||||||. |+|..|+++ .+.+++..++.++.||+.||++||+ ++||||||||.|||++..      -.
T Consensus        76 d~~~~~~~i~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   76 DCIEDDDFIYLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             EEEecCCeEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCce
Confidence            45678899999999999 699999987 6799999999999999999999999 599999999999999765      45


Q ss_pred             EEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH
Q psy3686          75 IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        75 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~  154 (296)
                      +||+|||+++.+.......+.+|++.|||||++     ...+|+.|+|+||+|+++|++++|+.||.. ....+.+..+.
T Consensus       154 LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~-----~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~  227 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGSMAETLCGSPLYMAPEVI-----MSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIK  227 (429)
T ss_pred             EEecccchhhhCCchhHHHHhhCCccccCHHHH-----HhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHh
Confidence            899999999999888777888999999999999     455899999999999999999999999998 45556666665


Q ss_pred             ccCC--CCCCCCcchhHHHHHHHHhccCCChH
Q psy3686         155 NDAP--PCLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       155 ~~~~--p~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      ++..  |.++.  .++..+.+++...+.++|.
T Consensus       228 k~~~~~~~~~~--~~s~~~~~Ll~~ll~~~~~  257 (429)
T KOG0595|consen  228 KGNEIVPVLPA--ELSNPLRELLISLLQRNPK  257 (429)
T ss_pred             ccccccCchhh--hccCchhhhhhHHHhcCcc
Confidence            5443  33333  3678888899888888875

>KOG0599|consensus

Probab=100.00  E-value=3.5e-36  Score=248.05  Aligned_cols=194  Identities=25%  Similarity=0.395  Sum_probs=173.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|+.+..+|+|+|+|+ |-|.+++.. ...++++..++|++|++.|+.|||.+ +||||||||+|||++++.+++|+||
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEecc
Confidence            56888999999999999 899999987 78899999999999999999999995 9999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPP-NPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..+.........+||+.|+|||.+.+. ....+.|+..+|+|++|+++|.|+.|.+||.. ...+-.++.|..|...
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccc
Confidence            999999888888888999999999999643 22455789999999999999999999999998 4566677788887653


Q ss_pred             -CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 -CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 -~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                       .-|.+..+|...++||.+||+.||.        .+.++.++++|+|+
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~--------~Ritake~LaHpff  286 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPT--------KRITAKEALAHPFF  286 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCch--------hcccHHHHhcChHH
Confidence             3356667999999999999999998        78889999999987

>KOG0583|consensus

Probab=100.00  E-value=3.8e-35  Score=263.06  Aligned_cols=187  Identities=27%  Similarity=0.390  Sum_probs=160.5

Q ss_pred             CccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-CCEEEeccC
Q psy3686           4 QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCDFG   81 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl~dfg   81 (296)
                      +.....+|||||||.| +|.+++.. .+++.|..+..+++||+.||+|||+ +||+||||||+|||++.+ +++||+|||
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            4567789999999995 99999998 8999999999999999999999999 599999999999999999 999999999


Q ss_pred             Ccccc-cCCccccccccCcCCCCccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          82 ISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDY-DIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        82 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ++... .........+|++.|+|||++.+.    ..| +.++||||+|++||.|++|..||.. .........|.++. .
T Consensus       167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~----~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~-~  240 (370)
T KOG0583|consen  167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGK----GTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGE-F  240 (370)
T ss_pred             cccccCCCCCcccCCCCCcccCCHHHhCCC----CCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCC-c
Confidence            99887 455666777999999999999753    114 4789999999999999999999998 45556666666554 3


Q ss_pred             CCCCCcch-hHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 CLPNDPLF-GRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 ~~~~~~~~-s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .+|..  + |++++.||.+||..+|.        .+.++.++..++|+..
T Consensus       241 ~~p~~--~~S~~~~~Li~~mL~~~P~--------~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 KIPSY--LLSPEARSLIEKMLVPDPS--------TRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCCC--cCCHHHHHHHHHHcCCCcc--------cCCCHHHHhhChhhcc
Confidence            55554  5 99999999999999998        5777888888877765

>KOG0198|consensus

Probab=100.00  E-value=7.9e-36  Score=258.42  Aligned_cols=187  Identities=33%  Similarity=0.519  Sum_probs=154.4

Q ss_pred             eEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEEeccCCcccc
Q psy3686           9 DVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRL   86 (296)
Q Consensus         9 ~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~   86 (296)
                      .++|+|||+. |+|.+++.+.++.|++..++.+++||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            6999999999 59999999865589999999999999999999999 59999999999999999 799999999999876


Q ss_pred             cC----CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH-HccCCCCC
Q psy3686          87 VD----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV-LNDAPPCL  161 (296)
Q Consensus        87 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i-~~~~~p~~  161 (296)
                      ..    ........||+.|||||++..    ......++|||||||++.+|+||..||.........+..+ .....|.+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~----g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i  244 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRN----GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI  244 (313)
T ss_pred             ccccccccccccccCCccccCchhhcC----CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence            53    122334589999999999963    1122358999999999999999999998732233333344 34446677


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      |..  +|.+.++||.+||.++|+        .+.++.+++.++++....
T Consensus       245 p~~--ls~~a~~Fl~~C~~~~p~--------~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  245 PDS--LSDEAKDFLRKCFKRDPE--------KRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             Ccc--cCHHHHHHHHHHhhcCcc--------cCcCHHHHhhChhhhccc
Confidence            766  899999999999999998        777889999999875543

>KOG0593|consensus

Probab=100.00  E-value=1.3e-35  Score=247.65  Aligned_cols=190  Identities=26%  Similarity=0.436  Sum_probs=161.4

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .|.....++||+|||+-++.+-+++....++...+.++++|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+
T Consensus        69 VFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   69 VFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             HHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCCcEEeccchh
Confidence            466788999999999998888888888899999999999999999999999 7999999999999999999999999999


Q ss_pred             ccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CC-
Q psy3686          83 SGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--AP-  158 (296)
Q Consensus        83 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~-  158 (296)
                      |+.+. .....+....|.+|.|||.+.+.    ..|+..+||||+||++.||++|.+-|++ .++.+.+..|...  .. 
T Consensus       148 AR~L~~pgd~YTDYVATRWYRaPELLvGD----tqYG~pVDiWAiGCv~aEl~~G~pL~PG-~SDiDQLy~I~ktLG~L~  222 (396)
T KOG0593|consen  148 ARTLSAPGDNYTDYVATRWYRAPELLVGD----TQYGKPVDIWAIGCVFAELLTGEPLWPG-RSDIDQLYLIRKTLGNLI  222 (396)
T ss_pred             hHhhcCCcchhhhhhhhhhccChhhhccc----CcCCCcccchhhhHHHHHHhcCCcCCCC-cchHHHHHHHHHHHcccC
Confidence            99887 45566777899999999999853    4789999999999999999999999998 5666655555431  10 


Q ss_pred             ----------C-----CCCC----------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 ----------P-----CLPN----------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 ----------p-----~~~~----------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                                |     .+|.          .+.++..+.+|+++||..||+        ++..|.+++.++.+
T Consensus       223 prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~--------~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  223 PRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPD--------DRLSCEQLLHHPYF  287 (396)
T ss_pred             HHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcc--------ccccHHHHhcChHH
Confidence                      1     1111          134678899999999999998        88888888888765

>KOG0661|consensus

Probab=100.00  E-value=2.9e-35  Score=258.44  Aligned_cols=192  Identities=19%  Similarity=0.313  Sum_probs=163.7

Q ss_pred             CccCC-eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           4 QSKES-DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         4 ~~~~~-~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      +.+++ .+|+|||||+.+|+++++.++..|++..++.|+.||++||+|+|. ||+.||||||+|||+..+..+||+|||+
T Consensus        78 i~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   78 IRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             hhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccceeEeccccc
Confidence            44555 999999999999999999989999999999999999999999999 7999999999999999999999999999


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cC---
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DA---  157 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~---  157 (296)
                      |+........+..+.|.+|.|||++.    ....|+.+.|+|++|||++|+.+-++.|.+. +..+.+.+|..  |.   
T Consensus       157 ARev~SkpPYTeYVSTRWYRAPEvLL----rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  157 AREVRSKPPYTEYVSTRWYRAPEVLL----RSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-SEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             ccccccCCCcchhhhcccccchHHhh----hccccCCchHHHHHHHHHHHHHHhcccCCCC-cHHHHHHHHHHHhCCCcc
Confidence            99988888888889999999999998    5558999999999999999999999999984 44444444432  11   


Q ss_pred             ----------------CCCCCC------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 ----------------PPCLPN------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ----------------~p~~~~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                      .|.++.      .+.++.++..+|.+|+..||.        .+.++.+++++++.+..
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~--------kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPD--------KRPTASQALQHPFFQVG  297 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCc--------cCccHHHHhcCcccccc
Confidence                            122211      123789999999999999998        77788888888887543

>KOG0582|consensus

Probab=100.00  E-value=2.6e-35  Score=257.04  Aligned_cols=199  Identities=34%  Similarity=0.544  Sum_probs=166.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +|..+..+|+||.||. ||+.++++.. ...++|..+..|++++++||.|||. +|.||||||+.||||+.+|.|||+||
T Consensus        92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen   92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             EEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCCcEEEcCc
Confidence            5788999999999999 6999999876 6679999999999999999999999 69999999999999999999999999


Q ss_pred             CCcccccCCcc----c-cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc
Q psy3686          81 GISGRLVDSKA----R-TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN  155 (296)
Q Consensus        81 g~~~~~~~~~~----~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~  155 (296)
                      |.+..+...+.    . ....+++.|||||++..   ....|+.|+|||||||+..||.+|..||.. -..+.++-..++
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q---~~~GYdfKaDIwSfGITA~ELA~G~aPf~k-~pPmkvLl~tLq  246 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ---QLHGYDFKADIWSFGITACELAHGHAPFSK-YPPMKVLLLTLQ  246 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhh---cccCccchhhhhhhhHHHHHHhcCCCCccc-CChHHHHHHHhc
Confidence            98866554432    1 45589999999999643   334799999999999999999999999998 466777777788


Q ss_pred             cCCCCC-----C--CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCCc
Q psy3686         156 DAPPCL-----P--NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNI  214 (296)
Q Consensus       156 ~~~p~~-----~--~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (296)
                      +.+|.+     +  ....++..++.+|..||.+||.        .+.++..++.+.|++.......
T Consensus       247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~--------kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPS--------KRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcc--------cCCCHHHHhccHHHhhccchhh
Confidence            888733     2  2345889999999999999998        5666777777777765544443

>KOG0192|consensus

Probab=100.00  E-value=2.8e-35  Score=261.95  Aligned_cols=184  Identities=32%  Similarity=0.497  Sum_probs=156.4

Q ss_pred             eEEEEecCcc-ccHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCcEEECCCC-CEEEeccCCcc
Q psy3686           9 DVWICMELMA-TCFDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHG-VIHRDVKPSNILLDERG-NIKLCDFGISG   84 (296)
Q Consensus         9 ~~~lv~E~~~-gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-ivH~dlkp~Nil~~~~~-~~kl~dfg~~~   84 (296)
                      .++|||||++ |+|.+++.. ....++...+..|+.||++|+.|||+ ++ ||||||||+|||++.++ ++||+|||+++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            6999999999 699999987 37899999999999999999999999 59 99999999999999997 99999999998


Q ss_pred             cccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH-HccCCCCCC
Q psy3686          85 RLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV-LNDAPPCLP  162 (296)
Q Consensus        85 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i-~~~~~p~~~  162 (296)
                      ..... .......||..|||||++.+.   ...|+.++||||||+++|+|+||..||.+... ..+...+ ..+.+|.+|
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p  268 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIP  268 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCC
Confidence            76654 333446899999999999643   44799999999999999999999999999655 5555555 467778887


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      ..  +++.+..+|.+||..+|+  .|++|.++...+...
T Consensus       269 ~~--~~~~l~~l~~~CW~~dp~--~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  269 KE--CPPHLSSLMERCWLVDPS--RRPSFLEIVSRLESI  303 (362)
T ss_pred             cc--CCHHHHHHHHHhCCCCCC--cCCCHHHHHHHHHHH
Confidence            76  799999999999999998  555566655555433

>KOG0605|consensus

Probab=100.00  E-value=5.6e-35  Score=260.18  Aligned_cols=191  Identities=26%  Similarity=0.371  Sum_probs=157.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|++..++||||||++| ++..+|.+ .+.|++..++.++.+++.||..||+ +|+|||||||+|+||+..|++||.|||
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCCEeecccc
Confidence            58999999999999995 99999987 6899999999999999999999999 799999999999999999999999999


Q ss_pred             CcccccC---------------C--------cc-----c--------------------cccccCcCCCCccccCCCCCC
Q psy3686          82 ISGRLVD---------------S--------KA-----R--------------------TKNAGCAAYMAPERIEPPNPQ  113 (296)
Q Consensus        82 ~~~~~~~---------------~--------~~-----~--------------------~~~~~~~~y~aPE~~~~~~~~  113 (296)
                      ++..+..               .        ..     .                    ....||+-|+|||++.+    
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~----  362 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG----  362 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc----
Confidence            9743211               0        00     0                    01259999999999964    


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccC
Q psy3686         114 KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYE  192 (296)
Q Consensus       114 ~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~  192 (296)
                       ..|+..+|+||||||+|||+.|.+||.+ ....+.+++|++.. ...+|....++++.++||.+||. ||+.|-.    
T Consensus       363 -kgY~~~cDwWSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG----  435 (550)
T KOG0605|consen  363 -KGYGKECDWWSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG----  435 (550)
T ss_pred             -CCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC----
Confidence             3799999999999999999999999999 67788888888754 34566666689999999999999 9983332    


Q ss_pred             CccchhhcccCCccc
Q psy3686         193 DKSTCYECGAEGHLS  207 (296)
Q Consensus       193 ~~~~~~~~~~~~~~~  207 (296)
                       -.-..++..|+|+.
T Consensus       436 -~~G~~EIK~HPfF~  449 (550)
T KOG0605|consen  436 -SKGAEEIKKHPFFK  449 (550)
T ss_pred             -cccHHHHhcCCccc
Confidence             22344555666653

>KOG0588|consensus

Probab=100.00  E-value=4.2e-35  Score=266.28  Aligned_cols=188  Identities=24%  Similarity=0.374  Sum_probs=164.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.++++.++|+|.||++ |-|.+++.+ .+++++.+..++++||+.|+.|+|. ++|+||||||+|+|++..+++||+||
T Consensus        79 dVwe~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   79 DVWENKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             eeeccCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccCEeeecc
Confidence            56889999999999999 599999877 7899999999999999999999999 69999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |+|..-.......+.||++.|++||++.|..    .-+.++||||+|||||.|++|++||.+ ++-...+.++.+|.. .
T Consensus       157 GMAsLe~~gklLeTSCGSPHYA~PEIV~G~p----YdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f-~  230 (786)
T KOG0588|consen  157 GMASLEVPGKLLETSCGSPHYAAPEIVSGRP----YDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF-E  230 (786)
T ss_pred             ceeecccCCccccccCCCcccCCchhhcCCC----CCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc-c
Confidence            9998766677777789999999999997542    335789999999999999999999997 555666777777754 5


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +|..  +|+++++||.+||..||+        .+.+..++..|+|++
T Consensus       231 MPs~--Is~eaQdLLr~ml~VDp~--------~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  231 MPSN--ISSEAQDLLRRMLDVDPS--------TRITTEEILKHPFLS  267 (786)
T ss_pred             CCCc--CCHHHHHHHHHHhccCcc--------ccccHHHHhhCchhh
Confidence            5544  899999999999999998        667777778888764

>KOG0597|consensus

Probab=100.00  E-value=2.1e-34  Score=257.53  Aligned_cols=186  Identities=28%  Similarity=0.478  Sum_probs=158.2

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ..|++..++|+|+|||.|+|..++.. .+.++|+.+..++.+++.||.|||+ ++|+|||+||.|||+...|.+|++|||
T Consensus        68 esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   68 ESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             HhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCCceeechhh
Confidence            46889999999999999999999987 8899999999999999999999999 799999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      +++.++.. .......||+.|||||++.     ...|+..+|+|||||++||+++|++||.. ..-......|+.. ++.
T Consensus       146 ~Ar~m~~~t~vltsikGtPlYmAPElv~-----e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d-~v~  218 (808)
T KOG0597|consen  146 LARAMSTNTSVLTSIKGTPLYMAPELVE-----EQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD-PVK  218 (808)
T ss_pred             hhhhcccCceeeeeccCcccccCHHHHc-----CCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC-CCC
Confidence            99877654 3445568999999999995     34899999999999999999999999987 3344445555544 334


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .|.  ..|..+..|++..|.+||.        .+.+...++.|+|.
T Consensus       219 ~p~--~~S~~f~nfl~gLL~kdP~--------~RltW~~Ll~HpF~  254 (808)
T KOG0597|consen  219 PPS--TASSSFVNFLQGLLIKDPA--------QRLTWTDLLGHPFW  254 (808)
T ss_pred             Ccc--cccHHHHHHHHHHhhcChh--------hcccHHHHhcChHH
Confidence            444  3799999999999999998        55555566666664

>KOG0579|consensus

Probab=100.00  E-value=4.4e-34  Score=258.37  Aligned_cols=198  Identities=27%  Similarity=0.461  Sum_probs=176.7

Q ss_pred             CCCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           1 MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ++.|+.++.+||..|||+| -.+.++-..+..|++.+|..+++|++.||.|||+ ++|||||||..|||++-+|.++|+|
T Consensus        95 l~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLAD  173 (1187)
T KOG0579|consen   95 LSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLAD  173 (1187)
T ss_pred             HHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeec
Confidence            3578889999999999995 8888887779999999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||++...... ..+..++||+.|||||++.+.......|+.++||||||++|.+|..+.+|... -+.+.++-+|.+..+
T Consensus       174 FGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSeP  252 (1187)
T KOG0579|consen  174 FGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEP  252 (1187)
T ss_pred             ccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCC
Confidence            9998665433 44566799999999999988877788999999999999999999999999887 678899999999999


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      |.+-.+..|+..+.+|+++||.+||.        .+..+.+++.|+|+..
T Consensus       253 PTLlqPS~Ws~~F~DfLk~cL~Knp~--------~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  253 PTLLQPSHWSRSFSDFLKRCLVKNPR--------NRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             CcccCcchhhhHHHHHHHHHHhcCCc--------cCCCHHHHhhCccccc
Confidence            99988888999999999999999998        5666777777777653

>KOG0201|consensus

Probab=100.00  E-value=2.8e-36  Score=262.63  Aligned_cols=196  Identities=34%  Similarity=0.491  Sum_probs=173.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|..+..+||+||||. |++.++++. +..+.+..+..++++++.||.|||. ++.+|||||+.|||+...|.+||+||
T Consensus        78 gsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~Df  155 (467)
T KOG0201|consen   78 GSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADF  155 (467)
T ss_pred             hheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEec
Confidence            45778889999999999 599999975 5556999999999999999999999 49999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..+.... ......||+.|||||++.+     ..|+.++||||||++.++|++|.+||.. -.++.++..|.+..+|
T Consensus       156 gVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-----~~Y~~KADIWSLGITaiEla~GePP~s~-~hPmrvlflIpk~~PP  229 (467)
T KOG0201|consen  156 GVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-----SGYDTKADIWSLGITAIELAKGEPPHSK-LHPMRVLFLIPKSAPP  229 (467)
T ss_pred             ceeeeeechhhccccccccccccchhhhcc-----ccccchhhhhhhhHHHHHHhcCCCCCcc-cCcceEEEeccCCCCC
Confidence            9998877554 3367799999999999953     3799999999999999999999999998 4567788888888888


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNIL  215 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (296)
                      .+..  .+|+.+++||..||.+||+        .+.++..++.+.|+...|+...+
T Consensus       230 ~L~~--~~S~~~kEFV~~CL~k~P~--------~RpsA~~LLKh~FIk~a~k~s~L  275 (467)
T KOG0201|consen  230 RLDG--DFSPPFKEFVEACLDKNPE--------FRPSAKELLKHKFIKRAKKTSEL  275 (467)
T ss_pred             cccc--ccCHHHHHHHHHHhhcCcc--------cCcCHHHHhhhHHHHhcCCchHH
Confidence            8877  4999999999999999998        77788889999998888866654

>KOG0694|consensus

Probab=100.00  E-value=8.3e-35  Score=265.67  Aligned_cols=194  Identities=23%  Similarity=0.377  Sum_probs=161.5

Q ss_pred             CCCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           1 MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++|++++++|+||||+.| ++..+.+  ...|++..+..++..|+.||.|||+ +||||||||.+|||++..|.+||+|
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCcEEecc
Confidence            3689999999999999995 7544443  5789999999999999999999999 7999999999999999999999999


Q ss_pred             cCCccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||+++..- .....++.+||+.|+|||++.+     ..|+.++|+|+|||++|+|+.|+.||.+ ++..++...|++.. 
T Consensus       512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e-----~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~-  584 (694)
T KOG0694|consen  512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-----QSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDE-  584 (694)
T ss_pred             cccccccCCCCCccccccCChhhcChhhhcc-----CcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC-
Confidence            99998754 4456677899999999999954     4899999999999999999999999998 56667777777654 


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +..|.+  +|.+...+++++|.++|+.|--..   -..+..+..++|....
T Consensus       585 ~~yP~~--ls~ea~~il~~ll~k~p~kRLG~~---e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  585 VRYPRF--LSKEAIAIMRRLLRKNPEKRLGSG---ERDAEDIKKHPFFRSI  630 (694)
T ss_pred             CCCCCc--ccHHHHHHHHHHhccCcccccCCC---CCCchhhhhCCccccC
Confidence            456665  899999999999999998443332   1224455666665443

>KOG0033|consensus

Probab=100.00  E-value=9.8e-34  Score=230.31  Aligned_cols=188  Identities=23%  Similarity=0.350  Sum_probs=160.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC---CCEEEe
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIKLC   78 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~---~~~kl~   78 (296)
                      .++.++..|||+|+|.| +|..-|-. ...++|..+...++||+.+|.|+|. +||||||+||+|+++...   .-+||+
T Consensus        78 ti~~~~~~ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   78 SIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             hhcccceeEEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeec
Confidence            46778899999999996 66544433 3678999999999999999999999 599999999999999543   458999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++...+.........||+.|+|||++     .+..|+..+|||+.|+++|-|+.|.+||.+ .....++++|.++..
T Consensus       156 ~FGvAi~l~~g~~~~G~~GtP~fmaPEvv-----rkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~y  229 (355)
T KOG0033|consen  156 DFGLAIEVNDGEAWHGFAGTPGYLSPEVL-----KKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAY  229 (355)
T ss_pred             ccceEEEeCCccccccccCCCcccCHHHh-----hcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhcccc
Confidence            99999988866667777999999999999     455889999999999999999999999998 566678888888765


Q ss_pred             CCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 PCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ..- |.+..++++.++||++||..||.        .+.++.+.+.++|+
T Consensus       230 d~~~~~w~~is~~Ak~LvrrML~~dP~--------kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  230 DYPSPEWDTVTPEAKSLIRRMLTVNPK--------KRITADEALKHPWI  270 (355)
T ss_pred             CCCCcccCcCCHHHHHHHHHHhccChh--------hhccHHHHhCCchh
Confidence            332 25666899999999999999998        77788888888765

>KOG0610|consensus

Probab=100.00  E-value=3.4e-33  Score=241.90  Aligned_cols=193  Identities=25%  Similarity=0.345  Sum_probs=158.1

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ..|+.+.+.|+|||||+| +|..+++++ +..|++..++.++..++.||+|||. +|||+|||||+||||..+|++.|.|
T Consensus       144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeee
Confidence            468899999999999995 999999887 6679999999999999999999999 6999999999999999999999999


Q ss_pred             cCCcccccCC--------------------------------c-c------------------------ccccccCcCCC
Q psy3686          80 FGISGRLVDS--------------------------------K-A------------------------RTKNAGCAAYM  102 (296)
Q Consensus        80 fg~~~~~~~~--------------------------------~-~------------------------~~~~~~~~~y~  102 (296)
                      |.++......                                . .                        .....||-.|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            9986432100                                0 0                        01125778899


Q ss_pred             CccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCC
Q psy3686         103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRS  182 (296)
Q Consensus       103 aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~  182 (296)
                      |||++.+.     ..+.++|+|+|||++|||+.|..||.+ .+..+.+.+|+... +.+|..+.++..+++||+++|.+|
T Consensus       303 APEvI~G~-----GHgsAVDWWtfGIflYEmLyG~TPFKG-~~~~~Tl~NIv~~~-l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  303 APEVIRGE-----GHGSAVDWWTFGIFLYEMLYGTTPFKG-SNNKETLRNIVGQP-LKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             cceeeecC-----CCCchhhHHHHHHHHHHHHhCCCCcCC-CCchhhHHHHhcCC-CcCCCCCcchhHHHHHHHHHhccC
Confidence            99999765     567799999999999999999999999 55667777777544 577777679999999999999999


Q ss_pred             hHHHhhhccCCccchhhcccCCcc
Q psy3686         183 TEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       183 P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      |..  |.-  -..=+.++.+|+|.
T Consensus       376 P~k--Rlg--~~rGA~eIK~HpFF  395 (459)
T KOG0610|consen  376 PSK--RLG--SKRGAAEIKRHPFF  395 (459)
T ss_pred             hhh--hhc--cccchHHhhcCccc
Confidence            982  222  12235667777775

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-33  Score=247.25  Aligned_cols=195  Identities=23%  Similarity=0.315  Sum_probs=156.0

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++.+|+||||+.| +|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Df  144 (323)
T cd05584          67 YAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDF  144 (323)
T ss_pred             eEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeC
Confidence            457788899999999995 99999976 6678999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......++..|+|||++.+     ..++.++|||||||++|+|++|..||.. ......+..+..+.. 
T Consensus       145 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~-  217 (323)
T cd05584         145 GLCKESIHEGTVTHTFCGTIEYMAPEILMR-----SGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL-  217 (323)
T ss_pred             cCCeecccCCCcccccCCCccccChhhccC-----CCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-
Confidence            998653322 22233468999999999953     3567899999999999999999999987 344455666665543 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      .++.  .+++.+.++|.+||..+|+.|+....   ..+.++..++++...+
T Consensus       218 ~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~---~~~~~l~~h~~~~~~~  263 (323)
T cd05584         218 NLPP--YLTPEARDLLKKLLKRNPSSRLGAGP---GDAAEVQSHPFFRHVN  263 (323)
T ss_pred             CCCC--CCCHHHHHHHHHHcccCHhHcCCCCC---CCHHHHhcCCCcCCCC
Confidence            3333  37999999999999999996653322   2566677777765443

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-33  Score=250.88  Aligned_cols=192  Identities=22%  Similarity=0.324  Sum_probs=153.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..++.+||||||+.| +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        63 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          63 SFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCC
Confidence            46778899999999995 99999876 6789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++...... .......|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+..+. +.
T Consensus       141 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~-~~  213 (323)
T cd05571         141 LCKEGISDGATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE-IR  213 (323)
T ss_pred             CCcccccCCCcccceecCccccChhhhcC-----CCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC-CC
Confidence            98653222 22334478999999999953     3678899999999999999999999987 33344444444433 34


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ++.  .+++.+.+||.+||..||+.|+....   ..+.+++.++++..
T Consensus       214 ~p~--~~~~~~~~li~~~L~~dP~~R~~~~~---~~~~~ll~h~~f~~  256 (323)
T cd05571         214 FPR--TLSPEAKSLLAGLLKKDPKQRLGGGP---EDAKEIMEHRFFAS  256 (323)
T ss_pred             CCC--CCCHHHHHHHHHHccCCHHHcCCCCC---CCHHHHHcCCCcCC
Confidence            443  37999999999999999995553221   25677777777644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0197|consensus

Probab=100.00  E-value=4.1e-34  Score=255.19  Aligned_cols=180  Identities=24%  Similarity=0.363  Sum_probs=151.9

Q ss_pred             ccCCeEEEEecCcc-ccHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           5 SKESDVWICMELMA-TCFDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         5 ~~~~~~~lv~E~~~-gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ..++.+|||||||. |+|.++|+. .+..+...+.+.++.||+.|++||++ +++|||||.+.||||+.+..+||+|||+
T Consensus       271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGL  349 (468)
T KOG0197|consen  271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGL  349 (468)
T ss_pred             ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCceEEEccccc
Confidence            34557999999999 899999987 46789999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCccccc--cccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          83 SGRLVDSKARTK--NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        83 ~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ++...+......  ..-...|.|||.+     ....++.++|||||||+|||++| |+.||.+ ....+++..+-+|.+ 
T Consensus       350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~-----~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyR-  422 (468)
T KOG0197|consen  350 ARLIGDDEYTASEGGKFPIKWTAPEAL-----NYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYR-  422 (468)
T ss_pred             ccccCCCceeecCCCCCCceecCHHHH-----hhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCc-
Confidence            995544432222  2345689999999     55589999999999999999999 9999999 466788888888875 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                       +|.+..+|+.+.++|..||..+|+  .|++|+.+.
T Consensus       423 -lp~P~~CP~~vY~lM~~CW~~~P~--~RPtF~~L~  455 (468)
T KOG0197|consen  423 -LPRPEGCPDEVYELMKSCWHEDPE--DRPTFETLR  455 (468)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhCCcc--cCCCHHHHH
Confidence             444445999999999999999998  555666443

>KOG0984|consensus

Probab=100.00  E-value=7.1e-34  Score=225.74  Aligned_cols=167  Identities=50%  Similarity=0.920  Sum_probs=150.7

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      +.+++++.+||.||.|..||+.+.++.   ++.++|..+-+|+..++.||.|||++..++|||+||+|||++..|++|+|
T Consensus       112 Ga~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  112 GALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             hhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEc
Confidence            456789999999999999998887654   78899999999999999999999999999999999999999999999999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++..+.++...+...|+..|+|||.+......+ .|+.++||||||+++.||.+++.||.....+.+.+.+++...+
T Consensus       192 DFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~-gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~  270 (282)
T KOG0984|consen  192 DFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQK-GYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS  270 (282)
T ss_pred             ccccceeehhhhHHHHhcCCCccCChhhcCcccCcc-cceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence            999999888776666668899999999997765444 8999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhHH
Q psy3686         159 PCLPNDPLFGRT  170 (296)
Q Consensus       159 p~~~~~~~~s~~  170 (296)
                      |.+|... +|++
T Consensus       271 P~Lp~~~-FS~e  281 (282)
T KOG0984|consen  271 PQLPADT-FSPE  281 (282)
T ss_pred             CCCcccc-cCCC
Confidence            9998775 6654

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.9e-33  Score=246.96  Aligned_cols=194  Identities=20%  Similarity=0.302  Sum_probs=155.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+.+.+||||||++ |+|..++.. ...+++..++.++.||+.||.|||+ +|++||||||+|||++.++.++|+||
T Consensus        63 ~~~~~~~~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~Df  140 (320)
T cd05590          63 CCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADF  140 (320)
T ss_pred             eEEEcCCEEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeC
Confidence            35678889999999999 599998876 5789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..... ........|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+..+.. 
T Consensus       141 G~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~-  213 (320)
T cd05590         141 GMCKEGIFNGKTTSTFCGTPDYIAPEILQE-----MLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV-  213 (320)
T ss_pred             CCCeecCcCCCcccccccCccccCHHHHcC-----CCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC-
Confidence            99865322 222334578999999999953     3678899999999999999999999987 445556666655443 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .++..  ++..+.++|.+||..||..|+  +..+.....++..++++..
T Consensus       214 ~~~~~--~~~~~~~li~~~L~~dP~~R~--~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         214 VYPTW--LSQDAVDILKAFMTKNPTMRL--GSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCC--CCHHHHHHHHHHcccCHHHCC--CCCCCCCHHHHHcCCCcCC
Confidence            33333  799999999999999998444  3333344466677777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0612|consensus

Probab=100.00  E-value=2.5e-33  Score=267.03  Aligned_cols=195  Identities=26%  Similarity=0.415  Sum_probs=162.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|+|+.++|+|||||+| +|..++.+.. .+++..++.++..|+.||.-||+ +|+|||||||+|||++..|++||+|||
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccch
Confidence            58999999999999995 9999998855 89999999999999999999999 799999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-CC
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-AP  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~~  158 (296)
                      .+..+...+  ......|||-|++||++......++.|+..+|+||+||++|+|+.|..||+. ++-.+.+.+|++- ..
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~  299 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKES  299 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhh
Confidence            998776333  3445689999999999977665567899999999999999999999999998 5667778888763 34


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYEC  200 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~  200 (296)
                      ..||....+|.+.++||.+.+........|..++++.....+
T Consensus       300 l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  300 LSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             cCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccc
Confidence            567766669999999999998755542222234444433333

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-32  Score=244.45  Aligned_cols=192  Identities=23%  Similarity=0.323  Sum_probs=152.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|..++.+||||||++ |+|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        62 ~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Df  139 (323)
T cd05595          62 YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDF  139 (323)
T ss_pred             eEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEeccc
Confidence            35678889999999999 599988876 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..... ........++..|+|||.+.+     ..++.++|||||||++|+|++|..||... ........+.... .
T Consensus       140 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~~~-~  212 (323)
T cd05595         140 GLCKEGISDGATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILMEE-I  212 (323)
T ss_pred             HHhccccCCCCccccccCCcCcCCcccccC-----CCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC-C
Confidence            98865322 222234568999999999953     36788999999999999999999999873 3444444444433 2


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .++.  .+++.+.++|.+||..+|..|+....   ..+.++..++++.
T Consensus       213 ~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~---~~~~~~l~h~~~~  255 (323)
T cd05595         213 RFPR--TLSPEAKSLLAGLLKKDPKQRLGGGP---SDAKEVMEHRFFL  255 (323)
T ss_pred             CCCC--CCCHHHHHHHHHHccCCHHHhCCCCC---CCHHHHHcCCCcC
Confidence            3443  37999999999999999996653321   3555566666553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-33  Score=245.06  Aligned_cols=191  Identities=26%  Similarity=0.356  Sum_probs=154.5

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++.+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+||
T Consensus        60 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Df  137 (312)
T cd05585          60 FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDF  137 (312)
T ss_pred             eEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEEC
Confidence            35678889999999999 599999976 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+..+. +
T Consensus       138 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~-~  210 (312)
T cd05585         138 GLCKLNMKDDDKTNTFCGTPEYLAPELLLG-----HGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEP-L  210 (312)
T ss_pred             cccccCccCCCccccccCCcccCCHHHHcC-----CCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCC-C
Confidence            998753322 22334578999999999953     3678899999999999999999999987 34445555665543 3


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .++.  .+++.+.++|.+||..+|..|+.     ..++.+++.++++..
T Consensus       211 ~~~~--~~~~~~~~li~~~L~~dp~~R~~-----~~~~~e~l~hp~~~~  252 (312)
T cd05585         211 RFPD--GFDRDAKDLLIGLLSRDPTRRLG-----YNGAQEIKNHPFFSQ  252 (312)
T ss_pred             CCCC--cCCHHHHHHHHHHcCCCHHHcCC-----CCCHHHHHcCCCcCC
Confidence            3443  37999999999999999985542     124666777777644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0663|consensus

Probab=100.00  E-value=1.1e-32  Score=232.85  Aligned_cols=190  Identities=22%  Similarity=0.335  Sum_probs=160.1

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +-+.+|||||||+.+|..++..+..+|...+++.++.|+++||+|||. +.|+|||||++|+|+++.|.+||+|||+|+.
T Consensus       148 ~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  148 NMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             ccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCCcEEecccchhhh
Confidence            445699999999999999999998899999999999999999999999 6999999999999999999999999999999


Q ss_pred             ccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCCC---
Q psy3686          86 LVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAPP---  159 (296)
Q Consensus        86 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~p---  159 (296)
                      ++.+ ...+....|.+|.|||.+.+.    ..|+...|+||+|||+.+++++.+-|.+ ....+.+.+|.+  |.+-   
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~----~tyst~iDMWSvGCI~aE~l~~kPlf~G-~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGA----KTYSTAVDMWSVGCIFAELLTQKPLFPG-KSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCC----cccCcchhhhhHHHHHHHHHhcCCCCCC-CchHHHHHHHHHHhCCCcccc
Confidence            8866 344556889999999999854    4799999999999999999999999998 566666666654  1110   


Q ss_pred             -----CCC--------CC-----------cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 -----CLP--------ND-----------PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 -----~~~--------~~-----------~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                           .+|        ..           ..++..-.+|+..+|..||.        .+.++.+.+.+.++...
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~--------kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG--------KRITAEDGLKHEYFRET  367 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc--------ccccHHHhhcccccccC
Confidence                 011        00           11568889999999999998        78888888988887553

>KOG0585|consensus

Probab=100.00  E-value=1.7e-33  Score=247.37  Aligned_cols=187  Identities=26%  Similarity=0.475  Sum_probs=149.8

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..+.+|||+|||. |.+...-.  ... +++.++++++++++.||+|||. +|||||||||+|+|++.+|++||+|||.+
T Consensus       181 ~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~~g~VKIsDFGVs  257 (576)
T KOG0585|consen  181 ESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSSDGTVKISDFGVS  257 (576)
T ss_pred             ccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcCCCcEEeecccee
Confidence            4578999999999 65544322  445 9999999999999999999999 59999999999999999999999999999


Q ss_pred             ccccCC------ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          84 GRLVDS------KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        84 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ......      .......||+.|+|||.+.+... ....+.+.||||+|++||.|+.|+.||.+ +...+...+|++..
T Consensus       258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~p  335 (576)
T KOG0585|consen  258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-FSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDP  335 (576)
T ss_pred             eecccCCccccHHHHhhcCCCccccchHhhcCCCC-ccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCc
Confidence            766222      22233589999999999976432 23456889999999999999999999998 56667777776654


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                       ..+|..+.+...+++||.++|.+||+        .+....++..|+|+
T Consensus       336 -L~fP~~pe~~e~~kDli~~lL~KdP~--------~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  336 -LEFPENPEINEDLKDLIKRLLEKDPE--------QRITLPDIKLHPWV  375 (576)
T ss_pred             -ccCCCcccccHHHHHHHHHHhhcChh--------heeehhhheeccee
Confidence             46666666899999999999999998        44445555555554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.4e-33  Score=242.16  Aligned_cols=195  Identities=19%  Similarity=0.303  Sum_probs=150.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +|.+++.+|+||||+. |+|..++... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+||
T Consensus        68 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Df  146 (285)
T cd05631          68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDL  146 (285)
T ss_pred             EEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeC
Confidence            5677889999999999 5998887653 3469999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcH--HHHHHHHccCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF--EVLSRVLNDAP  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~i~~~~~  158 (296)
                      |++.............++..|+|||++.+     ..++.++|||||||++|+|++|+.||.......  ..+...+....
T Consensus       147 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd05631         147 GLAVQIPEGETVRGRVGTVGYMAPEVINN-----EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ  221 (285)
T ss_pred             CCcEEcCCCCeecCCCCCCCccCHhhhcC-----CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc
Confidence            99976544433344578999999999953     368889999999999999999999998743321  22222222222


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ..++  ..++..+.+||.+||..+|..|+..+.   ..+.++..++++..
T Consensus       222 ~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~---~~~~~~~~h~~~~~  266 (285)
T cd05631         222 EEYS--EKFSEDAKSICRMLLTKNPKERLGCRG---NGAAGVKQHPIFKN  266 (285)
T ss_pred             ccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCC---CCHHHHhcCHhhcC
Confidence            2232  338999999999999999995554211   13556666666543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1006|consensus

Probab=100.00  E-value=1.7e-34  Score=237.23  Aligned_cols=192  Identities=51%  Similarity=0.838  Sum_probs=168.5

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRL----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      ..+.++..||.||+|+-||+.+.+..    ...++|..+-.|+..++.||.||-..+.|||||+||+|||++..|.+|||
T Consensus       131 a~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  131 ALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             hhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence            34678999999999998887776543    67899999999999999999999998899999999999999999999999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++..+..+...+...|+..|+|||.+...   ...|..++||||||++|||+.||..||....+..+.+..++.|.+
T Consensus       211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p~---~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp  287 (361)
T KOG1006|consen  211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDPS---DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP  287 (361)
T ss_pred             cccchHhHHHHHHhhhccCCccccChhccCCc---cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC
Confidence            99999988887777777899999999999754   236899999999999999999999999998888899999999999


Q ss_pred             CCCCCCcc---hhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         159 PCLPNDPL---FGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       159 p~~~~~~~---~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                      |.+..+..   ++..+..||..||.+|-+  .|+.|.++.+...
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~--~Rpky~~Lk~~~f  329 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRS--DRPKYDDLKKFPF  329 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccc--cCcchhhhhcCch
Confidence            98876543   999999999999999987  5555666654443

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.4e-33  Score=245.97  Aligned_cols=191  Identities=21%  Similarity=0.322  Sum_probs=151.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+||||||+. |+|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        63 ~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          63 SFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             EEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCc
Confidence            4677889999999999 599988876 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........+++.|+|||++.+     ..++.++|||||||++|+|++|..||... ........+.... ..
T Consensus       141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~~~~-~~  213 (328)
T cd05593         141 LCKEGITDAATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILMED-IK  213 (328)
T ss_pred             CCccCCCcccccccccCCcCccChhhhcC-----CCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhccCC-cc
Confidence            9865322 222334578999999999953     36788999999999999999999999873 3344444444433 33


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ++.  .+++.+.+||.+||..+|..|+...   ..++.++..++++.
T Consensus       214 ~p~--~~~~~~~~li~~~L~~dP~~R~~~~---~~~~~~il~h~~~~  255 (328)
T cd05593         214 FPR--TLSADAKSLLSGLLIKDPNKRLGGG---PDDAKEIMRHSFFT  255 (328)
T ss_pred             CCC--CCCHHHHHHHHHHcCCCHHHcCCCC---CCCHHHHhcCCCcC
Confidence            443  3799999999999999999554321   13566666776653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=240.27  Aligned_cols=189  Identities=25%  Similarity=0.355  Sum_probs=153.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||+ +|++||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          69 TEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             hhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecC
Confidence            4667889999999998 599999976 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ++......  .....+++.|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+..+.. .+
T Consensus       147 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~-~~  217 (291)
T cd05612         147 FAKKLRDR--TWTLCGTPEYLAPEVIQS-----KGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL-EF  217 (291)
T ss_pred             cchhccCC--cccccCChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc-CC
Confidence            98765432  223468899999999853     3578899999999999999999999987 445566666665543 34


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +..  ++..++++|++||..||..|+...   ...+.+++.++++.
T Consensus       218 ~~~--~~~~~~~li~~~l~~dp~~R~~~~---~~~~~~~l~h~~~~  258 (291)
T cd05612         218 PRH--LDLYAKDLIKKLLVVDRTRRLGNM---KNGADDVKNHRWFK  258 (291)
T ss_pred             Ccc--CCHHHHHHHHHHcCCCHHHccCCc---cCCHHHHhcCcccc
Confidence            433  699999999999999999554311   12455666777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0600|consensus

Probab=100.00  E-value=8.9e-33  Score=244.44  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=155.8

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      .+.+|||+|||+-+|..++......|++.+|..++.||+.||.|||.+ ||+|||||..||||+++|.+||+|||+|+++
T Consensus       190 ~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  190 SGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             CceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeec
Confidence            578999999999999999998778999999999999999999999995 9999999999999999999999999999977


Q ss_pred             cCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCCC---
Q psy3686          87 VDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAPP---  159 (296)
Q Consensus        87 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~p---  159 (296)
                      ....  ..+..+.|.+|.|||++.|.    ..|+.++|+||+||||.||+.|++.|++ ....+.+..|.+  |.+.   
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~----t~Yg~aVDlWS~GCIl~El~~gkPI~~G-~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGA----TSYGTAVDLWSVGCILAELFLGKPILQG-RTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCC----cccccceeehhhhHHHHHHHcCCCCcCC-ccHHHHHHHHHHHhCCCChhc
Confidence            6543  34556789999999999864    3899999999999999999999999999 566667766654  1110   


Q ss_pred             ----CCCC-----------------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 ----CLPN-----------------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ----~~~~-----------------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                          .+|.                 ...++....+|+..+|..||+        .+.++...+...++
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~--------kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD--------KRGTASSALQSEYF  403 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc--------ccccHHHHhcCccc
Confidence                1110                 123678999999999999998        55666666666555

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.8e-33  Score=246.57  Aligned_cols=189  Identities=23%  Similarity=0.381  Sum_probs=153.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++.+|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         86 SFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeecc
Confidence            46788999999999985 99999976 5789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ++.......  ....+++.|+|||++.+     ..++.++|||||||++|+|++|..||.+ .........+..+. +.+
T Consensus       164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~-~~~  234 (329)
T PTZ00263        164 FAKKVPDRT--FTLCGTPEYLAPEVIQS-----KGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGR-LKF  234 (329)
T ss_pred             CceEcCCCc--ceecCChhhcCHHHHcC-----CCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC-cCC
Confidence            987654322  23478999999999953     3578899999999999999999999987 44556666666554 334


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +..  ++..+++||.+||..||..|+..   -.....+++.++++.
T Consensus       235 p~~--~~~~~~~li~~~L~~dP~~R~~~---~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        235 PNW--FDGRARDLVKGLLQTDHTKRLGT---LKGGVADVKNHPYFH  275 (329)
T ss_pred             CCC--CCHHHHHHHHHHhhcCHHHcCCC---CCCCHHHHhcCCccC
Confidence            443  78999999999999999855431   112245566666654

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-32  Score=244.32  Aligned_cols=195  Identities=22%  Similarity=0.364  Sum_probs=152.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +|.+++.+|||||||+| +|..++.+ ...+++..++.++.||+.||.|||+ +|++||||||+||+++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          64 CFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             EEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCc
Confidence            46778899999999995 99988866 5789999999999999999999999 599999999999999999999999999


Q ss_pred             Cccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------CcHHHHHHH
Q psy3686          82 ISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK-------CDFEVLSRV  153 (296)
Q Consensus        82 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~-------~~~~~~~~i  153 (296)
                      ++.... .........|+..|+|||++.+     ..++.++|+|||||++|+|++|..||....       .......+.
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05588         142 MCKEGIRPGDTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV  216 (329)
T ss_pred             cccccccCCCccccccCCccccCHHHHcC-----CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH
Confidence            986432 2223334578999999999953     367889999999999999999999996311       112223333


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +......+|..  ++..+.++|.+||..+|..|.  +........++..++++..
T Consensus       217 ~~~~~~~~p~~--~~~~~~~li~~~L~~dP~~R~--~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         217 ILEKQIRIPRS--LSVKASSVLKGFLNKDPKERL--GCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHcCCCCCCCC--CCHHHHHHHHHHhccCHHHcC--CCCCCCCHHHHhcCCCCCC
Confidence            33333445543  799999999999999998443  3333345667777777643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0659|consensus

Probab=100.00  E-value=2.5e-32  Score=224.36  Aligned_cols=195  Identities=22%  Similarity=0.346  Sum_probs=163.3

Q ss_pred             CCCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           1 MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++.|-..+.+-||+|||+.+|..+++.....++...+..++.++++||+|||+ +.|+||||||.|+|++.+|.+||+||
T Consensus        67 iD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   67 IDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             hhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecc
Confidence            46788899999999999999999999988999999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccc-cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cC
Q psy3686          81 GISGRLVDSKAR-TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DA  157 (296)
Q Consensus        81 g~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~  157 (296)
                      |+++.+...... .....|.+|.|||.+.|.    ..|+..+|+||.||++.||+-|.+-|.+ +++.+.+..|..  |.
T Consensus       146 GLAr~f~~p~~~~~~~V~TRWYRAPELLfGs----r~Yg~~VDmWavGCI~AELllr~P~fpG-~sDidQL~~If~~LGT  220 (318)
T KOG0659|consen  146 GLARFFGSPNRIQTHQVVTRWYRAPELLFGS----RQYGTGVDMWAVGCIFAELLLRVPFFPG-DSDIDQLSKIFRALGT  220 (318)
T ss_pred             cchhccCCCCcccccceeeeeccChHHhccc----hhcCCcchhhhHHHHHHHHHccCCCCCC-CchHHHHHHHHHHcCC
Confidence            999988755432 333788999999999754    4899999999999999999999877877 677777766654  11


Q ss_pred             C-C-CCCC---------------------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 P-P-CLPN---------------------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ~-p-~~~~---------------------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      + + .+|.                     ....+.+..+|+.++|..||.        .+.++.+.+.+..+...
T Consensus       221 P~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~--------~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  221 PTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPK--------KRITASQALKHPYFKSL  287 (318)
T ss_pred             CCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCch--------hcccHHHHhcchhhhcC
Confidence            1 1 1111                     123468889999999999998        77888888888876553

>KOG0577|consensus

Probab=100.00  E-value=7.7e-34  Score=255.05  Aligned_cols=196  Identities=28%  Similarity=0.420  Sum_probs=174.2

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +||-.+...|||||||-||-.++++-...++.+-.|..|+.+.+.||+|||+ ++.||||||..|||++..|.|||+|||
T Consensus        93 gCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g~VKLaDFG  171 (948)
T KOG0577|consen   93 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPGLVKLADFG  171 (948)
T ss_pred             ceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCCeeeecccc
Confidence            5788888999999999999999998888999999999999999999999999 799999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .+....+   .+.++||+.|||||++...  -.+.|+-++|||||||+..+|...++|+.++ +.+..+..|..+..|.+
T Consensus       172 SAsi~~P---AnsFvGTPywMAPEVILAM--DEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtL  245 (948)
T KOG0577|consen  172 SASIMAP---ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTL  245 (948)
T ss_pred             chhhcCc---hhcccCCccccchhHheec--cccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCC
Confidence            9866543   3556999999999999776  4558999999999999999999999999884 66788889999999999


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCC
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQN  213 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (296)
                      +... ||..++.||..||.+-|.        ++.+..+++.+.|+....|..
T Consensus       246 qs~e-WS~~F~~Fvd~CLqKipq--------eRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  246 QSNE-WSDYFRNFVDSCLQKIPQ--------ERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             CCch-hHHHHHHHHHHHHhhCcc--------cCCcHHHHhhcchhccCCCch
Confidence            8765 999999999999999998        777888888888876554444

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-32  Score=243.05  Aligned_cols=174  Identities=23%  Similarity=0.366  Sum_probs=143.2

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++++|+||||+.| +|..++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.++|+||
T Consensus        63 ~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Df  140 (316)
T cd05620          63 CTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADF  140 (316)
T ss_pred             EEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCcc
Confidence            346778899999999995 99999876 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..... ........++..|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+.. ..+
T Consensus       141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~-~~~  213 (316)
T cd05620         141 GMCKENVFGDNRASTFCGTPDYIAPEILQG-----LKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRV-DTP  213 (316)
T ss_pred             CCCeecccCCCceeccCCCcCccCHHHHcC-----CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-CCC
Confidence            99864321 222334578999999999953     3678899999999999999999999987 344444444443 334


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .++..  ++..++++|.+||..||+.|
T Consensus       214 ~~~~~--~~~~~~~li~~~l~~dP~~R  238 (316)
T cd05620         214 HYPRW--ITKESKDILEKLFERDPTRR  238 (316)
T ss_pred             CCCCC--CCHHHHHHHHHHccCCHHHc
Confidence            55543  79999999999999999844

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-32  Score=242.29  Aligned_cols=174  Identities=24%  Similarity=0.424  Sum_probs=144.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++ |+|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          64 TFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCc
Confidence            4567889999999998 599999876 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++...... .......|+..|+|||++.+     ..++.++|||||||++|+|++|..||.+ .........+.. ..+.
T Consensus       142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~-~~~~  214 (316)
T cd05592         142 MCKENMNGEGKASTFCGTPDYIAPEILKG-----QKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILN-DRPH  214 (316)
T ss_pred             CCeECCCCCCccccccCCccccCHHHHcC-----CCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHc-CCCC
Confidence            98754322 23334578999999999953     3678899999999999999999999987 344455555544 3344


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ++..  ++..+.++|.+||..+|..|+
T Consensus       215 ~~~~--~~~~~~~ll~~~l~~~P~~R~  239 (316)
T cd05592         215 FPRW--ISKEAKDCLSKLFERDPTKRL  239 (316)
T ss_pred             CCCC--CCHHHHHHHHHHccCCHHHcC
Confidence            5543  799999999999999998444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-32  Score=243.10  Aligned_cols=189  Identities=24%  Similarity=0.365  Sum_probs=151.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||+.| +|..++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          64 SFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             EEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccC
Confidence            45678899999999995 99999876 6789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++...... .......+++.|+|||++.+     ..++.++|||||||++|+|++|..||.. ....+....+..+.. .
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~-~  214 (323)
T cd05575         142 LCKEGIEHSKTTSTFCGTPEYLAPEVLRK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL-R  214 (323)
T ss_pred             CCcccccCCCccccccCChhhcChhhhcC-----CCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC-C
Confidence            98653222 22334468999999999853     3678899999999999999999999987 344455566665543 2


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ++.  .++..+.++|.+||..+|..|+...    ....++..++++
T Consensus       215 ~~~--~~~~~~~~li~~~l~~~p~~R~~~~----~~~~~il~~~~~  254 (323)
T cd05575         215 LKP--NISVSARHLLEGLLQKDRTKRLGAK----DDFLEIKNHVFF  254 (323)
T ss_pred             CCC--CCCHHHHHHHHHHhhcCHHhCCCCC----CCHHHHHcCCCc
Confidence            332  3799999999999999999665432    233455556554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0596|consensus

Probab=100.00  E-value=7.1e-33  Score=247.22  Aligned_cols=196  Identities=22%  Similarity=0.364  Sum_probs=156.4

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +|-..++++||||||-+.+|..+|.+....++.-.++.+..||+.++.++|. +||||.||||.|+|+- .|.+||+|||
T Consensus       427 DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  427 DYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             eeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE-eeeEEeeeec
Confidence            5666789999999999999999999866666666999999999999999999 7999999999999984 5889999999


Q ss_pred             CcccccCCc---cccccccCcCCCCccccCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHH
Q psy3686          82 ISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQ------KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        82 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~------~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~  152 (296)
                      +|..+....   .....+||+.||+||.+......      +.+.++++||||||||||+|+.|+.||....+....+..
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~a  584 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHA  584 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHh
Confidence            998765432   23345899999999999654322      335788999999999999999999999885544444555


Q ss_pred             HHcc-CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         153 VLND-APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       153 i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      |... ....+|..+. ..++.++++.||.+||.        .+.++.++++++|+.-
T Consensus       585 I~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPk--------kR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPE-NDELIDVMKCCLARDPK--------KRWSIPELLQHPFLQI  632 (677)
T ss_pred             hcCCCccccccCCCC-chHHHHHHHHHHhcCcc--------cCCCcHHHhcCccccc
Confidence            5443 1124444331 23399999999999998        7777888999998755

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-32  Score=242.58  Aligned_cols=191  Identities=19%  Similarity=0.313  Sum_probs=150.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +|.+++.+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          69 CFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            4567789999999998 599999876 5679999999999999999999999 599999999999999999999999999


Q ss_pred             Cccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++.... .........|+..|+|||++.+     ..++.++|||||||++|+|++|+.||.+ ......+..+.... +.
T Consensus       147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~-~~  219 (324)
T cd05587         147 MCKENIFGGKTTRTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN-VS  219 (324)
T ss_pred             cceecCCCCCceeeecCCccccChhhhcC-----CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC-CC
Confidence            986432 1222334478999999999953     3578899999999999999999999987 34445555565543 33


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ++.  .++..+.++|.+||..+|..|.....   ....++..++++.
T Consensus       220 ~~~--~~~~~~~~li~~~l~~~P~~R~~~~~---~~~~~~~~hp~~~  261 (324)
T cd05587         220 YPK--SLSKEAVSICKGLLTKHPAKRLGCGP---TGERDIREHAFFR  261 (324)
T ss_pred             CCC--CCCHHHHHHHHHHhhcCHHHcCCCCC---CCHHHHhcCCCcC
Confidence            443  37999999999999999985543211   1223455555543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-32  Score=243.63  Aligned_cols=192  Identities=20%  Similarity=0.319  Sum_probs=152.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++.+|+||||+. |+|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          69 CFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCC
Confidence            4667889999999998 599999876 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+.... +.
T Consensus       147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~-~~  219 (323)
T cd05616         147 MCKENMWDGVTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN-VA  219 (323)
T ss_pred             CceecCCCCCccccCCCChhhcCHHHhcC-----CCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC-CC
Confidence            9865432 222334578999999999953     3678999999999999999999999987 34455666665544 33


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +|..  ++..+.++|.+||..+|..|.....+   ...++..++++..
T Consensus       220 ~p~~--~s~~~~~li~~~l~~~p~~R~~~~~~---~~~~i~~h~~~~~  262 (323)
T cd05616         220 YPKS--MSKEAVAICKGLMTKHPGKRLGCGPE---GERDIKEHAFFRY  262 (323)
T ss_pred             CCCc--CCHHHHHHHHHHcccCHHhcCCCCCC---CHHHHhcCCCcCC
Confidence            4433  79999999999999999955542211   2334455555543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-32  Score=243.95  Aligned_cols=194  Identities=22%  Similarity=0.333  Sum_probs=154.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+||||||+.| +|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+||
T Consensus        63 ~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Df  140 (321)
T cd05591          63 CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADF  140 (321)
T ss_pred             eEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeec
Confidence            456788899999999994 99988876 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......++..|+|||++.+     ..++.++|||||||++|+|++|..||.. ......+..+..+.. 
T Consensus       141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~-  213 (321)
T cd05591         141 GMCKEGILNGVTTTTFCGTPDYIAPEILQE-----LEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV-  213 (321)
T ss_pred             ccceecccCCccccccccCccccCHHHHcC-----CCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-
Confidence            998653322 22334468999999999853     3678899999999999999999999987 455566666665543 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .+|..  ++.++.++|.+||..+|+.|+.. ........++..++++.
T Consensus       214 ~~p~~--~~~~~~~ll~~~L~~dp~~R~~~-~~~~~~~~~~~~hp~~~  258 (321)
T cd05591         214 LYPVW--LSKEAVSILKAFMTKNPNKRLGC-VASQGGEDAIKQHPFFK  258 (321)
T ss_pred             CCCCC--CCHHHHHHHHHHhccCHHHcCCC-CCCCCCHHHHhcCCccC
Confidence            33333  79999999999999999854421 11112556667777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9e-33  Score=245.74  Aligned_cols=193  Identities=22%  Similarity=0.322  Sum_probs=151.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+||||||+. |+|..++.. ...+++..++.++.||+.||.|||+..||+||||||+|||++.++.+||+|||
T Consensus        63 ~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg  141 (325)
T cd05594          63 SFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG  141 (325)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCC
Confidence            4667889999999999 599988876 56899999999999999999999973499999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........++..|+|||++.+     ..++.++|||||||++|+|++|..||... ........+... ...
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~~-~~~  214 (325)
T cd05594         142 LCKEGIKDGATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILME-EIR  214 (325)
T ss_pred             CCeecCCCCcccccccCCcccCCHHHHcc-----CCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhcC-CCC
Confidence            9865332 222234468999999999953     36788999999999999999999999873 333444444433 333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ++..  +++.+.++|.+||..||+.|....   ..++.+++.++++..
T Consensus       215 ~p~~--~~~~~~~li~~~L~~dP~~R~~~~---~~~~~~il~h~~~~~  257 (325)
T cd05594         215 FPRT--LSPEAKSLLSGLLKKDPKQRLGGG---PDDAKEIMQHKFFAG  257 (325)
T ss_pred             CCCC--CCHHHHHHHHHHhhcCHHHhCCCC---CCCHHHHhcCCCcCC
Confidence            4433  799999999999999999554321   135566666766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-32  Score=242.95  Aligned_cols=190  Identities=24%  Similarity=0.351  Sum_probs=151.9

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|+||||+.| +|..++.  ...+++..++.++.||+.||.|||+ +|++||||||+||+++.++.+||+||
T Consensus        69 ~~~~~~~~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          69 ACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             eEEEcCCEEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcc
Confidence            356778899999999995 9988886  4679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......++..|+|||.+.+     ..++.++|||||||++|+|++|..||.+ .........+..+.. 
T Consensus       146 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~-  218 (324)
T cd05589         146 GLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV-  218 (324)
T ss_pred             cCCccCCCCCCcccccccCccccCHhHhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC-
Confidence            988653222 22334578999999999953     3678899999999999999999999987 344455555655443 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .++..  ++..+.++|.+||..+|..|+.....   .+.++..++++
T Consensus       219 ~~p~~--~~~~~~~li~~~L~~dP~~R~~~~~~---~~~~l~~~~~f  260 (324)
T cd05589         219 RYPRF--LSREAISIMRRLLRRNPERRLGSGEK---DAEDVKKQPFF  260 (324)
T ss_pred             CCCCC--CCHHHHHHHHHHhhcCHhHcCCCCCC---CHHHHhhCCCc
Confidence            34433  79999999999999999966654222   44555566654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589|consensus

Probab=100.00  E-value=6.5e-33  Score=246.56  Aligned_cols=189  Identities=26%  Similarity=0.399  Sum_probs=162.7

Q ss_pred             CCCccCCe-EEEEecCccc-cHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           2 SPQSKESD-VWICMELMAT-CFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~-~~lv~E~~~g-sL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      +.|..++. ++|||+||+| +|.+.+.+.. ..++++.+..|+.||+.||.|||+ ..|+|||||+.|||++.++.|+|+
T Consensus        70 ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLg  148 (426)
T KOG0589|consen   70 DSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLG  148 (426)
T ss_pred             cchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccCceeec
Confidence            35667777 9999999995 9999998875 789999999999999999999998 599999999999999999999999


Q ss_pred             ccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          79 DFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        79 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |||+++.+.... ......||+.|++||.+.     ...|+.++|||||||++|+|++-+.+|.. .+......+|.++.
T Consensus       149 DfGlaK~l~~~~~~a~tvvGTp~YmcPEil~-----d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~  222 (426)
T KOG0589|consen  149 DFGLAKILNPEDSLASTVVGTPYYMCPEILS-----DIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL  222 (426)
T ss_pred             chhhhhhcCCchhhhheecCCCcccCHHHhC-----CCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc
Confidence            999999988765 666779999999999995     44899999999999999999999999998 56667777888777


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ...+|..  ++.+++.+|+.||.++|+        .+..+.+++..+++.
T Consensus       223 ~~Plp~~--ys~el~~lv~~~l~~~P~--------~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  223 YSPLPSM--YSSELRSLVKSMLRKNPE--------HRPSALELLRRPHLL  262 (426)
T ss_pred             CCCCCcc--ccHHHHHHHHHHhhcCCc--------cCCCHHHHhhChhhh
Confidence            5555544  899999999999999998        445555555555543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-32  Score=242.89  Aligned_cols=195  Identities=21%  Similarity=0.352  Sum_probs=152.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +|.+.+.+|+||||+. |+|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          64 CFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccc
Confidence            4667889999999998 599998876 5689999999999999999999999 599999999999999999999999999


Q ss_pred             Cccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CcHHHHHHHHc
Q psy3686          82 ISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK-----CDFEVLSRVLN  155 (296)
Q Consensus        82 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~-----~~~~~~~~i~~  155 (296)
                      ++.... .........|+..|+|||++.+     ..++.++|||||||++|+|++|..||....     ...........
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  216 (327)
T cd05617         142 MCKEGLGPGDTTSTFCGTPNYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL  216 (327)
T ss_pred             cceeccCCCCceecccCCcccCCHHHHCC-----CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH
Confidence            986532 2223334578999999999953     367889999999999999999999996421     22233334433


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ..+..+|..  ++..+.++|.+||..+|..|.  +........++..++++..
T Consensus       217 ~~~~~~p~~--~~~~~~~li~~~L~~dP~~R~--~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         217 EKPIRIPRF--LSVKASHVLKGFLNKDPKERL--GCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             hCCCCCCCC--CCHHHHHHHHHHhccCHHHcC--CCCCCCCHHHHHcCCCCCC
Confidence            444445543  799999999999999998443  3333445556667776543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4721|consensus

Probab=100.00  E-value=1e-33  Score=253.24  Aligned_cols=187  Identities=27%  Similarity=0.407  Sum_probs=155.5

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.....+|||||||. |.|..+|+. +..++...+..|..+|+.|+.|||. |.|||||||.-||||+.+..|||+||
T Consensus       179 GVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  179 GVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             eeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccceEEeccc
Confidence            34566778999999999 899999987 7889999999999999999999999 79999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |.++......+...+.||..|||||++..     ..++.|+||||||||||+|+||..||.+.+.. .++.-+ ......
T Consensus       257 GTS~e~~~~STkMSFaGTVaWMAPEvIrn-----ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-AIIwGV-GsNsL~  329 (904)
T KOG4721|consen  257 GTSKELSDKSTKMSFAGTVAWMAPEVIRN-----EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-AIIWGV-GSNSLH  329 (904)
T ss_pred             cchHhhhhhhhhhhhhhhHhhhCHHHhhc-----CCcccccceehhHHHHHHHHhcCCCccccchh-eeEEec-cCCccc
Confidence            99988877777777899999999999954     47899999999999999999999999984332 222222 122334


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                      +|-...+++-++-||++||...|.  .|++|......+.
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpR--NRPSFrqil~Hld  366 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPR--NRPSFRQILLHLD  366 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCC--CCccHHHHHHHHh
Confidence            555555899999999999999994  5666665544443

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=244.86  Aligned_cols=192  Identities=23%  Similarity=0.364  Sum_probs=152.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|+||||+. |+|..++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          64 SFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             EEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCC
Confidence            3567889999999998 599998876 6789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........|+..|+|||.+.+    ...++.++|||||||++|+|++|..||.. ....+.+..+..+.. .
T Consensus       142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~-~  215 (330)
T cd05586         142 LSKANLTDNKTTNTFCGTTEYLAPEVLLD----EKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKV-R  215 (330)
T ss_pred             cCcCCCCCCCCccCccCCccccCHHHHcC----CCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCC-C
Confidence            9865322 223334578999999999853    22478899999999999999999999987 344455555554443 3


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ++.. .++..+.++|.+||..+|..|+.    ....+.++..++++.
T Consensus       216 ~~~~-~~~~~~~~li~~~L~~~P~~R~~----~~~~~~~ll~h~~~~  257 (330)
T cd05586         216 FPKN-VLSDEGRQFVKGLLNRNPQHRLG----AHRDAVELKEHPFFA  257 (330)
T ss_pred             CCCc-cCCHHHHHHHHHHcCCCHHHCCC----CCCCHHHHhcCcccc
Confidence            3333 37999999999999999985543    223566667777654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-32  Score=243.27  Aligned_cols=196  Identities=26%  Similarity=0.405  Sum_probs=157.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ..+.+++.+||||||++ |+|.+++.+....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             eEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccC
Confidence            34667889999999998 59999998766789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc--ccccccCcCCCCccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQ-KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |++..+.....  .....++..|+|||++...... ...++.++|||||||++|+|++|..||.. ......+.++....
T Consensus       147 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~  225 (330)
T cd05601         147 GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQ  225 (330)
T ss_pred             CCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCC
Confidence            99976543322  2233688999999998643222 34678899999999999999999999987 34445566665543


Q ss_pred             -CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 -PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 -~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                       ...++....++..+.+||.+||. +|.        ++.++.++..++++..
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~ll~-~p~--------~R~t~~~l~~h~~~~~  268 (330)
T cd05601         226 RFLKFPEDPKVSSDFLDLIQSLLC-GQK--------ERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CccCCCCCCCCCHHHHHHHHHHcc-Chh--------hCCCHHHHhCCCCcCC
Confidence             23455555589999999999997 997        5556667777777643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-32  Score=245.78  Aligned_cols=193  Identities=25%  Similarity=0.372  Sum_probs=152.6

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|||||||+| +|.+++.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          69 SFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeecc
Confidence            46678899999999984 99999976 5789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc------------------------------------cccccccCcCCCCccccCCCCCCCCCCCcchhHHH
Q psy3686          82 ISGRLVDSK------------------------------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS  125 (296)
Q Consensus        82 ~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Diws  125 (296)
                      ++.......                                    ......||+.|+|||++.+     ..++.++||||
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DvwS  221 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-----TGYNKLCDWWS  221 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-----CCCCCchhhhh
Confidence            986542110                                    0113468999999999953     36788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCC
Q psy3686         126 LGITLVELATGEFPYKDCKCDFEVLSRVLND-APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEG  204 (296)
Q Consensus       126 lG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~  204 (296)
                      |||++|+|++|..||.+ ....+...++... ....+|....+++.++++|.+++. +|..|.     .+..+.+++.++
T Consensus       222 lGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~-----~r~~~~ei~~hp  294 (363)
T cd05628         222 LGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRI-----GAPGVEEIKTNP  294 (363)
T ss_pred             hHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcC-----CCCCHHHHhCCC
Confidence            99999999999999987 3455666666653 233445444479999999999775 565232     234667778888


Q ss_pred             ccccc
Q psy3686         205 HLSYA  209 (296)
Q Consensus       205 ~~~~~  209 (296)
                      |+.-.
T Consensus       295 ~f~~~  299 (363)
T cd05628         295 FFEGV  299 (363)
T ss_pred             CCCCC
Confidence            77543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-32  Score=245.19  Aligned_cols=191  Identities=23%  Similarity=0.331  Sum_probs=154.7

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus        98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DF  175 (340)
T PTZ00426         98 GSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDF  175 (340)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecC
Confidence            35678889999999998 599999976 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++......  .....|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+..+.. .
T Consensus       176 G~a~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~-~  246 (340)
T PTZ00426        176 GFAKVVDTR--TYTLCGTPEYIAPEILLN-----VGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII-Y  246 (340)
T ss_pred             CCCeecCCC--cceecCChhhcCHHHHhC-----CCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC-C
Confidence            998765322  233478999999999953     3578899999999999999999999987 444455666665543 3


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +|..  +++.+.++|++||..+|..|...   ...++.++..++++..
T Consensus       247 ~p~~--~~~~~~~li~~~l~~dp~~R~~~---~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        247 FPKF--LDNNCKHLMKKLLSHDLTKRYGN---LKKGAQNVKEHPWFGN  289 (340)
T ss_pred             CCCC--CCHHHHHHHHHHcccCHHHcCCC---CCCCHHHHHcCCCcCC
Confidence            3433  78999999999999999855421   1235666777777643

>KOG0611|consensus

Probab=100.00  E-value=2.2e-32  Score=236.45  Aligned_cols=171  Identities=26%  Similarity=0.356  Sum_probs=150.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|++.+.+.|||||.. |.|++|+.+ .+.|++.+.+.+++||+.|+.|+|. ++++|||||.+|||++.++++||+|||
T Consensus       121 VFENkdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  121 VFENKDKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             hhcCCceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCCCeeeeccc
Confidence            5888999999999999 699999987 6899999999999999999999999 799999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ++..+.......+++|++.|.+||++.+.    +.-++.+|.||||++||.|+.|..||.+ .+....+.+|.+|.....
T Consensus       199 LSNly~~~kfLqTFCGSPLYASPEIvNG~----PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP  273 (668)
T KOG0611|consen  199 LSNLYADKKFLQTFCGSPLYASPEIVNGT----PYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP  273 (668)
T ss_pred             hhhhhccccHHHHhcCCcccCCccccCCC----CCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC
Confidence            99999888888889999999999999754    2446889999999999999999999999 344566667766653222


Q ss_pred             CCCcchhHHHHHHHHhccCCChH
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      +    -+.+..-||+.||..||+
T Consensus       274 ~----~PSdA~gLIRwmLmVNP~  292 (668)
T KOG0611|consen  274 E----TPSDASGLIRWMLMVNPE  292 (668)
T ss_pred             C----CCchHHHHHHHHHhcCcc
Confidence            2    366788999999999998

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.4e-32  Score=236.50  Aligned_cols=185  Identities=23%  Similarity=0.359  Sum_probs=147.3

Q ss_pred             cCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+..+++||||++++|.+++... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            45679999999999999999764 3468999999999999999999999 599999999999999999999999999997


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC----C
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP----C  160 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p----~  160 (296)
                      ............++..|+|||.+.+     ..++.++|||||||++|+|++|..||.+. ...+.+..+......    .
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~~f~~~-~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             eccCCcccccccccccccChHHHhC-----CCCCCccchHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHHhCCCChhh
Confidence            6654444445578999999999853     36788999999999999999999999883 444555555432110    0


Q ss_pred             CCC--------------------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         161 LPN--------------------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       161 ~~~--------------------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ++.                    .+.++..+.++|.+||..+|+        +|.++.+++.+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~s~~~~l~hp~  289 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA--------KRISAYSALSHPY  289 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch--------hcCCHHHHhcCCC
Confidence            000                    123678899999999999998        5556666666654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-32  Score=243.74  Aligned_cols=190  Identities=29%  Similarity=0.428  Sum_probs=153.9

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ..+.+++++|+||||+. |+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+||
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          68 YSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             hheecCCeEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecC
Confidence            35678889999999998 599999987 4789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc------------------------------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHH
Q psy3686          81 GISGRLVDSK------------------------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITL  130 (296)
Q Consensus        81 g~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l  130 (296)
                      |++.......                              ......++..|+|||++.+     ..++.++|||||||++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il  220 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-----TPYGLECDWWSLGVIL  220 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-----CCCCCceeeEecchhh
Confidence            9987654332                              2233468999999999954     3788999999999999


Q ss_pred             HHHHhCCCCCCCCCCcHHHHHHHHcc-CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc-hhhcccCCcccc
Q psy3686         131 VELATGEFPYKDCKCDFEVLSRVLND-APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST-CYECGAEGHLSY  208 (296)
Q Consensus       131 ~~l~~g~~Pf~~~~~~~~~~~~i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~-~~~~~~~~~~~~  208 (296)
                      |+|++|..||... .......++... ....++....+++.+.+||.+||. +|.        ++.. +.+++.++++..
T Consensus       221 ~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~--------~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         221 YEMLYGFPPFYSD-TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPE--------DRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             hhhccCCCCCCCC-CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Chh--------hcCCCHHHHhcCCCcCC
Confidence            9999999999884 344555555541 223344444479999999999997 898        4444 777777777643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8e-32  Score=234.66  Aligned_cols=194  Identities=26%  Similarity=0.425  Sum_probs=149.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      .|..++.+|+||||++ |+|..++...   ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.++|+
T Consensus        61 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~  139 (280)
T cd05608          61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRIS  139 (280)
T ss_pred             EEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEe
Confidence            4667888999999998 5998887532   4579999999999999999999999 599999999999999999999999


Q ss_pred             ccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---HHHHHHHH
Q psy3686          79 DFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD---FEVLSRVL  154 (296)
Q Consensus        79 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~i~  154 (296)
                      |||++..+.... ......++..|+|||.+.+     ..++.++|||||||++|+|++|+.||......   ......+.
T Consensus       140 dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  214 (280)
T cd05608         140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL  214 (280)
T ss_pred             eCccceecCCCCccccccCCCcCccCHHHhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc
Confidence            999987654332 2223468899999999953     36788999999999999999999999863322   12222222


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .. ...++  ..++..+.++|.+||..+|+.|+  ++++. ++.+++.++++.-
T Consensus       215 ~~-~~~~~--~~~~~~~~~li~~~l~~~P~~R~--~~~~~-~~~~~l~h~~~~~  262 (280)
T cd05608         215 ND-SVTYP--DKFSPASKSFCEALLAKDPEKRL--GFRDG-NCDGLRTHPLFRD  262 (280)
T ss_pred             cc-CCCCc--ccCCHHHHHHHHHHhcCCHHHhc--CCCCC-CHHHHhcChhhhc
Confidence            22 22222  34899999999999999998554  33322 5667777777643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8e-32  Score=238.94  Aligned_cols=193  Identities=23%  Similarity=0.350  Sum_probs=152.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+.+.+|+||||+. |+|..++.+ ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+||
T Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Df  140 (318)
T cd05570          63 SCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADF  140 (318)
T ss_pred             eEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEeccc
Confidence            34677889999999998 599998876 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..... ........++..|+|||++.+     ..++.++|||||||++|+|++|..||.. .........+.... +
T Consensus       141 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~-~  213 (318)
T cd05570         141 GMCKEGILGGVTTSTFCGTPDYIAPEILSY-----QPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDE-V  213 (318)
T ss_pred             CCCeecCcCCCcccceecCccccCHHHhcC-----CCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCC-C
Confidence            99865322 222233468899999999953     3678899999999999999999999987 34445555555443 3


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .++.  .++..+.+||.+||..+|..|+....   ....++..++++..
T Consensus       214 ~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~---~~~~~ll~~~~~~~  257 (318)
T cd05570         214 RYPR--WLSKEAKSILKSFLTKNPEKRLGCLP---TGEQDIKGHPFFRE  257 (318)
T ss_pred             CCCC--cCCHHHHHHHHHHccCCHHHcCCCCC---CCHHHHhcCCCcCC
Confidence            4443  37999999999999999995543322   23356666666543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=4.4e-32  Score=240.83  Aligned_cols=189  Identities=23%  Similarity=0.326  Sum_probs=149.4

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+.+.+|+||||++| +|...+.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          64 SFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             EEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCC
Confidence            46778899999999995 99888875 5789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........+++.|+|||.+.+     ..++.++|||||||++|+|++|..||... ........+.... ..
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~-~~  214 (321)
T cd05603         142 LCKEGVEPEETTSTFCGTPEYLAPEVLRK-----EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKP-LQ  214 (321)
T ss_pred             CCccCCCCCCccccccCCcccCCHHHhcC-----CCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHhcCC-CC
Confidence            9865322 222334468999999999853     36788999999999999999999999873 4445555555543 33


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ++..  .+..+.++|.+||..+|..|+.    ......++..+.++
T Consensus       215 ~~~~--~~~~~~~li~~~l~~~p~~R~~----~~~~~~~~~~~~~~  254 (321)
T cd05603         215 LPGG--KTVAACDLLVGLLHKDQRRRLG----AKADFLEIKNHVFF  254 (321)
T ss_pred             CCCC--CCHHHHHHHHHHccCCHhhcCC----CCCCHHHHhCCCCc
Confidence            4433  6899999999999999985543    22233455555554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=5.1e-32  Score=240.89  Aligned_cols=190  Identities=25%  Similarity=0.351  Sum_probs=152.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..++.+|+||||+.| +|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          64 SFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             EEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecC
Confidence            46778899999999995 99888876 6789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........++..|+|||++.+     ..++.++|||||||++|+|++|..||.. ....+....+.......
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~~  215 (325)
T cd05604         142 LCKEGIAQSDTTTTFCGTPEYLAPEVIRK-----QPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLVL  215 (325)
T ss_pred             CcccCCCCCCCcccccCChhhCCHHHHcC-----CCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCccC
Confidence            9865322 222334568999999999953     3678899999999999999999999987 34455666666554322


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .+   .++..+.++|.+||.++|..|+..    .....++..++++.
T Consensus       216 ~~---~~~~~~~~ll~~ll~~~p~~R~~~----~~~~~~i~~h~~f~  255 (325)
T cd05604         216 RP---GASLTAWSILEELLEKDRQRRLGA----KEDFLEIQEHPFFE  255 (325)
T ss_pred             CC---CCCHHHHHHHHHHhccCHHhcCCC----CCCHHHHhcCCCcC
Confidence            22   378999999999999999865542    22344556666554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=6.5e-32  Score=239.33  Aligned_cols=174  Identities=25%  Similarity=0.411  Sum_probs=142.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+||||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        64 ~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          64 TFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCC
Confidence            4667889999999998 599999976 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........++..|+|||++.+     ..++.++|||||||++|+|++|..||... ...+....+.... +.
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~~pf~~~-~~~~~~~~i~~~~-~~  214 (316)
T cd05619         142 MCKENMLGDAKTCTFCGTPDYIAPEILLG-----QKYNTSVDWWSFGVLLYEMLIGQSPFHGH-DEEELFQSIRMDN-PC  214 (316)
T ss_pred             cceECCCCCCceeeecCCccccCHHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCC-CC
Confidence            9865322 122234468999999999953     36788999999999999999999999873 4444554444333 44


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ++..  ++..++++|.+||..+|..|+
T Consensus       215 ~~~~--~~~~~~~li~~~l~~~P~~R~  239 (316)
T cd05619         215 YPRW--LTREAKDILVKLFVREPERRL  239 (316)
T ss_pred             CCcc--CCHHHHHHHHHHhccCHhhcC
Confidence            4443  799999999999999998443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=6.1e-32  Score=252.21  Aligned_cols=178  Identities=29%  Similarity=0.408  Sum_probs=148.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      ++|..++.+||||||+. |+|.+++...   ..++++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||
T Consensus       132 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL  210 (478)
T PTZ00267        132 DDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKL  210 (478)
T ss_pred             EEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEE
Confidence            35678899999999998 5999888643   4578999999999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH
Q psy3686          78 CDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        78 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~  154 (296)
                      +|||++..+....   ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.. ....+.+..+.
T Consensus       211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~  284 (478)
T PTZ00267        211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-----KRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVL  284 (478)
T ss_pred             EeCcCceecCCccccccccccCCCccccCHhHhCC-----CCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Confidence            9999998664332   2234468999999999843     3688899999999999999999999987 44556677777


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      .+..+.++.  .++..+.++|.+||..+|+.|+.
T Consensus       285 ~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps  316 (478)
T PTZ00267        285 YGKYDPFPC--PVSSGMKALLDPLLSKNPALRPT  316 (478)
T ss_pred             hCCCCCCCc--cCCHHHHHHHHHHhccChhhCcC
Confidence            666554443  37999999999999999984443

>KOG0660|consensus

Probab=99.98  E-value=2.1e-32  Score=233.71  Aligned_cols=189  Identities=27%  Similarity=0.385  Sum_probs=154.7

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ..-+.+|+|+|+|+.+|.++++. +..|++..+..+++||++||+|+|+. |++||||||.|+|++.+..+||+|||+|+
T Consensus        96 ~~f~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   96 DKFNDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             cccceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEecccccee
Confidence            34568999999999999999986 55699999999999999999999996 99999999999999999999999999998


Q ss_pred             cccC---CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--c---
Q psy3686          85 RLVD---SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--D---  156 (296)
Q Consensus        85 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~---  156 (296)
                      ....   ....+....|.+|.|||++..    ...|+.+.||||+|||+.||++|+.-|.+. +....+..|+.  |   
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~----~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~-d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLN----SSEYTKAIDIWSVGCILAEMLTGKPLFPGK-DYVHQLQLILELLGTPS  248 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhc----cccccchhhhhhhhHHHHHHHcCCCCCCCC-chHHHHHHHHHhcCCCC
Confidence            7753   333455688999999999963    448999999999999999999999999884 33322222221  1   


Q ss_pred             --------------------CCCCCC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         157 --------------------APPCLP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       157 --------------------~~p~~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                          ..|..+   ..+..++...+|+.+||..||.        .+.++.+.++|+.++.
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~--------kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPK--------KRITAEEALAHPYLAP  315 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcc--------ccCCHHHHhcChhhhh
Confidence                                111111   1135789999999999999998        8889999999998744

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.98  E-value=8.2e-32  Score=237.14  Aligned_cols=194  Identities=18%  Similarity=0.294  Sum_probs=151.8

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+.++..+|+||||+.++|.+++......+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCc
Confidence            456788999999999999999887766789999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCCC
Q psy3686          83 SGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAPP  159 (296)
Q Consensus        83 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~p  159 (296)
                      +...... .......++..|+|||++.+    ...++.++|||||||++|+|++|..||.+.......+..+..  +.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (303)
T cd07869         150 ARAKSVPSHTYSNEVVTLWYRPPDVLLG----STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN  225 (303)
T ss_pred             ceeccCCCccCCCCcccCCCCChHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence            8654322 22233467899999999853    235788999999999999999999999875444444433321  1100


Q ss_pred             -----------CC---------C-------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 -----------CL---------P-------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 -----------~~---------~-------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                 .+         +       ....+++.+.+||.+||..||.        +|.++.+++.++++...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~--------~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPK--------NRLSAQAALSHEYFSDL  294 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCch--------hccCHHHHhcCcccccC
Confidence                       00         0       0012457899999999999998        66678888899887654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=8.1e-32  Score=240.05  Aligned_cols=195  Identities=23%  Similarity=0.365  Sum_probs=150.4

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|+||||+. |+|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+||
T Consensus        63 ~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~Df  140 (329)
T cd05618          63 SCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDY  140 (329)
T ss_pred             eEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeC
Confidence            45677889999999999 599888866 5789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------CcHHHHHH
Q psy3686          81 GISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK-------CDFEVLSR  152 (296)
Q Consensus        81 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~-------~~~~~~~~  152 (296)
                      |++..... ........|+..|+|||++.+     ..++.++|||||||++|+|++|..||....       .....+..
T Consensus       141 G~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  215 (329)
T cd05618         141 GMCKEGLRPGDTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  215 (329)
T ss_pred             CccccccCCCCccccccCCccccCHHHHcC-----CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH
Confidence            99865322 222334578999999999953     367889999999999999999999995311       11222333


Q ss_pred             HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         153 VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       153 i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ........+|..  ++..+.++|.+||..+|..|+.  ........++..++++.
T Consensus       216 ~i~~~~~~~p~~--~~~~~~~ll~~~L~~dP~~R~~--~~~~~~~~~i~~hp~f~  266 (329)
T cd05618         216 VILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLG--CHPQTGFADIQGHPFFR  266 (329)
T ss_pred             HHhcCCCCCCCC--CCHHHHHHHHHHhcCCHHHcCC--CCCCCCHHHHhcCCCCC
Confidence            333333445543  7999999999999999985543  22223345666776653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.98  E-value=9.2e-32  Score=239.08  Aligned_cols=191  Identities=19%  Similarity=0.295  Sum_probs=150.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +|.+++.+|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          69 CFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccc
Confidence            5677889999999998 599999876 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++...... .......|+..|+|||++.+     ..++.++|||||||++|+|++|..||.+ .........+..... .
T Consensus       147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~-~  219 (323)
T cd05615         147 MCKEHMVDGVTTRTFCGTPDYIAPEIIAY-----QPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV-S  219 (323)
T ss_pred             cccccCCCCccccCccCCccccCHHHHcC-----CCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC-C
Confidence            98654322 22233468999999999953     3678899999999999999999999987 344555666655432 3


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +|.  .++..+.++|.+||.++|..|.....   ....++..++++.
T Consensus       220 ~p~--~~~~~~~~li~~~l~~~p~~R~~~~~---~~~~~i~~h~~f~  261 (323)
T cd05615         220 YPK--SLSKEAVSICKGLMTKHPSKRLGCGP---EGERDIREHAFFR  261 (323)
T ss_pred             CCc--cCCHHHHHHHHHHcccCHhhCCCCCC---CCHHHHhcCcccC
Confidence            343  37999999999999999985554211   1223445555543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=4.2e-32  Score=241.40  Aligned_cols=175  Identities=25%  Similarity=0.397  Sum_probs=144.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|+||||+.| +|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        64 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          64 SFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             EEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCC
Confidence            46778899999999995 99999976 5678999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++..... ........|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. ....+.+..+...... 
T Consensus       142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~-  214 (325)
T cd05602         142 LCKENIEHNGTTSTFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQ-  214 (325)
T ss_pred             CCcccccCCCCcccccCCccccCHHHHcC-----CCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCcC-
Confidence            9865432 222334578999999999953     3678899999999999999999999987 4445555566554332 


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      ++  ..++..+.++|.+||.++|..|+.
T Consensus       215 ~~--~~~~~~~~~li~~~l~~~p~~R~~  240 (325)
T cd05602         215 LK--PNITNSARHLLEGLLQKDRTKRLG  240 (325)
T ss_pred             CC--CCCCHHHHHHHHHHcccCHHHCCC
Confidence            22  237999999999999999985543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.98  E-value=1e-31  Score=239.59  Aligned_cols=189  Identities=37%  Similarity=0.717  Sum_probs=151.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||++++|+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          71 AFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             EEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence            45678899999999995 99999976 56799999999999999999999986579999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHH------------
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEV------------  149 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------  149 (296)
                      ++...... ......++..|+|||++.+     ..++.++|||||||++|+|++|+.||..... .+.            
T Consensus       150 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~  222 (331)
T cd06649         150 VSGQLIDS-MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGE  222 (331)
T ss_pred             cccccccc-ccccCCCCcCcCCHhHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccc
Confidence            98765432 2234468899999999953     3678899999999999999999999975321 111            


Q ss_pred             ----------------------------------HHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         150 ----------------------------------LSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       150 ----------------------------------~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                                                        ...+.....+..+.. .+++++++||.+||..||+        +|.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~~P~--------~Rp  293 (331)
T cd06649         223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNG-VFTPDFQEFVNKCLIKNPA--------ERA  293 (331)
T ss_pred             cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCc-cccHHHHHHHHHHccCCcc--------cCC
Confidence                                              111222223333322 3789999999999999998        777


Q ss_pred             chhhcccCCcccc
Q psy3686         196 TCYECGAEGHLSY  208 (296)
Q Consensus       196 ~~~~~~~~~~~~~  208 (296)
                      ++.+++.++|+..
T Consensus       294 t~~ell~h~~~~~  306 (331)
T cd06649         294 DLKMLMNHTFIKR  306 (331)
T ss_pred             CHHHHhcChHHhh
Confidence            7888888887653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=4.3e-32  Score=245.53  Aligned_cols=194  Identities=24%  Similarity=0.396  Sum_probs=155.0

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++.+|+||||++ |+|.+++..  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         111 AFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            4677889999999998 599999874  578999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-C
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-P  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~  158 (296)
                      ++.......  ......|++.|+|||++.+.. ....++.++|||||||++|+|++|..||.. ......+..+.... .
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~  265 (370)
T cd05596         188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNS  265 (370)
T ss_pred             ceeeccCCCcccCCCCCCCcCeECHHHhccCC-CCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCc
Confidence            987654322  223457899999999986432 122478899999999999999999999988 34455666666543 3


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..++....+|..+.+||.+||..+|. |.     .+.+..+++.++|+.
T Consensus       266 ~~~~~~~~~s~~~~~li~~~L~~~p~-r~-----~R~s~~ell~h~~~~  308 (370)
T cd05596         266 LTFPDDIEISKQAKDLICAFLTDREV-RL-----GRNGVDEIKSHPFFK  308 (370)
T ss_pred             CCCCCcCCCCHHHHHHHHHHccChhh-cc-----CCCCHHHHhcCcccC
Confidence            44555545899999999999998886 21     144666777777764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.98  E-value=6.3e-32  Score=240.89  Aligned_cols=193  Identities=25%  Similarity=0.325  Sum_probs=149.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..++.+|+||||+.| +|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          73 AFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             EEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCc
Confidence            46678899999999994 99999876 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CcH-HHHHHHHcc
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK--CDF-EVLSRVLND  156 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~--~~~-~~~~~i~~~  156 (296)
                      ++.......  ......|+..|+|||.+.+.    ..++.++|||||||++|+|++|..||....  ... .....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  226 (332)
T cd05614         151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGK----GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC  226 (332)
T ss_pred             CCccccccCCCccccccCCccccCHHHhcCC----CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC
Confidence            987643322  22234689999999998532    246789999999999999999999997421  222 333334433


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      . +.++.  .+++.+.++|.+||..+|+.|+....   ..+.+++.++++.
T Consensus       227 ~-~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~---~~~~~~l~h~~~~  271 (332)
T cd05614         227 D-PPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGP---QGASEIKEHPFFK  271 (332)
T ss_pred             C-CCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCC---CCHHHHHcCCCcC
Confidence            3 34443  37999999999999999995553221   1455666666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3.9e-32  Score=245.19  Aligned_cols=192  Identities=26%  Similarity=0.369  Sum_probs=152.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++++|||||||. |+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          69 SFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecc
Confidence            4678899999999998 599999976 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc---------------------------------------cccccccCcCCCCccccCCCCCCCCCCCcchh
Q psy3686          82 ISGRLVDSK---------------------------------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD  122 (296)
Q Consensus        82 ~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D  122 (296)
                      ++..+....                                       ......||+.|+|||++.     ...++.++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~D  221 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-----QTGYNKECD  221 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-----CCCCCCeee
Confidence            986542211                                       001235899999999984     336889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       123 iwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      ||||||++|+|++|..||... ........+.... ...++....+++.++++|.+||. +|..|+.  +   ..+.+++
T Consensus       222 iwSlG~il~el~~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~--~---~~~~~ll  294 (364)
T cd05599         222 WWSLGVIMYEMLVGYPPFCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG--N---NGVNEIK  294 (364)
T ss_pred             eecchhHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC--C---CCHHHHh
Confidence            999999999999999999873 4455555665533 23444444589999999999996 8873332  1   3577778


Q ss_pred             cCCcccc
Q psy3686         202 AEGHLSY  208 (296)
Q Consensus       202 ~~~~~~~  208 (296)
                      .++|+..
T Consensus       295 ~h~~~~~  301 (364)
T cd05599         295 SHPFFKG  301 (364)
T ss_pred             cCCCcCC
Confidence            8887654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.7e-32  Score=241.31  Aligned_cols=188  Identities=26%  Similarity=0.352  Sum_probs=150.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++++||||||++| +|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          69 AFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCc
Confidence            46678899999999984 99999976 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC----
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA----  157 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~----  157 (296)
                      ++.....  ......+++.|+|||++.+     ..++.++|||||||++|+|++|..||.. ....+.+..+....    
T Consensus       147 ~a~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~  218 (333)
T cd05600         147 LSKGIVT--YANSVVGSPDYMAPEVLRG-----KGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQ  218 (333)
T ss_pred             CCccccc--ccCCcccCccccChhHhcC-----CCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhcccccc
Confidence            9876543  2334578999999999953     3688899999999999999999999987 34444444444321    


Q ss_pred             CCCCC-CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 PPCLP-NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ~p~~~-~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .|... ....++.++.++|.+||..+|.        .+.++.++..++++..
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~--------rr~s~~~ll~h~~~~~  262 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSR--------RFGSLEDIKNHPFFKE  262 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhh--------hcCCHHHHHhCcccCC
Confidence            11111 1124799999999999998776        4445777777777654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.98  E-value=1e-31  Score=234.90  Aligned_cols=189  Identities=20%  Similarity=0.307  Sum_probs=148.0

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+.+++.+|+||||++|+|.+++......+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~  149 (288)
T cd07871          71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGL  149 (288)
T ss_pred             EEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcc
Confidence            456778899999999999999998766678999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CCC
Q psy3686          83 SGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--APP  159 (296)
Q Consensus        83 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~p  159 (296)
                      +...... .......++..|+|||.+.+    ...++.++||||+||++|+|++|..||.+. ...+.+..+...  .++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~  224 (288)
T cd07871         150 ARAKSVPTKTYSNEVVTLWYRPPDVLLG----STEYSTPIDMWGVGCILYEMATGRPMFPGS-TVKEELHLIFRLLGTPT  224 (288)
T ss_pred             eeeccCCCccccCceecccccChHHhcC----CcccCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCC
Confidence            8654322 22233467889999999853    235788999999999999999999999874 333333333221  000


Q ss_pred             ----------------CCC---------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         160 ----------------CLP---------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       160 ----------------~~~---------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                      .++         ....++.++.+||.+||..||.        +|.++.+++.+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~--------~R~t~~~~l~hp~  287 (288)
T cd07871         225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETK--------SRISAEAALRHSY  287 (288)
T ss_pred             hHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcc--------cCCCHHHHhcCCC
Confidence                            001         0123678999999999999998        6666777777765

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4279|consensus

Probab=99.98  E-value=7.3e-32  Score=246.14  Aligned_cols=195  Identities=27%  Similarity=0.428  Sum_probs=166.9

Q ss_pred             CCCCccCCeEEEEecCccc-cHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEC-CCCCEE
Q psy3686           1 MSPQSKESDVWICMELMAT-CFDRLLKRLHVSV--PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIK   76 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~-~~~~~k   76 (296)
                      ++++..++++-|+||-++| +|..+++..-+++  .|..+..+.+||+.||.|||+ +.|||||||-+|+||+ ..|.+|
T Consensus       638 LGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlK  716 (1226)
T KOG4279|consen  638 LGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLK  716 (1226)
T ss_pred             hhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEE
Confidence            4678999999999999995 9999999887888  899999999999999999999 6999999999999995 579999


Q ss_pred             EeccCCcccccC-CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH-H
Q psy3686          77 LCDFGISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV-L  154 (296)
Q Consensus        77 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i-~  154 (296)
                      |+|||.++++.. .....++.||..|||||++..   ....|+.++|||||||++.+|.||++||....+....+.++ +
T Consensus       717 ISDFGTsKRLAginP~TETFTGTLQYMAPEvIDq---G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm  793 (1226)
T KOG4279|consen  717 ISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQ---GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM  793 (1226)
T ss_pred             ecccccchhhccCCccccccccchhhhChHhhcc---CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc
Confidence            999999987754 345556789999999999964   44579999999999999999999999998877776666665 2


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      -...|.+|..  +|.+.+.||.+||..+|.        ++..+..++..+|++..
T Consensus       794 yKvHP~iPee--lsaeak~FilrcFepd~~--------~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  794 YKVHPPIPEE--LSAEAKNFILRCFEPDPC--------DRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             eecCCCCcHH--HHHHHHHHHHHHcCCCcc--------cCccHHHhccCcccccC
Confidence            3444666655  899999999999999997        66777778888887554

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.98  E-value=1.3e-31  Score=243.46  Aligned_cols=193  Identities=25%  Similarity=0.369  Sum_probs=149.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .++.+++++|+||||++ |+|.+++.+ ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DF  145 (381)
T cd05626          68 YSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDF  145 (381)
T ss_pred             EEEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeC
Confidence            35677889999999998 599999976 5679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc------------------------------------------------cccccccCcCCCCccccCCCCC
Q psy3686          81 GISGRLVDSK------------------------------------------------ARTKNAGCAAYMAPERIEPPNP  112 (296)
Q Consensus        81 g~~~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~  112 (296)
                      |++..+....                                                ......||..|+|||++.+   
T Consensus       146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---  222 (381)
T cd05626         146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR---  222 (381)
T ss_pred             cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC---
Confidence            9875321000                                                0012368999999999953   


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhcc
Q psy3686         113 QKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSY  191 (296)
Q Consensus       113 ~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~  191 (296)
                        ..++.++|||||||++|+|++|..||.... .......+.. .....++....+++++.+||.+++...++..     
T Consensus       223 --~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~-----  294 (381)
T cd05626         223 --KGYTQLCDWWSVGVILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL-----  294 (381)
T ss_pred             --CCCCCccceeehhhHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCccccc-----
Confidence              367889999999999999999999998743 3344444443 2334455544589999999999766544411     


Q ss_pred             CCccchhhcccCCcccc
Q psy3686         192 EDKSTCYECGAEGHLSY  208 (296)
Q Consensus       192 ~~~~~~~~~~~~~~~~~  208 (296)
                       .+.++.+++.++++..
T Consensus       295 -~R~~~~~~l~hp~f~~  310 (381)
T cd05626         295 -GRNGADDIKAHPFFSE  310 (381)
T ss_pred             -CCCCHHHHhcCcccCC
Confidence             3456677777777644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.7e-32  Score=243.84  Aligned_cols=192  Identities=24%  Similarity=0.351  Sum_probs=151.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++++||||||+. |+|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++.++|+||
T Consensus        68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          68 YSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             EEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeec
Confidence            35678889999999998 599999976 5789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc------------------------------------------------cccccccCcCCCCccccCCCCC
Q psy3686          81 GISGRLVDSK------------------------------------------------ARTKNAGCAAYMAPERIEPPNP  112 (296)
Q Consensus        81 g~~~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~  112 (296)
                      |++..+....                                                ......||+.|+|||++.+   
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---  222 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ---  222 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc---
Confidence            9985332100                                                0001358899999999853   


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhcc
Q psy3686         113 QKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSY  191 (296)
Q Consensus       113 ~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~  191 (296)
                        ..++.++|||||||++|+|++|..||... .....+..+... ....++....++..+.+||.+||. +|..|.    
T Consensus       223 --~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~----  294 (377)
T cd05629         223 --QGYGQECDWWSLGAIMFECLIGWPPFCSE-NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL----  294 (377)
T ss_pred             --CCCCCceeeEecchhhhhhhcCCCCCCCC-CHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC----
Confidence              36788999999999999999999999873 444555555543 233455544589999999999997 776442    


Q ss_pred             CCccchhhcccCCccc
Q psy3686         192 EDKSTCYECGAEGHLS  207 (296)
Q Consensus       192 ~~~~~~~~~~~~~~~~  207 (296)
                       .+.++.+++.++++.
T Consensus       295 -~r~~~~~~l~hp~~~  309 (377)
T cd05629         295 -GRGGAHEIKSHPFFR  309 (377)
T ss_pred             -CCCCHHHHhcCCCcC
Confidence             124666777777664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0604|consensus

Probab=99.97  E-value=8.6e-32  Score=224.59  Aligned_cols=190  Identities=22%  Similarity=0.275  Sum_probs=158.6

Q ss_pred             CccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC---CCCEEEe
Q psy3686           4 QSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---RGNIKLC   78 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~---~~~~kl~   78 (296)
                      |.....+.||||.|+| .|.+.++.+ ...++|.++..|+.||..|+.|||+ ++|.||||||+|+|+..   +..+||+
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEec
Confidence            4556788999999995 888888775 4569999999999999999999999 69999999999999964   4568999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CcHHHHHHHHc
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK---CDFEVLSRVLN  155 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~---~~~~~~~~i~~  155 (296)
                      |||+++...........+.|+.|.|||++     ....|+...|+||+|+++|-|++|.+||....   -......+|..
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevl-----g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHh-----CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            99999887766667777999999999999     45579999999999999999999999998632   22344455655


Q ss_pred             cCCCCCC--CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         156 DAPPCLP--NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       156 ~~~p~~~--~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      |.. .||  .+..+|...+++|+++|..+|.        ++.+..++..++|+.-
T Consensus       282 gqy-~FP~pEWs~VSe~aKdlIR~LLkt~Pt--------eRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  282 GQY-EFPEPEWSCVSEAAKDLIRKLLKTEPT--------ERLTIEEVMDHPWINQ  327 (400)
T ss_pred             cCc-cCCChhHhHHHHHHHHHHHHHhcCCch--------hheeHHHhhcCchhcc
Confidence            543 444  4456899999999999999998        8888888888887643

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=1.7e-31  Score=233.05  Aligned_cols=189  Identities=21%  Similarity=0.396  Sum_probs=144.7

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +++..++.+|+||||+.+++.+.+......+++..++.++.||+.||.|||+ +|++||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             hhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            3567888999999999975555555546789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cC
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DA  157 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~  157 (296)
                      ++.......  ......++..|+|||++.+     ..++.++|||||||++|+|++|+.||.... .......+..  +.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~  219 (287)
T cd07848         146 FARNLSEGSNANYTEYVATRWYRSPELLLG-----APYGKAVDMWSVGCILGELSDGQPLFPGES-EIDQLFTIQKVLGP  219 (287)
T ss_pred             CcccccccccccccccccccccCCcHHHcC-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCC
Confidence            987654322  2223468899999999953     357889999999999999999999998743 2222222211  10


Q ss_pred             CC----------------CCCC-----------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PP----------------CLPN-----------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p----------------~~~~-----------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .|                ..+.           ...+|..+.+||++||..||+        +|.++.+++.|++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~--------~R~s~~~~l~hp~  286 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT--------DRYLTEQCLNHPA  286 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcc--------cCCCHHHHhcCCC
Confidence            00                0010           012688899999999999998        6666667777665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.4e-31  Score=242.13  Aligned_cols=195  Identities=25%  Similarity=0.399  Sum_probs=154.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|+|||||+ |+|.+++..  ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecc
Confidence            4678889999999998 599999974  578999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-C
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-P  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~  158 (296)
                      ++.......  ......||+.|+|||++.+.. ....++.++|||||||++|+|++|..||.. ......+..+.... .
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~  265 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNS  265 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccC-CCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcc
Confidence            997654332  223457899999999996432 122477899999999999999999999987 44455566665432 3


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ..++....++..++++|.+||..++. |.     .+.++.+++.++|+..
T Consensus       266 ~~~p~~~~~s~~~~~li~~~L~~~~~-r~-----~R~~~~e~l~hp~~~~  309 (370)
T cd05621         266 LNFPEDVEISKHAKNLICAFLTDREV-RL-----GRNGVEEIKQHPFFKN  309 (370)
T ss_pred             cCCCCcccCCHHHHHHHHHHccCchh-cc-----CCCCHHHHhcCcccCC
Confidence            45555555899999999999985443 22     3456777788887644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=1.2e-31  Score=243.20  Aligned_cols=191  Identities=25%  Similarity=0.344  Sum_probs=148.1

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|||||||. |+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          69 SFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            4667889999999998 599999976 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC--------------------------------------------ccccccccCcCCCCccccCCCCCCCCCC
Q psy3686          82 ISGRLVDS--------------------------------------------KARTKNAGCAAYMAPERIEPPNPQKPDY  117 (296)
Q Consensus        82 ~~~~~~~~--------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~  117 (296)
                      ++..+...                                            .......||+.|+|||++.+     ..+
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~  221 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-----TGY  221 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-----CCC
Confidence            87432100                                            00012368999999999953     367


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         118 DIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       118 ~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      +.++|||||||++|+|++|..||... ...+....+... ....++....+++.+.++|.+|+ .+|..|...     .+
T Consensus       222 ~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~-----~t  294 (376)
T cd05598         222 TQLCDWWSVGVILYEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK-----NG  294 (376)
T ss_pred             CcceeeeeccceeeehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC-----CC
Confidence            88999999999999999999999884 334444444432 22333444458999999999976 589844432     15


Q ss_pred             hhhcccCCccc
Q psy3686         197 CYECGAEGHLS  207 (296)
Q Consensus       197 ~~~~~~~~~~~  207 (296)
                      +.+++.++++.
T Consensus       295 ~~ell~h~~~~  305 (376)
T cd05598         295 ADEIKAHPFFK  305 (376)
T ss_pred             HHHHhCCCCcC
Confidence            66777777754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=3.5e-31  Score=244.58  Aligned_cols=187  Identities=22%  Similarity=0.345  Sum_probs=146.1

Q ss_pred             CeEEEEecCccccHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEeccCCc
Q psy3686           8 SDVWICMELMATCFDRLLKR---LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCDFGIS   83 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~   83 (296)
                      ..+++||||++++|.+++..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus       140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            36789999999988887754   25679999999999999999999999 5999999999999998665 6999999999


Q ss_pred             ccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCCC--
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAPP--  159 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~p--  159 (296)
                      ..+..........+++.|+|||++.+    ...++.++|||||||++|+|++|.+||.+. ...+.+.+++.  +.++  
T Consensus       219 ~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        219 KNLLAGQRSVSYICSRFYRAPELMLG----ATNYTTHIDLWSLGCIIAEMILGYPIFSGQ-SSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             hhccCCCCcccCCCCcCccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHH
Confidence            87654444444578899999999853    236788999999999999999999999874 33333333332  1100  


Q ss_pred             ------------CCCC----------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 ------------CLPN----------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 ------------~~~~----------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                  .++.          ....+.++.+||.+||..+|.        .|.++.+++.++|+..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~--------~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL--------KRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChh--------HCcCHHHHhCChhHHh
Confidence                        0110          012578999999999999998        6667888888888754

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=231.34  Aligned_cols=196  Identities=20%  Similarity=0.320  Sum_probs=151.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +.+.+++.+|+||||+. |+|..++... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~D  145 (285)
T cd05605          67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             eeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEee
Confidence            35667789999999998 5999888654 3569999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcH--HHHHHHHccC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF--EVLSRVLNDA  157 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~i~~~~  157 (296)
                      ||++.............++..|+|||++.+     ..++.++||||+|+++|++++|..||.+.....  ..+...+...
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (285)
T cd05605         146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKN-----ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED  220 (285)
T ss_pred             CCCceecCCCCccccccCCCCccCcHHhcC-----CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc
Confidence            999876544333334578899999999953     367889999999999999999999998743221  1122222222


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .+.++.  .++..+.+||.+||..||..|+....   ..+.++..++++..
T Consensus       221 ~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~---~~~~~l~~~~~~~~  266 (285)
T cd05605         221 QEEYSE--KFSEAARSICRQLLTKDPGFRLGCRG---EGAEEVKAHPFFRT  266 (285)
T ss_pred             ccccCc--ccCHHHHHHHHHHccCCHHHhcCCCC---CCHHHHhcCcCccC
Confidence            223332  37999999999999999996664431   25556667766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=1.6e-31  Score=241.94  Aligned_cols=193  Identities=26%  Similarity=0.407  Sum_probs=151.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++++|+||||++ |+|.+++..  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         111 AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            4567889999999998 599999874  568999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-C
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-P  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~  158 (296)
                      ++.......  ......||+.|+|||++.+.. ....++.++|||||||++|+|++|..||.. .........+.... .
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~  265 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNS  265 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccC-CCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCc
Confidence            997654332  223457899999999986432 122478899999999999999999999987 44455666666543 3


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ..++....++..++++|.+||. +|..|.     .+.+..++..++++
T Consensus       266 ~~~~~~~~~s~~~~~li~~~L~-~~~~r~-----~r~~~~ei~~h~~~  307 (371)
T cd05622         266 LTFPDDNDISKEAKNLICAFLT-DREVRL-----GRNGVEEIKRHLFF  307 (371)
T ss_pred             ccCCCcCCCCHHHHHHHHHHcC-Chhhhc-----CCCCHHHHhcCccc
Confidence            3455555689999999999998 554333     12345555666654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=3.9e-31  Score=236.35  Aligned_cols=156  Identities=22%  Similarity=0.342  Sum_probs=122.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCcccc
Q psy3686          31 SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERI  107 (296)
Q Consensus        31 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~  107 (296)
                      .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.......   ......++..|+|||++
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  248 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI  248 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence            47888999999999999999999 599999999999999999999999999987653221   11223456789999998


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+     ..++.++|||||||++|+|++ |..||.+..........+..+..+..+.  .+++.+.++|.+||..+|+.|
T Consensus       249 ~~-----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         249 FD-----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE--NATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             hc-----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHccCChhhC
Confidence            43     367889999999999999997 9999988554444555555555444443  378999999999999999844


Q ss_pred             hhhccCCccc
Q psy3686         187 RKRSYEDKST  196 (296)
Q Consensus       187 ~~~~~~~~~~  196 (296)
                      |  ++.++..
T Consensus       322 P--s~~el~~  329 (338)
T cd05102         322 P--TFSALVE  329 (338)
T ss_pred             c--CHHHHHH
Confidence            4  4444433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=7e-31  Score=228.68  Aligned_cols=198  Identities=31%  Similarity=0.490  Sum_probs=157.6

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..++.+|+||||++| +|..++.+....+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             EEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCCCEEEcccc
Confidence            46677899999999995 9988886656789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|+|||.+.........++.++||||+||++|+|++|..||... ........+.....+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~  227 (282)
T cd06643         149 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPT  227 (282)
T ss_pred             ccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc-CHHHHHHHHhhcCCCC
Confidence            986553321 22334678899999998543333446788999999999999999999999873 4445555555554444


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      .+....++..+.++|.+||..+|.        ++.+..++..++++...+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         228 LAQPSRWSSEFKDFLKKCLEKNVD--------ARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             CCCccccCHHHHHHHHHHccCChh--------hCcCHHHHhcCCCEeccC
Confidence            444445899999999999999998        445566777777765543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.3e-31  Score=243.35  Aligned_cols=191  Identities=26%  Similarity=0.369  Sum_probs=148.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|||||||+ |+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          69 SFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECC
Confidence            4677889999999998 599999976 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC------------------------------------------------ccccccccCcCCCCccccCCCCCC
Q psy3686          82 ISGRLVDS------------------------------------------------KARTKNAGCAAYMAPERIEPPNPQ  113 (296)
Q Consensus        82 ~~~~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~  113 (296)
                      ++..+...                                                .......||+.|+|||++.+    
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----  222 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR----  222 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC----
Confidence            87432100                                                00112368899999999953    


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccC
Q psy3686         114 KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYE  192 (296)
Q Consensus       114 ~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~  192 (296)
                       ..++.++|||||||++|+|++|..||... ...+....+... ....+|....+++++.++|.+++ .+|..|..    
T Consensus       223 -~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~----  295 (382)
T cd05625         223 -TGYTQLCDWWSVGVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG----  295 (382)
T ss_pred             -CCCCCeeeEEechHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC----
Confidence             36788999999999999999999999874 444444455442 23344544558999999999976 58874432    


Q ss_pred             CccchhhcccCCccc
Q psy3686         193 DKSTCYECGAEGHLS  207 (296)
Q Consensus       193 ~~~~~~~~~~~~~~~  207 (296)
                       +..+.+++.++++.
T Consensus       296 -~~~~~ei~~hp~f~  309 (382)
T cd05625         296 -KNGADEIKAHPFFK  309 (382)
T ss_pred             -CCCHHHHhcCCCcC
Confidence             22366677777653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0594|consensus

Probab=99.97  E-value=3.8e-31  Score=226.25  Aligned_cols=189  Identities=21%  Similarity=0.380  Sum_probs=153.0

Q ss_pred             cCCeEEEEecCccccHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           6 KESDVWICMELMATCFDRLLKRLH---VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ..+.+++||||++-+|..++....   ..++...++.+++||+.||+|||+ ++|+||||||.||||+.+|.+||+|||+
T Consensus        88 ~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   88 GIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccch
Confidence            345899999999999999998865   468889999999999999999999 7999999999999999999999999999


Q ss_pred             cccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC-
Q psy3686          83 SGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP-  158 (296)
Q Consensus        83 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~-  158 (296)
                      ++.+.-+ .......+|.+|.|||++.+.    ..|+...||||+||++.+|++++.-|.+ ..+.+.+.+|..  |.+ 
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs----~~Ys~~vDiWs~GcIfaEm~~~~~LFpG-~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGS----TSYSTSVDIWSLGCIFAEMFTRRPLFPG-DSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCC----CcCCCCcchHhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHHcCCCC
Confidence            9877633 446667899999999999853    3699999999999999999999999998 455555555543  211 


Q ss_pred             -CCC-------------CCC----------cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 -PCL-------------PND----------PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 -p~~-------------~~~----------~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                       ..+             +.+          +..+++..+++.+||..+|.        .+.++...+.++.+..
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~--------~R~Sa~~al~h~yf~~  307 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA--------KRISAKGALTHPYFSE  307 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc--------cCcCHHHHhcChhhcc
Confidence             011             111          12235899999999999997        6677777777765543

>KOG4645|consensus

Probab=99.97  E-value=5.5e-33  Score=267.74  Aligned_cols=190  Identities=27%  Similarity=0.419  Sum_probs=164.0

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +.+.++|.||||. |+|.++++. ++..++.....+..|++.|+.|||+ +|||||||||.||+++.+|.+|++|||.|.
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCCcEEeeccccee
Confidence            3456789999999 699999986 7778999999999999999999999 799999999999999999999999999998


Q ss_pred             cccCCc-----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSK-----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      .+..+.     ......||+.|||||++.+..  ...-..++||||||||+.||+||+.||...++...++.++..|..|
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~--~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTK--GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccc--cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence            876552     123447999999999998763  2244568999999999999999999999999999999999999999


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .+|..  +|.+-++||.+||..||..|        -.+.+++.+.|..+.
T Consensus      1461 q~P~~--ls~~g~dFle~Cl~~dP~~R--------w~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 QIPER--LSSEGRDFLEHCLEQDPKMR--------WTASQLLEHAFGKSC 1500 (1509)
T ss_pred             CCchh--hhHhHHHHHHHHHhcCchhh--------hHHHHHHHhhccccc
Confidence            99987  89999999999999999955        344466777665543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=5.5e-31  Score=229.04  Aligned_cols=178  Identities=25%  Similarity=0.359  Sum_probs=141.9

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .|.++.++|+||||+.| +|..++... ...+++..++.++.||+.||+|||+ .|++||||||+||+++.++.++|+||
T Consensus        61 ~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Df  139 (277)
T cd05607          61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDL  139 (277)
T ss_pred             EEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeec
Confidence            46678899999999985 998888653 3468999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---HHHHHHHHccC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD---FEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~i~~~~  157 (296)
                      |++.............++..|+|||++.+     ..++.++|||||||++|+|++|..||......   ...........
T Consensus       140 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  214 (277)
T cd05607         140 GLAVELKDGKTITQRAGTNGYMAPEILKE-----EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE  214 (277)
T ss_pred             eeeeecCCCceeeccCCCCCccCHHHHcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc
Confidence            99876654433344578899999999853     35888999999999999999999999763322   22333333333


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      .+ .+. ..++.+++++|.+||..+|+.|+.
T Consensus       215 ~~-~~~-~~~~~~~~~li~~~L~~~P~~R~~  243 (277)
T cd05607         215 VK-FEH-QNFTEESKDICRLFLAKKPEDRLG  243 (277)
T ss_pred             cc-ccc-ccCCHHHHHHHHHHhccCHhhCCC
Confidence            22 221 248999999999999999984443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=1e-31  Score=242.22  Aligned_cols=192  Identities=25%  Similarity=0.386  Sum_probs=150.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+||||||++| +|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          69 SFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeecc
Confidence            46778899999999984 99999976 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc------------------------------------cccccccCcCCCCccccCCCCCCCCCCCcchhHHH
Q psy3686          82 ISGRLVDSK------------------------------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS  125 (296)
Q Consensus        82 ~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Diws  125 (296)
                      ++.......                                    ......||+.|+|||++.+     ..++.++||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~~~DiwS  221 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-----TGYNKLCDWWS  221 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-----CCCCCcceecc
Confidence            986442110                                    0112368999999999953     36788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCC
Q psy3686         126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDA-PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEG  204 (296)
Q Consensus       126 lG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~  204 (296)
                      |||++|+|++|..||.. .........+.... ...++....++..++++|.+++. +|..|..     .....++..++
T Consensus       222 lGvilyel~tG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~-----~~~~~ei~~hp  294 (360)
T cd05627         222 LGVIMYEMLIGYPPFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIG-----SNGVEEIKSHP  294 (360)
T ss_pred             ccceeeecccCCCCCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCC-----CCCHHHHhcCC
Confidence            99999999999999987 34455555665432 23344443479999999999774 8874432     12456677777


Q ss_pred             cccc
Q psy3686         205 HLSY  208 (296)
Q Consensus       205 ~~~~  208 (296)
                      |+.-
T Consensus       295 ~f~~  298 (360)
T cd05627         295 FFEG  298 (360)
T ss_pred             CCCC
Confidence            7643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=5.7e-31  Score=234.96  Aligned_cols=192  Identities=36%  Similarity=0.730  Sum_probs=150.8

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++.+|+||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.++++|+||||+|||++.++.+||+||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          70 GAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeC
Confidence            35678889999999998 499999976 5679999999999999999999998557999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcH-------------
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF-------------  147 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-------------  147 (296)
                      |++..+... ......++..|+|||++.+     ..++.++|||||||++|+|++|..||.......             
T Consensus       149 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (333)
T cd06650         149 GVSGQLIDS-MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP  222 (333)
T ss_pred             Ccchhhhhh-ccccCCCCccccCHHHhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCc
Confidence            998655322 2233468899999999953     367889999999999999999999997532110             


Q ss_pred             ------------------------------HHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         148 ------------------------------EVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       148 ------------------------------~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                                                    .....+.+..++.++.. .++.++++||.+||..||+        +|.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~P~--------~Rpt~  293 (333)
T cd06650         223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSG-VFGAEFQDFVNKCLIKNPA--------ERADL  293 (333)
T ss_pred             cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCC-CcCHHHHHHHHHhccCCcc--------cCcCH
Confidence                                          11112223333333332 2688999999999999998        66667


Q ss_pred             hhcccCCccccc
Q psy3686         198 YECGAEGHLSYA  209 (296)
Q Consensus       198 ~~~~~~~~~~~~  209 (296)
                      .++..++++...
T Consensus       294 ~ell~h~~~~~~  305 (333)
T cd06650         294 KQLMVHAFIKRS  305 (333)
T ss_pred             HHHhhCHHHhcC
Confidence            777788777543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1e-31  Score=238.18  Aligned_cols=176  Identities=28%  Similarity=0.418  Sum_probs=145.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.+++.+|+||||+. |+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.++|+||
T Consensus        65 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Df  142 (318)
T cd05582          65 YAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDF  142 (318)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeec
Confidence            34677889999999998 599999976 5679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......++..|+|||.+.+     ..++.++|||||||++|+|++|..||.. .........+..... 
T Consensus       143 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~-  215 (318)
T cd05582         143 GLSKESIDHEKKAYSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL-  215 (318)
T ss_pred             cCCcccCCCCCceecccCChhhcCHHHHcC-----CCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC-
Confidence            998765433 22334578999999999953     3567899999999999999999999987 344555555655432 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      .++.  .+++.+.++|.+||..+|+.|+.
T Consensus       216 ~~p~--~~~~~~~~li~~~l~~~P~~R~~  242 (318)
T cd05582         216 GMPQ--FLSPEAQSLLRALFKRNPANRLG  242 (318)
T ss_pred             CCCC--CCCHHHHHHHHHHhhcCHhHcCC
Confidence            3333  37999999999999999985544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-31  Score=228.11  Aligned_cols=197  Identities=31%  Similarity=0.496  Sum_probs=160.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++| +|.+++......+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             EEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCc
Confidence            46678899999999995 9999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .+....... ......++..|++||.+.........++.++|+||||+++|+|++|..||... .....+..+..+..+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~  227 (280)
T cd06611         149 VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPT  227 (280)
T ss_pred             cchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCC
Confidence            876543322 22334678899999998644323445778999999999999999999999873 4445566666666666


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +.....++..+.++|.+||..+|+        ++.++.+++.++|+...
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~--------~Rps~~~il~~~~~~~~  268 (280)
T cd06611         228 LDQPSKWSSSFNDFLKSCLVKDPD--------DRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             cCCcccCCHHHHHHHHHHhccChh--------hCcCHHHHhcChhhccc
Confidence            655556899999999999999998        55566777777776543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=1.3e-30  Score=228.14  Aligned_cols=196  Identities=29%  Similarity=0.489  Sum_probs=155.9

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++| +|..++.+....+++..++.++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             EEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCc
Confidence            45678899999999995 8888887656789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++...... .......++..|+|||.+.+.......++.++|+|||||++|+|++|..||... .......++.....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~  234 (292)
T cd06644         156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPT  234 (292)
T ss_pred             cceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCcc
Confidence            88654322 122334678899999998643323345788999999999999999999999873 3444555555555555


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ......++..+.++|.+||..+|+        .+.+..++..++++..
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~~~~  274 (292)
T cd06644         235 LSQPSKWSMEFRDFLKTALDKHPE--------TRPSAAQLLEHPFVSS  274 (292)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcc--------cCcCHHHHhcCccccc
Confidence            554455899999999999999998        4455667777776544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=2.7e-31  Score=231.77  Aligned_cols=181  Identities=17%  Similarity=0.230  Sum_probs=144.6

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ..++++||||+. |+|.+++.. ...+++.....++.|++.||.|||+..+++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            457899999999 599999976 568999999999999999999999845899999999999999999999999999876


Q ss_pred             ccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCCCCCCC
Q psy3686          86 LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPND  164 (296)
Q Consensus        86 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p~~~~~  164 (296)
                      .....  ....++..|+|||.+.+.   ...++.++|||||||++|+|++|..||.+. ...+....+.. +..+.++. 
T Consensus       173 ~~~~~--~~~~~~~~y~aPE~~~~~---~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~-  245 (283)
T PHA02988        173 LSSPP--FKNVNFMVYFSYKMLNDI---FSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPL-  245 (283)
T ss_pred             hcccc--ccccCcccccCHHHhhhc---cccccchhhhhHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcCCCCCCCC-
Confidence            54322  234678899999998531   136889999999999999999999999974 44455555543 33344442 


Q ss_pred             cchhHHHHHHHHhccCCChHHHhhhccCCccchh
Q psy3686         165 PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCY  198 (296)
Q Consensus       165 ~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~  198 (296)
                       .++..+++||.+||+.+|+.|  +++.++...+
T Consensus       246 -~~~~~l~~li~~cl~~dp~~R--ps~~ell~~l  276 (283)
T PHA02988        246 -DCPLEIKCIVEACTSHDSIKR--PNIKEILYNL  276 (283)
T ss_pred             -cCcHHHHHHHHHHhcCCcccC--cCHHHHHHHH
Confidence             379999999999999999844  4555544433

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=8.6e-31  Score=233.81  Aligned_cols=188  Identities=22%  Similarity=0.339  Sum_probs=144.6

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|+|||||+++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus        77 ~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          77 KDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             ceEEEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            46899999999999999876 5679999999999999999999999 599999999999999999999999999987543


Q ss_pred             CCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH----------
Q psy3686          88 DSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV----------  153 (296)
Q Consensus        88 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i----------  153 (296)
                      ...    ......++..|+|||++.+.   ...++.++|||||||++|+|++|+.||.+... ...+..+          
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLITDLLGTPSPE  230 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhcc---ccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCHH
Confidence            221    12234688999999998531   13678899999999999999999999976322 1111111          


Q ss_pred             -----------------HccCCCCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         154 -----------------LNDAPPCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       154 -----------------~~~~~p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                       ....+..+ ...+.+++.+.++|.+||..+|+        ++.++.+++.++++...
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK--------DRPTAEEALADPYFKGL  296 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcc--------cCCCHHHHhcCchhhhc
Confidence                             00011011 11123678899999999999998        66677888888887543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-31  Score=233.95  Aligned_cols=197  Identities=23%  Similarity=0.398  Sum_probs=151.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++++|+||||+. |+|.+++.+....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECC
Confidence            4677889999999998 59999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-C
Q psy3686          82 ISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-P  158 (296)
Q Consensus        82 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~  158 (296)
                      ++........  .....+++.|+|||++.........++.++|||||||++|+|++|..||.. ....+....+.... .
T Consensus       148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~  226 (331)
T cd05597         148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEH  226 (331)
T ss_pred             ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCc
Confidence            9866543322  122368999999999864322234578899999999999999999999987 34445555554422 1


Q ss_pred             CCCC-CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLP-NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~-~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..++ ....++..++++|++||...+. |+     .+..+.+++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~~~~-r~-----~r~~~~~~l~hp~~~  270 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICSPET-RL-----GRNGLQDFKDHPFFE  270 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccCccc-cc-----CCCCHHHHhcCCCCC
Confidence            1222 2234799999999999975443 21     244566777777653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=5.3e-31  Score=235.05  Aligned_cols=197  Identities=22%  Similarity=0.385  Sum_probs=153.4

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||+. |+|.+++.+....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             EEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecc
Confidence            4567889999999998 59999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-  158 (296)
                      ++.......  ......|++.|+|||++.+.......++.++|||||||++|+|++|+.||.. ....+.+..+..... 
T Consensus       148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~  226 (332)
T cd05623         148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKER  226 (332)
T ss_pred             hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCcc
Confidence            986543322  1223468999999999864322234678899999999999999999999987 345555666654331 


Q ss_pred             CCCCC-CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPN-DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~-~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..++. ...++..+++||.+||..++..+      .+..+.++..++|+.
T Consensus       227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~------~r~~~~~~~~h~~f~  270 (332)
T cd05623         227 FQFPAQVTDVSEDAKDLIRRLICSREHRL------GQNGIEDFKQHPFFT  270 (332)
T ss_pred             ccCCCccccCCHHHHHHHHHHccChhhhc------CCCCHHHHhCCCCcC
Confidence            22222 23479999999999998766421      234566677777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=9.9e-31  Score=227.52  Aligned_cols=197  Identities=46%  Similarity=0.831  Sum_probs=158.0

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ++..++.+|+||||++|+|.+++...   ...+++..++.++.||+.||.|||+..+++||||||+||+++.++.+||+|
T Consensus        68 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~d  147 (283)
T cd06617          68 ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCD  147 (283)
T ss_pred             EEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEee
Confidence            45678889999999999998888653   457899999999999999999999833899999999999999999999999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ||++..+..........++..|+|||.+.+.. ....++.++|+|||||++|+|++|..||.......+.+..+..+..+
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd06617         148 FGISGYLVDSVAKTIDAGCKPYMAPERINPEL-NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP  226 (283)
T ss_pred             cccccccccccccccccCCccccChhhcCCcc-cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC
Confidence            99987665433333346788999999886432 12356789999999999999999999998655555666666666666


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .++... +|..+.++|.+||..+|+        ++.+..++..++++...
T Consensus       227 ~~~~~~-~~~~l~~li~~~l~~~p~--------~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         227 QLPAEK-FSPEFQDFVNKCLKKNYK--------ERPNYPELLQHPFFELH  267 (283)
T ss_pred             CCCccc-cCHHHHHHHHHHccCChh--------hCcCHHHHhcCchhhhc
Confidence            665443 899999999999999998        44455666667665543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0032|consensus

Probab=99.97  E-value=1.1e-30  Score=234.26  Aligned_cols=190  Identities=25%  Similarity=0.362  Sum_probs=164.0

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC----CCEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER----GNIK   76 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~----~~~k   76 (296)
                      +.|++...+++|||+|. |.|.+.+...  .+++..+..++.|++.+++|||+ .|++||||||+|+|+...    +.+|
T Consensus       103 ~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  103 DAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEE
Confidence            35788899999999999 5999988764  49999999999999999999999 699999999999999643    4799


Q ss_pred             EeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc
Q psy3686          77 LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        77 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      ++|||++............+||+.|+|||++.     ...|+..+||||+|+++|.|++|..||.+ ........++..+
T Consensus       180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~-----~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~  253 (382)
T KOG0032|consen  180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG-----GRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRG  253 (382)
T ss_pred             EeeCCCceEccCCceEeeecCCccccCchhhc-----CCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcC
Confidence            99999999887766677789999999999994     34899999999999999999999999999 4555666677777


Q ss_pred             CCC-CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         157 APP-CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       157 ~~p-~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ... ..+.+..+|..+++||+++|..||.        .+.++.++++|+|+..
T Consensus       254 ~~~f~~~~w~~is~~akd~i~~ll~~dp~--------~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  254 DFDFTSEPWDDISESAKDFIRKLLEFDPR--------KRLTAAQALQHPWIKS  298 (382)
T ss_pred             CCCCCCCCccccCHHHHHHHHHhcccCcc--------cCCCHHHHhcCccccC
Confidence            552 2334556899999999999999997        8888899999998764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.3e-30  Score=227.11  Aligned_cols=197  Identities=60%  Similarity=1.034  Sum_probs=159.2

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +++.++..+|+||||+.++|.+++......+++..+..++.||+.||.|||+.+|++||||+|+||+++.++.++|+|||
T Consensus        81 ~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             eeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence            45678889999999999988888877667899999999999999999999974599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ++..+..........++..|+|||.+.+... ...++.++||||||+++|+|++|..||.......+.+..+.....+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T cd06618         161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL  239 (296)
T ss_pred             cchhccCCCcccCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence            9876654433334457788999999864321 235788999999999999999999999875555566666666665666


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +....++..+.+||.+||..+|.        .+.+..++..++++.
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~--------~Rp~~~~il~~~~~~  277 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHR--------KRPKYRELLQHPFIR  277 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChh--------hCCCHHHHhcChhhh
Confidence            55445899999999999999998        444455666666543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=6.6e-31  Score=234.37  Aligned_cols=197  Identities=22%  Similarity=0.366  Sum_probs=151.4

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++.+||||||+. |+|.+++.+....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEecc
Confidence            4667889999999998 59999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-C
Q psy3686          82 ISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-P  158 (296)
Q Consensus        82 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~  158 (296)
                      ++........  .....|++.|+|||++.+.......++.++|||||||++|+|++|+.||.. ....+....+.... .
T Consensus       148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~  226 (331)
T cd05624         148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEER  226 (331)
T ss_pred             ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCc
Confidence            9876543322  123468999999999864322223578899999999999999999999987 34445555555432 2


Q ss_pred             CCCCC-CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPN-DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~-~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..++. ...++..++++|.+||..++. |+     .+....++..++++.
T Consensus       227 ~~~p~~~~~~~~~~~~li~~ll~~~~~-~~-----~~~~~~~~~~h~~f~  270 (331)
T cd05624         227 FQFPSHITDVSEEAKDLIQRLICSRER-RL-----GQNGIEDFKKHAFFE  270 (331)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCchh-hc-----CCCCHHHHhcCCCcC
Confidence            22332 234789999999999986554 21     123445556666543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=2.6e-30  Score=221.41  Aligned_cols=186  Identities=22%  Similarity=0.405  Sum_probs=152.2

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++.+++.+|+||||+.| +|.+++... ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~d  144 (256)
T cd08529          66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGD  144 (256)
T ss_pred             eeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcc
Confidence            456778899999999985 999999875 4679999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||++........ .....++..|+|||.+.+     ..++.++|+||||+++|+|++|..||... ........+..+..
T Consensus       145 f~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~  218 (256)
T cd08529         145 LGVAKLLSDNTNFANTIVGTPYYLSPELCED-----KPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVF  218 (256)
T ss_pred             cccceeccCccchhhccccCccccCHHHhcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCC
Confidence            999876544322 223467889999999853     35778999999999999999999999873 45566666766666


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCC
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEG  204 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~  204 (296)
                      +.++.  .++..+.++|.+||..+|+        ++..+.++..++
T Consensus       219 ~~~~~--~~~~~~~~~i~~~l~~~p~--------~Rp~~~~ll~~~  254 (256)
T cd08529         219 PPVSQ--MYSQQLAQLIDQCLTKDYR--------QRPDTFQLLRNP  254 (256)
T ss_pred             CCCcc--ccCHHHHHHHHHHccCCcc--------cCcCHHHHhhCC
Confidence            55554  3799999999999999998        444455555444

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0658|consensus

Probab=99.97  E-value=5.8e-32  Score=231.38  Aligned_cols=187  Identities=25%  Similarity=0.399  Sum_probs=157.6

Q ss_pred             eEEEEecCccccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-CCEEEeccCCcc
Q psy3686           9 DVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCDFGISG   84 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~   84 (296)
                      ++.+|||||+-+|.++++..   +..++.-.++-++.||++||+|||+ +||+||||||.|+|++.+ |.+||||||.|+
T Consensus        96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            56799999999999999853   6789999999999999999999999 699999999999999976 899999999999


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC----
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP----  158 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~----  158 (296)
                      .+...........|..|.|||.+.+.    ..|+.+.||||.|||+.||+-|++-|.+ ++....+..|++  |.+    
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga----~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCc----cccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHH
Confidence            98877777777899999999999854    3899999999999999999999999999 455555554443  111    


Q ss_pred             -------------CCCC-------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         159 -------------PCLP-------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       159 -------------p~~~-------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                   |.+.       .....+++..+|+.++|..+|.        .+.++.+++.+++...+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~--------~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPS--------KRLSALEALAHPFFDEL  312 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChh--------hcCCHHHHhcchhhHHh
Confidence                         1111       1124689999999999999998        77888888888887655

>KOG0193|consensus

Probab=99.97  E-value=5.6e-32  Score=243.90  Aligned_cols=189  Identities=22%  Similarity=0.292  Sum_probs=153.4

Q ss_pred             CCCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           1 MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      |+++...+. .||+-+|+| +|+.+++....+|.....+.|++||++|+.|||.+ +|||+|||..|||+.++++|||+|
T Consensus       454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  454 MGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             ehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEec
Confidence            456666666 999999998 99999988888999999999999999999999997 999999999999999999999999


Q ss_pred             cCCccccc---CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc
Q psy3686          80 FGISGRLV---DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        80 fg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      ||++..-.   .........+...|||||++....  ...|++.+||||||||+|||++|.+||.. ....+++..+-+|
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd--~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG  608 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQD--DNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRG  608 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcc--cCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEeccc
Confidence            99986433   223334457889999999998653  45899999999999999999999999995 5666666666666


Q ss_pred             CC-CCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         157 AP-PCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       157 ~~-p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      .. |.+ ......+.++++|+..||..+++  .|+.|.++..
T Consensus       609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~--eRP~F~~il~  648 (678)
T KOG0193|consen  609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDRE--ERPLFPQLLS  648 (678)
T ss_pred             ccCccchhhhccCHHHHHHHHHHHHhcCcc--cCccHHHHHH
Confidence            21 222 22234788999999999999998  4444444443

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=2.4e-30  Score=232.67  Aligned_cols=192  Identities=23%  Similarity=0.427  Sum_probs=147.0

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++.+|+||||+.| +|...     ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus       139 ~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~Df  212 (353)
T PLN00034        139 DMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADF  212 (353)
T ss_pred             eEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccc
Confidence            356788899999999995 87542     356788899999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-c-HHHHHHHHccC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-D-FEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-~-~~~~~~i~~~~  157 (296)
                      |++..+.... ......++..|+|||.+..........+.++|||||||++|+|++|+.||..... . ......+....
T Consensus       213 G~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  292 (353)
T PLN00034        213 GVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ  292 (353)
T ss_pred             ccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC
Confidence            9987654332 2234478999999999854322222345689999999999999999999974221 1 22233333333


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .+..+.  .++..+++||.+||..+|+        ++.++.+++.++|+...
T Consensus       293 ~~~~~~--~~~~~l~~li~~~l~~~P~--------~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        293 PPEAPA--TASREFRHFISCCLQREPA--------KRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CCCCCC--ccCHHHHHHHHHHccCChh--------hCcCHHHHhcCcccccC
Confidence            333333  3799999999999999998        55667788888877553

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=1.1e-30  Score=228.20  Aligned_cols=194  Identities=20%  Similarity=0.327  Sum_probs=149.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+.+++.+|+||||+. |+|.+++... ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+||
T Consensus        68 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Df  146 (285)
T cd05630          68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDL  146 (285)
T ss_pred             EEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeec
Confidence            4567789999999998 4999988654 3469999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--HHHHHHHHccCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--FEVLSRVLNDAP  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--~~~~~~i~~~~~  158 (296)
                      |++.............++..|+|||.+.+     ..++.++||||+|+++|+|++|..||......  ......+.....
T Consensus       147 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd05630         147 GLAVHVPEGQTIKGRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ  221 (285)
T ss_pred             cceeecCCCccccCCCCCccccChHHHcC-----CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh
Confidence            99876543333334478899999999953     36788999999999999999999999874322  122333333222


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..++.  .+++.+.+||.+||..+|+.|+  +++. ..+.++..++++.
T Consensus       222 ~~~~~--~~~~~~~~li~~~l~~~p~~R~--s~~~-~~~~~~~~h~~~~  265 (285)
T cd05630         222 EEYSE--KFSPDARSLCKMLLCKDPKERL--GCQG-GGAREVKEHPLFK  265 (285)
T ss_pred             hhcCc--cCCHHHHHHHHHHhhcCHHHcc--CCCC-CchHHHHcChhhh
Confidence            23332  3789999999999999998443  3222 2456667777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4717|consensus

Probab=99.97  E-value=1e-30  Score=231.83  Aligned_cols=172  Identities=26%  Similarity=0.414  Sum_probs=151.3

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE-CCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL-DERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~-~~~~~~kl~dfg~~   83 (296)
                      +...+|||+|+-+ |+|++||.++...+.|....+++.||+.|+.|+|+ ..+|||||||+|+.+ ..-|-+||.|||++
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeecccc
Confidence            4568999999999 59999999988999999999999999999999999 589999999999765 56799999999999


Q ss_pred             ccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCC
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN  163 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~  163 (296)
                      ..+.+.......+|+..|.|||++.+..    .-.+++||||||+|||.|++|+.||+. .++.+.+..|+.... .+|.
T Consensus       167 Nkf~PG~kL~TsCGSLAYSAPEILLGDs----YDAPAVDiWSLGVILyMLVCGq~PFqe-ANDSETLTmImDCKY-tvPs  240 (864)
T KOG4717|consen  167 NKFQPGKKLTTSCGSLAYSAPEILLGDS----YDAPAVDIWSLGVILYMLVCGQPPFQE-ANDSETLTMIMDCKY-TVPS  240 (864)
T ss_pred             ccCCCcchhhcccchhhccCchhhhcCc----cCCcchhhhHHHHHHHHHHhCCCcccc-ccchhhhhhhhcccc-cCch
Confidence            9999888888899999999999998652    234789999999999999999999998 466678888877653 3444


Q ss_pred             CcchhHHHHHHHHhccCCChHHH
Q psy3686         164 DPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       164 ~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                        .+|.++++||..||.+||..|
T Consensus       241 --hvS~eCrdLI~sMLvRdPkkR  261 (864)
T KOG4717|consen  241 --HVSKECRDLIQSMLVRDPKKR  261 (864)
T ss_pred             --hhhHHHHHHHHHHHhcCchhh
Confidence              389999999999999999833

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.6e-30  Score=243.23  Aligned_cols=170  Identities=25%  Similarity=0.343  Sum_probs=142.4

Q ss_pred             eEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           9 DVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         9 ~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+++||||+. |+|.+++...   ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence            4789999999 5999998653   4579999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCC---ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          85 RLVDS---KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        85 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .+...   .......|++.|+|||++.+     ..++.++|||||||++|+|++|..||.. ......+..+..+..+.+
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRR-----KPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCCC
Confidence            65432   12234578999999999953     3688999999999999999999999987 445566667776665555


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..  +++.+.++|.+||..+|..||
T Consensus       266 ~~~--~~~~l~~li~~~L~~dP~~RP  289 (496)
T PTZ00283        266 PPS--ISPEMQEIVTALLSSDPKRRP  289 (496)
T ss_pred             CCC--CCHHHHHHHHHHcccChhhCc
Confidence            543  799999999999999998443

>KOG0690|consensus

Probab=99.97  E-value=2.2e-31  Score=224.55  Aligned_cols=193  Identities=22%  Similarity=0.321  Sum_probs=158.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|+.++++|+||||..| .|.-.+.+ ...+++.-.+.+...|+.||.|||++ +||+||||.+|+|++.+|++||.|||
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecc
Confidence            58899999999999995 88877766 67899999999999999999999995 99999999999999999999999999


Q ss_pred             Ccccc-cCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      +++.- .........+||+.|+|||++.     ...|+.++|.|.+|+++|+|++|++||.. ......+..|+-.. ..
T Consensus       314 LCKE~I~~g~t~kTFCGTPEYLAPEVle-----DnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed-~k  386 (516)
T KOG0690|consen  314 LCKEEIKYGDTTKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMED-LK  386 (516)
T ss_pred             cchhcccccceeccccCChhhcCchhhc-----cccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhh-cc
Confidence            99753 3345566789999999999994     44899999999999999999999999998 34445555555443 35


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +|..  ++++.+.|+...|.+||.+|---   ....+.++.++.|.+-.
T Consensus       387 FPr~--ls~eAktLLsGLL~kdP~kRLGg---GpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  387 FPRT--LSPEAKTLLSGLLKKDPKKRLGG---GPDDAKEIMRHRFFASV  430 (516)
T ss_pred             CCcc--CCHHHHHHHHHHhhcChHhhcCC---CchhHHHHHhhhhhccC
Confidence            5554  89999999999999999855432   22345556666665443

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=1.7e-30  Score=229.37  Aligned_cols=193  Identities=18%  Similarity=0.292  Sum_probs=150.7

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+..++.+|+||||++++|.+++......+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~  150 (309)
T cd07872          72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGL  150 (309)
T ss_pred             EEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcccc
Confidence            456788999999999999999987766678999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--C--
Q psy3686          83 SGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--A--  157 (296)
Q Consensus        83 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~--  157 (296)
                      +...... .......++..|+|||.+.+    ...++.++|||||||++|+|++|..||.+.. ..+.+..+...  .  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~  225 (309)
T cd07872         151 ARAKSVPTKTYSNEVVTLWYRPPDVLLG----SSEYSTQIDMWGVGCIFFEMASGRPLFPGST-VEDELHLIFRLLGTPT  225 (309)
T ss_pred             ceecCCCccccccccccccccCCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCC
Confidence            8654322 22233467889999999853    2357889999999999999999999998743 22222222210  0  


Q ss_pred             -----------------CCC------CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 -----------------PPC------LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 -----------------~p~------~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                       .+.      ......++.+++++|.+||..||.        +|.++.+++.++++...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~--------~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESK--------KRISAEEAMKHAYFRSL  292 (309)
T ss_pred             HHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChh--------hCCCHHHHhcChhhhhc
Confidence                             000      011124688999999999999998        66678888888887543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=3.4e-30  Score=232.20  Aligned_cols=182  Identities=23%  Similarity=0.383  Sum_probs=143.1

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|+||||++++|.+.+.   ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            4689999999998888774   468999999999999999999999 599999999999999999999999999997654


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc------------
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN------------  155 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~------------  155 (296)
                      .........++..|+|||++.+     ..++.++|||||||++|+|++|..||.+.+ ....+..+..            
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGELVKGSVIFQGTD-HIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cCccCCCCcccCCCCCchhccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCcHHHHHH
Confidence            4444444578899999999954     367889999999999999999999998743 2222211111            


Q ss_pred             ---------cCCCCCC------------------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         156 ---------DAPPCLP------------------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       156 ---------~~~p~~~------------------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                               ...+..+                  .....+..+++||.+||..||+        +|.++.+++.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~--------~R~t~~e~l~hp~~~  319 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD--------KRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc--------cCCCHHHHhcCchhh
Confidence                     0011111                  0112467899999999999998        667788888888875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=4e-30  Score=220.23  Aligned_cols=189  Identities=33%  Similarity=0.558  Sum_probs=151.1

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.++..+|++|||+.| +|.+++......+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        65 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             eeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCCcEEEccc
Confidence            456778899999999995 9999998767789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|+|||.+.+     ..++.++||||||+++|+|++|..||... ........+.....+
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~s~G~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~  217 (256)
T cd06612         144 GVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-----IGYNNKADIWSLGITAIEMAEGKPPYSDI-HPMRAIFMIPNKPPP  217 (256)
T ss_pred             ccchhcccCccccccccCCccccCHHHHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCc-chhhhhhhhccCCCC
Confidence            9987665433 2233457889999999853     36788999999999999999999999873 333333333333344


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+.....++..+.++|.+||..+|+        .|.++.+++.++|
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~--------~Rps~~~il~~~~  255 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPE--------ERPSAIQLLQHPF  255 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChh--------hCcCHHHHhcCCC
Confidence            4444445789999999999999998        4445555555544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0580|consensus

Probab=99.97  E-value=9.3e-31  Score=212.15  Aligned_cols=187  Identities=23%  Similarity=0.309  Sum_probs=159.5

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ++|-++..+||++||.. |.|...+... ...+++...+.++.|++.||.|+|.+ +++||||||+|+|++..+.+|++|
T Consensus        89 ~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   89 GYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             hheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccC
Confidence            57889999999999999 7888888743 56799999999999999999999995 999999999999999999999999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ||-+.... ...+...+||.-|++||...+     ...+..+|+|++|++.|+++.|..||... ...+.+++|.+-.. 
T Consensus       168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~-----~~hd~~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~~~-  239 (281)
T KOG0580|consen  168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEG-----RGHDKFVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKVDL-  239 (281)
T ss_pred             CCceeecC-CCCceeeecccccCCHhhcCC-----CCccchhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHccc-
Confidence            99986544 556677799999999999954     37788999999999999999999999984 46677777765432 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .+|.  .++...+++|.+||.++|.        ++....+...++++.
T Consensus       240 ~~p~--~is~~a~dlI~~ll~~~p~--------~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  240 KFPS--TISGGAADLISRLLVKNPI--------ERLALTEVMDHPWIV  277 (281)
T ss_pred             cCCc--ccChhHHHHHHHHhccCcc--------ccccHHHHhhhHHHH
Confidence            4443  3899999999999999998        666667777776653

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=2.1e-30  Score=233.94  Aligned_cols=184  Identities=22%  Similarity=0.335  Sum_probs=146.1

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ....+|+||||++++|.+++.   ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         100 EFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             ccCeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            345789999999999988885   358899999999999999999999 5999999999999999999999999999976


Q ss_pred             ccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-------
Q psy3686          86 LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-------  158 (296)
Q Consensus        86 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-------  158 (296)
                      ...........++..|+|||++.+     ..++.++|||||||++|+|++|..||.+. .....+..++....       
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGT-DHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHH
Confidence            654444445578999999999954     36788999999999999999999999873 33343333332110       


Q ss_pred             --------------CCCC------------------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 --------------PCLP------------------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 --------------p~~~------------------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                                    |.+.                  .....+..+++||.+||..||.        .+.++.+++.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~--------~R~t~~e~L~hp~~  321 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS--------KRISVDEALQHPYI  321 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc--------cCCCHHHHhcCccc
Confidence                          0000                  0011356789999999999998        77788888999887


Q ss_pred             c
Q psy3686         207 S  207 (296)
Q Consensus       207 ~  207 (296)
                      .
T Consensus       322 ~  322 (364)
T cd07875         322 N  322 (364)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0667|consensus

Probab=99.97  E-value=1.2e-30  Score=237.94  Aligned_cols=190  Identities=28%  Similarity=0.381  Sum_probs=155.3

Q ss_pred             CCCCccCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC--CEEE
Q psy3686           1 MSPQSKESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG--NIKL   77 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~--~~kl   77 (296)
                      ++||...+++|||+|++.-+|+++++.+ -..|+...++.++.||+.||.+||+ +||||+||||+|||+...+  .|||
T Consensus       254 ~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  254 LDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             eeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeE
Confidence            3689999999999999999999999886 3569999999999999999999999 6999999999999996543  6999


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--  155 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--  155 (296)
                      +|||.+........  ..+.+..|.|||++.|.     .|+.+.||||||||+.||++|.+.|.+ .+..+.+..|+.  
T Consensus       333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGl-----pY~~~IDmWSLGCIlAEL~tG~PLfpG-~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGL-----PYDTAIDMWSLGCILAELFTGEPLFPG-DNEYDQLARIIEVL  404 (586)
T ss_pred             EecccccccCCcce--eeeeccccccchhhccC-----CCCCccceeehhhhHHhHhcCccccCC-CCHHHHHHHHHHHh
Confidence            99999987655444  66889999999999754     899999999999999999999888888 455555555543  


Q ss_pred             cCCCC-------------------------------------------------CC-CC--------cchhHHHHHHHHh
Q psy3686         156 DAPPC-------------------------------------------------LP-ND--------PLFGRTIKASIAK  177 (296)
Q Consensus       156 ~~~p~-------------------------------------------------~~-~~--------~~~s~~l~~li~~  177 (296)
                      |.+|.                                                 .| ..        ..-...+.+||++
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence            22220                                                 00 00        0112568999999


Q ss_pred             ccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         178 DNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       178 cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ||..||.        .+.+..+.+.|+|+.
T Consensus       485 ~L~~dP~--------~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  485 CLEWDPA--------ERITPAQALNHPFLT  506 (586)
T ss_pred             HhccCch--------hcCCHHHHhcCcccc
Confidence            9999998        667788888888875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=2.8e-30  Score=224.85  Aligned_cols=176  Identities=23%  Similarity=0.319  Sum_probs=143.0

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+.+.+..|++|||+. |+|.+++....               ..+++..++.++.||+.||.|||+ .|++|+||||+|
T Consensus        76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~N  154 (283)
T cd05048          76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARN  154 (283)
T ss_pred             EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccce
Confidence            3456778999999998 59999997631               568899999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.++|+|||++.......   ......++..|+|||.+.+     ..++.++|||||||++|+|++ |..||.+
T Consensus       155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slG~il~el~~~g~~p~~~  229 (283)
T cd05048         155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-----GKFTTESDIWSFGVVLWEIFSYGLQPYYG  229 (283)
T ss_pred             EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-----CcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999987543221   1223355778999999843     367889999999999999998 9999987


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      . ...+....+..+..+..+.  .++..+.+|+.+||..+|..||
T Consensus       230 ~-~~~~~~~~i~~~~~~~~~~--~~~~~~~~l~~~c~~~~p~~Rp  271 (283)
T cd05048         230 F-SNQEVIEMIRSRQLLPCPE--DCPARVYALMIECWNEIPARRP  271 (283)
T ss_pred             C-CHHHHHHHHHcCCcCCCcc--cCCHHHHHHHHHHccCChhhCc
Confidence            3 4456666666666555543  3899999999999999998443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-30  Score=222.34  Aligned_cols=190  Identities=33%  Similarity=0.507  Sum_probs=151.2

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ....+|+||||+++ +|.+++...   +..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCc
Confidence            35578999999995 999988753   3689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .+...... .......++..|+|||.+.........++.++||||||+++|+|++|..||... ........+.....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~  237 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKIPRNPPPT  237 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-chHHHHHHhhccCCCC
Confidence            98765432 222334678899999998654334456788999999999999999999999863 4445555666665555


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +.....++..++++|.+||..||+        .+.+..++..++|
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~--------~Rpt~~~ll~~~~  274 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYE--------QRPFMEELLEHPF  274 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChh--------hCcCHHHHhcCCC
Confidence            555445889999999999999998        4445555555554

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=4.2e-30  Score=224.23  Aligned_cols=184  Identities=20%  Similarity=0.325  Sum_probs=143.4

Q ss_pred             CCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ...+++||||+.++|.+++... ...+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            4568999999999999998764 3458999999999999999999999 5999999999999999999999999999976


Q ss_pred             ccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC--C--CCC
Q psy3686          86 LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA--P--PCL  161 (296)
Q Consensus        86 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~--~--p~~  161 (296)
                      ...........++..|+|||++.+     ..++.++|||||||++|+|++|..||... .....+.++....  +  ..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKPLFCGN-SEADQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             ccCcccCCCccccccccCchHhhC-----CCCCCcchhhhHHHHHHHHHhCCcCcCCC-CHHHHHHHHHHHhCCCChhhC
Confidence            654433344567889999999853     36788999999999999999999999873 3333333332210  0  000


Q ss_pred             C--------------------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         162 P--------------------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       162 ~--------------------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +                    ..+.++..+.++|.+||..||+        +|.++.+++.++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~--------~R~t~~~~l~hp~  287 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPH--------KRISAFRALQHPF  287 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcc--------cCCCHHHHhcCCC
Confidence            0                    0123678899999999999998        4555666666654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=2.7e-30  Score=240.66  Aligned_cols=186  Identities=20%  Similarity=0.324  Sum_probs=143.7

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-------------
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-------------   73 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-------------   73 (296)
                      .+++|||||+++++|.+++.+ ...+++..++.++.||+.||.|||+..||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            468999999999899998876 578999999999999999999999734999999999999998765             


Q ss_pred             ---CEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHH
Q psy3686          74 ---NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVL  150 (296)
Q Consensus        74 ---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~  150 (296)
                         .+||+|||.+....  .......+|..|+|||++.+     ..++.++|||||||++|+|++|+.||.+.. ..+.+
T Consensus       283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~  354 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-----LGWMYSTDMWSMGCIIYELYTGKLLYDTHD-NLEHL  354 (467)
T ss_pred             CCceEEECCCCccccCc--cccccccCCccccCcHHhhc-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Confidence               49999999875432  22334578999999999954     368899999999999999999999998733 33333


Q ss_pred             HHHHc--cCCC------------------------CCCC-------------CcchhHHHHHHHHhccCCChHHHhhhcc
Q psy3686         151 SRVLN--DAPP------------------------CLPN-------------DPLFGRTIKASIAKDNGRSTEFIRKRSY  191 (296)
Q Consensus       151 ~~i~~--~~~p------------------------~~~~-------------~~~~s~~l~~li~~cl~~~P~~r~~~~~  191 (296)
                      ..+..  +..|                        ....             ....++.+.+||.+||..||.       
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~-------  427 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ-------  427 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh-------
Confidence            22211  1100                        0000             000245678999999999998       


Q ss_pred             CCccchhhcccCCccccc
Q psy3686         192 EDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~  209 (296)
                       .|.++.+++.|+|+...
T Consensus       428 -~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        428 -KRLNARQMTTHPYVLKY  444 (467)
T ss_pred             -hCCCHHHHhcCcccccc
Confidence             77788999999988654

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=5e-30  Score=223.28  Aligned_cols=194  Identities=24%  Similarity=0.328  Sum_probs=149.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||
T Consensus        65 ~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          65 AFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCC
Confidence            35567889999999994 99999876 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-cHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-~~~~~~~i~~~~~p~  160 (296)
                      ++....... .....++..|+|||.+..    ...++.++||||+||++|+|++|..||..... .............+.
T Consensus       143 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  217 (279)
T cd05633         143 LACDFSKKK-PHASVGTHGYMAPEVLQK----GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE  217 (279)
T ss_pred             cceeccccC-ccCcCCCcCccCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcC
Confidence            986543322 223468899999998842    22577899999999999999999999975322 222333333233333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ++.  .++..+.++|.+||..+|+.|+..-.   .++.++..+++...
T Consensus       218 ~~~--~~~~~~~~li~~~l~~~p~~R~~~~~---~~~~~~~~h~~~~~  260 (279)
T cd05633         218 LPD--SFSPELKSLLEGLLQRDVSKRLGCLG---RGAQEVKEHVFFKG  260 (279)
T ss_pred             Ccc--ccCHHHHHHHHHHhcCCHHHhcCCCC---CCHHHHHhCccccC
Confidence            433  37999999999999999995553222   24566777776644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=2.7e-30  Score=223.22  Aligned_cols=181  Identities=18%  Similarity=0.254  Sum_probs=143.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++ |+|.+++......+++..++.++.||+.||+|||+ .|++||||||+||+++.++.++++|||
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          74 VITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             EEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCc
Confidence            4567789999999999 59999998756689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcccc--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSKART--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      .+..........  ...++..|+|||.+.+     ..++.++|||||||++|++++ |..||... ........+..+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~  226 (266)
T cd05064         153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-----HHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFR  226 (266)
T ss_pred             ccccccccchhcccCCCCceeecCHHHHhh-----CCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCC
Confidence            875543221111  1234568999999843     368889999999999999875 99999873 44455555555544


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      +..+.  .++..+.+++.+||..+|+.||  ++.++
T Consensus       227 ~~~~~--~~~~~~~~li~~c~~~~p~~RP--~~~~i  258 (266)
T cd05064         227 LPAPR--NCPNLLHQLMLDCWQKERGERP--RFSQI  258 (266)
T ss_pred             CCCCC--CCCHHHHHHHHHHcCCCchhCC--CHHHH
Confidence            33333  3799999999999999998443  44444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.7e-30  Score=220.32  Aligned_cols=186  Identities=27%  Similarity=0.413  Sum_probs=146.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||++| +|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        71 ~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~df  148 (263)
T cd06625          71 GCLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDF  148 (263)
T ss_pred             EEEccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeec
Confidence            356677899999999985 99999876 5679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccc----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH-c
Q psy3686          81 GISGRLVDSKAR----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL-N  155 (296)
Q Consensus        81 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~-~  155 (296)
                      |++.........    ....++..|+|||.+.+.     .++.++||||||+++|++++|+.||.... .......+. .
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~  222 (263)
T cd06625         149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-----GYGRKADVWSVGCTVVEMLTEKPPWAEFE-AMAAIFKIATQ  222 (263)
T ss_pred             ccceeccccccccccccCCCcCccccCcceeccC-----CCCchhhhHHHHHHHHHHHhCCCCccccc-hHHHHHHHhcc
Confidence            998755322111    234577899999999542     57889999999999999999999998743 333333333 2


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ...+.++.  .++..+.++|.+||..+|.        .+.++.++..+++
T Consensus       223 ~~~~~~~~--~~~~~~~~li~~~l~~~p~--------~Rpt~~~ll~~~~  262 (263)
T cd06625         223 PTNPQLPS--HVSPDARNFLRRTFVENAK--------KRPSAEELLRHFF  262 (263)
T ss_pred             CCCCCCCc--cCCHHHHHHHHHHhhcCcc--------cCCCHHHHhhCCC
Confidence            33334443  3799999999999999998        4445555555543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=8.9e-30  Score=221.55  Aligned_cols=194  Identities=24%  Similarity=0.334  Sum_probs=150.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +|..++.+|+||||+.| +|..++.. ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus        65 ~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          65 AFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             eeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCc
Confidence            56678899999999995 99998875 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-cHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-~~~~~~~i~~~~~p~  160 (296)
                      ++....... .....++..|+|||.+.+    ...++.++||||+|+++|+|++|..||..... .............+.
T Consensus       143 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  217 (278)
T cd05606         143 LACDFSKKK-PHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE  217 (278)
T ss_pred             CccccCccC-CcCcCCCcCCcCcHHhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC
Confidence            986554322 223468899999999853    22477899999999999999999999986421 222222333333344


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ++..  ++..+.++|.+||..+|+.|+....   .+..+++.++++.-
T Consensus       218 ~~~~--~s~~~~~li~~~l~~~p~~R~~~~~---~~~~~ll~~~~~~~  260 (278)
T cd05606         218 LPDS--FSPELRSLLEGLLQRDVNRRLGCLG---RGAQEVKEHPFFRS  260 (278)
T ss_pred             CCCc--CCHHHHHHHHHHhhcCHHhccCCCC---CCHHHHHhCccccC
Confidence            5443  6999999999999999996654322   25556666665533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=5e-30  Score=220.36  Aligned_cols=172  Identities=22%  Similarity=0.315  Sum_probs=140.2

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+..+++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+ +|++|+||||.||+++.++.++|+|||++.
T Consensus        66 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~  143 (257)
T cd05116          66 EAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSK  143 (257)
T ss_pred             cCCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCcccc
Confidence            3567799999999 599999976 5679999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCCccc----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSKAR----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ........    ....++..|+|||.+.     ...++.++|+|||||++|+|++ |..||... ........+.++..+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~i~~~~~~  217 (257)
T cd05116         144 ALGADENYYKAKTHGKWPVKWYAPECMN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM-KGNEVTQMIESGERM  217 (257)
T ss_pred             ccCCCCCeeeecCCCCCCccccCHhHhc-----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC
Confidence            65433211    1123357899999884     3367789999999999999998 99999873 445566666666555


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+..  +++.+.++|.+||..+|+.||
T Consensus       218 ~~~~~--~~~~l~~li~~~~~~~p~~Rp  243 (257)
T cd05116         218 ECPQR--CPPEMYDLMKLCWTYGVDERP  243 (257)
T ss_pred             CCCCC--CCHHHHHHHHHHhccCchhCc
Confidence            55543  799999999999999998444

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=5.3e-30  Score=230.58  Aligned_cols=184  Identities=22%  Similarity=0.337  Sum_probs=144.4

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ...+|+||||++++|.+.+.   ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             cceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            35689999999998888875   368999999999999999999999 59999999999999999999999999999766


Q ss_pred             cCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc----------
Q psy3686          87 VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND----------  156 (296)
Q Consensus        87 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~----------  156 (296)
                      ..........++..|+|||++.+     ..++.++|||||||++|+|++|..||.+.. ....+..++..          
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             CCccccCCccccCCccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHH
Confidence            54444445578999999999953     367889999999999999999999998743 22222211110          


Q ss_pred             -----------CCCC--------------CC----CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         157 -----------APPC--------------LP----NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       157 -----------~~p~--------------~~----~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                 ..+.              ++    .....+..+++||.+||..||+        +|.++.+++.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~--------~Rps~~ell~hp~~~  315 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA--------KRISVDEALQHPYIN  315 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch--------hcCCHHHHhcCcchh
Confidence                       0000              00    0112457889999999999998        667788888888875


Q ss_pred             c
Q psy3686         208 Y  208 (296)
Q Consensus       208 ~  208 (296)
                      .
T Consensus       316 ~  316 (355)
T cd07874         316 V  316 (355)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG2345|consensus

Probab=99.97  E-value=5.8e-31  Score=214.35  Aligned_cols=179  Identities=23%  Similarity=0.302  Sum_probs=142.3

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEECCCCCEEEecc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ....||+++|+. |||.+.++..   +..+++.+++.|+.+|++||++||+. .  ++||||||.|||+++.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence            346899999998 8999999876   55799999999999999999999994 7  999999999999999999999999


Q ss_pred             CCcccccCCc----------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHH
Q psy3686          81 GISGRLVDSK----------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVL  150 (296)
Q Consensus        81 g~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~  150 (296)
                      |.+....-..          .......|..|.|||.+...  .....+.++|||||||++|.|+.|..||.........+
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk--~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK--SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc--cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            9986543111          11122578999999999765  33367899999999999999999999997522211122


Q ss_pred             HHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         151 SRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       151 ~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      ...+......+|....+|..+.++|+.||+.||..||+
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~  289 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT  289 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC
Confidence            22223334466777679999999999999999985554

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=6.3e-30  Score=221.24  Aligned_cols=187  Identities=25%  Similarity=0.361  Sum_probs=144.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~df   80 (296)
                      .|..++.+|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||+ .|++|+||+|.||+++.++ .++|+||
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         77 SVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             EEecCCeeEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            4667789999999998 599999976 4589999999999999999999999 5999999999999999988 9999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++......   ....++..|+|||.+.+     ..++.++||||+|+++|+|++|..||............+.......
T Consensus       155 g~~~~~~~~---~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (267)
T PHA03390        155 GLCKIIGTP---SCYDGTLDYFSPEKIKG-----HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK  226 (267)
T ss_pred             ccceecCCC---ccCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc
Confidence            998765432   22367889999999953     3678899999999999999999999986332211111111111112


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+....+++.+.+||.+||+.+|..|+       ....+++.++|+
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~-------~~~~~~l~h~~~  265 (267)
T PHA03390        227 LPFIKNVSKNANDFVQSMLKYNINYRL-------TNYNEIIKHPFL  265 (267)
T ss_pred             CCcccccCHHHHHHHHHHhccChhhCC-------chHHHHhcCCcc
Confidence            222234899999999999999998333       123666666654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=5.2e-30  Score=223.19  Aligned_cols=191  Identities=19%  Similarity=0.279  Sum_probs=145.9

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.+.+.+.+|+||||++++|.+++......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        66 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             HHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccc
Confidence            3567788999999999999999887666789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC---
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---  157 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~---  157 (296)
                      ++....... ......++..|+|||.+.+.    ..++.++|||||||++|+|++|..||.........+..+....   
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07839         145 LARAFGIPVRCYSAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  220 (284)
T ss_pred             hhhccCCCCCCcCCCccccCCcChHHHhCC----cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            987554322 22234567899999998532    2467899999999999999999888654344333333332110   


Q ss_pred             ----------------CCCCC-------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 ----------------PPCLP-------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ----------------~p~~~-------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                      .+.++       ..+.++..++++|.+||..+|.        ++.++.+++.++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~t~~~il~h~~  283 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV--------QRISAEEALQHPY  283 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChh--------hcCCHHHHhcCCC
Confidence                            00111       0123689999999999999998        4445556555554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.9e-30  Score=219.18  Aligned_cols=180  Identities=31%  Similarity=0.481  Sum_probs=143.2

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++.+|+||||++| +|.+++......+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        68 ~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCCCEEECccc
Confidence            45678899999999995 9999998755789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--AP  158 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~  158 (296)
                      .+....... ......++..|+|||.+.+..  ...++.++|+||||+++|+|++|..||.... .......+...  .+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~~~~~~~~~~~~  223 (262)
T cd06613         147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVER--KGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKSNFPP  223 (262)
T ss_pred             cchhhhhhhhccccccCCccccCchhhcccc--cCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCC
Confidence            987654332 223346788999999985431  1267789999999999999999999998743 33333333333  22


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      +.+.....++..+.++|.+||..+|..|
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~R  251 (262)
T cd06613         224 PKLKDKEKWSPVFHDFIKKCLTKDPKKR  251 (262)
T ss_pred             ccccchhhhhHHHHHHHHHHcCCChhhC
Confidence            2333334478999999999999999843

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=2.7e-30  Score=226.88  Aligned_cols=191  Identities=26%  Similarity=0.461  Sum_probs=150.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..+.++|+||||+.| +|.+++..  ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          85 SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             EEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccc
Confidence            45677899999999985 99999864  578999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|+|||.+.+     ..++.++|||||||++|+|++|..||..... ...+..+.....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~  235 (296)
T cd06654         162 FCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGTPE  235 (296)
T ss_pred             cchhccccccccCcccCCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHhHHHHhcCCCCC
Confidence            886543322 1223467889999999853     3577899999999999999999999987433 23333333333334


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      ++....++..+.++|.+||..+|+        ++.++.++..++++....
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~--------~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVE--------KRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcc--------cCcCHHHHhhChhhhccC
Confidence            443445889999999999999998        455666777777665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0986|consensus

Probab=99.97  E-value=1.3e-30  Score=227.99  Aligned_cols=195  Identities=22%  Similarity=0.308  Sum_probs=159.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .|++.+.+++||..|.| +|.-.|.+. +..++++.+..++.+|+.||++||++ +||+|||||+|||+|+.|+++|+|+
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeecc
Confidence            57889999999999995 998888765 35799999999999999999999996 9999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--HHHHHHHHccCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--FEVLSRVLNDAP  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--~~~~~~i~~~~~  158 (296)
                      |+|..+..........||..|||||++.+     ..|+...|.|+|||++|+|+.|+.||......  .+.+.+.....+
T Consensus       332 GLAvei~~g~~~~~rvGT~GYMAPEvl~n-----e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~  406 (591)
T KOG0986|consen  332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQN-----EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP  406 (591)
T ss_pred             ceEEecCCCCccccccCcccccCHHHHcC-----CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch
Confidence            99999887777777799999999999953     46999999999999999999999999864322  223333444444


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ..++  ..+|++.++|++..|.+||+.|--  ... ..+.+..+|++..-
T Consensus       407 ~ey~--~kFS~eakslc~~LL~Kdp~~RLG--crg-~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  407 EEYS--DKFSEEAKSLCEGLLTKDPEKRLG--CRG-EGAQEVKEHPFFKD  451 (591)
T ss_pred             hhcc--cccCHHHHHHHHHHHccCHHHhcc--CCC-cCcchhhhCccccc
Confidence            4555  349999999999999999984432  221 14455566666544

>KOG1026|consensus

Probab=99.97  E-value=9e-31  Score=244.77  Aligned_cols=193  Identities=20%  Similarity=0.314  Sum_probs=164.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh---------CCC----CCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL---------HVS----VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI   67 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~---------~~~----l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Ni   67 (296)
                      +....++-+|+|+|||. |+|.++|..+         +..    |+..+.+.|+.||+.|+.||-+ +.+|||||-..|+
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNC  634 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNC  634 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhc
Confidence            44567889999999999 9999999875         222    8999999999999999999999 6899999999999


Q ss_pred             EECCCCCEEEeccCCcccccCCcccc---ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3686          68 LLDERGNIKLCDFGISGRLVDSKART---KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDC  143 (296)
Q Consensus        68 l~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~  143 (296)
                      ||..+-.|||+|||+++.........   ...-.++|||||.+     ..++|+.++||||+||+|||+++ |..||.+ 
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI-----ly~kFTteSDVWs~GVvLWEIFsyG~QPy~g-  708 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI-----LYGKFTTESDVWSFGVVLWEIFSYGKQPYYG-  708 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh-----hcCcccchhhhhhhhhhhhhhhccccCcccc-
Confidence            99999999999999998665443322   22455799999999     56689999999999999999999 9999999 


Q ss_pred             CCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         144 KCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       144 ~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      -.+.+++..|.++..  ++....+|.++.+||..||+++|.  +|++|.++..+++......
T Consensus       709 lSn~EVIe~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~--~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  709 LSNQEVIECIRAGQL--LSCPENCPTEVYSLMLECWNENPK--RRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             cchHHHHHHHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcc--cCCCHHHHHHHHHHHHhcC
Confidence            567789989988887  444445899999999999999998  7778888888887665543

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=1e-29  Score=223.26  Aligned_cols=191  Identities=25%  Similarity=0.450  Sum_probs=153.7

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..++.+|+||||+.| +|..++..  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          83 DSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             eeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccC
Confidence            356678899999999995 99998874  579999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++........ .....++..|+|||.+.+     ..++.++|||||||++|++++|..||... .....+..+.....+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~~lltg~~pf~~~-~~~~~~~~~~~~~~~  233 (296)
T cd06655         160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTP  233 (296)
T ss_pred             ccchhcccccccCCCcCCCccccCcchhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCc
Confidence            98876543322 223467889999999853     35788999999999999999999999874 333444444444444


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .+.....+++.+.++|.+||..+|.        ++.++.++..++++...
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~--------~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVE--------KRGSAKELLQHPFLKLA  275 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChh--------hCCCHHHHhhChHhhhc
Confidence            4444445899999999999999998        55667777788777644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=5.6e-30  Score=223.61  Aligned_cols=193  Identities=19%  Similarity=0.306  Sum_probs=147.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .|.+++.+|+||||+.| +|..++... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+||
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Df  146 (285)
T cd05632          68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             EEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecC
Confidence            46678899999999995 998888654 3479999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH---HccC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV---LNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i---~~~~  157 (296)
                      |++.............++..|+|||.+.+     ..++.++|+||||+++|+|++|..||..... ......+   ....
T Consensus       147 g~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-~~~~~~~~~~~~~~  220 (285)
T cd05632         147 GLAVKIPEGESIRGRVGTVGYMAPEVLNN-----QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-KVKREEVDRRVLET  220 (285)
T ss_pred             CcceecCCCCcccCCCCCcCccChHHhcC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhhhcc
Confidence            99866543333334578899999999953     3678899999999999999999999987432 2222222   1121


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .+.++  ..++..+.+||.+||..+|+.|+..  .+. .+.++..++++.
T Consensus       221 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~--~~~-~~~~l~~~~~~~  265 (285)
T cd05632         221 EEVYS--AKFSEEAKSICKMLLTKDPKQRLGC--QEE-GAGEVKRHPFFR  265 (285)
T ss_pred             ccccC--ccCCHHHHHHHHHHccCCHhHcCCC--ccc-ChHHHHcChhhh
Confidence            22222  3378999999999999999844432  111 244555555543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=6.6e-30  Score=224.37  Aligned_cols=181  Identities=19%  Similarity=0.271  Sum_probs=141.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      ++...+.+|+||||++ |+|.+++....               ..+++..++.++.||+.||+|||+ +|++||||||+|
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~N  149 (297)
T cd05089          71 ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARN  149 (297)
T ss_pred             EEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcce
Confidence            4556778999999998 59999997531               358899999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC  145 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~  145 (296)
                      |+++.++.+||+|||++..............+..|+|||.+.+     ..++.++|||||||++|+|++ |..||... .
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~t~g~~pf~~~-~  223 (297)
T cd05089         150 VLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-T  223 (297)
T ss_pred             EEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-C
Confidence            9999999999999999864322111122233457999999843     367889999999999999997 99999873 4


Q ss_pred             cHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         146 DFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       146 ~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      .......+..+..+..+.  .++..+.+||.+||..+|..  |+++.++
T Consensus       224 ~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--Rp~~~~i  268 (297)
T cd05089         224 CAELYEKLPQGYRMEKPR--NCDDEVYELMRQCWRDRPYE--RPPFAQI  268 (297)
T ss_pred             HHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHcCCChhh--CcCHHHH
Confidence            445566666554444443  37999999999999999983  4444444

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG1989|consensus

Probab=99.97  E-value=1.2e-30  Score=244.68  Aligned_cols=171  Identities=24%  Similarity=0.342  Sum_probs=140.1

Q ss_pred             eEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           9 DVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         9 ~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .++|.||||. |+|-+++..+ ...|++.+|++|+.|+++|+.+||. ..  |||||||-+||||+.+|+.||||||.+.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            6789999999 5999999865 5669999999999999999999999 46  9999999999999999999999999986


Q ss_pred             cccCCcccc----------ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH
Q psy3686          85 RLVDSKART----------KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        85 ~~~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~  154 (296)
                      .........          ....|+.|++||.+.-.  .....+.|+|||+|||+||.|+....||.....     ..|+
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly--sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----laIl  267 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY--SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----LAIL  267 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh--cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----eeEE
Confidence            543222111          11478999999998544  444788999999999999999999999998322     2455


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      ++.. .+|..+.++..+++||+.||+.||+.||.
T Consensus       268 ng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPn  300 (738)
T KOG1989|consen  268 NGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPN  300 (738)
T ss_pred             eccc-cCCCCccHHHHHHHHHHHHhccCcccCCC
Confidence            5543 55555569999999999999999985554

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.3e-30  Score=230.34  Aligned_cols=192  Identities=20%  Similarity=0.236  Sum_probs=146.9

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.+..++..|+|||++.|+|.+++......+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus       124 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        124 DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             heEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCc
Confidence            4567788999999999999999998767789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCc--------HHHHHH
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEF-PYKDCKCD--------FEVLSR  152 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~-Pf~~~~~~--------~~~~~~  152 (296)
                      ++.............++..|+|||++.+     ..++.++|||||||++|+|+++.. +|......        ...+..
T Consensus       203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~  277 (357)
T PHA03209        203 AAQFPVVAPAFLGLAGTVETNAPEVLAR-----DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK  277 (357)
T ss_pred             cccccccCcccccccccccccCCeecCC-----CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHH
Confidence            9875443333344578999999999953     367899999999999999998544 44432111        111111


Q ss_pred             HHc---cCCCCCC----------------------------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         153 VLN---DAPPCLP----------------------------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       153 i~~---~~~p~~~----------------------------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      ++.   ..+..++                            ....++.++.+||.+||..||.        +|.++.+++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~--------~Rpta~e~l  349 (357)
T PHA03209        278 IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA--------MRPSAEEIL  349 (357)
T ss_pred             HHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcc--------cCcCHHHHh
Confidence            111   1111111                            0113567788899999999998        777788888


Q ss_pred             cCCccc
Q psy3686         202 AEGHLS  207 (296)
Q Consensus       202 ~~~~~~  207 (296)
                      .++|+.
T Consensus       350 ~hp~f~  355 (357)
T PHA03209        350 NYPMFA  355 (357)
T ss_pred             cCchhc
Confidence            888764

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=1.1e-29  Score=221.05  Aligned_cols=189  Identities=29%  Similarity=0.453  Sum_probs=146.4

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+..+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence            35689999999994 999999764 4568999999999999999999999 59999999999999999999999999998


Q ss_pred             ccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          84 GRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        84 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ...... .......++..|+|||.+.........++.++|+||||+++|+|++|..||.... .......+.....+.+.
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~  247 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLK  247 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhhCCCCCCc
Confidence            654322 1223346788999999986432234467889999999999999999999997743 33333334333333333


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      . ..++..+.+||.+||..+|.        ++.++.+++.+++
T Consensus       248 ~-~~~~~~~~~li~~cl~~~p~--------~Rp~~~ell~~~~  281 (282)
T cd06636         248 S-KKWSKKFIDFIEGCLVKNYL--------SRPSTEQLLKHPF  281 (282)
T ss_pred             c-cccCHHHHHHHHHHhCCChh--------hCcCHHHHhcCCC
Confidence            2 24899999999999999998        4445556665554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=5.4e-30  Score=223.65  Aligned_cols=195  Identities=50%  Similarity=0.844  Sum_probs=152.1

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKR----LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +.+..++..|+||||+.++|.++...    ....+++..+..++.|++.||+|||+..|++||||||+||+++.++.++|
T Consensus        70 ~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl  149 (288)
T cd06616          70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL  149 (288)
T ss_pred             eEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEE
Confidence            34567788999999999766554432    14679999999999999999999997459999999999999999999999


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      +|||++.............++..|+|||.+.+..  ...++.++||||||+++|+|++|..||.........+.++..+.
T Consensus       150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  227 (288)
T cd06616         150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD  227 (288)
T ss_pred             eecchhHHhccCCccccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC
Confidence            9999987655443334446788999999985421  13678899999999999999999999987544444455555555


Q ss_pred             CCCCCCC--cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         158 PPCLPND--PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       158 ~p~~~~~--~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+.++..  ..++..+.+||.+||..+|+        ++.+..++..++++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~--------~Rpt~~~i~~~~~~  270 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDES--------KRPKYKELLEHPFI  270 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChh--------hCcCHHHHhcChhh
Confidence            5544432  24899999999999999998        44556666666665

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=7.1e-30  Score=219.16  Aligned_cols=176  Identities=21%  Similarity=0.382  Sum_probs=143.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++ |+|.+++......+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        67 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCC
Confidence            4667788999999998 59999997655678999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      .+.........  ....++..|+|||.+.+     ..++.++||||||+++|+|++ |+.||.. ....+....+..+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~  219 (256)
T cd05114         146 MTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-----SKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFR  219 (256)
T ss_pred             CccccCCCceeccCCCCCchhhCChhhccc-----CccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCC
Confidence            88765332221  12234567999999853     367889999999999999999 8999987 445566667766655


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..+..  .+..+.++|.+||..+|..||
T Consensus       220 ~~~~~~--~~~~~~~li~~c~~~~p~~Rp  246 (256)
T cd05114         220 LYRPKL--ASMTVYEVMYSCWHEKPEGRP  246 (256)
T ss_pred             CCCCCC--CCHHHHHHHHHHccCCcccCc
Confidence            544443  688999999999999998444

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=3.4e-30  Score=233.41  Aligned_cols=186  Identities=20%  Similarity=0.308  Sum_probs=142.7

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhC---------------------------------------------------
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLH---------------------------------------------------   29 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------------------------------------------   29 (296)
                      +++...+.+|+|||||. |+|.+++....                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            45677889999999999 59999986421                                                   


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCcc
Q psy3686          30 ------------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA   91 (296)
Q Consensus        30 ------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~   91 (296)
                                        ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                              247888999999999999999999 5999999999999999999999999999876543221


Q ss_pred             ---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcch
Q psy3686          92 ---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF  167 (296)
Q Consensus        92 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~  167 (296)
                         .....++..|+|||++.     ...++.++|||||||++|+|++ |..||............+..+..+..+..  +
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~  340 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIF-----DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDF--A  340 (374)
T ss_pred             eeeccCCCCccceeCHHHhc-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCC--C
Confidence               11223456799999984     3368899999999999999997 99999875443333333333333333332  6


Q ss_pred             hHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         168 GRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       168 s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                      ++++.++|.+||..+|.  .|+++.++...
T Consensus       341 ~~~l~~li~~cl~~dp~--~RPs~~~l~~~  368 (374)
T cd05106         341 PPEIYSIMKMCWNLEPT--ERPTFSQISQL  368 (374)
T ss_pred             CHHHHHHHHHHcCCChh--hCcCHHHHHHH
Confidence            89999999999999998  44444444433

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=7.5e-30  Score=223.64  Aligned_cols=189  Identities=29%  Similarity=0.531  Sum_probs=151.4

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++++|+||||++| +|.+++.  ...+++..++.++.||+.||.|||+ +|++||||+|.||+++.++.++|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658          87 SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             heecCCeEEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCc
Confidence            46678899999999985 9999886  4579999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|+|||.+.+     ..++.++||||||+++|+|++|..||.. ......+..+.....+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~  237 (292)
T cd06658         164 FCAQVSKEVPKRKSLVGTPYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR  237 (292)
T ss_pred             chhhcccccccCceeecCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCc
Confidence            986543222 1223467889999999843     3678899999999999999999999987 34444454554444444


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ++....++..+.++|.+||..+|.        ++.++.++..++++..
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~P~--------~Rpt~~~il~~~~~~~  277 (292)
T cd06658         238 VKDSHKVSSVLRGFLDLMLVREPS--------QRATAQELLQHPFLKL  277 (292)
T ss_pred             cccccccCHHHHHHHHHHccCChh--------HCcCHHHHhhChhhhc
Confidence            444445789999999999999998        4455666777766654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=1.3e-29  Score=221.63  Aligned_cols=189  Identities=26%  Similarity=0.403  Sum_probs=151.0

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.+++.+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        68 ~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          68 GSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             eEEEcCCeEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeC
Confidence            35667889999999996 699999977 5789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++......  .....++..|+|||.+.+     ...+.++||||||+++|+|++|..||... ........+..+. +.
T Consensus       146 g~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~  216 (290)
T cd05580         146 GFAKRVKGR--TYTLCGTPEYLAPEIILS-----KGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGK-VR  216 (290)
T ss_pred             CCccccCCC--CCCCCCCccccChhhhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC-cc
Confidence            998766443  333467889999999853     25678899999999999999999999873 3444555555443 33


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ++..  ++..++++|.+||..+|..|+...   .....++..+++.
T Consensus       217 ~~~~--~~~~l~~li~~~l~~~p~~R~~~~---~~~~~~l~~~~~~  257 (290)
T cd05580         217 FPSF--FSPDAKDLIRNLLQVDLTKRLGNL---KNGVNDIKNHPWF  257 (290)
T ss_pred             CCcc--CCHHHHHHHHHHccCCHHHccCcc---cCCHHHHHcCccc
Confidence            4433  699999999999999999664321   1244455555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.3e-29  Score=221.10  Aligned_cols=194  Identities=39%  Similarity=0.740  Sum_probs=152.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      +.+..++.+|+||||++| +|..++...  ...+++..+..++.||+.||.|||+.+|++|+||+|+||+++.++.++|+
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~  145 (286)
T cd06622          66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLC  145 (286)
T ss_pred             hheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEe
Confidence            356778999999999995 999988753  23799999999999999999999974599999999999999999999999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--HHHHHHHHc
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--FEVLSRVLN  155 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--~~~~~~i~~  155 (296)
                      |||.+..+.... .....++..|+|||.+.+... ....++.++|+|||||++|+|++|..||......  ...+..+..
T Consensus       146 dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (286)
T cd06622         146 DFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD  224 (286)
T ss_pred             ecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence            999987653322 223457789999999854322 2234678999999999999999999999763221  123334555


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      +.++.++..  ++..+.+||.+||..+|+        .+.+..++..++++
T Consensus       225 ~~~~~~~~~--~~~~~~~li~~~l~~~p~--------~Rp~~~~l~~~~~~  265 (286)
T cd06622         225 GDPPTLPSG--YSDDAQDFVAKCLNKIPN--------RRPTYAQLLEHPWL  265 (286)
T ss_pred             cCCCCCCcc--cCHHHHHHHHHHcccCcc--------cCCCHHHHhcChhh
Confidence            555566554  899999999999999998        44555666676665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=6.4e-30  Score=223.44  Aligned_cols=185  Identities=19%  Similarity=0.286  Sum_probs=146.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL   69 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~   69 (296)
                      ++..++.+|+||||+. |+|.+++....            ..+++..++.++.||+.||+|||+ +|++||||||+||++
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili  153 (288)
T cd05093          75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLV  153 (288)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEE
Confidence            4567789999999999 59999997532            248999999999999999999999 599999999999999


Q ss_pred             CCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy3686          70 DERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC  145 (296)
Q Consensus        70 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~  145 (296)
                      +.++.++|+|||++........   .....++..|+|||.+.+     ..++.++|||||||++|+|++ |..||... .
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~  227 (288)
T cd05093         154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFTYGKQPWYQL-S  227 (288)
T ss_pred             ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-C
Confidence            9999999999999875533221   122345678999999853     367889999999999999998 99999873 4


Q ss_pred             cHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchh
Q psy3686         146 DFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCY  198 (296)
Q Consensus       146 ~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~  198 (296)
                      .......+..+..+..+.  .++..+.+||.+||..+|..|  +++.++...+
T Consensus       228 ~~~~~~~i~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R--pt~~~v~~~l  276 (288)
T cd05093         228 NNEVIECITQGRVLQRPR--TCPKEVYDLMLGCWQREPHMR--LNIKEIHSLL  276 (288)
T ss_pred             HHHHHHHHHcCCcCCCCC--CCCHHHHHHHHHHccCChhhC--CCHHHHHHHH
Confidence            455666676666554443  378999999999999999844  4444544433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0584|consensus

Probab=99.97  E-value=2.1e-30  Score=234.86  Aligned_cols=184  Identities=24%  Similarity=0.425  Sum_probs=159.7

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEECC-CCCEEEeccCCc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH-GVIHRDVKPSNILLDE-RGNIKLCDFGIS   83 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-~ivH~dlkp~Nil~~~-~~~~kl~dfg~~   83 (296)
                      +..+-+|+|+|. |+|..|+++ .+.++.+.++.|++||++||.|||++. .|+|||||-+||||+. .|.|||+|+|+|
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence            345889999999 799999988 678999999999999999999999943 5999999999999975 589999999999


Q ss_pred             ccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC-CC
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC-LP  162 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~-~~  162 (296)
                      .......... .+||+.|||||.+.      ..|+..+||||||++++||+|+..||..+.+..+++.++..|..|. +.
T Consensus       194 tl~r~s~aks-vIGTPEFMAPEmYE------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  194 TLLRKSHAKS-VIGTPEFMAPEMYE------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS  266 (632)
T ss_pred             HHhhccccce-eccCccccChHHHh------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence            8765544443 69999999999995      2799999999999999999999999999999999999999987653 33


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      ...  .+++++||.+||.. .+        ++.++.+++.++|+...
T Consensus       267 kV~--dPevr~fIekCl~~-~~--------~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  267 KVK--DPEVREFIEKCLAT-KS--------ERLSAKELLKDPFFDED  302 (632)
T ss_pred             ccC--CHHHHHHHHHHhcC-ch--------hccCHHHHhhChhhccc
Confidence            332  78999999999998 44        78888899988887653

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.3e-29  Score=217.95  Aligned_cols=178  Identities=23%  Similarity=0.331  Sum_probs=142.6

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ....+|+||||++ |+|.+++......+++..++.++.||+.||.|||+ +|++|+||||+||+++.++.+||+|||++.
T Consensus        65 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          65 EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             cCCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccc
Confidence            3457899999998 59999997656789999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCCcc----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSKA----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      .......    .....++..|+|||.+..     ..++.++||||||+++|++++ |..||... ........+..+..+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~  217 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL  217 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHcc-----CCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC
Confidence            5433211    111123468999999843     357889999999999999996 99999873 445566666666655


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      ..+..  .++++.++|.+||..+|+  .|+++.++
T Consensus       218 ~~~~~--~~~~l~~li~~c~~~~~~--~Rp~~~~i  248 (257)
T cd05115         218 DCPAE--CPPEMYALMKDCWIYKWE--DRPNFAKV  248 (257)
T ss_pred             CCCCC--CCHHHHHHHHHHcCCChh--hCcCHHHH
Confidence            55543  699999999999999998  44444443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=8.1e-30  Score=232.09  Aligned_cols=191  Identities=23%  Similarity=0.232  Sum_probs=146.3

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .|..++..++|||++.++|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus       151 ~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~  228 (391)
T PHA03212        151 TFTYNKFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGA  228 (391)
T ss_pred             EEEECCeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCc
Confidence            4667889999999999999998876 5679999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCC--ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------cHHHHHHHH
Q psy3686          83 SGRLVDS--KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC------DFEVLSRVL  154 (296)
Q Consensus        83 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~------~~~~~~~i~  154 (296)
                      +......  .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.....      ....+..++
T Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~  303 (391)
T PHA03212        229 ACFPVDINANKYYGWAGTIATNAPELLAR-----DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII  303 (391)
T ss_pred             ccccccccccccccccCccCCCChhhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence            8653322  12233478999999999953     3688999999999999999999988754210      111111111


Q ss_pred             c--cCCC-C--------------------------CC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhccc
Q psy3686         155 N--DAPP-C--------------------------LP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGA  202 (296)
Q Consensus       155 ~--~~~p-~--------------------------~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~  202 (296)
                      .  +..| .                          .+   ....++.++.+||.+||..||.        +|.++.+++.
T Consensus       304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~--------~Rpta~elL~  375 (391)
T PHA03212        304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH--------HRPSAEALLD  375 (391)
T ss_pred             HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChh--------hCCCHHHHhc
Confidence            1  1000 0                          00   0112567899999999999998        6677888888


Q ss_pred             CCcccc
Q psy3686         203 EGHLSY  208 (296)
Q Consensus       203 ~~~~~~  208 (296)
                      ++++..
T Consensus       376 hp~f~~  381 (391)
T PHA03212        376 FAAFQD  381 (391)
T ss_pred             Chhhcc
Confidence            887644

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=8.1e-30  Score=223.94  Aligned_cols=189  Identities=28%  Similarity=0.518  Sum_probs=151.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|..++.+|+||||++| +|..++..  ..+++..++.++.|++.||.|||+ +|++|+||+|.||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~df  161 (297)
T cd06659          85 KSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDF  161 (297)
T ss_pred             hheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeec
Confidence            456778899999999995 99998863  578999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|+|||.+.+     ..++.++||||||+++|+|++|..||.. ......+..+.....+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~  235 (297)
T cd06659         162 GFCAQISKDVPKRKSLVGTPYWMAPEVISR-----TPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP  235 (297)
T ss_pred             hhHhhcccccccccceecCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCC
Confidence            9986543322 2233467889999999953     3578899999999999999999999987 3444455555444444


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .......++..+.++|.+||..+|.        .+.+..++..++++.
T Consensus       236 ~~~~~~~~~~~l~~~i~~~l~~~P~--------~Rps~~~ll~~~~~~  275 (297)
T cd06659         236 KLKNAHKISPVLRDFLERMLTREPQ--------ERATAQELLDHPFLL  275 (297)
T ss_pred             CccccCCCCHHHHHHHHHHhcCCcc--------cCcCHHHHhhChhhc
Confidence            4444445789999999999999998        445666767766653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=2e-29  Score=220.52  Aligned_cols=190  Identities=31%  Similarity=0.501  Sum_probs=149.1

Q ss_pred             CCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+.+|+||||+.| +|.+++...   ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence            3579999999985 999988642   5679999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          83 SGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        83 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      +....... ......++..|+|||.+.........++.++|||||||++|+|++|+.||... .....+..+..+..+.+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~  253 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPRNPPPTL  253 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHhcCCCCCC
Confidence            87654322 22334678899999998543222224678999999999999999999999874 33444555555555555


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .....++..+.++|.+||..+|+        ++.+..++..++++
T Consensus       254 ~~~~~~~~~l~~li~~~l~~~p~--------~Rps~~~il~~~~~  290 (291)
T cd06639         254 LHPEKWCRSFNHFISQCLIKDFE--------ARPSVTHLLEHPFI  290 (291)
T ss_pred             CcccccCHHHHHHHHHHhhcChh--------hCcCHHHHhcCccc
Confidence            44445788999999999999998        44556666666543

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-29  Score=217.66  Aligned_cols=177  Identities=23%  Similarity=0.321  Sum_probs=146.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL--------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER   72 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~   72 (296)
                      +.+.+++.+++||||+. |+|.+++...        ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.+
T Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~  141 (262)
T cd00192          63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGED  141 (262)
T ss_pred             eeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCC
Confidence            34566889999999997 6999999875        3789999999999999999999999 599999999999999999


Q ss_pred             CCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHH
Q psy3686          73 GNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFE  148 (296)
Q Consensus        73 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~  148 (296)
                      +.++|+|||.+.......   ......++..|+|||.+..     ..++.++||||||+++|+|++ |..||... ....
T Consensus       142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~  215 (262)
T cd00192         142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-----GIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEE  215 (262)
T ss_pred             CcEEEcccccccccccccccccccCCCcCccccCHHHhcc-----CCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHH
Confidence            999999999997765432   2233456788999999853     367889999999999999999 69999884 4555


Q ss_pred             HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         149 VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       149 ~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ....+..+.....+.  .++..+.++|.+||..+|+.|+
T Consensus       216 ~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  252 (262)
T cd00192         216 VLEYLRKGYRLPKPE--YCPDELYELMLSCWQLDPEDRP  252 (262)
T ss_pred             HHHHHHcCCCCCCCc--cCChHHHHHHHHHccCCcccCc
Confidence            666666655444443  3799999999999999998443

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=1.7e-29  Score=222.62  Aligned_cols=191  Identities=26%  Similarity=0.379  Sum_probs=148.9

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++++|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||+ +|++|+||+|.||+++.++.++|+|||
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          69 SFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             EEecCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCC
Confidence            46678899999999995 99999976 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc----------------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3686          82 ISGRLVDSK----------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC  145 (296)
Q Consensus        82 ~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~  145 (296)
                      +++......                ......++..|+|||.+..     ..++.++|+||||+++|++++|..||.+ ..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~vl~el~~g~~pf~~-~~  220 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGCVPFFG-DT  220 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CC
Confidence            875321100                0112346778999999843     3678899999999999999999999987 34


Q ss_pred             cHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         146 DFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       146 ~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ..+....+..+..+.......++..+.++|.+||..+|+.|+..     ..+.+++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-----~~~~~ll~~~~~  276 (305)
T cd05609         221 PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGT-----GGAFEVKQHRFF  276 (305)
T ss_pred             HHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCc-----cCHHHHHhCccc
Confidence            44556666555432222222479999999999999999954432     245666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0607|consensus

Probab=99.97  E-value=5.2e-30  Score=215.69  Aligned_cols=202  Identities=21%  Similarity=0.367  Sum_probs=161.5

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCC---EEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~---~kl   77 (296)
                      ..|+++..+|||||-|.| +|...|.+ ...|++.++..++.+|+.||.|||.+ ||.||||||+|||....+.   +||
T Consensus       143 efFEdd~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  143 EFFEDDTRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             HHhcccceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceee
Confidence            468999999999999994 88888876 67899999999999999999999996 9999999999999977665   799


Q ss_pred             eccCCcccccCC--------ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----
Q psy3686          78 CDFGISGRLVDS--------KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK-----  144 (296)
Q Consensus        78 ~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~-----  144 (296)
                      +||.+...+...        ......+|+..|||||++.........|+.+.|.||||+|+|-|++|.+||.+.-     
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            999876543322        1223457889999999985444345578899999999999999999999997631     


Q ss_pred             ---------CcHHHHHHHHccCCCCCC--CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCC
Q psy3686         145 ---------CDFEVLSRVLNDAPPCLP--NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQN  213 (296)
Q Consensus       145 ---------~~~~~~~~i~~~~~p~~~--~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (296)
                               .....+..|..|. ..+|  .+..+|.+.+++|..+|.+++.        ++..+.+.+.++|+....+..
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~--------~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAK--------QRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHH--------hhhhhhhccCCccccccchhc
Confidence                     1224455555555 3555  3566899999999999999998        777888888999887665544


Q ss_pred             c
Q psy3686         214 I  214 (296)
Q Consensus       214 ~  214 (296)
                      .
T Consensus       372 a  372 (463)
T KOG0607|consen  372 A  372 (463)
T ss_pred             c
Confidence            3

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=2.1e-29  Score=218.00  Aligned_cols=188  Identities=28%  Similarity=0.467  Sum_probs=144.0

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +..+|+||||+. |+|.+++... ...+++..++.++.|++.||+|||+ +||+|+||+|.||+++.++.++|+|||++.
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            357899999999 5999998864 3568999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCC
Q psy3686          85 RLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN  163 (296)
Q Consensus        85 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~  163 (296)
                      ..... .......++..|+|||++.+.......++.++||||+||++|+|++|..||.... .......+.....+....
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCCCCCC
Confidence            55322 2223346888999999986433234467889999999999999999999997633 223333333322222222


Q ss_pred             CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         164 DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       164 ~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                       ..++..+.+||.+||..+|.        ++.+..++..++|
T Consensus       239 -~~~~~~~~~li~~~l~~~p~--------~Rpt~~~il~~~~  271 (272)
T cd06637         239 -KKWSKKFQSFIESCLVKNHS--------QRPTTEQLMKHPF  271 (272)
T ss_pred             -CCcCHHHHHHHHHHcCCChh--------hCCCHHHHhhCCC
Confidence             24789999999999999998        3344445555543

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=9.9e-30  Score=219.41  Aligned_cols=185  Identities=30%  Similarity=0.533  Sum_probs=148.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++++++||||++| +|.+++.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          74 SSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             EEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccC
Confidence            45677899999999985 99999976 5789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH
Q psy3686          82 ISGRLVDSK-------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        82 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~  154 (296)
                      .+.......       ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||... .....+..+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~  225 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-----TSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIG  225 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhcc-----CCCCchhhhHHHHHHHHHHhhCCCCCCCc-cHHHHHHHHh
Confidence            987664221       1112357789999999853     35778999999999999999999999874 3334444555


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ....+.++..  ++..+.++|.+||..+|.        .+.++.++..+++
T Consensus       226 ~~~~~~~~~~--~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~  266 (267)
T cd06628         226 ENASPEIPSN--ISSEAIDFLEKTFEIDHN--------KRPTAAELLKHPF  266 (267)
T ss_pred             ccCCCcCCcc--cCHHHHHHHHHHccCCch--------hCcCHHHHhhCCC
Confidence            5555555543  799999999999999998        3344555555543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0603|consensus

Probab=99.97  E-value=5.8e-30  Score=232.65  Aligned_cols=181  Identities=26%  Similarity=0.383  Sum_probs=148.2

Q ss_pred             CCCccCCeEEEEecCccc--cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE-CCCCCEEEe
Q psy3686           2 SPQSKESDVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL-DERGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g--sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~-~~~~~~kl~   78 (296)
                      +.+.++.+.|+|||++.|  .|..++.   .+.....+..|+++|+.|+.|||+ +|+|||||||+|||+ +..++++|+
T Consensus       383 ~v~~~~~~~~~v~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrlt  458 (612)
T KOG0603|consen  383 DVYEDGKEIYLVMELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLT  458 (612)
T ss_pred             ceecCCceeeeeehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEE
Confidence            457788999999999995  5555553   233337888899999999999999 699999999999999 688999999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||.+......  ....+-|..|.|||++.     ...|+.++||||||++||+|++|+.||.......++..++..+. 
T Consensus       459 yFG~a~~~~~~--~~tp~~t~~y~APEvl~-----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~-  530 (612)
T KOG0603|consen  459 YFGFWSELERS--CDTPALTLQYVAPEVLA-----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK-  530 (612)
T ss_pred             EechhhhCchh--hcccchhhcccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc-
Confidence            99999776544  34457788999999995     44899999999999999999999999998666655565554432 


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                        +.  ..+|...++||.+||+.+|.        .+....++..++|+
T Consensus       531 --~s--~~vS~~AKdLl~~LL~~dP~--------~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 --FS--ECVSDEAKDLLQQLLQVDPA--------LRLGADEIGAHPWF  566 (612)
T ss_pred             --cc--cccCHHHHHHHHHhccCChh--------hCcChhhhccCcch
Confidence              22  33899999999999999998        66667777777776

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=2.5e-29  Score=215.60  Aligned_cols=183  Identities=23%  Similarity=0.358  Sum_probs=147.6

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .++.+|+||||++ ++|.+++... ...+++.+++.++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccce
Confidence            3557899999998 4999998764 4568999999999999999999999 59999999999999999999999999998


Q ss_pred             ccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          84 GRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        84 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ....... ......++..|+|||.+.+     ..++.++||||||+++|++++|..||... ........+..+..+.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~~  223 (257)
T cd08223         150 RVLENQCDMASTLIGTPYYMSPELFSN-----KPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLPPMP  223 (257)
T ss_pred             EEecccCCccccccCCcCccChhHhcC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCc
Confidence            7654322 2233467889999999853     36778999999999999999999999873 334455556666555554


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .  .+++.+.++|.+||..+|+        ++.++.++..++|
T Consensus       224 ~--~~~~~~~~li~~~l~~~p~--------~Rp~~~~~l~~~~  256 (257)
T cd08223         224 K--DYSPELGELIATMLSKRPE--------KRPSVKSILRQPY  256 (257)
T ss_pred             c--ccCHHHHHHHHHHhccCcc--------cCCCHHHHhcCCC
Confidence            3  3799999999999999998        5555666666554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-29  Score=218.09  Aligned_cols=176  Identities=23%  Similarity=0.367  Sum_probs=141.8

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+...+.+|+||||++| +|.+++......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.+||+|||
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcc
Confidence            45677889999999985 9999998756689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ++.........  ....++..|+|||.+.+     ..++.++||||||+++|++++ |..||.. ....+....+..+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~  219 (256)
T cd05059         146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDY-----SRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYR  219 (256)
T ss_pred             cceecccccccccCCCCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCc
Confidence            98765432211  11123457999999853     367889999999999999999 8999976 344555556655544


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..+.  .++..+.+++.+||..+|+.|+
T Consensus       220 ~~~~~--~~~~~~~~li~~cl~~~p~~Rp  246 (256)
T cd05059         220 LYRPK--LAPTEVYTIMYSCWHEKPEDRP  246 (256)
T ss_pred             CCCCC--CCCHHHHHHHHHHhcCChhhCc
Confidence            44443  3799999999999999998443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=8.1e-30  Score=223.10  Aligned_cols=185  Identities=18%  Similarity=0.248  Sum_probs=145.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+..++.+++||||++ ++|.+++....               ..+++..++.++.||+.||+|||+ +|++||||||+|
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~N  153 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRN  153 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcce
Confidence            4566788999999998 59999997532               348999999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.++|+|||++.......   ......++..|+|||.+.+     ..++.++||||||+++|+|++ |..||..
T Consensus       154 il~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p~~~  228 (291)
T cd05094         154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVILWEIFTYGKQPWFQ  228 (291)
T ss_pred             EEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999987554322   1223345778999999853     367889999999999999998 9999977


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchh
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCY  198 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~  198 (296)
                       ......+..+..+..+..+..  ++..+.++|.+||..+|+.||  +..++...+
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~P~~Rp--t~~~v~~~l  279 (291)
T cd05094         229 -LSNTEVIECITQGRVLERPRV--CPKEVYDIMLGCWQREPQQRL--NIKEIYKIL  279 (291)
T ss_pred             -CCHHHHHHHHhCCCCCCCCcc--CCHHHHHHHHHHcccChhhCc--CHHHHHHHH
Confidence             344455555655555444433  789999999999999998444  444444433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-29  Score=219.57  Aligned_cols=193  Identities=35%  Similarity=0.550  Sum_probs=158.8

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.++..+|+|+||+.| +|.+++..  ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~  142 (274)
T cd06609          66 GSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADF  142 (274)
T ss_pred             EEEEECCeEEEEEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccc
Confidence            346677899999999995 99999975  389999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......++..|+|||.+.+     ..++.++||||||+++|+|++|..||... ........+..+..+
T Consensus       143 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~  216 (274)
T cd06609         143 GVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-----SGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPP  216 (274)
T ss_pred             ccceeecccccccccccCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCC
Confidence            999776544 22334467888999999954     25889999999999999999999999873 344555556666666


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCC
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQ  212 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (296)
                      .++... ++..+.++|.+||..+|+        ++.+..++..++++...+..
T Consensus       217 ~~~~~~-~~~~~~~~l~~~l~~~p~--------~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         217 SLEGNK-FSKPFKDFVSLCLNKDPK--------ERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             CCcccc-cCHHHHHHHHHHhhCChh--------hCcCHHHHhhChhhcCCCcc
Confidence            655443 799999999999999998        55567777788887766544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=1.2e-29  Score=223.07  Aligned_cols=194  Identities=20%  Similarity=0.294  Sum_probs=150.8

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.+..++.+|+||||+.++|.+++......+++..++.++.||+.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             EEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCc
Confidence            3466788999999999999999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC---
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---  157 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~---  157 (296)
                      ++...... .......++..|+|||.+.+    ...++.++||||||+++|+|++|..||.... ..+.+..+....   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~-~~~~~~~~~~~~~~~  224 (301)
T cd07873         150 LARAKSIPTKTYSNEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMSTGRPLFPGST-VEEQLHFIFRILGTP  224 (301)
T ss_pred             chhccCCCCCcccccceeecccCcHHHhC----CCCCccHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCC
Confidence            98654322 12223356889999999853    2257789999999999999999999998743 222222221100   


Q ss_pred             ------------------CCCCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 ------------------PPCLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ------------------~p~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                        .+...      ....+++.+++||.+||..+|.        +|.++.+++.++++...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~--------~R~t~~eil~h~~f~~~  292 (301)
T cd07873         225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGR--------KRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcc--------cCcCHHHHhcCcccccc
Confidence                              01100      0123788999999999999998        66677888888877543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.4e-29  Score=218.61  Aligned_cols=179  Identities=27%  Similarity=0.470  Sum_probs=140.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+.+.+|+||||+++ +|.+++.. .+.+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          74 SYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             EEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcce
Confidence            45677899999999995 99999876 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--AP  158 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~  158 (296)
                      ++....... ......++..|+|||.+...  ....++.++|+|||||++|+|++|..||...... .........  .+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~  228 (267)
T cd06645         152 VSAQITATIAKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMTKSNFQP  228 (267)
T ss_pred             eeeEccCcccccccccCcccccChhhhccc--cCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhHHhhhccCCCC
Confidence            986554321 22334688999999997422  2235778999999999999999999999763332 222222222  12


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      +.+.....++..+.++|.+||..+|+.|
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~R  256 (267)
T cd06645         229 PKLKDKMKWSNSFHHFVKMALTKNPKKR  256 (267)
T ss_pred             CcccccCCCCHHHHHHHHHHccCCchhC
Confidence            2222223478999999999999999844

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=1.4e-29  Score=218.20  Aligned_cols=175  Identities=22%  Similarity=0.277  Sum_probs=140.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+..++.+++||||++ |+|.+++... ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+||
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             EEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCC
Confidence            4566788999999998 5999998754 3468999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcccc--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKART--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |++..........  ....+..|+|||.+.+     ..++.++|||||||++|+|++ |..||.+ ....+....+..+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~  222 (263)
T cd05052         149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGY  222 (263)
T ss_pred             ccccccccceeeccCCCCCccccCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCC
Confidence            9987654332111  1233567999998843     367889999999999999998 9999987 34445555555554


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+..+.  .++..+.++|.+||..+|+.|
T Consensus       223 ~~~~~~--~~~~~~~~li~~cl~~~p~~R  249 (263)
T cd05052         223 RMERPE--GCPPKVYELMRACWQWNPSDR  249 (263)
T ss_pred             CCCCCC--CCCHHHHHHHHHHccCCcccC
Confidence            444443  379999999999999999833

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-29  Score=216.38  Aligned_cols=189  Identities=24%  Similarity=0.329  Sum_probs=147.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..++.+|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        64 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~df  141 (260)
T cd05611          64 YSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDF  141 (260)
T ss_pred             eeEEcCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeec
Confidence            356677899999999985 99999976 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++.....   .....++..|++||.+.+.     .++.++||||||+++|+|++|..||... ........+..+....
T Consensus       142 g~~~~~~~---~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~  212 (260)
T cd05611         142 GLSRNGLE---NKKFVGTPDYLAPETILGV-----GDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINW  212 (260)
T ss_pred             ccceeccc---cccCCCCcCccChhhhcCC-----CCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccCC
Confidence            98865432   2234577899999998532     4788999999999999999999999873 4444455554433211


Q ss_pred             C-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         161 L-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       161 ~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      . .....++..+.++|.+||..+|+.|+..     .+..+++.++++
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-----~~~~~~l~~~~~  254 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGA-----NGYQEIKSHPFF  254 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCC-----CcHHHHHcChHh
Confidence            1 1122479999999999999999955432     123445555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.5e-29  Score=230.69  Aligned_cols=192  Identities=23%  Similarity=0.267  Sum_probs=149.1

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.|..++.+|+|||++.++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus       153 ~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        153 HAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             eeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCc
Confidence            45677889999999999999999854 6789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--cHHHHHHHHc-
Q psy3686          82 ISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC--DFEVLSRVLN-  155 (296)
Q Consensus        82 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~--~~~~~~~i~~-  155 (296)
                      ++........   .....++..|+|||++.+     ..++.++|||||||++|+|++|..||.+...  ....+..++. 
T Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        231 AACKLDAHPDTPQCYGWSGTLETNSPELLAL-----DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             cccccCcccccccccccccccCccCHhHhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            9876543321   223468999999999953     3678899999999999999999999976322  1222222221 


Q ss_pred             --cCC-----------------------CCCC-----CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         156 --DAP-----------------------PCLP-----NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       156 --~~~-----------------------p~~~-----~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                        ..+                       +.+.     ....++.++.++|.+||..+|.        ++.++.+++.+++
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~--------~Rpsa~e~l~~p~  377 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE--------FRPSAQDILSLPL  377 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChh--------hCCCHHHHhhCch
Confidence              000                       0010     0123577899999999999998        6667888888877


Q ss_pred             ccc
Q psy3686         206 LSY  208 (296)
Q Consensus       206 ~~~  208 (296)
                      +..
T Consensus       378 f~~  380 (392)
T PHA03207        378 FTK  380 (392)
T ss_pred             hhc
Confidence            643

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=1.4e-29  Score=216.78  Aligned_cols=176  Identities=22%  Similarity=0.304  Sum_probs=139.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||+.| +|.+++......+++..++.++.|++.||.|||+ +|++|+||+|.||+++.++.++|+|||
T Consensus        61 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg  139 (252)
T cd05084          61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFG  139 (252)
T ss_pred             EEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCCcEEECccc
Confidence            45677889999999985 9999997655679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ++.........   .....+..|+|||.+.+     ..++.++||||||+++|++++ |..||... ........+....
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~  213 (252)
T cd05084         140 MSREEEDGVYASTGGMKQIPVKWTAPEALNY-----GRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGV  213 (252)
T ss_pred             cCcccccccccccCCCCCCceeecCchhhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCC
Confidence            98654322111   11122456999999843     357889999999999999998 88999763 3334444454444


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+.  .++..+.++|.+||..+|+.|+
T Consensus       214 ~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  241 (252)
T cd05084         214 RLPCPE--LCPDAVYRLMERCWEYDPGQRP  241 (252)
T ss_pred             CCCCcc--cCCHHHHHHHHHHcCCChhhCc
Confidence            444433  3789999999999999998443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=2.5e-29  Score=219.51  Aligned_cols=191  Identities=28%  Similarity=0.512  Sum_probs=154.6

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++..+++.|+|+||+.| +|.+++..  ..+++..++.++.|++.||+|||+ +|++||||+|.||+++.++.++|+|||
T Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648          84 SYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             EEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccc
Confidence            45677899999999985 99999975  679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .+....... ......++..|+|||.+.+     ..++.++||||||+++|+|++|..||.. .........+....++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~  234 (285)
T cd06648         161 FCAQVSKEVPRRKSLVGTPYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK  234 (285)
T ss_pred             cchhhccCCcccccccCCccccCHHHhcC-----CCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCC
Confidence            876543221 2223467889999999843     3578899999999999999999999987 34455555666555445


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      ......++..+.++|.+||..+|+        ++.++.++..+.++...+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~--------~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         235 LKNLHKVSPRLRSFLDRMLVRDPA--------QRATAAELLNHPFLAKAG  276 (285)
T ss_pred             CcccccCCHHHHHHHHHHcccChh--------hCcCHHHHccCcccccCC
Confidence            544444789999999999999998        555677777777766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=1.3e-29  Score=229.47  Aligned_cols=185  Identities=20%  Similarity=0.371  Sum_probs=143.2

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccC
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD   88 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~   88 (296)
                      .+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+ .|++||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          78 EIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            7899999999999988865 5689999999999999999999999 5999999999999999999999999999875432


Q ss_pred             Cc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-----------
Q psy3686          89 SK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-----------  155 (296)
Q Consensus        89 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-----------  155 (296)
                      ..  ......++..|+|||.+.+.    ..++.++|||||||++|+|++|+.||.+. .....+..+..           
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGS----RHYTSAVDIWSVGCIFAELLGRRILFQAQ-SPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCC----CCCCcHHHHHhHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHHcCCCCHHHHH
Confidence            21  22234678899999998642    25788999999999999999999999873 33333322221           


Q ss_pred             ------------c--CCCCC----CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         156 ------------D--APPCL----PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       156 ------------~--~~p~~----~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                  .  .++..    ......+..+.+||.+||..||.        +|.++.+++.++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~--------~R~t~~e~l~hp~~~~  293 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD--------KRISAADALAHPYLDE  293 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh--------hCcCHHHHhcCHhhCC
Confidence                        0  01110    11123588999999999999998        5556677777776543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1e-29  Score=218.93  Aligned_cols=188  Identities=43%  Similarity=0.773  Sum_probs=154.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE-THGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+..++.+|+||||++ ++|.+++......+++..++.++.|++.||.|||+ . |++|+||+|+||+++.++.++|+||
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             eeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeec
Confidence            4567789999999999 59999998755789999999999999999999999 6 9999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CcHHHHHHHHcc
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK----CDFEVLSRVLND  156 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~----~~~~~~~~i~~~  156 (296)
                      |.+.......... ..++..|+|||.+.+     ..++.++||||||+++|++++|..||....    .....+..+...
T Consensus       146 g~~~~~~~~~~~~-~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         146 GVSGQLVNSLAKT-FVGTSSYMAPERIQG-----NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             ccchhhHHHHhhc-ccCChhccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence            9986654332222 567889999999853     367889999999999999999999997642    333455556666


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      ..+.++... ++..+.++|.+||..+|.        ++.++.++..++++
T Consensus       220 ~~~~~~~~~-~~~~~~~li~~~l~~~p~--------~Rpt~~~ll~~~~~  260 (265)
T cd06605         220 PPPRLPSGK-FSPDFQDFVNLCLIKDPR--------ERPSYKELLEHPFI  260 (265)
T ss_pred             CCCCCChhh-cCHHHHHHHHHHcCCCch--------hCcCHHHHhhCchh
Confidence            666665543 799999999999999998        55556666666655

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=1.8e-29  Score=219.27  Aligned_cols=177  Identities=19%  Similarity=0.262  Sum_probs=142.4

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLH-------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI   67 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Ni   67 (296)
                      +++..++.+|+||||+. |+|.+++...+             ..+++..+..++.||+.||.|||+ +|++|+||||+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~ni  153 (280)
T cd05049          75 GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNC  153 (280)
T ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceE
Confidence            34567789999999999 49999997632             357899999999999999999999 5999999999999


Q ss_pred             EECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3686          68 LLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDC  143 (296)
Q Consensus        68 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~  143 (296)
                      +++.++.++|+|||++.......   ......++..|+|||.+.+     ..++.++||||||+++|+|++ |..||...
T Consensus       154 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             EEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-----CCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999986543221   1122345678999999853     367889999999999999998 99999873


Q ss_pred             CCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         144 KCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       144 ~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                       ........+..+..+..+.  .++..+.++|.+||..+|+.|+
T Consensus       229 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  269 (280)
T cd05049         229 -SNEEVIECITQGRLLQRPR--TCPSEVYDIMLGCWKRDPQQRI  269 (280)
T ss_pred             -CHHHHHHHHHcCCcCCCCC--CCCHHHHHHHHHHcCCCcccCC
Confidence             4445556666655544443  3799999999999999998443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=1.3e-29  Score=229.68  Aligned_cols=155  Identities=22%  Similarity=0.308  Sum_probs=120.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCccc---cccccCcCCCCcccc
Q psy3686          31 SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR---TKNAGCAAYMAPERI  107 (296)
Q Consensus        31 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~  107 (296)
                      .+++..++.++.||+.||.|||+ +|++||||||+|||++.++.+||+|||++.........   ....++..|+|||.+
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  288 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI  288 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHh
Confidence            47888999999999999999999 59999999999999999999999999998765432211   122345679999999


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+     ..++.++|||||||++|+|++ |..||............+..+..+..+..  .+.++.+||.+||..+|+.|
T Consensus       289 ~~-----~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~R  361 (375)
T cd05104         289 FN-----CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC--APSEMYDIMKSCWDADPLKR  361 (375)
T ss_pred             cC-----CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC--CCHHHHHHHHHHccCChhHC
Confidence            53     367889999999999999998 89999875444444444444443333332  58899999999999999844


Q ss_pred             hhhccCCcc
Q psy3686         187 RKRSYEDKS  195 (296)
Q Consensus       187 ~~~~~~~~~  195 (296)
                      |  ++.++.
T Consensus       362 P--s~~eil  368 (375)
T cd05104         362 P--TFKQIV  368 (375)
T ss_pred             c--CHHHHH
Confidence            3  444443

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=1.4e-29  Score=217.59  Aligned_cols=176  Identities=21%  Similarity=0.361  Sum_probs=142.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++...+.+|+||||+. |+|.+++......+++..++.++.||+.||.|||+ .|++|+||+|.||+++.++.+||+|||
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             EEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCc
Confidence            4566778899999998 59999997755579999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcccc--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSKART--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      .+..........  ...++..|++||.+.+     ..++.++||||||+++|+|++ |..||... ........+..+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~  219 (256)
T cd05113         146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-----SKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLR  219 (256)
T ss_pred             cceecCCCceeecCCCccChhhCCHHHHhc-----CcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCC
Confidence            987654332111  1234567999999843     357889999999999999998 99999873 34455666666655


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..+..  .+..+.++|.+||..+|..||
T Consensus       220 ~~~~~~--~~~~~~~li~~cl~~~p~~Rp  246 (256)
T cd05113         220 LYRPHL--ASEKVYAIMYSCWHEKAEERP  246 (256)
T ss_pred             CCCCCC--CCHHHHHHHHHHcCCCcccCC
Confidence            444443  689999999999999998443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=2.4e-29  Score=222.04  Aligned_cols=190  Identities=37%  Similarity=0.731  Sum_probs=149.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++.+|+||||++| +|.+++.+ ...+++..+..++.||+.||.|||+.++++|+||+|+||+++.++.++|+||
T Consensus        66 ~~~~~~~~~~lv~ey~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~df  144 (308)
T cd06615          66 GAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF  144 (308)
T ss_pred             EEEeeCCEEEEEeeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccC
Confidence            356788999999999995 99999976 5789999999999999999999997458999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHH-----------
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEV-----------  149 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----------  149 (296)
                      |++...... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||.... ....           
T Consensus       145 g~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~  217 (308)
T cd06615         145 GVSGQLIDS-MANSFVGTRSYMSPERLQG-----THYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEG  217 (308)
T ss_pred             CCccccccc-ccccCCCCcCccChhHhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccc
Confidence            998654332 2234467889999999853     357789999999999999999999996522 1111           


Q ss_pred             -------------------------HHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCC
Q psy3686         150 -------------------------LSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEG  204 (296)
Q Consensus       150 -------------------------~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~  204 (296)
                                               ...+....+|.++... ++..+++||.+||..+|+        ++.++.++..++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~P~--------~Rpt~~~ll~~~  288 (308)
T cd06615         218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA-FSDEFQDFVDKCLKKNPK--------ERADLKELTKHP  288 (308)
T ss_pred             cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcc-cCHHHHHHHHHHccCChh--------hCcCHHHHhcCh
Confidence                                     1112222233333332 788999999999999999        555677778887


Q ss_pred             cccc
Q psy3686         205 HLSY  208 (296)
Q Consensus       205 ~~~~  208 (296)
                      ++..
T Consensus       289 ~~~~  292 (308)
T cd06615         289 FIKR  292 (308)
T ss_pred             hhhh
Confidence            7644

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.8e-29  Score=245.83  Aligned_cols=176  Identities=26%  Similarity=0.383  Sum_probs=137.9

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHh------CCceeCCCCCCcEEECC----
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKET------HGVIHRDVKPSNILLDE----   71 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~------~~ivH~dlkp~Nil~~~----   71 (296)
                      ....+||||||+. |+|.++|...   ...+++..++.|+.||+.||.|||+.      .+|||+||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            3467999999999 5999998753   35799999999999999999999983      14999999999999964    


Q ss_pred             -------------CCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q psy3686          72 -------------RGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEF  138 (296)
Q Consensus        72 -------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~  138 (296)
                                   .+.+||+|||++..+..........+++.|+|||++.+.   ...++.++|||||||++|+|++|..
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge---~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE---TKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc---CCCCCchhHHHHHHHHHHHHHHCCC
Confidence                         235899999999766544444455789999999998542   2357889999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         139 PYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       139 Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ||.........+..+..+  |.++.. .++..+.+||.+||..+|..||
T Consensus       242 PF~~~~~~~qli~~lk~~--p~lpi~-~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        242 PFHKANNFSQLISELKRG--PDLPIK-GKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             CCCcCCcHHHHHHHHhcC--CCCCcC-CCCHHHHHHHHHHhcCChhHCc
Confidence            998744433444343333  233322 2689999999999999998333

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=1.9e-29  Score=219.67  Aligned_cols=190  Identities=21%  Similarity=0.295  Sum_probs=142.7

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++.+++.+|+||||+.++|.+++...  +..+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|
T Consensus        66 ~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECc
Confidence            356678899999999999999888654  2679999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-C
Q psy3686          80 FGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-A  157 (296)
Q Consensus        80 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~  157 (296)
                      ||++....... ......++..|+|||.+.+.    ..++.++|||||||++|+|++|+.||.+.... .....+... .
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~  219 (285)
T cd07861         145 FGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS----PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILG  219 (285)
T ss_pred             ccceeecCCCcccccCCcccccccChHHhcCC----CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhC
Confidence            99986543221 12233567899999988532    24678999999999999999999999873322 222111110 0


Q ss_pred             -------------------CCCC------CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 -------------------PPCL------PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 -------------------~p~~------~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                         .+..      .....+++++.++|.+||..||+        ++.++.++..+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~--------~Rpt~~~ll~~~~  284 (285)
T cd07861         220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA--------KRISAKKALNHPY  284 (285)
T ss_pred             CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChh--------hCCCHHHHhcCCC
Confidence                               0000      01123789999999999999998        4445555555544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=9.2e-30  Score=224.17  Aligned_cols=176  Identities=19%  Similarity=0.249  Sum_probs=137.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+.+++.+|+||||++ |+|.+++....               ..+++..++.++.||+.||+|||+ +|++||||||+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~N  154 (303)
T cd05088          76 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARN  154 (303)
T ss_pred             EECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchhe
Confidence            4567788999999998 59999997532               358899999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC  145 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~  145 (296)
                      ||++.++.++|+|||++..............+..|+|||.+.+     ..++.++|||||||++|+|++ |..||... .
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~-~  228 (303)
T cd05088         155 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T  228 (303)
T ss_pred             EEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-----cCCcccccchhhhhHHHHHHhcCCCCcccC-C
Confidence            9999999999999999854321111122234567999998843     357789999999999999998 99999863 3


Q ss_pred             cHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         146 DFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       146 ~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+....+..+..+..+.  .++..+.++|.+||..+|+.||
T Consensus       229 ~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  268 (303)
T cd05088         229 CAELYEKLPQGYRLEKPL--NCDDEVYDLMRQCWREKPYERP  268 (303)
T ss_pred             hHHHHHHHhcCCcCCCCC--CCCHHHHHHHHHHcCCChhhCc
Confidence            334444444433333332  3789999999999999998443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=2.4e-29  Score=219.30  Aligned_cols=190  Identities=32%  Similarity=0.526  Sum_probs=146.2

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .++.+|+||||++| +|.+++...   ...+++..++.++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCC
Confidence            45689999999985 999987642   4578999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|+|||.+.........++.++||||+||++|+|++|..||.... ....+..+.....+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~~~~~~  248 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPRNPPPT  248 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-hhHHHhhccccCCCc
Confidence            987654332 223346888999999985432223457889999999999999999999998743 333333443343333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ......++..+.++|.+||..+|+        ++.++.++..+.+
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~--------~Rps~~ell~~~~  285 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYE--------KRPTVSDLLQHVF  285 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcc--------cCCCHHHHhhccc
Confidence            333334788999999999999998        4445555555543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=2.8e-29  Score=216.41  Aligned_cols=186  Identities=27%  Similarity=0.432  Sum_probs=146.2

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||+.| +|.+++.+ ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~df  146 (265)
T cd06631          69 GTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDF  146 (265)
T ss_pred             eEeecCCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccc
Confidence            356678899999999985 99999976 5678999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-------ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH
Q psy3686          81 GISGRLVDS-------KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV  153 (296)
Q Consensus        81 g~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i  153 (296)
                      |.+......       .......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||...... .....+
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~  220 (265)
T cd06631         147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-----SGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAMFYI  220 (265)
T ss_pred             hhhHhhhhccccccccccccccCCCccccChhhhcC-----CCCcchhhHHHHHHHHHHHHhCCCccccCChH-HHHHHh
Confidence            988654211       11123357889999999853     35778999999999999999999999874333 233233


Q ss_pred             Hcc--CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         154 LND--APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       154 ~~~--~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ...  ..+.++.  .++..+.++|.+||..+|+        .+.++.+++.+++
T Consensus       221 ~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~--------~Rp~~~~~l~~~~  264 (265)
T cd06631         221 GAHRGLMPRLPD--SFSAAAIDFVTSCLTRDQH--------ERPSALQLLRHDF  264 (265)
T ss_pred             hhccCCCCCCCC--CCCHHHHHHHHHHhcCCcc--------cCCCHHHHhcCCC
Confidence            322  2333433  3899999999999999998        4445566666554

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=3e-29  Score=215.03  Aligned_cols=174  Identities=24%  Similarity=0.366  Sum_probs=145.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++.+++.+++||||++ |+|.+++... ...+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++.+||+|
T Consensus        66 ~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d  144 (256)
T cd08221          66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGD  144 (256)
T ss_pred             eEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCCCEEECc
Confidence            45778889999999998 5999999764 4568999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||.+....... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||.. ....+....+..+..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~  218 (256)
T cd08221         145 FGISKILGSEYSMAETVVGTPYYMSPELCQG-----VKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNY  218 (256)
T ss_pred             CcceEEcccccccccccCCCccccCHhhcCC-----CCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC
Confidence            99987654333 2334468899999999853     2567889999999999999999999987 445566666666655


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      +..+  ..++..+.++|.+||..+|+
T Consensus       219 ~~~~--~~~~~~~~~~i~~~l~~~p~  242 (256)
T cd08221         219 TPVV--SVYSSELISLVHSLLQQDPE  242 (256)
T ss_pred             CCCc--cccCHHHHHHHHHHcccCcc
Confidence            4443  34799999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=4.3e-29  Score=214.83  Aligned_cols=191  Identities=30%  Similarity=0.486  Sum_probs=153.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+.+.+++|+||+++ +|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          67 VEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             eEecCCEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccc
Confidence            45567899999999994 99999976 4568999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc-----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc
Q psy3686          82 ISGRLVDSKAR-----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        82 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      ++.........     ....++..|+|||.+.+..  ...++.++||||||+++|++++|..||............+..+
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~  222 (264)
T cd06626         145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG  222 (264)
T ss_pred             cccccCCCCCcccccccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC
Confidence            98765433221     1235778999999996431  1247889999999999999999999998754455555555556


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ..+.++....++..+.++|.+||..+|.        .+.++.++..++|
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~--------~R~~~~~i~~~~~  263 (264)
T cd06626         223 HKPPIPDSLQLSPEGKDFLDRCLESDPK--------KRPTASELLQHPF  263 (264)
T ss_pred             CCCCCCcccccCHHHHHHHHHHccCCcc--------cCCCHHHHhcCCC
Confidence            6667776655799999999999999998        4444555555544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=8.8e-30  Score=218.38  Aligned_cols=177  Identities=24%  Similarity=0.364  Sum_probs=144.9

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +.|.+++.+|+||||++ |+|.+++... ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|
T Consensus        65 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~d  143 (255)
T cd08219          65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGD  143 (255)
T ss_pred             EEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcc
Confidence            35678889999999998 5999988653 4568999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||.+....... ......++..|+|||++.+     ..++.++|+||||+++|+|++|..||.. .........+..+..
T Consensus       144 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~  217 (255)
T cd08219         144 FGSARLLTSPGAYACTYVGTPYYVPPEIWEN-----MPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSY  217 (255)
T ss_pred             cCcceeecccccccccccCCccccCHHHHcc-----CCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCC
Confidence            99987654332 2233467889999999853     3578899999999999999999999987 344445555656655


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +.++.  .++..+.++|.+||..+|+.||
T Consensus       218 ~~~~~--~~~~~~~~li~~~l~~~P~~Rp  244 (255)
T cd08219         218 KPLPS--HYSYELRSLIKQMFKRNPRSRP  244 (255)
T ss_pred             CCCCc--ccCHHHHHHHHHHHhCCcccCC
Confidence            54443  3789999999999999998443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=3.4e-29  Score=215.55  Aligned_cols=194  Identities=27%  Similarity=0.388  Sum_probs=152.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.+++.+|+||||++ ++|.+++.+ ...+++..+..++.||+.||+|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        60 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df  137 (262)
T cd05572          60 RTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDF  137 (262)
T ss_pred             eeEEcCCccEEEEecCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            34567889999999998 599999976 4679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-cHHHHHHHHc-cCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLN-DAP  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-~~~~~~~i~~-~~~  158 (296)
                      |++.............++..|++||.+..     ..++.++|+||||+++|++++|..||..... .......+.. ...
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  212 (262)
T cd05572         138 GFAKKLKSGQKTWTFCGTPEYVAPEIILN-----KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK  212 (262)
T ss_pred             CcccccCcccccccccCCcCccChhHhcC-----CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC
Confidence            99877654433333467889999999843     3578899999999999999999999987442 3445555553 233


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +..+..  .+..+.++|.+||..+|+.|+...-   ....++..++++.
T Consensus       213 ~~~~~~--~~~~~~~~i~~~l~~~p~~R~~~~~---~~~~~l~~~~~~~  256 (262)
T cd05572         213 LEFPNY--IDKAAKDLIKQLLRRNPEERLGNLK---GGIKDIKKHKWFN  256 (262)
T ss_pred             CCCCcc--cCHHHHHHHHHHccCChhhCcCCcc---cCHHHHhcChhhh
Confidence            344433  5899999999999999984443211   1256667777654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=5.3e-29  Score=213.30  Aligned_cols=186  Identities=21%  Similarity=0.327  Sum_probs=148.8

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEec
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCD   79 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~d   79 (296)
                      .+..++.+++||||++| +|.+++... ...+++..++.++.|++.+|.|||+ +|++|+||+|.||+++.++ .++|+|
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d  145 (256)
T cd08220          67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGD  145 (256)
T ss_pred             eEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcc
Confidence            45678899999999985 999999764 3458999999999999999999999 5999999999999998654 579999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ||.+.............++..|+|||.+.+     ..++.++||||||+++|+|++|..||... ........+..+...
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~  219 (256)
T cd08220         146 FGISKILSSKSKAYTVVGTPCYISPELCEG-----KPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA  219 (256)
T ss_pred             CCCceecCCCccccccccCCcccCchhccC-----CCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC
Confidence            999987654444344567889999999853     35778999999999999999999999874 334455555555444


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .++..  ++..+.++|.+||..+|+        ++.+..++..+++
T Consensus       220 ~~~~~--~~~~l~~li~~~l~~~p~--------~Rpt~~~ll~~p~  255 (256)
T cd08220         220 PISDR--YSPDLRQLILSMLNLDPS--------KRPQLSQIMAQPI  255 (256)
T ss_pred             CCCCC--cCHHHHHHHHHHccCChh--------hCCCHHHHhhCCC
Confidence            44433  799999999999999998        4455555555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0587|consensus

Probab=99.96  E-value=5.6e-30  Score=239.12  Aligned_cols=192  Identities=29%  Similarity=0.453  Sum_probs=173.4

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .++.+|||||||. ||.-++++.. +..+.|..+..|++.++.||.+||. +.++|||||-.|||++.++.|||+|||++
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeee
Confidence            4689999999999 5999999766 6789999999999999999999999 69999999999999999999999999999


Q ss_pred             ccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          84 GRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        84 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ..+... ..+++..||+.|||||++.+.......|+..+|+||||++..+|.-|.+|+-+ -..+..+..|..+++|.+.
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D-mHPmraLF~IpRNPPPkLk  249 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLK  249 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC-cchhhhhccCCCCCCcccc
Confidence            877654 45667799999999999998877777899999999999999999999999998 4777888899999999999


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .+.+|+..+.+||..||.+|-+        .+....+++.++|+.
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e--------~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYE--------QRPSTEELLKHPFIT  286 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccc--------cCcchhhhccCCccc
Confidence            8888999999999999999987        666677778888776

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=1.8e-29  Score=221.77  Aligned_cols=191  Identities=26%  Similarity=0.454  Sum_probs=150.4

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++..++++|+||||++| +|.+++.+  ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          83 DSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             EEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcC
Confidence            356678899999999985 99999864  578999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|+|||.+.+     ..++.++|+||||+++|++++|..||...... .....+.....+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-~~~~~~~~~~~~  233 (297)
T cd06656         160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGTP  233 (297)
T ss_pred             ccceEccCCccCcCcccCCccccCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-hheeeeccCCCC
Confidence            9987654332 1223467889999999853     36778999999999999999999999774332 222223333333


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .......++..+.+||.+||..+|+        .+.++.++..++++...
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~--------~Rps~~~il~~~~~~~~  275 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVD--------RRGSAKELLQHPFLKLA  275 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChh--------hCcCHHHHhcCchhccc
Confidence            4333345789999999999999998        45556677777766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=3.5e-29  Score=217.46  Aligned_cols=194  Identities=25%  Similarity=0.352  Sum_probs=148.4

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .|...+.+|+||||+.| +|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        61 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~df  139 (277)
T cd05577          61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDL  139 (277)
T ss_pred             EEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccC
Confidence            46678899999999995 9999987643 379999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--cHHHHHHHHccCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC--DFEVLSRVLNDAP  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~--~~~~~~~i~~~~~  158 (296)
                      |.+.............++..|+|||.+.+     ..++.++||||||+++|+|++|..||.....  ....+........
T Consensus       140 g~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  214 (277)
T cd05577         140 GLAVELKGGKKIKGRAGTPGYMAPEVLQG-----EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA  214 (277)
T ss_pred             cchhhhccCCccccccCCCCcCCHHHhcC-----CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc
Confidence            99876544333334467789999999853     2478899999999999999999999976432  1222222222222


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ...+.  .+++.+.++|.+||..+|+.|+..  .+ ..+.+++.++++.
T Consensus       215 ~~~~~--~~~~~~~~li~~~l~~~p~~R~~~--~~-~~~~~ll~h~~~~  258 (277)
T cd05577         215 VEYPD--KFSPEAKDLCEALLQKDPEKRLGC--RG-GSADEVREHPLFK  258 (277)
T ss_pred             ccCCc--cCCHHHHHHHHHHccCChhHccCC--Cc-ccHHHHHhChhhh
Confidence            23332  379999999999999999844432  22 1455566666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.96  E-value=2.7e-29  Score=218.56  Aligned_cols=176  Identities=19%  Similarity=0.268  Sum_probs=140.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH--------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI   67 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Ni   67 (296)
                      ++.+++.+|+||||+. |+|.+++....              ..+++..++.++.||+.||+|||+ +|++|+||||+||
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~ni  153 (280)
T cd05092          75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNC  153 (280)
T ss_pred             EEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhE
Confidence            4556788999999999 59999997642              358999999999999999999999 5999999999999


Q ss_pred             EECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3686          68 LLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDC  143 (296)
Q Consensus        68 l~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~  143 (296)
                      +++.++.++|+|||++........   .....++..|+|||.+.+     ..++.++|||||||++|+|++ |..||.. 
T Consensus       154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~-  227 (280)
T cd05092         154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-----RKFTTESDIWSFGVVLWEIFTYGKQPWYQ-  227 (280)
T ss_pred             EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-----CCcCchhhHHHHHHHHHHHHcCCCCCCcc-
Confidence            999999999999999865432221   112234678999999853     367889999999999999998 9999977 


Q ss_pred             CCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         144 KCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       144 ~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .........+..+..+..+.  .+++.+.++|.+||..+|..|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~P~~Rp  269 (280)
T cd05092         228 LSNTEAIECITQGRELERPR--TCPPEVYAIMQGCWQREPQQRM  269 (280)
T ss_pred             CCHHHHHHHHHcCccCCCCC--CCCHHHHHHHHHHccCChhhCC
Confidence            34445555666655444443  3799999999999999998443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=2e-29  Score=217.67  Aligned_cols=180  Identities=26%  Similarity=0.453  Sum_probs=139.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++ |+|.+++.. ...+++..+..++.|++.||.|||+ .||+|+||+|.||+++.++.++|+|||
T Consensus        74 ~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          74 SYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCc
Confidence            4567789999999999 599999876 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--AP  158 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~  158 (296)
                      ++....... ......++..|+|||.+...  ....++.++|+||+||++|+|++|..||...... .....+...  .+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~  228 (267)
T cd06646         152 VAAKITATIAKRKSFIGTPYWMAPEVAAVE--KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSKSNFQP  228 (267)
T ss_pred             cceeecccccccCccccCccccCHhHcccc--cCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeecCCCCC
Confidence            987654322 22334678899999988533  2234678999999999999999999999763322 222122111  22


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +.+.....++..+.++|.+||..+|+.|+
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  257 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRP  257 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCc
Confidence            22322234789999999999999998443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=3e-29  Score=217.80  Aligned_cols=176  Identities=22%  Similarity=0.310  Sum_probs=140.0

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER   72 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~   72 (296)
                      .+..++.+++||||++ |+|.+++....         ..++...+..++.|++.||.|||+ .|++|+||||+||+++.+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAED  155 (277)
T ss_pred             EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCC
Confidence            4567788999999999 59999997532         235778899999999999999999 599999999999999999


Q ss_pred             CCEEEeccCCcccccCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHH
Q psy3686          73 GNIKLCDFGISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFE  148 (296)
Q Consensus        73 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~  148 (296)
                      +.++|+|||++.........   ....++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.+ .....
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~  229 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQ  229 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-----CCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHH
Confidence            99999999998755332211   12244678999999843     367889999999999999999 7899987 34445


Q ss_pred             HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         149 VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       149 ~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ....+..+..+.++.  .++..+.++|.+||+.+|+.||
T Consensus       230 ~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  266 (277)
T cd05062         230 VLRFVMEGGLLDKPD--NCPDMLFELMRMCWQYNPKMRP  266 (277)
T ss_pred             HHHHHHcCCcCCCCC--CCCHHHHHHHHHHcCCChhhCc
Confidence            555555555444443  3789999999999999998444

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=6.2e-29  Score=222.60  Aligned_cols=183  Identities=22%  Similarity=0.369  Sum_probs=143.8

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|++|++++++|.+++.  ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          93 NEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             CcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            5689999999889999886  4679999999999999999999999 599999999999999999999999999987654


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--C--------
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--A--------  157 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~--------  157 (296)
                      ..  .....++..|+|||++.+    ...++.++|||||||++|+|++|..||... .....+..+...  .        
T Consensus       170 ~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         170 DE--MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLKGKALFPGN-DYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             CC--cCCccccccccCchHhcC----CccCCchhhhHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHHh
Confidence            32  233468899999999853    235788999999999999999999999873 222333222211  0        


Q ss_pred             ------------CCCCCC------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 ------------PPCLPN------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ------------~p~~~~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                  .+..+.      ....++.+.+||.+||..||.        ++.++.+++.++++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~--------~R~s~~ell~hp~~~~  303 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD--------KRISASEALAHPYFSQ  303 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChh--------hCCCHHHHhcCcchhc
Confidence                        011111      012467789999999999998        6667888888887744

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=3.1e-29  Score=215.17  Aligned_cols=178  Identities=22%  Similarity=0.336  Sum_probs=140.7

Q ss_pred             ccCCeEEEEecCcc-ccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           5 SKESDVWICMELMA-TCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         5 ~~~~~~~lv~E~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+++.+|+||||++ |+|.+++.... ..+++..++.++.||+.||+|||+ +|++|+||||+||+++.++.+||+|||+
T Consensus        70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             cCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCcc
Confidence            45678999999998 59999997643 348999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      +.......  .....+..|+|||.+.+     ..++.++|||||||++|+|++ |..||... ........+.++..+..
T Consensus       149 ~~~~~~~~--~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~  220 (256)
T cd05082         149 TKEASSTQ--DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDA  220 (256)
T ss_pred             ceeccccC--CCCccceeecCHHHHcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCCC
Confidence            86543322  22244568999999843     367889999999999999998 99999873 33444555555544444


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      +.  .+++.+.++|.+||..+|+.|  +++.++.
T Consensus       221 ~~--~~~~~~~~li~~~l~~~p~~R--pt~~~l~  250 (256)
T cd05082         221 PD--GCPPVVYDVMKQCWHLDAATR--PSFLQLR  250 (256)
T ss_pred             CC--CCCHHHHHHHHHHhcCChhhC--cCHHHHH
Confidence            33  379999999999999999844  4444443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.2e-29  Score=219.93  Aligned_cols=194  Identities=27%  Similarity=0.362  Sum_probs=149.9

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +.+.+++.+|+||||+.| +|.+++... ...+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.++|+|
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~d  146 (316)
T cd05574          68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSD  146 (316)
T ss_pred             eeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEee
Confidence            356678899999999985 999998764 3579999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCc------------------------------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHH
Q psy3686          80 FGISGRLVDSK------------------------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGIT  129 (296)
Q Consensus        80 fg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~  129 (296)
                      ||++.......                              ......++..|+|||.+.+     ..++.++||||||++
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~l  221 (316)
T cd05574         147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-----DGHGSAVDWWTLGIL  221 (316)
T ss_pred             cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-----CCCCchHHHHHHHHH
Confidence            99876543211                              0112356788999999953     357889999999999


Q ss_pred             HHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         130 LVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       130 l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +|+|++|..||... .....+..+.... +.++....++..+.++|.+||..+|+.|+..    ...+.+++.++++.
T Consensus       222 l~~l~~g~~pf~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~~~~~~ll~~~~~~  293 (316)
T cd05574         222 LYEMLYGTTPFKGS-NRDETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGS----KRGAAEIKQHPFFR  293 (316)
T ss_pred             HHHHhhCCCCCCCC-chHHHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCc----hhhHHHHHcCchhh
Confidence            99999999999874 3334444444333 3344443479999999999999999833321    11166777777654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=3.4e-29  Score=217.66  Aligned_cols=187  Identities=20%  Similarity=0.317  Sum_probs=143.0

Q ss_pred             CccC--CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           4 QSKE--SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         4 ~~~~--~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.++  +.+|+||||+.|+|.+.+......+++..++.++.||+.||.|||+ .|++|+||+|+||+++. +.++|+|||
T Consensus        67 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          67 LFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             EecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecc
Confidence            3444  7899999999999988887655679999999999999999999999 59999999999999999 999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC-
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP-  158 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~-  158 (296)
                      ++.............++..|+|||.+..    ...++.++|||||||++|+|++|..||... +..+.+..+..  +.+ 
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~  219 (282)
T cd07831         145 SCRGIYSKPPYTEYISTRWYRAPECLLT----DGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPD  219 (282)
T ss_pred             cccccccCCCcCCCCCCcccCChhHhhc----CCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCC
Confidence            9976654443344567889999998742    225678999999999999999999999873 32232222211  000 


Q ss_pred             --------------CCCCC---------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 --------------PCLPN---------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 --------------p~~~~---------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                    ..++.         ...++..+.++|.+||..+|+        +|.++.++..+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~~~~~~l~~~~  281 (282)
T cd07831         220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPD--------ERITAKQALRHPY  281 (282)
T ss_pred             HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcc--------cccCHHHHhhCCC
Confidence                          00110         123689999999999999998        4445555555544

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-29  Score=217.73  Aligned_cols=176  Identities=19%  Similarity=0.251  Sum_probs=137.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+...+.+|+||||+. |+|.+++....               ..+++..++.++.|++.||+|||+ .|++|+||||+|
T Consensus        64 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~n  142 (270)
T cd05047          64 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARN  142 (270)
T ss_pred             EEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccce
Confidence            4556778999999998 59999997532               247899999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC  145 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~  145 (296)
                      |+++.++.++|+|||++..............+..|+|||.+.     ...++.++||||||+++|+|++ |..||... .
T Consensus       143 ili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~il~el~~~g~~pf~~~-~  216 (270)
T cd05047         143 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T  216 (270)
T ss_pred             EEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHc-----cCCCCchhhHHHHHHHHHHHHcCCCCCcccc-C
Confidence            999999999999999985322111112223356799999984     3367889999999999999997 99999773 3


Q ss_pred             cHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         146 DFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       146 ~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .......+..+..+..+.  .++..+.+++.+||..+|..||
T Consensus       217 ~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  256 (270)
T cd05047         217 CAELYEKLPQGYRLEKPL--NCDDEVYDLMRQCWREKPYERP  256 (270)
T ss_pred             HHHHHHHHhCCCCCCCCC--cCCHHHHHHHHHHcccChhhCC
Confidence            344555555443333333  3688999999999999998433

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=5.2e-29  Score=219.71  Aligned_cols=189  Identities=28%  Similarity=0.420  Sum_probs=150.5

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+.+++..|+||||+.|+|.+++......+++..+..++.||+.||.|||+ .|++|+||+|.||+++.++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~  161 (307)
T cd06607          83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGS  161 (307)
T ss_pred             EEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCc
Confidence            456778899999999999988887656789999999999999999999999 5999999999999999999999999998


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      +......   ....++..|+|||.+.+.  ....++.++||||||+++|+|++|..||... ........+.....+.++
T Consensus       162 ~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~  235 (307)
T cd06607         162 ASLVSPA---NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLS  235 (307)
T ss_pred             ceecCCC---CCccCCccccCceeeecc--CCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCC
Confidence            8654322   234677889999988432  2235788999999999999999999999873 333444445445445544


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .. .++..+.++|.+||..+|+        .+.+..++..++++.
T Consensus       236 ~~-~~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~~~  271 (307)
T cd06607         236 SN-DWSDYFRNFVDSCLQKIPQ--------DRPSSEELLKHRFVL  271 (307)
T ss_pred             ch-hhCHHHHHHHHHHhcCChh--------hCcCHHHHhcChhhc
Confidence            33 3789999999999999998        444555666665543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=3.9e-29  Score=218.09  Aligned_cols=196  Identities=31%  Similarity=0.528  Sum_probs=157.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||++ ++|.+++......++...++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             EEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccc
Confidence            4566789999999999 59999998744489999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|++||.+.+     ..++.++|+||||+++|+|++|..||... ........+.....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~  235 (286)
T cd06614         162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKR-----KDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPP  235 (286)
T ss_pred             hhhhhccchhhhccccCCcccCCHhHhcC-----CCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCC
Confidence            876544321 2223356788999999853     35788999999999999999999999873 4444444454554455


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCC
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQN  213 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (296)
                      ++....++..+.++|.+||..+|.        .+.++.+++.++++...|...
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~--------~Rpt~~~il~~~~~~~~~~~~  280 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPE--------KRPSAEELLQHPFLKKACPKE  280 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChh--------hCcCHHHHhhChHhhccCchH
Confidence            544444889999999999999998        556777788888887777543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.96  E-value=5e-29  Score=216.64  Aligned_cols=178  Identities=22%  Similarity=0.302  Sum_probs=139.4

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ....+++|+|++ |+|.+++......+++..++.++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++..
T Consensus        80 ~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          80 TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             CCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceee
Confidence            345789999999 69999997756679999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          86 LVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        86 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .......   ....++..|+|||.+.+     ..++.++|||||||++|+|++ |..||... ........+..+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~  232 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILH-----RRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQ  232 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcCCC
Confidence            6433221   11234568999999843     367889999999999999998 99999763 33334444444444333


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      +.  .++..+.++|.+||..+|+.|  +++.++.
T Consensus       233 ~~--~~~~~~~~li~~~l~~dp~~R--p~~~~l~  262 (279)
T cd05109         233 PP--ICTIDVYMIMVKCWMIDSECR--PRFRELV  262 (279)
T ss_pred             Cc--cCCHHHHHHHHHHcCCChhhC--cCHHHHH
Confidence            32  379999999999999999844  4444443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=3.6e-29  Score=215.19  Aligned_cols=176  Identities=24%  Similarity=0.329  Sum_probs=142.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+.+.+.+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             eEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccc
Confidence            45677889999999995 999999764 4568999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          81 GISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        81 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |.+........ .....++..|++||.+..     ..++.++||||||+++|+|++ |..||.. ....+.+..+..+..
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~  222 (261)
T cd05148         149 GLARLIKEDVYLSSDKKIPYKWTAPEAASH-----GTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYR  222 (261)
T ss_pred             cchhhcCCccccccCCCCceEecCHHHHcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCc
Confidence            99876543321 112234567999999843     367889999999999999998 8999987 344556666665544


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..+  ..++..+.++|.+||..+|..||
T Consensus       223 ~~~~--~~~~~~~~~~i~~~l~~~p~~Rp  249 (261)
T cd05148         223 MPCP--AKCPQEIYKIMLECWAAEPEDRP  249 (261)
T ss_pred             CCCC--CCCCHHHHHHHHHHcCCCchhCc
Confidence            3333  34799999999999999998443

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=2.8e-29  Score=215.98  Aligned_cols=182  Identities=25%  Similarity=0.372  Sum_probs=143.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+.+.+.+|+||||+. |+|.+++... ...++...++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCC
Confidence            4567788999999998 5999999764 4678999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |++........  .....++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.. .........+..+.
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~  221 (261)
T cd05072         148 GLARVIEDNEYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGY  221 (261)
T ss_pred             ccceecCCCceeccCCCccceecCCHHHhcc-----CCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCC
Confidence            99976543221  122234568999999843     367889999999999999998 9999987 34445555555443


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      ..  +....++..+.++|.+||..+|+  .|++++++.
T Consensus       222 ~~--~~~~~~~~~~~~li~~~l~~~p~--~Rp~~~~i~  255 (261)
T cd05072         222 RM--PRMENCPDELYDIMKTCWKEKAE--ERPTFDYLQ  255 (261)
T ss_pred             CC--CCCCCCCHHHHHHHHHHccCCcc--cCcCHHHHH
Confidence            32  22234799999999999999998  444444443

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=4.4e-29  Score=217.20  Aligned_cols=179  Identities=20%  Similarity=0.300  Sum_probs=141.3

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +..+++||||+. |+|.+++......+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++..
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            456789999998 69999998766789999999999999999999999 5999999999999999999999999999976


Q ss_pred             ccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          86 LVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        86 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .....   ......++..|++||.+.+     ..++.++||||||+++|++++ |..||.+. ........+..+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~  232 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILF-----GRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLAQ  232 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhcc-----CCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcCCC
Confidence            53321   1223346678999999843     367899999999999999998 99999873 33333333444444433


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      +.  .++..+..++.+||..+|+.|  +++.++..
T Consensus       233 ~~--~~~~~~~~li~~c~~~~p~~R--ps~~el~~  263 (279)
T cd05111         233 PQ--ICTIDVYMVMVKCWMIDENVR--PTFKELAN  263 (279)
T ss_pred             CC--CCCHHHHHHHHHHcCCCcccC--cCHHHHHH
Confidence            33  268899999999999999844  45555544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=4.4e-29  Score=214.99  Aligned_cols=189  Identities=32%  Similarity=0.561  Sum_probs=150.6

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      .+..++.+|+|||++.| +|.+++...  ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|
T Consensus        67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             EEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcc
Confidence            45677899999999985 999999764  2568999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCccc-----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH
Q psy3686          80 FGISGRLVDSKAR-----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        80 fg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~  154 (296)
                      ||++..+......     ....++..|++||.+...    ..++.++|+||||+++|+|++|..||... .....+..+.
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~----~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~  220 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV----HGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTL  220 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccc----cCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHh
Confidence            9998766543221     233578899999998532    25788999999999999999999999874 4445555555


Q ss_pred             ccCCCCCCCC---cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         155 NDAPPCLPND---PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       155 ~~~~p~~~~~---~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ...++.++..   ..++..+.++|.+||..+|+        .+.++.++..+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~--------~Rp~~~~ll~~p~  266 (267)
T cd06610         221 QNDPPSLETGADYKKYSKSFRKMISLCLQKDPS--------KRPTAEELLKHKF  266 (267)
T ss_pred             cCCCCCcCCccccccccHHHHHHHHHHcCCChh--------hCcCHHHHhhCCC
Confidence            5555555443   25789999999999999998        3444555555544

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=4.5e-29  Score=221.02  Aligned_cols=179  Identities=22%  Similarity=0.308  Sum_probs=139.0

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      +..++|+||+. |+|.+++......++...++.++.||+.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEccccccccc
Confidence            45789999998 69999998766679999999999999999999999 59999999999999999999999999999766


Q ss_pred             cCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          87 VDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        87 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ......   .....+..|++||.+.     ...++.++||||||+++|+|++ |..||.+. ...+....+..+..+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~-  232 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ-  232 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhc-----cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhCCCCCCC-
Confidence            433221   1123456799999984     3367889999999999999998 99999873 33333333333333222 


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                       ...++..+.++|.+||..+|+.|  +++.++...
T Consensus       233 -~~~~~~~~~~li~~cl~~~p~~R--ps~~~l~~~  264 (316)
T cd05108         233 -PPICTIDVYMIMVKCWMIDADSR--PKFRELIIE  264 (316)
T ss_pred             -CCCCCHHHHHHHHHHccCChhhC--cCHHHHHHH
Confidence             23478999999999999999844  444444443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=5.4e-29  Score=214.89  Aligned_cols=175  Identities=25%  Similarity=0.321  Sum_probs=141.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||+.| +|.+++......+++..++.++.|++.||.|||+ +||+|+||+|.||+++.++.++|+|||
T Consensus        73 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          73 VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             EEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccc
Confidence            35677889999999985 9999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSK-AR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~-~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ++....... ..  ....++..|+|||.+.+     ..++.++||||||+++|++++ |..||... ........+..+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~  225 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-----RKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGY  225 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhcc-----CCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCC
Confidence            998764211 11  11234568999999853     367889999999999999998 99999773 4445555555543


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+..+  ..++..+.+++.+||..+|+.|
T Consensus       226 ~~~~~--~~~~~~l~~li~~cl~~~p~~R  252 (266)
T cd05033         226 RLPPP--MDCPSALYQLMLDCWQKDRNER  252 (266)
T ss_pred             CCCCC--CCCCHHHHHHHHHHcCCCcccC
Confidence            33333  2379999999999999999844

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=6.1e-30  Score=220.37  Aligned_cols=175  Identities=27%  Similarity=0.464  Sum_probs=139.1

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +...+.+++||||+. |+|.+++... ...+++..++.|+.||+.||.|||+ .+++|++|++.||+++.++.+||+|||
T Consensus        70 ~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   70 CIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             EESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence            345667999999998 6999999986 5789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ++.......   ..........|+|||.+..     ..++.++||||||+++|++++ |..||... ...+....+..+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~  222 (259)
T PF07714_consen  149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKD-----GEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQ  222 (259)
T ss_dssp             TGEETTTSSSEEESTTSESGGGGS-HHHHHH-----SEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTE
T ss_pred             ccccccccccccccccccccccccccccccc-----cccccccccccccccccccccccccccccc-ccccccccccccc
Confidence            997763221   1222346678999999843     358899999999999999999 78999884 5566666776665


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+.  .++..+.++|.+||..+|+.||
T Consensus       223 ~~~~~~--~~~~~~~~li~~C~~~~p~~RP  250 (259)
T PF07714_consen  223 RLPIPD--NCPKDIYSLIQQCWSHDPEKRP  250 (259)
T ss_dssp             ETTSBT--TSBHHHHHHHHHHT-SSGGGS-
T ss_pred             cceecc--chhHHHHHHHHHHcCCChhhCc
Confidence            544443  3799999999999999998444

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5.9e-29  Score=216.82  Aligned_cols=192  Identities=37%  Similarity=0.718  Sum_probs=151.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++...+.+|+||||++| +|.+++.. .+.+++..++.++.+++.+|.|||+.+|++|+||+|+||+++.++.++|+||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          70 GAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             eeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccC
Confidence            456778899999999995 99999876 5679999999999999999999997569999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc----------HHHH
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD----------FEVL  150 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----------~~~~  150 (296)
                      |++...... ......++..|+|||.+.+     ..++.++|||||||++|++++|..||......          ....
T Consensus       149 gl~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd06620         149 GVSGELINS-IADTFVGTSTYMSPERIQG-----GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL  222 (284)
T ss_pred             Ccccchhhh-ccCccccCcccCCHHHHcc-----CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence            988654322 2223468899999999843     36788999999999999999999999863321          1333


Q ss_pred             HHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         151 SRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       151 ~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      ..+....++.++... ++..+.+||.+||..+|+        ++.+..++..+.+....
T Consensus       223 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~--------~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         223 QQIVQEPPPRLPSSD-FPEDLRDFVDACLLKDPT--------ERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHhhccCCCCCchh-cCHHHHHHHHHHhcCCcc--------cCcCHHHHhcCcccccc
Confidence            444444444444332 788999999999999998        55556666666554333

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=5.4e-29  Score=212.76  Aligned_cols=175  Identities=23%  Similarity=0.321  Sum_probs=139.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+...+.+|+||||++ |+|.+++......+++..++.++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        60 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g  138 (250)
T cd05085          60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFG  138 (250)
T ss_pred             EEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCc
Confidence            3456778999999998 59999987656678999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ++.........  ....++..|+|||.+..     ..++.++||||||+++|++++ |..||... ........+..+..
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~  212 (250)
T cd05085         139 MSRQEDDGIYSSSGLKQIPIKWTAPEALNY-----GRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYR  212 (250)
T ss_pred             cceeccccccccCCCCCCcccccCHHHhcc-----CCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCC
Confidence            98654332211  11233567999999843     367889999999999999998 99999874 34444455555444


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ...+.  .++..+.+++.+||..+|+.|
T Consensus       213 ~~~~~--~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         213 MSCPQ--KCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             CCCCC--CCCHHHHHHHHHHcccCcccC
Confidence            33333  378999999999999999844

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1e-28  Score=212.22  Aligned_cols=183  Identities=24%  Similarity=0.390  Sum_probs=149.9

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH-----HhCCceeCCCCCCcEEECCCCCEE
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLK-----ETHGVIHRDVKPSNILLDERGNIK   76 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~ivH~dlkp~Nil~~~~~~~k   76 (296)
                      .+..+|++|||+++ +|.+++...   ...+++..++.++.||+.||.|||     + .+++|+||+|+||+++.++.++
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEE
Confidence            45678999999984 999999764   568999999999999999999999     7 5999999999999999999999


Q ss_pred             EeccCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc
Q psy3686          77 LCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN  155 (296)
Q Consensus        77 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~  155 (296)
                      |+|||++........ .....++..|+|||.+.+     ..++.++|+||||+++|+|++|..||... ........+..
T Consensus       151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~  224 (265)
T cd08217         151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-----MSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKE  224 (265)
T ss_pred             EecccccccccCCcccccccccCCCccChhhhcC-----CCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhc
Confidence            999999877654332 334468889999999853     35788999999999999999999999884 34455556666


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +..+.++.  .++..+.+++.+||..+|+        ++.+..++..+++
T Consensus       225 ~~~~~~~~--~~~~~~~~l~~~~l~~~p~--------~Rp~~~~il~~~~  264 (265)
T cd08217         225 GKFRRIPY--RYSSELNEVIKSMLNVDPD--------KRPSTEELLQLPL  264 (265)
T ss_pred             CCCCCCcc--ccCHHHHHHHHHHccCCcc--------cCCCHHHHhhCCC
Confidence            66555554  3799999999999999998        5555666666554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.2e-29  Score=216.16  Aligned_cols=188  Identities=32%  Similarity=0.564  Sum_probs=149.4

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||+.| +|.+++..  ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          69 GSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             eeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccC
Confidence            356778899999999985 99999864  589999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|+|||.+.+    ...++.++|+||||+++|+|++|..||... ........+....++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~  220 (277)
T cd06917         146 GVAALLNQNSSKRSTFVGTPYWMAPEVITE----GKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIPKSKPP  220 (277)
T ss_pred             CceeecCCCccccccccCCcceeCHHHhcc----CCccccchhHHHHHHHHHHHHhCCCCCCCC-ChhhhhhccccCCCC
Confidence            9987664432 2233467889999998853    225678999999999999999999999873 333333333334444


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .++... ++..+.++|.+||..+|+        ++.+..++..++++
T Consensus       221 ~~~~~~-~~~~~~~~i~~~l~~~p~--------~R~~~~~il~~~~~  258 (277)
T cd06917         221 RLEDNG-YSKLLREFVAACLDEEPK--------ERLSAEELLKSKWI  258 (277)
T ss_pred             CCCccc-CCHHHHHHHHHHcCCCcc--------cCcCHHHHhhChHh
Confidence            554433 789999999999999998        55556666666665

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=4.8e-29  Score=216.62  Aligned_cols=189  Identities=34%  Similarity=0.546  Sum_probs=150.4

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.+++.+|+||||++| +|.+++.  ..++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          69 GSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEccc
Confidence            346678899999999985 9999987  4679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||... ........+..+.++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~  219 (277)
T cd06640         146 GVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-----SAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNNPP  219 (277)
T ss_pred             ccceeccCCccccccccCcccccCHhHhcc-----CCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCCCC
Confidence            9987654332 1223357788999999853     35788999999999999999999999874 333444444444445


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .++..  ++..+.++|.+||..+|+        .+.++.++..+.++...
T Consensus       220 ~~~~~--~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         220 TLTGE--FSKPFKEFIDACLNKDPS--------FRPTAKELLKHKFIVKN  259 (277)
T ss_pred             CCchh--hhHHHHHHHHHHcccCcc--------cCcCHHHHHhChHhhhc
Confidence            44433  789999999999999998        44456666666665443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=7.5e-29  Score=215.90  Aligned_cols=189  Identities=26%  Similarity=0.387  Sum_probs=142.9

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..+..+|+||||+++ +|..++.. ...+++..++.++.||+.||.|||+ +|++|+||+|.||+++.++.++|+||
T Consensus        67 ~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~df  144 (286)
T cd07847          67 EVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDF  144 (286)
T ss_pred             eEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECcc
Confidence            356678899999999996 66666544 5679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC--
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA--  157 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~--  157 (296)
                      |++....... ......++..|+|||.+.+    ...++.++||||||+++|+|++|..||.+... .+....+....  
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~  219 (286)
T cd07847         145 GFARILTGPGDDYTDYVATRWYRAPELLVG----DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-VDQLYLIRKTLGD  219 (286)
T ss_pred             ccceecCCCcccccCcccccccCCHHHHhC----CCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence            9987664432 2223457788999999853    22567899999999999999999999987433 23332221100  


Q ss_pred             -------------------CCCCC-------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 -------------------PPCLP-------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 -------------------~p~~~-------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                         .|...       ....++..+.+||.+||..+|+        .+.++.++..++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~--------~Rp~~~eil~~~~  285 (286)
T cd07847         220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPT--------ERLSCEELLEHPY  285 (286)
T ss_pred             CChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcc--------ccCCHHHHhcCCC
Confidence                               00000       0123688999999999999998        4445556665554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=5.3e-29  Score=230.17  Aligned_cols=191  Identities=16%  Similarity=0.165  Sum_probs=145.4

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ++..++..|||||++.++|..++......+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+|||+
T Consensus       228 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        228 VRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             EEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCC
Confidence            356678999999999999999987656689999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------cHHHHHHH
Q psy3686          83 SGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC------DFEVLSRV  153 (296)
Q Consensus        83 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~------~~~~~~~i  153 (296)
                      +.......   ......||..|+|||++.+     ..++.++|||||||++|+|++|..|+.....      ....+.++
T Consensus       307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~  381 (461)
T PHA03211        307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAG-----DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI  381 (461)
T ss_pred             ceecccccccccccccCCCcCCcCHHHHcC-----CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHH
Confidence            87653321   1223468999999999954     3678899999999999999998765432111      11222222


Q ss_pred             Hc-cCC--CCC-----------------------------CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         154 LN-DAP--PCL-----------------------------PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       154 ~~-~~~--p~~-----------------------------~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      +. ...  ..+                             .....++..+.+||.+||..||.        ++.++.+++
T Consensus       382 i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~--------~RPsa~elL  453 (461)
T PHA03211        382 IRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGA--------RRPSAAELL  453 (461)
T ss_pred             HHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChh--------hCcCHHHHh
Confidence            21 110  011                             11113567899999999999998        666788888


Q ss_pred             cCCccc
Q psy3686         202 AEGHLS  207 (296)
Q Consensus       202 ~~~~~~  207 (296)
                      .++++.
T Consensus       454 ~hp~f~  459 (461)
T PHA03211        454 RLPLFQ  459 (461)
T ss_pred             hCcccC
Confidence            887753

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=8.6e-29  Score=212.12  Aligned_cols=174  Identities=32%  Similarity=0.554  Sum_probs=141.9

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||++| +|.+++.+ ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.+||+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          69 GTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eeEecCCeEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccC
Confidence            355677899999999985 99999976 4579999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPP  159 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p  159 (296)
                      |++.............++..|++||.+...    ..++.++|+||||+++|+|++|..||.... .......+.. ...+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~----~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~  221 (258)
T cd06632         147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ----GGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKELP  221 (258)
T ss_pred             ccceeccccccccccCCCcceeCHHHhcCC----CCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccCC
Confidence            998765444333445678899999998532    137889999999999999999999998744 3333334333 3344


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChH
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      .++.  .++..+.++|.+||..+|+
T Consensus       222 ~~~~--~~~~~~~~li~~~l~~~p~  244 (258)
T cd06632         222 PIPD--HLSDEAKDFILKCLQRDPS  244 (258)
T ss_pred             CcCC--CcCHHHHHHHHHHhhcCcc
Confidence            4443  3799999999999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=5.6e-29  Score=215.06  Aligned_cols=179  Identities=22%  Similarity=0.398  Sum_probs=144.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +.+.+++.+|+||||+.| +|.+++...   ...+++..++.++.|++.+|.|||+..|++|+||+|.||+++.++.++|
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence            356778999999999995 998887542   5679999999999999999999996348999999999999999999999


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      +|||.+.............++..|++||.+.+     ..++.++|+||||+++|+|++|..||.. .........+..+.
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~  229 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-----EPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAV  229 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcC-----CCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhcc
Confidence            99999976654443344568889999999953     3578899999999999999999999976 34444444555444


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ....+. ..+++.+.++|.+||..+|+.||
T Consensus       230 ~~~~~~-~~~~~~l~~li~~cl~~~p~~Rp  258 (269)
T cd08528         230 YEPLPE-GMYSEDVTDVITSCLTPDAEARP  258 (269)
T ss_pred             CCcCCc-ccCCHHHHHHHHHHCCCCCccCC
Confidence            333332 23789999999999999998443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0614|consensus

Probab=99.96  E-value=8.8e-30  Score=225.50  Aligned_cols=172  Identities=27%  Similarity=0.402  Sum_probs=155.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.++.++|+.||-|- |.|..+++. .+.|.+...+.++.-++.|++|||+ +|||+|||||+|++++.+|.+||.|||
T Consensus       488 Tfrd~kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  488 TFRDSKYVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             HhccchhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCCceEEeehh
Confidence            3778999999999998 599999987 7899999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-CC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-PC  160 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-p~  160 (296)
                      +++++.......+++||+.|.|||++.+.     ..+.++|.||||+++|||++|.+||.+ .+++..+..|++|.. ..
T Consensus       566 FAKki~~g~KTwTFcGTpEYVAPEIILnK-----GHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~  639 (732)
T KOG0614|consen  566 FAKKIGSGRKTWTFCGTPEYVAPEIILNK-----GHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIE  639 (732)
T ss_pred             hHHHhccCCceeeecCCcccccchhhhcc-----CcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhh
Confidence            99999988888889999999999999643     567899999999999999999999999 677888888888754 23


Q ss_pred             CCCCcchhHHHHHHHHhccCCChH
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      +|  ..++....+||++....+|.
T Consensus       640 ~P--r~I~k~a~~Lik~LCr~~P~  661 (732)
T KOG0614|consen  640 FP--RRITKTATDLIKKLCRDNPT  661 (732)
T ss_pred             cc--cccchhHHHHHHHHHhcCcH
Confidence            44  34899999999999999998

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.7e-29  Score=216.32  Aligned_cols=177  Identities=23%  Similarity=0.338  Sum_probs=142.0

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL---------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE   71 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~   71 (296)
                      +++..++.+|+||||+. |+|.+++...         ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.
T Consensus        76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~  154 (277)
T cd05032          76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE  154 (277)
T ss_pred             EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC
Confidence            34567788999999998 6999999753         1246888999999999999999999 59999999999999999


Q ss_pred             CCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcH
Q psy3686          72 RGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDF  147 (296)
Q Consensus        72 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~  147 (296)
                      ++.++|+|||++........   .....++..|+|||.+.     ...++.++|||||||++|++++ |..||.. ....
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~  228 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNE  228 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh-----cCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHH
Confidence            99999999999876543321   12234567899999984     3367889999999999999998 9999987 3444


Q ss_pred             HHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         148 EVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       148 ~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .....+..+..+.++..  ++..+.++|.+||..+|+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rp  266 (277)
T cd05032         229 EVLKFVIDGGHLDLPEN--CPDKLLELMRMCWQYNPKMRP  266 (277)
T ss_pred             HHHHHHhcCCCCCCCCC--CCHHHHHHHHHHcCCChhhCC
Confidence            55555555555555543  699999999999999998443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0696|consensus

Probab=99.96  E-value=1.8e-29  Score=218.85  Aligned_cols=174  Identities=22%  Similarity=0.381  Sum_probs=150.6

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|++-+++|+||||+.| +|--.+++ -+.+.+..+..++..|+-||-+||++ ||++||||.+|||++..|++||+||
T Consensus       417 ScFQTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  417 SCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             HHhhhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeec
Confidence            578899999999999995 88888876 67899999999999999999999996 9999999999999999999999999


Q ss_pred             CCccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |+++.-. ...+..+.+||+.|+|||++     ....|+.++|+||+|++||+|+.|+.||.+ ....+.++.|.... .
T Consensus       495 GmcKEni~~~~TTkTFCGTPdYiAPEIi-----~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn-v  567 (683)
T KOG0696|consen  495 GMCKENIFDGVTTKTFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN-V  567 (683)
T ss_pred             ccccccccCCcceeeecCCCcccccceE-----EecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc-C
Confidence            9997543 33455667999999999999     444789999999999999999999999999 45556677766543 3


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+|..  +|.+..++++..|.+.|..|
T Consensus       568 syPKs--lSkEAv~ickg~ltK~P~kR  592 (683)
T KOG0696|consen  568 SYPKS--LSKEAVAICKGLLTKHPGKR  592 (683)
T ss_pred             cCccc--ccHHHHHHHHHHhhcCCccc
Confidence            45554  89999999999999999844

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.8e-29  Score=212.21  Aligned_cols=172  Identities=24%  Similarity=0.318  Sum_probs=137.8

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ..+.+++||||+. |+|.+++.. ...+++..++.++.|++.||.|||. .|++|+||||+||+++.++.++|+|||.+.
T Consensus        66 ~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          66 KGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             cCCceEEEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccc
Confidence            3557899999998 599999986 4579999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCCcccc----ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSKART----KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      .........    ...++..|+|||.+.+     ..++.++||||||+++|++++ |..||... ...+....+..+...
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~  217 (257)
T cd05060         144 ALGAGSDYYRATTAGRWPLKWYAPECINY-----GKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERL  217 (257)
T ss_pred             eeecCCcccccccCccccccccCHHHhcC-----CCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCcC
Confidence            654332111    1123457999999843     367889999999999999998 99999873 344555555555443


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+  ..++..++++|.+||..+|+.||
T Consensus       218 ~~~--~~~~~~l~~li~~cl~~~p~~Rp  243 (257)
T cd05060         218 PRP--EECPQEIYSIMLSCWKYRPEDRP  243 (257)
T ss_pred             CCC--CCCCHHHHHHHHHHhcCChhhCc
Confidence            333  34789999999999999998444

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=6.7e-29  Score=219.75  Aligned_cols=176  Identities=20%  Similarity=0.280  Sum_probs=139.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+.+++.+|+||||+. |+|.+++....               ..++...+..++.||+.||.|||+ +|++|+||||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  164 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN  164 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence            3556788999999998 59999997631               358899999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.+||+|||.++.......   .....++..|+|||.+.+     ..++.++||||||+++|+|++ |..||..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-----CCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999976543211   111233457999999843     367889999999999999999 8999977


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                       .........+..+..+..+.  .++..+.++|.+||..+|+.|+
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~Rp  281 (314)
T cd05099         240 -IPVEELFKLLREGHRMDKPS--NCTHELYMLMRECWHAVPTQRP  281 (314)
T ss_pred             -CCHHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHHcCCCcccCc
Confidence             34445555555554444433  3788999999999999998443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1e-28  Score=210.23  Aligned_cols=176  Identities=37%  Similarity=0.634  Sum_probs=144.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.++++|||++ ++|.+++......+++..++.++.|++.+|.+||. .|++|+||+|.||+++.++.++|+|||
T Consensus        65 ~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             EEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecc
Confidence            4556788999999999 49999998755689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .+.............++..|++||.+.+.     .++.++|+||||+++|+|++|..||.... .......+.....+.+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~  217 (253)
T cd05122         144 LSAQLSDTKARNTMVGTPYWMAPEVINGK-----PYDYKADIWSLGITAIELAEGKPPYSELP-PMKALFKIATNGPPGL  217 (253)
T ss_pred             ccccccccccccceecCCcccCHHHHcCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCc-hHHHHHHHHhcCCCCc
Confidence            98766544323345678899999998532     47889999999999999999999998743 3333434444445555


Q ss_pred             CCCcchhHHHHHHHHhccCCChHH
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEF  185 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~  185 (296)
                      +....++..+.++|.+||..+|+.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~  241 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEK  241 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhh
Confidence            555446899999999999999983

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=9.3e-29  Score=221.07  Aligned_cols=156  Identities=24%  Similarity=0.374  Sum_probs=121.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCcccc
Q psy3686          31 SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERI  107 (296)
Q Consensus        31 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~  107 (296)
                      .+++..+..++.||+.||.|||+ .||+||||||.||+++.++.++|+|||++..+....   ......++..|+|||.+
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  247 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI  247 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence            68999999999999999999999 599999999999999999999999999997653221   11223456789999998


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+     ..++.++|||||||++|+|++ |..||.+..........+..+..+..+.  .+++.+.+++.+||..+|+.|
T Consensus       248 ~~-----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         248 FD-----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE--YATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             cC-----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCc--cCCHHHHHHHHHHccCChhhC
Confidence            43     368889999999999999998 9999987443333344444444444433  378999999999999999833


Q ss_pred             hhhccCCccc
Q psy3686         187 RKRSYEDKST  196 (296)
Q Consensus       187 ~~~~~~~~~~  196 (296)
                        +++.++..
T Consensus       321 --Ps~~ell~  328 (337)
T cd05054         321 --PTFSELVE  328 (337)
T ss_pred             --cCHHHHHH
Confidence              44444433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=8.7e-29  Score=219.11  Aligned_cols=188  Identities=23%  Similarity=0.361  Sum_probs=139.5

Q ss_pred             cCCeEEEEecCccccHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----CCCC
Q psy3686           6 KESDVWICMELMATCFDRLLKRL--------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERG   73 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~----~~~~   73 (296)
                      .+..+|+||||+.++|.+++...        ...+++..++.++.||+.||.|||+ +||+||||||+|||+    +.++
T Consensus        71 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~  149 (317)
T cd07868          71 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG  149 (317)
T ss_pred             CCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcC
Confidence            45678999999999999888643        2358999999999999999999999 599999999999999    4567


Q ss_pred             CEEEeccCCcccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---
Q psy3686          74 NIKLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD---  146 (296)
Q Consensus        74 ~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---  146 (296)
                      .+||+|||++.......    ......+|..|+|||++.+.    ..++.++||||+||++|+|++|..||......   
T Consensus       150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~  225 (317)
T cd07868         150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  225 (317)
T ss_pred             cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCC----CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccc
Confidence            89999999997654322    22334678999999998632    35788999999999999999999999753221   


Q ss_pred             -----HHHHHHHHc--cCCC--------CCC-------------------------CCcchhHHHHHHHHhccCCChHHH
Q psy3686         147 -----FEVLSRVLN--DAPP--------CLP-------------------------NDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       147 -----~~~~~~i~~--~~~p--------~~~-------------------------~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                           ...+..+..  +.++        .++                         .....+..+.+||.+||..||.  
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~--  303 (317)
T cd07868         226 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI--  303 (317)
T ss_pred             cccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcc--
Confidence                 111222211  0000        000                         0011346788999999999998  


Q ss_pred             hhhccCCccchhhcccCCcc
Q psy3686         187 RKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~  206 (296)
                            .|.++.+++.++|+
T Consensus       304 ------~R~t~~e~l~hp~f  317 (317)
T cd07868         304 ------KRITSEQAMQDPYF  317 (317)
T ss_pred             ------cCCCHHHHhcCCCC
Confidence                  67777787777753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=6.3e-29  Score=218.83  Aligned_cols=178  Identities=23%  Similarity=0.307  Sum_probs=134.4

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH------------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVK   63 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlk   63 (296)
                      ++.+++.+|+||||+. |+|.+++....                  ..+++..++.++.||+.||.|||+ +||+|||||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ivH~dlk  165 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LNFVHRDLA  165 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CCccccCcc
Confidence            4566788999999998 59999986531                  246788999999999999999999 599999999


Q ss_pred             CCcEEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCC
Q psy3686          64 PSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT--GEF  138 (296)
Q Consensus        64 p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~--g~~  138 (296)
                      |+|||++.++.+||+|||++........   .....++..|+|||.+.+     ..++.++||||||+++|+|++  +..
T Consensus       166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-----GKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-----CCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999876533221   122345678999999843     368889999999999999987  567


Q ss_pred             CCCCCCCcHHHHHHHH---ccC--CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         139 PYKDCKCDFEVLSRVL---NDA--PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       139 Pf~~~~~~~~~~~~i~---~~~--~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ||... .....+..+.   ...  .........++..+.+||.+||..+|+.||
T Consensus       241 p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP  293 (304)
T cd05096         241 PYGEL-TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP  293 (304)
T ss_pred             CCCcC-CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence            88763 3333332221   111  111112223789999999999999998444

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=1.1e-28  Score=211.47  Aligned_cols=175  Identities=22%  Similarity=0.383  Sum_probs=144.8

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++...+++|+||||+.| +|.+++... ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d  144 (256)
T cd08218          66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGD  144 (256)
T ss_pred             eeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEee
Confidence            456788899999999985 999998764 3468999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||.+........ .....++..|+|||.+.+     ..++.++|+||||+++|++++|..||.. ....+....+..+..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~  218 (256)
T cd08218         145 FGIARVLNSTVELARTCIGTPYYLSPEICEN-----RPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSY  218 (256)
T ss_pred             ccceeecCcchhhhhhccCCccccCHHHhCC-----CCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCC
Confidence            999876543321 123357788999999853     3577899999999999999999999987 344556666667666


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEF  185 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~  185 (296)
                      +..+..  ++..+.++|.+||+.+|+.
T Consensus       219 ~~~~~~--~~~~~~~li~~~l~~~p~~  243 (256)
T cd08218         219 PPVSSH--YSYDLRNLVSQLFKRNPRD  243 (256)
T ss_pred             CCCccc--CCHHHHHHHHHHhhCChhh
Confidence            555543  7999999999999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=5.6e-29  Score=216.22  Aligned_cols=175  Identities=23%  Similarity=0.292  Sum_probs=137.1

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC--
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG--   73 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~--   73 (296)
                      .+.+.+..|+||||+. |+|.+++....      ..+++..++.++.||+.||+|||+ .|++|+||+|+||+++.++  
T Consensus        77 ~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          77 VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             EEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCC
Confidence            4566778899999998 59999997642      258999999999999999999999 5999999999999998654  


Q ss_pred             -CEEEeccCCcccccCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHH
Q psy3686          74 -NIKLCDFGISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFE  148 (296)
Q Consensus        74 -~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~  148 (296)
                       .+||+|||++.........   .....+..|+|||.+.     ...++.++|||||||++|+|++ |..||... ....
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~  229 (277)
T cd05036         156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-----DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQE  229 (277)
T ss_pred             cceEeccCccccccCCccceecCCCCCccHhhCCHHHHh-----cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHH
Confidence             5899999998765322111   1223346799999984     3368899999999999999997 99999873 3344


Q ss_pred             HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         149 VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       149 ~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ....+.....+..+.  .++..+.++|.+||..+|+.|
T Consensus       230 ~~~~~~~~~~~~~~~--~~~~~~~~~i~~cl~~~p~~R  265 (277)
T cd05036         230 VMEFVTGGGRLDPPK--GCPGPVYRIMTDCWQHTPEDR  265 (277)
T ss_pred             HHHHHHcCCcCCCCC--CCCHHHHHHHHHHcCCCcccC
Confidence            454554444444433  378999999999999999833

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=7.3e-29  Score=214.21  Aligned_cols=176  Identities=23%  Similarity=0.300  Sum_probs=140.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+.+.+|+||||+++ +|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          74 VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             EEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCc
Confidence            45677889999999995 9999997766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcccc----ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHcc
Q psy3686          82 ISGRLVDSKART----KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        82 ~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      ++..........    ....+..|+|||.+.+     ..++.++|||||||++|++++ |..||... ........+..+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~  226 (268)
T cd05063         153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-----RKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDG  226 (268)
T ss_pred             cceecccccccceeccCCCcCceecCHHHhhc-----CCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcC
Confidence            987654321111    1123457999999843     367889999999999999997 99999773 444555555554


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .....+  ..++..+.+++.+||..+|+.||
T Consensus       227 ~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp  255 (268)
T cd05063         227 FRLPAP--MDCPSAVYQLMLQCWQQDRARRP  255 (268)
T ss_pred             CCCCCC--CCCCHHHHHHHHHHcCCCcccCc
Confidence            332222  23789999999999999998444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=8.4e-29  Score=218.02  Aligned_cols=176  Identities=21%  Similarity=0.294  Sum_probs=138.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++..++.+|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||+ +|++|+||||+||+++.++.++|+||
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCC
Confidence            4567788999999998 59999997643 348999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHcc
Q psy3686          81 GISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        81 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      |++........   .....++..|+|||.+.+     ..++.++||||+||++|+|++ |..||............+..+
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~  260 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG  260 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhcc-----CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence            99876543221   112245678999999843     357889999999999999998 999998744433333333333


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ..+..+.  ..+..+.++|.+||..+|+.|
T Consensus       261 ~~~~~~~--~~~~~~~~li~~cl~~~p~~R  288 (302)
T cd05055         261 YRMAQPE--HAPAEIYDIMKTCWDADPLKR  288 (302)
T ss_pred             CcCCCCC--CCCHHHHHHHHHHcCCCchhC
Confidence            3333332  368999999999999999844

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=9.9e-29  Score=212.20  Aligned_cols=178  Identities=28%  Similarity=0.450  Sum_probs=144.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.++..+|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||+ +|++|+||+|.||+++.++.++|+|||
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          68 SFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             hhcCCCeEEEEEeCCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeecc
Confidence            46678899999999985 99999976 4689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-HHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD-FEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-~~~~~~i~~~~~p~  160 (296)
                      .+.............++..|+|||.+..     ..++.++|+||||+++|+|++|..||...... ...+........+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  220 (258)
T cd05578         146 IATKVTPDTLTTSTSGTPGYMAPEVLCR-----QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL  220 (258)
T ss_pred             cccccCCCccccccCCChhhcCHHHHcc-----cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc
Confidence            9876654433344567889999999853     24788999999999999999999999874431 22222333323333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKR  189 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~  189 (296)
                      .+.  .++..+.++|.+||..+|..|+..
T Consensus       221 ~~~--~~~~~~~~~i~~~l~~~p~~R~~~  247 (258)
T cd05578         221 YPA--TWSTEAIDAINKLLERDPQKRLGD  247 (258)
T ss_pred             Ccc--cCcHHHHHHHHHHccCChhHcCCc
Confidence            443  378999999999999999955543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=7.8e-29  Score=220.58  Aligned_cols=194  Identities=23%  Similarity=0.422  Sum_probs=146.0

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ++|.+++.+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+++.|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~  144 (327)
T cd08227          66 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSG  144 (327)
T ss_pred             EEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcc
Confidence            35678889999999999 5999999754 3569999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCcc--------ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHH
Q psy3686          80 FGISGRLVDSKA--------RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS  151 (296)
Q Consensus        80 fg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~  151 (296)
                      |+..........        .....++..|+|||.+.+.   ...++.++|||||||++|+|++|..||...... ....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~  220 (327)
T cd08227         145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLL  220 (327)
T ss_pred             cchhhccccccccccccccccccccceecccChHHhhcc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh-HHHH
Confidence            986543321111        1122456779999998532   125788999999999999999999999864322 2222


Q ss_pred             HHHccCCCCC-------------------------------------------CCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         152 RVLNDAPPCL-------------------------------------------PNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       152 ~i~~~~~p~~-------------------------------------------~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      ....+..+..                                           +....+++.+.+||.+||..||+    
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~----  296 (327)
T cd08227         221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD----  296 (327)
T ss_pred             HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch----
Confidence            2222221110                                           11123578999999999999998    


Q ss_pred             hccCCccchhhcccCCcccc
Q psy3686         189 RSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~  208 (296)
                          .|.++.+++.++|+..
T Consensus       297 ----~Rpt~~ell~~p~f~~  312 (327)
T cd08227         297 ----ARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ----hcCCHHHHhcChhhhh
Confidence                6666777888887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=8.3e-29  Score=212.93  Aligned_cols=189  Identities=33%  Similarity=0.610  Sum_probs=154.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE-THGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+..++.+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+ . |++|+||+|+||+++.++.++|+||
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df  144 (264)
T cd06623          67 AFYKEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADF  144 (264)
T ss_pred             EEccCCeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccC
Confidence            4567789999999999 599999986 4789999999999999999999999 7 9999999999999999999999999


Q ss_pred             CCcccccCCccc-cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKAR-TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK--CDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~--~~~~~~~~i~~~~  157 (296)
                      |.+......... ....++..|+|||.+..     ..++.++|+||||+++|+|++|..||....  ...+....+....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  219 (264)
T cd06623         145 GISKVLENTLDQCNTFVGTVTYMSPERIQG-----ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP  219 (264)
T ss_pred             ccceecccCCCcccceeecccccCHhhhCC-----CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC
Confidence            998766433322 23467889999999843     367889999999999999999999998754  4445555666555


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .+.++... ++..+.++|.+||..+|+        ++.++.++..+++++
T Consensus       220 ~~~~~~~~-~~~~l~~li~~~l~~~p~--------~R~~~~~ll~~~~~~  260 (264)
T cd06623         220 PPSLPAEE-FSPEFRDFISACLQKDPK--------KRPSAAELLQHPFIK  260 (264)
T ss_pred             CCCCCccc-CCHHHHHHHHHHccCChh--------hCCCHHHHHhCHHHH
Confidence            55554432 799999999999999998        555666666666654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=7.9e-29  Score=213.77  Aligned_cols=179  Identities=25%  Similarity=0.456  Sum_probs=142.2

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      .+|..++.+++||||+.| +|.+++...   ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|
T Consensus        69 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             heeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEE
Confidence            456778899999999995 999988642   4568999999999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-HHHHHHHHc
Q psy3686          78 CDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD-FEVLSRVLN  155 (296)
Q Consensus        78 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-~~~~~~i~~  155 (296)
                      +|||++........ .....++..|+|||.+.+     ..++.++|+||||+++|+|++|..||...... ......+..
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T cd08229         148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ  222 (267)
T ss_pred             CcchhhhccccCCcccccccCCcCccCHHHhcC-----CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc
Confidence            99998876543221 223467889999999843     35778999999999999999999999764332 233334444


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ...+..+.. .++..+.++|.+||..+|+.||
T Consensus       223 ~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rp  253 (267)
T cd08229         223 CDYPPLPSD-HYSEELRQLVNMCINPDPEKRP  253 (267)
T ss_pred             CCCCCCCcc-cccHHHHHHHHHhcCCCcccCC
Confidence            444444332 3789999999999999998444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=6.1e-29  Score=216.55  Aligned_cols=176  Identities=20%  Similarity=0.291  Sum_probs=140.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL----------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS   65 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~   65 (296)
                      ++..++..|+||||+. |+|.+++...                ...+++..+..++.||+.||.|||+ +|++|+||||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~  153 (283)
T cd05090          75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAAR  153 (283)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccc
Confidence            4566788999999999 5999998532                1347889999999999999999999 59999999999


Q ss_pred             cEEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy3686          66 NILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK  141 (296)
Q Consensus        66 Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~  141 (296)
                      ||+++.++.++|+|||++.......   ......++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.
T Consensus       154 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-----GKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             eEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-----CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999997654322   1222345667999999843     357889999999999999998 999998


Q ss_pred             CCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         142 DCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       142 ~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +. ........+.....+..+.  .++..+.++|.+||..+|..||
T Consensus       229 ~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp  271 (283)
T cd05090         229 GF-SNQEVIEMVRKRQLLPCSE--DCPPRMYSLMTECWQEGPSRRP  271 (283)
T ss_pred             CC-CHHHHHHHHHcCCcCCCCC--CCCHHHHHHHHHHcccCcccCc
Confidence            73 4445555555554444433  3799999999999999998444

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=7.7e-29  Score=226.07  Aligned_cols=156  Identities=23%  Similarity=0.350  Sum_probs=121.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCcccc
Q psy3686          31 SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERI  107 (296)
Q Consensus        31 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~  107 (296)
                      .+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++........   .....++..|+|||.+
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  311 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI  311 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence            47888899999999999999999 5999999999999999999999999999876533221   1223456789999998


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+     ..++.++|||||||++|+|++ |..||............+..+..+..+  ..++..+.++|.+||..+|+.|
T Consensus       312 ~~-----~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~R  384 (400)
T cd05105         312 FD-----NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKR  384 (400)
T ss_pred             cC-----CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHCccCHhHC
Confidence            53     367889999999999999997 999998754444444555555443333  3479999999999999999855


Q ss_pred             hhhccCCccc
Q psy3686         187 RKRSYEDKST  196 (296)
Q Consensus       187 ~~~~~~~~~~  196 (296)
                      |  ++.++..
T Consensus       385 P--t~~~l~~  392 (400)
T cd05105         385 P--SFLHLSD  392 (400)
T ss_pred             c--CHHHHHH
Confidence            4  4444433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=8.4e-29  Score=213.10  Aligned_cols=176  Identities=24%  Similarity=0.342  Sum_probs=140.0

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++..++.+|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             EEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCc
Confidence            4566788999999996 69999997642 468999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccc--cccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKARTK--NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |++...........  ...+..|+|||.+.+     ..++.++||||||+++|+|++ |+.||.+ ......+..+....
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~  221 (261)
T cd05068         148 GLARVIKEDIYEAREGAKFPIKWTAPEAALY-----NRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGY  221 (261)
T ss_pred             ceEEEccCCcccccCCCcCceeccCcccccc-----CCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC
Confidence            99877653321111  122357999998843     367889999999999999999 9999987 34445555555543


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+  ..++..+.++|.+||..+|..||
T Consensus       222 ~~~~~--~~~~~~~~~li~~~l~~~P~~Rp  249 (261)
T cd05068         222 RMPCP--PGCPKELYDIMLDCWKEDPDDRP  249 (261)
T ss_pred             CCCCC--CcCCHHHHHHHHHHhhcCcccCC
Confidence            33333  23789999999999999998443

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=8.5e-29  Score=213.55  Aligned_cols=179  Identities=23%  Similarity=0.434  Sum_probs=142.0

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +++.+.+.+|+||||+++ +|.+++...   ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|
T Consensus        69 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             eeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEE
Confidence            456678899999999994 999888642   4568999999999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-HHHHHHHHc
Q psy3686          78 CDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD-FEVLSRVLN  155 (296)
Q Consensus        78 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-~~~~~~i~~  155 (296)
                      +|||++........ .....++..|+|||.+.+     ..++.++|+||+|+++|+|++|..||...... ......+..
T Consensus       148 ~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T cd08228         148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ  222 (267)
T ss_pred             CccccceeccchhHHHhcCCCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc
Confidence            99999876543321 223467789999999853     35778999999999999999999999764333 344444444


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ...+..+.. .++..+.++|.+||..+|+.||
T Consensus       223 ~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rp  253 (267)
T cd08228         223 CDYPPLPTE-HYSEKLRELVSMCIYPDPDQRP  253 (267)
T ss_pred             CCCCCCChh-hcCHHHHHHHHHHCCCCcccCc
Confidence            444444332 3789999999999999998433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.3e-28  Score=211.84  Aligned_cols=174  Identities=22%  Similarity=0.347  Sum_probs=137.8

Q ss_pred             ccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           5 SKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         5 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..++..|+||||+. |+|.+++......++...+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++
T Consensus        67 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~  145 (262)
T cd05058          67 PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLA  145 (262)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCcccc
Confidence            34667899999999 59999998755667888899999999999999999 59999999999999999999999999998


Q ss_pred             ccccCCc-----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          84 GRLVDSK-----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        84 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      .......     ......++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.. .........+..+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~  219 (262)
T cd05058         146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGR  219 (262)
T ss_pred             ccccCCcceeecccccCcCCccccChhHhcc-----CccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC
Confidence            6543221     1112245668999999843     367889999999999999999 4566765 34445555566655


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+.  .++..+.++|.+||..+|+.||
T Consensus       220 ~~~~~~--~~~~~~~~li~~cl~~~p~~Rp  247 (262)
T cd05058         220 RLLQPE--YCPDPLYEVMLSCWHPKPEMRP  247 (262)
T ss_pred             CCCCCC--cCCHHHHHHHHHHcCCChhhCC
Confidence            444443  3689999999999999998443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=9.9e-29  Score=217.56  Aligned_cols=176  Identities=19%  Similarity=0.275  Sum_probs=140.0

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+...+.+|+||||+. |+|.+++....               ..++...++.++.||+.||.|||+ +|++|+||||+|
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  167 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARN  167 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccce
Confidence            4566788999999998 59999997631               357888999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.++|+|||++........   .....++..|+|||.+.+     ..++.++||||||+++|++++ |..||..
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999876543221   112234568999999843     367889999999999999998 8889977


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                       ....+....+..+..+..+.  .++..+.+||.+||..+|+.|+
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp  284 (304)
T cd05101         243 -IPVEELFKLLKEGHRMDKPA--NCTNELYMMMRDCWHAIPSHRP  284 (304)
T ss_pred             -CCHHHHHHHHHcCCcCCCCC--CCCHHHHHHHHHHcccChhhCC
Confidence             34445555555554444433  3799999999999999998443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=2e-28  Score=216.62  Aligned_cols=190  Identities=28%  Similarity=0.434  Sum_probs=152.3

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ++.++...|+||||+.|+|.+++......+++..++.++.||+.+|.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        89 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             EEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCC
Confidence            456778899999999999989887767789999999999999999999999 5999999999999999999999999998


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      +....   ......++..|+|||.+...  ....++.++||||||+++|+|++|..||... ........+.....+...
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~  241 (313)
T cd06633         168 ASKSS---PANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLQ  241 (313)
T ss_pred             CcccC---CCCCccccccccChhhcccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCC
Confidence            85432   22334678899999998532  1235778999999999999999999999874 344444455554444444


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .. .++..+++||.+||+.+|.        ++.+..++..++++..
T Consensus       242 ~~-~~~~~l~~li~~~l~~~P~--------~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         242 SN-EWTDSFRGFVDYCLQKIPQ--------ERPASAELLRHDFVRR  278 (313)
T ss_pred             cc-ccCHHHHHHHHHHccCChh--------hCcCHHHHhcCcccCC
Confidence            33 3788999999999999998        5556667777776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=1.2e-28  Score=214.65  Aligned_cols=191  Identities=22%  Similarity=0.353  Sum_probs=147.7

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.+.+++.+|+||||+.++|.+++......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        66 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          66 DVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             eEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeee
Confidence            3456788999999999669999998766789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-  158 (296)
                      .+.......  ......++..|+|||.+.+    ...++.++||||+|+++|+|++|..||.+ ......+..+..... 
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~-~~~~~~~~~~~~~~~~  219 (286)
T cd07832         145 LARLFSEEEPRLYSHQVATRWYRAPELLYG----ARKYDPGVDLWAVGCIFAELLNGSPLFPG-ENDIEQLAIVFRTLGT  219 (286)
T ss_pred             ecccccCCCCCccccccCcccccCceeeec----cccCCchhHHHHHHHHHHHHHcCCcCcCC-CCHHHHHHHHHHHcCC
Confidence            987654332  1233467889999999853    22567899999999999999999888876 333344433332100 


Q ss_pred             C-----------------CCC---------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 P-----------------CLP---------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 p-----------------~~~---------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      +                 .++         .....+..+.++|.+||..+|.        +|.++.+++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~--------~R~~~~~~l~h~~~  285 (286)
T cd07832         220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS--------KRLSAAEALRHPYF  285 (286)
T ss_pred             CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChh--------hCCCHHHHhhCcCc
Confidence            0                 000         0123578999999999999998        55566666666653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=9.6e-29  Score=214.65  Aligned_cols=186  Identities=34%  Similarity=0.569  Sum_probs=147.4

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..++.+|+||||++| +|.+++.  ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06642          69 GSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             cccccCCceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccc
Confidence            467788899999999995 9999886  4679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||... ........+..+..+
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~  219 (277)
T cd06642         146 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-----SAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPP  219 (277)
T ss_pred             cccccccCcchhhhcccCcccccCHHHhCc-----CCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCCCC
Confidence            9987654332 2223357889999999853     36788999999999999999999999763 333334344444444


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .++.  .++..+.++|.+||..+|+        ++.+..++..++++
T Consensus       220 ~~~~--~~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~~  256 (277)
T cd06642         220 TLEG--QYSKPFKEFVEACLNKDPR--------FRPTAKELLKHKFI  256 (277)
T ss_pred             CCCc--ccCHHHHHHHHHHccCCcc--------cCcCHHHHHHhHHH
Confidence            4433  3789999999999999998        44445555555543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=5e-29  Score=218.08  Aligned_cols=175  Identities=20%  Similarity=0.288  Sum_probs=140.1

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL---------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      ++..++.+|+||||+. |+|..++...               ...+++..++.++.||+.||.|||+ +||+|+||||.|
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~N  162 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARN  162 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceee
Confidence            4567788999999998 5999999642               3568999999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.++|+|||++..+.....   .....++..|+|||.+.     ...++.++|||||||++|++++ |..||..
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-----cCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            9999999999999999876543221   11123456799999884     3367889999999999999998 9999987


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                       ....+....+..+..+..+.  .++..+.+||.+||..+|..|
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R  278 (293)
T cd05053         238 -IPVEELFKLLKEGYRMEKPQ--NCTQELYHLMRDCWHEVPSQR  278 (293)
T ss_pred             -CCHHHHHHHHHcCCcCCCCC--CCCHHHHHHHHHHcccCcccC
Confidence             34445555555554444433  368999999999999999843

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=9.5e-29  Score=212.75  Aligned_cols=173  Identities=24%  Similarity=0.351  Sum_probs=138.8

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..+..|+||||+.+ +|.+++... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~  149 (260)
T cd05069          71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLA  149 (260)
T ss_pred             cCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccc
Confidence            45678999999995 999999764 3458999999999999999999999 59999999999999999999999999998


Q ss_pred             ccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          84 GRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        84 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .........  ....++..|+|||.+.     ...++.++||||||+++|+|++ |..||.+ .........+..+..+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~  223 (260)
T cd05069         150 RLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRMP  223 (260)
T ss_pred             eEccCCcccccCCCccchhhCCHHHhc-----cCCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence            765433211  1224556799999884     3367889999999999999999 9999987 34445555665554443


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+.  .++..+.++|.+||..+|+.||
T Consensus       224 ~~~--~~~~~~~~li~~~l~~~p~~Rp  248 (260)
T cd05069         224 CPQ--GCPESLHELMKLCWKKDPDERP  248 (260)
T ss_pred             CCc--ccCHHHHHHHHHHccCCcccCc
Confidence            333  3789999999999999998554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=5.9e-29  Score=216.54  Aligned_cols=176  Identities=19%  Similarity=0.276  Sum_probs=141.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL---------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+.+.+.+++++||+. ++|.+++...               ...++...++.++.|++.||.|||+ +|++||||||.|
T Consensus        76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~N  154 (283)
T cd05091          76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRN  154 (283)
T ss_pred             EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhh
Confidence            3456678999999999 5999998532               2358889999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.+||+|||++........   .....+++.|+|||.+.+     ..++.++|||||||++|+|++ |..||.+
T Consensus       155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-----GKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999876543221   122345678999999843     357889999999999999998 8889987


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                       ....+....+..+..+..+..  ++..+.++|.+||+.+|+.||
T Consensus       230 -~~~~~~~~~i~~~~~~~~~~~--~~~~~~~li~~cl~~~p~~RP  271 (283)
T cd05091         230 -YSNQDVIEMIRNRQVLPCPDD--CPAWVYTLMLECWNEFPSRRP  271 (283)
T ss_pred             -CCHHHHHHHHHcCCcCCCCCC--CCHHHHHHHHHHhCCCcccCC
Confidence             445566667766665544443  799999999999999998443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=1.4e-28  Score=214.04  Aligned_cols=187  Identities=36%  Similarity=0.653  Sum_probs=145.0

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++..++.+++||||++| +|..+     ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+||
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          66 GAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             EEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeC
Confidence            456778899999999995 77543     357899999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------cHHHHHHHH
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC------DFEVLSRVL  154 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~------~~~~~~~i~  154 (296)
                      |++...... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||.....      .......+.
T Consensus       140 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  213 (279)
T cd06619         140 GVSTQLVNS-IAKTYVGTNAYMAPERISG-----EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV  213 (279)
T ss_pred             Ccceecccc-cccCCCCChhhcCceeecC-----CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh
Confidence            998765432 2233478889999999953     3678899999999999999999999965221      112233333


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      ....+.++.. .+++.+.++|.+||..+|+        .+.+..++..++++...
T Consensus       214 ~~~~~~~~~~-~~~~~~~~li~~~l~~~P~--------~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         214 DEDPPVLPVG-QFSEKFVHFITQCMRKQPK--------ERPAPENLMDHPFIVQY  259 (279)
T ss_pred             ccCCCCCCCC-cCCHHHHHHHHHHhhCChh--------hCCCHHHHhcCcccccc
Confidence            3444444332 3789999999999999998        44456666667665443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=2.4e-28  Score=216.50  Aligned_cols=188  Identities=29%  Similarity=0.432  Sum_probs=149.9

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ++.++...|+||||+.|+|.+++.....++++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             EEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCC
Confidence            456778899999999999888887667789999999999999999999999 5999999999999999999999999998


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      +.....   .....++..|+|||.+...  ....++.++||||||+++|+|++|..||... ........+..+..+..+
T Consensus       172 ~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~  245 (317)
T cd06635         172 ASIASP---ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQ  245 (317)
T ss_pred             ccccCC---cccccCCccccChhhhhcC--CCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCCCCC
Confidence            765432   2234678899999998432  1235788999999999999999999999873 444455555555444443


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .. .++..++++|.+||..+|.        ++.+..++..+.+.
T Consensus       246 ~~-~~~~~l~~li~~~l~~~p~--------~Rpt~~~il~~~~~  280 (317)
T cd06635         246 SN-EWSDYFRNFVDSCLQKIPQ--------DRPTSEELLKHMFV  280 (317)
T ss_pred             Cc-cccHHHHHHHHHHccCCcc--------cCcCHHHHHhChhh
Confidence            32 3789999999999999998        44455666666554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=1.2e-28  Score=212.96  Aligned_cols=177  Identities=24%  Similarity=0.299  Sum_probs=139.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||++| +|.+++......+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          73 VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             EECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCc
Confidence            45677889999999985 9999998766779999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcccc---c-cc--cCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHH
Q psy3686          82 ISGRLVDSKART---K-NA--GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVL  154 (296)
Q Consensus        82 ~~~~~~~~~~~~---~-~~--~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~  154 (296)
                      ++..........   . ..  .+..|+|||.+.     ...++.++||||||+++|++++ |..||... ........+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~  225 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIE  225 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhc-----cCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHH
Confidence            986554322111   1 11  134799999984     3367889999999999999886 99999873 3444555554


Q ss_pred             ccCCCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         155 NDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       155 ~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      .......  ...++..+.+++.+||..+|+.||.
T Consensus       226 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~  257 (269)
T cd05065         226 QDYRLPP--PMDCPTALHQLMLDCWQKDRNARPK  257 (269)
T ss_pred             cCCcCCC--cccCCHHHHHHHHHHcCCChhhCcC
Confidence            4332222  2347899999999999999985543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=9.4e-29  Score=218.05  Aligned_cols=181  Identities=19%  Similarity=0.274  Sum_probs=140.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      ++..++.+|+||||+. |+|.+++....               ..++...++.++.||+.||+|||+ +|++|+||||+|
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  170 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  170 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence            4566788999999999 59999997632               258899999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.++|+|||.+........   .....++..|+|||.+.+     ..++.++|||||||++|+|++ |..||..
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-----CCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            9999999999999999875532211   111133468999999853     367889999999999999998 8899976


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                       ....+....+..+..+..+.  .++..+.++|.+||..+|..||  ++.++
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp--s~~ev  292 (307)
T cd05098         246 -VPVEELFKLLKEGHRMDKPS--NCTNELYMMMRDCWHAVPSQRP--TFKQL  292 (307)
T ss_pred             -CCHHHHHHHHHcCCCCCCCC--cCCHHHHHHHHHHcccChhhCc--CHHHH
Confidence             34444444444444334433  3789999999999999998443  44444

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=1.1e-28  Score=212.37  Aligned_cols=173  Identities=25%  Similarity=0.344  Sum_probs=138.9

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..+..|+||||+.+ +|.+++... ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             CCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceee
Confidence            45568999999984 999999754 3468999999999999999999999 59999999999999999999999999999


Q ss_pred             ccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          84 GRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        84 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .........  ....++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.. ....+....+..+..+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~  223 (260)
T cd05070         150 RLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRMP  223 (260)
T ss_pred             eeccCcccccccCCCCCccccChHHHhc-----CCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence            765433211  11234567999998843     367889999999999999999 8999987 34445566665554444


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+.  .++..+.++|.+||..+|+.||
T Consensus       224 ~~~--~~~~~~~~li~~~l~~~p~~Rp  248 (260)
T cd05070         224 CPQ--DCPISLHELMLQCWKKDPEERP  248 (260)
T ss_pred             CCC--cCCHHHHHHHHHHcccCcccCc
Confidence            443  3789999999999999998554

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.9e-28  Score=214.82  Aligned_cols=190  Identities=29%  Similarity=0.502  Sum_probs=152.5

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..++++|+||||+++ +|.+++.  ...+++..++.++.|++.+|+|||+ .|++|+||+|.||+++.++.++|+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg  161 (292)
T cd06657          85 SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFG  161 (292)
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccc
Confidence            56678899999999995 9999876  4578999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|++||.+.+     ..++.++|+||+|+++|+|++|..||.. .........+....++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~  235 (292)
T cd06657         162 FCAQVSKEVPRRKSLVGTPYWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPK  235 (292)
T ss_pred             cceecccccccccccccCccccCHHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcc
Confidence            876543321 2233467889999998843     3567899999999999999999999987 34444444444444445


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +.....++..+.++|.+||..+|.        ++.+..+++.++++...
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~P~--------~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         236 LKNLHKVSPSLKGFLDRLLVRDPA--------QRATAAELLKHPFLAKA  276 (292)
T ss_pred             cCCcccCCHHHHHHHHHHHhCCcc--------cCcCHHHHhcChHHhcc
Confidence            544445789999999999999998        66667777777766443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=2.1e-28  Score=213.85  Aligned_cols=196  Identities=23%  Similarity=0.307  Sum_probs=149.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|..++.+|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          73 AFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCc
Confidence            46677889999999995 99999976 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---cHHHHHHHHcc
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC---DFEVLSRVLND  156 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~---~~~~~~~i~~~  156 (296)
                      ++.......  ......++..|+|||.+...   ...++.++||||||+++|+|++|..||.....   .......+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  227 (290)
T cd05613         151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGG---DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  227 (290)
T ss_pred             cceecccccccccccccCCcccCChhhccCC---CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence            987654322  11234578899999998532   12456789999999999999999999974211   12223333333


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      . +.++.  .+++.+.+++.+||..+|+.|+...   ...+.+++.++++...
T Consensus       228 ~-~~~~~--~~~~~~~~ll~~~l~~~p~~R~~~~---~~~~~~l~~~~~~~~~  274 (290)
T cd05613         228 E-PPYPQ--EMSALAKDIIQRLLMKDPKKRLGCG---PSDADEIKKHPFFQKI  274 (290)
T ss_pred             C-CCCCc--cCCHHHHHHHHHHhcCCHHHhcCCC---CCCHHHHHcCcccccC
Confidence            3 33333  3789999999999999999665332   3345556666665443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.1e-28  Score=209.90  Aligned_cols=174  Identities=21%  Similarity=0.292  Sum_probs=139.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+.+++..|+||||++ ++|.+++.... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+||
T Consensus        68 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             EEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCCCEEEccc
Confidence            4556889999999999 59999997643 379999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |.+........  ....+..|+|||.+..     ..++.++||||||+++|++++ |..||... ........+..+..+
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~ape~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~  218 (256)
T cd05039         147 GLAKEASQGQD--SGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRM  218 (256)
T ss_pred             ccccccccccc--cCCCcccccCchhhcC-----CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCC
Confidence            99876532222  2244567999999843     367789999999999999997 99999873 444444444444343


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+.  .+++.+.++|.+||..+|+.||
T Consensus       219 ~~~~--~~~~~~~~li~~~l~~~p~~Rp  244 (256)
T cd05039         219 EAPE--GCPPEVYKVMKDCWELDPAKRP  244 (256)
T ss_pred             CCcc--CCCHHHHHHHHHHhccChhhCc
Confidence            3333  3799999999999999998443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.6e-28  Score=211.91  Aligned_cols=172  Identities=24%  Similarity=0.310  Sum_probs=132.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCC-------
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN-------   74 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~-------   74 (296)
                      ++..+...++||||++ |+|..++......+++..++.++.||+.||.|||+ .||+||||||+|||++.++.       
T Consensus        72 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          72 VCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCce
Confidence            4566778899999999 59988887656779999999999999999999999 59999999999999987664       


Q ss_pred             EEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCcHHHHHHH
Q psy3686          75 IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELA-TGEFPYKDCKCDFEVLSRV  153 (296)
Q Consensus        75 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~-~g~~Pf~~~~~~~~~~~~i  153 (296)
                      ++++|||++......   ....++..|+|||.+..    ...++.++|||||||++|+|+ +|..||.... . ......
T Consensus       151 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~-~~~~~~  221 (262)
T cd05077         151 IKLSDPGIPITVLSR---QECVERIPWIAPECVED----SKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-L-AEKERF  221 (262)
T ss_pred             eEeCCCCCCccccCc---ccccccccccChhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-h-hHHHHH
Confidence            899999988654322   23356788999998852    236788999999999999998 4888887632 2 222222


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+.... .  ...+.++.+||.+||..+|..||
T Consensus       222 ~~~~~~~-~--~~~~~~~~~li~~cl~~dp~~Rp  252 (262)
T cd05077         222 YEGQCML-V--TPSCKELADLMTHCMNYDPNQRP  252 (262)
T ss_pred             HhcCccC-C--CCChHHHHHHHHHHcCCChhhCc
Confidence            2322221 1  12578899999999999998444

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=1.4e-28  Score=215.67  Aligned_cols=191  Identities=26%  Similarity=0.470  Sum_probs=150.6

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..++.+|+||||+.| +|.+++.+  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          83 DSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             heeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccC
Confidence            356677899999999984 99999974  568999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++....... ......++..|++||.+..     ..++.++|+||||+++|++++|..||.... ....+..+.....+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~  233 (293)
T cd06647         160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIATNGTP  233 (293)
T ss_pred             cceecccccccccccccCChhhcCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhhheeehhcCCCC
Confidence            9886554332 2233467788999999843     357889999999999999999999998743 22333333334444


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .++....++..++++|.+||..+|+        ++.+..++..+.++...
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~--------~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVE--------KRGSAKELLQHPFLKIA  275 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChh--------hCcCHHHHhcCHHHhcC
Confidence            4544445789999999999999998        44456667777766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.3e-28  Score=217.29  Aligned_cols=190  Identities=28%  Similarity=0.416  Sum_probs=150.6

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ++..+..+|+||||+.|+|.+++......+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             EEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCccc
Confidence            456678899999999999988887656779999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      +......   ....++..|+|||.+.+.  ....++.++|||||||++|+|++|..||... ........+..+..+...
T Consensus       162 ~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~  235 (308)
T cd06634         162 ASIMAPA---NXFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQ  235 (308)
T ss_pred             ceeecCc---ccccCCccccCHHHHhhc--ccCCCCcccchHHHHHHHHHHHcCCCCCccc-cHHHHHHHHhhcCCCCcC
Confidence            8654322   234577899999997532  1225678999999999999999999999874 333444455555544443


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .. .++..+.++|.+||..+|+        ++.+..++..+++...
T Consensus       236 ~~-~~~~~~~~li~~cl~~~P~--------~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         236 SG-HWSEYFRNFVDSCLQKIPQ--------DRPTSEVLLKHRFVLR  272 (308)
T ss_pred             cc-cccHHHHHHHHHHhhCCcc--------cCCCHHHHhhCccccc
Confidence            33 3899999999999999998        5556666666665433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=2e-28  Score=211.04  Aligned_cols=179  Identities=25%  Similarity=0.461  Sum_probs=143.2

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +++.+++.+++||||++| +|.+++...   ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             eeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEE
Confidence            456778899999999995 999998653   4568999999999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-HHHHHHHHc
Q psy3686          78 CDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD-FEVLSRVLN  155 (296)
Q Consensus        78 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-~~~~~~i~~  155 (296)
                      +|||++....... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||...... ......+..
T Consensus       148 ~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T cd08224         148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK  222 (267)
T ss_pred             eccceeeeccCCCcccceecCCccccCHHHhcc-----CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc
Confidence            9999987654322 1223467788999999853     36788999999999999999999999764332 233444445


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..+..+.. .++..+.++|.+||..+|+.||
T Consensus       223 ~~~~~~~~~-~~~~~~~~~i~~cl~~~p~~Rp  253 (267)
T cd08224         223 CDYPPLPAD-HYSEELRDLVSRCINPDPEKRP  253 (267)
T ss_pred             CCCCCCChh-hcCHHHHHHHHHHcCCCcccCC
Confidence            555445432 3789999999999999998444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=1.8e-28  Score=215.01  Aligned_cols=193  Identities=22%  Similarity=0.329  Sum_probs=148.1

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +++.+++.+|+||||+.|+|.+++......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg  147 (298)
T cd07841          69 DVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFG  147 (298)
T ss_pred             heeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccce
Confidence            4566788999999999779999997643479999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC--
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP--  158 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~--  158 (296)
                      ++....... ......++..|+|||.+.+    ...++.++|||||||++|+|++|..||... .....+.++.....  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~e~~~g~~~~~~~-~~~~~~~~~~~~~~~~  222 (298)
T cd07841         148 LARSFGSPNRKMTHQVVTRWYRAPELLFG----ARHYGVGVDMWSVGCIFAELLLRVPFLPGD-SDIDQLGKIFEALGTP  222 (298)
T ss_pred             eeeeccCCCccccccccceeeeCHHHHhC----CCCCCcHHHHHHHHHHHHHHHcCCccccCC-ccHHHHHHHHHHcCCC
Confidence            987654332 2223356778999998842    235688999999999999999998888763 34343333322100  


Q ss_pred             --------------------CCCC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 --------------------PCLP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 --------------------p~~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                          +..+   .....+..+.++|.+||..+|+        .+.+..++..+.++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~s~~e~l~~~~~~~  287 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPN--------KRITARQALEHPYFSN  287 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcc--------cCcCHHHHhhCccccC
Confidence                                0000   0123578999999999999998        5556777777776644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=2e-28  Score=209.42  Aligned_cols=176  Identities=23%  Similarity=0.315  Sum_probs=138.8

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+.+..|+||||+.| +|.+++......++...+..++.+++.+|.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        60 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g  138 (251)
T cd05041          60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFG  138 (251)
T ss_pred             EEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeecc
Confidence            45677889999999985 9999997656678999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      .+.........   .....+..|+|||.+.+     ..++.++|+||||+++|+|++ |..||... ........+....
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~  212 (251)
T cd05041         139 MSREEEGGIYTVSDGLKQIPIKWTAPEALNY-----GRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY  212 (251)
T ss_pred             ccccccCCcceeccccCcceeccCChHhhcc-----CCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC
Confidence            98754322111   11123557999999843     367889999999999999999 88999773 3334444444433


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+  ..++..+.++|.+||..+|..|+
T Consensus       213 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rp  240 (251)
T cd05041         213 RMPAP--QLCPEEIYRLMLQCWAYDPENRP  240 (251)
T ss_pred             CCCCC--ccCCHHHHHHHHHHhccChhhCc
Confidence            33333  23789999999999999998544

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.96  E-value=3.2e-28  Score=210.26  Aligned_cols=190  Identities=27%  Similarity=0.421  Sum_probs=145.8

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSV--PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl   77 (296)
                      +++..++.+++||||+.| +|.+++......+  ++..+..++.||+.||.|||+ .||+|+||+|.||+++. ++.++|
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             eeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEE
Confidence            456778899999999995 9999998654556  889999999999999999999 59999999999999976 678999


Q ss_pred             eccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH-Hc
Q psy3686          78 CDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV-LN  155 (296)
Q Consensus        78 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i-~~  155 (296)
                      +|||.+....... ......++..|+|||.+...   ...++.++|+||||+++|+|++|..||............. ..
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~  227 (268)
T cd06624         151 SDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG---PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF  227 (268)
T ss_pred             ecchhheecccCCCccccCCCCccccChhhhccc---cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh
Confidence            9999986553222 12233578899999998532   2246789999999999999999999997643332222222 22


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ...+.++..  +++.+.++|.+||..+|.        ++.++.++..++|
T Consensus       228 ~~~~~~~~~--~~~~~~~li~~~l~~~p~--------~Rpt~~~ll~~~~  267 (268)
T cd06624         228 KIHPEIPES--LSAEAKNFILRCFEPDPD--------KRASAHDLLQDPF  267 (268)
T ss_pred             ccCCCCCcc--cCHHHHHHHHHHcCCCch--------hCCCHHHHHhCCC
Confidence            333444443  789999999999999998        4455566666554

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=2.8e-28  Score=210.89  Aligned_cols=179  Identities=25%  Similarity=0.358  Sum_probs=141.8

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ++..|+||||+. |+|.+++......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          78 ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             CCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeee
Confidence            456789999998 59999998755679999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCcccc--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          86 LVDSKART--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        86 ~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ........  ...++..|+|||.+..     ..++.++||||||+++|++++ |..||... ...+....+.++..+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~~~~~  230 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMLGVKPFQGV-KNNDVIGRIENGERLPMP  230 (270)
T ss_pred             cccccceecCCCCccccccChhhhcc-----CCCCchhhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCcCCCC
Confidence            54332211  1233467999998843     367889999999999999986 99999874 344555556555544444


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      .  .++..+.++|.+||..+|+.||  ++.++..
T Consensus       231 ~--~~~~~~~~li~~~l~~~P~~Rp--t~~~~~~  260 (270)
T cd05056         231 P--NCPPTLYSLMTKCWAYDPSKRP--RFTELKA  260 (270)
T ss_pred             C--CCCHHHHHHHHHHcCCChhhCc--CHHHHHH
Confidence            3  3799999999999999998543  4444433

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=2.8e-28  Score=215.18  Aligned_cols=186  Identities=24%  Similarity=0.334  Sum_probs=145.9

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      +.+|+||||+.++|.+++......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          81 DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            5789999999999999998766789999999999999999999999 599999999999999999999999999987664


Q ss_pred             CCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC-------
Q psy3686          88 DSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP-------  159 (296)
Q Consensus        88 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p-------  159 (296)
                      ... ......++..|+|||.+.+.    ..++.++||||||+++|+|++|..||.. ......+..+......       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGC----TTYTTAIDMWAVGCILAELLAHKPLLPG-KSEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccCCCCcccccccccChhhhcCC----CCcCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhcCCCChhhch
Confidence            331 22223457789999998532    2577899999999999999999999987 3444444444331100       


Q ss_pred             -----------CCCC---------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 -----------CLPN---------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 -----------~~~~---------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                 .++.         ...+++.+.++|.+||..||+        ++.++.+++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~--------~R~t~~~il~h~~f~  294 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPK--------KRATAEEALESSYFK  294 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChh--------hCcCHHHHhcChhhc
Confidence                       0000         012588999999999999998        555677777777763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=3e-29  Score=215.21  Aligned_cols=189  Identities=31%  Similarity=0.533  Sum_probs=147.2

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.++..+++|||++.+ +|.+++.. ...+++..++.++.||+.||.+||+ .|++|+||||+||+++.++.++|+|||
T Consensus        66 ~~~~~~~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg  143 (260)
T PF00069_consen   66 VFQDDNYLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFG  143 (260)
T ss_dssp             EEEESSEEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGT
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence            34567899999999996 99999984 6789999999999999999999999 599999999999999999999999999


Q ss_pred             Ccccc-cCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CcHHHHHHHHccCC
Q psy3686          82 ISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK--CDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~--~~~~~~~~i~~~~~  158 (296)
                      .+... ..........++..|+|||.+.    ....++.++||||||+++|+|++|..||....  ..............
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~  219 (260)
T PF00069_consen  144 SSVKLSENNENFNPFVGTPEYMAPEVLQ----QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL  219 (260)
T ss_dssp             TTEESTSTTSEBSSSSSSGGGSCHHHHT----TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH
T ss_pred             cccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence            98753 2233344557889999999985    13478899999999999999999999999841  22233333332111


Q ss_pred             C-CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 P-CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 p-~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      + ........+..+.++|.+||..+|+        +|.+..++..++|
T Consensus       220 ~~~~~~~~~~~~~l~~li~~~l~~~p~--------~R~~~~~l~~~~~  259 (260)
T PF00069_consen  220 PSSSQQSREKSEELRDLIKKMLSKDPE--------QRPSAEELLKHPW  259 (260)
T ss_dssp             HHHTTSHTTSHHHHHHHHHHHSSSSGG--------GSTTHHHHHTSGG
T ss_pred             cccccccchhHHHHHHHHHHHccCChh--------HCcCHHHHhcCCC
Confidence            1 1111111358999999999999998        5556666666655

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=2.4e-28  Score=212.70  Aligned_cols=190  Identities=21%  Similarity=0.379  Sum_probs=144.5

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||+.++|.+++... ...+++..++.++.||+.||+|||+ +|++|+||+|+||+++.++.++|+||
T Consensus        66 ~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             hhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeec
Confidence            456788899999999998999988654 4678999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAP  158 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~  158 (296)
                      |++....... ......++..|+|||.+.+.    ..++.++||||||+++|+|++|..||.... ......++.. ...
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~  219 (284)
T cd07860         145 GLARAFGVPVRTYTHEVVTLWYRAPEILLGC----KYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQLFRIFRTLGT  219 (284)
T ss_pred             cchhhcccCccccccccccccccCCeEEecC----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHhCC
Confidence            9986554321 22233567889999988532    245778999999999999999999998743 3233322221 111


Q ss_pred             C----------------CCCC---------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 P----------------CLPN---------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 p----------------~~~~---------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +                .++.         ...+++.++++|.+||..||+        +|.+..+++.++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~Rpt~~~~l~~~~  283 (284)
T cd07860         220 PDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN--------KRISAKAALAHPF  283 (284)
T ss_pred             CChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcc--------cCCCHHHHhcCCC
Confidence            0                0000         123678999999999999998        5555666666654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1095|consensus

Probab=99.96  E-value=4.8e-29  Score=240.75  Aligned_cols=182  Identities=24%  Similarity=0.363  Sum_probs=151.8

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEE
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRL------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIK   76 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~k   76 (296)
                      ..+.+..+|++|||. |+|..+|++.      ...++...++.++.||++|.+||+++ ++|||||...|+|++....+|
T Consensus       764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEE
Confidence            445788999999999 5999999987      67899999999999999999999995 899999999999999999999


Q ss_pred             EeccCCcccccCCccc-c--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHH
Q psy3686          77 LCDFGISGRLVDSKAR-T--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        77 l~dfg~~~~~~~~~~~-~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~  152 (296)
                      |+|||+|+-+...... .  ...-...|||||.+     ....++.++|||||||++||+++ |..||.+ ....+++..
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl-----~d~iFtskSDvWsFGVllWEifslG~~PY~~-~~n~~v~~~  916 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL-----KDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-RSNFEVLLD  916 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHH-----hhcccccccchhhhHHHHHHHHhCCCCCCCC-cchHHHHHH
Confidence            9999999844332211 1  11344689999999     45689999999999999999999 9999999 566778877


Q ss_pred             HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         153 VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       153 i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      ++.+.  .++....++..+.++|.+||+.+|+.||  +|..+..
T Consensus       917 ~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP--~F~~i~~  956 (1025)
T KOG1095|consen  917 VLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRP--SFRTIVE  956 (1025)
T ss_pred             HHhCC--ccCCCCCCChHHHHHHHHHccCChhhCc--cHHHHHh
Confidence            77776  4555555999999999999999999444  4444444

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=1.3e-28  Score=215.58  Aligned_cols=183  Identities=20%  Similarity=0.326  Sum_probs=142.3

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      +.+||||||++++|.+++......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          79 DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             CcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            7899999999999999998755679999999999999999999999 599999999999999999999999999987665


Q ss_pred             CC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC--------
Q psy3686          88 DS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP--------  158 (296)
Q Consensus        88 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~--------  158 (296)
                      .. .......++..|+|||.+.+.    ..++.++|+||||+++|+|++|..||... .......++.....        
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGA----KEYSTAIDMWSVGCIFAELLTKKPLFPGK-SEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             CCccccccccccccccCchhhcCC----ccccchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCchHHHH
Confidence            43 222334567889999998532    24678999999999999999999999873 33333333321100        


Q ss_pred             ----------------------CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 ----------------------PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 ----------------------p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                            ..++.. .+++.+.++|++||..+|+        ++.++.+++.+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~--------~R~t~~ell~~~~  292 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPA--------KRISAEDALKHPY  292 (293)
T ss_pred             Hhhccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCcc--------ccCCHHHHhcCCC
Confidence                                  001111 1488899999999999998        5555666665544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0608|consensus

Probab=99.96  E-value=1.3e-28  Score=223.02  Aligned_cols=170  Identities=26%  Similarity=0.407  Sum_probs=137.8

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+.+.+|+||+|++| ++-.+|-+ -+-|.|..++.++..+..|+++.|. +|+|||||||+||||+.+|++||.|||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeecc
Confidence            58899999999999995 99988876 5789999999999999999999999 699999999999999999999999999


Q ss_pred             Cccccc---------CC------------------c----------------cccccccCcCCCCccccCCCCCCCCCCC
Q psy3686          82 ISGRLV---------DS------------------K----------------ARTKNAGCAAYMAPERIEPPNPQKPDYD  118 (296)
Q Consensus        82 ~~~~~~---------~~------------------~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~  118 (296)
                      ++.-+.         ..                  .                ......||..|+|||++     .+..++
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-----~r~g~~  849 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-----ARTGYT  849 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-----cccCcc
Confidence            975321         00                  0                00112589999999999     455889


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCCCCCCCcchhHHHHHHHHhccC
Q psy3686         119 IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDPLFGRTIKASIAKDNG  180 (296)
Q Consensus       119 ~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p~~~~~~~~s~~l~~li~~cl~  180 (296)
                      ..+|+||.|+|||+|+.|+.||... ...+...++++ .....++.-..+|+++.++|.++..
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~-tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~  911 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLAD-TPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC  911 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCC-CCCcceeeeeehhhccccccccccCHHHHHHHHHHhc
Confidence            9999999999999999999999874 33344444443 3334555556699999999988654

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.5e-28  Score=210.20  Aligned_cols=171  Identities=19%  Similarity=0.273  Sum_probs=138.0

Q ss_pred             CeEEEEecCcc-ccHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           8 SDVWICMELMA-TCFDRLLKRL-----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ...++||||+. |+|..++...     ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCcc
Confidence            35899999999 5999998543     2468999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ++.........   .....+..|+|||.+.     ...++.++|||||||++|+|++ |..||.+ ....+....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGN  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCC
Confidence            98765433211   1123456899999984     3367889999999999999999 8999987 34455666666665


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+.  .++..+.++|.+||..+|..||
T Consensus       233 ~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  260 (273)
T cd05035         233 RLKQPE--DCLDELYDLMYSCWRADPKDRP  260 (273)
T ss_pred             CCCCCc--CCCHHHHHHHHHHcCCChhhCc
Confidence            555544  3799999999999999998443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=1.9e-28  Score=210.20  Aligned_cols=174  Identities=21%  Similarity=0.287  Sum_probs=138.2

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.+ ..+++||||+. |+|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||
T Consensus        65 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg  142 (257)
T cd05040          65 VLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFG  142 (257)
T ss_pred             EcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCCEEEecccc
Confidence            344 78999999998 59999998754 578999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHcc
Q psy3686          82 ISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        82 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      ++..+....    ......++..|+|||.+..     ..++.++|||||||++|+|++ |..||... ...+....+.. 
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~-  215 (257)
T cd05040         143 LMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-----RTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDK-  215 (257)
T ss_pred             ccccccccccceecccCCCCCceecCHHHhcc-----cCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHh-
Confidence            987664321    1112346678999999843     367889999999999999998 99999763 33444444443 


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ....++....++..+.++|.+||..+|+.|
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  245 (257)
T cd05040         216 EGERLERPEACPQDIYNVMLQCWAHNPADR  245 (257)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHCCCCcccC
Confidence            122223333478999999999999999833

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=1.9e-28  Score=211.30  Aligned_cols=172  Identities=26%  Similarity=0.373  Sum_probs=137.7

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .++..|+||||+. |+|.+++... ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|+|||.+
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             CCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCce
Confidence            4566899999999 5999999763 3468999999999999999999999 59999999999999999999999999998


Q ss_pred             ccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          84 GRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        84 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .........  ....++..|+|||.+.     ...++.++||||||+++|++++ |..||... ........+..+..+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~  223 (262)
T cd05071         150 RLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMP  223 (262)
T ss_pred             eeccccccccccCCcccceecCHhHhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCCC
Confidence            765433221  1224566899999884     3367889999999999999999 88899873 4445555555544333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+  ..++..+.++|.+||..+|+.|
T Consensus       224 ~~--~~~~~~l~~li~~~l~~~p~~R  247 (262)
T cd05071         224 CP--PECPESLHDLMCQCWRKEPEER  247 (262)
T ss_pred             Cc--cccCHHHHHHHHHHccCCcccC
Confidence            32  3479999999999999999844

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=2e-28  Score=211.46  Aligned_cols=177  Identities=25%  Similarity=0.322  Sum_probs=140.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-   73 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-   73 (296)
                      +.+..++..|+||||++ |+|.+++...      ...+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++ 
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~  144 (269)
T cd05044          66 GVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGY  144 (269)
T ss_pred             eeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCC
Confidence            45677888999999998 5999999753      2347889999999999999999999 4999999999999999877 


Q ss_pred             ----CEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy3686          74 ----NIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC  145 (296)
Q Consensus        74 ----~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~  145 (296)
                          .++|+|||++........   ......+..|+|||.+.     ...++.++||||||+++|+|++ |..||.. ..
T Consensus       145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~  218 (269)
T cd05044         145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL-----DGKFTTQSDVWSFGVLMWEILTLGQQPYPA-LN  218 (269)
T ss_pred             CCCcceEECCcccccccccccccccCcccCCCccccCHHHHc-----cCCcccchhHHHHHHHHHHHHHcCCCCCcc-cC
Confidence                899999999875532211   11224567899999984     3367889999999999999998 9999986 34


Q ss_pred             cHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         146 DFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       146 ~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .......+..+..+..+.  .++..+.++|.+||..+|..|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp  258 (269)
T cd05044         219 NQEVLQHVTAGGRLQKPE--NCPDKIYQLMTNCWAQDPSERP  258 (269)
T ss_pred             HHHHHHHHhcCCccCCcc--cchHHHHHHHHHHcCCCcccCC
Confidence            445555554444333333  3789999999999999998443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=3.5e-28  Score=209.90  Aligned_cols=182  Identities=29%  Similarity=0.409  Sum_probs=142.3

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ++.+++||||++| +|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            4678999999985 99999976 5579999999999999999999999 5999999999999999999999999999875


Q ss_pred             ccCC----ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          86 LVDS----KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        86 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ....    .......++..|+|||.+.+     ..++.++||||+||++|+|++|..||..................+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISG-----EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL  230 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC
Confidence            4321    11122357789999999853     35788999999999999999999999875433333333333334444


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      +..  +++.++++| +||..+|+        ++.++.++..++++
T Consensus       231 ~~~--~~~~~~~li-~~~~~~p~--------~Rp~~~eil~hp~~  264 (266)
T cd06651         231 PSH--ISEHARDFL-GCIFVEAR--------HRPSAEELLRHPFA  264 (266)
T ss_pred             chh--cCHHHHHHH-HHhcCChh--------hCcCHHHHhcCccc
Confidence            433  689999999 67778998        44456666666654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=2.9e-28  Score=210.83  Aligned_cols=170  Identities=21%  Similarity=0.291  Sum_probs=136.3

Q ss_pred             CeEEEEecCcc-ccHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           8 SDVWICMELMA-TCFDRLLKRL-----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ...++||||+. |+|.+++...     ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+|||
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCC
Confidence            35789999999 5999887432     3458999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ++........   ......+..|++||.+.     ...++.++||||||+++|+|++ |..||.. .........+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLA-----DRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHcc-----CCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence            9876543321   11224566899999984     3367889999999999999999 8999987 34455566666655


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+..+.  .++..+.++|.+||..+|+.|
T Consensus       232 ~~~~~~--~~~~~~~~li~~~l~~~p~~R  258 (272)
T cd05075         232 RLKQPP--DCLDGLYSLMSSCWLLNPKDR  258 (272)
T ss_pred             CCCCCC--CCCHHHHHHHHHHcCCCcccC
Confidence            433333  378999999999999999844

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=2.9e-28  Score=215.40  Aligned_cols=195  Identities=25%  Similarity=0.390  Sum_probs=149.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ++|.+++.+|++|||++ |+|.+++... ...+++..+..++.|++.||.|||+ +||+|+||+|+||+++.++.++|+|
T Consensus        66 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d  144 (314)
T cd08216          66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSG  144 (314)
T ss_pred             heeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCCceEEec
Confidence            45778889999999999 5999999764 4568999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCcc--------ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHH
Q psy3686          80 FGISGRLVDSKA--------RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS  151 (296)
Q Consensus        80 fg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~  151 (296)
                      ||.+........        .....++..|+|||.+...   ...++.++|+||+||++|+|++|..||...........
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~  221 (314)
T cd08216         145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN---LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE  221 (314)
T ss_pred             CccceeeccccccccccccccccccccccccCHHHhcCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            998865432211        1223466789999998542   12577899999999999999999999987433333332


Q ss_pred             HHHccCC------------------------------CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         152 RVLNDAP------------------------------PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       152 ~i~~~~~------------------------------p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      .+....+                              ...+....++..+.+||.+||..+|+        +|.++.+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~Rpt~~~ll  293 (314)
T cd08216         222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE--------SRPSASQLL  293 (314)
T ss_pred             HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC--------cCcCHHHHh
Confidence            2211100                              00111123568899999999999998        667788888


Q ss_pred             cCCcccc
Q psy3686         202 AEGHLSY  208 (296)
Q Consensus       202 ~~~~~~~  208 (296)
                      .++++..
T Consensus       294 ~~p~~~~  300 (314)
T cd08216         294 NHSFFKQ  300 (314)
T ss_pred             cCchHhh
Confidence            8888653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=1.9e-28  Score=211.61  Aligned_cols=176  Identities=22%  Similarity=0.288  Sum_probs=140.7

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+++.+|+||||++ |+|.+++......++...++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          73 VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCC
Confidence            4567788999999998 49999998766778999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccc----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHcc
Q psy3686          82 ISGRLVDSKAR----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        82 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      ++.........    ....++..|++||.+.+     ..++.++|+||||+++|++++ |..||... ...+....+.++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~  225 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEG  225 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhcc-----CccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCC
Confidence            98765432211    11123467999999943     367889999999999999886 99999873 334455555554


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+..  ...++..+.+++.+||..+|..||
T Consensus       226 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp  254 (267)
T cd05066         226 YRLPA--PMDCPAALHQLMLDCWQKDRNERP  254 (267)
T ss_pred             CcCCC--CCCCCHHHHHHHHHHcccCchhCC
Confidence            33322  234789999999999999998444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=3.8e-28  Score=212.60  Aligned_cols=184  Identities=19%  Similarity=0.342  Sum_probs=139.6

Q ss_pred             eEEEEecCccccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEEeccCCc
Q psy3686           9 DVWICMELMATCFDRLLKRL----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFGIS   83 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~   83 (296)
                      .+|+||||++++|.+++...    ...+++..++.++.||+.||.|||+ .|++||||+|+||+++. ++.++|+|||++
T Consensus        80 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            48999999999999988654    2458999999999999999999999 59999999999999998 889999999998


Q ss_pred             ccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CC--
Q psy3686          84 GRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--AP--  158 (296)
Q Consensus        84 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~--  158 (296)
                      ..+... .......++..|+|||.+.+    ...++.++||||||+++|+|++|..||.+. ........+...  .+  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLG----STHYSTPVDIWSVGCIFAEMSRKQPLFPGD-SELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhC----CCCCCchHHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHHhCCCCh
Confidence            765332 12222356788999998853    235688999999999999999999999873 333333332221  00  


Q ss_pred             ---------------CCCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 ---------------PCLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 ---------------p~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                                     +.+.      ..+.++..+.+||.+||..+|.        ++.+..+++.++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~--------~R~~~~eil~~~~~  294 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA--------KRISAKAALTHPYF  294 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh--------hcCCHHHHhcCCCc
Confidence                           0000      0123789999999999999998        44456666666654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-28  Score=213.23  Aligned_cols=191  Identities=18%  Similarity=0.288  Sum_probs=142.3

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +++.+++.+|+||||+.++|.+++......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             EEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccc
Confidence            3466788999999999999999988766689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc---cC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---DA  157 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~---~~  157 (296)
                      ++...... .......++..|+|||.+.+    ...++.++||||+|+++|+|++|..||.......+.+..+..   ..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07844         149 LARAKSVPSKTYSNEVVTLWYRPPDVLLG----STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP  224 (291)
T ss_pred             cccccCCCCccccccccccccCCcHHhhc----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence            98654322 11122346788999998853    225678999999999999999999999764433333322211   00


Q ss_pred             CC------------------CC------CCCcchh--HHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PP------------------CL------PNDPLFG--RTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p------------------~~------~~~~~~s--~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+                  ..      .....++  ..+.++|.+||..+|+        .+.+..+++.+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~--------~Rps~~e~l~~~~  290 (291)
T cd07844         225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK--------KRISAAEAMKHPY  290 (291)
T ss_pred             ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcc--------cccCHHHHhcCCC
Confidence            00                  00      0001234  8889999999999998        4444555555443

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=2.8e-28  Score=213.04  Aligned_cols=184  Identities=20%  Similarity=0.318  Sum_probs=142.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER   72 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~   72 (296)
                      .+.+++..|+||||+. |+|.+++....         ..++...+..++.||+.||.|||+ +|++||||||+||+++.+
T Consensus        77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~  155 (288)
T cd05061          77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCC
Confidence            4566778999999998 59999997532         234677889999999999999999 599999999999999999


Q ss_pred             CCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHH
Q psy3686          73 GNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFE  148 (296)
Q Consensus        73 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~  148 (296)
                      +.++|+|||++........   .....++..|+|||.+.+     ..++.++|||||||++|+|++ |..||.+ ....+
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~  229 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-----GVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQ  229 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhcc-----CCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence            9999999999875433221   111234567999999843     367889999999999999998 7889987 34445


Q ss_pred             HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         149 VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       149 ~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                      ....+..+..+..+..  ++..+.++|.+||..+|+.|  +++.++...
T Consensus       230 ~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R--ps~~~ll~~  274 (288)
T cd05061         230 VLKFVMDGGYLDQPDN--CPERVTDLMRMCWQFNPKMR--PTFLEIVNL  274 (288)
T ss_pred             HHHHHHcCCCCCCCCC--CCHHHHHHHHHHcCCChhHC--cCHHHHHHH
Confidence            5555665554444433  68999999999999999844  444444433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=3.3e-28  Score=208.31  Aligned_cols=176  Identities=26%  Similarity=0.342  Sum_probs=143.4

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+.+.+.+|+||||+.| +|.+++...... +++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       69 VCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             EEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCCeEEEccc
Confidence            45566889999999985 999999764333 9999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcccc--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKART--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |++..........  ...++..|+|||.+.     ...++.++||||||+++|+|++ |..||.. .........+..+.
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~  221 (258)
T smart00219      148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGY  221 (258)
T ss_pred             CCceecccccccccccCCCcccccChHHhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCC
Confidence            9987665432211  123567899999983     3367889999999999999998 8888887 45556666666666


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+..+..  ++..+.+++.+||..+|+.||
T Consensus       222 ~~~~~~~--~~~~~~~~i~~~l~~~p~~Rp  249 (258)
T smart00219      222 RLPKPEN--CPPEIYKLMLQCWAEDPEDRP  249 (258)
T ss_pred             CCCCCCc--CCHHHHHHHHHHCcCChhhCc
Confidence            5555443  799999999999999998443

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=4.2e-28  Score=207.91  Aligned_cols=170  Identities=23%  Similarity=0.312  Sum_probs=135.6

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+.+|+||||+. |+|.+++... ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.
T Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccce
Confidence            345799999999 5999999764 3468999999999999999999999 599999999999999999999999999986


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCC
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPN  163 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~  163 (296)
                      .....  ......+..|+|||.+.+     ..++.++|+||||+++|+|++ |..||... ........+..+..+..+ 
T Consensus       149 ~~~~~--~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~-  219 (254)
T cd05083         149 VGSMG--VDNSKLPVKWTAPEALKH-----KKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRMEPP-  219 (254)
T ss_pred             ecccc--CCCCCCCceecCHHHhcc-----CCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCCCC-
Confidence            54322  122234567999998843     367889999999999999998 99999873 333444455554433333 


Q ss_pred             CcchhHHHHHHHHhccCCChHHHh
Q psy3686         164 DPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       164 ~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                       ..++..+.++|.+||..+|..||
T Consensus       220 -~~~~~~~~~li~~~l~~~p~~Rp  242 (254)
T cd05083         220 -EGCPADVYVLMTSCWETEPKKRP  242 (254)
T ss_pred             -CcCCHHHHHHHHHHcCCChhhCc
Confidence             23799999999999999998554

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=2.8e-28  Score=209.77  Aligned_cols=180  Identities=23%  Similarity=0.346  Sum_probs=141.4

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..+.+|+||||+. |+|.+++... +..+++..++.++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcce
Confidence            4567899999998 5999998754 4578999999999999999999999 59999999999999999999999999998


Q ss_pred             ccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          84 GRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        84 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ........  .....++..|+|||.+..     ..++.++||||||+++|++++ |..||.+. ........+..+..+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~  223 (260)
T cd05067         150 RLIEDNEYTAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRMP  223 (260)
T ss_pred             eecCCCCcccccCCcccccccCHHHhcc-----CCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCCC
Confidence            76542221  112245578999999843     357889999999999999999 99999873 4445555554444333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      .+.  .++..+.++|.+||..+|+.|  ++++++..
T Consensus       224 ~~~--~~~~~~~~li~~~l~~~p~~R--p~~~~l~~  255 (260)
T cd05067         224 RPD--NCPEELYELMRLCWKEKPEER--PTFEYLRS  255 (260)
T ss_pred             CCC--CCCHHHHHHHHHHccCChhhC--CCHHHHHH
Confidence            333  378999999999999999844  44444433

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=4.1e-28  Score=207.46  Aligned_cols=186  Identities=25%  Similarity=0.425  Sum_probs=151.4

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      .+..++.+++||||++| +|.+++...   ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~  145 (258)
T cd08215          67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLG  145 (258)
T ss_pred             EEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCCcEEEC
Confidence            45567899999999995 999999875   3789999999999999999999999 599999999999999999999999


Q ss_pred             ccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          79 DFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        79 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |||.+....... ......++..|+|||.+..     ..++.++|+||+|+++|+|++|..||... ........+....
T Consensus       146 d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~  219 (258)
T cd08215         146 DFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-----KPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ  219 (258)
T ss_pred             CccceeecccCcceecceeeeecccChhHhcc-----CCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC
Confidence            999987654432 2233467888999998843     35788999999999999999999999873 3455556666665


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+.++.  .++..+.++|.+||..+|+        .+.++.+++.+++
T Consensus       220 ~~~~~~--~~~~~~~~~i~~~l~~~p~--------~Rp~~~~ll~~~~  257 (258)
T cd08215         220 YPPIPS--QYSSELRNLVSSLLQKDPE--------ERPSIAQILQSPF  257 (258)
T ss_pred             CCCCCC--CCCHHHHHHHHHHcCCChh--------hCcCHHHHhcCCC
Confidence            555554  3799999999999999998        4455555555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=5.6e-28  Score=206.81  Aligned_cols=186  Identities=25%  Similarity=0.374  Sum_probs=151.5

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +.+.++..+|+||||++| +|.+++.+.   ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl  144 (256)
T cd08530          66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKI  144 (256)
T ss_pred             hhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCCcEEE
Confidence            356677899999999985 999998663   3578999999999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      +|||++...... ......++..|++||.+.+     ..++.++|+||||+++|+|++|..||... ........+..+.
T Consensus       145 ~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~  217 (256)
T cd08530         145 GDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG-----RPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGK  217 (256)
T ss_pred             eeccchhhhccC-CcccccCCccccCHHHHCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC
Confidence            999998766544 2233467889999999853     36778999999999999999999999874 4444555566666


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+.++.  .++.++.++|.+||..+|+        ++.++.++..+++
T Consensus       218 ~~~~~~--~~~~~~~~li~~~l~~~p~--------~Rp~~~~~l~~p~  255 (256)
T cd08530         218 YPPIPP--IYSQDLQNFIRSMLQVKPK--------LRPNCDKILASPA  255 (256)
T ss_pred             CCCCch--hhCHHHHHHHHHHcCCCcc--------cCCCHHHHhcCCC
Confidence            555554  3899999999999999998        5555566555543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=2.2e-28  Score=211.45  Aligned_cols=182  Identities=20%  Similarity=0.283  Sum_probs=136.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH----VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      .+.+.+.+|+||||+. |+|.+++....    ...++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||
T Consensus        63 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl  141 (269)
T cd05042          63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKI  141 (269)
T ss_pred             EECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEE
Confidence            4567788999999999 59999997642    234678889999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCc---cccccccCcCCCCccccCCCC--CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHH
Q psy3686          78 CDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPN--PQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLS  151 (296)
Q Consensus        78 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~  151 (296)
                      +|||++.......   ......++..|+|||++....  .....++.++|||||||++|+|++ |..||... ...+.+.
T Consensus       142 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~  220 (269)
T cd05042         142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVLK  220 (269)
T ss_pred             eccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHH
Confidence            9999986533221   112224566799999975321  112356789999999999999999 78898873 4444555


Q ss_pred             HHHccCCCCCCC---CcchhHHHHHHHHhccCCChHHHh
Q psy3686         152 RVLNDAPPCLPN---DPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       152 ~i~~~~~p~~~~---~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+.......++.   ...++..+.+++..|| .+|+.||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rp  258 (269)
T cd05042         221 QVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRP  258 (269)
T ss_pred             HHhhccCccCCCCcccccCCHHHHHHHHHHh-cCccccc
Confidence            544443322221   2348899999999999 4898333

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=1.8e-28  Score=214.47  Aligned_cols=184  Identities=20%  Similarity=0.321  Sum_probs=142.5

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCce
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-----------------------HVSVPEPICGKITLSTVKALHYLKETHGVI   58 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~iv   58 (296)
                      .+..++..|+||||+. |+|.+++...                       ...+++..++.++.|++.||.|||+ +|++
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iv  149 (290)
T cd05045          71 ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLV  149 (290)
T ss_pred             EEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCee
Confidence            4567788999999999 5999998652                       1357899999999999999999999 5999


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy3686          59 HRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT  135 (296)
Q Consensus        59 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~  135 (296)
                      ||||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+     ..++.++||||||+++|+|++
T Consensus       150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~t  224 (290)
T cd05045         150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-----HIYTTQSDVWSFGVLLWEIVT  224 (290)
T ss_pred             hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-----CCcchHhHHHHHHHHHHHHHh
Confidence            999999999999999999999999875432221   122245678999998843     367889999999999999998


Q ss_pred             -CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         136 -GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       136 -g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                       |..||.+ ......+..+..+..+..+  ..++..+.++|.+||..+|+  .|+++.++...
T Consensus       225 ~g~~p~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~cl~~~P~--~Rp~~~~i~~~  282 (290)
T cd05045         225 LGGNPYPG-IAPERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPD--KRPTFADISKE  282 (290)
T ss_pred             cCCCCCCC-CCHHHHHHHHhCCCCCCCC--CCCCHHHHHHHHHHccCCcc--cCCCHHHHHHH
Confidence             9999977 3444545444444333333  33789999999999999998  34444444433

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=2.6e-28  Score=209.27  Aligned_cols=175  Identities=22%  Similarity=0.372  Sum_probs=140.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.....+|+||||+.| +|.+++......+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             EEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCCeEEECCCc
Confidence            45677889999999995 9999998756678999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      .+........  .....++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.. .........+..+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~  219 (256)
T cd05112         146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-----SKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFR  219 (256)
T ss_pred             ceeecccCcccccCCCccchhhcCHhHhcc-----CCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCC
Confidence            9875543221  112234568999999853     357789999999999999998 9999987 344455555554444


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      +..+..  .+..+.+|+.+||..+|+.|
T Consensus       220 ~~~~~~--~~~~~~~l~~~~l~~~p~~R  245 (256)
T cd05112         220 LYKPRL--ASQSVYELMQHCWKERPEDR  245 (256)
T ss_pred             CCCCCC--CCHHHHHHHHHHcccChhhC
Confidence            333332  68999999999999999844

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=3.3e-28  Score=206.77  Aligned_cols=170  Identities=24%  Similarity=0.295  Sum_probs=135.4

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+.+.+|+||||+.| +|.+++.+ ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++++||
T Consensus        52 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df  129 (237)
T cd05576          52 KYIVSEDSVFLVLQHAEGGKLWSHISK-FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYF  129 (237)
T ss_pred             hheecCCeEEEEEecCCCCCHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecc
Confidence            346678899999999995 99999876 4579999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |.+.......  ....++..|+|||.+..     ..++.++|+||+|+++|+|++|..||......      +.......
T Consensus       130 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~  196 (237)
T cd05576         130 SRWSEVEDSC--DGEAVENMYCAPEVGGI-----SEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLN  196 (237)
T ss_pred             cchhcccccc--ccCCcCccccCCcccCC-----CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccC
Confidence            9876554321  22345677999998843     35778999999999999999999887652111      11111112


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      ++.  .+++.++++|.+||+.||+.|+.
T Consensus       197 ~~~--~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         197 IPE--WVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             Ccc--cCCHHHHHHHHHHccCCHHHhcC
Confidence            332  37899999999999999996654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=3e-28  Score=219.12  Aligned_cols=183  Identities=22%  Similarity=0.369  Sum_probs=143.2

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ...+|+||||+.++|.+.+..   .+++..+..++.||+.||.|||+ +|++||||||+||+++.++.++|+|||++...
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            356899999999999998864   39999999999999999999999 59999999999999999999999999999766


Q ss_pred             cCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC------
Q psy3686          87 VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP------  158 (296)
Q Consensus        87 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~------  158 (296)
                      ..........++..|+|||.+.+     ..++.++|||||||++|+|++|..||...+ ....+..+..  +.+      
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGTVLFPGTD-HIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhC-----CCCCCchhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHH
Confidence            54433334467889999999953     367889999999999999999999998643 2222222211  000      


Q ss_pred             -------------CC--------------CCC-----CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         159 -------------PC--------------LPN-----DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       159 -------------p~--------------~~~-----~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                                   +.              ++.     ....+..++++|.+||..||+        ++.++.+++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~--------~R~t~~eiL~~~~~  314 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE--------KRISVDDALQHPYI  314 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh--------hCcCHHHHhcChhH
Confidence                         00              000     112467789999999999998        66678888888876


Q ss_pred             c
Q psy3686         207 S  207 (296)
Q Consensus       207 ~  207 (296)
                      .
T Consensus       315 ~  315 (353)
T cd07850         315 N  315 (353)
T ss_pred             h
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=5.4e-28  Score=207.70  Aligned_cols=190  Identities=28%  Similarity=0.376  Sum_probs=148.0

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+..++.+|+||||+.| +|.+++.+ ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        61 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg  138 (265)
T cd05579          61 SFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFG  138 (265)
T ss_pred             heecCcEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecc
Confidence            45678899999999985 99999987 4589999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc---------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHH
Q psy3686          82 ISGRLVDSK---------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        82 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~  152 (296)
                      ++.......         ......++..|++||.+..     ...+.++|+||||+++|++++|..||... ........
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~  212 (265)
T cd05579         139 LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-----QGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQN  212 (265)
T ss_pred             cchhcccCcccccccccccccCcccCccccCHHHhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Confidence            886543221         1223357788999999853     24778999999999999999999999873 44455555


Q ss_pred             HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         153 VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       153 i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      +..+. ..++....++..+.++|.+||..+|..|+.  +   ....+++.++++
T Consensus       213 ~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt--~---~~~~~~l~~~~~  260 (265)
T cd05579         213 ILNGK-IEWPEDVEVSDEAIDLISKLLVPDPEKRLG--A---KSIEEIKNHPFF  260 (265)
T ss_pred             HhcCC-cCCCccccCCHHHHHHHHHHhcCCHhhcCC--C---ccHHHHhcCccc
Confidence            55433 333433336999999999999999984432  2   112455555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=1.9e-28  Score=237.53  Aligned_cols=178  Identities=24%  Similarity=0.272  Sum_probs=137.2

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL----------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE   71 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~   71 (296)
                      .+.+++..|+||||++| +|.+++...          ...++...++.++.||+.||+|||+ .||+||||||+||+++.
T Consensus        70 v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~  148 (932)
T PRK13184         70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL  148 (932)
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC
Confidence            35677899999999995 999998642          2345667889999999999999999 59999999999999999


Q ss_pred             CCCEEEeccCCcccccCC-------------------ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHH
Q psy3686          72 RGNIKLCDFGISGRLVDS-------------------KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE  132 (296)
Q Consensus        72 ~~~~kl~dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~  132 (296)
                      ++.++|+|||++......                   .......||+.|+|||.+.+     ..++.++|||||||++|+
T Consensus       149 dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-----~~~S~kSDIWSLGVILyE  223 (932)
T PRK13184        149 FGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-----VPASESTDIYALGVILYQ  223 (932)
T ss_pred             CCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-----CCCCcHhHHHHHHHHHHH
Confidence            999999999999765211                   01112368999999999853     367889999999999999


Q ss_pred             HHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         133 LATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       133 l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      |++|..||..... ...........+..+.....+++.+.+++.+||..+|+.|+
T Consensus       224 LLTG~~PF~~~~~-~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~  277 (932)
T PRK13184        224 MLTLSFPYRRKKG-RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY  277 (932)
T ss_pred             HHHCCCCCCCcch-hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence            9999999987332 22222221222222222334889999999999999999654

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.9e-28  Score=209.58  Aligned_cols=182  Identities=25%  Similarity=0.341  Sum_probs=143.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+..+..+|+||||+.+ +|.+++... ...++...+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~  147 (261)
T cd05034          69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENLVCKIADF  147 (261)
T ss_pred             eeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCCCEEECcc
Confidence            45666889999999985 999999764 3578999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccc--cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |.+.........  .....+..|+|||.+.+     ..++.++|+||||+++|++++ |+.||.+ ......+..+..+.
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~  221 (261)
T cd05034         148 GLARLIEDDEYTAREGAKFPIKWTAPEAANY-----GRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGY  221 (261)
T ss_pred             ccceeccchhhhhhhccCCCccccCHHHhcc-----CCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCC
Confidence            998765432111  11234568999999853     367889999999999999998 9999987 34455666665554


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      ....+.  ..+..+.++|.+||..+|+.|  +++.++.
T Consensus       222 ~~~~~~--~~~~~~~~~i~~~l~~~p~~R--p~~~~l~  255 (261)
T cd05034         222 RMPRPP--NCPEELYDLMLQCWDKDPEER--PTFEYLQ  255 (261)
T ss_pred             CCCCCC--CCCHHHHHHHHHHcccCcccC--CCHHHHH
Confidence            333333  268999999999999999844  3444433

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.9e-28  Score=209.57  Aligned_cols=172  Identities=23%  Similarity=0.275  Sum_probs=133.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCC-------
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN-------   74 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~-------   74 (296)
                      .+..++..++||||+. |+|.+++......+++..++.++.||+.||+|||+ .||+||||||+||+++.++.       
T Consensus        67 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~  145 (258)
T cd05078          67 VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPP  145 (258)
T ss_pred             EEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCc
Confidence            4556678999999999 59999998755678999999999999999999999 59999999999999987664       


Q ss_pred             -EEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCcHHHHHH
Q psy3686          75 -IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE-FPYKDCKCDFEVLSR  152 (296)
Q Consensus        75 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~-~Pf~~~~~~~~~~~~  152 (296)
                       ++++|||.+......   ....++..|+|||.+.+    ...++.++||||||+++|+|++|. .||.. ....... .
T Consensus       146 ~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~-~  216 (258)
T cd05078         146 FIKLSDPGISITVLPK---EILLERIPWVPPECIEN----PQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKL-Q  216 (258)
T ss_pred             eEEecccccccccCCc---hhccccCCccCchhccC----CCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHH-H
Confidence             699999988654322   22457788999999853    224678999999999999999984 66655 2222222 2


Q ss_pred             HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         153 VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       153 i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +.. ..+.++..  .+..+.++|.+||+.+|+.||
T Consensus       217 ~~~-~~~~~~~~--~~~~~~~li~~~l~~~p~~Rp  248 (258)
T cd05078         217 FYE-DRHQLPAP--KWTELANLINQCMDYEPDFRP  248 (258)
T ss_pred             HHH-ccccCCCC--CcHHHHHHHHHHhccChhhCC
Confidence            222 22334433  578899999999999999554

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=4.6e-28  Score=211.84  Aligned_cols=190  Identities=18%  Similarity=0.291  Sum_probs=142.4

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ++.+++..|+||||+.++|.+++......+++..+..++.||+.||.|||+ +|++|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             EEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEecccc
Confidence            456778899999999988888776655678899999999999999999999 5999999999999999999999999998


Q ss_pred             cccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC-
Q psy3686          83 SGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP-  158 (296)
Q Consensus        83 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~-  158 (296)
                      +....... ......++..|+|||.+.+.    ..++.++||||||+++|+|++|..||.......+.+..+..  +.+ 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07870         150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGA----TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT  225 (291)
T ss_pred             ccccCCCCCCCCCccccccccCCceeecC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCC
Confidence            86543221 12233568899999998532    24677899999999999999999999875443333333221  000 


Q ss_pred             ----------CC-----C----C-------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 ----------PC-----L----P-------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 ----------p~-----~----~-------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                +.     +    +       .....+..+.++|.+||..+|.        .+.++.++..+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~--------~R~t~~~~l~h~~  290 (291)
T cd07870         226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK--------DRISAQDALLHPY  290 (291)
T ss_pred             hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc--------cCcCHHHHhcCCC
Confidence                      00     0    0       0001367899999999999998        5555666666554

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=4.6e-28  Score=214.28  Aligned_cols=132  Identities=26%  Similarity=0.475  Sum_probs=110.0

Q ss_pred             cCCeEEEEecCccccHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----CCCC
Q psy3686           6 KESDVWICMELMATCFDRLLKRL--------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERG   73 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~----~~~~   73 (296)
                      .+..+|+||||++++|.+++...        ...+++..++.++.||+.||.|||+ .||+||||||+||++    +.++
T Consensus        71 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~  149 (317)
T cd07867          71 SDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG  149 (317)
T ss_pred             CCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC
Confidence            46788999999999998887532        2358999999999999999999999 599999999999999    4567


Q ss_pred             CEEEeccCCcccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3686          74 NIKLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD  142 (296)
Q Consensus        74 ~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  142 (296)
                      .+||+|||++.......    ......++..|+|||.+.+    ...++.++|||||||++|+|++|..||..
T Consensus       150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cEEEeeccceeccCCCcccccccCcceecccccCcHHhcC----CCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            89999999997654332    1223467889999999853    23578899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=2.4e-28  Score=213.95  Aligned_cols=178  Identities=24%  Similarity=0.328  Sum_probs=138.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH----------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE   71 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~   71 (296)
                      ++..++.+++|||++. ++|.+++....          ..+++..++.++.|++.||.|||+ +|++|+||||+||+++.
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp~Nili~~  165 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLATRNCLVGK  165 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccchhceeecC
Confidence            3556688999999998 59999997642          268999999999999999999999 59999999999999999


Q ss_pred             CCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCc
Q psy3686          72 RGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT--GEFPYKDCKCD  146 (296)
Q Consensus        72 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~--g~~Pf~~~~~~  146 (296)
                      ++.++|+|||++.......   ......++..|+|||.+.+     ..++.++|||||||++|+|++  |..||... ..
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~-~~  239 (296)
T cd05051         166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-----GKFTTKSDVWAFGVTLWEILTLCREQPYEHL-TD  239 (296)
T ss_pred             CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-----CCCCccchhhhhHHHHHHHHhcCCCCCCCCc-Ch
Confidence            9999999999987543322   1223345678999999853     367889999999999999998  77888763 33


Q ss_pred             HHHHHHHHcc-----CCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         147 FEVLSRVLND-----APPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       147 ~~~~~~i~~~-----~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ...+..+...     ..+..+....++.++.++|.+||..+|..||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  285 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP  285 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence            4444444322     2222333334789999999999999998443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=3.7e-28  Score=211.59  Aligned_cols=178  Identities=19%  Similarity=0.282  Sum_probs=134.6

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +..+|+||||+. |+|.+++..  ..+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++..
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccc
Confidence            457899999999 599999975  569999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCcc----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHH-------------
Q psy3686          86 LVDSKA----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFE-------------  148 (296)
Q Consensus        86 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-------------  148 (296)
                      ......    .....++..|+|||.+.+     ..++.++||||||+++|+|++|..||........             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKE-----NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV  231 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcc-----cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence            543221    112244567999999843     3678899999999999999999999865322111             


Q ss_pred             -HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         149 -VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       149 -~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                       ....+..+..  .+....++..+.+++.+||..+|+  .|+++.++..
T Consensus       232 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~--~Rps~~~i~~  276 (283)
T cd05080         232 RLIELLERGMR--LPCPKNCPQEVYILMKNCWETEAK--FRPTFRSLIP  276 (283)
T ss_pred             hhhhhhhcCCC--CCCCCCCCHHHHHHHHHHhccChh--hCCCHHHHHH
Confidence             1111111111  122234789999999999999998  4444444433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.8e-28  Score=207.88  Aligned_cols=180  Identities=26%  Similarity=0.397  Sum_probs=140.1

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .+.+++||||++| +|.+++.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            4578999999985 99999976 4578999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH-ccCCCC
Q psy3686          86 LVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL-NDAPPC  160 (296)
Q Consensus        86 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~-~~~~p~  160 (296)
                      .....    ......++..|+|||.+.+     ..++.++|+|||||++|+|++|..||...... ....++. ....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~  229 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISG-----EGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIFKIATQPTKPM  229 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHHHHHcCCCCCC
Confidence            53211    1123457889999999853     35678999999999999999999999874333 3333443 333344


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +|..  ++..+.++|.+||.. |.        .+.++.+++.+++
T Consensus       230 ~p~~--~~~~~~~~i~~~l~~-~~--------~r~~~~~~~~~~~  263 (264)
T cd06653         230 LPDG--VSDACRDFLKQIFVE-EK--------RRPTAEFLLRHPF  263 (264)
T ss_pred             CCcc--cCHHHHHHHHHHhcC-cc--------cCccHHHHhcCCC
Confidence            4443  799999999999994 55        3444445555543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.2e-28  Score=209.77  Aligned_cols=171  Identities=23%  Similarity=0.321  Sum_probs=138.6

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ...++||||+. |+|.+++......+++..++.++.||+.||+|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            67899999998 59999998766679999999999999999999999 59999999999999999999999999998765


Q ss_pred             cCCcccc---ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          87 VDSKART---KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        87 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      .......   ...++..|+|||.+.     ...++.++|+||||+++|++++ |..||... ...+....+..+.....+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~  233 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESIL-----HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQP  233 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhh-----cCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCCCCC
Confidence            4322111   112346799999884     3367889999999999999998 99999873 444555555555444444


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHh
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .  .++..+.+++.+||..+|..||
T Consensus       234 ~--~~~~~~~~~~~~~l~~~p~~Rp  256 (279)
T cd05057         234 P--ICTIDVYMVLVKCWMIDAESRP  256 (279)
T ss_pred             C--CCCHHHHHHHHHHcCCChhhCC
Confidence            3  3689999999999999998443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=6.2e-28  Score=208.14  Aligned_cols=180  Identities=28%  Similarity=0.408  Sum_probs=138.4

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +..+|+||||++| +|.+++.+ ...+++..+..++.|++.||.|||+ .|++|+||+|.||+++.++.++|+|||++..
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            3578999999985 99999876 4678999999999999999999999 5999999999999999999999999999875


Q ss_pred             ccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCCC
Q psy3686          86 LVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPC  160 (296)
Q Consensus        86 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p~  160 (296)
                      .....    ......++..|+|||.+.+     ..++.++||||||+++|+|++|+.||...... .....+.. ...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~  229 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISG-----EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPV  229 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcC-----CCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHHHhcCCCCCC
Confidence            43211    1122357889999999853     35778999999999999999999999874333 33333332 22233


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ++.  .++..+.++|.+||. +|+        .+.+..++..+++
T Consensus       230 ~~~--~~~~~~~~~i~~~l~-~p~--------~Rp~~~~il~~~~  263 (265)
T cd06652         230 LPP--HVSDHCRDFLKRIFV-EAK--------LRPSADELLRHTF  263 (265)
T ss_pred             Cch--hhCHHHHHHHHHHhc-Chh--------hCCCHHHHhcCcc
Confidence            332  378899999999995 787        3334455555544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=6.6e-28  Score=208.68  Aligned_cols=189  Identities=24%  Similarity=0.388  Sum_probs=144.8

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++...+.+++||||+.| +|.+++.+ ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEeecc
Confidence            45677889999999985 99999977 4689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH-ccC
Q psy3686          82 ISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL-NDA  157 (296)
Q Consensus        82 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~-~~~  157 (296)
                      ++.......   ......++..|+|||.+....   ..++.++|+||||+++|++++|..||..... ...+..+. ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~  229 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS---QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-IAAMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhcccc---CCCCccchhHHHHHHHHHHHhCCCCCcCcch-HHHHHHhhcccc
Confidence            986543221   122335778999999985421   2478899999999999999999999976333 23333322 222


Q ss_pred             CCCCCCC--cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PPCLPND--PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p~~~~~--~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+.++..  ..++..+.++|.+||..+|+        .+.++.+++.+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~--------~Rps~~~il~~~~  271 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPD--------NRPTARELLQHPF  271 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChh--------hCCCHHHHhhCCC
Confidence            2333221  24789999999999999998        3334555555544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=7.5e-28  Score=209.50  Aligned_cols=180  Identities=21%  Similarity=0.339  Sum_probs=137.9

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++..|+||||++++|.+++.... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+||
T Consensus        65 ~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             heeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeec
Confidence            3566788999999999989999987632 369999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc---
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND---  156 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~---  156 (296)
                      |++....... ......++..|+|||.+.+    ...++.++|+||||+++|+|++|..||... .....+..+...   
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~  218 (283)
T cd07835         144 GLARAFGVPVRTYTHEVVTLWYRAPEILLG----SRQYSTPVDIWSIGCIFAEMVNRRPLFPGD-SEIDQLFRIFRTLGT  218 (283)
T ss_pred             ccccccCCCccccCccccccCCCCCceeec----CcccCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCC
Confidence            9986553221 2223356788999998753    224678999999999999999999999873 332222222211   


Q ss_pred             ----------------------CCCCC-CCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         157 ----------------------APPCL-PNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       157 ----------------------~~p~~-~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                                            ..+.. .....++..+.++|.+||..+|..|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  272 (283)
T cd07835         219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI  272 (283)
T ss_pred             CChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc
Confidence                                  00000 01234678999999999999998443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=9.4e-28  Score=207.04  Aligned_cols=187  Identities=26%  Similarity=0.461  Sum_probs=145.6

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEec
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~d   79 (296)
                      +.+.+++.+++||||+.| +|.+++.+ ..++++..++.++.||+.||.|||+ .|++|+||+|.||+++.++ .++|+|
T Consensus        70 ~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~d  147 (268)
T cd06630          70 GATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIAD  147 (268)
T ss_pred             ceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcc
Confidence            456788899999999995 99999976 5689999999999999999999999 5999999999999998776 599999


Q ss_pred             cCCcccccCCcc-----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--cHHHHHH
Q psy3686          80 FGISGRLVDSKA-----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC--DFEVLSR  152 (296)
Q Consensus        80 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~--~~~~~~~  152 (296)
                      ||.+........     .....++..|+|||.+.+     ..++.++|+||||+++|++++|..||.....  .......
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  222 (268)
T cd06630         148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-----EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK  222 (268)
T ss_pred             cccccccccccccCCccccccccccceeCHhHhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH
Confidence            999876643311     122357789999999843     3577899999999999999999999975322  1222222


Q ss_pred             HHc-cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         153 VLN-DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       153 i~~-~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +.. ...+.++.  .+++.+.++|.+||..+|+        .+.++.++..+++
T Consensus       223 ~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~--------~R~~~~~ll~~~~  266 (268)
T cd06630         223 IASATTAPSIPE--HLSPGLRDVTLRCLELQPE--------DRPPSRELLKHPV  266 (268)
T ss_pred             HhccCCCCCCch--hhCHHHHHHHHHHcCCCcc--------cCcCHHHHhcCcc
Confidence            222 22333333  3789999999999999998        5556666666654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.2e-27  Score=209.04  Aligned_cols=189  Identities=37%  Similarity=0.598  Sum_probs=148.0

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ..+.+|+||||++| +|.+++...   ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeecc
Confidence            34579999999985 998887542   4568999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CCcHHHHHHHHccC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC----KCDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~----~~~~~~~~~i~~~~  157 (296)
                      ++....... .....++..|++||.+.     ...++.++||||||+++|+|++|..||...    ....+....+....
T Consensus       151 ~~~~~~~~~-~~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         151 VSGELVNSL-AGTFTGTSFYMAPERIQ-----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             ccccccccc-cccccCCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            986543322 12345778899999984     336788999999999999999999999874    22334444444433


Q ss_pred             CCCCCCC----cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 PPCLPND----PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ~p~~~~~----~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      .+.++..    ..+++.+.+||.+||..+|+        ++.+..++..++++...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~--------~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPT--------RRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             chhhccCCCCCCchHHHHHHHHHHHcCCCcc--------cCCCHHHHHhCcccccc
Confidence            3333322    23688999999999999998        66667788888877443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=6.9e-28  Score=215.10  Aligned_cols=184  Identities=18%  Similarity=0.263  Sum_probs=142.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+..++.+|+||||++ |+|.+++.+..               ..++...+..++.||+.||.|||+ +|++||||||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence            4566788999999998 59999997531               247888999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      |+++.++.++|+|||++........   .....++..|+|||.+.+     ..++.++||||||+++|+|++ |..||.+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-----CCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            9999999999999999876543221   111233467999999843     367889999999999999998 8899987


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                       ....+....+..+..+..+.  .++..+.++|.+||..+|..|  +++.++...
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~R--ps~~ell~~  289 (334)
T cd05100         240 -IPVEELFKLLKEGHRMDKPA--NCTHELYMIMRECWHAVPSQR--PTFKQLVED  289 (334)
T ss_pred             -CCHHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHHcccChhhC--cCHHHHHHH
Confidence             34445555555554444443  378999999999999999844  344444433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257|consensus

Probab=99.96  E-value=5.9e-29  Score=224.90  Aligned_cols=179  Identities=25%  Similarity=0.379  Sum_probs=152.4

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+.-.|||||+++ |-|..|++.....|+...+..++.||+.||.|||++ .+|||||...|||+.....+||+|||+++
T Consensus       461 ~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  461 VEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhh
Confidence            3567899999999 999999999888999999999999999999999996 99999999999999999999999999999


Q ss_pred             cccCCcccccc--ccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          85 RLVDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        85 ~~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .+.+.......  .-.+.|||||.+     ....++.++|||.||+++||++. |..||.+..+. +++-.+-+|.++..
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESI-----NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-DVI~~iEnGeRlP~  613 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESI-----NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-DVIGHIENGERLPC  613 (974)
T ss_pred             hccccchhhccccccceeecCcccc-----chhcccchhhHHHHHHHHHHHHHhcCCcccccccc-ceEEEecCCCCCCC
Confidence            88766443332  345689999999     55589999999999999999998 99999995444 56667777776666


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      |..  +++.+..|+.+||..+|..|  ++|.++.
T Consensus       614 P~n--CPp~LYslmskcWayeP~kR--Prftei~  643 (974)
T KOG4257|consen  614 PPN--CPPALYSLMSKCWAYEPSKR--PRFTEIK  643 (974)
T ss_pred             CCC--CChHHHHHHHHHhccCcccC--CcHHHHH
Confidence            554  89999999999999999844  4455543

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=5.7e-28  Score=209.88  Aligned_cols=188  Identities=33%  Similarity=0.547  Sum_probs=149.6

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++..++.+|+||||++| +|.+++.  ...+++..+..++.|++.+|.|||+ .|++|+||+|.||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          70 SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             EEEeCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecc
Confidence            46678899999999995 9999987  4679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ++....... ......++..|+|||.+.+     ..++.++|+|||||++|+|++|..||... ........+..+..+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~  220 (277)
T cd06641         147 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPT  220 (277)
T ss_pred             cceecccchhhhccccCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCCCCC
Confidence            986654322 2223467888999999853     35678999999999999999999999863 3444444555555555


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      ++..  ++..+.++|.+||..+|+        .+....++..++++...
T Consensus       221 ~~~~--~~~~~~~~i~~~l~~~p~--------~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         221 LEGN--YSKPLKEFVEACLNKEPS--------FRPTAKELLKHKFIVRF  259 (277)
T ss_pred             CCcc--cCHHHHHHHHHHccCChh--------hCcCHHHHHhCHHHhhh
Confidence            5443  789999999999999998        34445555666655443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=7.1e-28  Score=209.32  Aligned_cols=189  Identities=22%  Similarity=0.376  Sum_probs=145.7

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+.+++.+|+||||++++|.+++......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||.
T Consensus        66 ~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~  144 (283)
T cd05118          66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGL  144 (283)
T ss_pred             hhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeee
Confidence            456778999999999999999988766789999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-C--
Q psy3686          83 SGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-P--  158 (296)
Q Consensus        83 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-~--  158 (296)
                      +....... ......++..|+|||.+.+    ...++.++|+||||+++|+|++|+.||... +..+.+..+.... .  
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~-~~~~~~~~~~~~~~~~~  219 (283)
T cd05118         145 ARSFGSPVRPYTHYVVTRWYRAPELLLG----DKGYSTPVDIWSVGCIFAELLSRRPLFPGK-SEIDQLFKIFRTLGTPD  219 (283)
T ss_pred             eEecCCCcccccCccCcccccCcHHHhc----CCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCc
Confidence            87665433 2223457788999999853    225788999999999999999999999773 3333333332210 0  


Q ss_pred             C----CC-----------C---------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 P----CL-----------P---------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 p----~~-----------~---------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +    .+           +         ....++..+.++|.+||..+|.        ++.+..++..+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~--------~Rp~~~~ll~~~~  282 (283)
T cd05118         220 PEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH--------KRITAEQALAHPY  282 (283)
T ss_pred             hHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcc--------cCcCHHHHhhCCC
Confidence            0    00           0         0123688999999999999998        4445555555543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=208.52  Aligned_cols=180  Identities=24%  Similarity=0.383  Sum_probs=136.6

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.+.+++.+|+||||+++++...+......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        67 ~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             heEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeee
Confidence            4566788999999999975544444446679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc---c
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---D  156 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~---~  156 (296)
                      ++.......  ......++..|+|||.+.+.    ..++.++||||||+++|+|++|..||.+... .+.+..+..   .
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~  220 (288)
T cd07833         146 FARALRARPASPLTDYVATRWYRAPELLVGD----TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-IDQLYLIQKCLGP  220 (288)
T ss_pred             cccccCCCccccccCcccccCCcCCchhcCC----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            987655433  23334677889999998532    2677899999999999999999999987432 222222111   0


Q ss_pred             CCC---------------CCC-----------CCcchhHHHHHHHHhccCCChHHHh
Q psy3686         157 APP---------------CLP-----------NDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       157 ~~p---------------~~~-----------~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .++               .++           ....++..+.+||++||..+|+.|+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  277 (288)
T cd07833         221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL  277 (288)
T ss_pred             CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc
Confidence            000               000           0112488999999999999999444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=8.8e-28  Score=207.74  Aligned_cols=189  Identities=20%  Similarity=0.247  Sum_probs=137.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIK   76 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~k   76 (296)
                      +++.+...+|+||||++ |+|.+++...    ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++
T Consensus        62 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~k  140 (269)
T cd05087          62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVK  140 (269)
T ss_pred             EEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEE
Confidence            34567778999999999 5999999753    2346778888999999999999999 5999999999999999999999


Q ss_pred             EeccCCcccccCCcc---ccccccCcCCCCccccCCCCCC--CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHH
Q psy3686          77 LCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQ--KPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVL  150 (296)
Q Consensus        77 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~  150 (296)
                      |+|||.+........   .....++..|+|||++.+....  ...++.++||||||+++|+|++ |..||..... .+..
T Consensus       141 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~~~~  219 (269)
T cd05087         141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-EQVL  219 (269)
T ss_pred             ECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-HHHH
Confidence            999999865432211   1223567789999998532111  1245789999999999999996 9999987433 3333


Q ss_pred             HHHHccCCCCCCC---CcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         151 SRVLNDAPPCLPN---DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       151 ~~i~~~~~p~~~~---~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      ..........++.   ...++..+.++|.+|| .+|+  .|++++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~--~Rpt~~~l~  264 (269)
T cd05087         220 TYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPE--QRPSAEEVH  264 (269)
T ss_pred             HHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcc--cCCCHHHHH
Confidence            3333322222221   1236889999999999 5797  444444443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=4.1e-28  Score=212.86  Aligned_cols=173  Identities=21%  Similarity=0.303  Sum_probs=133.1

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccC
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD   88 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~   88 (296)
                      ..|++|+++..++.+++.. ....++..++.++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++..+..
T Consensus       101 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~  178 (294)
T PHA02882        101 YRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRGYIIDYGIASHFII  178 (294)
T ss_pred             EEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCcEEEEEcCCceeecc
Confidence            4578999988888887765 3457899999999999999999999 5999999999999999999999999999876532


Q ss_pred             Cc--------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHH--------HH
Q psy3686          89 SK--------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVL--------SR  152 (296)
Q Consensus        89 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--------~~  152 (296)
                      ..        ......+|+.|+|||++.+     ..++.++|||||||++|+|++|..||.+........        .+
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~ape~~~~-----~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~  253 (294)
T PHA02882        179 HGKHIEYSKEQKDLHRGTLYYAGLDAHNG-----ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKR  253 (294)
T ss_pred             CCcccccccccccccCCCccccCHHHhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHH
Confidence            21        1122368999999999853     367899999999999999999999998753332222        22


Q ss_pred             HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         153 VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       153 i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      +..+.. ..   ...+..+.+++..||..+|+  .|++|.++
T Consensus       254 ~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~--~rp~~~~l  289 (294)
T PHA02882        254 LHEGKI-KI---KNANKFIYDFIECVTKLSYE--EKPDYDAL  289 (294)
T ss_pred             hhhhhh-cc---CCCCHHHHHHHHHHHhCCCC--CCCCHHHH
Confidence            222211 11   22689999999999999998  33344443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=202.68  Aligned_cols=176  Identities=28%  Similarity=0.429  Sum_probs=143.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..++.+|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        60 ~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~  137 (250)
T cd05123          60 YAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDF  137 (250)
T ss_pred             HHeecCCeeEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeec
Confidence            34678889999999996 699999976 4579999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |.+...... .......++..|++||.+.+     ...+.++|+||||+++|++++|..||... ........+... ..
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~-~~  210 (250)
T cd05123         138 GLAKELSSEGSRTNTFCGTPEYLAPEVLLG-----KGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILKD-PL  210 (250)
T ss_pred             CcceecccCCCcccCCcCCccccChHHhCC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcC-CC
Confidence            998765433 22334467889999999853     25678999999999999999999999763 334445555442 23


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      .++.  .++..+.++|++||..+|+.|+.
T Consensus       211 ~~~~--~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         211 RFPE--FLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             CCCC--CCCHHHHHHHHHHhcCCHhhCCC
Confidence            3333  36999999999999999985543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.5e-28  Score=214.68  Aligned_cols=186  Identities=26%  Similarity=0.347  Sum_probs=146.7

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      +.+|+||||++++|.+++.+ ...+++..++.++.||+.||.|||+ +|++|+||||.||+++.++.++|+|||++....
T Consensus        77 ~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          77 NDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             cceEEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            47899999999999999976 5589999999999999999999999 599999999999999999999999999998765


Q ss_pred             CCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-CC--
Q psy3686          88 DSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-PC--  160 (296)
Q Consensus        88 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-p~--  160 (296)
                      ...    ......++..|+|||.+.+.    ..++.++|+||||+++|+|++|..||... ...+.+..+..... +.  
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSS----SRYTKAIDIWSVGCIFAELLTRKPLFPGR-DYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             ccccccccccccccccCcCCceeeecc----cCCCcchhHHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHhcCCCChh
Confidence            442    12334678889999999642    16788999999999999999999999873 33333333332110 00  


Q ss_pred             ----------------------C---CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 ----------------------L---PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ----------------------~---~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                            .   ...+.++..+.++|.+||..+|+        ++.+..++..++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK--------KRITADEALAHPYLAQ  294 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChh--------hCCCHHHHHhCccHHh
Confidence                                  0   00123688999999999999998        5666777888887754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-27  Score=213.03  Aligned_cols=187  Identities=26%  Similarity=0.367  Sum_probs=141.4

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .....+|+||||+.++|.+++.  ...+++..++.++.||+.||.|||+ +|++||||||+||+++.++.++|+|||++.
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          78 ESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             cccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECccccee
Confidence            3445789999999999998886  4689999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCCcc----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHH---ccC
Q psy3686          85 RLVDSKA----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL---NDA  157 (296)
Q Consensus        85 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~---~~~  157 (296)
                      .......    .....++..|+|||.+.+    ...++.++||||||+++|+|++|+.||.+... ...+..+.   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~  229 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTP  229 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCC
Confidence            6543221    122367889999998742    22578899999999999999999999976321 11111110   000


Q ss_pred             -------------------C---CCCC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         158 -------------------P---PCLP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       158 -------------------~---p~~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                         .   +..+   ..+.++..+.++|.+||..+|+        ++.++.++..++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~--------~Rpt~~e~l~hp~~~  296 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH--------KRITVEEALAHPYLE  296 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh--------hCcCHHHHhcCcccc
Confidence                               0   0000   0123578899999999999998        455667777777764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=1.1e-27  Score=213.83  Aligned_cols=191  Identities=21%  Similarity=0.324  Sum_probs=147.5

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +++..++.+|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCCEEECCcc
Confidence            34667889999999999999999976 5679999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC---------------ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q psy3686          82 ISGRLVDS---------------KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD  146 (296)
Q Consensus        82 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~  146 (296)
                      .+......               .......++..|+|||.+.+.    ..++.++|||||||++|+|++|..||... ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~-~~  239 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA----EKYHFAVDMWSVGCIFAELLTGKPLFPGE-NE  239 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CH
Confidence            98765411               111122457789999998532    24678999999999999999999999874 33


Q ss_pred             HHHHHHHHc---cCCCC-CC---------------------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         147 FEVLSRVLN---DAPPC-LP---------------------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       147 ~~~~~~i~~---~~~p~-~~---------------------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      ...+..+..   ...+. ++                     ....++..+.++|.+||..+|+        ++.++.+++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~s~~~~l  311 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL--------ERISAKEAL  311 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch--------hccCHHHHh
Confidence            343333322   11000 00                     0123578899999999999998        556677777


Q ss_pred             cCCccc
Q psy3686         202 AEGHLS  207 (296)
Q Consensus       202 ~~~~~~  207 (296)
                      .++++.
T Consensus       312 ~~~~~~  317 (335)
T PTZ00024        312 KHEYFK  317 (335)
T ss_pred             cCcccC
Confidence            777764

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=1.1e-27  Score=209.24  Aligned_cols=192  Identities=25%  Similarity=0.323  Sum_probs=145.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+..+..+|+||||+.| +|.+++.. ...+++..++.++.|++.+|.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          72 YAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             eeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEEC
Confidence            356778899999999985 99999876 5679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---cHHHHHHHHc
Q psy3686          81 GISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC---DFEVLSRVLN  155 (296)
Q Consensus        81 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~---~~~~~~~i~~  155 (296)
                      |++........  .....++..|++||.+.+.   ....+.++|+||||+++|+|++|..||.....   .......+..
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  226 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG---SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK  226 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCC---CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence            99876543321  1223578899999998542   11367799999999999999999999964221   1222333333


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .. +..+.  .++..+.++|.+||..+|+.|+.  ..   ...+++.++++
T Consensus       227 ~~-~~~~~--~~~~~l~~li~~~l~~~p~~R~t--~~---~~~~~l~~~~~  269 (288)
T cd05583         227 SK-PPFPK--TMSAEARDFIQKLLEKDPKKRLG--AN---GADEIKNHPFF  269 (288)
T ss_pred             cC-CCCCc--ccCHHHHHHHHHHhcCCHhhccC--cc---hHHHHhcCccc
Confidence            33 23333  37899999999999999995553  22   23344555554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=1e-27  Score=208.67  Aligned_cols=190  Identities=19%  Similarity=0.320  Sum_probs=143.4

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLH--VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++.+.+.+||||||+.|+|.+++....  ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|
T Consensus        65 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d  143 (284)
T cd07836          65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLAD  143 (284)
T ss_pred             eeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEee
Confidence            4567788999999999999999887643  568999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-
Q psy3686          80 FGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-  157 (296)
Q Consensus        80 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-  157 (296)
                      ||++....... ......++..|++||.+.+.    ..++.++||||||+++|+|++|..||.+.. ..+....+.... 
T Consensus       144 ~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~-~~~~~~~~~~~~~  218 (284)
T cd07836         144 FGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS----RTYSTSIDIWSVGCIMAEMITGRPLFPGTN-NEDQLLKIFRIMG  218 (284)
T ss_pred             cchhhhhcCCccccccccccccccChHHhcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhC
Confidence            99986543321 22233567889999988532    256789999999999999999999998743 333333322110 


Q ss_pred             C------------C----CCCC---------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 P------------P----CLPN---------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~------------p----~~~~---------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .            +    .++.         .+.++..+.++|.+||+.+|.        ++.+..++..+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~--------~R~~~~~~l~~~~  283 (284)
T cd07836         219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPE--------LRISAHDALQHPW  283 (284)
T ss_pred             CCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcc--------cCCCHHHHhcCCC
Confidence            0            0    0000         013578899999999999998        4444555555543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-27  Score=203.17  Aligned_cols=174  Identities=31%  Similarity=0.557  Sum_probs=142.9

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||+.| +|.+++.. ...+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          67 SIETSDSLYIILEYAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccc
Confidence            34567889999999995 99999976 4789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      .+........ .....++..|+|||.+.+.     .++.++|||+||+++|+|++|..||.... .......+.....+.
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~  218 (254)
T cd06627         145 VATKLNDVSKDDASVVGTPYWMAPEVIEMS-----GASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQDDHPP  218 (254)
T ss_pred             cceecCCCcccccccccchhhcCHhhhcCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhccCCCC
Confidence            9876654322 2234678899999998532     47789999999999999999999998743 444444454454455


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ++..  ++..+.++|.+||..+|+.|
T Consensus       219 ~~~~--~~~~~~~~i~~~l~~~p~~R  242 (254)
T cd06627         219 LPEG--ISPELKDFLMQCFQKDPNLR  242 (254)
T ss_pred             CCCC--CCHHHHHHHHHHHhCChhhC
Confidence            5443  79999999999999999833

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=8.6e-28  Score=209.23  Aligned_cols=182  Identities=20%  Similarity=0.326  Sum_probs=140.8

Q ss_pred             eEEEEecCccccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           9 DVWICMELMATCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      .+|++|||+.++|.+++.... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+..+.
T Consensus        80 ~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            399999999999999887643 369999999999999999999999 599999999999999999999999999987765


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC---------
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP---------  158 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~---------  158 (296)
                      .........++..|+|||.+.+     ..++.++|+|||||++|+|++|..||.. ....+.+.++.....         
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~s~G~~l~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQ-----SSYATPVDMWSVGCIFAELFRRRPLFRG-TSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             CCcccccccccccccChHHhcc-----CCCCCcchhhhHHHHHHHHHhCCCcccC-CChHHHHHHHHHHcCCCChHhcCC
Confidence            4433334457888999999853     3577899999999999999999999987 344444444432100         


Q ss_pred             ------CCCC---------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 ------PCLP---------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 ------p~~~---------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                            +.++         ....++..+.++|.+||..+|+        .+.+..++..+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~--------~Rp~~~~il~~~~  286 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH--------KRISAFEALQHPY  286 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCc--------cCCCHHHHhcCcC
Confidence                  0000         0113578889999999999998        4445555555543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-27  Score=210.04  Aligned_cols=178  Identities=22%  Similarity=0.297  Sum_probs=135.2

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLH-----------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD   70 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~   70 (296)
                      ++..++.+|+||||+.| +|.+++....           ..+++..++.++.|++.||.|||+ +|++|+||||+||+++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nill~  163 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChhhEEEc
Confidence            45677889999999995 9999986531           246889999999999999999999 5999999999999999


Q ss_pred             CCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCC
Q psy3686          71 ERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT--GEFPYKDCKC  145 (296)
Q Consensus        71 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~--g~~Pf~~~~~  145 (296)
                      .++.+||+|||++........   .....++..|+|||.+.+     ..++.++||||||+++|+|++  |..||... .
T Consensus       164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~-~  237 (295)
T cd05097         164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-----GKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-S  237 (295)
T ss_pred             CCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-----CCcCchhhHHHHHHHHHHHHHcCCCCCCccc-C
Confidence            999999999999875432211   122244678999999843     367889999999999999998  66788763 3


Q ss_pred             cHHHHHHHHc-----cCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         146 DFEVLSRVLN-----DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       146 ~~~~~~~i~~-----~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .......+..     +..........++..+.+||.+||..+|+.||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP  284 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP  284 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence            3333333221     11111222334789999999999999998444

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=1.3e-27  Score=213.38  Aligned_cols=188  Identities=23%  Similarity=0.382  Sum_probs=144.0

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ....+|+||||+.|+|.+++.. ...+++..++.++.||+.||.|||+ +|++|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          79 DFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             CCceEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            4568999999999999999875 5679999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCcc-----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC
Q psy3686          86 LVDSKA-----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP  158 (296)
Q Consensus        86 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~  158 (296)
                      ......     .....++..|+|||.+.+    ...++.++||||||+++|+|++|+.||..... ...+..+..  +.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~g~~  231 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLS----LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY-VHQLKLILSVLGSP  231 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcC----CcccccccchHHHHHHHHHHHcCCCccCCCCh-HHHHHHHHHHhCCC
Confidence            543221     123367889999999853    22578899999999999999999999977432 222211111  100


Q ss_pred             -----------------------CCCC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 -----------------------PCLP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 -----------------------p~~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                             +..+   ....++..+.++|++||+.+|+        ++.++.++..++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE--------ERITVEQALQHPFLAQ  299 (334)
T ss_pred             hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChh--------hCcCHHHHHhChhhhh
Confidence                                   0111   0123689999999999999998        4555667777777653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=1.6e-27  Score=203.73  Aligned_cols=181  Identities=33%  Similarity=0.549  Sum_probs=145.6

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      +.+++||||+. ++|.+++.. ...+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.+...
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            78999999997 599999987 4489999999999999999999999 59999999999999999999999999998776


Q ss_pred             cCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCCCCC
Q psy3686          87 VDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLP  162 (296)
Q Consensus        87 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p~~~  162 (296)
                      .....   .....++..|++||.+..     ...+.++||||||+++|+|++|..||............+.. ...+.++
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRG-----EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP  226 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence            55432   344578889999999853     24788999999999999999999999885534444444433 2333444


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      ..  ++..+.++|.+||..+|+        .+.+..++..+++
T Consensus       227 ~~--~~~~l~~~i~~~l~~~p~--------~Rp~~~~ll~~~~  259 (260)
T cd06606         227 EH--LSEEAKDFLRKCLRRDPK--------KRPTADELLQHPF  259 (260)
T ss_pred             cc--cCHHHHHHHHHhCcCChh--------hCCCHHHHhhCCC
Confidence            33  699999999999999998        4444444444443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=8.2e-28  Score=208.79  Aligned_cols=172  Identities=25%  Similarity=0.314  Sum_probs=132.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-------C
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-------N   74 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-------~   74 (296)
                      ++.+++..|+||||++ |+|..++......+++..+..++.||+.||+|||++ ||+||||||+||+++..+       .
T Consensus        84 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~~~~  162 (274)
T cd05076          84 VCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGTSPF  162 (274)
T ss_pred             EEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCccce
Confidence            4556788999999999 599999876567899999999999999999999995 999999999999997643       4


Q ss_pred             EEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCcHHHHHHH
Q psy3686          75 IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELA-TGEFPYKDCKCDFEVLSRV  153 (296)
Q Consensus        75 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~-~g~~Pf~~~~~~~~~~~~i  153 (296)
                      ++++|||.+......   ....++..|+|||.+.+    ...++.++||||||+++|+++ +|..||..... .... ..
T Consensus       163 ~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~-~~  233 (274)
T cd05076         163 IKLSDPGVSFTALSR---EERVERIPWIAPECVPG----GNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEKE-RF  233 (274)
T ss_pred             eeecCCccccccccc---cccccCCcccCchhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHHH-HH
Confidence            899999987543221   22356778999998853    235788999999999999985 69999987432 2222 22


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .... ..++..  .++.+.++|.+||..+|+.||
T Consensus       234 ~~~~-~~~~~~--~~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         234 YEKK-HRLPEP--SCKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             HHhc-cCCCCC--CChHHHHHHHHHcccChhhCc
Confidence            2221 222322  567899999999999999443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=207.86  Aligned_cols=174  Identities=24%  Similarity=0.373  Sum_probs=136.1

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      +.+|+||||++++|.+++......+++..++.++.||+.||+|||+ .|++|+||+|.||+++.++.++|+|||++....
T Consensus        73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          73 GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             CcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            7899999999999999997655689999999999999999999999 599999999999999999999999999987665


Q ss_pred             CCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-C---CC
Q psy3686          88 DSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-P---CL  161 (296)
Q Consensus        88 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-p---~~  161 (296)
                      ...  ......++..|+|||.+.+    ...++.++||||||+++|+|++|..||.... ....+..+..... +   .+
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07840         152 KRNSADYTNRVITLWYRPPELLLG----ATRYGPEVDMWSVGCILAELFLGKPIFQGST-ELEQLEKIFELCGSPTDENW  226 (287)
T ss_pred             CCCcccccccccccccCCceeeEc----cccCChHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCchhhc
Confidence            432  1233356788999998753    2256789999999999999999999998743 3333333332110 0   00


Q ss_pred             CC-----------------------Ccc-hhHHHHHHHHhccCCChHHHh
Q psy3686         162 PN-----------------------DPL-FGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       162 ~~-----------------------~~~-~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +.                       ... ++..+.++|.+||..+|..|+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  276 (287)
T cd07840         227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI  276 (287)
T ss_pred             cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence            00                       011 388999999999999998444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=1.3e-27  Score=210.40  Aligned_cols=181  Identities=20%  Similarity=0.345  Sum_probs=139.1

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ...++|+||++ |+|.+++......+++..++.++.||+.||.|||+ +||+|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEccccccccc
Confidence            45679999999 69999998766679999999999999999999999 59999999999999999999999999999765


Q ss_pred             cCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          87 VDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        87 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      .....   .....++..|++||.+.+     ..++.++||||||+++|++++ |..||.+. ........+..+..+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~  233 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHY-----RKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQP  233 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhcc-----CCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCCCC
Confidence            43221   112234678999999843     367889999999999999997 99999773 233333333333333222


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                        ..++..+.++|.+||..+|+.  |+++.++.....
T Consensus       234 --~~~~~~~~~li~~c~~~~p~~--Rp~~~~l~~~l~  266 (303)
T cd05110         234 --PICTIDVYMVMVKCWMIDADS--RPKFKELAAEFS  266 (303)
T ss_pred             --CCCCHHHHHHHHHHcCCChhh--CcCHHHHHHHHH
Confidence              336889999999999999984  444555444333

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=7.7e-28  Score=211.11  Aligned_cols=178  Identities=22%  Similarity=0.308  Sum_probs=135.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH----------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE   71 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~   71 (296)
                      ++..++.+|+||||+. |+|.+++....          ..+++..++.++.||+.||+|||+ +|++|+||||+||+++.
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~Nili~~  165 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATRNCLVGK  165 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChheEEEcC
Confidence            4566788999999998 59999997632          246788999999999999999999 59999999999999999


Q ss_pred             CCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCc
Q psy3686          72 RGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT--GEFPYKDCKCD  146 (296)
Q Consensus        72 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~--g~~Pf~~~~~~  146 (296)
                      ++.++|+|||++..+.....   ......+..|++||...+     ..++.++|||||||++|+|++  |..||... ..
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~-~~  239 (296)
T cd05095         166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-----GKFTTASDVWAFGVTLWEILTLCKEQPYSQL-SD  239 (296)
T ss_pred             CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-----CCccchhhhhHHHHHHHHHHHhCCCCCcccc-Ch
Confidence            99999999999876533221   112234568999998743     367889999999999999998  77899763 22


Q ss_pred             HHHHHHHHc-----cCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         147 FEVLSRVLN-----DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       147 ~~~~~~i~~-----~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+.+.....     .....++....++..+.+||.+||..+|..||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  285 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP  285 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence            333322211     11122333334789999999999999998443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-27  Score=207.17  Aligned_cols=189  Identities=21%  Similarity=0.338  Sum_probs=144.0

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+||||+.|+|.+++.... ..+++..++.++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        66 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          66 VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             HhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecc
Confidence            456788999999999889999887643 478999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--APP  159 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~p  159 (296)
                      .+.............++..|+|||.+..    ...++.++|+||||+++|+|++|..||.... .......+...  .++
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~-~~~~~~~~~~~~~~~~  219 (283)
T cd07830         145 LAREIRSRPPYTDYVSTRWYRAPEILLR----STSYSSPVDIWALGCIMAELYTLRPLFPGSS-EIDQLYKICSVLGTPT  219 (283)
T ss_pred             cceeccCCCCcCCCCCcccccCceeeec----CcCcCCccchhhHHHHHHHHHhCCCccCCCC-hHHHHHHHHHhcCCCC
Confidence            9976654444444567889999998853    2256789999999999999999999997743 22222222210  000


Q ss_pred             ----------------CCC---C------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         160 ----------------CLP---N------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       160 ----------------~~~---~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                      .++   .      ....+..+.++|.+||..+|+        ++.+..++..+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~--------~Rpt~~ei~~~~~  282 (283)
T cd07830         220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK--------KRPTASQALQHPY  282 (283)
T ss_pred             hhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcc--------cCCCHHHHhhCCC
Confidence                            000   0      011368899999999999998        4445555555543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=6.6e-28  Score=210.54  Aligned_cols=175  Identities=22%  Similarity=0.283  Sum_probs=138.9

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------------VSVPEPICGKITLSTVKALHYLKETHGVIHR   60 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~   60 (296)
                      .+.++..+|+||||++ |+|.+++....                     ..+++..++.++.||+.||.|||+ .|++|+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~  154 (288)
T cd05050          76 VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHR  154 (288)
T ss_pred             EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence            4566778999999999 59999997531                     247889999999999999999999 599999


Q ss_pred             CCCCCcEEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy3686          61 DVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-G  136 (296)
Q Consensus        61 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g  136 (296)
                      ||+|.||+++.++.++|+|||++........   ......+..|+|||.+.+     ..++.++|||||||++|+|++ |
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-----NRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-----CCCCchhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999865432211   112234567999998843     367889999999999999998 8


Q ss_pred             CCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         137 EFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       137 ~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ..||.+. ...+....+..+..+..+.  .++..+.+||.+||..+|+.|
T Consensus       230 ~~p~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R  276 (288)
T cd05050         230 MQPYYGM-AHEEVIYYVRDGNVLSCPD--NCPLELYNLMRLCWSKLPSDR  276 (288)
T ss_pred             CCCCCCC-CHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHcccCcccC
Confidence            8899773 4445566666555443333  378999999999999999843

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=2.1e-27  Score=209.15  Aligned_cols=185  Identities=21%  Similarity=0.279  Sum_probs=138.6

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      .+.+|+||||+.++|.+++......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            45779999999999999987756689999999999999999999999 59999999999999999999999999998765


Q ss_pred             cCCcc-----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cC-C
Q psy3686          87 VDSKA-----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DA-P  158 (296)
Q Consensus        87 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~-~  158 (296)
                      .....     .....++..|+|||.+.+.    ..++.++||||||+++|+|++|..||.... .......+..  +. +
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~~~~  244 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGE----RDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCGSIT  244 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCC----cccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCC
Confidence            43221     1223567889999988532    246779999999999999999999998733 2222221111  11 1


Q ss_pred             CC---------------CCC-----------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         159 PC---------------LPN-----------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       159 p~---------------~~~-----------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +.               ++.           ....+..+.++|.+||..+|.        ++.++.+++.+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~--------~R~t~~e~l~h~~  309 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA--------KRIDADTALNHDF  309 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh--------hccCHHHHhcCCC
Confidence            00               000           001356788999999999998        4555566665554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=1.3e-27  Score=204.93  Aligned_cols=168  Identities=26%  Similarity=0.299  Sum_probs=131.3

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-------CEEEec
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-------NIKLCD   79 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-------~~kl~d   79 (296)
                      +..|+||||+. |+|.+++......++...+..++.||+.||.|||+ .||+|+||||+||+++.++       .++|+|
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCC
Confidence            67899999999 59999998755589999999999999999999999 5999999999999999887       799999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      ||++.....   .....++..|+|||.+.+..   ..++.++||||||+++|+|++ |..||.... ...........  
T Consensus       152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~--  222 (259)
T cd05037         152 PGIPITVLS---REERVERIPWIAPECIRNGQ---ASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ--  222 (259)
T ss_pred             CCccccccc---ccccccCCCccChhhhcCCC---CCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC--
Confidence            999876543   22235667899999985421   367889999999999999999 678887643 22222222221  


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ...+..  ....+.++|.+||..+|..||
T Consensus       223 ~~~~~~--~~~~~~~li~~~l~~~p~~Rp  249 (259)
T cd05037         223 HRLPMP--DCAELANLINQCWTYDPTKRP  249 (259)
T ss_pred             CCCCCC--CchHHHHHHHHHhccChhhCC
Confidence            122222  248999999999999998444

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=2.2e-27  Score=211.71  Aligned_cols=185  Identities=21%  Similarity=0.330  Sum_probs=142.1

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ...+|++|+|++++|.+++.. ...+++..++.++.||+.||.|||+ +|++|+||||+||+++.++.++|+|||++..+
T Consensus        78 ~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          78 FNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            356899999999999999865 6789999999999999999999999 59999999999999999999999999998765


Q ss_pred             cCCcc-----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-----
Q psy3686          87 VDSKA-----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-----  156 (296)
Q Consensus        87 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-----  156 (296)
                      .....     .....++..|+|||.+.+    ...++.++||||+|+++|++++|..||.... ....+..++..     
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~  230 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLS----FQSYTKAIDVWSVGCILAELLGRKPVFKGKD-YVDQLNQILQVLGTPD  230 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC-HHHHHHHHHHHhCCCC
Confidence            43211     123367889999998753    2257789999999999999999999998632 22222221110     


Q ss_pred             ----------------------CCCCCC-CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         157 ----------------------APPCLP-NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       157 ----------------------~~p~~~-~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                                            ....+. ....++..+.++|.+||+.+|.        ++.+..++..++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~t~~~ll~~~~~  295 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT--------KRISVEEALEHPYL  295 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc--------cCCCHHHHhcChhh
Confidence                                  001111 1123578999999999999998        55566777777765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=2.2e-27  Score=203.38  Aligned_cols=187  Identities=24%  Similarity=0.365  Sum_probs=145.3

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCC-EEEe
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN-IKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~-~kl~   78 (296)
                      +.+..++.+|+||||+.| +|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|.||+++.++. ++|+
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             heeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEec
Confidence            456778899999999985 999998764 3358999999999999999999999 59999999999999988864 6999


Q ss_pred             ccCCcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          79 DFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        79 dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |||.+........ .....++..|+|||.+..     ..++.++|+||||+++|++++|..||... ........+..+.
T Consensus       145 d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~  218 (257)
T cd08225         145 DFGIARQLNDSMELAYTCVGTPYYLSPEICQN-----RPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGY  218 (257)
T ss_pred             ccccchhccCCcccccccCCCccccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhccc
Confidence            9999876543321 223357889999998843     35788999999999999999999999873 3334444454444


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+..+  ..++..+.++|.+||..+|+        ++.++.++..+++
T Consensus       219 ~~~~~--~~~~~~~~~~i~~~l~~~p~--------~Rpt~~~ll~~~~  256 (257)
T cd08225         219 FAPIS--PNFSRDLRSLISQLFKVSPR--------DRPSITSILKRPF  256 (257)
T ss_pred             CCCCC--CCCCHHHHHHHHHHhccChh--------hCcCHHHHhhCCC
Confidence            33333  23789999999999999998        4444555554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=2.3e-27  Score=212.43  Aligned_cols=188  Identities=20%  Similarity=0.310  Sum_probs=142.5

Q ss_pred             CccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEEeccCC
Q psy3686           4 QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFGI   82 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl~dfg~   82 (296)
                      +.+...+|+||||++++|.+++.  ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||.
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCccc
Confidence            44556799999999999998886  4579999999999999999999999 59999999999999975 55789999999


Q ss_pred             cccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC-
Q psy3686          83 SGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA-  157 (296)
Q Consensus        83 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~-  157 (296)
                      +.......    ......++..|+|||.+..    ...++.++|||||||++|+|++|..||.... .......+.... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~  236 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILESVP  236 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhC----ccccCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcC
Confidence            87543221    1122356788999998742    2357789999999999999999999998632 223332222211 


Q ss_pred             -----------------------CCCCC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         158 -----------------------PPCLP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       158 -----------------------~p~~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                             .+..+   ....++.++.+||.+||..+|.        ++.++.+++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~--------~R~t~~ell~h~~~~  304 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM--------DRLTAEEALMHPYMS  304 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCch--------hccCHHHHhCCCccc
Confidence                                   11111   0123678999999999999998        556777888888774

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=2.2e-27  Score=205.32  Aligned_cols=182  Identities=18%  Similarity=0.222  Sum_probs=135.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      .+.+...+|+||||+. |+|.+++.+.   ...+++..++.++.||+.||.|||+ .+++|+||||+|||++.++.++|+
T Consensus        63 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~  141 (268)
T cd05086          63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVG  141 (268)
T ss_pred             EecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEec
Confidence            4566788999999999 5999999764   2346778889999999999999999 599999999999999999999999


Q ss_pred             ccCCcccccCC---ccccccccCcCCCCccccCCCCC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHH
Q psy3686          79 DFGISGRLVDS---KARTKNAGCAAYMAPERIEPPNP--QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        79 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~  152 (296)
                      |||++......   .......++..|+|||++.....  ....++.++||||||+++|+|++ |..||.. ....+.+..
T Consensus       142 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~~~~~~~~  220 (268)
T cd05086         142 DYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH-LSDREVLNH  220 (268)
T ss_pred             ccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence            99987542211   11223457789999999853211  12245789999999999999997 5778876 344455555


Q ss_pred             HHccCCCCCC---CCcchhHHHHHHHHhccCCChHHHh
Q psy3686         153 VLNDAPPCLP---NDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       153 i~~~~~p~~~---~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..+....++   ....+++.+.+++.+|| .+|+.||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp  257 (268)
T cd05086         221 VIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRA  257 (268)
T ss_pred             HHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCC
Confidence            5444322221   11237899999999999 5687443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=1.7e-27  Score=206.98  Aligned_cols=180  Identities=22%  Similarity=0.309  Sum_probs=141.5

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLH-------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      .+...+++++|+. |+|.+++....       ..+++..++.++.||+.||+|||+ +|++|+||+|+||+++.++.+||
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCCcEEE
Confidence            3577899999998 69999987642       468999999999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHH
Q psy3686          78 CDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV  153 (296)
Q Consensus        78 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i  153 (296)
                      +|||+++.+.....   .....++..|+|||.+.+     ..++.++||||||+++|++++ |..||... ...+....+
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~  232 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-----KEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYL  232 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-----CCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHH
Confidence            99999976533221   122345678999999853     357889999999999999999 99999873 444555555


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      ..+..+..+  ..+++.+.++|.+||..+|+.|  +++.++..
T Consensus       233 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R--ps~~~~~~  271 (280)
T cd05043         233 KDGYRLAQP--INCPDELFAVMACCWALDPEER--PSFSQLVQ  271 (280)
T ss_pred             HcCCCCCCC--CcCCHHHHHHHHHHcCCChhhC--CCHHHHHH
Confidence            554433333  3378999999999999999844  44444433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0194|consensus

Probab=99.95  E-value=1.3e-28  Score=222.98  Aligned_cols=187  Identities=23%  Similarity=0.370  Sum_probs=151.0

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ...+.-+|||||+|. |+|.++|++....++..+...++.+.+.||+|||+ ++++||||-..|+|++.++.+||+|||+
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEeCcccc
Confidence            345678999999999 59999999866679999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCcccc-ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHH-HccCCC
Q psy3686          83 SGRLVDSKART-KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV-LNDAPP  159 (296)
Q Consensus        83 ~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i-~~~~~p  159 (296)
                      ++......... ...-...|+|||.+     ....|+.++|||||||++||+++ |..||.+. ...++..+| ..+.+.
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl-----~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~-~~~~v~~kI~~~~~r~  382 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETL-----NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM-KNYEVKAKIVKNGYRM  382 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhh-----ccCccccccchhheeeeEEeeeccCCCCCCCC-CHHHHHHHHHhcCccC
Confidence            87643222111 22355799999999     45589999999999999999999 89999994 555777777 445544


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      ..+.  ..+..+..++.+||..+|+  .|+++.......+..
T Consensus       383 ~~~~--~~p~~~~~~~~~c~~~~p~--~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  383 PIPS--KTPKELAKVMKQCWKKDPE--DRPTMSTIKKKLEAL  420 (474)
T ss_pred             CCCC--CCHHHHHHHHHHhccCChh--hccCHHHHHHHHHHH
Confidence            4444  3699999999999999998  444455554444433

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=2.6e-27  Score=208.01  Aligned_cols=175  Identities=23%  Similarity=0.290  Sum_probs=135.1

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +++.+|+||||++++|..++......+++..++.++.||+.||.|||+ +||+|+||+|.||+++.++.+||+|||++..
T Consensus        87 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          87 DKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             cCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence            345899999999998888887655679999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc---cCCCC
Q psy3686          86 LVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---DAPPC  160 (296)
Q Consensus        86 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~---~~~p~  160 (296)
                      .....  ......++..|+|||.+.+    ...++.++|||||||++|+|++|+.||... .....+..+..   ...+.
T Consensus       166 ~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~~~el~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         166 YNSEESRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFTKKPIFQAN-QELAQLELISRLCGSPCPA  240 (302)
T ss_pred             ccCCcccccccceeccCccChHHhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChh
Confidence            54322  1122245678999998853    224678999999999999999999999863 33333333222   21110


Q ss_pred             -C-----------------------CCCcchhHHHHHHHHhccCCChHHH
Q psy3686         161 -L-----------------------PNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       161 -~-----------------------~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                       +                       .....++..+.++|.+||..+|+.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  290 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR  290 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhC
Confidence             0                       0112368999999999999999833

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=1.3e-27  Score=205.58  Aligned_cols=171  Identities=25%  Similarity=0.366  Sum_probs=136.5

Q ss_pred             CeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           8 SDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ..+|+||||++ |+|.+++... ...++...++.++.|++.||.|||+ .|++|+||+|+||+++..+.++|+|||.+..
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceee
Confidence            67899999998 5999999763 4568899999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          86 LVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        86 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ......  .....++..|+|||.+..     ..++.++|+||||+++|++++ |..||... ........+..+.....+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~  225 (260)
T cd05073         152 IEDNEYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRP  225 (260)
T ss_pred             ccCCCcccccCCcccccccCHhHhcc-----CCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCCCCc
Confidence            543221  112234567999999843     367889999999999999998 99999873 444455555554333333


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHh
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                        ..++..+.+++.+||..+|+.|+
T Consensus       226 --~~~~~~~~~~i~~~l~~~p~~Rp  248 (260)
T cd05073         226 --ENCPEELYNIMMRCWKNRPEERP  248 (260)
T ss_pred             --ccCCHHHHHHHHHHcccCcccCc
Confidence              34789999999999999998444

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1.2e-27  Score=218.11  Aligned_cols=157  Identities=22%  Similarity=0.329  Sum_probs=120.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCcccc
Q psy3686          31 SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERI  107 (296)
Q Consensus        31 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~  107 (296)
                      .++...++.++.||+.||.|||+ .|++||||||.|||++.++.++|+|||++.......   ......++..|+|||.+
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  313 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI  313 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence            36777889999999999999999 599999999999999999999999999987643221   11223456789999998


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+     ..++.++||||||+++|+|++ |..||............+..+..+..+.  .++..+.++|.+||..+|..|
T Consensus       314 ~~-----~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~l~~li~~cl~~~P~~R  386 (401)
T cd05107         314 FN-----NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPA--HASDEIYEIMQKCWEEKFEIR  386 (401)
T ss_pred             cC-----CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHHcCCChhHC
Confidence            53     357889999999999999998 8999987443333334444444444443  378999999999999999844


Q ss_pred             hhhccCCccch
Q psy3686         187 RKRSYEDKSTC  197 (296)
Q Consensus       187 ~~~~~~~~~~~  197 (296)
                        +++.++...
T Consensus       387 --Ps~~ell~~  395 (401)
T cd05107         387 --PDFSQLVHL  395 (401)
T ss_pred             --cCHHHHHHH
Confidence              444454433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=2.2e-27  Score=212.64  Aligned_cols=156  Identities=24%  Similarity=0.370  Sum_probs=120.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCcccc
Q psy3686          31 SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERI  107 (296)
Q Consensus        31 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~  107 (296)
                      .++...+..++.||+.||+|||+ +||+||||||.||+++.++.++|+|||++........   .....++..|+|||.+
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  253 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  253 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHh
Confidence            36788889999999999999999 5999999999999999999999999999876532211   1122345679999998


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+     ..++.++||||||+++|++++ |..||............+..+..+..+..  +++.+.+++.+||..+|+.|
T Consensus       254 ~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~cl~~~p~~R  326 (343)
T cd05103         254 FD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQR  326 (343)
T ss_pred             cC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCC--CCHHHHHHHHHHccCChhhC
Confidence            43     367889999999999999997 99999875444444555555554444433  68899999999999999844


Q ss_pred             hhhccCCccc
Q psy3686         187 RKRSYEDKST  196 (296)
Q Consensus       187 ~~~~~~~~~~  196 (296)
                        +++.++..
T Consensus       327 --ps~~eil~  334 (343)
T cd05103         327 --PTFSELVE  334 (343)
T ss_pred             --cCHHHHHH
Confidence              34444443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=2.1e-27  Score=206.95  Aligned_cols=179  Identities=23%  Similarity=0.395  Sum_probs=136.7

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+||||+.+ +|..+... ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~df  144 (286)
T cd07846          67 EVFRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDF  144 (286)
T ss_pred             HhcccCCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEee
Confidence            356788899999999996 77776654 5569999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc---
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND---  156 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~---  156 (296)
                      |++....... ......++..|+|||.+.+    ...++.++||||||+++|+|++|..||... ...+.+..+...   
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el~~g~~~~~~~-~~~~~~~~~~~~~~~  219 (286)
T cd07846         145 GFARTLAAPGEVYTDYVATRWYRAPELLVG----DTKYGRAVDIWAVGCLVTEMLTGEPLFPGD-SDIDQLYHIIKCLGN  219 (286)
T ss_pred             eeeeeccCCccccCcccceeeccCcHHhcc----ccccCchHhHHHHHHHHHHHHcCCCCCCCC-chHHHHHHHHHHhCC
Confidence            9987654322 2223457889999999853    224678899999999999999999999763 323332222210   


Q ss_pred             ------------------CCCCCC-------CCcchhHHHHHHHHhccCCChHHHh
Q psy3686         157 ------------------APPCLP-------NDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       157 ------------------~~p~~~-------~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                                        ..+...       ..+.++..+.+||.+||..+|+.|+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  275 (286)
T cd07846         220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP  275 (286)
T ss_pred             CchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence                              000000       1124688999999999999998444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=1.5e-27  Score=206.75  Aligned_cols=176  Identities=18%  Similarity=0.274  Sum_probs=138.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH--------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG   73 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~   73 (296)
                      .+.+.+..|+||||++ |+|.+++....        ..+++..++.++.||+.||.|||+ .|++|+||||+||+++.++
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~  154 (275)
T cd05046          76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR  154 (275)
T ss_pred             EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC
Confidence            4566788999999999 59999997643        168999999999999999999999 5999999999999999999


Q ss_pred             CEEEeccCCcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHH
Q psy3686          74 NIKLCDFGISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVL  150 (296)
Q Consensus        74 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~  150 (296)
                      .++++|||++.......  ......++..|+|||.+.+     ..++.++||||||+++|++++ |..||... .....+
T Consensus       155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~  228 (275)
T cd05046         155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-----DDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVL  228 (275)
T ss_pred             cEEEcccccccccCcccccccCCceeEEeecChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHH
Confidence            99999999886443221  1122345677999998853     356788999999999999998 88999763 344455


Q ss_pred             HHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         151 SRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       151 ~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      ..+..+.. .++....++..+.++|.+||..+|+.|
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~l~~~i~~~l~~~p~~R  263 (275)
T cd05046         229 NRLQAGKL-ELPVPEGCPSRLYKLMTRCWAVNPKDR  263 (275)
T ss_pred             HHHHcCCc-CCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence            55544433 233333489999999999999999844

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG1151|consensus

Probab=99.95  E-value=3.6e-28  Score=212.46  Aligned_cols=189  Identities=28%  Similarity=0.443  Sum_probs=152.0

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEECC---CCCEEEecc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH-GVIHRDVKPSNILLDE---RGNIKLCDF   80 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-~ivH~dlkp~Nil~~~---~~~~kl~df   80 (296)
                      +.+.+|-|+|||+| +|+-||+. +..+++++++.|+.||+.||.||.+.. .|||-||||.|||+-+   .|.+||.||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            56688999999998 99888876 788999999999999999999998732 5999999999999943   478999999


Q ss_pred             CCcccccCCcc--------ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHH
Q psy3686          81 GISGRLVDSKA--------RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        81 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~  152 (296)
                      |+++.+.+...        .+...||.+|++||++.-.. ..+..+.++||||+|+|+|.++.|+.||.......++++.
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-ePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-EPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCC-CCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            99988764422        23447999999999985432 3457889999999999999999999999986555555543


Q ss_pred             --HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCC
Q psy3686         153 --VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEG  204 (296)
Q Consensus       153 --i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~  204 (296)
                        |++.....+|..+.++.+.++||++||...-+        ++....++..++
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKe--------DR~DV~qLA~dp  742 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKE--------DRIDVQQLACDP  742 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhh--------hhhhHHHHccCc
Confidence              45555556776677999999999999988775        555555544443

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.9e-27  Score=207.34  Aligned_cols=172  Identities=20%  Similarity=0.283  Sum_probs=131.4

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ...+|+||||++| +|.+++.+....+++..++.++.||+.||+|||+ .|++||||||+||+++.++.++|+|||++..
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCccccc
Confidence            3678999999985 9999997655578999999999999999999999 5999999999999999999999999999876


Q ss_pred             ccCCcc----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------------c-H
Q psy3686          86 LVDSKA----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-------------D-F  147 (296)
Q Consensus        86 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-------------~-~  147 (296)
                      +.....    .....++..|+|||.+.+     ..++.++||||||+++|+|+++..|+.....             . .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQ-----SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhcc-----CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            543321    123356678999999843     3678899999999999999998766532110             0 1


Q ss_pred             HHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         148 EVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       148 ~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .....+..+...  +....++..+.+||.+||..+|..|
T Consensus       234 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R  270 (284)
T cd05079         234 RLVRVLEEGKRL--PRPPNCPEEVYQLMRKCWEFQPSKR  270 (284)
T ss_pred             HHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCCcccC
Confidence            111122222222  2223479999999999999999833

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=2.4e-27  Score=207.61  Aligned_cols=191  Identities=19%  Similarity=0.330  Sum_probs=141.5

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEEec
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl~d   79 (296)
                      +++.+++.+|+||||++++|.+++... ...+++..++.++.||+.||+|||+ .|++|+||+|+||+++. ++.+||+|
T Consensus        68 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~d  146 (294)
T PLN00009         68 DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLAD  146 (294)
T ss_pred             EEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcc
Confidence            356678899999999998888888653 2346889999999999999999999 59999999999999985 55799999


Q ss_pred             cCCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--c
Q psy3686          80 FGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--D  156 (296)
Q Consensus        80 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~  156 (296)
                      ||++...... .......++..|+|||.+.+    ...++.++||||||+++|+|++|..||... .....+.++..  +
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~-~~~~~~~~~~~~~~  221 (294)
T PLN00009        147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLG----SRHYSTPVDIWSVGCIFAEMVNQKPLFPGD-SEIDELFKIFRILG  221 (294)
T ss_pred             cccccccCCCccccccCceeecccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhC
Confidence            9998654332 12223356789999998853    225778999999999999999999999873 33333333221  1


Q ss_pred             CC------------------CCCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         157 AP------------------PCLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       157 ~~------------------p~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+                  +.++      ....++..+.++|.+||..+|+        .+.+..++..++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~--------~Rps~~~~l~~~~~  287 (294)
T PLN00009        222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPS--------KRITARAALEHEYF  287 (294)
T ss_pred             CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChh--------hCcCHHHHhcCchH
Confidence            00                  0000      0123688999999999999998        44445555555544

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=2.5e-27  Score=211.78  Aligned_cols=186  Identities=24%  Similarity=0.365  Sum_probs=143.8

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            46899999999999999876 5789999999999999999999999 599999999999999999999999999987654


Q ss_pred             CC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc---c-------
Q psy3686          88 DS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---D-------  156 (296)
Q Consensus        88 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~---~-------  156 (296)
                      .. .......++..|+|||.+...    ..++.++|||||||++|+|++|..||.+... ......+..   .       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNC----SEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             CCcccccccccccCccChHHHhcC----CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence            33 222334678899999988532    2478899999999999999999999976321 111111110   0       


Q ss_pred             -----------------CCCCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         157 -----------------APPCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       157 -----------------~~p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                       ..+.+ .....+++.+.++|.+||..+|+        ++.+..+++.++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~Rps~~ell~h~~~~~  296 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS--------KRITVEEALAHPYLAS  296 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh--------hccCHHHHHcCcchhh
Confidence                             00000 01124789999999999999998        5556788888887654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=2.8e-27  Score=208.40  Aligned_cols=187  Identities=21%  Similarity=0.312  Sum_probs=140.7

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+...+|+||||+.++|...+......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence            3455789999999998888887656789999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCCcc------------ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHH
Q psy3686          85 RLVDSKA------------RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        85 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~  152 (296)
                      .......            .....++..|+|||.+.+    ...++.++||||||+++|+|++|..||.+. ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~~g~~~~~~~-~~~~~~~~  238 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMFTRRPILQGK-SDIDQLHL  238 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhC----CCccCchhHhHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Confidence            5532211            112245778999998853    225778999999999999999999999873 33333333


Q ss_pred             HHcc--C-CC----------C---------CC-----CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         153 VLND--A-PP----------C---------LP-----NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       153 i~~~--~-~p----------~---------~~-----~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      +...  . .+          .         .+     ....++..+.++|.+||..+|.        ++.+..++..++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~--------~R~t~~ell~~~~  310 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY--------KRLTASDALEHPY  310 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc--------cCcCHHHHhcCCC
Confidence            3221  0 00          0         00     0123457899999999999998        5555566665554

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=3.2e-27  Score=204.73  Aligned_cols=173  Identities=26%  Similarity=0.428  Sum_probs=139.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+++.+|+|||++. ++|.+++.+ ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          70 TFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             HhcCCceEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCc
Confidence            4567889999999996 699999987 5589999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc---------------------ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy3686          82 ISGRLVDSKA---------------------RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY  140 (296)
Q Consensus        82 ~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf  140 (296)
                      ++........                     .....++..|+|||.+..     ..++.++|+||||++++++++|..||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-----KPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-----CCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            9876543221                     122356788999998853     35788999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         141 KDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       141 ~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .... .......+.... ..++  ..++..+.++|.+||..+|+.|
T Consensus       223 ~~~~-~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~R  264 (280)
T cd05581         223 RGSN-EYLTFQKILKLE-YSFP--PNFPPDAKDLIEKLLVLDPQDR  264 (280)
T ss_pred             CCcc-HHHHHHHHHhcC-CCCC--CccCHHHHHHHHHHhcCCHhhC
Confidence            8743 334444444322 2222  2378999999999999999943

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.7e-27  Score=204.04  Aligned_cols=189  Identities=21%  Similarity=0.342  Sum_probs=144.6

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      .+.+.+.+|+||||++++|.+++.+....+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.
T Consensus        66 ~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~  144 (282)
T cd07829          66 VIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGL  144 (282)
T ss_pred             hhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCc
Confidence            456678999999999999999998754689999999999999999999999 5999999999999999999999999999


Q ss_pred             cccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc------
Q psy3686          83 SGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN------  155 (296)
Q Consensus        83 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~------  155 (296)
                      +....... .......+..|+|||.+.+    ...++.++||||||+++|++++|..||... .....+..+..      
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~  219 (282)
T cd07829         145 ARAFGIPLRTYTHEVVTLWYRAPEILLG----SKHYSTAVDIWSVGCIFAEMITGKPLFPGD-SEIDQLFKIFQILGTPT  219 (282)
T ss_pred             ccccCCCccccCccccCcCcCChHHhcC----CcCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHHHhCCCc
Confidence            87654332 2223355678999999853    226788999999999999999999999873 33333322221      


Q ss_pred             --------------cCCCCCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         156 --------------DAPPCLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       156 --------------~~~p~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                    ...+...      ..+.++..+.++|.+||..+|+        ++.++.++..++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~--------~Rp~~~~~l~~p~  281 (282)
T cd07829         220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA--------KRISAKEALKHPY  281 (282)
T ss_pred             HHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcc--------cCCCHHHHhhCcC
Confidence                          0001110      0112578999999999999998        5555556555554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=3.1e-27  Score=203.08  Aligned_cols=185  Identities=24%  Similarity=0.411  Sum_probs=147.1

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      ++.+...+++||||+.+ +|.+++...   ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++. +.++|+
T Consensus        70 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          70 SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             HHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-CCEeec
Confidence            45667889999999995 999888642   4679999999999999999999999 59999999999999975 669999


Q ss_pred             ccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          79 DFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        79 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |||++....... ......++..|+|||.+.+     ..++.++|+||||+++|+|++|..||.. .........+..+.
T Consensus       148 d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~  221 (260)
T cd08222         148 DFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-----QGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGP  221 (260)
T ss_pred             ccCceeecCCCcccccCCCCCcCccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCC
Confidence            999987654332 2233467889999998843     3567789999999999999999999976 34455555666666


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                      .+.++.  .++..+.++|.+||..+|+        .+.+..++..+++
T Consensus       222 ~~~~~~--~~~~~~~~li~~~l~~~p~--------~Rp~~~~il~~~~  259 (260)
T cd08222         222 TPSLPE--TYSRQLNSIMQSMLNKDPS--------LRPSAAEILRNPF  259 (260)
T ss_pred             CCCCcc--hhcHHHHHHHHHHhcCChh--------hCcCHHHHhhCCC
Confidence            666554  3799999999999999998        4444555555544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0695|consensus

Probab=99.95  E-value=1.3e-27  Score=202.76  Aligned_cols=174  Identities=24%  Similarity=0.412  Sum_probs=147.5

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|+++..+|+|.||++| +|--.+++ ..+++++.++.+...|+.||.|||++ ||++||||.+|+|++..|.+||.|+
T Consensus       318 scfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  318 SCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             hhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeeccc
Confidence            689999999999999995 88666655 68999999999999999999999996 9999999999999999999999999


Q ss_pred             CCccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC------CCcHHHHHHH
Q psy3686          81 GISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC------KCDFEVLSRV  153 (296)
Q Consensus        81 g~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~------~~~~~~~~~i  153 (296)
                      |+++.-- +....++.+||+.|.|||++.+.     .|...+|+|+||+++++|+.|+.||...      .+..+.+.++
T Consensus       396 gmcke~l~~gd~tstfcgtpnyiapeilrge-----eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-----EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             chhhcCCCCCcccccccCCCcccchhhhccc-----ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            9987643 44566778999999999999654     7999999999999999999999999632      2233445555


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChH
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      +-.....+|..  +|-....+++..|++||.
T Consensus       471 ilekqiriprs--lsvkas~vlkgflnkdp~  499 (593)
T KOG0695|consen  471 ILEKQIRIPRS--LSVKASHVLKGFLNKDPK  499 (593)
T ss_pred             Hhhhcccccce--eehhhHHHHHHhhcCCcH
Confidence            44444455554  788889999999999997

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=2.5e-27  Score=206.44  Aligned_cols=180  Identities=22%  Similarity=0.323  Sum_probs=133.7

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +...+|+||||++ |+|.+++......+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            4457899999998 59999997655679999999999999999999999 599999999999999999999999999987


Q ss_pred             cccCCccc----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcH-------------
Q psy3686          85 RLVDSKAR----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF-------------  147 (296)
Q Consensus        85 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-------------  147 (296)
                      ........    ....++..|+|||.+.+     ..++.++||||||+++|+|++|..|+.......             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI  231 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhcc-----CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence            65432211    11123446999999853     357889999999999999999877764321100             


Q ss_pred             -HHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         148 -EVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       148 -~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                       ..+..++... ..++....++..+.+||.+||..+|+.|  +++.++
T Consensus       232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~R--pt~~ei  276 (284)
T cd05081         232 VYHLIELLKNN-GRLPAPPGCPAEIYAIMKECWNNDPSQR--PSFSEL  276 (284)
T ss_pred             hHHHHHHHhcC-CcCCCCCCCCHHHHHHHHHHccCChhhC--CCHHHH
Confidence             0011112111 1222233478999999999999999844  344443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.7e-27  Score=212.10  Aligned_cols=182  Identities=25%  Similarity=0.369  Sum_probs=143.4

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|+||||++++|.+++..  ..+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++....
T Consensus        93 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             ccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            35899999998899999974  679999999999999999999999 599999999999999999999999999987654


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC--C------
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP--P------  159 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~--p------  159 (296)
                      ..  .....++..|+|||.+.+.    ..++.++||||||+++|++++|..||... .....+..+.....  +      
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslGv~l~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         170 DE--MTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGKTLFPGS-DHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             cc--ccCCcccccccCHHHHhCC----CCCCchHhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhh
Confidence            32  2334677889999998532    25678999999999999999999999873 33344444333111  0      


Q ss_pred             --------------CCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 --------------CLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 --------------~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                    ...      ....++..+.++|.+||..+|.        .+.++.+++.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~--------~Rpt~~ell~h~~~~  302 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD--------KRITAAEALAHPYLA  302 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh--------hCCCHHHHhcCCCcc
Confidence                          000      0113588999999999999998        555677778887764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.9e-27  Score=221.80  Aligned_cols=194  Identities=19%  Similarity=0.223  Sum_probs=143.5

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +++.+++..|+||+++.++|.+++...    ........++.++.||+.||.|||+ +||+||||||+|||++.++.+||
T Consensus       230 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~~~~~vkL  308 (501)
T PHA03210        230 EILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLNCDGKIVL  308 (501)
T ss_pred             EEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEE
Confidence            346678889999999999888887542    1223466788999999999999999 59999999999999999999999


Q ss_pred             eccCCcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCC-CcHHHHHHH
Q psy3686          78 CDFGISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEF-PYKDCK-CDFEVLSRV  153 (296)
Q Consensus        78 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~-Pf~~~~-~~~~~~~~i  153 (296)
                      +|||++..+.....  .....|+..|+|||++.+     ..++.++|||||||++|+|++|.. ||.... .....+.++
T Consensus       309 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-----DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             EeCCCceecCcccccccccccCCcCCCCchhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            99999976643322  223478999999999953     368889999999999999999875 444321 222222222


Q ss_pred             HccCC---CCCC--------------------------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCC
Q psy3686         154 LNDAP---PCLP--------------------------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEG  204 (296)
Q Consensus       154 ~~~~~---p~~~--------------------------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~  204 (296)
                      +....   ..++                          ....++.++.++|.+||..||.        ++.++.+++.++
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~--------~Rpsa~elL~hp  455 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH--------LRPGAAELLALP  455 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc--------cCcCHHHHhhCh
Confidence            21100   0000                          0112567788899999999998        777888888888


Q ss_pred             ccccc
Q psy3686         205 HLSYA  209 (296)
Q Consensus       205 ~~~~~  209 (296)
                      ++...
T Consensus       456 ~f~~~  460 (501)
T PHA03210        456 LFSAE  460 (501)
T ss_pred             hhhcC
Confidence            87543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=3e-27  Score=208.81  Aligned_cols=131  Identities=27%  Similarity=0.435  Sum_probs=110.3

Q ss_pred             CeEEEEecCccccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC----CCCEEEec
Q psy3686           8 SDVWICMELMATCFDRLLKRL----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE----RGNIKLCD   79 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~----~~~~kl~d   79 (296)
                      +.+|+||||++++|.+++...    ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.    ++.+||+|
T Consensus        77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            789999999998888877543    2378999999999999999999999 59999999999999999    89999999


Q ss_pred             cCCcccccCCcc----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3686          80 FGISGRLVDSKA----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC  143 (296)
Q Consensus        80 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  143 (296)
                      ||++........    .....++..|+|||.+.+    ...++.++||||||+++|+|++|..||...
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            999876543321    223356788999998853    225678999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1187|consensus

Probab=99.95  E-value=7.8e-28  Score=215.34  Aligned_cols=184  Identities=24%  Similarity=0.313  Sum_probs=138.2

Q ss_pred             CCCCccCC-eEEEEecCcc-ccHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEECCCCCE
Q psy3686           1 MSPQSKES-DVWICMELMA-TCFDRLLKRLHV-SVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPSNILLDERGNI   75 (296)
Q Consensus         1 ~~~~~~~~-~~~lv~E~~~-gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~dlkp~Nil~~~~~~~   75 (296)
                      ++|+.+.+ ..+||+|||. |+|.+.+..... .++|....+|+.++++||+|||....  |||||||+.|||+|.+..+
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            35677777 5999999999 799999987555 89999999999999999999999543  9999999999999999999


Q ss_pred             EEeccCCcccccC-Ccccccc-ccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--Cc--HHH
Q psy3686          76 KLCDFGISGRLVD-SKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK--CD--FEV  149 (296)
Q Consensus        76 kl~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~--~~--~~~  149 (296)
                      ||+|||+++.... ....... .||..|++||.+.     .+..+.++||||||+++.|+++|+.+.....  ..  ...
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~-----~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS-----TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhc-----cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            9999999965443 2222222 7999999999994     4578999999999999999999998877422  11  111


Q ss_pred             H--HHHHcc-----CCCCCC-CC-c--chhHHHHHHHHhccCCChHHHhhh
Q psy3686         150 L--SRVLND-----APPCLP-ND-P--LFGRTIKASIAKDNGRSTEFIRKR  189 (296)
Q Consensus       150 ~--~~i~~~-----~~p~~~-~~-~--~~s~~l~~li~~cl~~~P~~r~~~  189 (296)
                      +  ..+..+     ..|.+. .. .  ..-..+..+..+|++.+|..||.+
T Consensus       292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m  342 (361)
T KOG1187|consen  292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM  342 (361)
T ss_pred             HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence            1  111121     122322 11 1  122346778889999999755553

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=3e-27  Score=210.49  Aligned_cols=194  Identities=24%  Similarity=0.415  Sum_probs=145.7

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ++|..++.+|+||||+. |+|.+++.+. ...+++..++.++.||+.||.|||+ .|++||||||+||+++.++.++++|
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~  144 (328)
T cd08226          66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSG  144 (328)
T ss_pred             eeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEec
Confidence            45678889999999999 5999998764 3468999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCccc--------cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHH
Q psy3686          80 FGISGRLVDSKAR--------TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS  151 (296)
Q Consensus        80 fg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~  151 (296)
                      |+.+.........        ....++..|+|||.+.+.   ...++.++|||||||++|+|++|..||.......... 
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-  220 (328)
T cd08226         145 LSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD---LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL-  220 (328)
T ss_pred             hHHHhhhhccCccccccccccccccCccCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH-
Confidence            9765332211100        011245679999998642   2257889999999999999999999998744332222 


Q ss_pred             HHHccCCC--------------------------------------------CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         152 RVLNDAPP--------------------------------------------CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       152 ~i~~~~~p--------------------------------------------~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .++.....                                            ..+....+++.+.+||.+||..+|+   
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~---  297 (328)
T cd08226         221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE---  297 (328)
T ss_pred             HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcc---
Confidence            22221110                                            0011123678899999999999998   


Q ss_pred             hhccCCccchhhcccCCcccc
Q psy3686         188 KRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~  208 (296)
                           .+.++.+++.++++..
T Consensus       298 -----~Rpta~e~l~~~~~~~  313 (328)
T cd08226         298 -----KRPSASSLLSHAFFKQ  313 (328)
T ss_pred             -----cCCCHHHHhhCHHHHH
Confidence                 7777888888887644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4236|consensus

Probab=99.95  E-value=1.4e-28  Score=218.82  Aligned_cols=186  Identities=23%  Similarity=0.364  Sum_probs=150.5

Q ss_pred             CccCCeEEEEecCccccHHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC---CCEEEec
Q psy3686           4 QSKESDVWICMELMATCFDRLL-KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIKLCD   79 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~---~~~kl~d   79 (296)
                      |++.+.+|+|||.+.|+..+.| ....+.|++.....++.||+.||+|||-+ ||+|+||||+|||+...   -++||||
T Consensus       632 ~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCD  710 (888)
T KOG4236|consen  632 FETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCD  710 (888)
T ss_pred             ecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeecc
Confidence            6788999999999999666655 44478999999999999999999999995 99999999999999654   3799999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ||+++.++....+....||+.|+|||++.     ...|+..-|+||+|+++|.-++|.+||....   ++-.+|.+...-
T Consensus       711 FGfARiIgEksFRrsVVGTPAYLaPEVLr-----nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFM  782 (888)
T KOG4236|consen  711 FGFARIIGEKSFRRSVVGTPAYLAPEVLR-----NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFM  782 (888)
T ss_pred             ccceeecchhhhhhhhcCCccccCHHHHh-----hccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccc
Confidence            99999998888888889999999999995     4478999999999999999999999998733   333344333221


Q ss_pred             CC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         160 CL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       160 ~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .. ..+..+++...+||...|+....        .+.+....+.++|+
T Consensus       783 yPp~PW~eis~~AidlIn~LLqVkm~--------kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  783 YPPNPWSEISPEAIDLINNLLQVKMR--------KRYSVDKSLSHPWL  822 (888)
T ss_pred             cCCCchhhcCHHHHHHHHHHHHHHHH--------HhcchHhhccchhh
Confidence            11 13455899999999999998886        33334445555554

>KOG0586|consensus

Probab=99.95  E-value=7.9e-28  Score=217.80  Aligned_cols=173  Identities=27%  Similarity=0.344  Sum_probs=147.5

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      .+......+|+||||+. |.+.+++.+ ++.+.+..+..++.|++.|++|||++ +|+|||||++|||++.+.++||+||
T Consensus       122 ~v~~t~~~lylV~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  122 SVIETEATLYLVMEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eeeeecceeEEEEEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeecc
Confidence            34567889999999999 599999988 67788899999999999999999995 9999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++..+.........+|++.|.|||++.+.    ..-++.+|+||+|+++|.|+.|.+||.+. .-.+...+++.+.. .
T Consensus       200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~----~y~gpe~D~Wslgvvly~LV~GsLPFDG~-~lk~Lr~rvl~gk~-r  273 (596)
T KOG0586|consen  200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGK----KYDGPEVDIWSLGVVLYALVEGSLPFDGQ-NLKELRPRVLRGKY-R  273 (596)
T ss_pred             ccceeecccccccccCCCCCccChHhhcCc----ccCCcceehhhhhhhheeeeecccccCCc-ccccccchheeeee-c
Confidence            999998877777778999999999999754    24578999999999999999999999983 33344444444432 3


Q ss_pred             CCCCcchhHHHHHHHHhccCCChH
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      +|..  ++.++.++|+++|..+|.
T Consensus       274 Ip~~--ms~dce~lLrk~lvl~Ps  295 (596)
T KOG0586|consen  274 IPFY--MSCDCEDLLRKFLVLNPS  295 (596)
T ss_pred             ccce--eechhHHHHHHhhccCcc
Confidence            3333  799999999999999998

>KOG0671|consensus

Probab=99.95  E-value=6.4e-28  Score=207.32  Aligned_cols=193  Identities=23%  Similarity=0.301  Sum_probs=152.8

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC---------
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---------   71 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~---------   71 (296)
                      ++|...++.|||+|.++-|+.+++..+ -.+++...++.|++|++.+++|||+ ++++|.||||+|||+.+         
T Consensus       158 ~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEecc
Confidence            568889999999999999999999874 4578999999999999999999999 69999999999999832         


Q ss_pred             -----------CCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy3686          72 -----------RGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY  140 (296)
Q Consensus        72 -----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf  140 (296)
                                 +..|+|+|||.+.....  .......|..|.|||++.+-     .++..+||||+||||+|+.+|...|
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgL-----GwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGL-----GWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheecc-----CcCCccCceeeeeEEEEeeccceec
Confidence                       22489999999976433  33566889999999999654     7899999999999999999999999


Q ss_pred             CCCCCc--HHHHHHHHccCCCCC-----------------CC-----------------------CcchhHHHHHHHHhc
Q psy3686         141 KDCKCD--FEVLSRVLNDAPPCL-----------------PN-----------------------DPLFGRTIKASIAKD  178 (296)
Q Consensus       141 ~~~~~~--~~~~~~i~~~~~p~~-----------------~~-----------------------~~~~s~~l~~li~~c  178 (296)
                      +..++.  ...+++|+...|..+                 +.                       ...--..+.+||++|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            885422  234555554221110                 00                       001125689999999


Q ss_pred             cCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         179 NGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       179 l~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      |..||.        .+.++.+.+.++|.....
T Consensus       390 L~fDP~--------~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  390 LEFDPA--------RRITLREALSHPFFARLT  413 (415)
T ss_pred             HccCcc--------ccccHHHHhcCHHhhcCC
Confidence            999998        788888889998876653

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=1.6e-26  Score=206.41  Aligned_cols=186  Identities=25%  Similarity=0.342  Sum_probs=141.4

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ...+|+||||+.++|..++..  ..+++..++.++.||+.||.|||+ +||+|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            447899999999999999875  388999999999999999999999 59999999999999999999999999998755


Q ss_pred             cCCc------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC---
Q psy3686          87 VDSK------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---  157 (296)
Q Consensus        87 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~---  157 (296)
                      ....      ......++..|+|||.+.+    ...++.++||||||+++|+|++|+.||.+.. .......+....   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~el~tg~~pf~~~~-~~~~~~~~~~~~~~~  232 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLG----STRYTKGVDMWSVGCILGEMLLGKPLFPGTS-TLNQLEKIIEVIGPP  232 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeec----cccccccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCC
Confidence            4321      1223357889999998853    2356789999999999999999999997632 222222221110   


Q ss_pred             ------------------------CCCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 ------------------------PPCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ------------------------~p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                              ...+ .....++..+.++|.+||..+|+        .+.+..++..++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~--------~Rps~~~il~~~~~~~  300 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN--------KRLTAEEALEHPYVAQ  300 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc--------cccCHHHHhhChhhhh
Confidence                                    0000 11123689999999999999998        5555666666766533

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.7e-26  Score=206.82  Aligned_cols=182  Identities=24%  Similarity=0.362  Sum_probs=139.7

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|+||||+.++|..++   ...+++..++.++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++....
T Consensus        93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            467999999998887765   4579999999999999999999999 599999999999999999999999999986543


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC----------
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA----------  157 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~----------  157 (296)
                      .  ......++..|+|||.+.+    ...++.++|||||||++|+|++|+.||.+. .....+..+....          
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slGvil~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         169 A--EMTGYVVTRWYRAPEVILN----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-DYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             C--CCCCceeeecccChhhhcC----ccccCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHHHH
Confidence            2  1223356788999999853    225778999999999999999999999873 3333333332211          


Q ss_pred             ------------CCCCCC------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 ------------PPCLPN------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ------------~p~~~~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                  .+..+.      .+.++..+.+||.+||..+|.        +|.+..+++.++++.-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~--------~R~~~~e~l~h~~f~~  302 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD--------KRLTATEALEHPYFDS  302 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChh--------hCcCHHHHhcCcchhh
Confidence                        011111      123678899999999999998        4556677777776643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=1.2e-26  Score=201.75  Aligned_cols=174  Identities=22%  Similarity=0.317  Sum_probs=134.5

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +..+|+||||+. |+|.+++......+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||.+..
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            567999999998 59999998755579999999999999999999999 5999999999999999999999999999977


Q ss_pred             ccCCccc----cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-------------HH
Q psy3686          86 LVDSKAR----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD-------------FE  148 (296)
Q Consensus        86 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-------------~~  148 (296)
                      .......    ....++..|++||.+.+     ..++.++||||||+++|+|++|..||......             ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRT-----SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHcc-----CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            6522111    11234557999998843     36788999999999999999999998653221             11


Q ss_pred             HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         149 VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       149 ~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .+...+... ...+....++..+.+++.+||..+|+.|+
T Consensus       234 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  271 (284)
T cd05038         234 RLLELLKEG-ERLPRPPSCPDEVYDLMKLCWEAEPQDRP  271 (284)
T ss_pred             HHHHHHHcC-CcCCCCccCCHHHHHHHHHHhccChhhCC
Confidence            122222222 12233334789999999999999998443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.2e-26  Score=205.28  Aligned_cols=184  Identities=22%  Similarity=0.333  Sum_probs=141.1

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      .+.+|+++++++++|.+++..  ..+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus        94 ~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          94 FNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             cccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            356899999998899998863  579999999999999999999999 59999999999999999999999999998654


Q ss_pred             cCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC---------
Q psy3686          87 VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---------  157 (296)
Q Consensus        87 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~---------  157 (296)
                      ..  ......++..|+|||.+.+    ...++.++|||||||++|+|++|..||.... .......+....         
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         171 DD--EMTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             cc--cccccccCCCccCHHHHhC----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHh
Confidence            32  2223467889999998853    2257789999999999999999999997632 222222221110         


Q ss_pred             -------------CCCCCC------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 -------------PPCLPN------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 -------------~p~~~~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                   .+..+.      ....++.+.++|.+||..+|.        .+.+..+++.++++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~--------~R~t~~e~l~h~~f~~  305 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD--------KRITAAQALAHAYFAQ  305 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChh--------hcCCHHHHhcChhhhh
Confidence                         001111      012578899999999999998        5556777788877653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=7.1e-26  Score=191.33  Aligned_cols=177  Identities=33%  Similarity=0.481  Sum_probs=142.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+......++||||+++ +|.+++.. ...++...++.++.+++.+|.+||+ .|++|+||+|.||+++.++.++|+|||
T Consensus        55 ~~~~~~~~~l~~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~  132 (244)
T smart00220       55 VFEDEDKLYLVMEYCDGGDLFDLLKK-RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFG  132 (244)
T ss_pred             heeeCCEEEEEEeCCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEcccc
Confidence            44566889999999996 99999976 3348999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .+.............++..|++||.+.     ...++.++|||+||+++|++++|..||............+..+.....
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~pE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~  207 (244)
T smart00220      133 LARQLDPGGLLTTFVGTPEYMAPEVLL-----GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP  207 (244)
T ss_pred             ceeeeccccccccccCCcCCCCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc
Confidence            997765543444456788999999985     336778999999999999999999999874444444444444433322


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHH
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .....++..+.+++.+||..+|+.|
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhc
Confidence            2222278999999999999999833

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=6e-26  Score=203.39  Aligned_cols=183  Identities=26%  Similarity=0.366  Sum_probs=141.8

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccC
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD   88 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~   88 (296)
                      .+|+||||++++|.+++.  ...+++..++.++.||+.||.|||+ +||+||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            569999999889999886  4689999999999999999999999 5999999999999999999999999999876533


Q ss_pred             CccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC----------
Q psy3686          89 SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP----------  158 (296)
Q Consensus        89 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~----------  158 (296)
                      .  .....++..|++||.+.+.    ..++.++|+||||+++|++++|..||..... ......+.....          
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         171 E--MTGYVVTRWYRAPEVILNW----MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             C--ccccccCCcccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhh
Confidence            2  2233568899999998531    2477899999999999999999999987432 222222221110          


Q ss_pred             ------------CCCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         159 ------------PCLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       159 ------------p~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                  +.+.      ....+++.+.++|.+||..+|+        .+.+..++..++++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~--------~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE--------SRITAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChh--------hCCCHHHHhcCccHhhh
Confidence                        0000      0123688899999999999998        55567777788876544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.7e-26  Score=187.26  Aligned_cols=148  Identities=27%  Similarity=0.308  Sum_probs=117.3

Q ss_pred             ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCccccccccC
Q psy3686          19 TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC   98 (296)
Q Consensus        19 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~   98 (296)
                      |+|.+++...+..+++..++.++.||+.||.|||+. +      ||+|||++.++.+++  ||.+.......    ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc----CCCc
Confidence            689999987667799999999999999999999994 6      999999999999999  99987654322    2678


Q ss_pred             cCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC----CCcchhH--HHH
Q psy3686          99 AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP----NDPLFGR--TIK  172 (296)
Q Consensus        99 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~----~~~~~s~--~l~  172 (296)
                      +.|+|||++.+     ..++.++|||||||++|+|++|..||.........+..+.....+..+    ....++.  .+.
T Consensus        68 ~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (176)
T smart00750       68 PYFMAPEVIQG-----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA  142 (176)
T ss_pred             ccccChHHhcC-----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence            99999999953     367889999999999999999999997643333444444443332221    1122444  699


Q ss_pred             HHHHhccCCChH
Q psy3686         173 ASIAKDNGRSTE  184 (296)
Q Consensus       173 ~li~~cl~~~P~  184 (296)
                      ++|.+||..+|.
T Consensus       143 ~~i~~cl~~~p~  154 (176)
T smart00750      143 DFMRVCASRLPQ  154 (176)
T ss_pred             HHHHHHHhcccc
Confidence            999999999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=6.4e-26  Score=196.24  Aligned_cols=169  Identities=18%  Similarity=0.316  Sum_probs=132.2

Q ss_pred             EEEEecCcc-ccHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          10 VWICMELMA-TCFDRLLKRL-----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        10 ~~lv~E~~~-gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+++++|+. |+|..++...     ...++...++.++.||+.||+|||+ .||+|+||||+||+++.++.++|+|||.+
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECccccc
Confidence            478999998 6998887532     2357899999999999999999999 59999999999999999999999999998


Q ss_pred             ccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          84 GRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        84 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ........   .....++..|++||.+.     ...++.++||||||+++|+|++ |..||... ........+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~sDi~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~  234 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLA-----DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRL  234 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHh-----cCccchhhhhHHHHHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCcC
Confidence            76533211   11223456799999884     3357789999999999999999 88999773 444555555555443


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+.  .++..+.+++.+||..+|+.|+
T Consensus       235 ~~~~--~~~~~~~~l~~~~l~~~p~~Rp  260 (273)
T cd05074         235 KQPP--DCLEDVYELMCQCWSPEPKCRP  260 (273)
T ss_pred             CCCC--CCCHHHHHHHHHHcCCChhhCc
Confidence            3332  3789999999999999998443

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4278|consensus

Probab=99.94  E-value=1.2e-26  Score=210.16  Aligned_cols=190  Identities=22%  Similarity=0.314  Sum_probs=151.3

Q ss_pred             CCCCccCCeEEEEecCcc-ccHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           1 MSPQSKESDVWICMELMA-TCFDRLLKRLHV-SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      |+.+..+--+|||+|||. |+|.+||++++. .++.-.++.|+.||..|+.||..+ ++|||||...|+|+..+..+|++
T Consensus       329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEee
Confidence            356677888999999999 899999998744 467777789999999999999996 89999999999999999999999


Q ss_pred             ccCCcccccCCcccc--ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHc
Q psy3686          79 DFGISGRLVDSKART--KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN  155 (296)
Q Consensus        79 dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~  155 (296)
                      |||+++.+.......  ...-.+.|.|||.+     ....++.++|||+||++||++.| |-.||.+. .-.+++..+-+
T Consensus       408 DFGLsRlMtgDTYTAHAGAKFPIKWTAPEsL-----AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-dlSqVY~LLEk  481 (1157)
T KOG4278|consen  408 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYGLLEK  481 (1157)
T ss_pred             ccchhhhhcCCceecccCccCcccccCcccc-----cccccccchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHhc
Confidence            999998876443222  12345689999999     34478899999999999999999 99999993 33344444444


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                      +-  .+.....+++.+.+||+.||+.+|+  .|++|.+...+.+..
T Consensus       482 gy--RM~~PeGCPpkVYeLMraCW~WsPs--DRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  482 GY--RMDGPEGCPPKVYELMRACWNWSPS--DRPSFAEIHQAFETM  523 (1157)
T ss_pred             cc--cccCCCCCCHHHHHHHHHHhcCCcc--cCccHHHHHHHHHHH
Confidence            44  3344445999999999999999998  666666665555433

>KOG0662|consensus

Probab=99.94  E-value=3.3e-26  Score=178.73  Aligned_cols=191  Identities=21%  Similarity=0.344  Sum_probs=155.5

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .++.+.+|+|||..+|..++...++.++.+.++.++.|+++||.|+|+ ++++||||||.|++|+.+|.+||+|||+++.
T Consensus        72 sdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   72 SDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             cCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhh
Confidence            467899999999999999999999999999999999999999999999 6999999999999999999999999999988


Q ss_pred             ccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHc--cCC---
Q psy3686          86 LVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN--DAP---  158 (296)
Q Consensus        86 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~--~~~---  158 (296)
                      ++-+. +.+....|.+|.+|.++.+.    .-|+...|+||.||++.++.. |++.|++. ...+.+.+|..  |.+   
T Consensus       151 fgipvrcysaevvtlwyrppdvlfga----kly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed  225 (292)
T KOG0662|consen  151 FGIPVRCYSAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTED  225 (292)
T ss_pred             cCCceEeeeceeeeeeccCcceeeee----ehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccc
Confidence            87654 55666889999999999753    378899999999999999998 77778874 33444444433  111   


Q ss_pred             --------------CCCCCC-------cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         159 --------------PCLPND-------PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       159 --------------p~~~~~-------~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                                    |.+|..       ++++..-++++++.|.-+|.        .+..+.+.++++.++-.|
T Consensus       226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~--------qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPA--------QRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcc--------cccCHHHHhcCccccccC
Confidence                          111111       23445678999999999998        777777888887766554

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=7.6e-26  Score=201.53  Aligned_cols=185  Identities=25%  Similarity=0.381  Sum_probs=140.3

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ++.+|+||||++++|.+++.  ...+++..+..++.||+.||.|||+ .|++|+||+|.||+++.++.++|+|||.+...
T Consensus        82 ~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          82 LEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             CCcEEEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            56789999999989999886  4578999999999999999999999 59999999999999999999999999998654


Q ss_pred             cCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHH---HHHc--------
Q psy3686          87 VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS---RVLN--------  155 (296)
Q Consensus        87 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~i~~--------  155 (296)
                      ...  .....++..|+|||.+.+    ...++.++||||||+++|+|++|..||..... .....   ....        
T Consensus       159 ~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         159 DPQ--MTGYVSTRYYRAPEIMLT----WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             CCC--cCCCcccccccCceeeec----cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence            322  223356788999998742    23578899999999999999999999976332 11111   1100        


Q ss_pred             ----cC----------CCCCC---CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         156 ----DA----------PPCLP---NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       156 ----~~----------~p~~~---~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                          ..          ....+   ....++..+.++|.+||..+|+        ++.+..++..++++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~--------~R~t~~ell~~~~~~~~  294 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ--------KRISAAEALAHPYLAPY  294 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChh--------hCCCHHHHhcCCccccc
Confidence                00          00111   1123688999999999999998        55566777777766443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0200|consensus

Probab=99.94  E-value=2.1e-26  Score=219.71  Aligned_cols=188  Identities=20%  Similarity=0.314  Sum_probs=154.3

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      +..+.+.+++|+||+. |+|.++++...               ..++...+..++.||+.|++||+++ ++|||||-..|
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRN  448 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARN  448 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-Cccchhhhhhh
Confidence            3445789999999999 89999998755               3499999999999999999999996 89999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcccc--ccc--cCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKART--KNA--GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK  141 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~  141 (296)
                      ||+..+..+|++|||+++.........  ...  -...|||||.+.     ...|+.++||||+|+++||+++ |..||.
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-----~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-----DRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-----cCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            999999999999999998544332221  112  245699999994     4589999999999999999999 999999


Q ss_pred             CCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhc
Q psy3686         142 DCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYEC  200 (296)
Q Consensus       142 ~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~  200 (296)
                      +.....+.+..+..|.....|..  ++.++.++|+.||+.+|+  .|++|.+.....+.
T Consensus       524 ~~~~~~~l~~~l~~G~r~~~P~~--c~~eiY~iM~~CW~~~p~--~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  524 GIPPTEELLEFLKEGNRMEQPEH--CSDEIYDLMKSCWNADPE--DRPTFSECVEFFEK  578 (609)
T ss_pred             CCCcHHHHHHHHhcCCCCCCCCC--CCHHHHHHHHHHhCCCcc--cCCCHHHHHHHHHH
Confidence            86556677777788887777765  799999999999999998  44555555544443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.5e-26  Score=228.09  Aligned_cols=182  Identities=15%  Similarity=0.104  Sum_probs=130.0

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-------------
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-------------   72 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-------------   72 (296)
                      ....++++||+++++|.+++......+++..++.++.||+.||.|||+ +||+||||||+||||+..             
T Consensus        51 ~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~  129 (793)
T PLN00181         51 DDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVHNVRPSCFVMSSFNHVSFIESASCSD  129 (793)
T ss_pred             ccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh-CCeeeccCCchhEEEcccCcEEEeeccccCc
Confidence            345788999999999999997655679999999999999999999999 599999999999999654             


Q ss_pred             ------CCEEEeccCCcccccCCc-----------------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHH
Q psy3686          73 ------GNIKLCDFGISGRLVDSK-----------------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGIT  129 (296)
Q Consensus        73 ------~~~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~  129 (296)
                            +.+|++|||+++......                 ......+|+.|+|||++.+     ..++.++|||||||+
T Consensus       130 ~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~~sDVwSlGvi  204 (793)
T PLN00181        130 SGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-----SSSNCASDVYRLGVL  204 (793)
T ss_pred             ccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-----CCCCchhhhhhHHHH
Confidence                  445666666654321100                 0011257888999999853     367899999999999


Q ss_pred             HHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         130 LVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       130 l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      +|+|++|..|+....   ..+..+.....|.....  -.+....++.+||..+|.        .+.++.+++.++++
T Consensus       205 L~ELl~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~L~~~P~--------~Rps~~eil~h~~~  268 (793)
T PLN00181        205 LFELFCPVSSREEKS---RTMSSLRHRVLPPQILL--NWPKEASFCLWLLHPEPS--------CRPSMSELLQSEFI  268 (793)
T ss_pred             HHHHhhCCCchhhHH---HHHHHHHHhhcChhhhh--cCHHHHHHHHHhCCCChh--------hCcChHHHhhchhh
Confidence            999999988876421   22222222221211111  245567899999999998        33445555556554

>KOG0666|consensus

Probab=99.94  E-value=4.5e-26  Score=191.43  Aligned_cols=187  Identities=22%  Similarity=0.339  Sum_probs=144.2

Q ss_pred             CCeEEEEecCccccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC----CCEEEe
Q psy3686           7 ESDVWICMELMATCFDRLLKRL----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER----GNIKLC   78 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~----~~~kl~   78 (296)
                      +..+|+++||.+-+|.++|+..    ...++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+    |.|||+
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEee
Confidence            7899999999999999999765    4568999999999999999999999 579999999999999877    899999


Q ss_pred             ccCCcccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------
Q psy3686          79 DFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--------  146 (296)
Q Consensus        79 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--------  146 (296)
                      |||+++.+...-    .......|.+|.|||.+.+.    ..|+.+.|||++|||+.||++-.+.|.+....        
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa----~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA----RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhccc----ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            999998876552    22344678999999999864    48999999999999999999988888653211        


Q ss_pred             HHHHHHHHc--cCC--CCCC------CC------------------------cchhHHHHHHHHhccCCChHHHhhhccC
Q psy3686         147 FEVLSRVLN--DAP--PCLP------ND------------------------PLFGRTIKASIAKDNGRSTEFIRKRSYE  192 (296)
Q Consensus       147 ~~~~~~i~~--~~~--p~~~------~~------------------------~~~s~~l~~li~~cl~~~P~~r~~~~~~  192 (296)
                      .+.+.+|.+  |.+  ..+|      ..                        ..=++...+|+.++|..||-        
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~--------  326 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPI--------  326 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCch--------
Confidence            133333332  111  0111      10                        00135578999999999997        


Q ss_pred             CccchhhcccCCcc
Q psy3686         193 DKSTCYECGAEGHL  206 (296)
Q Consensus       193 ~~~~~~~~~~~~~~  206 (296)
                      .+.++.+.+++.++
T Consensus       327 kRIta~qAleh~yF  340 (438)
T KOG0666|consen  327 KRITAEQALEHPYF  340 (438)
T ss_pred             hhccHHHHhccccc
Confidence            56666666666654

>KOG0669|consensus

Probab=99.94  E-value=4.2e-26  Score=186.67  Aligned_cols=187  Identities=18%  Similarity=0.279  Sum_probs=144.9

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +...+|+||.+|+.+|..++......++...+.+++.+++.||.|+|+ +.|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            445799999999999999998877899999999999999999999999 6999999999999999999999999999976


Q ss_pred             ccCCc-----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--c-C
Q psy3686          86 LVDSK-----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--D-A  157 (296)
Q Consensus        86 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~-~  157 (296)
                      +....     .......|.+|.+||.+.+.    ..|++..|||..||++.+|+++.+-+.+ +.....+..|..  | .
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~----r~yg~~iDiWgAgCimaeMwtrspimqg-nteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD----REYGPPIDIWGAGCIMAEMWTRSPIMQG-NTEQQQLHLISQLCGSI  248 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcc----cccCCcchhHhHHHHHHHHHccCccccC-ChHHHHHHHHHHHhccC
Confidence            65432     22334568999999999864    4889999999999999999999999988 333333333321  1 1


Q ss_pred             CC-C-----------------CCCC--cc---------hhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         158 PP-C-----------------LPND--PL---------FGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       158 ~p-~-----------------~~~~--~~---------~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+ .                 ++..  ..         -.++..+|+.++|..||.        .+..+.+.+.+.++
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~--------kR~~ad~alnh~~F  318 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT--------KRIDADQALNHDFF  318 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc--------cCcchHhhhchhhh
Confidence            11 1                 1111  00         124778999999999998        44455555555543

>KOG0196|consensus

Probab=99.94  E-value=1.9e-27  Score=219.74  Aligned_cols=183  Identities=25%  Similarity=0.356  Sum_probs=153.4

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ...-+.||+|||+ |+|+.+|+.+.+.|+.-++..|++.|+.|++||-+ +|+|||||...|||++.+-.+|++|||+++
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccceEEEecccccee
Confidence            4456789999999 89999999998999999999999999999999999 799999999999999999999999999999


Q ss_pred             cccCCc--ccccccc--CcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSK--ARTKNAG--CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~--~~~~~~~--~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      .+.+..  ..+...|  ..+|.|||.+     ...+++.++||||+|+++||.++ |..||.++ ...+++..|-.+-. 
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAI-----a~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-SNQdVIkaIe~gyR-  852 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAI-----AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIEQGYR-  852 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHh-----hhcccCchhhccccceEEEEecccCCCccccc-chHHHHHHHHhccC-
Confidence            775443  2222223  3689999999     55689999999999999999888 99999985 55688888877754 


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                       +|.+..++..+..|+..||+++=.  .|+.|.++...+.
T Consensus       853 -LPpPmDCP~aL~qLMldCWqkdR~--~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  853 -LPPPMDCPAALYQLMLDCWQKDRN--RRPKFAQIVSTLD  889 (996)
T ss_pred             -CCCCCCCcHHHHHHHHHHHHHHhh--cCCCHHHHHHHHH
Confidence             444444899999999999999987  5555666555444

>KOG1035|consensus

Probab=99.94  E-value=4.5e-26  Score=219.28  Aligned_cols=185  Identities=24%  Similarity=0.370  Sum_probs=138.3

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSV-PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l-~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      -.+||-||||+. +|.+++.+ +... .....|+++++|+.||.|+|+ .|||||||||.|||++.++.|||+|||++..
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~-~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHD-QGIIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHh-CceeeccCCcceeEEcCCCCeeecccccchh
Confidence            678999999995 77777765 3333 578899999999999999999 5999999999999999999999999999976


Q ss_pred             cc-------------------CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q psy3686          86 LV-------------------DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD  146 (296)
Q Consensus        86 ~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~  146 (296)
                      ..                   .....+...||.-|+|||++.+..  ...|+.|+|+||||||++||+.   ||...-.-
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~--~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER  821 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS--SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER  821 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--cccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence            11                   011334457999999999997653  2479999999999999999974   57653333


Q ss_pred             HHHHHHHHccCCCCCCCC-cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         147 FEVLSRVLNDAPPCLPND-PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       147 ~~~~~~i~~~~~p~~~~~-~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..++..+.++..|..+.. ..--+.-..+|+.++++||+        +++++.+++....+.
T Consensus       822 a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~--------kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  822 ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS--------KRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc--------cCCCHHHHhhccCCC
Confidence            344555555554443110 11235668899999999999        555666666555433

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=2.1e-25  Score=211.08  Aligned_cols=192  Identities=20%  Similarity=0.264  Sum_probs=133.4

Q ss_pred             ccCCeEEEEecCcc-ccHHHHHHHhCCC-------------------CCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q psy3686           5 SKESDVWICMELMA-TCFDRLLKRLHVS-------------------VPEPICGKITLSTVKALHYLKETHGVIHRDVKP   64 (296)
Q Consensus         5 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp   64 (296)
                      ..+..+||||||++ ++|.+++......                   .....+..++.||+.||.|||+ +||+||||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP  283 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKP  283 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCH
Confidence            45678999999999 5999998753211                   1234577899999999999999 5999999999


Q ss_pred             CcEEECC-CCCEEEeccCCcccccCC--ccccccccCcCCCCccccCCCCCC-----------------CCCCCcchhHH
Q psy3686          65 SNILLDE-RGNIKLCDFGISGRLVDS--KARTKNAGCAAYMAPERIEPPNPQ-----------------KPDYDIRADVW  124 (296)
Q Consensus        65 ~Nil~~~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-----------------~~~~~~~~Diw  124 (296)
                      +|||++. ++.+||+|||++..+...  .......+++.|+|||.+......                 ...++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999985 579999999999754322  222345788999999976432111                 11244567999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc-C----------CCCCCC--------CcchhHHHHHHHHhccCCChHH
Q psy3686         125 SLGITLVELATGEFPYKDCKCDFEVLSRVLND-A----------PPCLPN--------DPLFGRTIKASIAKDNGRSTEF  185 (296)
Q Consensus       125 slG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~-~----------~p~~~~--------~~~~s~~l~~li~~cl~~~P~~  185 (296)
                      ||||++|+|+++..++..   ....+..++.. .          .+....        ........++||.+||..||+ 
T Consensus       364 SlGviL~el~~~~~~~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~-  439 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDS---NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR-  439 (566)
T ss_pred             HHHHHHHHHHhCcCCCch---HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc-
Confidence            999999999998766543   11111111111 0          000000        001233456899999999998 


Q ss_pred             HhhhccCCccchhhcccCCcccc
Q psy3686         186 IRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       186 r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                             ++.++.+++.|+|+..
T Consensus       440 -------kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        440 -------QRISAKAALAHPYFDR  455 (566)
T ss_pred             -------cCCCHHHHhCCcCcCC
Confidence                   7777888899988754

>KOG4250|consensus

Probab=99.93  E-value=8.1e-26  Score=207.60  Aligned_cols=144  Identities=33%  Similarity=0.536  Sum_probs=121.6

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEC--CCC--CEEEec
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD--ERG--NIKLCD   79 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~--~~~--~~kl~d   79 (296)
                      ...-.+|||||. |||..++++.  ...|++.+++.++..++.||.|||+ +||+||||||.||++-  .+|  ..||+|
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeec
Confidence            345689999999 5999999875  5679999999999999999999998 7999999999999883  334  369999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---HHHHHHHHc
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD---FEVLSRVLN  155 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~i~~  155 (296)
                      ||+|+.+.+........||..|++||.+..    ...|+..+|.|||||++|+++||..||.....+   .+++..+..
T Consensus       168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~----q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  168 FGAARELDDNSLFTSLVGTEEYLHPELYER----QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             ccccccCCCCCeeeeecCchhhcChHHHhh----ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            999999988888888899999999999952    357899999999999999999999999753332   334444443

>KOG0665|consensus

Probab=99.93  E-value=7.5e-26  Score=190.65  Aligned_cols=182  Identities=22%  Similarity=0.342  Sum_probs=146.0

Q ss_pred             CeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686           8 SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus         8 ~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ..+|+|||+|..+|.+++.   -.++...+..++.|++.|++|||+ .||+||||||+||++..+..+||.|||+++.-.
T Consensus        94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchhheeeccchhhcccC
Confidence            4679999999999999996   578899999999999999999999 599999999999999999999999999998765


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--c---------
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--D---------  156 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~---------  156 (296)
                      ..-..+....+..|.|||++.+.     .+...+||||+||++.+|++|+.-|.+. ...+.+.++..  |         
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~-----~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccccCchhheeeccCchheecc-----CCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHHH
Confidence            55455666889999999999754     4888999999999999999999999873 22222222221  0         


Q ss_pred             ----------CCC---------CCCC---------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         157 ----------APP---------CLPN---------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       157 ----------~~p---------~~~~---------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                ..|         .+|.         ...=+..+++++.+||..+|+        ++.....++.|+.+.
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe--------~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE--------KRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh--------hcccHHHHhcCCeee
Confidence                      000         0111         112347789999999999998        777788888888765

>KOG0199|consensus

Probab=99.93  E-value=8.4e-26  Score=206.82  Aligned_cols=176  Identities=20%  Similarity=0.356  Sum_probs=146.8

Q ss_pred             CeEEEEecCcc-ccHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           8 SDVWICMELMA-TCFDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .-+.+|||++. |+|.+.|++ ....|-...+..++.||+.|+.||..+ ++|||||-..|+|+.....|||+|||+.+.
T Consensus       183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceec
Confidence            34568999999 799999987 467788999999999999999999996 999999999999999999999999999988


Q ss_pred             ccCCcccc----ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          86 LVDSKART----KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        86 ~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      +.......    .......|+|||.+     ....++.++|||++|+++|||++ |..||.+ -....++++|-.+....
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsL-----rh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~iD~~erLp  335 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESL-----RHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKNIDAGERLP  335 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHh-----ccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHhccccccCC
Confidence            76553222    22345689999999     55689999999999999999999 9999999 46678888887666544


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      .|.  .+|.++.++++.||..+|.  .|++|-.+
T Consensus       336 RPk--~csedIY~imk~cWah~pa--DRptFsai  365 (1039)
T KOG0199|consen  336 RPK--YCSEDIYQIMKNCWAHNPA--DRPTFSAI  365 (1039)
T ss_pred             CCC--CChHHHHHHHHHhccCCcc--ccccHHHH
Confidence            444  4899999999999999998  44444444

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=5.3e-25  Score=212.78  Aligned_cols=79  Identities=37%  Similarity=0.593  Sum_probs=72.3

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      +...+++||||||+. |+|.+++.. ...+++..++.++.||+.||.|||. +||+||||||+|||++.++.++|+|||+
T Consensus        73 ~~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          73 LQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             EEECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence            456789999999998 599999976 5678999999999999999999999 5999999999999999999999999998


Q ss_pred             cc
Q psy3686          83 SG   84 (296)
Q Consensus        83 ~~   84 (296)
                      ++
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            75

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1345|consensus

Probab=99.93  E-value=6.3e-26  Score=187.35  Aligned_cols=177  Identities=20%  Similarity=0.329  Sum_probs=143.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC--CCCEEEec
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE--RGNIKLCD   79 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~--~~~~kl~d   79 (296)
                      .|++.+.++++|||++ |+|..-+.  ...+.|.....++.|+++||.|||++ ++||||||.+||||-.  ..++||||
T Consensus        90 aFqt~d~YvF~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   90 AFQTSDAYVFVQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             HhhcCceEEEeeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeee
Confidence            4778889999999999 89999887  46799999999999999999999996 9999999999999943  34799999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCcHHHHHHHHcc
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC---KCDFEVLSRVLND  156 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~---~~~~~~~~~i~~~  156 (296)
                      ||.....+.....  .-.+..|.+||.+......+....+.+|+|.||+++|.+++|.+||+..   +.....+.+..++
T Consensus       167 FG~t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  167 FGLTRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             cccccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence            9998765433222  2345679999987554445556788999999999999999999999853   2334445566667


Q ss_pred             CCCCCCCC-cchhHHHHHHHHhccCCChH
Q psy3686         157 APPCLPND-PLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       157 ~~p~~~~~-~~~s~~l~~li~~cl~~~P~  184 (296)
                      ..+.+|.. ..+++.+..+.++-|..+++
T Consensus       245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~  273 (378)
T KOG1345|consen  245 KNPALPKKFNPFSEKALRLFKKSLTPRFK  273 (378)
T ss_pred             cCccCchhhcccCHHHHHHHHHhcCCccc
Confidence            77777643 45899999999999999997

>KOG0670|consensus

Probab=99.92  E-value=1.3e-25  Score=199.76  Aligned_cols=191  Identities=27%  Similarity=0.368  Sum_probs=152.3

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-CCEEEe
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl~   78 (296)
                      .+|...+++|||+|-+.-+|.++|++.  +..|....|..++.|++.||..|-. .||+|.||||+|||++.. ..+|||
T Consensus       501 r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             HHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeec
Confidence            468899999999999999999999887  5678999999999999999999999 599999999999999865 568999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcH-HHHHHHHccC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF-EVLSRVLNDA  157 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~i~~~~  157 (296)
                      |||.|........ ..+..+..|.|||++.|.     .|+...|+||+||+||+|.||+..|++..+.. -.+..-++|.
T Consensus       580 DfGSA~~~~enei-tPYLVSRFYRaPEIiLG~-----~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  580 DFGSASFASENEI-TPYLVSRFYRAPEIILGL-----PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             cCccccccccccc-cHHHHHHhccCcceeecC-----cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            9999977654432 334667799999999754     78899999999999999999999999854332 1222223443


Q ss_pred             CCC------------------------------------------------------CCC-CcchhHHHHHHHHhccCCC
Q psy3686         158 PPC------------------------------------------------------LPN-DPLFGRTIKASIAKDNGRS  182 (296)
Q Consensus       158 ~p~------------------------------------------------------~~~-~~~~s~~l~~li~~cl~~~  182 (296)
                      .|.                                                      +|. ....-..+++|+.+||..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            331                                                      010 0112367999999999999


Q ss_pred             hHHHhhhccCCccchhhcccCCccc
Q psy3686         183 TEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       183 P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      |+        .+.++.+.+.|+|+.
T Consensus       734 P~--------KRit~nqAL~HpFi~  750 (752)
T KOG0670|consen  734 PE--------KRITVNQALKHPFIT  750 (752)
T ss_pred             hh--------hcCCHHHHhcCCccc
Confidence            98        778889999998864

>KOG3653|consensus

Probab=99.92  E-value=1.4e-24  Score=191.30  Aligned_cols=191  Identities=22%  Similarity=0.297  Sum_probs=141.9

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCcEEECCCCCEEE
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--------GVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      ...+|||++|.+ |+|.+||.  ...+++....+|+..|++||+|||+..        .|+|||||..||||.+++.+.|
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            458999999999 89999998  468999999999999999999999732        5999999999999999999999


Q ss_pred             eccCCcccccCCccc---cccccCcCCCCccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCC------------CCCC
Q psy3686          78 CDFGISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQK-PDYDIRADVWSLGITLVELATGE------------FPYK  141 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~DiwslG~~l~~l~~g~------------~Pf~  141 (296)
                      +|||++.++......   ....||.+|||||++.+.-... ...-.+.||||+|.|+||+++..            .||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999887644322   2258999999999997643222 22235699999999999999743            2343


Q ss_pred             ---CCCCcHHHHHHH--HccCCCCCCCC---cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcc
Q psy3686         142 ---DCKCDFEVLSRV--LNDAPPCLPND---PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECG  201 (296)
Q Consensus       142 ---~~~~~~~~~~~i--~~~~~p~~~~~---~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~  201 (296)
                         +.....+.++..  .+..+|.+|..   ..-...+++.|..||..|++  .|.+..-...+...+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDae--ARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAE--ARLTAGCVEERMAEL  503 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchh--hhhhhHHHHHHHHHH
Confidence               112333444332  34556776642   12467899999999999998  444444443333333

>KOG1094|consensus

Probab=99.92  E-value=1.3e-25  Score=202.06  Aligned_cols=189  Identities=22%  Similarity=0.331  Sum_probs=145.7

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +.+..++-+++|||||+ |+|.+++..+..+ +..+....|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|
T Consensus       602 GVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiad  680 (807)
T KOG1094|consen  602 GVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIAD  680 (807)
T ss_pred             eeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecC
Confidence            34556788999999999 8999999886333 3556667799999999999999 6999999999999999999999999


Q ss_pred             cCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCcHHHHHH--
Q psy3686          80 FGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT--GEFPYKDCKCDFEVLSR--  152 (296)
Q Consensus        80 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~--g~~Pf~~~~~~~~~~~~--  152 (296)
                      ||+++.+.....   .....-.++|||+|.+.     .++++.++|+|+||+++||+++  ...||... .+.++..+  
T Consensus       681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsil-----lgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~  754 (807)
T KOG1094|consen  681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL-----LGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAG  754 (807)
T ss_pred             cccccccccCCceeeecceeeeeeehhHHHHH-----hccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhh
Confidence            999986543322   22335568999999995     3489999999999999999876  78999874 33333333  


Q ss_pred             -HHccCC--CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         153 -VLNDAP--PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       153 -i~~~~~--p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                       +.....  ..++.+.-++..+.++|.+||.++-+  .|++|+++...++
T Consensus       755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~--~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESE--QRPSFEQLHLFLQ  802 (807)
T ss_pred             hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhh--cCCCHHHHHHHHH
Confidence             222222  12334445899999999999999997  6667777655544

>KOG2052|consensus

Probab=99.91  E-value=3.8e-24  Score=187.29  Aligned_cols=175  Identities=25%  Similarity=0.402  Sum_probs=135.1

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCcEEECCCCCEEEec
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH-------GVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      .++|||++|.+ |||++||.+  ..++.....+++..++.||++||..-       .|.|||||+.||||.+++.+.|+|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            37999999999 899999985  78999999999999999999999721       489999999999999999999999


Q ss_pred             cCCcccccCC-----ccccccccCcCCCCccccCCCCCCCCCC--CcchhHHHHHHHHHHHHhC----------CCCCCC
Q psy3686          80 FGISGRLVDS-----KARTKNAGCAAYMAPERIEPPNPQKPDY--DIRADVWSLGITLVELATG----------EFPYKD  142 (296)
Q Consensus        80 fg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~--~~~~DiwslG~~l~~l~~g----------~~Pf~~  142 (296)
                      +|+|......     ...+..+||.+|||||++...-... .+  -..+||||||.|+||++..          ++||.+
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~-~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMK-HFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChh-hhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            9999765433     2334558999999999995432111 11  2469999999999998752          478875


Q ss_pred             C---CCcHHHHHHHH--ccCCCCCCCC---cchhHHHHHHHHhccCCChHH
Q psy3686         143 C---KCDFEVLSRVL--NDAPPCLPND---PLFGRTIKASIAKDNGRSTEF  185 (296)
Q Consensus       143 ~---~~~~~~~~~i~--~~~~p~~~~~---~~~s~~l~~li~~cl~~~P~~  185 (296)
                      .   +...+.+.+++  +...|.+|..   ...-..+..+|+.||..||..
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~a  489 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAA  489 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchh
Confidence            3   45556666653  3444555432   123467888999999999983

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1e-23  Score=195.56  Aligned_cols=194  Identities=14%  Similarity=0.191  Sum_probs=138.7

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCC
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLH-----------------------VSVPEPICGKITLSTVKALHYLKETHGVIHRD   61 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~d   61 (296)
                      ..+..||||||+. |+|.+++....                       ..+++..++.++.|++.+|.|||+ .+|+|||
T Consensus       256 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrD  334 (507)
T PLN03224        256 TKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRD  334 (507)
T ss_pred             cCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCC
Confidence            3467899999999 59999886421                       124567888999999999999999 5999999


Q ss_pred             CCCCcEEECCCCCEEEeccCCcccccCCccccc--cccCcCCCCccccCCCCCCC-----------------CCCCcchh
Q psy3686          62 VKPSNILLDERGNIKLCDFGISGRLVDSKARTK--NAGCAAYMAPERIEPPNPQK-----------------PDYDIRAD  122 (296)
Q Consensus        62 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~-----------------~~~~~~~D  122 (296)
                      |||.|||++.++.+||+|||++...........  ..+++.|+|||.+.......                 .....+.|
T Consensus       335 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~D  414 (507)
T PLN03224        335 IKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFD  414 (507)
T ss_pred             CchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccc
Confidence            999999999999999999999865433222111  23478999999985321110                 01123579


Q ss_pred             HHHHHHHHHHHHhCCC-CCCCCC----------CcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhcc
Q psy3686         123 VWSLGITLVELATGEF-PYKDCK----------CDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSY  191 (296)
Q Consensus       123 iwslG~~l~~l~~g~~-Pf~~~~----------~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~  191 (296)
                      |||+||++|+|++|.. ||....          .....+. ...+....++.....++..++||.++|.++|...     
T Consensus       415 vwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~-----  488 (507)
T PLN03224        415 SYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQAN-----  488 (507)
T ss_pred             hhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-hhcccCCCcccccccChHHHHHHHHHhccCCCCc-----
Confidence            9999999999999875 775421          1111111 2233334455455579999999999999876311     


Q ss_pred             CCccchhhcccCCcc
Q psy3686         192 EDKSTCYECGAEGHL  206 (296)
Q Consensus       192 ~~~~~~~~~~~~~~~  206 (296)
                      .++.++.+.+.|+|+
T Consensus       489 ~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        489 RGRLSVGQALSHRFF  503 (507)
T ss_pred             ccCCCHHHHhCCCCc
Confidence            267788888888876

>KOG1027|consensus

Probab=99.91  E-value=4.5e-25  Score=205.61  Aligned_cols=186  Identities=22%  Similarity=0.341  Sum_probs=140.1

Q ss_pred             CccCCeEEEEecCccccHHHHHHHh--CCCC-CHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC---C--CCE
Q psy3686           4 QSKESDVWICMELMATCFDRLLKRL--HVSV-PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---R--GNI   75 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~gsL~~~l~~~--~~~l-~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~---~--~~~   75 (296)
                      -.+.+.+||+.|+|..+|.++++..  .... ..-..+.++.|++.||++||+ .+||||||||.||||+.   +  .++
T Consensus       572 E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra  650 (903)
T KOG1027|consen  572 EQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRA  650 (903)
T ss_pred             ccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeE
Confidence            3567899999999999999999873  1111 114557899999999999999 69999999999999976   3  468


Q ss_pred             EEeccCCcccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHH
Q psy3686          76 KLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVL  150 (296)
Q Consensus        76 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~  150 (296)
                      +|+|||+++++....    ......||-+|+|||++...     .-+.++|||||||++|+.++ |..||..   ..+..
T Consensus       651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~-----~~~~avDiFslGCvfyYvltgG~HpFGd---~~~R~  722 (903)
T KOG1027|consen  651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED-----RKTQAVDIFSLGCVFYYVLTGGSHPFGD---SLERQ  722 (903)
T ss_pred             EecccccccccCCCcchhhcccCCCCcccccCHHHHhcc-----ccCcccchhhcCceEEEEecCCccCCCc---hHHhh
Confidence            999999999876442    23455799999999999654     33558999999999999998 5999987   23444


Q ss_pred             HHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         151 SRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       151 ~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+|+.+..-...-...-..+..+||.+|++.+|.        .|..+...+.|+++
T Consensus       723 ~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~--------~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  723 ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQ--------LRPSATDVLNHPLF  770 (903)
T ss_pred             hhhhcCccceeeeccCchHHHHHHHHHhcCCCcc--------cCCCHHHHhCCCcc
Confidence            5666665432221111112899999999999998        44456666666653

>KOG1025|consensus

Probab=99.90  E-value=4.3e-24  Score=198.64  Aligned_cols=169  Identities=22%  Similarity=0.358  Sum_probs=142.0

Q ss_pred             EEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccC
Q psy3686          10 VWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD   88 (296)
Q Consensus        10 ~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~   88 (296)
                      +-||++|++ |+|.++++.....+..+..+.|..||++|+.|||. ++++||||-..|+||.....+|+.|||+++.+..
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            678999999 79999999989999999999999999999999999 5999999999999999999999999999987654


Q ss_pred             Cccc-cc--cccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCC
Q psy3686          89 SKAR-TK--NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPND  164 (296)
Q Consensus        89 ~~~~-~~--~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~  164 (296)
                      .... ..  ....+.|+|-|.+     ....|++++||||+||++||++| |..||.+ ....++-..+..+..  ++..
T Consensus       851 d~~ey~~~~gK~pikwmale~i-----~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR--LsqP  922 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESI-----RIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER--LSQP  922 (1177)
T ss_pred             ccccccccccccCcHHHHHHHh-----hccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc--CCCC
Confidence            4322 11  2334679999988     55689999999999999999999 9999998 344445444445554  5555


Q ss_pred             cchhHHHHHHHHhccCCChHHHh
Q psy3686         165 PLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       165 ~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +.++-++..++.+||..|+..||
T Consensus       923 piCtiDVy~~mvkCwmid~~~rp  945 (1177)
T KOG1025|consen  923 PICTIDVYMVMVKCWMIDADSRP  945 (1177)
T ss_pred             CCccHHHHHHHHHHhccCcccCc
Confidence            56899999999999999998444

>KOG0664|consensus

Probab=99.90  E-value=3.1e-25  Score=183.56  Aligned_cols=129  Identities=23%  Similarity=0.493  Sum_probs=113.1

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccC
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD   88 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~   88 (296)
                      .+|+|+|+|..+|..+|-. ...++...++-+++||++||+|||+. ||+||||||.|+|++.+-.+||||||+++....
T Consensus       131 EiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  131 ELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccch
Confidence            4688999999999999976 78899999999999999999999996 999999999999999999999999999976543


Q ss_pred             Cc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3686          89 SK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC  143 (296)
Q Consensus        89 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  143 (296)
                      ..  .......|..|.|||++.+.    ..|+.+.||||+||++.||+..+..|+..
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGa----RhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGA----RRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcc----hhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            32  23344678899999999853    48999999999999999999999988763

>KOG1024|consensus

Probab=99.90  E-value=2.3e-23  Score=179.89  Aligned_cols=184  Identities=21%  Similarity=0.320  Sum_probs=150.7

Q ss_pred             ccCCeEEEEecCcc-ccHHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEE
Q psy3686           5 SKESDVWICMELMA-TCFDRLLKRL-------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIK   76 (296)
Q Consensus         5 ~~~~~~~lv~E~~~-gsL~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~k   76 (296)
                      ++....++++.+++ |+|..++..+       ...++..++..++.|++.|++|||+ +|+||.||...|++|++.-++|
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhheeEE
Confidence            35567789999999 8999999843       3457888899999999999999999 7999999999999999999999


Q ss_pred             EeccCCcccccCCccc--c-ccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHH
Q psy3686          77 LCDFGISGRLVDSKAR--T-KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        77 l~dfg~~~~~~~~~~~--~-~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~  152 (296)
                      |+|-.+++-+-+....  . ..-....||++|.+.     ...|+.++|+||||+++|||+| |+.||.. .++.+....
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-----n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~y  510 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-----NSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHY  510 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHh-----hhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHH
Confidence            9998888755433211  1 113456899999995     4489999999999999999999 9999988 566777777


Q ss_pred             HHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         153 VLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       153 i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                      +..|.+...|.+  +++++..+|..||...|+  .|++|+++..|+.
T Consensus       511 lkdGyRlaQP~N--CPDeLf~vMacCWallpe--eRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  511 LKDGYRLAQPFN--CPDELFTVMACCWALLPE--ERPSFSQLVICLS  553 (563)
T ss_pred             HhccceecCCCC--CcHHHHHHHHHHHhcCcc--cCCCHHHHHHHHH
Confidence            888876655554  899999999999999998  6666666665543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.90  E-value=1.6e-23  Score=211.14  Aligned_cols=180  Identities=21%  Similarity=0.285  Sum_probs=128.4

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HhCCceeCCCCCCcEEECCCCCEEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLK---ETHGVIHRDVKPSNILLDERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~~ivH~dlkp~Nil~~~~~~~kl   77 (296)
                      +++.+++.+|+||||++ |+|.++++    .+++..+..++.||+.||+|||   + .+|+||||||+||+++.++..++
T Consensus       750 ~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        750 GLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             EEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCCceEE
Confidence            34567788999999999 59999995    3889999999999999999999   5 38999999999999999888777


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---cHHHHHHH-
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC---DFEVLSRV-  153 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~---~~~~~~~i-  153 (296)
                      . ||.......   .....++..|+|||++.     ...++.++|||||||++|||++|+.||.....   ....+.+. 
T Consensus       825 ~-~~~~~~~~~---~~~~~~t~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  895 (968)
T PLN00113        825 R-LSLPGLLCT---DTKCFISSAYVAPETRE-----TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC  895 (968)
T ss_pred             E-ecccccccc---CCCccccccccCccccc-----CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh
Confidence            5 554432211   12236788999999984     33688999999999999999999999864211   11111111 


Q ss_pred             Hcc------CCCCC----CCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         154 LND------APPCL----PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       154 ~~~------~~p~~----~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                      ...      ..|.+    +........+.+++.+||..+|+.||  ++.++...
T Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP--t~~evl~~  947 (968)
T PLN00113        896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP--CANDVLKT  947 (968)
T ss_pred             cCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc--CHHHHHHH
Confidence            100      01111    11112345678899999999998444  44444333

>KOG0576|consensus

Probab=99.90  E-value=3.7e-24  Score=195.24  Aligned_cols=181  Identities=27%  Similarity=0.469  Sum_probs=153.8

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|-....+||+||||+ |+|.++..- .+++++.++..+.+..++||+|||+ .|-+|||||-.||+++..|.+|++||
T Consensus        79 gsylr~dklwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDf  156 (829)
T KOG0576|consen   79 GSYLRRDKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADF  156 (829)
T ss_pred             hhhhhhcCcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeeccc
Confidence            45677889999999999 599998865 7899999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DA  157 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~  157 (296)
                      |.+..++.. ..+..+.||+.|||||+..-.  .++.|...+|||++|+...++..-+.|-.. ...+..+..+-+  ..
T Consensus       157 gvsaqitati~KrksfiGtpywmapEvaave--rkggynqlcdiwa~gitAiel~eLqpplfd-lhpmr~l~LmTkS~~q  233 (829)
T KOG0576|consen  157 GVSAQITATIAKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWALGITAIELGELQPPLFD-LHPMRALFLMTKSGFQ  233 (829)
T ss_pred             CchhhhhhhhhhhhcccCCccccchhHHHHH--hcccccccccccccccchhhhhhcCCcccc-cchHHHHHHhhccCCC
Confidence            999877655 344567999999999988554  566899999999999999999888888766 466666655543  34


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +|.+....++++.+.+|++.||.++|.+||
T Consensus       234 pp~lkDk~kws~~fh~fvK~altknpKkRp  263 (829)
T KOG0576|consen  234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRP  263 (829)
T ss_pred             CCcccCCccchHHHHHHHHHHhcCCCccCC
Confidence            566766677999999999999999998443

>KOG1152|consensus

Probab=99.89  E-value=1.5e-23  Score=188.61  Aligned_cols=135  Identities=25%  Similarity=0.411  Sum_probs=120.1

Q ss_pred             CCCCccCCeEEEEecCcc-c-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEe
Q psy3686           1 MSPQSKESDVWICMELMA-T-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~-g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      |+.|++++++||+||-.+ | +|.++|+. ...++|.+...|++||+.|+++||+ .||||||||-+|+.++.+|.+||+
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCeEEEe
Confidence            467999999999999998 7 99999987 6789999999999999999999999 599999999999999999999999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD  142 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  142 (296)
                      |||.+... ..+......||..|.|||++.+..    ..+...|||+||+++|.++....||.+
T Consensus       713 dfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~----y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEK----YLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhh-cCCCcceeeeeccccchhhhCCCc----cCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99998543 445556679999999999997652    335668999999999999999999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=4.6e-22  Score=166.48  Aligned_cols=155  Identities=26%  Similarity=0.375  Sum_probs=125.7

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.....+++++|++++ +|.+++......+++..++.++.+++.+|.+||+ ++++|+||+|.||+++.++.++|+|||
T Consensus        65 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       65 VFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             eeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            34556789999999996 9999998743338999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCCcHHHHHHHHccCC
Q psy3686          82 ISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD-CKCDFEVLSRVLNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~-~~~~~~~~~~i~~~~~  158 (296)
                      .+.......  ......++..|++||.+.    ....++.++|+|+||+++++|++|+.||.. ......+...+..+.+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      144 LARFIHRDLAALLKTVKGTPFYLAPEVLL----GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             eeeEecCcccccccceeccCCcCCHhHhc----CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence            987765432  223346778899999984    222566799999999999999999999977 4455566666776665


Q ss_pred             CCCC
Q psy3686         159 PCLP  162 (296)
Q Consensus       159 p~~~  162 (296)
                      +.+|
T Consensus       220 ~~~~  223 (225)
T smart00221      220 LLWE  223 (225)
T ss_pred             cccc
Confidence            4443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668|consensus

Probab=99.87  E-value=6e-22  Score=160.30  Aligned_cols=185  Identities=21%  Similarity=0.326  Sum_probs=147.1

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-CCEEEeccCCcc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCDFGISG   84 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~   84 (296)
                      .....||+||+.. ++..+..    .|+.-.+..++.++++||.|+|+ +||.|||+||.|++|+.. -.++|+|+|++.
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHh
Confidence            4456789999985 7666653    68889999999999999999999 599999999999999875 469999999999


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--c------
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--D------  156 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~------  156 (296)
                      ++......+....+..|--||.+...    ..|...-|+|||||++..|+..+.||....+..+.+.+|.+  |      
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy----~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeec----hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            98887777777888899999999743    36788999999999999999999998765555555544432  1      


Q ss_pred             --------CCCCCC-----------------CC-cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         157 --------APPCLP-----------------ND-PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       157 --------~~p~~~-----------------~~-~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                              -.|.+.                 .. ..++++..+|+.+.|..|-.        ++.++.++..++++.-
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHq--------eRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQ--------ERLTAKEAMAHPYFAP  327 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccc--------cccchHHHhcCchHHH
Confidence                    011110                 11 12569999999999999987        8888888888886543

>KOG1290|consensus

Probab=99.85  E-value=7.8e-21  Score=168.27  Aligned_cols=64  Identities=28%  Similarity=0.494  Sum_probs=59.4

Q ss_pred             cCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q psy3686           6 KESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL   69 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~   69 (296)
                      ++.++|||+|+++.+|..+|... -..++...|+.|++||+.||.|||.+.||||.||||+|||+
T Consensus       157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            46699999999999999998876 56799999999999999999999999999999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.84  E-value=2.7e-20  Score=153.31  Aligned_cols=145  Identities=37%  Similarity=0.552  Sum_probs=121.4

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEEecc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl~df   80 (296)
                      ++......++|||++. ++|.+++......++...++.++.+++.+|.+||+. |++|+||+|.||+++. ++.++|+||
T Consensus        59 ~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~  137 (215)
T cd00180          59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADF  137 (215)
T ss_pred             eeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecC
Confidence            4455678999999999 599999986435799999999999999999999994 9999999999999999 899999999


Q ss_pred             CCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |.+....... ......+...|++||.+...    ...+.+.|+|++|++++++                          
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~----~~~~~~~D~~~lg~~~~~l--------------------------  187 (215)
T cd00180         138 GLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK----GYYSEKSDIWSLGVILYEL--------------------------  187 (215)
T ss_pred             CceEEccCCcchhhcccCCCCccChhHhccc----CCCCchhhhHHHHHHHHHH--------------------------
Confidence            9987654332 12234577889999998532    2567889999999999999                          


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                               ..+.+++.+|+..+|+.|+
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~  206 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRP  206 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCc
Confidence                     6789999999999998333

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4158|consensus

Probab=99.84  E-value=2.8e-20  Score=161.48  Aligned_cols=185  Identities=19%  Similarity=0.205  Sum_probs=140.5

Q ss_pred             CccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEC--CCC--CEEEec
Q psy3686           4 QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD--ERG--NIKLCD   79 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~--~~~--~~kl~d   79 (296)
                      +..+..+|+||..+..+|.+++-  ....+.....-|+.|++.|+.|||+ |||.|||+|++|||+.  .++  ++.|+|
T Consensus       312 ~g~~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             cCCCceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcc
Confidence            34567899999999999999997  4677888888999999999999999 7999999999999994  333  578999


Q ss_pred             cCCcccccCC-------ccccccccCcCCCCccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHH
Q psy3686          80 FGISGRLVDS-------KARTKNAGCAAYMAPERIEPPNPQKPDY-DIRADVWSLGITLVELATGEFPYKDCKCDFEVLS  151 (296)
Q Consensus        80 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~  151 (296)
                      ||++.-....       .......|...-||||+........... -.++|.|+.|.+.||++....||.......-...
T Consensus       389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r  468 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR  468 (598)
T ss_pred             cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh
Confidence            9987543321       1222336788899999986543222122 2589999999999999999999987322111122


Q ss_pred             HHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCC
Q psy3686         152 RVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYED  193 (296)
Q Consensus       152 ~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~  193 (296)
                      .......|.+|..  +++.++++|...|++||++|..+....
T Consensus       469 ~Yqe~qLPalp~~--vpp~~rqlV~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  469 TYQESQLPALPSR--VPPVARQLVFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             hhhhhhCCCCccc--CChHHHHHHHHHhcCCccccCCccHHH
Confidence            2344556777765  899999999999999999777665443

>KOG1167|consensus

Probab=99.83  E-value=3.4e-20  Score=161.75  Aligned_cols=189  Identities=24%  Similarity=0.365  Sum_probs=141.7

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-CCEEEec
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl~d   79 (296)
                      .++..++.+.+||||++- ...+++.    .++...+..+++.++.||.++|. +|||||||||.|+|++.. +.-.|+|
T Consensus       102 ~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  102 GCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             hhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEe
Confidence            567889999999999994 8888875    57789999999999999999999 599999999999999764 6789999


Q ss_pred             cCCccccc-----------------C-C-----------------cc----------ccccccCcCCCCccccCCCCCCC
Q psy3686          80 FGISGRLV-----------------D-S-----------------KA----------RTKNAGCAAYMAPERIEPPNPQK  114 (296)
Q Consensus        80 fg~~~~~~-----------------~-~-----------------~~----------~~~~~~~~~y~aPE~~~~~~~~~  114 (296)
                      ||++....                 . .                 ..          .....||++|.|||++..    .
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k----~  252 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR----C  252 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh----c
Confidence            99986210                 0 0                 00          001248999999999973    3


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--------------cC--------CCC----------C-
Q psy3686         115 PDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--------------DA--------PPC----------L-  161 (296)
Q Consensus       115 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--------------~~--------~p~----------~-  161 (296)
                      +..++++||||.|+|+..++++..||.....+...+..+..              |.        .+.          + 
T Consensus       253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~  332 (418)
T KOG1167|consen  253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH  332 (418)
T ss_pred             cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence            36678999999999999999999999764433322221110              11        000          0 


Q ss_pred             -----C----------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         162 -----P----------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       162 -----~----------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                           +          ....++..+.+|+.+||..||.        .+.++.+.+.|+|+.
T Consensus       333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~--------kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQ--------KRITAEDALKHPFFD  385 (418)
T ss_pred             hhhcccccccceeeccccccccHHHHHHHHHHccCChh--------hcccHHHHhcCcCCc
Confidence                 0          0112456899999999999998        778888888888875

>KOG0590|consensus

Probab=99.81  E-value=1.5e-20  Score=178.03  Aligned_cols=185  Identities=22%  Similarity=0.285  Sum_probs=143.5

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccC
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD   88 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~   88 (296)
                      ..+-+||||+++|..++.. ...++...+-.++.|++.||+|||. +||.|||||++|+++..+|.+||+|||.+..+..
T Consensus       395 ~~~~~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  395 GILQSMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             cchhhhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            3344499999999999986 4689999999999999999999999 6999999999999999999999999999876543


Q ss_pred             Cc-----cccccccCcCCCCccccCCCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCC---
Q psy3686          89 SK-----ARTKNAGCAAYMAPERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAP---  158 (296)
Q Consensus        89 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~---  158 (296)
                      ..     .....+|+..|+|||++.+.     .|. ...||||.|++++.|++|+.||.........+..... ...   
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~-----~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~  547 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK-----EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF  547 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc-----ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence            32     23445889999999999643     444 4689999999999999999999864433222111111 100   


Q ss_pred             -CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 -PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 -p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                       ........++...+.+|.++|+.+|.        .|.+..++++..|+..
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~--------~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPT--------KRITIEQILNDEWIRS  590 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChh--------heecHHHHhhChHhhh
Confidence             01112234789999999999999998        7777888888888754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1.6e-20  Score=161.14  Aligned_cols=164  Identities=22%  Similarity=0.274  Sum_probs=108.6

Q ss_pred             EEEEecCccccHHHHHHHh---CC---CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          10 VWICMELMATCFDRLLKRL---HV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        10 ~~lv~E~~~gsL~~~l~~~---~~---~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ++++|+-+.++|.+++.-.   ..   .+.......+..|+++.+++||. +|++|+||+|+|++++.+|.+.|+||+..
T Consensus       114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecccceeeEEEcCCCCEEEcChHHH
Confidence            4789999999988886543   11   23344556777999999999999 59999999999999999999999999887


Q ss_pred             ccccCCccccccccCcCCCCccccCCCC---CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPN---PQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      ...+.....  ...+..|.|||......   .....++.+.|.|+||+++|.|++|..||..........        ..
T Consensus       193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~--------~~  262 (288)
T PF14531_consen  193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE--------WD  262 (288)
T ss_dssp             EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG--------GG
T ss_pred             eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc--------cc
Confidence            665443332  34457899999774210   012256889999999999999999999998632210000        02


Q ss_pred             CCCCcchhHHHHHHHHhccCCChH
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      +..-..++..++.||..+|+++|.
T Consensus       263 f~~C~~~Pe~v~~LI~~lL~~~~~  286 (288)
T PF14531_consen  263 FSRCRDMPEPVQFLIRGLLQRNPE  286 (288)
T ss_dssp             GTTSS---HHHHHHHHHHT-SSGG
T ss_pred             chhcCCcCHHHHHHHHHHccCCcc
Confidence            222224899999999999999997

>KOG1164|consensus

Probab=99.78  E-value=2.5e-18  Score=152.73  Aligned_cols=134  Identities=27%  Similarity=0.395  Sum_probs=113.0

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-----CCEEEe
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-----GNIKLC   78 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-----~~~kl~   78 (296)
                      ..+++.||||++++.+|.++..... ..++..++..++.|++.+|++||+. |++||||||.|+++...     ..+.|.
T Consensus        91 ~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   91 STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEE
Confidence            3667899999999999999987664 7899999999999999999999994 99999999999999865     358999


Q ss_pred             ccCCcc--cccCCc------c---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3686          79 DFGISG--RLVDSK------A---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK  144 (296)
Q Consensus        79 dfg~~~--~~~~~~------~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  144 (296)
                      |||+++  .+....      .   .....||..|+++....+.     ..+.+.|+||++.++.+++.|..||....
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-----e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-----EQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-----ccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            999998  432111      1   1234599999999988543     67889999999999999999999998744

>KOG1163|consensus

Probab=99.78  E-value=5.9e-19  Score=144.03  Aligned_cols=170  Identities=18%  Similarity=0.245  Sum_probs=132.4

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC---CCCEEEec
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---RGNIKLCD   79 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~---~~~~kl~d   79 (296)
                      ++.+..+-.+||++++.||.+++.-+...++.++++.++-|++.-|+|+|.+ +++||||||+|+|..-   ..++.|+|
T Consensus        79 y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   79 YGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             hccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEe
Confidence            4556677799999999999999988888999999999999999999999995 9999999999999964   46789999


Q ss_pred             cCCcccccCCccc--------cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--HHH
Q psy3686          80 FGISGRLVDSKAR--------TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--FEV  149 (296)
Q Consensus        80 fg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--~~~  149 (296)
                      ||+++++.+....        ....||.+|.+-....+.     ..+.+.|+-|+|.++.++..|..||++....  .+.
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-----eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-----EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhh-----hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            9999987654322        233689999998777543     4567889999999999999999999985433  233


Q ss_pred             HHHHHccCCCCCC--CCcchhHHHHHHHHhc
Q psy3686         150 LSRVLNDAPPCLP--NDPLFGRTIKASIAKD  178 (296)
Q Consensus       150 ~~~i~~~~~p~~~--~~~~~s~~l~~li~~c  178 (296)
                      ..+|.........  --..+|.++.-.+.-|
T Consensus       233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~  263 (341)
T KOG1163|consen  233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYC  263 (341)
T ss_pred             HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHH
Confidence            3444433221111  1134788888888888

>KOG0603|consensus

Probab=99.77  E-value=2.9e-19  Score=163.27  Aligned_cols=189  Identities=24%  Similarity=0.303  Sum_probs=152.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|+.++.+++++++..| .|...+.. ...+.+..+..+...++.+++++|+ .|++|+|+|++||+++.+|.+++.|||
T Consensus        65 afqt~~kl~l~ld~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfg  142 (612)
T KOG0603|consen   65 AFQTDGKLYLILDFLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFG  142 (612)
T ss_pred             eeccccchhHhhhhcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCccccCCch
Confidence            57888999999999995 77777655 5678899999999999999999999 699999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      .++........   +|+..|+|||++.       ....++|.||+|+++++|++|..||..     +++.+|++... .+
T Consensus       143 lske~v~~~~~---cgt~eymApEI~~-------gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~-~~  206 (612)
T KOG0603|consen  143 LSKEAVKEKIA---CGTYEYRAPEIIN-------GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL-EM  206 (612)
T ss_pred             hhhHhHhhhhc---ccchhhhhhHhhh-------ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc-CC
Confidence            99876544333   8999999999995       356689999999999999999999988     67777776543 23


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCCc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQNI  214 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (296)
                      |  ..++..+++++..++.++|..|--.   ...-..+..++.+.+-.+-...
T Consensus       207 p--~~l~~~a~~~~~~l~~r~p~nrLg~---~~~~~~eik~h~f~~~i~~~~l  254 (612)
T KOG0603|consen  207 P--RELSAEARSLFRQLFKRNPENRLGA---GPDGVDEIKQHEFFQSIDWNEL  254 (612)
T ss_pred             c--hhhhHHHHHHHHHHHhhCHHHHhcc---CcchhHHHhccchheeeeHhhH
Confidence            3  3389999999999999999844332   2233455566666655544433

>KOG1165|consensus

Probab=99.76  E-value=5.4e-18  Score=144.21  Aligned_cols=195  Identities=18%  Similarity=0.286  Sum_probs=140.5

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-----CEEEeccCCc
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-----NIKLCDFGIS   83 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-----~~kl~dfg~~   83 (296)
                      +-.||||+++.||.+++.-++..|+.++|..++.|++.-++|+|++ .+|.|||||+|+||...+     .+.++|||++
T Consensus        98 ~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   98 YNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            4569999999999999988899999999999999999999999995 999999999999997654     4899999999


Q ss_pred             ccccCCccc--------cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--HHHHHHH
Q psy3686          84 GRLVDSKAR--------TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--FEVLSRV  153 (296)
Q Consensus        84 ~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--~~~~~~i  153 (296)
                      +.+.++.+.        ....||.+||+-....+.     .-+.+.|+-|||-++++.+.|.+||++.+.+  .+.+++|
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-----EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-----EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccc-----hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            988766443        234799999999888654     5677899999999999999999999985433  3445555


Q ss_pred             HccCCCCCC--CCcchhHHHHHHHHhc----cCCChHHHh-hhccCCccchhhcccCCccccc
Q psy3686         154 LNDAPPCLP--NDPLFGRTIKASIAKD----NGRSTEFIR-KRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       154 ~~~~~p~~~--~~~~~s~~l~~li~~c----l~~~P~~r~-~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      -......-.  --..+|.++...+.-.    +...|+... +..|.++.............|.
T Consensus       252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~  314 (449)
T KOG1165|consen  252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM  314 (449)
T ss_pred             ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence            332221110  0122566665555433    333343221 2244455555555544444443

>KOG1023|consensus

Probab=99.75  E-value=4.2e-18  Score=155.14  Aligned_cols=186  Identities=20%  Similarity=0.218  Sum_probs=143.2

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ..+++.+++|.+||. |+|.+.+......++.-....++++|+.||.|||......|+.+++.|++++....+||.|||+
T Consensus        16 ~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl   95 (484)
T KOG1023|consen   16 SVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGL   95 (484)
T ss_pred             EecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhh
Confidence            445688999999999 8999999987788999999999999999999999963349999999999999999999999999


Q ss_pred             cccccCC---ccccccccCcCCCCccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---HHHHHHHH
Q psy3686          83 SGRLVDS---KARTKNAGCAAYMAPERIEPPNPQK--PDYDIRADVWSLGITLVELATGEFPYKDCKCD---FEVLSRVL  154 (296)
Q Consensus        83 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~i~  154 (296)
                      .......   ...........|.|||.+.+.....  ...+.+.||||+|++++++++...||......   .+++.++.
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~  175 (484)
T KOG1023|consen   96 NSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVK  175 (484)
T ss_pred             cccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHH
Confidence            8665321   1111223456799999997642211  23577899999999999999999999863222   34555655


Q ss_pred             c-cCCCCCCC---CcchhHHHHHHHHhccCCChHHHhhh
Q psy3686         155 N-DAPPCLPN---DPLFGRTIKASIAKDNGRSTEFIRKR  189 (296)
Q Consensus       155 ~-~~~p~~~~---~~~~s~~l~~li~~cl~~~P~~r~~~  189 (296)
                      + +..+..|.   ...+.+.+..++++||..+|+.||..
T Consensus       176 ~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  176 KGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             hcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence            5 44333332   22467789999999999999855543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.75  E-value=4e-17  Score=142.76  Aligned_cols=180  Identities=32%  Similarity=0.467  Sum_probs=137.0

Q ss_pred             ccCCeEEEEecCccc-cHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEecc
Q psy3686           5 SKESDVWICMELMAT-CFDRLLKRLH--VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCDF   80 (296)
Q Consensus         5 ~~~~~~~lv~E~~~g-sL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~df   80 (296)
                      ...+..+++++++.| +|.+++....  ..++...+..++.|++.++.|+|+ .|++||||||+||+++..+ .++++||
T Consensus        68 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          68 QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEecc
Confidence            445558999999995 8887776533  279999999999999999999999 5999999999999999988 7999999


Q ss_pred             CCcccccCCc-------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---cHHHH
Q psy3686          81 GISGRLVDSK-------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC---DFEVL  150 (296)
Q Consensus        81 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~---~~~~~  150 (296)
                      |.+.......       ......++..|++||.+.+..  ...+....|+|++|++++++++|..||.....   .....
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~  224 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL  224 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence            9987554332       235568999999999996410  13677899999999999999999999887443   23444


Q ss_pred             HHHHccCCC-CCCCC-cch----hHHHHHHHHhccCCChHHHh
Q psy3686         151 SRVLNDAPP-CLPND-PLF----GRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       151 ~~i~~~~~p-~~~~~-~~~----s~~l~~li~~cl~~~P~~r~  187 (296)
                      ..+.....+ ..... ...    ...+.+++.+++..+|..|.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~  267 (384)
T COG0515         225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL  267 (384)
T ss_pred             HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC
Confidence            444444333 11111 111    25899999999999987443

>KOG1033|consensus

Probab=99.73  E-value=9.2e-19  Score=157.13  Aligned_cols=165  Identities=25%  Similarity=0.387  Sum_probs=130.3

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..++||.|++|. ++|.+++.+.  ....+....+.++.|+..|+.|   + |.+|+|+||.||++..+.++||.|||+.
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhhe
Confidence            347899999999 6999999753  4456788889999999999999   5 8999999999999999999999999998


Q ss_pred             ccccCCc-------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHc
Q psy3686          84 GRLVDSK-------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN  155 (296)
Q Consensus        84 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~  155 (296)
                      .......       ..+...+|..||+||.+.+.     .|+.++|||+||+++++++. -..+|..    ...+..+..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-----~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~  474 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-----QYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRD  474 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhh-----hhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhc
Confidence            7654433       34555899999999999643     89999999999999999988 4444433    234455556


Q ss_pred             cCCC-CCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         156 DAPP-CLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       156 ~~~p-~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +..| .+-.+   -+.-..|+.+++...|..||
T Consensus       475 g~ip~~~~~d---~p~e~~ll~~lls~~p~~RP  504 (516)
T KOG1033|consen  475 GIIPPEFLQD---YPEEYTLLQQLLSPSPEERP  504 (516)
T ss_pred             CCCChHHhhc---CcHHHHHHHHhcCCCcccCc
Confidence            6555 22222   34556899999999998666

>KOG0606|consensus

Probab=99.71  E-value=1.9e-17  Score=158.75  Aligned_cols=190  Identities=27%  Similarity=0.382  Sum_probs=137.7

Q ss_pred             HHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCC----------------ccccccccCcCCCCcccc
Q psy3686          44 TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----------------KARTKNAGCAAYMAPERI  107 (296)
Q Consensus        44 i~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~  107 (296)
                      ++.+++|||+ .||+|||+||+|++|+.-|++|+.|||+++.....                ......++|+.|.|||++
T Consensus       152 mvla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  152 MVLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hhHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            3789999999 69999999999999999999999999998653211                111234899999999999


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         108 EPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       108 ~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .     ...|+..+|+|++|+|+|+.+.|..||.+ +...+.+..++.........+..++++.+++|.++|+.+|..|-
T Consensus       231 l-----rqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  231 L-----RQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             h-----hhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            5     34788899999999999999999999999 66677777777655544445566899999999999999997332


Q ss_pred             hhccCCccchhhcccCCcccccCCCCccCCCCCCchhhhccccccCCCCCCcCCccccccCCCCcccccc
Q psy3686         188 KRSYEDKSTCYECGAEGHLSYACPQNILGIREPPPKKEKKRKKKQFGDDPQASSKTLYQDLGSDSEVEDQ  257 (296)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pp~k~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (296)
                      -     -....++.++.++..+-   +.         .--|++-.|.+.-....+..|=++..+++.+..
T Consensus       305 g-----t~ga~evk~h~ff~~LD---w~---------~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~  357 (1205)
T KOG0606|consen  305 G-----TGGALEVKQHGFFQLLD---WK---------SLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFE  357 (1205)
T ss_pred             c-----cchhhhhhhccceeecc---cc---------hhhhhhccccccccccccchhhcccchheeecc
Confidence            1     12445555666654431   10         111333345555455556666666666665544

>KOG1240|consensus

Probab=99.70  E-value=1.7e-17  Score=159.49  Aligned_cols=169  Identities=20%  Similarity=0.171  Sum_probs=122.0

Q ss_pred             CCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           7 ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         7 ~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      +...|||-+|...+|++.+.. +..+..-+.+.|+.||+.||.-+|. .||+|||||.+||||+.-+++.|.||..-+..
T Consensus        93 ~kAAylvRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   93 DKAAYLVRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             hHHHHHHHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCc
Confidence            445577888888899998875 4567888999999999999999999 59999999999999999999999999866433


Q ss_pred             cCC----ccc----cccccCcCCCCccccCCCC-----CC-CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHH
Q psy3686          87 VDS----KAR----TKNAGCAAYMAPERIEPPN-----PQ-KPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLS  151 (296)
Q Consensus        87 ~~~----~~~----~~~~~~~~y~aPE~~~~~~-----~~-~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~  151 (296)
                      .-+    ...    .+.....+|+|||.+....     .. ....+++.||||+||++.||++ |++||.-     ..+.
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~  245 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLL  245 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHH
Confidence            211    111    1123446899999985421     01 1126789999999999999999 8999964     1111


Q ss_pred             HHHccCCC----CCCCCcchhHHHHHHHHhccCCChH
Q psy3686         152 RVLNDAPP----CLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       152 ~i~~~~~p----~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      ....+..-    .+...  -+..++.+|..|++++|+
T Consensus       246 aYr~~~~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs  280 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLEKI--EDVSLRNLILSMIQRDPS  280 (1431)
T ss_pred             hHhccCccCHHHHHHhC--cCccHHHHHHHHHccCch
Confidence            11122100    00011  145789999999999998

>KOG0195|consensus

Probab=99.61  E-value=4.2e-15  Score=123.72  Aligned_cols=181  Identities=18%  Similarity=0.268  Sum_probs=133.4

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCc-eeCCCCCCcEEECCCCCEEE-
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGV-IHRDVKPSNILLDERGNIKL-   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~i-vH~dlkp~Nil~~~~~~~kl-   77 (296)
                      +......++.++..||+ |+|+.++... +.-.+..++.+++.+|++|++|||+-..+ .--.|.+..++|+.+-..+| 
T Consensus       254 gacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  254 GACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             hhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence            34556678999999999 8999999875 34468889999999999999999994333 44478889999998876554 


Q ss_pred             -eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHH-HHHHHc
Q psy3686          78 -CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEV-LSRVLN  155 (296)
Q Consensus        78 -~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~i~~  155 (296)
                       +|--++..      .......+.|++||.+....  ...--.++|+|||++++|+|.|...||... .+++. +...+.
T Consensus       334 mad~kfsfq------e~gr~y~pawmspealqrkp--ed~n~raadmwsfaillwel~trevpfadl-spmecgmkiale  404 (448)
T KOG0195|consen  334 MADTKFSFQ------EVGRAYSPAWMSPEALQRKP--EDLNIRAADMWSFAILLWELNTREVPFADL-SPMECGMKIALE  404 (448)
T ss_pred             cccceeeee------ccccccCcccCCHHHHhcCc--hhcchhhhhHHHHHHHHHHhhccccccccC-Cchhhhhhhhhc
Confidence             34322211      12235578999999996431  112235799999999999999999999984 44444 444466


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      |-.+.+|.-  +++.+..||.-|++.||.  +|+.|+-..
T Consensus       405 glrv~ippg--is~hm~klm~icmnedpg--krpkfdmiv  440 (448)
T KOG0195|consen  405 GLRVHIPPG--ISRHMNKLMNICMNEDPG--KRPKFDMIV  440 (448)
T ss_pred             cccccCCCC--ccHHHHHHHHHHhcCCCC--cCCCcceeh
Confidence            777777654  799999999999999998  444455443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.58  E-value=5.7e-15  Score=121.05  Aligned_cols=122  Identities=20%  Similarity=0.178  Sum_probs=90.2

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCcEEECCCCCEEEeccCCccc
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV-KPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dl-kp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +..|++|||+.| +|.+.+..       . ...++.|++.+|.++|+ +||+|||| ||.|||++.++.++|+|||++..
T Consensus        71 ~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         71 DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            456999999998 77654321       1 23578899999999999 59999999 79999999999999999999975


Q ss_pred             ccCCccc--------------cccccCcCCCCccccCCCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q psy3686          86 LVDSKAR--------------TKNAGCAAYMAPERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD  142 (296)
Q Consensus        86 ~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~  142 (296)
                      .......              .....++.|+.|+.....    ...+ ...+.++.|+-+|.++|+..++.+
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l----~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL----KRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh----ccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            4433210              011356777777755311    1222 567888999999999999888765

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.55  E-value=5.4e-15  Score=132.16  Aligned_cols=95  Identities=19%  Similarity=0.211  Sum_probs=73.6

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCcEEECCCCCEEEeccCCcc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV-KPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dl-kp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+..||||||++| +|.. +.    ...   ...++.|++.+|.|||+ +||+|||| ||.|||++.++.++|+|||++.
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            3568999999996 7862 21    111   14678999999999999 59999999 9999999999999999999998


Q ss_pred             cccCCccc---------cccccCcCCCCccccCCC
Q psy3686          85 RLVDSKAR---------TKNAGCAAYMAPERIEPP  110 (296)
Q Consensus        85 ~~~~~~~~---------~~~~~~~~y~aPE~~~~~  110 (296)
                      .+......         ....++..|.+||.+...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            66543211         223567789999998643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.55  E-value=8.9e-15  Score=120.00  Aligned_cols=74  Identities=16%  Similarity=0.302  Sum_probs=63.2

Q ss_pred             EEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686          10 VWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYL-KETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus        10 ~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      .||||||++| +|...... ...++...+..++.|++.+|.+| |+ .||+||||||+|||++ ++.++|+|||++...
T Consensus        92 ~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            3899999997 55544333 56899999999999999999999 68 5999999999999998 578999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.54  E-value=3.6e-15  Score=124.48  Aligned_cols=100  Identities=16%  Similarity=0.333  Sum_probs=74.9

Q ss_pred             CCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .+..+|||||++| +|.++..     +++    ....+++.+|..||+ +|++||||+|.||+++.+| ++|+|||....
T Consensus       115 ~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g-i~liDfg~~~~  183 (232)
T PRK10359        115 AHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRC  183 (232)
T ss_pred             cCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence            4568999999998 8988742     333    345699999999999 5999999999999999988 99999998765


Q ss_pred             ccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHH
Q psy3686          86 LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL  133 (296)
Q Consensus        86 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l  133 (296)
                      .........           .+     ....+..++|+|+||+++..+
T Consensus       184 ~~e~~a~d~-----------~v-----ler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        184 TAQRKAKDR-----------ID-----LERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             ccchhhHHH-----------HH-----HHhHhcccccccceeEeehHH
Confidence            432211110           11     222456789999999987654

>KOG1166|consensus

Probab=99.53  E-value=2.1e-14  Score=139.91  Aligned_cols=127  Identities=20%  Similarity=0.236  Sum_probs=107.1

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-------CCCE
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-------RGNI   75 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-------~~~~   75 (296)
                      +.-.+.-+||+||.+ |||.+++.. .+.+++..++.++.||+..|+.||. ++||||||||+|+||..       ...+
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccce
Confidence            344566789999999 899999984 7889999999999999999999999 69999999999999953       2358


Q ss_pred             EEeccCCccccc---CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy3686          76 KLCDFGISGRLV---DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE  137 (296)
Q Consensus        76 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~  137 (296)
                      +|+|||.+.-+.   +........+|-.+-.+|...|     ..++..+|.|.|+.+++.|+.|+
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-----rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-----RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-----CCCchhhhhHHHHHHHHHHHHHH
Confidence            999999986443   2224445577888999999954     37999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.49  E-value=6e-14  Score=115.20  Aligned_cols=75  Identities=23%  Similarity=0.281  Sum_probs=63.7

Q ss_pred             EEEEecCccc-cHH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686          10 VWICMELMAT-CFD-RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus        10 ~~lv~E~~~g-sL~-~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      .||||||++| ++. ..+.  ...++...+..++.|++.+|.+||...||+||||||.||+++ ++.++|+|||++....
T Consensus        92 ~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            3899999997 343 3343  467889999999999999999999933999999999999998 8999999999996653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590|consensus

Probab=99.38  E-value=7.4e-14  Score=132.67  Aligned_cols=178  Identities=24%  Similarity=0.323  Sum_probs=138.6

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCcEEECCCC-CEEE
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLL-KRLHVSVPEPICGKITLSTVKALHYLK-ETHGVIHRDVKPSNILLDERG-NIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~ivH~dlkp~Nil~~~~~-~~kl   77 (296)
                      ....+....+++++|..| ++...+ .......+......++.|+..++.|+| . .++.|+||+|+|.+++..+ .+++
T Consensus        88 ~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   88 EPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             CccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccC
Confidence            455677889999999885 888888 442227788888999999999999999 7 5999999999999999999 9999


Q ss_pred             eccCCcccccC-Cc---ccccccc-CcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHH
Q psy3686          78 CDFGISGRLVD-SK---ARTKNAG-CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR  152 (296)
Q Consensus        78 ~dfg~~~~~~~-~~---~~~~~~~-~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~  152 (296)
                      .|||++..+.. .+   .....+| ++.|+|||...+.    ....+..|+||+|+++..+++|..||............
T Consensus       167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~----~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~  242 (601)
T KOG0590|consen  167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK----AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS  242 (601)
T ss_pred             CCchhhccccccCCcceeeecccCCCCCCCCcccccch----hhcCCCcccccccccccccccCCCCcccccccccccee
Confidence            99999987655 22   2233467 9999999999642    34567899999999999999999999874333323222


Q ss_pred             HHcc-CCCCCCCCcchhHHHHHHHHhccCCChH
Q psy3686         153 VLND-APPCLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       153 i~~~-~~p~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      .... .......+..++....+++.+++..+|+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~  275 (601)
T KOG0590|consen  243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPS  275 (601)
T ss_pred             ecccccccccCccccCChhhhhcccccccCCch
Confidence            2222 2223444556899999999999998887

>smart00090 RIO RIO-like kinase

Probab=99.35  E-value=1.2e-12  Score=111.08  Aligned_cols=75  Identities=20%  Similarity=0.248  Sum_probs=63.6

Q ss_pred             eEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           9 DVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG-VIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         9 ~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ..||||||++| +|...... ...+....+..++.||+.+|.+||. +| ++|+||||+||+++ ++.++|+|||.+...
T Consensus       122 ~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            45899999997 77665432 4566777788999999999999999 59 99999999999999 889999999988643

>PRK10345 hypothetical protein; Provisional

Probab=99.29  E-value=8.4e-12  Score=103.64  Aligned_cols=71  Identities=18%  Similarity=0.253  Sum_probs=56.0

Q ss_pred             CeEE-EEecCcc---ccHHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHhCCceeCCCCCCcEEECC----CCCEEEe
Q psy3686           8 SDVW-ICMELMA---TCFDRLLKRLHVSVPEPICGKITLSTVKAL-HYLKETHGVIHRDVKPSNILLDE----RGNIKLC   78 (296)
Q Consensus         8 ~~~~-lv~E~~~---gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~ivH~dlkp~Nil~~~----~~~~kl~   78 (296)
                      +.+| +||||++   |+|.+++.+  ..+++.  ..++.|++.++ +|||+ ++|+||||||+|||++.    ++.++|+
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            3544 8999954   599999975  356666  35688888887 99999 69999999999999974    3479999


Q ss_pred             ccCCc
Q psy3686          79 DFGIS   83 (296)
Q Consensus        79 dfg~~   83 (296)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.27  E-value=9.8e-12  Score=103.55  Aligned_cols=75  Identities=24%  Similarity=0.332  Sum_probs=64.7

Q ss_pred             CccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           4 QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      +.+.+..++||||++| +|.+++....    . .+..++.+++.+|.+||+ .|++|+|++|.||+++ ++.++|+|||.
T Consensus        68 ~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         68 FVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCc
Confidence            3456778999999997 9999986421    2 788999999999999999 5999999999999999 78899999998


Q ss_pred             ccc
Q psy3686          83 SGR   85 (296)
Q Consensus        83 ~~~   85 (296)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            754

>KOG1266|consensus

Probab=99.24  E-value=3.5e-11  Score=103.02  Aligned_cols=174  Identities=19%  Similarity=0.239  Sum_probs=117.7

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEECCCCCEEEe
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETH-GVIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-~ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      +.+.....+++|||. |+|.++|++.   +..+......+|+.||+.||.|||+.. -|+|+++..+.|++..+|-+|+.
T Consensus       141 ~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  141 YEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEec
Confidence            345667889999999 7999999876   567899999999999999999999832 49999999999999999988876


Q ss_pred             ccCCccc-----ccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH
Q psy3686          79 DFGISGR-----LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV  153 (296)
Q Consensus        79 dfg~~~~-----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i  153 (296)
                      --.-...     ...........+-+.|.+||.=     .....+..+|||++|+...+|..+..--.........-..+
T Consensus       221 ~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-----~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i  295 (458)
T KOG1266|consen  221 SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-----TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI  295 (458)
T ss_pred             ccCccccchhhhhhhHhhhhccccCCccccCCcC-----cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh
Confidence            4221100     0011111223456788888865     23356678999999999999988875543323322222222


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChHHHhh
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK  188 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~  188 (296)
                      .+-. ..+.     .+.-+.+|.+|++..|.-||.
T Consensus       296 a~~i-~~le-----n~lqr~~i~kcl~~eP~~rp~  324 (458)
T KOG1266|consen  296 ANVI-IGLE-----NGLQRGSITKCLEGEPNGRPD  324 (458)
T ss_pred             hhhe-eecc-----CccccCcCcccccCCCCCCcc
Confidence            1111 1111     222367888899999874433

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.24  E-value=2.6e-11  Score=103.01  Aligned_cols=68  Identities=26%  Similarity=0.321  Sum_probs=58.6

Q ss_pred             EEEecCccc--cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686          11 WICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus        11 ~lv~E~~~g--sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +||||+++|  +|.+++..  ..+++..    +.||+.+|.+||+ .||+|+||||.|||++.++.++|+|||.+..
T Consensus       122 ~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        122 DILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             eEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            599999995  89998864  4566543    5689999999999 5999999999999999989999999998854

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.22  E-value=1.7e-11  Score=101.20  Aligned_cols=72  Identities=19%  Similarity=0.195  Sum_probs=60.7

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      +..++||||++| +|..+...       .....++.+++.++.++|+ .|++|+||+|.||+++.++.++|+|||.+...
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            456899999997 87765421       3456788999999999999 59999999999999999999999999998554


Q ss_pred             c
Q psy3686          87 V   87 (296)
Q Consensus        87 ~   87 (296)
                      .
T Consensus       176 ~  176 (198)
T cd05144         176 D  176 (198)
T ss_pred             C
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606|consensus

Probab=99.22  E-value=4.8e-11  Score=115.47  Aligned_cols=173  Identities=21%  Similarity=0.249  Sum_probs=139.3

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      -....+|||+|..| +|...++. .+..+..-.+..+..+..++++||.. .+.|+|++|.|+++..++..++.+|+...
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCcccccc
Confidence            45678999999985 99998876 45678888888999999999999995 69999999999999999999999998432


Q ss_pred             cccCC--------------------------------ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHH
Q psy3686          85 RLVDS--------------------------------KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE  132 (296)
Q Consensus        85 ~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~  132 (296)
                      .....                                .......+++.|.+||...+.     .....+|+|++|+++++
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-----~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-----RHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-----cCCCcchhhhhhhhhhh
Confidence            21100                                001223578899999999654     45668899999999999


Q ss_pred             HHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         133 LATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       133 l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .++|..||.. .....++..+.++..|........+...++++.+.+..+|..|
T Consensus      1028 ~l~g~pp~na-~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1028 VLTGIPPFNA-ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred             hhcCCCCCCC-cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhc
Confidence            9999999998 5666788888887776555555689999999999999999733

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.22  E-value=1.7e-11  Score=101.20  Aligned_cols=71  Identities=20%  Similarity=0.340  Sum_probs=60.6

Q ss_pred             ccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           5 SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         5 ~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+++..++||||++| +|.+++... ..       .++.+++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++
T Consensus        67 ~~~~~~~lv~e~~~g~~l~~~~~~~-~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        67 VDPDNKTIVMEYIEGKPLKDVIEEG-ND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EECCCCEEEEEEECCccHHHHHhhc-HH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            345667999999996 999887542 11       789999999999999 5999999999999999 889999999987


Q ss_pred             cc
Q psy3686          84 GR   85 (296)
Q Consensus        84 ~~   85 (296)
                      ..
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            54

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.16  E-value=4.5e-11  Score=113.38  Aligned_cols=70  Identities=20%  Similarity=0.336  Sum_probs=61.1

Q ss_pred             ccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           5 SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         5 ~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+....++||||++| +|.+++.         ....++.+++.+|.+||+ .|++||||||.||++ .++.++|+|||++
T Consensus       406 ~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        406 VDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             EeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            345577899999996 9999885         346789999999999999 599999999999999 6788999999998


Q ss_pred             cc
Q psy3686          84 GR   85 (296)
Q Consensus        84 ~~   85 (296)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            54

>KOG0601|consensus

Probab=99.13  E-value=6.9e-11  Score=108.48  Aligned_cols=173  Identities=18%  Similarity=0.234  Sum_probs=132.4

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHH----HHHHHHHhCCceeCCCCCCcEEECCC-CCEEE
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVK----ALHYLKETHGVIHRDVKPSNILLDER-GNIKL   77 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl   77 (296)
                      .+...+.+||-+|+|+.+|..+.......++...++..+.+...    ||.++|. .+++|-|++|.||++..+ ...++
T Consensus       186 ~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  186 AWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             ccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccceeec
Confidence            46778899999999999999999887777999999999999999    9999999 599999999999999999 78999


Q ss_pred             eccCCcccccCCccc------cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHH
Q psy3686          78 CDFGISGRLVDSKAR------TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS  151 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~  151 (296)
                      +|||+...+......      ....+...|++||...+      .++...|++++|.++.+..++..++......  .+.
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~  336 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG------LATFASDIFSLGEVILEAILGSHLPSVGKNS--SWS  336 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc------ccchHhhhcchhhhhHhhHhhcccccCCCCC--Ccc
Confidence            999999887655321      12257788999999854      5788999999999999998887665542111  122


Q ss_pred             HHHccC-CCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         152 RVLNDA-PPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       152 ~i~~~~-~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+.++. +..+-.  ..+..+...+..++..+|-.|
T Consensus       337 ~~r~~~ip~e~~~--~~s~~l~~~~~~~~d~~~~~~  370 (524)
T KOG0601|consen  337 QLRQGYIPLEFCE--GGSSSLRSVTSQMLDEDPRLR  370 (524)
T ss_pred             ccccccCchhhhc--CcchhhhhHHHHhcCcchhhh
Confidence            222211 111211  246667778888888888533

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.05  E-value=3.4e-10  Score=92.38  Aligned_cols=75  Identities=19%  Similarity=0.250  Sum_probs=58.6

Q ss_pred             eEEEEecCccc-cHH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           9 DVWICMELMAT-CFD-RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         9 ~~~lv~E~~~g-sL~-~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ..++||||++| ++. ..+....  .. ..+..++.+++.++.++|..+||+|+||+|+||+++ ++.++|+|||.+...
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            46899999996 221 2222111  11 667899999999999999833999999999999999 899999999998654


Q ss_pred             c
Q psy3686          87 V   87 (296)
Q Consensus        87 ~   87 (296)
                      .
T Consensus       165 ~  165 (187)
T cd05119         165 D  165 (187)
T ss_pred             c
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=7.4e-09  Score=91.92  Aligned_cols=171  Identities=15%  Similarity=0.189  Sum_probs=121.7

Q ss_pred             EEEEecCccc--cHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCC
Q psy3686          10 VWICMELMAT--CFDRLLKRL-----HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus        10 ~~lv~E~~~g--sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      +=+.|+.+.|  .+..++.-.     -....+..+.+.++.++.+.+.||. +|.+-||++++|+|+++++.+.|.|-..
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEcccc
Confidence            4578888876  555554321     2246788999999999999999999 6999999999999999999999998654


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC------CcHHHHHHHHc
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG-EFPYKDCK------CDFEVLSRVLN  155 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g-~~Pf~~~~------~~~~~~~~i~~  155 (296)
                      ..............+...|.+||...-........+...|.|.||+++++++.| +.||.+..      ...+  ..|..
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia~  241 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIAH  241 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhhc
Confidence            333333344455688999999998764433444567789999999999999985 99997631      1111  01111


Q ss_pred             c-------------CCCCCCCCcchhHHHHHHHHhccCCCh
Q psy3686         156 D-------------APPCLPNDPLFGRTIKASIAKDNGRST  183 (296)
Q Consensus       156 ~-------------~~p~~~~~~~~s~~l~~li~~cl~~~P  183 (296)
                      +             .+|.-+...-+++.+..+..+||...-
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~  282 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESG  282 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccC
Confidence            1             111112223478999999999987543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.97  E-value=1.2e-09  Score=89.33  Aligned_cols=76  Identities=17%  Similarity=0.230  Sum_probs=59.8

Q ss_pred             CeEEEEecCccc-cHH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           8 SDVWICMELMAT-CFD-RLLKRLHVSVPEPICGKITLSTVKALHYL-KETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~-~~l~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ..-+|||||++| .+. ..++  ...++...+..+..+++.+|..| |. .|++||||++.||++. ++.+.|+|||.+.
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs~~NIL~~-~~~v~iIDF~qav  172 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLSEYNMLWH-DGKVWFIDVSQSV  172 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEE-CCcEEEEECCCce
Confidence            456899999986 332 2233  34566677788899999999999 78 5999999999999996 5789999999886


Q ss_pred             ccc
Q psy3686          85 RLV   87 (296)
Q Consensus        85 ~~~   87 (296)
                      ...
T Consensus       173 ~~~  175 (197)
T cd05146         173 EPT  175 (197)
T ss_pred             eCC
Confidence            543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=2.5e-09  Score=85.20  Aligned_cols=73  Identities=22%  Similarity=0.320  Sum_probs=60.3

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      ++.+.+...|+|||++| .|.+++...        ...++..+-.-+.-||. .||+||||.++||++...+ +.++|||
T Consensus        67 ~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          67 YDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             EEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCCc-EEEEECC
Confidence            45677888999999998 888888752        24566677777888999 6999999999999997766 9999999


Q ss_pred             Cccc
Q psy3686          82 ISGR   85 (296)
Q Consensus        82 ~~~~   85 (296)
                      ++..
T Consensus       137 Lg~~  140 (204)
T COG3642         137 LGEF  140 (204)
T ss_pred             cccc
Confidence            9853

>KOG2137|consensus

Probab=98.92  E-value=5.4e-10  Score=104.30  Aligned_cols=163  Identities=15%  Similarity=0.116  Sum_probs=112.0

Q ss_pred             cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccccCCccc-------
Q psy3686          20 CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-------   92 (296)
Q Consensus        20 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------   92 (296)
                      +|.++....+....-+....=+.+++.|+.|+|..-++||++|.|++|.++.++..||+.|+.+.........       
T Consensus        84 ~~~~lr~~~~vs~aTe~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~  163 (700)
T KOG2137|consen   84 SLQQLRGLDGVSKATEDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDP  163 (700)
T ss_pred             HHHHHhcccchhhcccHhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCC
Confidence            5555553222233334444445566799999999669999999999999999999999999987654432111       


Q ss_pred             ---cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchh
Q psy3686          93 ---TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFG  168 (296)
Q Consensus        93 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s  168 (296)
                         ........|.|||.+..     ...+.++|++|+|+++|.+.. |+.-+.........-..........+.....++
T Consensus       164 ~lp~~~~~~~~f~apE~~~~-----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p  238 (700)
T KOG2137|consen  164 PLPLLLQPHLNFLAPEYLLG-----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLP  238 (700)
T ss_pred             CCChhhccCcccccchhhcc-----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCc
Confidence               11134567999999954     367889999999999999985 555555432222222222223333333335589


Q ss_pred             HHHHHHHHhccCCChHHHh
Q psy3686         169 RTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       169 ~~l~~li~~cl~~~P~~r~  187 (296)
                      .++++-|.+++..++..|+
T Consensus       239 ~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  239 SELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             HHHHHHHHHHhcCCcccCc
Confidence            9999999999999999777

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.92  E-value=1.7e-09  Score=84.31  Aligned_cols=73  Identities=22%  Similarity=0.338  Sum_probs=60.5

Q ss_pred             CccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCcEEECCCCCEEEecc
Q psy3686           4 QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--GVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +...+..|++|||+.| .+..+        +......++.+++.+|.+||...  +++|+||+|.||+++..+.++++||
T Consensus        62 ~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df  133 (155)
T cd05120          62 GESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW  133 (155)
T ss_pred             cCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEec
Confidence            3445689999999996 55433        45666788999999999999832  6999999999999999899999999


Q ss_pred             CCcc
Q psy3686          81 GISG   84 (296)
Q Consensus        81 g~~~   84 (296)
                      |.+.
T Consensus       134 ~~~~  137 (155)
T cd05120         134 EYAG  137 (155)
T ss_pred             cccc
Confidence            9874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243|consensus

Probab=98.92  E-value=8.5e-09  Score=96.14  Aligned_cols=124  Identities=20%  Similarity=0.375  Sum_probs=92.9

Q ss_pred             CCCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           1 MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         1 ~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      |+.+..++.+|||+|.+.. |..++++    +....+..-+.||+.||.|||...+++|++|+-+.|+|+..|..||++|
T Consensus        75 L~t~e~~~~~ylvTErV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggl  149 (690)
T KOG1243|consen   75 LDTTEEEGTLYLVTERVRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGL  149 (690)
T ss_pred             hhhhcccCceEEEeecccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeee
Confidence            4567888999999999874 3445543    2277788899999999999997679999999999999999999999999


Q ss_pred             CCcccccCCccc-cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy3686          81 GISGRLVDSKAR-TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG  136 (296)
Q Consensus        81 g~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g  136 (296)
                      .++......... .....-..|..|+.+..       -.-..|.|-|||++++++.|
T Consensus       150 e~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-------s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  150 ELVSKASGFNAPAKSLYLIESFDDPEEIDP-------SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             EEEeccccCCcccccchhhhcccChhhcCc-------cccchhhhhHHHHHHHHhCc
Confidence            887654433221 11122234666665521       11356999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.87  E-value=4.4e-09  Score=97.03  Aligned_cols=76  Identities=25%  Similarity=0.382  Sum_probs=58.9

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHH-HHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVK-ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      +..+|||||++| +|.++.......+.   ...++.+++. .+..+|. .|++|+|++|.||+++.++.++++|||++..
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~-~g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR-DGFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh-CCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            446899999997 88887653222232   3345556655 4778898 5999999999999999999999999999977


Q ss_pred             cc
Q psy3686          86 LV   87 (296)
Q Consensus        86 ~~   87 (296)
                      +.
T Consensus       307 l~  308 (437)
T TIGR01982       307 LS  308 (437)
T ss_pred             CC
Confidence            64

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087|consensus

Probab=98.85  E-value=7.6e-09  Score=82.29  Aligned_cols=82  Identities=23%  Similarity=0.261  Sum_probs=65.5

Q ss_pred             CCccCCeEEEEecCccc--cHHHHHHHhCCCCCHH-HHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC---CEE
Q psy3686           3 PQSKESDVWICMELMAT--CFDRLLKRLHVSVPEP-ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG---NIK   76 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g--sL~~~l~~~~~~l~~~-~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~---~~k   76 (296)
                      +|.+...-+|+|||++|  ++.+++......-.+. ....++.+|-..|.-||. ++|+||||..+||++..++   .+.
T Consensus        78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceE
Confidence            35566677899999998  9999987763333333 337889999999999999 6999999999999997654   358


Q ss_pred             EeccCCccc
Q psy3686          77 LCDFGISGR   85 (296)
Q Consensus        77 l~dfg~~~~   85 (296)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999854

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.84  E-value=1.4e-08  Score=87.49  Aligned_cols=76  Identities=13%  Similarity=0.145  Sum_probs=64.6

Q ss_pred             CeEEEEecCccc--cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-------CCCEEE
Q psy3686           8 SDVWICMELMAT--CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-------RGNIKL   77 (296)
Q Consensus         8 ~~~~lv~E~~~g--sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-------~~~~kl   77 (296)
                      ..-|||||+++|  +|.+++... ....+......++.+++..+.-||. .||+|+|+++.|||++.       .+.+.|
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            357899999997  899998643 3456677888999999999999999 59999999999999975       467899


Q ss_pred             eccCCcc
Q psy3686          78 CDFGISG   84 (296)
Q Consensus        78 ~dfg~~~   84 (296)
                      +||+.+.
T Consensus       187 IDl~r~~  193 (268)
T PRK15123        187 IDLHRAQ  193 (268)
T ss_pred             EECCccc
Confidence            9999774

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=1.9e-08  Score=83.58  Aligned_cols=75  Identities=20%  Similarity=0.308  Sum_probs=65.7

Q ss_pred             eEEEEecCccc--cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC---CEEEeccCCc
Q psy3686           9 DVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG---NIKLCDFGIS   83 (296)
Q Consensus         9 ~~~lv~E~~~g--sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~---~~kl~dfg~~   83 (296)
                      ..|||||+++|  +|.+++... ..++......++.+++..+.-||. .||+|+|+++.|||++.++   .+.|+||+.+
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~  168 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM  168 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence            45899999997  899999863 237778888999999999999999 5999999999999999887   8999999877


Q ss_pred             cc
Q psy3686          84 GR   85 (296)
Q Consensus        84 ~~   85 (296)
                      ..
T Consensus       169 ~~  170 (206)
T PF06293_consen  169 RF  170 (206)
T ss_pred             ee
Confidence            54

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.68  E-value=1.8e-08  Score=80.77  Aligned_cols=65  Identities=23%  Similarity=0.246  Sum_probs=51.3

Q ss_pred             eEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCcEEECCCCCEEEeccCC
Q psy3686           9 DVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGV-----IHRDVKPSNILLDERGNIKLCDFGI   82 (296)
Q Consensus         9 ~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~i-----vH~dlkp~Nil~~~~~~~kl~dfg~   82 (296)
                      ..++||||++| ++...      .   .....++.+++.+|+.||.. ++     +|+|++|.||+++ ++.++++||+.
T Consensus        65 ~~~lv~e~i~G~~l~~~------~---~~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          65 TGVLITEFIEGSELLTE------D---FSDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             CCeEEEEecCCCccccc------c---ccCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            45899999997 65432      0   11234567899999999994 74     9999999999998 67899999998


Q ss_pred             cc
Q psy3686          83 SG   84 (296)
Q Consensus        83 ~~   84 (296)
                      +.
T Consensus       134 a~  135 (170)
T cd05151         134 AG  135 (170)
T ss_pred             cc
Confidence            74

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.63  E-value=3.7e-08  Score=80.26  Aligned_cols=72  Identities=24%  Similarity=0.352  Sum_probs=50.2

Q ss_pred             EEEEecCcc--c-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686          10 VWICMELMA--T-CFDRLLKRLHVSVPEPICGKITLSTVKALHY-LKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus        10 ~~lv~E~~~--g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      -+|||||++  | .+..+..   ..++......++.+++..+.. +|. .||+||||++.||+++.+ .+.++|||.+..
T Consensus        81 ~~ivME~I~~~G~~~~~l~~---~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKD---VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHH---CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             CEEEEEecCCCccchhhHHh---ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEEecCccee
Confidence            369999999  7 5555443   233355567788888886555 467 599999999999999877 899999998855


Q ss_pred             c
Q psy3686          86 L   86 (296)
Q Consensus        86 ~   86 (296)
                      .
T Consensus       156 ~  156 (188)
T PF01163_consen  156 S  156 (188)
T ss_dssp             T
T ss_pred             c
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601|consensus

Probab=98.60  E-value=1.9e-08  Score=92.71  Aligned_cols=166  Identities=21%  Similarity=0.173  Sum_probs=116.2

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC-CCEEEecc
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCDF   80 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~-~~~kl~df   80 (296)
                      .+......||-.|||.| ++...+ .....+.+.-++.+..|++.++.++|+. .++|+|++|+||++.++ +..++.||
T Consensus       334 ~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  334 SWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             CccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhcccc
Confidence            35556677899999984 443333 2245788999999999999999999994 99999999999999887 67789999


Q ss_pred             CCcccccCCccccccccCcCCC-CccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCcHHHHHHHHccCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYM-APERIEPPNPQKPDYDIRADVWSLGITLVELATGEF-PYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~-Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |+...+.-  .........++. ..|++.    ....+..+.|+++||..+.+.++|.. +...     ..+..+..+..
T Consensus       412 ~~~t~~~~--~~~~~~~~~r~~p~~~~~~----e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----~~~~~i~~~~~  480 (524)
T KOG0601|consen  412 GCWTRLAF--SSGVFHHIDRLYPIAEILL----EDYPHLSKADIFSLGLSVDEAITGSPLSESG-----VQSLTIRSGDT  480 (524)
T ss_pred             ccccccce--ecccccccccccccchhhc----cccccccccccccccccccccccCcccCccc-----ccceeeecccc
Confidence            98864221  111122333334 244443    33366789999999999999999863 2222     23344555655


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChH
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      |..+.   ....+..+.+.+...++.
T Consensus       481 p~~~~---~~~~~q~~~kv~~~~~~~  503 (524)
T KOG0601|consen  481 PNLPG---LKLQLQVLLKVMINPDRK  503 (524)
T ss_pred             cCCCc---hHHhhhhhhhhhcCCccc
Confidence            55554   347788888888777775

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.59  E-value=7.3e-08  Score=90.48  Aligned_cols=73  Identities=23%  Similarity=0.291  Sum_probs=53.5

Q ss_pred             CeEEEEecCccc-cHHHHH--HHhCC---CCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC----CEEE
Q psy3686           8 SDVWICMELMAT-CFDRLL--KRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG----NIKL   77 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l--~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~----~~kl   77 (296)
                      +..+|||||+.| .|.++-  ...+.   .+.+..+..++.|++       . +|++|+|+||.||+++.++    ++++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~-~GffHaDpHPGNIlv~~~g~~~~~i~l  305 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------R-DGFFHADMHPGNIFVSYDPPENPRYIA  305 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h-CCeeeCCCChHHeEEecCCCCCCeEEE
Confidence            344599999997 887653  22111   244555555555554       3 6999999999999999888    9999


Q ss_pred             eccCCcccccC
Q psy3686          78 CDFGISGRLVD   88 (296)
Q Consensus        78 ~dfg~~~~~~~   88 (296)
                      +|||++..+..
T Consensus       306 lDFGivg~l~~  316 (537)
T PRK04750        306 LDFGIVGSLNK  316 (537)
T ss_pred             EecceEEECCH
Confidence            99999877643

>PRK09902 hypothetical protein; Provisional

Probab=98.42  E-value=1.2e-06  Score=72.09  Aligned_cols=76  Identities=13%  Similarity=0.109  Sum_probs=64.7

Q ss_pred             eEEEEecCccc--cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCC--EEEeccCCc
Q psy3686           9 DVWICMELMAT--CFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN--IKLCDFGIS   83 (296)
Q Consensus         9 ~~~lv~E~~~g--sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~   83 (296)
                      .-+||+|-++|  +|.+++... -.+.+......++.+++..|+-||. .|+.|+|+.+.||+++..+.  ++++||..+
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            46899999986  999998653 2356788888999999999999999 59999999999999987777  999999766


Q ss_pred             cc
Q psy3686          84 GR   85 (296)
Q Consensus        84 ~~   85 (296)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            43

>KOG3741|consensus

Probab=98.40  E-value=5.1e-06  Score=75.92  Aligned_cols=148  Identities=16%  Similarity=0.242  Sum_probs=105.6

Q ss_pred             CccCCeEEEEecCccc--cHHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q psy3686           4 QSKESDVWICMELMAT--CFDRLLKRL--------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI   67 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~g--sL~~~l~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Ni   67 (296)
                      -+.+..+++|++|+++  +|.++.-..              +...+|..+|.++.|+..||.++|+. |+.-+-|.+.+|
T Consensus       346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kI  424 (655)
T KOG3741|consen  346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKI  424 (655)
T ss_pred             ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHe
Confidence            3567789999999994  888876432              45678999999999999999999995 999999999999


Q ss_pred             EECCCCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCc
Q psy3686          68 LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFP-YKDCKCD  146 (296)
Q Consensus        68 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~P-f~~~~~~  146 (296)
                      +++.+-+++|...|....+....           .  +.+        .-..+-|.-.||.++..|.+|..- +.. +..
T Consensus       425 lv~G~~RIriS~C~i~Dvl~~d~-----------~--~~l--------e~~Qq~D~~~lG~ll~aLAt~~~ns~~~-d~~  482 (655)
T KOG3741|consen  425 LVTGKMRIRISGCGIMDVLQEDP-----------T--EPL--------ESQQQNDLRDLGLLLLALATGTENSNRT-DST  482 (655)
T ss_pred             EeeCcceEEEecccceeeecCCC-----------C--cch--------hHHhhhhHHHHHHHHHHHhhcccccccc-cch
Confidence            99999899998887765443221           0  112        112367999999999999998533 222 222


Q ss_pred             HHH-HHHHHccCCCCCCCCcchhHHHHHHHHhccCCChH
Q psy3686         147 FEV-LSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTE  184 (296)
Q Consensus       147 ~~~-~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~  184 (296)
                      ... +..|..          .+|.+++++|.-....+++
T Consensus       483 ~~s~~~~I~~----------~yS~D~rn~v~yl~s~~~~  511 (655)
T KOG3741|consen  483 QSSHLTRITT----------TYSTDLRNVVEYLESLNFR  511 (655)
T ss_pred             HHHHHHHhhh----------hhhHHHHHHHHHHHhcCcc
Confidence            222 222211          1677777777776666654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=5.1e-07  Score=74.64  Aligned_cols=66  Identities=26%  Similarity=0.425  Sum_probs=51.1

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ...+|||||++| .|.++..     +++    .+...+..++.-||+ +|++|||++|.|++++.++ ++++||+..+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            456799999998 7766542     222    244567778999999 6999999999999998555 9999997653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.16  E-value=3.2e-06  Score=70.51  Aligned_cols=75  Identities=15%  Similarity=0.234  Sum_probs=57.2

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHh--------------------------------
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKET--------------------------------   54 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------------   54 (296)
                      +..|+||||++| +|...+.  ...+++.....++.+++.+|..||+.                                
T Consensus        73 ~~~~~v~e~i~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (223)
T cd05154          73 GTPFYVMERVDGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR  150 (223)
T ss_pred             CCceEEEEEeCCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence            367899999997 6766542  13567777777777777777777731                                


Q ss_pred             -----------------------CCceeCCCCCCcEEECC--CCCEEEeccCCcc
Q psy3686          55 -----------------------HGVIHRDVKPSNILLDE--RGNIKLCDFGISG   84 (296)
Q Consensus        55 -----------------------~~ivH~dlkp~Nil~~~--~~~~kl~dfg~~~   84 (296)
                                             ..++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                   24699999999999998  5668999998774

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.95  E-value=2e-05  Score=66.88  Aligned_cols=73  Identities=21%  Similarity=0.240  Sum_probs=53.2

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +-++-.+||||++| -|...      +++......++..|+.-+.-+-. .|+||||+++-||+++.+|.+.++||-.+.
T Consensus       178 ~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         178 AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEecCCCEEEEeCcccc
Confidence            34667899999998 44433      22344444555556555555555 599999999999999999999999996553


Q ss_pred             c
Q psy3686          85 R   85 (296)
Q Consensus        85 ~   85 (296)
                      .
T Consensus       251 ~  251 (304)
T COG0478         251 P  251 (304)
T ss_pred             c
Confidence            3

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.87  E-value=3.4e-05  Score=72.28  Aligned_cols=81  Identities=26%  Similarity=0.382  Sum_probs=57.3

Q ss_pred             ccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           5 SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         5 ~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      +-.+.-.|+|||++| .+.++.......++.+.+.....++.  +.-+-. +|++|.|.+|.||++..+|++.+.|||+.
T Consensus       236 e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~-dgffHaDpHpGNi~v~~~g~i~~lDfGi~  312 (517)
T COG0661         236 EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR-DGFFHADPHPGNILVRSDGRIVLLDFGIV  312 (517)
T ss_pred             hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh-cCccccCCCccceEEecCCcEEEEcCcce
Confidence            345667899999999 78777433335566444443333321  222233 69999999999999999999999999998


Q ss_pred             ccccC
Q psy3686          84 GRLVD   88 (296)
Q Consensus        84 ~~~~~   88 (296)
                      ..+..
T Consensus       313 g~l~~  317 (517)
T COG0661         313 GRLDP  317 (517)
T ss_pred             ecCCH
Confidence            77653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.67  E-value=7.4e-05  Score=62.78  Aligned_cols=75  Identities=20%  Similarity=0.225  Sum_probs=56.7

Q ss_pred             EEEEecCcccc--HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686          10 VWICMELMATC--FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus        10 ~~lv~E~~~gs--L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      -.|||||++..  -.-.|.  ...+.......+..++++.+.-|-...|+||+||+.-|||+. ++.+.++|||.+....
T Consensus       141 nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         141 NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            46999999842  122222  233444467788889999998887745999999999999999 8899999999886543

>KOG1235|consensus

Probab=97.65  E-value=0.00013  Score=68.42  Aligned_cols=81  Identities=17%  Similarity=0.175  Sum_probs=53.5

Q ss_pred             ccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC----CCCEEEec
Q psy3686           5 SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE----RGNIKLCD   79 (296)
Q Consensus         5 ~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~----~~~~kl~d   79 (296)
                      .-.+.-.|+||||+| .+.++-.-....++...+..-+.+...  +-|-. +|++|+|-+|.||++..    ++.+.+.|
T Consensus       272 ~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllD  348 (538)
T KOG1235|consen  272 DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLD  348 (538)
T ss_pred             hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHh-cCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence            344567899999997 333322111356666655544444322  22222 59999999999999983    67899999


Q ss_pred             cCCcccccC
Q psy3686          80 FGISGRLVD   88 (296)
Q Consensus        80 fg~~~~~~~   88 (296)
                      ||+...+..
T Consensus       349 hGl~~~is~  357 (538)
T KOG1235|consen  349 HGLYAVISH  357 (538)
T ss_pred             ccccccccH
Confidence            999876543

>KOG1035|consensus

Probab=97.13  E-value=0.0027  Score=63.80  Aligned_cols=167  Identities=20%  Similarity=0.236  Sum_probs=105.7

Q ss_pred             ecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC---cEEECCCCCEEEe--ccCCccccc
Q psy3686          14 MELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS---NILLDERGNIKLC--DFGISGRLV   87 (296)
Q Consensus        14 ~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~---Nil~~~~~~~kl~--dfg~~~~~~   87 (296)
                      .++|.+ ++...+.. -..++...++.+..+++.||.|+|+ +...|.-+...   +.-++..+.+.+.  ||+....+.
T Consensus       265 ~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~-~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~  342 (1351)
T KOG1035|consen  265 QEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHS-LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP  342 (1351)
T ss_pred             HhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHH-hccceeEEecccccccccCccceeecchhhhcccccCC
Confidence            456664 66666665 5788999999999999999999999 46666655555   3334445555555  888777665


Q ss_pred             CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCCCcch
Q psy3686          88 DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF  167 (296)
Q Consensus        88 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~  167 (296)
                      .............+.++|.....   ........|+|.+|..+..+..|..+-...    .....+       ++..  .
T Consensus       343 d~~~~~~~~~~~~~~~~e~~~~~---~~~~~r~~dL~~lgll~~~~~~~~~i~~~~----~~~~~~-------l~~~--~  406 (1351)
T KOG1035|consen  343 DNEKSFSDLLAEIRNADEDLKEN---TAKKSRLTDLWCLGLLLLQLSQGEDISEKS----AVPVSL-------LDVL--S  406 (1351)
T ss_pred             CcccchhhcCccccccccccccc---cchhhhhhHHHHHHHHHhhhhhcCcccccc----cchhhh-------hccc--c
Confidence            55444444555667777776432   223344579999999999998876443321    111111       1111  1


Q ss_pred             hHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         168 GRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       168 s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .....+++.+|+..+++        .+..+.+++.+.+.
T Consensus       407 ~~~~~d~~~~~~~~~~~--------~Rl~~~~ll~~~f~  437 (1351)
T KOG1035|consen  407 TSELLDALPKCLDEDSE--------ERLSALELLTHPFL  437 (1351)
T ss_pred             chhhhhhhhhhcchhhh--------hccchhhhhhchhc
Confidence            22678888899988887        44444444444443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.92  E-value=0.002  Score=57.26  Aligned_cols=74  Identities=22%  Similarity=0.262  Sum_probs=61.5

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ..-+.|++|++-+++|.-+     .....+++..++.+.+..+.-+..+..+-||++...||||+ .|+|.|+||-+++.
T Consensus       297 e~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3457789999998765432     23457788899999999998888877899999999999999 99999999999873

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.91  E-value=0.0018  Score=54.95  Aligned_cols=29  Identities=31%  Similarity=0.339  Sum_probs=25.6

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999997778899998763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.86  E-value=0.0053  Score=51.71  Aligned_cols=28  Identities=25%  Similarity=0.438  Sum_probs=25.1

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .++|+|++|.||+++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2268|consensus

Probab=96.80  E-value=0.0013  Score=57.66  Aligned_cols=71  Identities=21%  Similarity=0.308  Sum_probs=52.5

Q ss_pred             ccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           5 SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         5 ~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+.+..++|||++.| .|.++-+-    .+..   .+...+..-+.-|-. +|+||||..--||++..++.++++||-..
T Consensus       178 iD~~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  178 IDHNRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             ccccceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHHH-cCceecccchheeEEecCCCEEEeechHh
Confidence            356778999999998 77665432    2222   334444445555666 79999999999999999999999999644

>KOG0576|consensus

Probab=96.74  E-value=0.00013  Score=68.65  Aligned_cols=129  Identities=24%  Similarity=0.301  Sum_probs=91.8

Q ss_pred             CCCccCCeEEEEecCccc--cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g--sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ..+.-+.+.+++|+++.+  +-..........+.+-+...+.+.-++++++||+. --+|+|    ||+... +..++.+
T Consensus       301 ~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~  374 (829)
T KOG0576|consen  301 EDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLD  374 (829)
T ss_pred             ccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-ccccccc
Confidence            456677889999999984  22222111122344455566677777889999984 458888    666544 7789999


Q ss_pred             cCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3686          80 FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK  141 (296)
Q Consensus        80 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~  141 (296)
                      |+....+..........++..++|||+...     ..+....|.|++|.-..++.-|..|-.
T Consensus       375 ~~v~~~L~~~~~~~t~~~~~~~~~pev~~~-----~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  375 FAVPPQLTRTMKPRTAIGTPEPLAPEVIQE-----NTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCCcccCcccccccCCCCCCCCCchhhcc-----cccccCCCccCCCcchhhcCCCCCCCC
Confidence            999877766656667789999999998843     367778899999987667766666543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.63  E-value=0.004  Score=50.82  Aligned_cols=74  Identities=22%  Similarity=0.257  Sum_probs=57.4

Q ss_pred             EEEecCcc-ccHHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          11 WICMELMA-TCFDRL---LKRLHVSVPEPICGKITLSTVKALHYLKETH--GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        11 ~lv~E~~~-gsL~~~---l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ++|+||.+ +++...   +.. -...++..+.+|+.+++..+.+|+...  .+.-.|++++|+-++.++++|++|...+.
T Consensus        32 ~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   32 FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            56889998 555421   111 234689999999999999999998611  37778999999999999999999998664


Q ss_pred             c
Q psy3686          85 R   85 (296)
Q Consensus        85 ~   85 (296)
                      .
T Consensus       111 ~  111 (188)
T PF12260_consen  111 V  111 (188)
T ss_pred             h
Confidence            3

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1826|consensus

Probab=96.17  E-value=0.00055  Score=70.45  Aligned_cols=131  Identities=9%  Similarity=0.005  Sum_probs=95.7

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCC----ceeCCCCCCcEEECCCCCEEEe
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHG----VIHRDVKPSNILLDERGNIKLC   78 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~----ivH~dlkp~Nil~~~~~~~kl~   78 (296)
                      +...|++++|+. |.+.+++-+.   ...+.+.-+.....+.+.+..-+|+..|    .+|++|++.|.+|..+..+++.
T Consensus      1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred             ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence            445677888998 6888888654   2345555555555555666666666433    5899999999999999999999


Q ss_pred             ccCCccccc-CCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3686          79 DFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD  142 (296)
Q Consensus        79 dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  142 (296)
                      ++|+.+... .....+...+++.|+.+++.     ..-.++.++|+|..|+.+|....|..+|-.
T Consensus      1383 k~gLdKIknp~~sf~Gl~l~sp~~v~qli~-----N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1383 KGGLDKIKNPVLSFFGLELCSPIYVLQLIK-----NEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred             ccccccccCchHhhhhhhhCCHHHHHHHHH-----HHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence            999998322 22334445677788888887     344677779999999999998888777643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.35  E-value=0.035  Score=48.76  Aligned_cols=29  Identities=31%  Similarity=0.428  Sum_probs=26.0

Q ss_pred             CceeCCCCCCcEEECCC----CCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDER----GNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~----~~~kl~dfg~~~   84 (296)
                      +++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            68999999999999875    889999998773

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.31  E-value=0.02  Score=48.23  Aligned_cols=29  Identities=28%  Similarity=0.584  Sum_probs=25.8

Q ss_pred             CceeCCCCCCcEEECC-CCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDE-RGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~   84 (296)
                      +++|+|+.+.|||++. ++.+.|+||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999998 5789999998763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PLN02876 acyl-CoA dehydrogenase

Probab=95.15  E-value=0.043  Score=55.17  Aligned_cols=30  Identities=23%  Similarity=0.524  Sum_probs=24.1

Q ss_pred             CceeCCCCCCcEEECCC-CC-EEEeccCCccc
Q psy3686          56 GVIHRDVKPSNILLDER-GN-IKLCDFGISGR   85 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~-~~-~kl~dfg~~~~   85 (296)
                      .+||+|+++.||+++.+ +. +-|.||.++..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            49999999999999853 34 57999988753

>KOG2270|consensus

Probab=94.95  E-value=0.047  Score=48.94  Aligned_cols=74  Identities=19%  Similarity=0.262  Sum_probs=59.6

Q ss_pred             EEEEecCccc--cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686          10 VWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus        10 ~~lv~E~~~g--sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      -.|||+|+++  =-.-.|+  ...++...+..+-.|++.-+.-|.+..++||.||+--|+|+ .+|.+.++|.+.+...
T Consensus       239 hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  239 HVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             ceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccC
Confidence            4799999984  2222333  56788888999999999999999887799999999999998 5688999998876543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.84  E-value=0.044  Score=46.29  Aligned_cols=28  Identities=29%  Similarity=0.463  Sum_probs=24.4

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      +++|+|+++.||+++..+..-|+||+.+
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            5899999999999987665679999876

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.80  E-value=0.049  Score=47.98  Aligned_cols=29  Identities=38%  Similarity=0.613  Sum_probs=26.1

Q ss_pred             CCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          55 HGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        55 ~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+++|+|+++.||+++.++.+.|+||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            37999999999999998887789999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.64  E-value=0.079  Score=46.57  Aligned_cols=28  Identities=32%  Similarity=0.558  Sum_probs=24.7

Q ss_pred             CCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          55 HGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        55 ~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .+++|||+++.||+++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            37899999999999987 67899999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.54  E-value=0.058  Score=46.67  Aligned_cols=52  Identities=25%  Similarity=0.380  Sum_probs=38.9

Q ss_pred             HHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686          34 EPICGKITLSTVKALHYLKET-HGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus        34 ~~~~~~i~~qi~~~L~~LH~~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ...+...+..+-.++.-++.. .-++|+|+.|.|++.+..+.++|+||..|..
T Consensus       131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            344444555555666666552 2489999999999999999999999988743

>PRK05231 homoserine kinase; Provisional

Probab=94.41  E-value=0.11  Score=45.90  Aligned_cols=29  Identities=31%  Similarity=0.444  Sum_probs=25.2

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      |++|+|+++.||+++.+...-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            89999999999999866656899998763

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=94.09  E-value=0.23  Score=40.89  Aligned_cols=68  Identities=24%  Similarity=0.386  Sum_probs=45.8

Q ss_pred             ccCCeEEEEecCcc---c----cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC----
Q psy3686           5 SKESDVWICMELMA---T----CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG----   73 (296)
Q Consensus         5 ~~~~~~~lv~E~~~---g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~----   73 (296)
                      .++-.+=+|+|.+.   |    ||.+++.  ...+++ .+...+.   .-..||-+ ++|+.+||+|.||++....    
T Consensus        87 eT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~-~~Iv~~dl~~~NIv~~~~~~~~~  159 (199)
T PF10707_consen   87 ETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLD-HHIVIRDLNPHNIVVQRRDSGEF  159 (199)
T ss_pred             ecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHH-cCCeecCCCcccEEEEecCCCce
Confidence            34445566777663   3    8999996  456666 4444443   44566777 6999999999999995432    


Q ss_pred             CEEEec
Q psy3686          74 NIKLCD   79 (296)
Q Consensus        74 ~~kl~d   79 (296)
                      .+.|+|
T Consensus       160 ~lvlID  165 (199)
T PF10707_consen  160 RLVLID  165 (199)
T ss_pred             EEEEEe
Confidence            477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.06  E-value=0.046  Score=44.44  Aligned_cols=28  Identities=29%  Similarity=0.604  Sum_probs=24.8

Q ss_pred             ceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686          57 VIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus        57 ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .+|+|+.|.||+++.++ ++|+||+.+..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            69999999999998777 99999998853

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.03  E-value=0.047  Score=45.25  Aligned_cols=30  Identities=40%  Similarity=0.753  Sum_probs=21.3

Q ss_pred             CceeCCCCCCcEEE-CCCCCEEEeccCCccc
Q psy3686          56 GVIHRDVKPSNILL-DERGNIKLCDFGISGR   85 (296)
Q Consensus        56 ~ivH~dlkp~Nil~-~~~~~~kl~dfg~~~~   85 (296)
                      .++|+||.+.||++ ..++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 8889999999988743

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.00  E-value=0.032  Score=46.43  Aligned_cols=29  Identities=45%  Similarity=0.771  Sum_probs=20.4

Q ss_pred             CceeCCCCCCcEEEC-CCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLD-ERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~-~~~~~kl~dfg~~~   84 (296)
                      .++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             EEEEeccccccceeeeccceeEEEecccce
Confidence            599999999999999 66667899998763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.86  E-value=0.12  Score=45.99  Aligned_cols=64  Identities=19%  Similarity=0.155  Sum_probs=38.5

Q ss_pred             eEEEEecCccccHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---HHhCCceeCCCCCCcEEECCC
Q psy3686           9 DVWICMELMATCFDRLLKRL----HVSVPEPICGKITLSTVKALHYL---KETHGVIHRDVKPSNILLDER   72 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~~ivH~dlkp~Nil~~~~   72 (296)
                      .-.||+++..++-.++-...    +...-..-++.+..||+.-.--+   -...+++|-||||+|||+-++
T Consensus       245 GnIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  245 GNIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             CcEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence            34588888875433332221    33334456667788876543212   112479999999999999443

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.61  E-value=0.048  Score=47.63  Aligned_cols=29  Identities=34%  Similarity=0.466  Sum_probs=25.9

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            79999999999999987777899998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.23  E-value=0.067  Score=45.76  Aligned_cols=29  Identities=28%  Similarity=0.548  Sum_probs=25.3

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .++|+|+.|.||+++.++ +.|+||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            489999999999999877 78999988743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.03  E-value=0.17  Score=44.60  Aligned_cols=29  Identities=21%  Similarity=0.285  Sum_probs=26.6

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +++|+|+.++|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.02  E-value=0.29  Score=43.39  Aligned_cols=66  Identities=18%  Similarity=0.140  Sum_probs=41.8

Q ss_pred             CCeEEEEecCcccc-----HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCcEEECCCC
Q psy3686           7 ESDVWICMELMATC-----FDRLLKRLHVSVPEPICGKITLSTVKALHYLKE---THGVIHRDVKPSNILLDERG   73 (296)
Q Consensus         7 ~~~~~lv~E~~~gs-----L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~~ivH~dlkp~Nil~~~~~   73 (296)
                      +..-.||+++..++     +....+. +..--..-++.+..||+.-.-.+-+   ..+++|-||||+|||+-++.
T Consensus       247 drGnIIIfPLArcSadkv~~~~~~e~-GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        247 DRGNIIIFPLARCSADKVTEENAAEL-GFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             cCCcEEEEehhhcccccCCHHHHHHc-CCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            33556888887653     3333321 3333455677888888765544422   23799999999999995443

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=92.46  E-value=0.24  Score=39.93  Aligned_cols=66  Identities=17%  Similarity=0.180  Sum_probs=43.7

Q ss_pred             EEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCC-CCcEEECCCCCEEEeccCCcc
Q psy3686          10 VWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK-PSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        10 ~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlk-p~Nil~~~~~~~kl~dfg~~~   84 (296)
                      -++.|||+.| .|.+....  .  +.+.+.    .++..---|-. .||-|+.|+ |...++.+++.+.|+||..|.
T Consensus        87 ~~i~me~i~G~~L~~~~~~--~--~rk~l~----~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIG--G--DRKHLL----RVLEKAYKLDR-LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhhcCcchhhhhhc--c--cHHHHH----HHHHHHHHHHH-hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            3566999998 88776642  1  333333    34444333444 699999998 555555566699999998875

>KOG1236|consensus

Probab=92.22  E-value=0.42  Score=43.64  Aligned_cols=61  Identities=25%  Similarity=0.331  Sum_probs=46.8

Q ss_pred             eEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC
Q psy3686           9 DVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE   71 (296)
Q Consensus         9 ~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~   71 (296)
                      ...||-+|..| ++..++.  ....+++.+.+++.-.+.||--+--..+++|.|++|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~--~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVK--WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhh--cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            34566677778 9999997  4567777778888777777665554458999999999999953

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.21  E-value=0.15  Score=42.70  Aligned_cols=39  Identities=31%  Similarity=0.439  Sum_probs=32.4

Q ss_pred             HHHHHHHHHhC-CceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          45 VKALHYLKETH-GVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        45 ~~~L~~LH~~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      +.+|.-.|+.+ +.+|||..|+||+-+..|.+||.|=+..
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            45677778533 7999999999999999999999997643

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.76  E-value=0.28  Score=43.73  Aligned_cols=27  Identities=33%  Similarity=0.685  Sum_probs=24.7

Q ss_pred             ceeCCCCCCcEEECCCCC-EEEeccCCc
Q psy3686          57 VIHRDVKPSNILLDERGN-IKLCDFGIS   83 (296)
Q Consensus        57 ivH~dlkp~Nil~~~~~~-~kl~dfg~~   83 (296)
                      +||+|+.|.||+++.+.. +.++||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            999999999999998885 889999876

>PLN02236 choline kinase

Probab=91.60  E-value=0.25  Score=44.41  Aligned_cols=29  Identities=31%  Similarity=0.610  Sum_probs=25.5

Q ss_pred             CceeCCCCCCcEEECC-CCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDE-RGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~   84 (296)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999976 4689999998774

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.42  E-value=0.18  Score=41.28  Aligned_cols=29  Identities=28%  Similarity=0.429  Sum_probs=24.5

Q ss_pred             CceeCCCCCCcEEECCCC-----CEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERG-----NIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~-----~~kl~dfg~~~   84 (296)
                      .++|||+.+.||++..++     .+.++||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            689999999999997543     58999998763

subfamily of choline kinases

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.19  E-value=0.17  Score=44.00  Aligned_cols=29  Identities=31%  Similarity=0.555  Sum_probs=24.5

Q ss_pred             CceeCCCCCCcEEECCCCC-EEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGN-IKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~-~kl~dfg~~~   84 (296)
                      .++|+|+++.||+++.++. .-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            4899999999999987565 4699999874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093|consensus

Probab=90.63  E-value=0.46  Score=44.65  Aligned_cols=68  Identities=21%  Similarity=0.120  Sum_probs=40.2

Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCCC---------CcchhHHHHHHHHhccCCChHHHh
Q psy3686         119 IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN---------DPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       119 ~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~~---------~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      +++|||++|.++.++.-|..-|... ...+....+.+-.......         .-.++..+..+..+|+-..|..|+
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~-~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~  186 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAEL-TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP  186 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHH-HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence            5999999999999999888776552 2222222222211100000         011456677778888888887554

>PRK06148 hypothetical protein; Provisional

Probab=89.59  E-value=0.45  Score=49.02  Aligned_cols=30  Identities=43%  Similarity=0.601  Sum_probs=25.4

Q ss_pred             CceeCCCCCCcEEECCCC--CEE-EeccCCccc
Q psy3686          56 GVIHRDVKPSNILLDERG--NIK-LCDFGISGR   85 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~--~~k-l~dfg~~~~   85 (296)
                      ++||+|+++.||+++.++  ++. |+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            799999999999998775  554 999997743

>PRK11768 serine/threonine protein kinase; Provisional

Probab=89.30  E-value=0.44  Score=42.45  Aligned_cols=27  Identities=26%  Similarity=0.356  Sum_probs=23.3

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      +++|+|+.+.||+++ + .+.|+||+-+.
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            789999999999995 4 57899998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=88.51  E-value=0.58  Score=41.75  Aligned_cols=29  Identities=28%  Similarity=0.559  Sum_probs=25.2

Q ss_pred             ceeCCCCCCcEEECC-CCCEEEeccCCccc
Q psy3686          57 VIHRDVKPSNILLDE-RGNIKLCDFGISGR   85 (296)
Q Consensus        57 ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~   85 (296)
                      ++|.|+.+.||+++. ++.++++||..+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999988743

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=88.17  E-value=0.44  Score=42.17  Aligned_cols=30  Identities=20%  Similarity=0.458  Sum_probs=27.1

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      .++|||+++.||+++..+-+-++||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            489999999999999988899999998854

>KOG2464|consensus

Probab=86.78  E-value=1.9  Score=36.79  Aligned_cols=60  Identities=20%  Similarity=0.212  Sum_probs=46.9

Q ss_pred             eEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC
Q psy3686           9 DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG   73 (296)
Q Consensus         9 ~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~   73 (296)
                      +..++++.....|..+     ...+..++..++.|+...+.-...+.++.|+|+.+.||++...+
T Consensus       116 ~~~~~~~~~~~~l~~~-----~~~~~~~~~si~~q~~~~l~i~~~~~~~~hrdl~~gnili~k~~  175 (246)
T KOG2464|consen  116 YLALVVEKGGLGLEHY-----KLESKNQALSIFWQLVLSLAIAEKSLGFEHRDLHLGNILIKKTG  175 (246)
T ss_pred             eeEEEEecCCccceec-----ccccHHHHHHHHHHHHHHHHHhhhhhcccccccCcCcEEEeccc
Confidence            4445555554444443     34567888999999999999999888999999999999998865

>COG4499 Predicted membrane protein [Function unknown]

Probab=86.77  E-value=5.7  Score=35.70  Aligned_cols=104  Identities=16%  Similarity=0.181  Sum_probs=66.0

Q ss_pred             cCCeEEEEecCccc--cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~g--sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      +++.+.|-.+-...  ++..+-     .+.....++++.|.+..|.-+..  .-.|-=|.|+||+++.++.+.+.-+|+-
T Consensus        59 ~~Ds~vIsy~i~~~~~~F~~~k-----~~~k~~Klr~a~~~I~~l~e~~~--tr~~~~laPeNilf~~~l~p~~vH~Glk  131 (434)
T COG4499          59 DNDSFVISYPIPEAAKSFASAK-----RKEKTRKLRLALQNIATLSELNN--TRYTFFLAPENILFDGGLTPFFVHRGLK  131 (434)
T ss_pred             cCceeEEEecCccccchHHHHH-----HHHHHHHHHHHHHHHHHHHHhhc--cceeEEecchheEEcCCCceEEEecchh
Confidence            34444455554442  443332     34556677778888877776543  4677789999999999999999999875


Q ss_pred             ccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD  142 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  142 (296)
                      ..+.           |.=+.||.+               .-.+-+++..++.|..+|..
T Consensus       132 ~~lp-----------Pye~tee~f---------------~~~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         132 NSLP-----------PYEMTEERF---------------LKEYKALAIYAFNGKFSFES  164 (434)
T ss_pred             ccCC-----------CCCCCHHHH---------------HHHHHHHHHHHHcCCccHHH
Confidence            3321           111233333               23466777788888888853

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=86.48  E-value=1.3  Score=38.50  Aligned_cols=28  Identities=32%  Similarity=0.521  Sum_probs=23.4

Q ss_pred             CceeCCCCCCcEEECCC--C---CEEEeccCCc
Q psy3686          56 GVIHRDVKPSNILLDER--G---NIKLCDFGIS   83 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~--~---~~kl~dfg~~   83 (296)
                      -++|||++..|||+..+  |   .++++||.++
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~  248 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLA  248 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeeccccc
Confidence            38999999999999655  3   5899999766

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK12396 5-methylribose kinase; Reviewed

Probab=86.32  E-value=0.67  Score=42.35  Aligned_cols=33  Identities=15%  Similarity=0.455  Sum_probs=25.8

Q ss_pred             HHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686          50 YLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus        50 ~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ||-+...++||||+|.|||++.+ .+|++|..++
T Consensus       222 F~~~~~aLlHGDlHtGSI~v~~~-~~kvIDpEFA  254 (409)
T PRK12396        222 FMTNAQALIHGDLHTGSVFVKND-STKVIDPEFA  254 (409)
T ss_pred             HHhcchhhccCcCCCCCEEecCC-ceEEEccccc
Confidence            33333469999999999999875 4899997666

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	296
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-67
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-51
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-44
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-42
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-39
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-35
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-35
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-34
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-32
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-31
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-31
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-31
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-31
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-31
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-31
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-21
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-07
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-07
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-06
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-05
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  252 bits (643), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 116/160 (72%), Positives = 137/160 (85%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPSNI
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           LLDERG IKLCDFGISGRLVD KA+ ++AGCAAYMAPERI+PP+P KPDYDIRADVWSLG
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF 167
           I+LVELATG+FPYK+CK DFEVL++VL + PP LP    F
Sbjct: 217 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  199 bits (506), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 101/190 (53%), Positives = 130/190 (68%), Gaps = 11/190 (5%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVS----VPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +E D WICMELM+T FD+  K ++      +PE I GKITL+TVKAL++LKE   +IHRD
Sbjct: 92  REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+ P+  +  YD+R+
Sbjct: 152 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID-PSASRQGYDVRS 210
Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN------DPLFGRTIKASI 175
           DVWSLGITL ELATG FPY      F+ L++V+   PP L N       P F   +   +
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL 270
Query: 176 AKDNGRSTEF 185
            KD  +  ++
Sbjct: 271 TKDESKRPKY 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  174 bits (440), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 85/162 (52%), Positives = 110/162 (67%), Gaps = 4/162 (2%)
Query: 6   KESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICMELM T  D+  K++     ++PE I GKI +S VKAL +L     VIHRDV
Sbjct: 121 REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 180
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L++  G +K+CDFGISG LVDS A+T +AGC  YMAPERI P   QK  Y +++D
Sbjct: 181 KPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK-GYSVKSD 239
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +WSLGIT++ELA   FPY      F+ L +V+ +  P LP D
Sbjct: 240 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 281

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 83/162 (51%), Positives = 108/162 (66%), Gaps = 4/162 (2%)
Query: 6   KESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICMELM T  D+  K++     ++PE I GKI +S VKAL +L     VIHRDV
Sbjct: 77  REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L++  G +K+CDFGISG LVD  A+  +AGC  YMAPERI P   QK  Y +++D
Sbjct: 137 KPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK-GYSVKSD 195
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +WSLGIT++ELA   FPY      F+ L +V+ +  P LP D
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 80/162 (49%), Positives = 103/162 (63%), Gaps = 4/162 (2%)
Query: 6   KESDVWICMELMATCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWIC EL  T  D+  K++     ++PE I GKI +S VKAL +L     VIHRDV
Sbjct: 104 REGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 163
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L++  G +K CDFGISG LVD  A+  +AGC  Y APERI P   QK  Y +++D
Sbjct: 164 KPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK-GYSVKSD 222
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +WSLGIT +ELA   FPY      F+ L +V+ +  P LP D
Sbjct: 223 IWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 264

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 70/161 (43%), Positives = 108/161 (67%), Gaps = 11/161 (6%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 95  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 153
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 154 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 207
Query: 126 LGITLVELATGEFPY---KDCKCDFEVLSRVLNDAPPCLPN 163
           +G++LVE+A G +P          FE+L  ++N+ PP LP+
Sbjct: 208 MGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPS 248

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 73/167 (43%), Positives = 111/167 (66%), Gaps = 17/167 (10%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 188
Query: 126 LGITLVELATGEFPY--KDCKCD-------FEVLSRVLNDAPPCLPN 163
           +G++LVE+A G +P    D K D       FE+L  ++N+ PP LP+
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPS 235

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 69/158 (43%), Positives = 108/158 (68%), Gaps = 9/158 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 79  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 137
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+D  A  +  G  +YM+PER+     Q   Y +++D+WS
Sbjct: 138 NILVNSRGEIKLCDFGVSGQLIDEMA-NEFVGTRSYMSPERL-----QGTHYSVQSDIWS 191
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           +G++LVE+A G +P +     FE+L  ++N+ PP LP+
Sbjct: 192 MGLSLVEMAVGRYP-RPPMAIFELLDYIVNEPPPKLPS 228

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  133 bits (335), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 138 DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 196
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 197 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 250
Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 251 MGLSLVEMAVGRYP 264

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 162 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 215
Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 216 MGLSLVEMAVGRYP 229

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 188
Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 189 MGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 188
Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 189 MGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 188
Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 189 MGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 62/134 (46%), Positives = 95/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKPS
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWS 188
Query: 126 LGITLVELATGEFP 139
           +G++LVE+A G +P
Sbjct: 189 MGLSLVEMAVGRYP 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 63/134 (47%), Positives = 94/134 (70%), Gaps = 8/134 (5%)
Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ICME M     D++LK     +PE I GK++++ ++ L YL+E H ++HRDVKPS
Sbjct: 86  DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 144
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NIL++ RG IKLCDFG+SG+L+DS A +   G  +YMAPER+     Q   Y +++D+WS
Sbjct: 145 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMAPERL-----QGTHYSVQSDIWS 198
Query: 126 LGITLVELATGEFP 139
           +G++LVELA G +P
Sbjct: 199 MGLSLVELAVGRYP 212

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 97/178 (54%), Gaps = 15/178 (8%)
Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           K + +WI ME +   +  D LLK     + E     I    +K L YL  +   IHRD+K
Sbjct: 88  KSTKLWIIMEYLGGGSALD-LLKP--GPLEETYIATILREILKGLDYL-HSERKIHRDIK 143
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            +N+LL E+G++KL DFG++G+L D++  R    G   +MAPE I     ++  YD +AD
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-----KQSAYDFKAD 198
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP--NDPLFGRTIKASIAKD 178
           +WSLGIT +ELA GE P  D      VL  +  ++PP L   +   F   ++A + KD
Sbjct: 199 IWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKD 255

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/171 (38%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           K S +WI ME +       L R      E     +    +K L YL  +   IHRD+K +
Sbjct: 92  KGSKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYL-HSEKKIHRDIKAA 149
Query: 66  NILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+LL E+G++KL DFG++G+L D++  R    G   +MAPE I     Q+  YD +AD+W
Sbjct: 150 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----QQSAYDSKADIW 204
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASI 175
           SLGIT +ELA GE P  D      VL  +  + PP L  D  F ++ K  I
Sbjct: 205 SLGITAIELAKGEPPNSDMHP-MRVLFLIPKNNPPTLVGD--FTKSFKEFI 252

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/161 (36%), Positives = 87/161 (54%), Gaps = 17/161 (10%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPI----CGKITLSTVKALHYLKETHGVIHRD 61
           K++ +WI ME +          L +  P P+       I    +K L YL  +   IHRD
Sbjct: 91  KDTKLWIIMEYLGGG-----SALDLLEPGPLDETQIATILREILKGLDYL-HSEKKIHRD 144
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +K +N+LL E G +KL DFG++G+L D++  R    G   +MAPE I     ++  YD +
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-----KQSAYDSK 199
Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           AD+WSLGIT +ELA GE P+ +     +VL  +  + PP L
Sbjct: 200 ADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTL 239

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/161 (36%), Positives = 87/161 (54%), Gaps = 17/161 (10%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPI----CGKITLSTVKALHYLKETHGVIHRD 61
           K++ +WI ME +          L +  P P+       I    +K L YL  +   IHRD
Sbjct: 96  KDTKLWIIMEYLGGG-----SALDLLEPGPLDETQIATILREILKGLDYL-HSEKKIHRD 149
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +K +N+LL E G +KL DFG++G+L D++  R    G   +MAPE I     ++  YD +
Sbjct: 150 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDSK 204
Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           AD+WSLGIT +ELA GE P+ +     +VL  +  + PP L
Sbjct: 205 ADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTL 244

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/164 (35%), Positives = 88/164 (53%), Gaps = 17/164 (10%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPI----CGKITLSTVKALHYLKETHGVIHRD 61
           K++ +WI ME +          L +  P P+       I    +K L YL  +   IHRD
Sbjct: 76  KDTKLWIIMEYLGGG-----SALDLLEPGPLDETQIATILREILKGLDYL-HSEKKIHRD 129
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +K +N+LL E G +KL DFG++G+L D++  R    G   +MAPE I     ++  YD +
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDSK 184
Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           AD+WSLGIT +ELA GE P+ +     +VL  +  + PP L  +
Sbjct: 185 ADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTLEGN 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/164 (35%), Positives = 88/164 (53%), Gaps = 17/164 (10%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPI----CGKITLSTVKALHYLKETHGVIHRD 61
           K++ +WI ME +          L +  P P+       I    +K L YL  +   IHRD
Sbjct: 76  KDTKLWIIMEYLGGG-----SALDLLEPGPLDETQIATILREILKGLDYL-HSEKKIHRD 129
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +K +N+LL E G +KL DFG++G+L D++  R    G   +MAPE I     ++  YD +
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-----KQSAYDSK 184
Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           AD+WSLGIT +ELA GE P+ +     +VL  +  + PP L  +
Sbjct: 185 ADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTLEGN 227

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/140 (40%), Positives = 79/140 (56%), Gaps = 8/140 (5%)
Query: 6   KESDVWICMEL-MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           K +D+WI ME   A     +++  + ++ E     I  ST+K L YL      IHRD+K 
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-IHRDIKA 153
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
            NILL+  G+ KL DFG++G+L D  A R    G   +MAPE I     Q+  Y+  AD+
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-----QEIGYNCVADI 208
Query: 124 WSLGITLVELATGEFPYKDC 143
           WSLGIT +E+A G+ PY D 
Sbjct: 209 WSLGITAIEMAEGKPPYADI 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/168 (36%), Positives = 90/168 (53%), Gaps = 22/168 (13%)
Query: 9   DVWICMELMA--TCFDRLLKRL-----HVS--VPEPICGKITLSTVKALHYLKETHGVIH 59
           ++W+ M+L++  +  D ++K +     H S  + E     I    ++ L YL + +G IH
Sbjct: 87  ELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIH 144
Query: 60  RDVKPSNILLDERGNIKLCDFGIS------GRLVDSKARTKNAGCAAYMAPERIEPPNPQ 113
           RDVK  NILL E G++++ DFG+S      G +  +K R    G   +MAPE +E    Q
Sbjct: 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME----Q 200
Query: 114 KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
              YD +AD+WS GIT +ELATG  PY       +VL   L + PP L
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSL 247

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/168 (36%), Positives = 90/168 (53%), Gaps = 22/168 (13%)
Query: 9   DVWICMELMA--TCFDRLLKRL-----HVS--VPEPICGKITLSTVKALHYLKETHGVIH 59
           ++W+ M+L++  +  D ++K +     H S  + E     I    ++ L YL + +G IH
Sbjct: 82  ELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIH 139
Query: 60  RDVKPSNILLDERGNIKLCDFGIS------GRLVDSKARTKNAGCAAYMAPERIEPPNPQ 113
           RDVK  NILL E G++++ DFG+S      G +  +K R    G   +MAPE +E    Q
Sbjct: 140 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME----Q 195
Query: 114 KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
              YD +AD+WS GIT +ELATG  PY       +VL   L + PP L
Sbjct: 196 VRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSL 242

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 89/173 (51%), Gaps = 4/173 (2%)
Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+++WI +E  A    D ++  L   + E     +   T+ AL+YL + + +IHRD+K  
Sbjct: 106 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAG 164
Query: 66  NILLDERGNIKLCDFGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NIL    G+IKL DFG+S +   + + R    G   +MAPE +     +   YD +ADVW
Sbjct: 165 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 224
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           SLGITL+E+A  E P+ +      VL ++    PP L     +    K  + K
Sbjct: 225 SLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 88/173 (50%), Gaps = 4/173 (2%)
Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+++WI +E  A    D ++  L   + E     +   T+ AL+YL + + +IHRD+K  
Sbjct: 106 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAG 164
Query: 66  NILLDERGNIKLCDFGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NIL    G+IKL DFG+S +     + R    G   +MAPE +     +   YD +ADVW
Sbjct: 165 NILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 224
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           SLGITL+E+A  E P+ +      VL ++    PP L     +    K  + K
Sbjct: 225 SLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 88/173 (50%), Gaps = 4/173 (2%)
Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+++WI +E  A    D ++  L   + E     +   T+ AL+YL + + +IHRD+K  
Sbjct: 106 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAG 164
Query: 66  NILLDERGNIKLCDFGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NIL    G+IKL DFG+S +     + R    G   +MAPE +     +   YD +ADVW
Sbjct: 165 NILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVW 224
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           SLGITL+E+A  E P+ +      VL ++    PP L     +    K  + K
Sbjct: 225 SLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 4/154 (2%)
Query: 10  VWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           +WI +E       D ++  L   + EP    +    ++AL++L  +  +IHRD+K  N+L
Sbjct: 91  LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL-HSKRIIHRDLKAGNVL 149
Query: 69  LDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           +   G+I+L DFG+S + L   + R    G   +MAPE +     +   YD +AD+WSLG
Sbjct: 150 MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
Query: 128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           ITL+E+A  E P+ +      VL ++    PP L
Sbjct: 210 ITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTL 242

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 4/154 (2%)
Query: 10  VWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           +WI +E       D ++  L   + EP    +    ++AL++L  +  +IHRD+K  N+L
Sbjct: 83  LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL-HSKRIIHRDLKAGNVL 141
Query: 69  LDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           +   G+I+L DFG+S + L   + R    G   +MAPE +     +   YD +AD+WSLG
Sbjct: 142 MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 201
Query: 128 ITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           ITL+E+A  E P+ +      VL ++    PP L
Sbjct: 202 ITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTL 234

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 71/141 (50%), Gaps = 4/141 (2%)
Query: 2   SPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +P   +  +W+ ME     +  D +      ++ E     I    ++ L +L + H VIH
Sbjct: 94  NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIH 152
Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYD 118
           RD+K  N+LL E   +KL DFG+S +L  +  R     G   +MAPE I         YD
Sbjct: 153 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 119 IRADVWSLGITLVELATGEFP 139
            ++D+WSLGIT +E+A G  P
Sbjct: 213 FKSDLWSLGITAIEMAEGAPP 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + LS ++AL YL    GVIHRD+K  +I
Sbjct: 116 ELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYL-HNQGVIHRDIKSDSI 172
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G IKL DFG   ++     + K   G   +MAPE I      +  Y    D+WSL
Sbjct: 173 LLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS-----RLPYGTEVDIWSL 227
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
           GI ++E+  GE PY + +   + + R+ +  PP
Sbjct: 228 GIMVIEMIDGEPPYFN-EPPLQAMRRIRDSLPP 259

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 66/134 (49%), Gaps = 3/134 (2%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           E D+++ ++L+     R   + +V   E          V AL YL +   +IHRD+KP N
Sbjct: 87  EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL-QNQRIIHRDMKPDN 145
Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDE G++ + DF I+  L      T  AG   YMAPE     + +   Y    D WSL
Sbjct: 146 ILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS--SRKGAGYSFAVDWWSL 203
Query: 127 GITLVELATGEFPY 140
           G+T  EL  G  PY
Sbjct: 204 GVTAYELLRGRRPY 217

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ ++AL  L    GVIHRD+K  +I
Sbjct: 222 ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSI 278
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K   G   +MAPE I      +  Y    D+WSL
Sbjct: 279 LLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-----RLPYGPEVDIWSL 333
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 334 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKN 369

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 15/138 (10%)
Query: 20  CFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---I 75
            FD ++ R+  + V   +  K  LS V  LH     H ++HRD+KP N+LL+ +     I
Sbjct: 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALI 178
Query: 76  KLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           K+ DFG+S    + K   +  G A Y+APE +      +  YD + DVWS+G+ L  L  
Sbjct: 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVL------RKKYDEKCDVWSIGVILFILLA 232
Query: 136 GEFPYKDCKCDFEVLSRV 153
           G  P+   + D E+L +V
Sbjct: 233 GYPPF-GGQTDQEILRKV 249

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ ++AL  L    GVIHRD+K  +I
Sbjct: 145 ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSI 201
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K   G   +MAPE I      +  Y    D+WSL
Sbjct: 202 LLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-----RLPYGPEVDIWSL 256
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 257 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKN 292

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 27/158 (17%)
Query: 10  VWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           V++  ELM      D++L++   S  E     +  +  K + YL    GV+HRD+KPSNI
Sbjct: 91  VYVVTELMKGGELLDKILRQKFFSERE--ASAVLFTITKTVEYL-HAQGVVHRDLKPSNI 147
Query: 68  L-LDERGN---IKLCDFGISGRLVDSKARTKNA------GCAAYMAPERIEPPNPQKPDY 117
           L +DE GN   I++CDFG + +L     R +N         A ++APE +E     +  Y
Sbjct: 148 LYVDESGNPESIRICDFGFAKQL-----RAENGLLMTPCYTANFVAPEVLE-----RQGY 197
Query: 118 DIRADVWSLGITLVELATGEFPYKDCKCDF--EVLSRV 153
           D   D+WSLG+ L  + TG  P+ +   D   E+L+R+
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ ++AL  L    GVIHRD+K  +I
Sbjct: 102 ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSI 158
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K   G   +MAPE I      +  Y    D+WSL
Sbjct: 159 LLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-----RLPYGPEVDIWSL 213
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 214 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKN 249

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ ++AL  L    GVIHRD+K  +I
Sbjct: 100 ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSI 156
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K   G   +MAPE I      +  Y    D+WSL
Sbjct: 157 LLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-----RLPYGPEVDIWSL 211
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 212 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKN 247

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ ++AL  L    GVIHRD+K  +I
Sbjct: 95  ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSI 151
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K   G   +MAPE I      +  Y    D+WSL
Sbjct: 152 LLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-----RLPYGPEVDIWSL 206
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 207 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKN 242

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME +       ++   H  + E     + L+ ++AL  L    GVIHRD+K  +I
Sbjct: 91  ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSI 147
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++     R K   G   +MAPE I      +  Y    D+WSL
Sbjct: 148 LLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-----RLPYGPEVDIWSL 202
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY + +   + +  + ++ PP L N
Sbjct: 203 GIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKN 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 53/87 (60%), Gaps = 6/87 (6%)
Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQK 114
           G+I+RD+KP NILLDE G+IKL DFG+S   +D + +  +  G   YMAPE +      +
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV-----NR 204
Query: 115 PDYDIRADVWSLGITLVELATGEFPYK 141
             +   AD WS G+ + E+ TG  P++
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 9   DVWICME-LMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++W+ ME L       ++ ++ ++  E     +  + ++AL YL    GVIHRD+K  +I
Sbjct: 116 ELWVLMEFLQGGALTDIVSQVRLN--EEQIATVCEAVLQALAYL-HAQGVIHRDIKSDSI 172
Query: 68  LLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           LL   G +KL DFG   ++  D   R    G   +MAPE I      +  Y    D+WSL
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVIS-----RSLYATEVDIWSL 227
Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           GI ++E+  GE PY       + + R+ +  PP L N
Sbjct: 228 GIMVIEMVDGEPPYF-SDSPVQAMKRLRDSPPPKLKN 263

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 53/87 (60%), Gaps = 6/87 (6%)
Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQK 114
           G+I+RD+KP NILLDE G+IKL DFG+S   +D + +  +  G   YMAPE +      +
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-----NR 200
Query: 115 PDYDIRADVWSLGITLVELATGEFPYK 141
             +   AD WS G+ + E+ TG  P++
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 53/87 (60%), Gaps = 6/87 (6%)
Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQK 114
           G+I+RD+KP NILLDE G+IKL DFG+S   +D + +  +  G   YMAPE +      +
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-----NR 200
Query: 115 PDYDIRADVWSLGITLVELATGEFPYK 141
             +   AD WS G+ + E+ TG  P++
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 53/87 (60%), Gaps = 6/87 (6%)
Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQK 114
           G+I+RD+KP NILLDE G+IKL DFG+S   +D + +  +  G   YMAPE +      +
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-----NR 201
Query: 115 PDYDIRADVWSLGITLVELATGEFPYK 141
             +   AD WS G+ + E+ TG  P++
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 70/134 (52%), Gaps = 8/134 (5%)
Query: 11  WICMELM--ATCFDRLLKRLHVSVPEP-ICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++  +LM     FD L +++ +S  E     +  L  + ALH L     ++HRD+KP NI
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENI 155
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE-PPNPQKPDYDIRADVWSL 126
           LLD+  NIKL DFG S +L   +   +  G  +Y+APE IE   N   P Y    D+WS 
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 216 GVIMYTLLAGSPPF 229

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +E   W+ ME        LL+     + E     +T   ++ L YL  +H +IHRDVK  
Sbjct: 125 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKAG 183
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NILL E G +KL DFG +  +  +       G   +MAPE I   +  +  YD + DVWS
Sbjct: 184 NILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAPEVILAMD--EGQYDGKVDVWS 238
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAP 158
           LGIT +ELA  + P  +      +     N++P
Sbjct: 239 LGITCIELAERKPPLFNMNAMSALYHIAQNESP 271

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 70/134 (52%), Gaps = 8/134 (5%)
Query: 11  WICMELM--ATCFDRLLKRLHVSVPEP-ICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++  +LM     FD L +++ +S  E     +  L  + ALH L     ++HRD+KP NI
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENI 142
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE-PPNPQKPDYDIRADVWSL 126
           LLD+  NIKL DFG S +L   +   +  G  +Y+APE IE   N   P Y    D+WS 
Sbjct: 143 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 203 GVIMYTLLAGSPPF 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 7/156 (4%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +E   W+ ME        LL+     + E     +T   ++ L YL  +H +IHRDVK  
Sbjct: 86  REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKAG 144
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NILL E G +KL DFG +  +  +       G   +MAPE I   +  +  YD + DVWS
Sbjct: 145 NILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMD--EGQYDGKVDVWS 199
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           LGIT +ELA  + P  +       L  +  +  P L
Sbjct: 200 LGITCIELAERKPPLFNMNA-MSALYHIAQNESPAL 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 69/134 (51%), Gaps = 8/134 (5%)
Query: 11  WICMELM--ATCFDRLLKRLHVSVPEP-ICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++  +LM     FD L +++ +S  E     +  L  + ALH L     ++HRD+KP NI
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENI 155
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE-PPNPQKPDYDIRADVWSL 126
           LLD+  NIKL DFG S +L   +      G  +Y+APE IE   N   P Y    D+WS 
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 216 GVIMYTLLAGSPPF 229

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 6   KESDVWICMELM-ATCFDRLLKRLHVS---VPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +++++ I +EL  A    R++K        +PE    K  +    AL ++  +  V+HRD
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM-HSRRVMHRD 161
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAPERIEPPNPQKPDYDI 119
           +KP+N+ +   G +KL D G+ GR   SK    ++  G   YM+PERI      +  Y+ 
Sbjct: 162 IKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPYYMSPERI-----HENGYNF 215
Query: 120 RADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAPPCLPND 164
           ++D+WSLG  L E+A  + P+   K +   L + +   D PP LP+D
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPSD 261

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 27/158 (17%)
Query: 10  VWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           V++  EL       D++L++   S  E     +  +  K + YL    GV+HRD+KPSNI
Sbjct: 91  VYVVTELXKGGELLDKILRQKFFSERE--ASAVLFTITKTVEYL-HAQGVVHRDLKPSNI 147
Query: 68  L-LDERGN---IKLCDFGISGRLVDSKARTKNA------GCAAYMAPERIEPPNPQKPDY 117
           L +DE GN   I++CDFG + +L     R +N         A ++APE +E     +  Y
Sbjct: 148 LYVDESGNPESIRICDFGFAKQL-----RAENGLLXTPCYTANFVAPEVLE-----RQGY 197
Query: 118 DIRADVWSLGITLVELATGEFPYKDCKCDF--EVLSRV 153
           D   D+WSLG+ L    TG  P+ +   D   E+L+R+
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARI 235

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 28/143 (19%)
Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFL-HSNQVI 138
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++  +   R++  G   +MAPE +      +  Y
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV-----TRKAY 193
Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           S  +I  EL      FD ++KR   S  E    +I       + Y+ + H ++HRD+KP 
Sbjct: 94  SSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMHK-HNIVHRDLKPE 150
Query: 66  NILLDERG---NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           NILL+ +    +IK+ DFG+S     +       G A Y+APE +      +  YD + D
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL------RGTYDEKCD 204
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           VWS G+ L  L +G  P+   K ++++L RV
Sbjct: 205 VWSAGVILYILLSGTPPFY-GKNEYDILKRV 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFL-HSNQVI 138
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++  +   R+   G   +MAPE +      +  Y
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-----TRKAY 193
Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 92  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFL-HSNQVI 139
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++  +   R+   G   +MAPE +      +  Y
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-----TRKAY 194
Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFL-HSNQVI 138
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           HRD+K  NILL   G++KL DFG   ++  +   R+   G   +MAPE +      +  Y
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAY 193
Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 58/102 (56%), Gaps = 7/102 (6%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAA 100
           +  ++ LHY K    +IHRD+KPSN+L+ E G+IK+ DFG+S     S A   N  G  A
Sbjct: 147 IKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA 202
Query: 101 YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           +MAPE +     +K       DVW++G+TL     G+ P+ D
Sbjct: 203 FMAPESLS--ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 19/154 (12%)
Query: 10  VWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTV-KALHYLKETHGVIHRDVKPSN 66
           V++  ELM      D++L++   S  E       L T+ K + YL  + GV+HRD+KPSN
Sbjct: 96  VYLVTELMRGGELLDKILRQKFFSERE---ASFVLHTIGKTVEYL-HSQGVVHRDLKPSN 151
Query: 67  IL-LDERGN---IKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           IL +DE GN   +++CDFG + +L  ++         A ++APE +     ++  YD   
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-----KRQGYDEGC 206
Query: 122 DVWSLGITLVELATGEFPYKDCKCDF--EVLSRV 153
           D+WSLGI L  +  G  P+ +   D   E+L+R+
Sbjct: 207 DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI 240

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 19/154 (12%)
Query: 10  VWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTV-KALHYLKETHGVIHRDVKPSN 66
           V++  ELM      D++L++   S  E       L T+ K + YL  + GV+HRD+KPSN
Sbjct: 96  VYLVTELMRGGELLDKILRQKFFSERE---ASFVLHTIGKTVEYL-HSQGVVHRDLKPSN 151
Query: 67  IL-LDERGN---IKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           IL +DE GN   +++CDFG + +L  ++         A ++APE +     ++  YD   
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-----KRQGYDEGC 206
Query: 122 DVWSLGITLVELATGEFPYKDCKCDF--EVLSRV 153
           D+WSLGI L  +  G  P+ +   D   E+L+R+
Sbjct: 207 DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 84/197 (42%), Gaps = 21/197 (10%)
Query: 9   DVWICMELMAT--------CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           +V+I  E M           F  L K     +P  +   I  S + +  Y+     + HR
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           DVKPSNIL+D+ G +KL DFG S  +VD K +  + G   +M PE     +        +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFSNESSYNG---AK 232
Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLS--RVLNDAPPCLPNDPLFGRTIKASIAKD 178
            D+WSLGI L  +     P+       E+ +  R  N   P   N  L+  T K S   +
Sbjct: 233 VDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 179 NGRSTE-------FIRK 188
           N  S E       F+RK
Sbjct: 293 NFLSNEDIDFLKLFLRK 309

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           S  +I  EL      FD ++KR   S  E    +I       + Y+ + H ++HRD+KP 
Sbjct: 94  SSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMHK-HNIVHRDLKPE 150
Query: 66  NILLDERG---NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           NILL+ +    +IK+ DFG+S     +       G A Y+APE +      +  YD + D
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL------RGTYDEKCD 204
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           VWS G+ L  L +G  P+   K ++++L RV
Sbjct: 205 VWSAGVILYILLSGTPPFYG-KNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           S  +I  EL      FD ++KR   S  E    +I       + Y+ + H ++HRD+KP 
Sbjct: 94  SSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMHK-HNIVHRDLKPE 150
Query: 66  NILLDERG---NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           NILL+ +    +IK+ DFG+S     +       G A Y+APE +      +  YD + D
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL------RGTYDEKCD 204
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           VWS G+ L  L +G  P+   K ++++L RV
Sbjct: 205 VWSAGVILYILLSGTPPFYG-KNEYDILKRV 234

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 125 IARQTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 184 GSILWMAPEVIRMQDSNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 125 IARQTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 184 GSILWMAPEVIRMQDSNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 113 IARQTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 172 GSILWMAPEVIRMQDSNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)
Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           S  +D ++ ME ++    FD + K  H  V E    ++    + A+ Y    H V+HRD+
Sbjct: 81  STPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDL 137
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KP N+LLD   N K+ DFG+S  + D +    + G   Y APE I       P+     D
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE----VD 193
Query: 123 VWSLGITLVELATGEFPYKD 142
           +WS G+ L  L  G  P+ D
Sbjct: 194 IWSCGVILYALLCGTLPFDD 213

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 9   DVWICMELM--ATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ME+      FD ++ R   S V   +  K  LS    LH     H ++HRD+KP 
Sbjct: 95  NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH----KHNIVHRDLKPE 150
Query: 66  NILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           N+LL+ +     IK+ DFG+S          +  G A Y+APE +      +  YD + D
Sbjct: 151 NLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL------RKKYDEKCD 204
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           VWS G+ L  L  G  P+   + D E+L RV
Sbjct: 205 VWSCGVILYILLCGYPPF-GGQTDQEILKRV 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 9   DVWICMELM--ATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           + ++ ME+      FD ++ R   S V   +  K  LS    LH     H ++HRD+KP 
Sbjct: 78  NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH----KHNIVHRDLKPE 133
Query: 66  NILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           N+LL+ +     IK+ DFG+S          +  G A Y+APE +      +  YD + D
Sbjct: 134 NLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL------RKKYDEKCD 187
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           VWS G+ L  L  G  P+   + D E+L RV
Sbjct: 188 VWSCGVILYILLCGYPPF-GGQTDQEILKRV 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)
Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           S  +D ++ ME ++    FD + K  H  V E    ++    + A+ Y    H V+HRD+
Sbjct: 81  STPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDL 137
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KP N+LLD   N K+ DFG+S  + D +    + G   Y APE I       P+     D
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPE----VD 193
Query: 123 VWSLGITLVELATGEFPYKD 142
           +WS G+ L  L  G  P+ D
Sbjct: 194 IWSCGVILYALLCGTLPFDD 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 9   DVWICMELMA----------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           ++W+ ME +A          TC D           E     +    ++AL +L  ++ VI
Sbjct: 92  ELWVVMEYLAGGSLTDVVTETCMD-----------EGQIAAVCRECLQALEFL-HSNQVI 139
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           HR++K  NILL   G++KL DFG   ++  +   R+   G   +MAPE +      +  Y
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAY 194
Query: 118 DIRADVWSLGITLVELATGEFPY 140
             + D+WSLGI  +E+  GE PY
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 91  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 147
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 138 FPY 140
            P+
Sbjct: 204 LPW 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/128 (35%), Positives = 67/128 (52%), Gaps = 13/128 (10%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN 95
            G+I L+ ++ LH L    G+I+RD+K  NILLD  G++ L DFG+S   V D   R  +
Sbjct: 165 VGEIVLA-LEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 96  A-GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK---DCKCDFEVLS 151
             G   YMAP+ +   +     +D   D WSLG+ + EL TG  P+    +     E+  
Sbjct: 220 FCGTIEYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
Query: 152 RVLNDAPP 159
           R+L   PP
Sbjct: 277 RILKSEPP 284

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           H ++HRD+KP N+LLD+  N+K+ DFG+S  + D      + G   Y APE I       
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 115 PDYDIRADVWSLGITLVELATGEFPYKD 142
           P+     DVWS GI L  +  G  P+ D
Sbjct: 187 PE----VDVWSCGIVLYVMLVGRLPFDD 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 93  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 149
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 138 FPY 140
            P+
Sbjct: 206 LPW 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N  C    Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 61/109 (55%), Gaps = 7/109 (6%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART 93
           EP     T   V  L +L + + +I+RD+KP N+LLD+ GN+++ D G++  L   + +T
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 94  KN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           K  AG   +MAPE +        +YD   D ++LG+TL E+     P++
Sbjct: 347 KGYAGTPGFMAPELL-----LGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 61/109 (55%), Gaps = 7/109 (6%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART 93
           EP     T   V  L +L + + +I+RD+KP N+LLD+ GN+++ D G++  L   + +T
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 94  KN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           K  AG   +MAPE +        +YD   D ++LG+TL E+     P++
Sbjct: 347 KGYAGTPGFMAPELL-----LGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 61/109 (55%), Gaps = 7/109 (6%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART 93
           EP     T   V  L +L + + +I+RD+KP N+LLD+ GN+++ D G++  L   + +T
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 94  KN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           K  AG   +MAPE +        +YD   D ++LG+TL E+     P++
Sbjct: 347 KGYAGTPGFMAPELL-----LGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHRDVKPSN 66
           +I ME +    D +  R  V    P+  K  +  +    +AL++  + +G+IHRDVKP+N
Sbjct: 92  YIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPAN 146
Query: 67  ILLDERGNIKLCDFGISGRLVDS-KARTKNA---GCAAYMAPERIEPPNPQKPDYDIRAD 122
           I++     +K+ DFGI+  + DS  + T+ A   G A Y++PE+      +    D R+D
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSD 201
Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
           V+SLG  L E+ TGE P+     D      V  D  P
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIP 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 61/109 (55%), Gaps = 7/109 (6%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART 93
           EP     T   V  L +L + + +I+RD+KP N+LLD+ GN+++ D G++  L   + +T
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 94  KN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           K  AG   +MAPE +        +YD   D ++LG+TL E+     P++
Sbjct: 347 KGYAGTPGFMAPELL-----LGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 66/124 (53%), Gaps = 10/124 (8%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD 79
            FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ D
Sbjct: 92  LFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISD 148
Query: 80  FGISGRL-VDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           FG++     +++ R  N   G   Y+APE ++    ++  +    DVWS GI L  +  G
Sbjct: 149 FGLATVFRYNNRERLLNKMXGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAG 204
Query: 137 EFPY 140
           E P+
Sbjct: 205 ELPW 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 66/124 (53%), Gaps = 10/124 (8%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD 79
            FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ D
Sbjct: 91  LFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISD 147
Query: 80  FGISGRL-VDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           FG++     +++ R  N   G   Y+APE ++    ++  +    DVWS GI L  +  G
Sbjct: 148 FGLATVFRYNNRERLLNKMXGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAG 203
Query: 137 EFPY 140
           E P+
Sbjct: 204 ELPW 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 66/124 (53%), Gaps = 10/124 (8%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD 79
            FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ D
Sbjct: 91  LFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISD 147
Query: 80  FGISGRL-VDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           FG++     +++ R  N   G   Y+APE ++    ++  +    DVWS GI L  +  G
Sbjct: 148 FGLATVFRYNNRERLLNKMXGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAG 203
Query: 137 EFPY 140
           E P+
Sbjct: 204 ELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N   G   Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMXGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 10/123 (8%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           FDR+     + +PEP   +     +  + YL    G+ HRD+KP N+LLDER N+K+ DF
Sbjct: 92  FDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDF 148
Query: 81  GISGRL-VDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
           G++     +++ R  N   G   Y+APE ++    ++  +    DVWS GI L  +  GE
Sbjct: 149 GLATVFRYNNRERLLNKMXGTLPYVAPELLK----RREFHAEPVDVWSCGIVLTAMLAGE 204
Query: 138 FPY 140
            P+
Sbjct: 205 LPW 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/125 (36%), Positives = 65/125 (52%), Gaps = 13/125 (10%)
Query: 24  LLKRLHVSVPEPICGK---ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF 80
           L K LHV   +    +   I   T + + YL     +IHRD+K +NI L E   +K+ DF
Sbjct: 118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYL-HAKNIIHRDMKSNNIFLHEGLTVKIGDF 176
Query: 81  GIS---GRLVDSKARTKNAGCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G++    R   S+   +  G   +MAPE  R++  NP    +  ++DV+S GI L EL T
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP----FSFQSDVYSYGIVLYELMT 232
Query: 136 GEFPY 140
           GE PY
Sbjct: 233 GELPY 237

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 69/142 (48%), Gaps = 13/142 (9%)
Query: 5   SKESDVWICMELMA--TCFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           S  SD+++ ME ++    FD + K  RL       +  +I LS V   H     H V+HR
Sbjct: 86  STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI-LSGVDYCH----RHMVVHR 140
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KP N+LLD   N K+ DFG+S  + D +    + G   Y APE I       P+    
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE---- 196
Query: 121 ADVWSLGITLVELATGEFPYKD 142
            D+WS G+ L  L  G  P+ D
Sbjct: 197 VDIWSSGVILYALLCGTLPFDD 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 76/138 (55%), Gaps = 18/138 (13%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHRDVKPSN 66
           +I ME +    D +  R  V    P+  K  +  +    +AL++  + +G+IHRDVKP+N
Sbjct: 92  YIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPAN 146
Query: 67  ILLDERGNIKLCDFGISGRLVDS-KARTKNA---GCAAYMAPERIEPPNPQKPDYDIRAD 122
           I++     +K+ DFGI+  + DS  + T+ A   G A Y++PE+      +    D R+D
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSD 201
Query: 123 VWSLGITLVELATGEFPY 140
           V+SLG  L E+ TGE P+
Sbjct: 202 VYSLGCVLYEVLTGEPPF 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHRDVKPSN 66
           +I ME +    D +  R  V    P+  K  +  +    +AL++    +G+IHRDVKP+N
Sbjct: 92  YIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPAN 146
Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNA----GCAAYMAPERIEPPNPQKPDYDIRAD 122
           IL+     +K+ DFGI+  + DS           G A Y++PE+      +    D R+D
Sbjct: 147 ILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA-----RGDSVDARSD 201
Query: 123 VWSLGITLVELATGEFPY 140
           V+SLG  L E+ TGE P+
Sbjct: 202 VYSLGCVLYEVLTGEPPF 219

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 114 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 173 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 75/138 (54%), Gaps = 18/138 (13%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHRDVKPSN 66
           +I ME +    D +  R  V    P+  K  +  +    +AL++    +G+IHRDVKP+N
Sbjct: 92  YIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPAN 146
Query: 67  ILLDERGNIKLCDFGISGRLVDS-KARTKNA---GCAAYMAPERIEPPNPQKPDYDIRAD 122
           I++     +K+ DFGI+  + DS  + T+ A   G A Y++PE+      +    D R+D
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSD 201
Query: 123 VWSLGITLVELATGEFPY 140
           V+SLG  L E+ TGE P+
Sbjct: 202 VYSLGCVLYEVLTGEPPF 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 75/138 (54%), Gaps = 18/138 (13%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHRDVKPSN 66
           +I ME +    D +  R  V    P+  K  +  +    +AL++    +G+IHRDVKP+N
Sbjct: 92  YIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPAN 146
Query: 67  ILLDERGNIKLCDFGISGRLVDS-KARTKNA---GCAAYMAPERIEPPNPQKPDYDIRAD 122
           I++     +K+ DFGI+  + DS  + T+ A   G A Y++PE+      +    D R+D
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSD 201
Query: 123 VWSLGITLVELATGEFPY 140
           V+SLG  L E+ TGE P+
Sbjct: 202 VYSLGCVLYEVLTGEPPF 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 129 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 188 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 137 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 196 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 114 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 173 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 109 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 168 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 137 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 196 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 136 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 195 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---RGNIKLCDFGISGRLV 87
           ++ E    ++    + AL Y    H V+H+D+KP NIL  +      IK+ DFG++    
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 88  DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF 147
             +  T  AG A YMAPE        K D   + D+WS G+ +  L TG  P+     + 
Sbjct: 179 SDEHSTNAAGTALYMAPEVF------KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE- 231
Query: 148 EVLSRVL----NDAPPCLPNDPLFGRTIKASIAKDNGR 181
           EV  +      N A  C P  P     +K  + KD  R
Sbjct: 232 EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPER 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 109 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 168 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG 84
           L R     P P+          AL YL  +  +I+RD+KP NILLD+ G+IK+ DFG + 
Sbjct: 96  LLRKSQRFPNPVAKFYAAEVCLALEYL-HSKDIIYRDLKPENILLDKNGHIKITDFGFAK 154
Query: 85  RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK 144
            + D        G   Y+APE +      KP Y+   D WS GI + E+  G  P+ D  
Sbjct: 155 YVPDVTYXL--CGTPDYIAPEVVS----TKP-YNKSIDWWSFGILIYEMLAGYTPFYDSN 207
Query: 145 CDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
              +   ++LN A    P  P F   +K  +++
Sbjct: 208 T-MKTYEKILN-AELRFP--PFFNEDVKDLLSR 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 3/119 (2%)
Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL +    +PE +        V A+  + + H  +HRD+KP NIL+D  G+I+L DFG  
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 84  GRLV-DSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +L+ D   ++  A G   Y++PE ++     K  Y    D WSLG+ + E+  GE P+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 71/136 (52%), Gaps = 6/136 (4%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           S +++  +LM     FD L ++  V++ E     I  S ++A+ +L   + ++HRD+KP 
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFL-HANNIVHRDLKPE 229
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE-PPNPQKPDYDIRADVW 124
           NILLD+   I+L DFG S  L   +   +  G   Y+APE ++   +   P Y    D+W
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 125 SLGITLVELATGEFPY 140
           + G+ L  L  G  P+
Sbjct: 290 ACGVILFTLLAGSPPF 305

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 111 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 170 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS---GRLVDSKARTKNA 96
           I   T + + YL     +IHRD+K +NI L E   +K+ DFG++    R   S    + +
Sbjct: 109 IARQTAQGMDYL-HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 97  GCAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           G   +MAPE  R++  NP    Y  ++DV++ GI L EL TG+ PY +     +++  V
Sbjct: 168 GSILWMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 75/138 (54%), Gaps = 18/138 (13%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHRDVKPSN 66
           +I ME +    D +  R  V    P+  K  +  +    +AL++    +G+IHRDVKP+N
Sbjct: 109 YIVMEYV----DGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPAN 163
Query: 67  ILLDERGNIKLCDFGISGRLVDS-KARTKNA---GCAAYMAPERIEPPNPQKPDYDIRAD 122
           I++     +K+ DFGI+  + DS  + T+ A   G A Y++PE+      +    D R+D
Sbjct: 164 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ-----ARGDSVDARSD 218
Query: 123 VWSLGITLVELATGEFPY 140
           V+SLG  L E+ TGE P+
Sbjct: 219 VYSLGCVLYEVLTGEPPF 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 13/137 (9%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIK 76
            FD ++ R   S  E    +I    +  + Y+ +   ++HRD+KP N+LL+ +    NI+
Sbjct: 136 LFDEIISRKRFS--EVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 192
Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           + DFG+S     SK      G A Y+APE +         YD + DVWS G+ L  L +G
Sbjct: 193 IIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT------YDEKCDVWSTGVILYILLSG 246
Query: 137 EFPYKDCKCDFEVLSRV 153
             P+     ++++L +V
Sbjct: 247 CPPFNGAN-EYDILKKV 262

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 13/137 (9%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIK 76
            FD ++ R   S  E    +I    +  + Y+ +   ++HRD+KP N+LL+ +    NI+
Sbjct: 137 LFDEIISRKRFS--EVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 193
Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           + DFG+S     SK      G A Y+APE +         YD + DVWS G+ L  L +G
Sbjct: 194 IIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT------YDEKCDVWSTGVILYILLSG 247
Query: 137 EFPYKDCKCDFEVLSRV 153
             P+     ++++L +V
Sbjct: 248 CPPFNGAN-EYDILKKV 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 13/137 (9%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIK 76
            FD ++ R   S  E    +I    +  + Y+ +   ++HRD+KP N+LL+ +    NI+
Sbjct: 113 LFDEIISRKRFS--EVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 169
Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           + DFG+S     SK      G A Y+APE +         YD + DVWS G+ L  L +G
Sbjct: 170 IIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT------YDEKCDVWSTGVILYILLSG 223
Query: 137 EFPYKDCKCDFEVLSRV 153
             P+     ++++L +V
Sbjct: 224 CPPFNGAN-EYDILKKV 239

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 4   QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +SK+  + +        FD +++R  +S  E    +     + A+ Y    H ++HRD+K
Sbjct: 84  KSKDEIIMVIEYAGNELFDYIVQRDKMSEQE--ARRFFQQIISAVEYCHR-HKIVHRDLK 140
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           P N+LLDE  N+K+ DFG+S  + D      + G   Y APE I       P+     DV
Sbjct: 141 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE----VDV 196
Query: 124 WSLGITLVELATGEFPYKD 142
           WS G+ L  +     P+ D
Sbjct: 197 WSCGVILYVMLCRRLPFDD 215

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 4   QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +SK+  + +        FD +++R  +S  E    +     + A+ Y    H ++HRD+K
Sbjct: 83  KSKDEIIMVIEYAGNELFDYIVQRDKMSEQE--ARRFFQQIISAVEYCHR-HKIVHRDLK 139
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           P N+LLDE  N+K+ DFG+S  + D      + G   Y APE I       P+     DV
Sbjct: 140 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE----VDV 195
Query: 124 WSLGITLVELATGEFPYKD 142
           WS G+ L  +     P+ D
Sbjct: 196 WSCGVILYVMLCRRLPFDD 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 4   QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +SK+  + +        FD +++R  +S  E    +     + A+ Y    H ++HRD+K
Sbjct: 78  KSKDEIIMVIEYAGNELFDYIVQRDKMSEQE--ARRFFQQIISAVEYCHR-HKIVHRDLK 134
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           P N+LLDE  N+K+ DFG+S  + D      + G   Y APE I       P+     DV
Sbjct: 135 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE----VDV 190
Query: 124 WSLGITLVELATGEFPYKD 142
           WS G+ L  +     P+ D
Sbjct: 191 WSCGVILYVMLCRRLPFDD 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 62/109 (56%), Gaps = 6/109 (5%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRLVDSKAR 92
           E   G  T   ++ L YL +   ++HRD+K  N+L++   G +K+ DFG S RL      
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 93  TKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           T+   G   YMAPE I+   P+   Y   AD+WSLG T++E+ATG+ P+
Sbjct: 180 TETFTGTLQYMAPEIIDK-GPR--GYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 4   QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +SK+  + +        FD +++R  +S  E    +     + A+ Y    H ++HRD+K
Sbjct: 74  KSKDEIIMVIEYAGNELFDYIVQRDKMSEQE--ARRFFQQIISAVEYCHR-HKIVHRDLK 130
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           P N+LLDE  N+K+ DFG+S  + D      + G   Y APE I       P+     DV
Sbjct: 131 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE----VDV 186
Query: 124 WSLGITLVELATGEFPYKD 142
           WS G+ L  +     P+ D
Sbjct: 187 WSCGVILYVMLCRRLPFDD 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 62/109 (56%), Gaps = 6/109 (5%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRLVDSKAR 92
           E   G  T   ++ L YL +   ++HRD+K  N+L++   G +K+ DFG S RL      
Sbjct: 107 EQTIGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 93  TKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           T+   G   YMAPE I+   P+   Y   AD+WSLG T++E+ATG+ P+
Sbjct: 166 TETFTGTLQYMAPEIIDK-GPR--GYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 13/137 (9%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIK 76
            FD ++ R   S  E    +I    +  + Y+ +   ++HRD+KP N+LL+ +    NI+
Sbjct: 119 LFDEIISRKRFS--EVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 175
Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           + DFG+S     SK      G A Y+APE +         YD + DVWS G+ L  L +G
Sbjct: 176 IIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT------YDEKCDVWSTGVILYILLSG 229
Query: 137 EFPYKDCKCDFEVLSRV 153
             P+     ++++L +V
Sbjct: 230 CPPFNGAN-EYDILKKV 245

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 7/149 (4%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +S++ +  + M T  + ++K   + +         L T++ L YL + H ++HRD+KP+N
Sbjct: 84  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNN 142
Query: 67  ILLDERGNIKLCDFGISGRLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           +LLDE G +KL DFG++      ++A         Y APE +         Y +  D+W+
Sbjct: 143 LLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARM----YGVGVDMWA 198
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVL 154
           +G  L EL     P+     D + L+R+ 
Sbjct: 199 VGCILAELLL-RVPFLPGDSDLDQLTRIF 226

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           +++  EL      +  +    S+PE         T+ AL +L  + G++H DVKP+NI L
Sbjct: 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL-HSQGLVHLDVKPANIFL 190
Query: 70  DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGIT 129
             RG  KL DFG+   L  + A     G   YMAPE ++        Y   ADV+SLG+T
Sbjct: 191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ------GSYGTAADVFSLGLT 244
Query: 130 LVELA 134
           ++E+A
Sbjct: 245 ILEVA 249

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 13/137 (9%)
Query: 20  CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIK 76
            FD ++ R   S  E    +I    +  + Y  +   ++HRD+KP N+LL+ +    NI+
Sbjct: 113 LFDEIISRKRFS--EVDAARIIRQVLSGITYXHKNK-IVHRDLKPENLLLESKSKDANIR 169
Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           + DFG+S     SK      G A Y+APE +         YD + DVWS G+ L  L +G
Sbjct: 170 IIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT------YDEKCDVWSTGVILYILLSG 223
Query: 137 EFPYKDCKCDFEVLSRV 153
             P+     ++++L +V
Sbjct: 224 CPPFNGAN-EYDILKKV 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 73/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT   AG   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLAGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 8/109 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 318 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 8/109 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 261 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 320
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 321 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQKF-IVHRDLKA 141
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S          +  G   Y APE  +      P+     DVW
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE----VDVW 197
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 198 SLGVILYTLVSGSLPF-DGQNLKELRERVL 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  + + ++HRD+K 
Sbjct: 86  EKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQKY-IVHRDLKA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 143 ENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE----VDVW 198
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 199 SLGVILYTLVSGSLPF-DGQNLKELRERVL 227

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME M     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 8/109 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 118 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 177
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 178 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 8/109 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 119 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 178
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 179 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 8/109 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 120 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 179
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 180 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 3/119 (2%)
Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL +    +PE +        V A+  + + H  +HRD+KP N+LLD  G+I+L DFG  
Sbjct: 180 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH-YVHRDIKPDNVLLDVNGHIRLADFGSC 238
Query: 84  GRLVD--SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            ++ D  +   +   G   Y++PE ++        Y    D WSLG+ + E+  GE P+
Sbjct: 239 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME M     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 3/119 (2%)
Query: 24  LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS 83
           LL +    +PE +        V A+  + + H  +HRD+KP N+LLD  G+I+L DFG  
Sbjct: 164 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH-YVHRDIKPDNVLLDVNGHIRLADFGSC 222
Query: 84  GRLVD--SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            ++ D  +   +   G   Y++PE ++        Y    D WSLG+ + E+  GE P+
Sbjct: 223 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQKF-IVHRDLKA 141
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE----VDVW 197
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 198 SLGVILYTLVSGSLPF-DGQNLKELRERVL 226

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQKF-IVHRDLKA 141
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE----VDVW 197
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 198 SLGVILYTLVSGSLPF-DGQNLKELRERVL 226

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI---SGRLVDSKARTKN 95
           KI       +++L E H  IHRD+K +NILLDE    K+ DFG+   S +   +   ++ 
Sbjct: 137 KIAQGAANGINFLHENHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRI 195
Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
            G  AYMAPE +      + +   ++D++S G+ L+E+ TG
Sbjct: 196 VGTTAYMAPEAL------RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           +++RD+KP NILLD+ G+I++ D G++  + + +      G   YMAPE +     +   
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-----KNER 361
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDF--EVLSRVLNDAP 158
           Y    D W+LG  L E+  G+ P++  K     E + R++ + P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQKF-IVHRDLKA 141
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE----VDVW 197
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 198 SLGVILYTLVSGSLPF-DGQNLKELRERVL 226

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQKF-IVHRDLKA 141
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE----VDVW 197
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 198 SLGVILYTLVSGSLPF-DGQNLKELRERVL 226

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 69/134 (51%), Gaps = 8/134 (5%)
Query: 2   SPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           S +SK   ++I ME     T    + KR    + + +  ++     K + Y+  +  +IH
Sbjct: 101 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI-HSKKLIH 159
Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
           RD+KPSNI L +   +K+ DFG+   L +   RT++ G   YM+PE+I        DY  
Sbjct: 160 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-----QDYGK 214
Query: 120 RADVWSLGITLVEL 133
             D+++LG+ L EL
Sbjct: 215 EVDLYALGLILAEL 228

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 102 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 158
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 159 LNTTSDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 213
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 214 WSVGCILAEMLSNRPIFPGK 233

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 63/131 (48%), Gaps = 17/131 (12%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRL--------V 87
           ++      AL +L  T G+ HRD+KP NIL +   +   +K+CDF +   +        +
Sbjct: 115 RVVRDVAAALDFL-HTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI 173
Query: 88  DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY-----KD 142
            +   T   G A YMAPE +E    Q   YD R D+WSLG+ L  + +G  P+      D
Sbjct: 174 TTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGAD 233
Query: 143 CKCDFEVLSRV 153
           C  D   + RV
Sbjct: 234 CGWDRGEVCRV 244

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           +++RD+KP NILLD+ G+I++ D G++  + + +      G   YMAPE +     +   
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-----KNER 361
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDF--EVLSRVLNDAP 158
           Y    D W+LG  L E+  G+ P++  K     E + R++ + P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 101 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 155
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+DE+G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 156 PENLLIDEQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 207
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 208 WWALGVLIYEMAAGYPPF 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE----VDVW 198
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 199 SLGVILYTLVSGSLPF-DGQNLKELRERVL 227

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 83  EKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKA 139
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 140 ENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE----VDVW 195
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 196 SLGVILYTLVSGSLPF-DGQNLKELRERVL 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI---SGRLVDSKARTKN 95
           KI       +++L E H  IHRD+K +NILLDE    K+ DFG+   S +   +    + 
Sbjct: 137 KIAQGAANGINFLHENHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRI 195
Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
            G  AYMAPE +      + +   ++D++S G+ L+E+ TG
Sbjct: 196 VGTTAYMAPEAL------RGEITPKSDIYSFGVVLLEIITG 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLXGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 100 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 156
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 157 LNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 211
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 212 WSVGCILAEMLSNRPIFPGK 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 104 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 160
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 161 LNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 215
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 216 WSVGCILAEMLSNRPIFPGK 235

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 100 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 156
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 157 LNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 211
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 212 WSVGCILAEMLSNRPIFPGK 231

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 104 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 160
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 161 LNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 215
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 216 WSVGCILAEMLSNRPIFPGK 235

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 78  EKTLYLVMEYASGGEVFDYLVA--HGWMKEKEARAKFRQIVSAVQYCHQKF-IVHRDLKA 134
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LLD   NIK+ DFG S             G   Y APE  +      P+     DVW
Sbjct: 135 ENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE----VDVW 190
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           SLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 191 SLGVILYTLVSGSLPF-DGQNLKELRERVL 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQ 113
           H V+HRD+KP+N+ LD + N+KL DFG++  L    +  K   G   YM+PE++      
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-----N 189
Query: 114 KPDYDIRADVWSLGITLVEL 133
           +  Y+ ++D+WSLG  L EL
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           V A+ Y  +   ++HRD+K  N+LLD   NIK+ DFG S             G   Y AP
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           E  +      P+     DVWSLG+ L  L +G  P+ D +   E+  RVL
Sbjct: 182 ELFQGKKYDGPE----VDVWSLGVILYTLVSGSLPF-DGQNLKELRERVL 226

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG 84
           L R    VPE +   IT  T++A+++  + H  IHRDVKP NIL+ +   IKLCDFG + 
Sbjct: 92  LDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFAR 150
Query: 85  RLVD-SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
            L   S           Y +PE +       P      DVW++G    EL +G
Sbjct: 151 LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP----VDVWAIGCVFAELLSG 199

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 59/129 (45%), Gaps = 12/129 (9%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL--DERGNIKLCDFGISGRLV---- 87
           E +   I      ALHYL    G+ HRD+KP N L   ++   IKL DFG+S        
Sbjct: 167 EKLISNIMRQIFSALHYL-HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 88  -DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD 146
            +    T  AG   ++APE +   N     Y  + D WS G+ L  L  G  P+     D
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTN---ESYGPKCDAWSAGVLLHLLLMGAVPFPGVN-D 281
Query: 147 FEVLSRVLN 155
            + +S+VLN
Sbjct: 282 ADTISQVLN 290

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 108 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 164
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 165 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 219
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 220 WSVGCILAEMLSNRPIFPGK 239

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 100 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 156
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 157 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 211
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 212 WSVGCILAEMLSNRPIFPGK 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 102 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 158
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 159 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 213
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 214 WSVGCILAEMLSNRPIFPGK 233

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 87  DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 141
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 142 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 199
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 200 DCWSLGVILFICLSGYPPFSE 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 102 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 158
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 159 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 213
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 214 WSVGCILAEMLSNRPIFPGK 233

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI---SGRLVDSKARTKN 95
           KI       +++L E H  IHRD+K +NILLDE    K+ DFG+   S +        + 
Sbjct: 131 KIAQGAANGINFLHENHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRI 189
Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
            G  AYMAPE +      + +   ++D++S G+ L+E+ TG
Sbjct: 190 VGTTAYMAPEAL------RGEITPKSDIYSFGVVLLEIITG 224

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 105 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 161
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 162 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 216
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 217 WSVGCILAEMLSNRPIFPGK 236

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 106 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 162
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 163 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 217
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 218 WSVGCILAEMLSNRPIFPGK 237

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 97  DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 153
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 154 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 208
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 209 WSVGCILAEMLSNRPIFPGK 228

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 104 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 160
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 161 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 215
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 216 WSVGCILAEMLSNRPIFPGK 235

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 142
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 200
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 201 DCWSLGVILFICLSGYPPFSE 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 22/157 (14%)
Query: 10  VWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
            ++ MEL+     F+R+ K+ H S  E     I    V A+ ++ +  GV+HRD+KP N+
Sbjct: 81  TFLVMELLNGGELFERIKKKKHFSETE--ASYIMRKLVSAVSHMHDV-GVVHRDLKPENL 137
Query: 68  LL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRAD 122
           L  DE  N  IK+ DFG + RL     +     C    Y APE +      +  YD   D
Sbjct: 138 LFTDENDNLEIKIIDFGFA-RLKPPDNQPLKTPCFTLHYAAPELL-----NQNGYDESCD 191
Query: 123 VWSLGITLVELATGEFPYKD------CKCDFEVLSRV 153
           +WSLG+ L  + +G+ P++       C    E++ ++
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 142
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 200
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 201 DCWSLGVILFICLSGYPPFSE 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 142
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 200
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 201 DCWSLGVILFICLSGYPPFSE 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 98  DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 154
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 155 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 209
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 210 WSVGCILAEMLSNRPIFPGK 229

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 17/123 (13%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNI---KLCDFGISGRL--------VD 88
           +      AL +L    G+ HRD+KP NIL +    +   K+CDFG+   +        + 
Sbjct: 116 VVQDVASALDFL-HNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 89  SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY-----KDC 143
           +       G A YMAPE +E  + +   YD R D+WSLG+ L  L +G  P+      DC
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 144 KCD 146
             D
Sbjct: 235 GWD 237

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 98  DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 154
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 155 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 209
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 210 WSVGCILAEMLSNRPIFPGK 229

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 94  DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 148
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 149 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 206
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 207 DCWSLGVILFICLSGYPPFSE 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 104 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 160
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 161 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 215
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 216 WSVGCILAEMLSNRPIFPGK 235

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 100 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 156
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 157 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 211
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 212 WSVGCILAEMLSNRPIFPGK 231

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 72/140 (51%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+     V+HRD+KPSN+L
Sbjct: 120 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYIHSA-NVLHRDLKPSNLL 176
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 177 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 231
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 232 WSVGCILAEMLSNRPIFPGK 251

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQ 113
           H V+HRD+KP+N+ LD + N+KL DFG++  L  D+       G   YM+PE++      
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-----N 189
Query: 114 KPDYDIRADVWSLGITLVEL 133
           +  Y+ ++D+WSLG  L EL
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 115 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 174 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 118 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 176
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 177 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 115 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 174 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 227 DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 281
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 282 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 339
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 340 DCWSLGVILFICLSGYPPFSE 360

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERG---NIKLCDFGISGRLV-DSKARTK 94
           K  LS +  LH     H ++HRD+KP NILL+ +    NIK+ DFG+S     D K R +
Sbjct: 153 KQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
             G A Y+APE +      K  Y+ + DVWS G+ +  L  G  P+
Sbjct: 209 -LGTAYYIAPEVL------KKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 6/80 (7%)
Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQ 113
           H V+HRD+KP+N+ LD + N+KL DFG++  L   +   K   G   YM+PE++      
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM-----N 189
Query: 114 KPDYDIRADVWSLGITLVEL 133
           +  Y+ ++D+WSLG  L EL
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/124 (37%), Positives = 64/124 (51%), Gaps = 11/124 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNI-KLCDFGISGRLVDSKARTKNAGCAAYMA 103
           V  LH + +   +IHRD+KP N+LL   G + K+CDFG +  +      T N G AA+MA
Sbjct: 116 VAYLHSM-QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMA 172
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLNDA-PPCL 161
           PE  E  N     Y  + DV+S GI L E+ T   P+ +     F ++  V N   PP +
Sbjct: 173 PEVFEGSN-----YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 227
Query: 162 PNDP 165
            N P
Sbjct: 228 KNLP 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 9   DVWICMELM--ATCFDRLL--KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           D +I +ELM     FD+++  KRL     E  C       + A+ YL E +G+IHRD+KP
Sbjct: 213 DYYIVLELMEGGELFDKVVGNKRLK----EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 267
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL--VSVGTAGYNRAV 325
Query: 122 DVWSLGITLVELATGEFPYKD 142
           D WSLG+ L    +G  P+ +
Sbjct: 326 DCWSLGVILFICLSGYPPFSE 346

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/124 (37%), Positives = 64/124 (51%), Gaps = 11/124 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNI-KLCDFGISGRLVDSKARTKNAGCAAYMA 103
           V  LH + +   +IHRD+KP N+LL   G + K+CDFG +  +      T N G AA+MA
Sbjct: 115 VAYLHSM-QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMA 171
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLNDA-PPCL 161
           PE  E  N     Y  + DV+S GI L E+ T   P+ +     F ++  V N   PP +
Sbjct: 172 PEVFEGSN-----YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 162 PNDP 165
            N P
Sbjct: 227 KNLP 230

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNA--G 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N+  G
Sbjct: 138 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 197 TAQYVSPELLTEKSASK-----SSDLWALGCIIYQLVAGLPPFR 235

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 115 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 174 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 115 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 174 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 120 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 178
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 179 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMA 103
           V AL YL  +  V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 115 VSALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY--KDCKCDFEVL 150
           PE +E       DY    D W LG+ + E+  G  P+  +D +  FE++
Sbjct: 174 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLIIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIISKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNA--G 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    NA  G
Sbjct: 136 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 195 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    + P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + ++A G  P+
Sbjct: 221 WWALGVLIYQMAAGYPPF 238

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 61/131 (46%), Gaps = 8/131 (6%)
Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART 93
           EP           AL YL  +  +++RD+KP NILLD +G+I L DFG+    ++  + T
Sbjct: 138 EPRARFYAAEIASALGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 94  KNA-GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSR 152
               G   Y+APE +      K  YD   D W LG  L E+  G  P+   +   E+   
Sbjct: 197 STFCGTPEYLAPEVL-----HKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDN 250
Query: 153 VLNDAPPCLPN 163
           +LN      PN
Sbjct: 251 ILNKPLQLKPN 261

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           VPE      T   V AL  +  + G+IHRDVKP N+LLD+ G++KL DFG   ++ ++  
Sbjct: 171 VPEKWAKFYTAEVVLALDAI-HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 229
Query: 92  R--TKNAGCAAYMAPERIEPPNPQKPD--YDIRADVWSLGITLVELATGEFPY 140
                  G   Y++PE ++    Q  D  Y    D WS+G+ L E+  G+ P+
Sbjct: 230 VHCDTAVGTPDYISPEVLK---SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    L      +   G   Y+APE
Sbjct: 165 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  DY    D W+LG+ + E+  G  P+
Sbjct: 224 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    L      +   G   Y+APE
Sbjct: 133 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  DY    D W+LG+ + E+  G  P+
Sbjct: 192 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 138 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 197 TAQYVSPELLTEKSAXK-----SSDLWALGCIIYQLVAGLPPFR 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G IK+ DFG++ R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLMIDQQGYIKVTDFGLAKRV---KGRTWXLCGTPEYLAPEII-----LSKGYNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    L      +   G   Y+APE
Sbjct: 118 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  DY    D W+LG+ + E+  G  P+
Sbjct: 177 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +E+   C  R L  LH    +V EP        T++ + YL     VIHRD+K  N
Sbjct: 117 VYVVLEI---CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGN 172
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L++  ++K+ DFG++ ++  D + +    G   Y+APE +      K  +    D+WS
Sbjct: 173 LFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL-----CKKGHSFEVDIWS 227
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           LG  L  L  G+ P+ +  C  E   R+
Sbjct: 228 LGCILYTLLVGKPPF-ETSCLKETYIRI 254

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 61/116 (52%), Gaps = 8/116 (6%)
Query: 29  HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-V 87
           +  VPE      T   V AL  +  + G IHRDVKP N+LLD+ G++KL DFG   ++  
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 88  DSKARTKNA-GCAAYMAPERIEPPNPQKPD--YDIRADVWSLGITLVELATGEFPY 140
           +   R   A G   Y++PE ++    Q  D  Y    D WS+G+ L E+  G+ P+
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLK---SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 100 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 154
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 155 PENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIILSKG-----YNKAVD 206
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 207 WWALGVLIYEMAAGYPPF 224

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 135 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 189
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 241
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 242 WWALGVLIYEMAAGYPPF 259

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +E+   C  R L  LH    +V EP        T++ + YL     VIHRD+K  N
Sbjct: 117 VYVVLEI---CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGN 172
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L++  ++K+ DFG++ ++  D + +    G   Y+APE +      K  +    D+WS
Sbjct: 173 LFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL-----CKKGHSFEVDIWS 227
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           LG  L  L  G+ P+ +  C  E   R+
Sbjct: 228 LGCILYTLLVGKPPF-ETSCLKETYIRI 254

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +E+   C  R L  LH    +V EP        T++ + YL     VIHRD+K  N
Sbjct: 117 VYVVLEI---CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGN 172
Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L++  ++K+ DFG++ ++     R K+  G   Y+APE +      K  +    D+WS
Sbjct: 173 LFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL-----CKKGHSFEVDIWS 227
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           LG  L  L  G+ P+ +  C  E   R+
Sbjct: 228 LGCILYTLLVGKPPF-ETSCLKETYIRI 254

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 104 DVYIVQDLMETDLYKLLKCQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 160
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 161 LNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 215
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 216 WSVGCILAEMLSNRPIFPGK 235

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR-LVDSKARTKNAGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    L      +   G   Y+APE
Sbjct: 122 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +     +  DY    D W+LG+ + E+  G  P+
Sbjct: 181 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 4/111 (3%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           VPE      T   V AL  +  + G IHRDVKP N+LLD+ G++KL DFG   ++  +  
Sbjct: 170 VPEKWARFYTAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 91  ARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            R   A G   Y++PE ++        Y    D WS+G+ L E+  G+ P+
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGY-YGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 189
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 241
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 242 WWALGVLIYEMAAGYPPF 259

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           VPE      T   V AL  +  + G IHRDVKP N+LLD+ G++KL DFG   ++  +  
Sbjct: 170 VPEKWARFYTAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 91  ARTKNA-GCAAYMAPERIEPPNPQKPD--YDIRADVWSLGITLVELATGEFPY 140
            R   A G   Y++PE ++    Q  D  Y    D WS+G+ L E+  G+ P+
Sbjct: 229 VRCDTAVGTPDYISPEVLK---SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 107 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 161
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 213
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 214 WWALGVLIYEMAAGYPPF 231

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 109 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 163
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 164 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 215
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 216 WWALGVLIYEMAAGYPPF 233

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSL----DLIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G IK+ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +E+   C  R L  LH    +V EP        T++ + YL     VIHRD+K  N
Sbjct: 101 VYVVLEI---CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGN 156
Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L++  ++K+ DFG++ ++     R K+  G   Y+APE +      K  +    D+WS
Sbjct: 157 LFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL-----CKKGHSFEVDIWS 211
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           LG  L  L  G+ P+ +  C  E   R+
Sbjct: 212 LGCILYTLLVGKPPF-ETSCLKETYIRI 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 16/137 (11%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 189
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           P N+L+D++G I++ DFG + R+    A     G   Y+APE I         Y+   D 
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRV--KGATWTLCGTPEYLAPEIILSKG-----YNKAVDW 242
Query: 124 WSLGITLVELATGEFPY 140
           W+LG+ + E+A G  P+
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT  +G   Y+ PE IE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR-RTTLSGTLDYLPPEMIEGRM----- 183
Query: 117 YDIRADVWSLGITLVELATGEFPYK--DCKCDFEVLSRV 153
           +D + D+WSLG+   E   G+ P++    +  ++ +SRV
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++++W+    MA  +  D +       + E     I    +KAL Y+    G +HR VK 
Sbjct: 98  DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKA 156
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTK--------NAGCAAYMAPERIEPPNPQKPD 116
           S+IL+   G + L     +  ++    R +        +     +++PE ++  N Q   
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ-NLQ--G 213
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           YD ++D++S+GIT  ELA G  P+KD     ++L   LN   PCL
Sbjct: 214 YDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNGTVPCL 257

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYM 102
           T + LH L     +I+RD+KP N+L+D++G IK+ DFG + R+   K RT    G   Y+
Sbjct: 154 TFEYLHSL----DLIYRDLKPENLLIDQQGYIKVADFGFAKRV---KGRTWXLCGTPEYL 206
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           APE I         Y+   D W+LG+ + E+A G  P+
Sbjct: 207 APEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++++W+    MA  +  D +       + E     I    +KAL Y+    G +HR VK 
Sbjct: 82  DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKA 140
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTK--------NAGCAAYMAPERIEPPNPQKPD 116
           S+IL+   G + L     +  ++    R +        +     +++PE ++  N Q   
Sbjct: 141 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ-NLQ--G 197
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL 161
           YD ++D++S+GIT  ELA G  P+KD     ++L   LN   PCL
Sbjct: 198 YDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNGTVPCL 241

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 104 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 160
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +    +      Y APE +         Y    D+
Sbjct: 161 LNTTCDLKICDFGLA-RVADPDHDHTGFLXEXVATRWYRAPEIML----NSKGYTKSIDI 215
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 216 WSVGCILAEMLSNRPIFPGK 235

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 105 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 161
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +    +      Y APE +         Y    D+
Sbjct: 162 LNTTCDLKICDFGLA-RVADPDHDHTGFLXEXVATRWYRAPEIML----NSKGYTKSIDI 216
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 217 WSVGCILAEMLSNRPIFPGK 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEXIE-----GRX 187
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT+  G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTELCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPS 65
           ++V+I  ELM T   R++    +S        I     + L  +K  HG  VIHRD+KPS
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLS-----DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141
Query: 66  NILLDERGNIKLCDFGISGRLVDSKA------RTKNAGCAAYMAPERIEPPNPQ--KPDY 117
           N+L++   ++K+CDFG++ R++D  A        + +G   Y+A      P        Y
Sbjct: 142 NLLINSNCDLKVCDFGLA-RIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKY 200
Query: 118 DIRADVWSLGITLVELATGE--FPYKDCK 144
               DVWS G  L EL      FP +D +
Sbjct: 201 SRAMDVWSCGCILAELFLRRPIFPGRDYR 229

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNA--G 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N+  G
Sbjct: 135 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 194 TAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFR 232

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V++RD+KP+NILLDE G++++ D G++      K    + G   YMAPE ++    +   
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ----KGVA 367
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCK 144
           YD  AD +SLG  L +L  G  P++  K
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V++RD+KP+NILLDE G++++ D G++      K    + G   YMAPE ++    +   
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ----KGVA 366
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCK 144
           YD  AD +SLG  L +L  G  P++  K
Sbjct: 367 YDSSADWFSLGCMLFKLLRGHSPFRQHK 394

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+AP  I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPAIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V++RD+KP+NILLDE G++++ D G++      K    + G   YMAPE ++    +   
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ----KGVA 367
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCK 144
           YD  AD +SLG  L +L  G  P++  K
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V++RD+KP+NILLDE G++++ D G++      K    + G   YMAPE ++    +   
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ----KGVA 367
Query: 117 YDIRADVWSLGITLVELATGEFPYKDCK 144
           YD  AD +SLG  L +L  G  P++  K
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI---SGRLVDSKARTKN 95
           KI       +++L E H  IHRD+K +NILLDE    K+ DFG+   S +       ++ 
Sbjct: 128 KIAQGAANGINFLHENHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRI 186
Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
            G  AY APE +      + +   ++D++S G+ L+E+ TG
Sbjct: 187 VGTTAYXAPEAL------RGEITPKSDIYSFGVVLLEIITG 221

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERGNIKLCDFGISGRLV 87
           +PE     +    V  +++L+E +G++HR++KP NI+     D +   KL DFG +  L 
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 88  DSKARTKNAGCAAYMAP---ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC- 143
           D +      G   Y+ P   ER       +  Y    D+WS+G+T    ATG  P++   
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 144 --KCDFEVLSRVLNDAP 158
             + + EV+ +++   P
Sbjct: 228 GPRRNKEVMYKIITGKP 244

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNA--G 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N+  G
Sbjct: 139 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 198 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 236

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 129 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 178
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y++ 
Sbjct: 179 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNMT 232
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPPC 160
            D+WS+G  + EL TG   FP  D     + + R L   PP 
Sbjct: 233 VDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMR-LTGTPPA 273

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV++   LM     +LLK  H+S  + IC       ++ L Y+     V+HRD+KPSN+L
Sbjct: 120 DVYLVTHLMGADLYKLLKTQHLS-NDHIC-YFLYQILRGLKYIHSA-NVLHRDLKPSNLL 176
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 177 LNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 231
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 232 WSVGCILAEMLSNRPIFPGK 251

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIE-----GRM 208
Query: 117 YDIRADVWSLGITLVELATGEFPYK--DCKCDFEVLSRV 153
           +D + D+WSLG+   E   G+ P++    +  ++ +SRV
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 135 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 194 TAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFR 232

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 11  WICMELMA--TCFDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++ M+L++    FDR+L+R ++      +  +  LS VK LH     +G++HRD+KP N+
Sbjct: 82  YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENL 137
Query: 68  LL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L    +E   I + DFG+S ++  +   +   G   Y+APE +     QKP Y    D W
Sbjct: 138 LYLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYVAPEVL----AQKP-YSKAVDCW 191
Query: 125 SLGITLVELATGEFPYKD 142
           S+G+    L  G  P+ +
Sbjct: 192 SIGVITYILLCGYPPFYE 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 68/134 (50%), Gaps = 9/134 (6%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +D ++ M  M T   +L+K  H  + E     +    +K L Y+    G+IHRD+KP N+
Sbjct: 103 TDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI-HAAGIIHRDLKPGNL 159
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
            ++E   +K+ DFG++ R  DS+          Y APE I   N  +  Y    D+WS+G
Sbjct: 160 AVNEDCELKILDFGLA-RQADSEM-XGXVVTRWYRAPEVI--LNWMR--YTQTVDIWSVG 213
Query: 128 ITLVELATGEFPYK 141
             + E+ TG+  +K
Sbjct: 214 CIMAEMITGKTLFK 227

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 138 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 197 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 235

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 136 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 195 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 120 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 179 TAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFR 217

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 185
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G I++ DFG++ R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLMIDQQGYIQVTDFGLAKRV---KGRTWXLCGTPEYLAPEII-----LSKGYNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 138 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 197 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 235

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +++ M+L++    FDR++++   +  E    ++    + A+ YL +  G++HRD+KP N+
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYT--ERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENL 147
Query: 68  L---LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L   LDE   I + DFG+S         +   G   Y+APE +     QKP Y    D W
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL----AQKP-YSKAVDCW 202
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           S+G+    L  G  P+ D + D ++  ++L 
Sbjct: 203 SIGVIAYILLCGYPPFYD-ENDAKLFEQILK 232

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 187
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 136 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 195 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 233

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 187
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 136 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 195 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 233

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 199
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 200 HDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 31  SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERGNIKLCDFGISGRL 86
            +PE     +    V  +++L+E +G++HR++KP NI+     D +   KL DFG +  L
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 87  VDSKARTKNAGCAAYMAP---ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
            D +      G   Y+ P   ER       +  Y    D+WS+G+T    ATG  P++  
Sbjct: 167 EDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 144 ---KCDFEVLSRVLNDAP 158
              + + EV+ +++   P
Sbjct: 227 EGPRRNKEVMYKIITGKP 244

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 141 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 200 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 238

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 143 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 202 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 240

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 138 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 197 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 235

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTXLCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 114 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 173 TAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFR 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 115 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 174 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 212

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +++ M+L++    FDR++++   +  E    ++    + A+ YL +  G++HRD+KP N+
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYT--ERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENL 147
Query: 68  L---LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L   LDE   I + DFG+S         +   G   Y+APE +     QKP Y    D W
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL----AQKP-YSKAVDCW 202
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           S+G+    L  G  P+ D + D ++  ++L 
Sbjct: 203 SIGVIAYILLCGYPPFYD-ENDAKLFEQILK 232

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 186
Query: 117 YDIRADVWSLGITLVELATGEFPYK--DCKCDFEVLSRV 153
           +D + D+WSLG+   E   G+ P++    +  ++ +SRV
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 185
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYM 102
           T + LH L     +I+RD+KP N+++D++G IK+ DFG + R+   K RT    G   Y+
Sbjct: 154 TFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRV---KGRTWXLCGTPEYL 206
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           APE I         Y+   D W+LG+ + E+A G  P+
Sbjct: 207 APEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 181
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 139 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 198 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 236

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 113 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 172 TAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFR 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 138 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 197 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYM 102
           T + LH L     +I+RD+KP N+++D++G IK+ DFG + R+   K RT    G   Y+
Sbjct: 153 TFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRV---KGRTWXLCGTPEYL 205
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           APE I         Y+   D W+LG+ + E+A G  P+
Sbjct: 206 APEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 51  LKETH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAAYMAPER 106
           LK  H   ++HRD+K  NI L + G ++L DFGI+ R+++S      A  G   Y++PE 
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA-RVLNSTVELARACIGTPYYLSPEI 196
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPL 166
            E     KP Y+ ++D+W+LG  L EL T +  ++       VL  +    PP   +   
Sbjct: 197 CE----NKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSY 251
Query: 167 FGRTIKASIAKDNGR 181
             R++ + + K N R
Sbjct: 252 DLRSLVSQLFKRNPR 266

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +++ M+L++    FDR++++   +  E    ++    + A+ YL +  G++HRD+KP N+
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYT--ERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENL 147
Query: 68  L---LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L   LDE   I + DFG+S         +   G   Y+APE +     QKP Y    D W
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL----AQKP-YSKAVDCW 202
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           S+G+    L  G  P+ D + D ++  ++L 
Sbjct: 203 SIGVIAYILLCGYPPFYD-ENDAKLFEQILK 232

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 58/120 (48%), Gaps = 9/120 (7%)
Query: 29  HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 88
           H  + EP+   I    V A+ YL+    +IHRD+K  NI++ E   IKL DFG +  L  
Sbjct: 124 HPRLDEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182
Query: 89  SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFE 148
            K      G   Y APE +     + P+ ++    WSLG+TL  L   E P+    C+ E
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEM----WSLGVTLYTLVFEENPF----CELE 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKN--AG 97
           T   V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L  +SK    N   G
Sbjct: 116 TAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 98  CAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
            A Y++PE +   +  K      +D+W+LG  + +L  G  P++
Sbjct: 175 TAQYVSPELLTEKSACK-----SSDLWALGCIIYQLVAGLPPFR 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 179
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRM----- 187
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME       F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+++D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLMIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRM----- 183
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +++ M+L++    FDR++++   +  E    ++    + A+ YL +  G++HRD+KP N+
Sbjct: 91  LYLIMQLVSGGELFDRIVEKGFYT--ERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENL 147
Query: 68  L---LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L   LDE   I + DFG+S         +   G   Y+APE +     QKP Y    D W
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL----AQKP-YSKAVDCW 202
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           S+G+    L  G  P+ D + D ++  ++L 
Sbjct: 203 SIGVIAYILLCGYPPFYD-ENDAKLFEQILK 232

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 40  ITLSTVKALHYLKETHG-VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AG 97
           +     K ++YL   +  ++HRD+K  N+L+D++  +K+CDFG+S         +K  AG
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAG 201
Query: 98  CAAYMAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
              +MAPE  R EP N        ++DV+S G+ L ELAT + P+
Sbjct: 202 TPEWMAPEVLRDEPSNE-------KSDVYSFGVILWELATLQQPW 239

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 16/137 (11%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +A    F  L +    S P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           P N+L+D++G I++ DFG + R+   K RT    C     PE + P       Y+   D 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXL-CG---TPEALAPEIILSKGYNKAVDW 221
Query: 124 WSLGITLVELATGEFPY 140
           W+LG+ + E+A G  P+
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
           ALHY  E   VIHRD+KP N+L+  +G +K+ DFG S     S  R    G   Y+ PE 
Sbjct: 127 ALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEM 184
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---DAPPCL 161
           IE        +D + D+W  G+   E   G  P+ D     E   R++N     PP L
Sbjct: 185 IEGKT-----HDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL 236

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
           ALHY  E   VIHRD+KP N+L+  +G +K+ DFG S     S  R    G   Y+ PE 
Sbjct: 126 ALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEM 183
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---DAPPCL 161
           IE        +D + D+W  G+   E   G  P+ D     E   R++N     PP L
Sbjct: 184 IEGKT-----HDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL 235

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 100 DVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 156
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L+   ++K+ DFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 157 LNTTXDLKIXDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDI 211
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 212 WSVGCILAEMLSNRPIFPGK 231

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 12/112 (10%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNI---KLCDFGISGRL--------VD 88
           +      AL +L    G+ HRD+KP NIL +    +   K+CDF +   +        + 
Sbjct: 116 VVQDVASALDFL-HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 89  SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           +       G A YMAPE +E  + +   YD R D+WSLG+ L  L +G  P+
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 15/140 (10%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV+I  +LM T   +LLK   +S  + IC       ++ L Y+  +  V+HRD+KPSN+L
Sbjct: 120 DVYIVQDLMETDLYKLLKSQQLS-NDHIC-YFLYQILRGLKYI-HSANVLHRDLKPSNLL 176
Query: 69  LDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           ++   ++K+CDFG++ R+ D     +   T+      Y APE +         Y    D+
Sbjct: 177 INTTCDLKICDFGLA-RIADPEHDHTGFLTEXVATRWYRAPEIML----NSKGYTKSIDI 231
Query: 124 WSLGITLVELATGE--FPYK 141
           WS+G  L E+ +    FP K
Sbjct: 232 WSVGCILAEMLSNRPIFPGK 251

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 169
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 221
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEP--ICGKITLSTVKALHYLKETHGVIHRDVK 63
           S++++ ME +     F  L +      P       +I L T + LH L     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL-TFEYLHSLD----LIYRDLK 168
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+L+D++G I++ DFG + R+   K RT    G   Y+APE I         Y+   D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKG-----YNKAVD 220
Query: 123 VWSLGITLVELATGEFPY 140
            W+LG+ + E+A G  P+
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYM 102
           T + LH L     +I+RD+KP N+L+D++G I++ DFG + R+   K RT    G   Y+
Sbjct: 146 TFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWXLCGTPEYL 198
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           APE I         Y+   D W+LG+ + E+A G  P+
Sbjct: 199 APEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ RT   G   Y+ PE IE        
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 186
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G  P++
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 60/101 (59%), Gaps = 11/101 (10%)
Query: 44  TVKALHYLKETHG-VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAY 101
             K ++YL   +  ++HR++K  N+L+D++  +K+CDFG+S     +   +K+ AG   +
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205
Query: 102 MAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           MAPE  R EP N        ++DV+S G+ L ELAT + P+
Sbjct: 206 MAPEVLRDEPSNE-------KSDVYSFGVILWELATLQQPW 239

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 26/153 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPS 65
           ++V+I  ELM T   R++    +S        I     + L  +K  HG  VIHRD+KPS
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLS-----DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141
Query: 66  NILLDERGNIKLCDFGISGRLVDSKA------------RTKNAGCAAYMAPERIEPPNPQ 113
           N+L++   ++K+CDFG++ R++D  A             T+      Y APE +      
Sbjct: 142 NLLINSNCDLKVCDFGLA-RIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVML----T 196
Query: 114 KPDYDIRADVWSLGITLVELATGE--FPYKDCK 144
              Y    DVWS G  L EL      FP +D +
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPS 65
           ++V+I  ELM T   R++    +S        I     + L  +K  HG  VIHRD+KPS
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLS-----DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141
Query: 66  NILLDERGNIKLCDFGISGRLVDSKA------RTKNAGCAAYMAPERIEPPNPQ--KPDY 117
           N+L++   ++K+CDFG++ R++D  A        + +G   ++A      P        Y
Sbjct: 142 NLLINSNCDLKVCDFGLA-RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200
Query: 118 DIRADVWSLGITLVELATGE--FPYKDCK 144
               DVWS G  L EL      FP +D +
Sbjct: 201 SRAMDVWSCGCILAELFLRRPIFPGRDYR 229

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 167 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 225
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 226 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 14  MELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ER 72
           ME +   FD + +R   ++ E +        ++A+ +     GV+HRD+K  NIL+D  R
Sbjct: 95  MEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNR 151
Query: 73  GNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR-ADVWSLGITLV 131
           G +KL DFG SG L+     T   G   Y  PE I     +   Y  R A VWSLGI L 
Sbjct: 152 GELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RYHRYHGRSAAVWSLGILLY 205
Query: 132 ELATGEFPYK 141
           ++  G+ P++
Sbjct: 206 DMVCGDIPFE 215

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + + G      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G+ + E+  G
Sbjct: 207 DIWSVGVIMGEMIKG 221

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 2   SPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           S +SK   ++I ME     T    + KR    + + +  ++     K + Y+  +  +I+
Sbjct: 87  SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI-HSKKLIN 145
Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
           RD+KPSNI L +   +K+ DFG+   L +   R ++ G   YM+PE+I        DY  
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISS-----QDYGK 200
Query: 120 RADVWSLGITLVEL 133
             D+++LG+ L EL
Sbjct: 201 EVDLYALGLILAEL 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 44  TVKALHYLKETHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN--AGCA 99
           T + L  +K  H   ++HRD+KP NIL+D    +K+ DFGI+  L ++     N   G  
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 100 AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
            Y +PE+      +    D   D++S+GI L E+  GE P+ + +    +  + + D+ P
Sbjct: 177 QYFSPEQ-----AKGEATDECTDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHIQDSVP 230
Query: 160 CLPND 164
            +  D
Sbjct: 231 NVTTD 235

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + + G      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G+ + E+  G
Sbjct: 207 DIWSVGVIMGEMIKG 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 145 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 204 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 236

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 161 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 219
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 220 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 252

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 152 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 211 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 141 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 200 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 134 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 193 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 145 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 204 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 236

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 137 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 196 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 228

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 167 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 226 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 12/109 (11%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKART 93
           C +  L ++   H    ++G++HR++KP N+LL  +     +KL DFG++  + DS+A  
Sbjct: 110 CIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165
Query: 94  KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             AG   Y++PE ++     KP      D+W+ G+ L  L  G  P+ D
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKP-----VDIWACGVILYILLVGYPPFWD 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 12/109 (11%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKART 93
           C +  L ++   H    ++G++HR++KP N+LL  +     +KL DFG++  + DS+A  
Sbjct: 109 CIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 164
Query: 94  KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             AG   Y++PE ++     KP      D+W+ G+ L  L  G  P+ D
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKP-----VDIWACGVILYILLVGYPPFWD 208

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 230
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 230
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 138 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 196
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 197 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 12/109 (11%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKART 93
           C +  L ++   H    ++G++HR++KP N+LL  +     +KL DFG++  + DS+A  
Sbjct: 110 CIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165
Query: 94  KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             AG   Y++PE ++     KP      D+W+ G+ L  L  G  P+ D
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKP-----VDIWACGVILYILLVGYPPFWD 209

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 216
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 215
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 188
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 216
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RXXLXGTLDYLPPEMIEGRM----- 187
Query: 117 YDIRADVWSLGITLVELATGEFPYK--DCKCDFEVLSRV 153
           +D + D+WSLG+   E   G+ P++    +  ++ +SRV
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 215
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 169 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 227
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 228 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 260

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 133 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 186
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 212 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 270
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 271 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 303

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 157 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 210
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 187
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 215
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 171 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 229
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 230 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 188
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 216
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 183
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 183
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 188
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 216
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 146 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 205 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 237

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 102 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 152 DLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 205
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 230
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 106 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 156 DLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 209
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 215
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 183
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGIS-GRLVDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           V+HRD+KP N+L++ERG +KL DFG++  + + +K          Y  P+ +        
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST---- 176
Query: 116 DYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
           DY  + D+W +G    E+ATG   FP    +     + R+L
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 107 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIM----LNWMHYNQT 210
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           ++L Y+  + G+ HRD+KP N+LLD +   +KLCDFG + +LV  +          Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
           E I        DY    DVWS G  L EL  G+  FP
Sbjct: 192 ELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 61/120 (50%), Gaps = 16/120 (13%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGV--IHRDVKPSNILL---DERGNI-----KLCDFG 81
           +P  I     +   + ++YL +   V  IHRD+K SNIL+    E G++     K+ DFG
Sbjct: 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161
Query: 82  ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
           ++ R      +   AG  A+MAPE I      K      +DVWS G+ L EL TGE P++
Sbjct: 162 LA-REWHRTTKMSAAGAYAWMAPEVIRASMFSK-----GSDVWSYGVLLWELLTGEVPFR 215

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 222
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +++ M+L++    FDR++++   +  E     +    + A++YL    G++HRD+KP N+
Sbjct: 95  LYLVMQLVSGGELFDRIVEKGFYT--EKDASTLIRQVLDAVYYLHRM-GIVHRDLKPENL 151
Query: 68  LL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L    DE   I + DFG+S         +   G   Y+APE +     QKP Y    D W
Sbjct: 152 LYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVL----AQKP-YSKAVDCW 206
Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           S+G+    L  G  P+ D + D ++  ++L
Sbjct: 207 SIGVIAYILLCGYPPFYD-ENDSKLFEQIL 235

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 150 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 203
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 149 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 202
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 149 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 202
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ +FG S     S+ RT   G   Y+ PE IE        
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 184
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 150 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 203
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 182 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 235
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 107 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIM----LNWMHYNQT 210
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 54  THGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPP 110
           ++G++HR++KP N+LL  +     +KL DFG++  + DS+A    AG   Y++PE ++  
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 111 NPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
              KP      D+W+ G+ L  L  G  P+ D
Sbjct: 206 PYSKP-----VDIWACGVILYILLVGYPPFWD 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 107 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIM----LNWMHYNQT 210
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 56  GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           GV+HRD+K  NIL+D  RG +KL DFG SG L+     T   G   Y  PE I     + 
Sbjct: 150 GVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWI-----RY 203
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYK 141
             Y  R A VWSLGI L ++  G+ P++
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPE 105
           AL +L +  G+I+RD+KP NI+L+ +G++KL DFG+    + D        G   YMAPE
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +      +  ++   D WSLG  + ++ TG  P+
Sbjct: 192 IL-----MRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/89 (40%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 54  THGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           + GV+HRD+K  NIL+D  RG  KL DFG SG L+  +  T   G   Y  PE I     
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFDGTRVYSPPEWIS---- 211
Query: 113 QKPDYDIRADVWSLGITLVELATGEFPYK 141
           +   + + A VWSLGI L ++  G+ P++
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ +FG S     S+ RT   G   Y+ PE IE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM----- 185
Query: 117 YDIRADVWSLGITLVELATGEFPYK--DCKCDFEVLSRV 153
           +D + D+WSLG+   E   G+ P++    +  ++ +SRV
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPE 105
           AL +L +  G+I+RD+KP NI+L+ +G++KL DFG+    + D        G   YMAPE
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
            +      +  ++   D WSLG  + ++ TG  P+
Sbjct: 192 IL-----MRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RAALCGTLDYLPPEMIEGRM----- 185
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 105 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 155 DLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 208
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RXXLCGTLDYLPPEMIEGRM----- 184
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 105 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 155 DLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 208
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RAALCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RAALCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 13/112 (11%)
Query: 37  CGKITLS--------TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 88
           C K  LS         +  L +L  + G+++RD+K  NILLD+ G+IK+ DFG+    + 
Sbjct: 112 CHKFDLSRATFYAAEIILGLQFL-HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 89  SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
             A+T N  C     P+ I P       Y+   D WS G+ L E+  G+ P+
Sbjct: 171 GDAKT-NXFCG---TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 111 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 160
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 161 DLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 214
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 25/154 (16%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGK-ITLSTVKALHYLKETHGVIHRDVKPS 65
           + DV++  + M T    +++    ++ EP+  + +    +K + YL  + G++HRD+KPS
Sbjct: 83  DRDVYLVFDYMETDLHAVIR---ANILEPVHKQYVVYQLIKVIKYL-HSGGLLHRDMKPS 138
Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD----IRA 121
           NILL+   ++K+ DFG+S   V+ +  T N   +     E  +   P   DY      RA
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198
Query: 122 --------------DVWSLGITLVELATGE--FP 139
                         D+WSLG  L E+  G+  FP
Sbjct: 199 PEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 13/112 (11%)
Query: 37  CGKITLS--------TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 88
           C K  LS         +  L +L  + G+++RD+K  NILLD+ G+IK+ DFG+    + 
Sbjct: 113 CHKFDLSRATFYAAEIILGLQFL-HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 171
Query: 89  SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
             A+T N  C     P+ I P       Y+   D WS G+ L E+  G+ P+
Sbjct: 172 GDAKT-NEFCG---TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RXXLCGTLDYLPPEMIEGRM----- 185
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNAMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RXXLCGTLDYLPPEMIEGRM----- 182
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 96  NDVYLVTHLMGADLNNIVK----------CAKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 199
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RDDLCGTLDYLPPEMIEGRM----- 208
Query: 117 YDIRADVWSLGITLVELATGEFPYK--DCKCDFEVLSRV 153
           +D + D+WSLG+   E   G+ P++    +  ++ +SRV
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 57  VIHRDVKPSNILLD--ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           V HRD+K  N LLD      +K+CDFG S   V         G  AY+APE +      K
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-----LK 190
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYKD---CKCDFEVLSRVLN 155
            +YD + ADVWS G+TL  +  G +P++D    K   + + R+LN
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RDTLCGTLDYLPPEMIEGRM----- 183
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 106 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 156 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 209
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 57  VIHRDVKPSNILLDERG--NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           V HRD+K  N LLD      +K+CDFG S   V         G  AY+APE +      K
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-----LK 189
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYKD---CKCDFEVLSRVLN 155
            +YD + ADVWS G+TL  +  G +P++D    K   + + R+LN
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 234

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 139 LQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 256
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 257 QPEYCPDPLYEVMLK 271

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 106 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 156 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 209
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 102 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 152 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 205
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 163 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 154 LN 155
           ++
Sbjct: 281 ID 282

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RDDLCGTLDYLPPEMIEGRM----- 185
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G+ P++
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 119 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 168
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 169 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 222
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 81  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 139
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 140 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----GXKYYSTAVDIW 195
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 196 SLGCIFAEMVT 206

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 120 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 169
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 170 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 223
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 110 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 159
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 160 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 213
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 214 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 249

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 135 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 154 LN 155
           ++
Sbjct: 253 ID 254

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 105 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 155 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 208
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 102 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 152 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 205
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 99  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 148
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 149 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 202
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 203 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 238

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 116 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 154 LN 155
           ++
Sbjct: 234 ID 235

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 112 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 161
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 162 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 215
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 123 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 172
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 173 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 226
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 112 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 161
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 162 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 215
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 105 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 155 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 208
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 140 LQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 257
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 258 QPEYCPDPLYEVMLK 272

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 107 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 210
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 119 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 168
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 169 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 222
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 17/94 (18%)
Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGIS------GRLVDSKARTKNAGCAAYMAPERI 107
           +H +IHRD+KP NIL+ + G +KLCDFG +      G + D +  T+      Y APE +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELL 196
Query: 108 EPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
                    Y    DVW++G  + E+  GE  FP
Sbjct: 197 ----VGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 138 LQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 255
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 256 QPEYCPDPLYEVMLK 270

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 139 LQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 256
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 257 QPEYCPDPLYEVMLK 271

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 163 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 154 LN 155
           ++
Sbjct: 281 ID 282

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 163 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 154 LN 155
           ++
Sbjct: 281 ID 282

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIE 108
           +  ++ G+I+RD+K  N++LD  G+IK+ DFG+    +     TK   G   Y+APE I 
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII- 514
Query: 109 PPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
                +P Y    D W+ G+ L E+  G+ P++
Sbjct: 515 ---AYQP-YGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 112 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 161
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 162 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 215
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 135 LQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 252
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 253 QPEYCPDPLYEVMLK 267

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 140 LQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 257
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 258 QPEYCPDPLYEVMLK 272

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----GXKYYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 102 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 152 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 205
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIE 108
           +  ++ G+I+RD+K  N++LD  G+IK+ DFG+    +     TK   G   Y+APE I 
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII- 193
Query: 109 PPNPQKPDYDIRADVWSLGITLVELATGEFPYK 141
                +P Y    D W+ G+ L E+  G+ P++
Sbjct: 194 ---AYQP-YGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 120 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 169
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 170 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 223
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 137 LQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 254
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 255 QPEYCPDPLYEVMLK 269

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 106 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 156 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 209
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 111 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 160
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 161 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 214
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 132 LQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 249
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 250 QPEYCPDPLYEVMLK 264

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 158 LQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 275
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 276 QPEYCPDPLYEVMLK 290

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + YL  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 159 LQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 276
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 277 QPEYCPDPLYEVMLK 291

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 1   MSPQSKESDVWICMELMA---TCFDRLLKRLHVSV--PEPICGKITLSTVKALHYLKETH 55
           +   S +  +++  E M     CF+ ++KR        E +        ++AL Y  + +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 56  GVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPN 111
            +IHRDVKP N+LL  + N   +KL DFG++ +L +S        G   +MAPE ++   
Sbjct: 151 -IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYKDCK 144
             KP      DVW  G+ L  L +G  P+   K
Sbjct: 210 YGKP-----VDVWGCGVILFILLSGCLPFYGTK 237

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 96  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 199
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 96  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 199
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 97  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 146
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 147 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 200
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 5   SKESDVWICMELMATCFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           S+   + + ME +     ++LK   R   S+P  +         +A+ ++  + G+ HRD
Sbjct: 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI-HSLGICHRD 166
Query: 62  VKPSNILLDERGN-IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           +KP N+L++ + N +KLCDFG + +L+ S+          Y APE +        +Y   
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELML----GATEYTPS 222
Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL 154
            D+WS+G    EL  G+ P    +   + L R++
Sbjct: 223 IDLWSIGCVFGELILGK-PLFSGETSIDQLVRII 255

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 119 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 236
Query: 154 LN 155
           ++
Sbjct: 237 ID 238

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++     S  +    G  
Sbjct: 115 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 232
Query: 154 LN 155
           ++
Sbjct: 233 ID 234

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 97  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 146
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 147 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 200
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 8   SDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +++ + +EL+     FDR++++ + S  E          ++A+ YL E +G++HRD+KP 
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYS--ERDAADAVKQILEAVAYLHE-NGIVHRDLKPE 177
Query: 66  NILLDE---RGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRA 121
           N+L         +K+ DFG+S ++V+ +   K   G   Y APE +     +   Y    
Sbjct: 178 NLLYATPAPDAPLKIADFGLS-KIVEHQVLMKTVCGTPGYCAPEIL-----RGCAYGPEV 231
Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           D+WS+GI    L  G  P+ D + D  +  R+LN
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 154 SFQVAKGMEFLA-SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 213 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           + AL +L +  G+I+RD+K  N+LLD  G+ KL DFG+    + +   T    G   Y+A
Sbjct: 134 ISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND 156
           PE +     Q+  Y    D W++G+ L E+  G  P++    D ++   +LND
Sbjct: 193 PEIL-----QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILND 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 98  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 147
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 148 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 201
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 202 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 237

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           VIHRD+KP N+LL   G +K+ DFG S     S+ R    G   Y+ PE IE        
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR-RDTLCGTLDYLPPEMIEGRM----- 186
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
           +D + D+WSLG+   E   G  P++
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D  A         Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 18/145 (12%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPE---PICGK--ITLSTVKALHYLKETHGVIHR 60
           ++  +++ ME        +L     SVPE   P+C         +  L YL  + G++H+
Sbjct: 79  EKQKMYMVMEYCVCGMQEMLD----SVPEKRFPVCQAHGYFCQLIDGLEYL-HSQGIVHK 133
Query: 61  DVKPSNILLDERGNIKLCDFGISGRL----VDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           D+KP N+LL   G +K+   G++  L     D   RT + G  A+  PE     N     
Sbjct: 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIA---NGLDTF 189
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
              + D+WS G+TL  + TG +P++
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLD--ERGNIKLCDFGISGRLVDSKARTKNAGCA 99
           LS V   H ++    + HRD+K  N LLD      +K+CDFG S   V         G  
Sbjct: 126 LSGVSYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181
Query: 100 AYMAPERIEPPNPQKPDYDIR-ADVWSLGITLVELATGEFPYKD 142
           AY+APE +      + +YD + ADVWS G+TL  +  G +P++D
Sbjct: 182 AYIAPEVL-----LRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D  A         Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 154 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 213 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 63/135 (46%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + + G      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 150 SFQVAKGMEFLA-SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 209 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 260

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 154 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 213 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 3   PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG- 56
           P  +   V++ ++LM +   +++   H S P      +TL  V+   Y     LK  H  
Sbjct: 127 PYGEFKSVYVVLDLMESDLHQII---HSSQP------LTLEHVRYFLYQLLRGLKYMHSA 177
Query: 57  -VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-----TKNAGCAAYMAPERIEPP 110
            VIHRD+KPSN+L++E   +K+ DFG++  L  S A      T+      Y APE +   
Sbjct: 178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237
Query: 111 NPQKPDYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPPCL 161
           +    +Y    D+WS+G    E+      FP K+     +++  VL    P +
Sbjct: 238 H----EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 76/150 (50%), Gaps = 23/150 (15%)
Query: 1   MSPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           M+   K+S ++I ME     T +D L+   +++       ++    ++AL Y+  + G+I
Sbjct: 81  MTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQILEALSYI-HSQGII 138
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRL--------VDSK-------ARTKNAGCAAYMA 103
           HRD+KP NI +DE  N+K+ DFG++  +        +DS+         T   G A Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            E ++        Y+ + D++SLGI   E+
Sbjct: 199 TEVLDGTG----HYNEKIDMYSLGIIFFEM 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 518
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 573
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 618

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 156 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 215 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 266

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 154 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 213 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 154 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 213 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           D ++ M  M T   +++    +   E     +    +K L Y+  + GV+HRD+KP N+ 
Sbjct: 121 DFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYI-HSAGVVHRDLKPGNLA 176
Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           ++E   +K+ DFG++ R  D++  T       Y APE I         Y+   D+WS+G 
Sbjct: 177 VNEDCELKILDFGLA-RHADAEM-TGYVVTRWYRAPEVI----LSWMHYNQTVDIWSVGC 230
Query: 129 TLVELATGEFPYK 141
            + E+ TG+  +K
Sbjct: 231 IMAEMLTGKTLFK 243

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           D ++ M  M T   +++    +   E     +    +K L Y+  + GV+HRD+KP N+ 
Sbjct: 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYI-HSAGVVHRDLKPGNLA 158
Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           ++E   +K+ DFG++ R  D++  T       Y APE I         Y+   D+WS+G 
Sbjct: 159 VNEDCELKILDFGLA-RHADAEM-TGYVVTRWYRAPEVI----LSWMHYNQTVDIWSVGC 212
Query: 129 TLVELATGEFPYK 141
            + E+ TG+  +K
Sbjct: 213 IMAEMLTGKTLFK 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 96  NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D  A         Y APE +         Y+  
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIM----LNWMHYNQT 199
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 7/124 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           VP      +    ++ L +L  +H V+HRD+KP NIL+   G IKL DFG++       A
Sbjct: 117 VPTETIKDMMFQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS 151
            T       Y APE +      +  Y    D+WS+G    E+   + P      D + L 
Sbjct: 176 LTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLG 229
Query: 152 RVLN 155
           ++L+
Sbjct: 230 KILD 233

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 204 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 263 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 314

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 206 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 265 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 316

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 7/124 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           VP      +    ++ L +L  +H V+HRD+KP NIL+   G IKL DFG++       A
Sbjct: 117 VPTETIKDMMFQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS 151
            T       Y APE +      +  Y    D+WS+G    E+   + P      D + L 
Sbjct: 176 LTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLG 229
Query: 152 RVLN 155
           ++L+
Sbjct: 230 KILD 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 145 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 204 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 145 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 204 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 199 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 258 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 191 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 250 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 152
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 153 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 207
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 208 DIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 7/124 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 91
           VP      +    ++ L +L  +H V+HRD+KP NIL+   G IKL DFG++       A
Sbjct: 117 VPTETIKDMMFQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLS 151
            T       Y APE +      +  Y    D+WS+G    E+   + P      D + L 
Sbjct: 176 LTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLG 229
Query: 152 RVLN 155
           ++L+
Sbjct: 230 KILD 233

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 145 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 204 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 3   PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG- 56
           P  +   V++ ++LM +   +++   H S P      +TL  V+   Y     LK  H  
Sbjct: 128 PYGEFKSVYVVLDLMESDLHQII---HSSQP------LTLEHVRYFLYQLLRGLKYMHSA 178
Query: 57  -VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-----TKNAGCAAYMAPERIEPP 110
            VIHRD+KPSN+L++E   +K+ DFG++  L  S A      T+      Y APE +   
Sbjct: 179 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 238
Query: 111 NPQKPDYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPPCL 161
           +    +Y    D+WS+G    E+      FP K+     +++  VL    P +
Sbjct: 239 H----EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 287

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 145 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 204 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 255

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +      
Sbjct: 197 SFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 256 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 307

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 138
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 139 ARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI---NFRR--FTSAS 193
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 238

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  ++D +  + +    A 
Sbjct: 141 LQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 258
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 259 QPEYCPDPLYEVMLK 273

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +EL   C  R L  LH    ++ EP         V    YL     VIHRD+K  N
Sbjct: 96  VFVVLEL---CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGN 151
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DVWS
Sbjct: 152 LFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-----SKKGHSFEVDVWS 206
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           +G  +  L  G+ P+ +  C  E   R+
Sbjct: 207 IGCIMYTLLVGKPPF-ETSCLKETYLRI 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 81  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 139
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 140 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 195
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 196 SLGCIFAEMVT 206

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 11/110 (10%)
Query: 33  PEPICGKITL----STVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLV 87
           P PI  K+ L     ++  LH    +  V HRD+KP N+L++E  G +KLCDFG + +L 
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHL--PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 88  DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE 137
            S+          Y APE I         Y    D+WS+G    E+  GE
Sbjct: 184 PSEPNVAYICSRYYRAPELIF----GNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 133
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 189
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 190 SLGCIFAEMVT 200

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ D+G++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDYGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 518
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 519 ARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 573
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 618

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 131
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 187
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 188 SLGCIFAEMVT 198

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +EL   C  R L  LH    ++ EP         V    YL     VIHRD+K  N
Sbjct: 92  VFVVLEL---CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGN 147
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DVWS
Sbjct: 148 LFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-----SKKGHSFEVDVWS 202
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           +G  +  L  G+ P+ +  C  E   R+
Sbjct: 203 IGCIMYTLLVGKPPF-ETSCLKETYLRI 229

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 131
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 187
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 188 SLGCIFAEMVT 198

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 131
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 187
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 188 SLGCIFAEMVT 198

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 309
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG+ GRL++    T   G  A    +   P       + I++DVW
Sbjct: 310 ANILVGENLVCKVADFGL-GRLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 367 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 408

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +EL   C  R L  LH    ++ EP         V    YL     VIHRD+K  N
Sbjct: 92  VFVVLEL---CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGN 147
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DVWS
Sbjct: 148 LFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-----SKKGHSFEVDVWS 202
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           +G  +  L  G+ P+ +  C  E   R+
Sbjct: 203 IGCIMYTLLVGKPPF-ETSCLKETYLRI 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 29/158 (18%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 123 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 172
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP--QKPDYD 118
           D+KPSN+ ++E   +K+ DFG+        AR  +     Y+A      P        Y+
Sbjct: 173 DLKPSNLAVNEDCELKILDFGL--------ARHTDDEMXGYVATRWYRAPEIMLNWMHYN 224
Query: 119 IRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
              D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 225 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 78  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 136
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 137 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK----YYSTAVDIW 192
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 193 SLGCIFAEMVT 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 76/150 (50%), Gaps = 23/150 (15%)
Query: 1   MSPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           M+   K+S ++I ME     T +D L+   +++       ++    ++AL Y+  + G+I
Sbjct: 81  MTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDEYWRLFRQILEALSYI-HSQGII 138
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRL--------VDSK-------ARTKNAGCAAYMA 103
           HRD+KP NI +DE  N+K+ DFG++  +        +DS+         T   G A Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            E ++        Y+ + D++SLGI   E+
Sbjct: 199 TEVLDGTG----HYNEKIDMYSLGIIFFEM 224

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 8   SDVWICMELMATCFDRLL------KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     +++      +R+   + + +CG      +K LH    + G+IHRD
Sbjct: 100 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 149
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     +   T       Y APE I         Y    
Sbjct: 150 LKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI-----LGMGYKENV 204
Query: 122 DVWSLGITLVELATGEFPYK 141
           D+WS+G  + EL  G   ++
Sbjct: 205 DIWSVGCIMGELVKGSVIFQ 224

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           S+V++   LM    + ++K   +S  +     +    ++ L Y+  + G+IHRD+KPSN+
Sbjct: 106 SEVYLVTTLMGADLNNIVKSQALS--DEHVQFLVYQLLRGLKYI-HSAGIIHRDLKPSNV 162
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
            ++E   +++ DFG++ R  D +  T       Y APE +         Y+   D+WS+G
Sbjct: 163 AVNEDSELRILDFGLA-RQADEEM-TGYVATRWYRAPEIM----LNWMHYNQTVDIWSVG 216
Query: 128 ITLVELATGE--FPYKDCKCDFEVLSRVLNDAPP 159
             + EL  G+  FP  D     + +  V+    P
Sbjct: 217 CIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 250

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLL------KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     +++      +R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     +   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI-----LGMGYAANV 206
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + EL  G
Sbjct: 207 DIWSVGCIMGELVKG 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 120 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 169
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++ R  D +     A    Y APE +         Y+  
Sbjct: 170 DLKPSNLAVNEDCELKILDFGLA-RHTDDEMXGXVA-TRWYRAPEIM----LNWMHYNQT 223
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +EL   C  R L  LH    ++ EP         V    YL     VIHRD+K  N
Sbjct: 116 VFVVLEL---CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGN 171
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DVWS
Sbjct: 172 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVWS 226
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           +G  +  L  G+ P+ +  C  E   R+
Sbjct: 227 IGCIMYTLLVGKPPF-ETSCLKETYLRI 253

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +EL   C  R L  LH    ++ EP         V    YL     VIHRD+K  N
Sbjct: 114 VFVVLEL---CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGN 169
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DVWS
Sbjct: 170 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVWS 224
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           +G  +  L  G+ P+ +  C  E   R+
Sbjct: 225 IGCIMYTLLVGKPPF-ETSCLKETYLRI 251

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 84  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 140
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 141 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 195
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 196 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 240

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 110 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 166
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 167 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 221
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 222 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 266

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 85  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 141
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 142 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 196
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 197 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 241

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +P P+        ++ L +   +H V+HRD+KP N+L++  G IKL DFG++    V  +
Sbjct: 99  IPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
             T       Y APE +         Y    D+WSLG    E+ T
Sbjct: 158 TYTHEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVT 198

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 141 LQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 258
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 259 QPEYCPDPLYEVMLK 273

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 140 LQVAKGMKFL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 257
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 258 QPEYCPDPLYEVMLK 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGI-SGRLVDSKARTKNAGCAAYMAPERIE 108
           +     G+I+RD+K  N++LD  G+IK+ DFG+    ++D     +  G   Y+APE I 
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII- 192
Query: 109 PPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
                +P Y    D W+ G+ L E+  G+ P+
Sbjct: 193 ---AYQP-YGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 138
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 139 ARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 193
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 238

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 63/122 (51%), Gaps = 11/122 (9%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKARTKNAGCA 99
           + ++A+H + + HG++H D+KP+N L+ + G +KL DFGI+ ++        +    G  
Sbjct: 135 NMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVKDSQVGTV 192
Query: 100 AYMAPERIEPPNPQKPD------YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
            YM PE I+  +  + +         ++DVWSLG  L  +  G+ P++        L  +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 154 LN 155
           ++
Sbjct: 253 ID 254

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 10  VWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           V++ +EL   C  R L  LH    ++ EP         V    YL     VIHRD+K  N
Sbjct: 90  VFVVLEL---CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGN 145
Query: 67  ILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           + L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DVWS
Sbjct: 146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVWS 200
Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRV 153
           +G  +  L  G+ P+ +  C  E   R+
Sbjct: 201 IGCIMYTLLVGKPPF-ETSCLKETYLRI 227

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 9   DVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD+
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRDL 190
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSNI++     +K+ DFG++     S   T       Y APE I         Y    D
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVD 245
Query: 123 VWSLGITLVELATGE--FPYKD 142
           +WS+G  + E+   +  FP +D
Sbjct: 246 IWSVGCIMGEMVRHKILFPGRD 267

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 87  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 143
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 144 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 198
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 243

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 138 LQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 255
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 256 QPEYCPDPLYEVMLK 270

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 140 LQVAKGMKFL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 257
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 258 QPEYCPDPLYEVMLK 272

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 199 LQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 316
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 317 QPEYCPDPLYEVMLK 331

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 79  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 135
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 190
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 235

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 138
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 139 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 193
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 238

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           AL YL E   +IHRD+KP NI+L    +R   K+ D G +  L   +  T+  G   Y+A
Sbjct: 134 ALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +E     +  Y +  D WS G    E  TG  P+
Sbjct: 193 PELLE-----QKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           AL YL E   +IHRD+KP NI+L    +R   K+ D G +  L   +  T+  G   Y+A
Sbjct: 133 ALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +E     +  Y +  D WS G    E  TG  P+
Sbjct: 192 PELLE-----QKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 7   ESDVWICMELMATCFDR---LLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E+ VWI MEL      R    +++  + +   I     LST  AL YL E+   +HRD+ 
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST--ALAYL-ESKRFVHRDIA 138
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+     +KL DFG+S  + DS     + G     +MAPE I   N ++  +   +
Sbjct: 139 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FTSAS 193
Query: 122 DVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
           DVW  G+ + E L  G  P++  K + +V+ R+ N +  P  PN P
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCP 238

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   K + +L  +   +HRD+   N +LDE+  +K+ DFG++  + D +  + +    A 
Sbjct: 145 LQVAKGMKFL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPC 160
           +  + +   + Q   +  ++DVWS G+ L EL T G  PY D    F++   +L      
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLL 262
Query: 161 LPN---DPLFGRTIK 172
            P    DPL+   +K
Sbjct: 263 QPEYCPDPLYEVMLK 277

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETH--GVIHR 60
           S+V++   LM    + ++K          C  ++   V+ L Y     LK  H  G+IHR
Sbjct: 106 SEVYLVTTLMGADLNNIVK----------CQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 155
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +++ DFG++ R  D +  T       Y APE +         Y+  
Sbjct: 156 DLKPSNVAVNEDSELRILDFGLA-RQADEEM-TGYVATRWYRAPEIM----LNWMHYNQT 209
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPP 159
            D+WS+G  + EL  G+  FP  D     + +  V+    P
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 250

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I ME M+     D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 143 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 200 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 189
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 244
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRD 267

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E ++    + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 75  ENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPE 133
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 189
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 190 SLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E ++    + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 77  ENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPE 135
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 191
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 192 SLGCIFAEMVT 202

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 96  QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 145
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 146 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 200
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 201 DLWSVGCIMGEMVCHKILFPGRD 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 107 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 156
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 157 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 211
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 212 DLWSVGCIMGEMVCHKILFPGRD 234

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           +  + YL  +HG++HRD+  SN+LL    NIK+ DFG++ +L     +     C     P
Sbjct: 122 ITGMLYL-HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CG---TP 176
Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
             I P    +  + + +DVWSLG     L  G  P+
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 11/105 (10%)
Query: 57  VIHRDVKPSNILLD--ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           V HRD+K  N LLD      +K+C FG S   V         G  AY+APE +      K
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVL-----LK 190
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYKD---CKCDFEVLSRVLN 155
            +YD + ADVWS G+TL  +  G +P++D    K   + + R+LN
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 103 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 152
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 153 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 207
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 208 DIWSVGCIMGEMVRHKILFPGRD 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 96  QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 145
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 146 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 200
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 201 DIWSVGCIMGEMVRHKILFPGRD 223

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 132 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 188
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 189 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 95  QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 144
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 145 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 199
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 200 DIWSVGCIMGEMVRHKILFPGRD 222

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I +E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 79  TREPPFYIIIEFMT--YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHR 135
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 118 DIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
            I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 134 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 190
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 191 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 103 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 152
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 153 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 207
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 208 DIWSVGCIMGEMVRHKILFPGRD 230

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 96  QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 145
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 146 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 200
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 201 DIWSVGCIMGEMVRHKILFPGRD 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 101 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 150
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 151 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 205
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 206 DIWSVGCIMGEMVRHKILFPGRD 228

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I +E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 79  TREPPFYIIIEFMT--YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHR 135
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 118 DIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
            I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 182
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 183 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 128 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 184
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 185 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 182
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 183 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 127 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 183
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 184 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K            K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------XQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 56  GVIHRDVKPSNILLDER---GNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPN 111
           GV+HRD+KP N+LL  +     +KL DFG++  +  D +A    AG   Y++PE +    
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             KP      D+W+ G+ L  L  G  P+ D
Sbjct: 183 YGKP-----VDIWACGVILYILLVGYPPFWD 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 135 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAI-- 191
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 192 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 132 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 188
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 189 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 131 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 187
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 188 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 136 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 192
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 193 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 11/105 (10%)
Query: 57  VIHRDVKPSNILLD--ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           V HRD+K  N LLD      +K+C FG S   V         G  AY+APE +      K
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVL-----LK 190
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYKD---CKCDFEVLSRVLN 155
            +YD + ADVWS G+TL  +  G +P++D    K   + + R+LN
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+  FG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILGFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 121 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 177
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 178 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 182
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 183 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 63/135 (46%), Gaps = 21/135 (15%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 104 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 153
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S           Y APE I         Y    
Sbjct: 154 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI-----LGMGYKENV 208
Query: 122 DVWSLGITLVELATG 136
           D+WS+G  + E+  G
Sbjct: 209 DIWSVGCIMGEMIKG 223

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 25  LKRLHV---SVPEPICGKITLSTVKALHYL-KETHGVIHRDVKPSNILLDE-RGNIKLCD 79
           LKR  V    V    C +I    +K L +L   T  +IHRD+K  NI +    G++K+ D
Sbjct: 120 LKRFKVXKIKVLRSWCRQI----LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 80  FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFP 139
            G++     S A+    G   + APE  E        YD   DV++ G   +E AT E+P
Sbjct: 176 LGLATLKRASFAKA-VIGTPEFXAPEXYEEK------YDESVDVYAFGXCXLEXATSEYP 228
Query: 140 YKDCKCDFEVLSRVLNDAPPC 160
           Y +C+   ++  RV +   P 
Sbjct: 229 YSECQNAAQIYRRVTSGVKPA 249

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDAEXTAREGAKFPIKWTAPEAI-- 182
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 183 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 33/148 (22%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI-----EPPNPQKPD 116
           +KPSNI++     +K+ DFG+        ART  AG +  M PE +      P       
Sbjct: 152 LKPSNIVVKSDCTLKILDFGL--------ART--AGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 117 YDIRADVWSLGITLVELATGE--FPYKD 142
           Y    D+WS+G  + E+   +  FP +D
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRD 229

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 17/144 (11%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I +E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 77  TREPPFYIIIEFMT--YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHR 133
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 134 DLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESL-----AYNKF 187
Query: 118 DIRADVWSLGITLVELAT-GEFPY 140
            I++DVW+ G+ L E+AT G  PY
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 64/137 (46%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 145
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T+      Y+APE + P       YD   D+
Sbjct: 146 LLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEK-----YDKSCDM 200
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 201 WSLGVIMYILLCGYPPF 217

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I +E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 143 ANILVGENLVCKVADFGLA-RLIEDNEXTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 200 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 11/105 (10%)
Query: 57  VIHRDVKPSNILLD--ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           V HRD+K  N LLD      +K+ DFG S   V         G  AY+APE +      K
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVL-----LK 190
Query: 115 PDYDIR-ADVWSLGITLVELATGEFPYKD---CKCDFEVLSRVLN 155
            +YD + ADVWS G+TL  +  G +P++D    K   + + R+LN
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 11/134 (8%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME +     F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N+L 
Sbjct: 106 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLY 164
Query: 70  -DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
             +R N  +KL DFG +       + T       Y+APE + P       YD   D+WSL
Sbjct: 165 TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSL 219
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 220 GVIMYILLCGYPPF 233

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 133
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 189
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 190 SLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 77  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 135
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 191
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 192 SLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 76  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 134
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 190
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 191 SLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 77  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 135
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 191
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 192 SLGCIFAEMVT 202

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DF ++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFYLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I +E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 80  TREPPFYIIIEFMT--YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHR 136
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 137 DLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESL-----AYNKF 190
Query: 118 DIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
            I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 228

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 128 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 185
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 186 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 232

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I +E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 143 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 200 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 13/142 (9%)
Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +KE  ++I  E MA  +  D L       V  P     +    + + Y+ E    IHRD+
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI-ERKNYIHRDL 135
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDI 119
           + +N+L+ E    K+ DFG++ R+++    T   G      + APE I         + I
Sbjct: 136 RAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGC-----FTI 189
Query: 120 RADVWSLGITLVELAT-GEFPY 140
           +++VWS GI L E+ T G+ PY
Sbjct: 190 KSNVWSFGILLYEIVTYGKIPY 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 76  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 134
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 190
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 191 SLGCIFAEMVT 201

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 128 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 185
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 186 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 123 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 180
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 181 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 123 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 180
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 181 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 95  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 153
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D+
Sbjct: 154 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDM 208
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 209 WSLGVIMYILLCGYPPF 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 94  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 152
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D+
Sbjct: 153 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDM 207
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 208 WSLGVIMYILLCGYPPF 224

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 136 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 194 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 240

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 93  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 151
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D+
Sbjct: 152 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDM 206
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 207 WSLGVIMYILLCGYPPF 223

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 125 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 182
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 183 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 229

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I +E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 84  TREPPFYIIIEFMT--YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHR 140
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 141 DLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 194
Query: 118 DIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
            I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K            K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------SQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG+     D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 131
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 187
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 188 SLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 131
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 187
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 188 SLGCIFAEMVT 198

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 128 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTA 185
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 186 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 232

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 125 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 182
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 183 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 132
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 188
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 189 SLGCIFAEMVT 199

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 128 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 185
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 186 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 232

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 78  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 136
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 137 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 192
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 193 SLGCIFAEMVT 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQ 133
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 189
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 190 SLGCIFAEMVT 200

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 121 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTA 178
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           PE +         + I++DVW+ G+ L E+AT G  PY
Sbjct: 179 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 76  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPE 134
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 190
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 191 SLGCIFAEMVT 201

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 88  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 146
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D+
Sbjct: 147 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDM 201
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 202 WSLGVIMYILLCGYPPF 218

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 11/134 (8%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME +     F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N+L 
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLY 194
Query: 70  -DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
             +R N  +KL DFG +       + T       Y+APE + P       YD   D+WSL
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSL 249
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 250 GVIMYILLCGYPPF 263

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 13/142 (9%)
Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           ++E  ++I  E MA  +  D L       V  P     +    + + Y+ E    IHRD+
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI-ERKNYIHRDL 136
Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDI 119
           + +N+L+ E    K+ DFG++ R+++    T   G      + APE I         + I
Sbjct: 137 RAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGC-----FTI 190
Query: 120 RADVWSLGITLVELAT-GEFPY 140
           ++DVWS GI L E+ T G+ PY
Sbjct: 191 KSDVWSFGILLYEIVTYGKIPY 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 123 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 180
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 181 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 7   ESDVWICMELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +    ++ +P P+        ++ L +   +H V+HRD+KP 
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPE 133
Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +          Y APE +         Y    D+W
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK----YYSTAVDIW 189
Query: 125 SLGITLVELAT 135
           SLG    E+ T
Sbjct: 190 SLGCIFAEMVT 200

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 147
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D+
Sbjct: 148 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDM 202
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 203 WSLGVIMYILLCGYPPF 219

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 127 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 184
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 185 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPEN 145
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D+
Sbjct: 146 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDM 200
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+ +  L  G  P+
Sbjct: 201 WSLGVIMYILLCGYPPF 217

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 7   ESDVWICMEL-----MATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           E+ +++ ME      + T   +  +R+   +      +I ++ + ++H L    G +HRD
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA-IDSVHRL----GYVHRD 187
Query: 62  VKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDI 119
           +KP NILLD  G+I+L DFG   +L  D   R+  A G   Y++PE ++           
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247
Query: 120 --RADVWSLGITLVELATGEFPY 140
               D W+LG+   E+  G+ P+
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPF 270

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 142 AMEYL-EKKNFIHRDLAARNCLVGENHVVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 199
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           PE +         + I++DVW+ G+ L E+AT G  PY
Sbjct: 200 PESL-----AYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 11/134 (8%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME +     F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N+L 
Sbjct: 142 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLY 200
Query: 70  -DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
             +R N  +KL DFG +       + T       Y+APE + P       YD   D+WSL
Sbjct: 201 TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSL 255
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 256 GVIMYILLCGYPPF 269

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 123 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 180
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 181 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 11/134 (8%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME +     F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N+L 
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLY 150
Query: 70  -DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
             +R N  +KL DFG +       + T       Y+APE + P       YD   D+WSL
Sbjct: 151 TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSL 205
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 206 GVIMYILLCGYPPF 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ D G++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDAGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 147
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSK---FPVRWSPPEVLMYSKFSSKSD 203
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 204 IWAFGVLMWEIYSLGKMPYE 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K            K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------XQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ DFG++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    K + +L  +   IHRD+   NILL E+  +K+ DFG++  +       +      
Sbjct: 150 SFQVAKGMEFLA-SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+
Sbjct: 209 PLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRL 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I  E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 286 TREPPFYIITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHR 342
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           ++   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 343 NLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 396
Query: 118 DIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
            I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 33/148 (22%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV+I MELM     ++++      R+   + + +CG      +K LH    + G+IHRD
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI-----EPPNPQKPD 116
           +KPSNI++     +K+ DFG+        ART  AG +  M PE +      P       
Sbjct: 152 LKPSNIVVKSDCTLKILDFGL--------ART--AGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 117 YDIRADVWSLGITLVELATGE--FPYKD 142
           Y    D+WS+G  + E+   +  FP +D
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRD 229

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T +AG      + A
Sbjct: 121 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIKWTA 178
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           PE +         + I++DVW+ G+ L E+AT G  PY
Sbjct: 179 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +P P+        ++ L +   +H V+HRD+KP N+L++  G IKL DFG++    V  +
Sbjct: 103 IPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                     Y APE +         Y    D+WSLG    E+ T
Sbjct: 162 TYXHEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVT 202

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 12/134 (8%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME M     F R+ +R   +  E    +I      A+ +L  +H + HRDVKP N+L 
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL-HSHNIAHRDVKPENLLY 161
Query: 70  DERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
             +     +KL DFG +     +  +T       Y+APE + P       YD   D+WSL
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK-----YDKSCDMWSL 215
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 216 GVIMYILLCGFPPF 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +P P+        ++ L +   +H V+HRD+KP N+L++  G IKL DFG++    V  +
Sbjct: 102 IPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 160
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                     Y APE +         Y    D+WSLG    E+ T
Sbjct: 161 TYXHEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVT 201

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 65/137 (47%), Gaps = 13/137 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++I  E MA  +  D L        P P     +    + + ++ E    IHRD++ +NI
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRNYIHRDLRAANI 315
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDIRADVW 124
           L+      K+ DFG++ R+++    T   G      + APE I   +     + I++DVW
Sbjct: 316 LVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGS-----FTIKSDVW 369
Query: 125 SLGITLVELAT-GEFPY 140
           S GI L+E+ T G  PY
Sbjct: 370 SFGILLMEIVTYGRIPY 386

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 353
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 407

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 12/134 (8%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME M     F R+ +R   +  E    +I      A+ +L  +H + HRDVKP N+L 
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL-HSHNIAHRDVKPENLLY 142
Query: 70  DERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
             +     +KL DFG +     +  +T       Y+APE + P       YD   D+WSL
Sbjct: 143 TSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK-----YDKSCDMWSL 196
Query: 127 GITLVELATGEFPY 140
           G+ +  L  G  P+
Sbjct: 197 GVIMYILLCGFPPF 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 127
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK---FPVRWSPPEVLMYSKFSSKSD 183
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 184 IWAFGVLMWEIYSLGKMPYE 203

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 27/145 (18%)
Query: 36  ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--------- 86
           +C  I L   +A+ +L  + G++HRD+KPSNI       +K+ DFG+   +         
Sbjct: 119 VCLHIFLQIAEAVEFL-HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 87  ---VDSKAR-TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
              + + AR T   G   YM+PE+I         Y  + D++SLG+ L EL    +P+  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQI-----HGNSYSHKVDIFSLGLILFELL---YPFST 229
Query: 143 CKCDFEVLSRVLNDAPPCLPNDPLF 167
                  L+ V N   P     PLF
Sbjct: 230 QMERVRTLTDVRNLKFP-----PLF 249

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ D G++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDRGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +P P+        ++ L +   +H V+HRD+KP N+L++  G IKL DFG++    V  +
Sbjct: 103 IPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                     Y APE +         Y    D+WSLG    E+ T
Sbjct: 162 TYXHEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVT 202

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 353
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 407

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 353
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 407

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 8/120 (6%)
Query: 23  RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFG 81
           R   +L  ++P  +        +++L Y+    G+ HRD+KP N+LLD   G +KL DFG
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 82  ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
            +  L+  +          Y APE I        +Y    D+WS G  + EL  G+  FP
Sbjct: 188 SAKILIAGEPNVSXICSRYYRAPELIF----GATNYTTNIDIWSTGCVMAELMQGQPLFP 243

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 143 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 200 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G  A++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPAFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 138
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK---FPVRWSPPEVLMYSKFSSKSD 194
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 195 IWAFGVLMWEIYSLGKMPYE 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 5/124 (4%)
Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           +++  ELM T   +++    + +            +  LH L E  GV+HRD+ P NILL
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILL 167
Query: 70  DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGIT 129
            +  +I +CDF ++        +T       Y APE +     Q   +    D+WS G  
Sbjct: 168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM----QFKGFTKLVDMWSAGCV 223
Query: 130 LVEL 133
           + E+
Sbjct: 224 MAEM 227

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 131
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK---FPVRWSPPEVLMYSKFSSKSD 187
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 188 IWAFGVLMWEIYSLGKMPYE 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 132
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK---FPVRWSPPEVLMYSKFSSKSD 188
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 189 IWAFGVLMWEIYSLGKMPYE 208

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 5/124 (4%)
Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           +++  ELM T   +++    + +            +  LH L E  GV+HRD+ P NILL
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILL 167
Query: 70  DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGIT 129
            +  +I +CDF ++        +T       Y APE +     Q   +    D+WS G  
Sbjct: 168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM----QFKGFTKLVDMWSAGCV 223
Query: 130 LVEL 133
           + E+
Sbjct: 224 MAEM 227

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 147
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK---FPVRWSPPEVLMYSKFSSKSD 203
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 204 IWAFGVLMWEIYSLGKMPYE 223

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +P P+        ++ L +   +H V+HRD+KP N+L++  G IKL DFG++    V  +
Sbjct: 103 IPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                     Y APE +         Y    D+WSLG    E+ T
Sbjct: 162 TYXHEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVT 202

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETHG--VIHR 60
           +DV++   LM    + ++K          C K+T   V+ L Y     LK  H   +IHR
Sbjct: 100 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +K+ D G++    D    T       Y APE +         Y+  
Sbjct: 150 DLKPSNLAVNEDCELKILDGGLARHTDDEM--TGYVATRWYRAPEIM----LNWMHYNQT 203
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVL 154
            D+WS+G  + EL TG   FP  D     +++ R++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 143 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 200 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 32  VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSK 90
           +P P+        ++ L +   +H V+HRD+KP N+L++  G IKL DFG++    V  +
Sbjct: 100 IPLPLIKSYLFQLLQGLAFC-HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 158
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                     Y APE +         Y    D+WSLG    E+ T
Sbjct: 159 TYXHEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVT 199

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + + G      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 19/127 (14%)
Query: 35  PICGKITLSTVKALHYLKE--THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 90
           P   +I L + + L YL +     +IHRDVK +NILLDE     + DFG++ +L+D K  
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDX 197
Query: 91  -ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEV 149
                  G   ++APE +      +     + DV+  G+ L+EL TG+  +         
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQRAFD-------- 244
Query: 150 LSRVLND 156
           L+R+ ND
Sbjct: 245 LARLAND 251

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L       +  P    +       + Y+ E    +HRD++ 
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 391
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 392 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 449 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 490

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHY-----LKETH--GVIHR 60
           S+V++   LM    + ++K          C  ++   V+ L Y     LK  H  G+IHR
Sbjct: 98  SEVYLVTTLMGADLNNIVK----------CQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 147
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KPSN+ ++E   +++ DFG++ R  D +  T       Y APE +         Y+  
Sbjct: 148 DLKPSNVAVNEDCELRILDFGLA-RQADEEM-TGYVATRWYRAPEIM----LNWMHYNQT 201
Query: 121 ADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPP 159
            D+WS+G  + EL  G+  FP  D     + +  V+    P
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 242

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKARTKNAGC--AAYM 102
            + YL+E +  +HRD+   N+LL  R   K+ DFG+S  L   DS    ++AG     + 
Sbjct: 122 GMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N +K  +  R+DVWS G+T+ E L+ G+ PYK  K
Sbjct: 181 APECI---NFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + + G      +K LH    + G+IHRD
Sbjct: 102 QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG------IKHLH----SAGIIHRD 151
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 152 LKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 206
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 207 DIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 23/143 (16%)
Query: 8   SDVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            DV++ MELM     ++++      R+   + + + G      +K LH    + G+IHRD
Sbjct: 95  QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG------IKHLH----SAGIIHRD 144
Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNI++     +K+ DFG++     S   T       Y APE I         Y    
Sbjct: 145 LKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENV 199
Query: 122 DVWSLGITLVELATGE--FPYKD 142
           D+WS+G  + E+   +  FP +D
Sbjct: 200 DIWSVGCIMGEMVRHKILFPGRD 222

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQ 113
           H ++HRD+KP N+L++  G +KL DFG++    +  ++ T       Y AP+ +      
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK-- 195
Query: 114 KPDYDIRADVWSLGITLVELATGE--FP 139
              Y    D+WS+G    E+ TG+  FP
Sbjct: 196 --KYSTSVDIWSIGCIFAEMITGKPLFP 221

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQ 113
           H ++HRD+KP N+L++  G +KL DFG++    +  ++ T       Y AP+ +      
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK-- 195
Query: 114 KPDYDIRADVWSLGITLVELATGE--FP 139
              Y    D+WS+G    E+ TG+  FP
Sbjct: 196 --KYSTSVDIWSIGCIFAEMITGKPLFP 221

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV----KALHYLKETHGVIHR 60
           ++E   +I  E M   +  LL  L     + +   + L        A+ YL E    IHR
Sbjct: 325 TREPPFYIITEFM--TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHR 381
Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           ++   N L+ E   +K+ DFG+S RL+     T +AG      + APE +         +
Sbjct: 382 NLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 435
Query: 118 DIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
            I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 473

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLV-DSKAR 92
           C +  L +V   H     +G++HRD+KP N+LL  +     +KL DFG++  +  D +A 
Sbjct: 108 CIQQILESVNHCH----LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW 163
Query: 93  TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
              AG   Y++PE +      KP      D+W+ G+ L  L  G  P+ D
Sbjct: 164 FGFAGTPGYLSPEVLRKDPYGKP-----VDMWACGVILYILLVGYPPFWD 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 133
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 134 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 191 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 232

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L   +   +  P    +       + Y+ E    +HRD++ 
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRA 131
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 132 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 189 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 230

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR---LVDSKARTKN 95
           +I +   + LHYL  T  +IHRDVK  NILLDE    K+ DFGIS +   L  +      
Sbjct: 143 EICIGAARGLHYL-HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            G   Y+ PE        K     ++DV+S G+ L E+
Sbjct: 202 KGTLGYIDPEYF-----IKGRLTEKSDVYSFGVVLFEV 234

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHR+++ +NIL+ +  + K+ DFG++ RL++    T   G      + APE I  
Sbjct: 122 EERNYIHRNLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI-- 178
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                  + I++DVWS GI L E+ T G  PY
Sbjct: 179 ---NYGTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 19/127 (14%)
Query: 35  PICGKITLSTVKALHYLKE--THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 90
           P   +I L + + L YL +     +IHRDVK +NILLDE     + DFG++ +L+D K  
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDX 189
Query: 91  -ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEV 149
                  G   ++APE +      +     + DV+  G+ L+EL TG+  +         
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQRAFD-------- 236
Query: 150 LSRVLND 156
           L+R+ ND
Sbjct: 237 LARLAND 243

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER---GNIKLCDFGISGRLV-DSKAR 92
           C    L +V  +H     H ++HRD+KP N+LL  +     +KL DFG++  +  + +A 
Sbjct: 135 CIHQILESVNHIH----QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW 190
Query: 93  TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
              AG   Y++PE +      KP      D+W+ G+ L  L  G  P+ D
Sbjct: 191 FGFAGTPGYLSPEVLRKDPYGKP-----VDIWACGVILYILLVGYPPFWD 235

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 187
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 13/137 (9%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++I  E MA  +  D L        P P     +    + + ++ E    IHRD++ +NI
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRNYIHRDLRAANI 142
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDIRADVW 124
           L+      K+ DFG++ R+++    T   G      + APE I         + I++DVW
Sbjct: 143 LVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAI-----NFGSFTIKSDVW 196
Query: 125 SLGITLVELAT-GEFPY 140
           S GI L+E+ T G  PY
Sbjct: 197 SFGILLMEIVTYGRIPY 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 187
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICG-KITLSTVKALHYLKETHGVIHRDVKP 64
           +DV + +EL++    FD L ++  +S  E     K  L  V  LH    T  + H D+KP
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++     +IKL DFG++  + D        G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG------- 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T  AG      + A
Sbjct: 124 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTA 181
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 182 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 228

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 37  CGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLV-DSKAR 92
           C +  L +V   H     +G++HRD+KP N+LL  +     +KL DFG++  +  D +A 
Sbjct: 108 CIQQILESVNHCH----LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW 163
Query: 93  TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
              AG   Y++PE +     +K  Y    D+W+ G+ L  L  G  P+ D
Sbjct: 164 FGFAGTPGYLSPEVL-----RKDPYGKPVDMWACGVILYILLVGYPPFWD 208

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 121 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEXTARQG--AKFPIKWTAPEAA 177
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 231

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 132
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRAD 122
             N L++++G +K+ DFG+S  ++D +  T + G      P R  PP       +  ++D
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSRGSK---FPVRWSPPEVLMYSKFSSKSD 188
Query: 123 VWSLGITLVEL-ATGEFPYK 141
           +W+ G+ + E+ + G+ PY+
Sbjct: 189 IWAFGVLMWEIYSLGKMPYE 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 128 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 184
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 238

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 128 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEWTARQG--AKFPIKWTAPEAA 184
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 238

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR---LVDSKARTKN 95
           +I +   + LHYL  T  +IHRDVK  NILLDE    K+ DFGIS +   L  +      
Sbjct: 143 EICIGAARGLHYL-HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 96  AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            G   Y+ PE        K     ++DV+S G+ L E+
Sbjct: 202 KGTLGYIDPEYF-----IKGRLTEKSDVYSFGVVLFEV 234

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 13/112 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMA 103
           A+ YL E    IHRD+   N L+ E   +K+ DFG+S RL+     T  AG      + A
Sbjct: 125 AMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTA 182
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK--DCKCDFEVLSR 152
           PE +         + I++DVW+ G+ L E+AT G  PY   D    +E+L +
Sbjct: 183 PESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 229

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP 112
           E    +HRD++ +NIL+ E    K+ DFG++ RL++    T   G  A    +   P   
Sbjct: 124 ERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAA 180
Query: 113 QKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAP-PCLPNDP 165
               + I++DVWS GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 19/111 (17%)
Query: 36  ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKART- 93
           +C  I +   +A+ +L  + G++HRD+KPSNI       +K+ DFG+   +  D + +T 
Sbjct: 165 VCLHIFIQIAEAVEFL-HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 94  -----------KNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
                         G   YM+PE+I   N     Y  + D++SLG+ L EL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNN-----YSHKVDIFSLGLILFEL 269

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICG-KITLSTVKALHYLKETHGVIHRDVKP 64
           +DV + +EL++    FD L ++  +S  E     K  L  V  LH    T  + H D+KP
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++     +IKL DFG++  + D        G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-------LG 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 10/117 (8%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-- 98
           +    + + +L  +   IHRD+   NILL E   +K+CDFG++  +  +    +      
Sbjct: 205 SFQVARGMEFLS-SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
              +MAPE I         Y  ++DVWS G+ L E+ + G  PY   + D +  SR+
Sbjct: 264 PLKWMAPESI-----FDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL 315

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICG-KITLSTVKALHYLKETHGVIHRDVKP 64
           +DV + +EL++    FD L ++  +S  E     K  L  V  LH    T  + H D+KP
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++     +IKL DFG++  + D        G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-------LG 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 18/112 (16%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-------GRLVDSKARTK 94
           +   K ++YL+E HG++HR++   N+LL     +++ DFG++        +L+ S+A+T 
Sbjct: 122 VQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC 145
                 +MA E I         Y  ++DVWS G+T+ EL T G  PY   + 
Sbjct: 181 ----IKWMALESI-----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 18/112 (16%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS-------GRLVDSKARTK 94
           +   K ++YL+E HG++HR++   N+LL     +++ DFG++        +L+ S+A+T 
Sbjct: 140 VQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKC 145
                 +MA E I         Y  ++DVWS G+T+ EL T G  PY   + 
Sbjct: 199 ----IKWMALESI-----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 241

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 35/198 (17%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY-KDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASI 175
             + AD+WS+G+    L +G  P+  D K   E L+ V   A      D  F  T  +++
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANV--SAVNYEFEDEYFSNT--SAL 247
Query: 176 AKDNGRSTEFIRKRSYED 193
           AKD      FIR+   +D
Sbjct: 248 AKD------FIRRLLVKD 259

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICG-KITLSTVKALHYLKETHGVIHRDVKP 64
           +DV + +EL++    FD L ++  +S  E     K  L  V  LH    T  + H D+KP
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++     +IKL DFG++  + D        G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG------- 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 61/137 (44%), Gaps = 15/137 (10%)
Query: 13  CMELMATC------FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           C+ ++  C      F R+  R   +  E    +I  S  +A+ YL   + + HRDVKP N
Sbjct: 133 CLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN-IAHRDVKPEN 191
Query: 67  ILL-DERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +L   +R N  +KL DFG +       + T       Y+APE + P       YD   D 
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDX 246
Query: 124 WSLGITLVELATGEFPY 140
           WSLG+    L  G  P+
Sbjct: 247 WSLGVIXYILLCGYPPF 263

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICG-KITLSTVKALHYLKETHGVIHRDVKP 64
           +DV + +EL++    FD L ++  +S  E     K  L  V  LH    T  + H D+KP
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++     +IKL DFG++  + D        G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-------LG 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  ++I  E M+  +  D L   +   +  P    +       + Y+ E    +HRD+  
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLAA 142
Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           +NIL+ E    K+ DFG++ RL++    T   G  A    +   P       + I++DVW
Sbjct: 143 ANILVGENLVCKVADFGLA-RLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PPCLPNDP 165
           S GI L EL T G  PY     + EVL +V      PC P  P
Sbjct: 200 SFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECP 241

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 85  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 140
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 192
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 193 LGLEADMWSIGVITYILLSGASPF 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICG-KITLSTVKALHYLKETHGVIHRDVKP 64
           +DV + +EL++    FD L ++  +S  E     K  L  V  LH    T  + H D+KP
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++     +IKL DFG++  + D        G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-------LG 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 85  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 140
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 192
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 193 LGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 35/144 (24%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDER-GNIKLCDFGISG----------RLVDSK 90
           L+  KAL  + +  G++HRDVKPSN L + R     L DFG++           + V S+
Sbjct: 124 LNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182
Query: 91  ARTK-------------------NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLV 131
           A+ +                    AG   + APE +     + P+     D+WS G+  +
Sbjct: 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL----TKCPNQTTAIDMWSAGVIFL 238
Query: 132 ELATGEFPYKDCKCDFEVLSRVLN 155
            L +G +P+     D   L++++ 
Sbjct: 239 SLLSGRYPFYKASDDLTALAQIMT 262

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 2/101 (1%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY 101
           L   + + YL E    +HRD+   N +LDE   +K+ DFG++  ++D +  +      A 
Sbjct: 131 LQVARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK 141
           +  +     + Q   +  ++DVWS G+ L EL T G  PY+
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 18/142 (12%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++DV + +EL++    FD L ++   S+ E    +     +  +HYL  +  + H D+KP
Sbjct: 87  KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKP 143
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++      IKL DFGI+ ++          G   ++APE +  EP         
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-------LG 196
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 197 LEADMWSIGVITYILLSGASPF 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV + +EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 18/142 (12%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++DV + +EL++    FD L ++   S+ E    +     +  +HYL  +  + H D+KP
Sbjct: 101 KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKP 157
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++      IKL DFGI+ ++          G   ++APE +  EP         
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-------LG 210
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 211 LEADMWSIGVITYILLSGASPF 232

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKARTKNAGC--AAYM 102
            + YL+E +  +HR++   N+LL  R   K+ DFG+S  L   DS    ++AG     + 
Sbjct: 448 GMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N +K  +  R+DVWS G+T+ E L+ G+ PYK  K
Sbjct: 507 APECI---NFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 56  GVIHRDVKPSNILLDER---GNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPN 111
           GV+HRD+KP N+LL  +     +KL DFG++  +  + +A    AG   Y++PE +    
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             KP      D+W+ G+ L  L  G  P+ D
Sbjct: 201 YGKP-----VDLWACGVILYILLVGYPPFWD 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 18/142 (12%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++DV + +EL++    FD L ++   S+ E    +     +  +HYL  +  + H D+KP
Sbjct: 80  KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKP 136
Query: 65  SNILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERI--EPPNPQKPDYD 118
            NI+L ++      IKL DFGI+ ++          G   ++APE +  EP         
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-------LG 189
Query: 119 IRADVWSLGITLVELATGEFPY 140
           + AD+WS+G+    L +G  P+
Sbjct: 190 LEADMWSIGVITYILLSGASPF 211

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 14/114 (12%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG---ISGRLV----DSKA 91
           +I    VK + YL    G++H+D+K  N+  D  G + + DFG   ISG L     + K 
Sbjct: 134 QIAQEIVKGMGYL-HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKL 191
Query: 92  RTKNAGCAAYMAPERIEPPNP----QKPDYDIRADVWSLGITLVELATGEFPYK 141
           R +N G   ++APE I   +P     K  +   +DV++LG    EL   E+P+K
Sbjct: 192 RIQN-GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 17/152 (11%)
Query: 8   SDVWICMELM--ATCFDRLL-KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +D+++ MEL      F+R++ KR+          K  LS V   H L     V HRD+KP
Sbjct: 96  TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKP 151
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N L         +KL DFG++ R    K      G   Y++P+ +E        Y    
Sbjct: 152 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL------YGPEC 205
Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           D WS G+ +  L  G  P+     D EV+ ++
Sbjct: 206 DEWSAGVMMYVLLCGYPPF-SAPTDXEVMLKI 236

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 68/141 (48%), Gaps = 17/141 (12%)
Query: 8   SDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           S++ + +E  A    F   L  L   V E    ++    ++ ++YL + + ++H D+KP 
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQ 160
Query: 66  NILLDE---RGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD---I 119
           NILL      G+IK+ DFG+S ++  +    +  G   Y+APE +        +YD    
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL--------NYDPITT 212
Query: 120 RADVWSLGITLVELATGEFPY 140
             D+W++GI    L T   P+
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPF 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 5   SKESDVWICMELMA---TCFDRLLKRLHVSV--PEPICGKITLSTVKALHYLKETHGVIH 59
           S +  +++  E M     CF+ ++KR        E +        ++AL Y  + + +IH
Sbjct: 98  SSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-IIH 155
Query: 60  RDVKPSNILLDERGN---IKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKP 115
           RDVKP  +LL  + N   +KL  FG++ +L +S        G   +MAPE ++     KP
Sbjct: 156 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP 215
Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCK 144
                 DVW  G+ L  L +G  P+   K
Sbjct: 216 -----VDVWGCGVILFILLSGCLPFYGTK 239

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 59/129 (45%), Gaps = 11/129 (8%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           ++HRD+KP N+L+++RG +KL DFG++    +     +       Y AP+ +        
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR---- 184
Query: 116 DYDIRADVWSLGITLVELATGE--FP----YKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
            Y    D+WS G  L E+ TG+  FP     +  K  F+++        P +   P +  
Sbjct: 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244
Query: 170 TIKASIAKD 178
            I+    +D
Sbjct: 245 NIQQRPPRD 253

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 20/103 (19%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--------VDSK------ 90
           ++AL Y+  + G+IHR++KP NI +DE  N+K+ DFG++  +        +DS+      
Sbjct: 126 LEALSYI-HSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 91  -ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE 132
              T   G A Y+A E ++        Y+ + D +SLGI   E
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTG----HYNEKIDXYSLGIIFFE 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 17/152 (11%)
Query: 8   SDVWICMELM--ATCFDRLL-KRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +D+++ MEL      F+R++ KR+          K  LS V   H L     V HRD+KP
Sbjct: 79  TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKP 134
Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N L         +KL DFG++ R    K      G   Y++P+ +E        Y    
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL------YGPEC 188
Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           D WS G+ +  L  G  P+     D EV+ ++
Sbjct: 189 DEWSAGVMMYVLLCGYPPF-SAPTDXEVMLKI 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 1   MSPQSKESDVWICMELMA---TCFDRLLKRLHVSV--PEPICGKITLSTVKALHYLKETH 55
           +   S +  +++  E M     CF+ ++KR        E +        ++AL Y  + +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 56  GVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPN 111
            +IHRDVKP  +LL  + N   +KL  FG++ +L +S        G   +MAPE ++   
Sbjct: 151 -IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYKDCK 144
             KP      DVW  G+ L  L +G  P+   K
Sbjct: 210 YGKP-----VDVWGCGVILFILLSGCLPFYGTK 237

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           ++  ++I  E MA  +  D L  R    +      K +L   +A+ YL E +  +HRD+ 
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNFVHRDLA 144
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+ E    K+ DFG    L    + T++ G     + APE +     ++  +  ++
Sbjct: 145 ARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL-----REKKFSTKS 195
Query: 122 DVWSLGITLVELAT-GEFPY 140
           DVWS GI L E+ + G  PY
Sbjct: 196 DVWSFGILLWEIYSFGRVPY 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++I  E MA  +  D L  R    +      K +L   +A+ YL E +  +HRD+   N+
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNFVHRDLAARNV 320
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRADVWS 125
           L+ E    K+ DFG    L    + T++ G     + APE +     ++  +  ++DVWS
Sbjct: 321 LVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL-----REKKFSTKSDVWS 371
Query: 126 LGITLVELAT-GEFPY 140
            GI L E+ + G  PY
Sbjct: 372 FGILLWEIYSFGRVPY 387

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEP 109
           E    IHRD++ +NIL+      K+ DFG++ RL++    T   G      + APE    
Sbjct: 122 ERMNYIHRDLRSANILVGNGLICKIADFGLA-RLIEDNEXTARQGAKFPIKWTAPE---- 176
Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
                  + I++DVWS GI L EL T G  PY     + EVL +V
Sbjct: 177 -AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQV 219

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVK 63
           ++DV +  EL+A    FD L ++  ++  E     K  L+ V  LH L+    + H D+K
Sbjct: 86  KTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ----IAHFDLK 141
Query: 64  PSNILLDERG----NIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERI--EPPNPQKPD 116
           P NI+L +R      IK+ DFG++ + +D     KN  G   ++APE +  EP       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP------- 193
Query: 117 YDIRADVWSLGITLVELATGEFPY 140
             + AD+WS+G+    L +G  P+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           ++  ++I  E MA  +  D L  R    +      K +L   +A+ YL E +  +HRD+ 
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNFVHRDLA 135
Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRA 121
             N+L+ E    K+ DFG    L    + T++ G     + APE +     ++  +  ++
Sbjct: 136 ARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL-----REAAFSTKS 186
Query: 122 DVWSLGITLVELAT-GEFPY 140
           DVWS GI L E+ + G  PY
Sbjct: 187 DVWSFGILLWEIYSFGRVPY 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++I  E MA  +  D L  R    +      K +L   +A+ YL E +  +HRD+   N+
Sbjct: 75  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNFVHRDLAARNV 133
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRADVWS 125
           L+ E    K+ DFG    L    + T++ G     + APE +     ++  +  ++DVWS
Sbjct: 134 LVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL-----REKKFSTKSDVWS 184
Query: 126 LGITLVELAT-GEFPY 140
            GI L E+ + G  PY
Sbjct: 185 FGILLWEIYSFGRVPY 200

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 66/135 (48%), Gaps = 10/135 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D ++  ++L D+G++     ++          +  
Sbjct: 142 LKALDYC-HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG 200
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           PE +   + Q  DY +  D+WSLG  L  +     P+   + +++ L R+       L  
Sbjct: 201 PELL--VDYQMYDYSL--DMWSLGCMLASMIFRREPFFHGQDNYDQLVRI----AKVLGT 252
Query: 164 DPLFGRTIKASIAKD 178
           + L+G   K  I  D
Sbjct: 253 EELYGYLKKYHIDLD 267

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 66/135 (48%), Gaps = 10/135 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D ++  ++L D+G++     ++          +  
Sbjct: 147 LKALDYC-HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG 205
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           PE +   + Q  DY +  D+WSLG  L  +     P+   + +++ L R+       L  
Sbjct: 206 PELL--VDYQMYDYSL--DMWSLGCMLASMIFRREPFFHGQDNYDQLVRI----AKVLGT 257
Query: 164 DPLFGRTIKASIAKD 178
           + L+G   K  I  D
Sbjct: 258 EELYGYLKKYHIDLD 272

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 56  GVIHRDVKPSNILLDER---GNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPN 111
           GV+HR++KP N+LL  +     +KL DFG++  +  + +A    AG   Y++PE +    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYKD 142
             KP      D+W+ G+ L  L  G  P+ D
Sbjct: 190 YGKP-----VDLWACGVILYILLVGYPPFWD 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 60/134 (44%), Gaps = 17/134 (12%)
Query: 10  VWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           ++I  E MA  +  D L        P P     +    + + ++ E    IHRD++ +NI
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRNYIHRDLRAANI 309
Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLG 127
           L+      K+ DFG+        AR        + APE I   +     + I++DVWS G
Sbjct: 310 LVSASLVCKIADFGL--------ARVGAKFPIKWTAPEAINFGS-----FTIKSDVWSFG 356
Query: 128 ITLVELAT-GEFPY 140
           I L+E+ T G  PY
Sbjct: 357 ILLMEIVTYGRIPY 370

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 39/85 (45%), Gaps = 7/85 (8%)
Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKART--KNAGCAAYMAPERIEPPNPQKPD 116
           HRDVKP NIL+       L DFGI+    D K        G   Y APER    +     
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHAT--- 213
Query: 117 YDIRADVWSLGITLVELATGEFPYK 141
              RAD+++L   L E  TG  PY+
Sbjct: 214 --YRADIYALTCVLYECLTGSPPYQ 236

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 16/124 (12%)
Query: 30  VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL----DERGNIKLCDFGISGR 85
           V +P  +   +    +  +HYL   + V+HRD+KP+NIL+     ERG +K+ D G + R
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYL-HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-R 180
Query: 86  LVDSKARTKN-----AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           L +S  +             Y APE +         Y    D+W++G    EL T E P 
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSE-PI 235
Query: 141 KDCK 144
             C+
Sbjct: 236 FHCR 239

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 39  KITLSTVKALHYL-KETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAG 97
           KI   T +A+ ++ ++   +IHRD+K  N+LL  +G IKLCDFG +  +      + +A 
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 98  CAAYMAPERIEPPNPQKPDYDI-----------RADVWSLGITLVELATGEFPYKD 142
             A +  E      P     +I           + D+W+LG  L  L   + P++D
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 12  ICM--ELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           ICM  EL++     L+K+        P+  K   S ++ L  L +   +IH D+KP NIL
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENIL 232
Query: 69  LDERG--NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           L ++G   IK+ DFG S    + +          Y APE I         Y +  D+WSL
Sbjct: 233 LKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-----YGMPIDMWSL 285
Query: 127 GITLVELATG 136
           G  L EL TG
Sbjct: 286 GCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 12  ICM--ELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           ICM  EL++     L+K+        P+  K   S ++ L  L +   +IH D+KP NIL
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENIL 232
Query: 69  LDERG--NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           L ++G   IK+ DFG S    + +          Y APE I         Y +  D+WSL
Sbjct: 233 LKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-----YGMPIDMWSL 285
Query: 127 GITLVELATG 136
           G  L EL TG
Sbjct: 286 GCILAELLTG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 12  ICM--ELMATCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           ICM  EL++     L+K+        P+  K   S ++ L  L +   +IH D+KP NIL
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENIL 232
Query: 69  LDERG--NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           L ++G   IK+ DFG S    + +          Y APE I         Y +  D+WSL
Sbjct: 233 LKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR-----YGMPIDMWSL 285
Query: 127 GITLVELATG 136
           G  L EL TG
Sbjct: 286 GCILAELLTG 295

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+L+D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           D L  +  +   E + G + L   + + YL+E   VIHRD+   N L+ E   IK+ DFG
Sbjct: 91  DYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEA-SVIHRDLAARNCLVGENQVIKVSDFG 148
Query: 82  ISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE-LATGE 137
           ++ R V     T + G      + +PE           Y  ++DVWS G+ + E  + G+
Sbjct: 149 MT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGK 202
Query: 138 FPYKD 142
            PY++
Sbjct: 203 IPYEN 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           V+HRD+KP N+L++  G +K+ DFG++    +  +  T       Y AP+ +        
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK---- 176
Query: 116 DYDIRADVWSLGITLVELATG 136
            Y    D+WS+G    E+  G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           V+HRD+KP N+L++  G +K+ DFG++    +  +  T       Y AP+ +        
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK---- 176
Query: 116 DYDIRADVWSLGITLVELATG 136
            Y    D+WS+G    E+  G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           ++HRD+KP NIL+   G +KL DFG++       A T       Y APE +      +  
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL-----LQST 195
Query: 117 YDIRADVWSLGITLVEL 133
           Y    D+WS+G    E+
Sbjct: 196 YATPVDMWSVGCIFAEM 212

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 7   ESDVWICMELMATC--FDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E++ W+ +  MA     ++ L++  HV     I  ++       + YL+E++  +HRD+ 
Sbjct: 441 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEESN-FVHRDLA 497
Query: 64  PSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
             N+LL  +   K+ DFG+S  L       KA+T       + APE I   N  K  +  
Sbjct: 498 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI---NYYK--FSS 552
Query: 120 RADVWSLGITLVE-LATGEFPYKDCK 144
           ++DVWS G+ + E  + G+ PY+  K
Sbjct: 553 KSDVWSFGVLMWEAFSYGQKPYRGMK 578

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 7   ESDVWICMELMATC--FDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E++ W+ +  MA     ++ L++  HV     I  ++       + YL+E++  +HRD+ 
Sbjct: 440 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEESN-FVHRDLA 496
Query: 64  PSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
             N+LL  +   K+ DFG+S  L       KA+T       + APE I   N  K  +  
Sbjct: 497 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI---NYYK--FSS 551
Query: 120 RADVWSLGITLVE-LATGEFPYKDCK 144
           ++DVWS G+ + E  + G+ PY+  K
Sbjct: 552 KSDVWSFGVLMWEAFSYGQKPYRGMK 577

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 51  LKETH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTK---NAGCAAYMAPE 105
           LK+ H   + HRD+K  N+LL       + DFG++ +    K+        G   YMAPE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELAT 135
            +E     + D  +R D++++G+ L ELA+
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 149 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 207
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 208 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 243

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG-VIHRDVKPSNIL 68
           + ME +     + RLL + H  +   +  ++ L     + Y++  +  ++HRD++  NI 
Sbjct: 98  MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 69  L---DERGNI--KLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L   DE   +  K+ DFG+S + V S +     G   +MAPE I     ++  Y  +AD 
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGL--LGNFQWMAPETI---GAEEESYTEKADT 211
Query: 124 WSLGITLVELATGEFPYKD 142
           +S  + L  + TGE P+ +
Sbjct: 212 YSFAMILYTILTGEGPFDE 230

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 123 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 181
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 182 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--RTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 118 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 177 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 212

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 121 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 180 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 121 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 180 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 125 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 183
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 184 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 124 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 182
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 183 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 118 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 177 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKP 115
           V+HRD+KP N+L++  G +K+ DFG++    +  +  T       Y AP+ +        
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK---- 176
Query: 116 DYDIRADVWSLGITLVELATG 136
            Y    D+WS+G    E+  G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 120 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 179 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 234
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 235 HDNYDQLVRI 244

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 121 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 180 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 215

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 120 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 179 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 234
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 235 HDNYDQLVRI 244

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 126 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 184
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 185 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 240
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 241 HDNYDQLVRI 250

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 116 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 174
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 175 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 210

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 118 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 177 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 122 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 180
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 181 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 119 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 178 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 233
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 234 HDNYDQLVRI 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 117 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 175
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 176 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCA--AY 101
           K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  G +   +
Sbjct: 143 KGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
            APE +      +  + + +DVWS G+ L EL T
Sbjct: 202 YAPESL-----TESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNA 96
           + T    K + YL  T   IHRD+   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 136 QYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 194
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 195 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 230

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTK-NAG 97
                 K + +L E    +HRD+   N+L+     +K+CDFG++  ++ DS    + NA 
Sbjct: 177 FAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235
Query: 98  C-AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPY 140
               +MAPE +      +  Y I++DVWS GI L E+ + G  PY
Sbjct: 236 LPVKWMAPESL-----FEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/83 (39%), Positives = 45/83 (54%), Gaps = 9/83 (10%)
Query: 57  VIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           +IH D+KP NILL   +R  IK+ DFG S +L   +   +      Y +PE +       
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVL-----LG 232
Query: 115 PDYDIRADVWSLGITLVELATGE 137
             YD+  D+WSLG  LVE+ TGE
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           D L  +  +   E + G + L   + + YL+E   VIHRD+   N L+ E   IK+ DFG
Sbjct: 94  DYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFG 151
Query: 82  ISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE-LATGE 137
           ++ R V     T + G      + +PE           Y  ++DVWS G+ + E  + G+
Sbjct: 152 MT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGK 205
Query: 138 FPYKD 142
            PY++
Sbjct: 206 IPYEN 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           D L  +  +   E + G + L   + + YL+E   VIHRD+   N L+ E   IK+ DFG
Sbjct: 91  DYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFG 148
Query: 82  ISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE-LATGE 137
           ++ R V     T + G      + +PE           Y  ++DVWS G+ + E  + G+
Sbjct: 149 MT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGK 202
Query: 138 FPYKD 142
            PY++
Sbjct: 203 IPYEN 207

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV----DSKARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 123 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY 181
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 182 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 139 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 197
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 198 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 139 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 197
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 198 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           D L  +  +   E + G + L   + + YL+E   VIHRD+   N L+ E   IK+ DFG
Sbjct: 89  DYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 82  ISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE-LATGE 137
           ++ R V     T + G      + +PE           Y  ++DVWS G+ + E  + G+
Sbjct: 147 MT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGK 200
Query: 138 FPYKD 142
            PY++
Sbjct: 201 IPYEN 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 137 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 195
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 196 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 233

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 22  DRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG 81
           D L  +  +   E + G + L   + + YL+E   VIHRD+   N L+ E   IK+ DFG
Sbjct: 92  DYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFG 149
Query: 82  ISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE-LATGE 137
           ++ R V     T + G      + +PE           Y  ++DVWS G+ + E  + G+
Sbjct: 150 MT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGK 203
Query: 138 FPYKD 142
            PY++
Sbjct: 204 IPYEN 208

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/83 (39%), Positives = 45/83 (54%), Gaps = 9/83 (10%)
Query: 57  VIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           +IH D+KP NILL   +R  IK+ DFG S +L   +   +      Y +PE +       
Sbjct: 161 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVL-----LG 213
Query: 115 PDYDIRADVWSLGITLVELATGE 137
             YD+  D+WSLG  LVE+ TGE
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGE 236

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 123 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 181
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 182 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 25  LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGIS 83
            K+L+ ++ +          +KAL Y   + G++HRDVKP N+++D E   ++L D+G++
Sbjct: 121 FKQLYQTLTDYDIRFYMYEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 84  GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
                 +          +  PE +   + Q  DY +  D+WSLG  L  +   + P+   
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHG 235
Query: 144 KCDFEVLSRV 153
             +++ L R+
Sbjct: 236 HDNYDQLVRI 245

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K + YL+E   ++HRD+   N+L+    ++K+ DFG++ RL++   +  NA     
Sbjct: 124 VQIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKM 181
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         +  ++DVWS G+T+ EL T G  PY
Sbjct: 182 PIKWMALECI-----HYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 117 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 175
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 176 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 213

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 31/152 (20%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           K  +++I +E+  +   +L K   + + E     I  + +   +++ E+ G+IHRD+KP+
Sbjct: 101 KFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPA 158
Query: 66  NILLDERGNIKLCDFGISGRLVDS------------------------KARTKNAGCAAY 101
           N LL++  ++K+CDFG++ R ++S                        K  T +     Y
Sbjct: 159 NCLLNQDCSVKVCDFGLA-RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
            APE I      + +Y    D+WS G    EL
Sbjct: 218 RAPELI----LLQENYTKSIDIWSTGCIFAEL 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 11/107 (10%)
Query: 40  ITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC- 98
           + L   + + YL+E   VIHRD+   N L+ E   IK+ DFG++ R V     T + G  
Sbjct: 128 MCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTK 185
Query: 99  --AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKD 142
               + +PE           Y  ++DVWS G+ + E  + G+ PY++
Sbjct: 186 FPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 129 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 188 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K + YL+E   ++HRD+   N+L+    ++K+ DFG++ RL++   +  NA     
Sbjct: 147 VQIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKM 204
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         +  ++DVWS G+T+ EL T G  PY
Sbjct: 205 PIKWMALECI-----HYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYM 102
            + YL+E++  +HRD+   N+LL  +   K+ DFG+S  L       KA+T       + 
Sbjct: 119 GMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCK 144
           APE I   N  K  +  ++DVWS G+ + E  + G+ PY+  K
Sbjct: 178 APECI---NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/83 (39%), Positives = 45/83 (54%), Gaps = 9/83 (10%)
Query: 57  VIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           +IH D+KP NILL   +R  IK+ DFG S +L   +   +      Y +PE +       
Sbjct: 180 IIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVL-----LG 232
Query: 115 PDYDIRADVWSLGITLVELATGE 137
             YD+  D+WSLG  LVE+ TGE
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 6/110 (5%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      +          +  
Sbjct: 141 LKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
           PE +   + Q  DY +  D+WSLG  L  +   + P+     +++ L R+
Sbjct: 200 PELL--VDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 1   MSPQSKESDVWICMELMA------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE- 53
           ++  +K++  W  + L++      + FD  L R  V+V   I  K+ LST   L +L   
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMI--KLALSTASGLAHLHME 122
Query: 54  ---THG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART------KNAGCAAY 101
              T G   + HRD+K  NIL+ + G   + D G++ R  DS   T         G   Y
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRY 181
Query: 102 MAPERIEPP-NPQKPDYDIRADVWSLGITLVELA 134
           MAPE ++   N +  +   RAD++++G+   E+A
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 14/139 (10%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG-VIHRDVKPSNIL 68
           + ME +     + RLL + H  +   +  ++ L     + Y++  +  ++HRD++  NI 
Sbjct: 98  MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 69  L---DERGNI--KLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L   DE   +  K+ DFG S + V S +     G   +MAPE I     ++  Y  +AD 
Sbjct: 157 LQSLDENAPVCAKVADFGTSQQSVHSVSGL--LGNFQWMAPETI---GAEEESYTEKADT 211
Query: 124 WSLGITLVELATGEFPYKD 142
           +S  + L  + TGE P+ +
Sbjct: 212 YSFAMILYTILTGEGPFDE 230

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 1   MSPQSKESDVWICMELMA------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE- 53
           ++  +K++  W  + L++      + FD  L R  V+V   I  K+ LST   L +L   
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMI--KLALSTASGLAHLHME 125
Query: 54  ---THG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART------KNAGCAAY 101
              T G   + HRD+K  NIL+ + G   + D G++ R  DS   T         G   Y
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRY 184
Query: 102 MAPERIEPP-NPQKPDYDIRADVWSLGITLVELA 134
           MAPE ++   N +  +   RAD++++G+   E+A
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 1   MSPQSKESDVWICMELMA------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE- 53
           ++  +K++  W  + L++      + FD  L R  V+V   I  K+ LST   L +L   
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMI--KLALSTASGLAHLHME 145
Query: 54  ---THG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART------KNAGCAAY 101
              T G   + HRD+K  NIL+ + G   + D G++ R  DS   T         G   Y
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRY 204
Query: 102 MAPERIEPP-NPQKPDYDIRADVWSLGITLVELA 134
           MAPE ++   N +  +   RAD++++G+   E+A
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 155 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 214 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 1   MSPQSKESDVWICMELMA------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE- 53
           ++  +K++  W  + L++      + FD  L R  V+V   I  K+ LST   L +L   
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMI--KLALSTASGLAHLHME 120
Query: 54  ---THG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART------KNAGCAAY 101
              T G   + HRD+K  NIL+ + G   + D G++ R  DS   T         G   Y
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRY 179
Query: 102 MAPERIEPP-NPQKPDYDIRADVWSLGITLVELA 134
           MAPE ++   N +  +   RAD++++G+   E+A
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 150 TYQLARGMEYLA-SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 209 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL  +   IHRD+   N +L E   + + DFG+S ++       +  GCA+ +  + 
Sbjct: 149 GMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ--GCASKLPVKW 205
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           +   +     Y + +DVW+ G+T+ E+ T G+ PY
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 152 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 211 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 1   MSPQSKESDVWICMELMA------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE- 53
           ++  +K++  W  + L++      + FD  L R  V+V   I  K+ LST   L +L   
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMI--KLALSTASGLAHLHME 158
Query: 54  ---THG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART------KNAGCAAY 101
              T G   + HRD+K  NIL+ + G   + D G++ R  DS   T         G   Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRY 217
Query: 102 MAPERIEPP-NPQKPDYDIRADVWSLGITLVELA 134
           MAPE ++   N +  +   RAD++++G+   E+A
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 1   MSPQSKESDVWICMELMA------TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE- 53
           ++  +K++  W  + L++      + FD  L R  V+V   I  K+ LST   L +L   
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMI--KLALSTASGLAHLHME 119
Query: 54  ---THG---VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART------KNAGCAAY 101
              T G   + HRD+K  NIL+ + G   + D G++ R  DS   T         G   Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRY 178
Query: 102 MAPERIEPP-NPQKPDYDIRADVWSLGITLVELA 134
           MAPE ++   N +  +   RAD++++G+   E+A
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 58/150 (38%), Gaps = 38/150 (25%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   NILL      K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP----VKWMAPESI--- 242
Query: 111 NPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
                 Y   +DVWS GI L EL + G  PY                  P +P D  F +
Sbjct: 243 --FNCVYTFESDVWSYGIFLWELFSLGSSPY------------------PGMPVDSKFYK 282
Query: 170 TIKASIAKDNGRSTEFIRKRSYEDKSTCYE 199
            IK         S E      Y+   TC++
Sbjct: 283 MIKEGFRM---LSPEHAPAEMYDIMKTCWD 309

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 58/150 (38%), Gaps = 38/150 (25%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   NILL      K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP----VKWMAPESI--- 235
Query: 111 NPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
                 Y   +DVWS GI L EL + G  PY                  P +P D  F +
Sbjct: 236 --FNCVYTFESDVWSYGIFLWELFSLGSSPY------------------PGMPVDSKFYK 275
Query: 170 TIKASIAKDNGRSTEFIRKRSYEDKSTCYE 199
            IK         S E      Y+   TC++
Sbjct: 276 MIKEGFRM---LSPEHAPAEMYDIMKTCWD 302

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 58/150 (38%), Gaps = 38/150 (25%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   NILL      K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP----VKWMAPESI--- 237
Query: 111 NPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
                 Y   +DVWS GI L EL + G  PY                  P +P D  F +
Sbjct: 238 --FNCVYTFESDVWSYGIFLWELFSLGSSPY------------------PGMPVDSKFYK 277
Query: 170 TIKASIAKDNGRSTEFIRKRSYEDKSTCYE 199
            IK         S E      Y+   TC++
Sbjct: 278 MIKEGF---RMLSPEHAPAEMYDIMKTCWD 304

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 58/150 (38%), Gaps = 38/150 (25%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   NILL      K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP----VKWMAPESI--- 242
Query: 111 NPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
                 Y   +DVWS GI L EL + G  PY                  P +P D  F +
Sbjct: 243 --FNCVYTFESDVWSYGIFLWELFSLGSSPY------------------PGMPVDSKFYK 282
Query: 170 TIKASIAKDNGRSTEFIRKRSYEDKSTCYE 199
            IK         S E      Y+   TC++
Sbjct: 283 MIKEGFRM---LSPEHAPAEMYDIMKTCWD 309

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 58/150 (38%), Gaps = 38/150 (25%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPP 110
           IHRD+   NILL      K+CDFG+       S  +V   AR        +MAPE I   
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP----VKWMAPESI--- 219
Query: 111 NPQKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGR 169
                 Y   +DVWS GI L EL + G  PY                  P +P D  F +
Sbjct: 220 --FNCVYTFESDVWSYGIFLWELFSLGSSPY------------------PGMPVDSKFYK 259
Query: 170 TIKASIAKDNGRSTEFIRKRSYEDKSTCYE 199
            IK         S E      Y+   TC++
Sbjct: 260 MIKEGFRM---LSPEHAPAEMYDIMKTCWD 286

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N   
Sbjct: 209 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 268 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCAAYMAPERIEPP 110
           E+H  IHRD+   N L+D    +K+ DFG++  ++D +  +         + APE     
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF--- 177
Query: 111 NPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCKCDFEVLSRV 153
                 Y  ++DVW+ GI + E  + G+ PY D   + EV+ +V
Sbjct: 178 --HYFKYSSKSDVWAFGILMWEVFSLGKMPY-DLYTNSEVVLKV 218

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 7   ESDVWICMELM--ATCFDRLLKRLH--VSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           ++D+ + ME +     FDR++   +    +   +  K     ++ +H +     ++H D+
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY----ILHLDL 213
Query: 63  KPSNILLDERG--NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           KP NIL   R    IK+ DFG++ R    +    N G   ++APE +        +YD  
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV--------NYDFV 265
Query: 121 A---DVWSLGITLVELATGEFPYKDCKCDFEVLSRVL 154
           +   D+WS+G+    L +G  P+     D E L+ +L
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNIL 301

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 137 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 195
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 196 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 136 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 194
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 195 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 135 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 194 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 135 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 194 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 136 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 194
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 195 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 135 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 194 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 135 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 194 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 156 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 214
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 215 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 135 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           PE +        DYD   D+WSLG     +   + P+
Sbjct: 194 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 6/84 (7%)
Query: 45  VKALHYLKETHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMA 103
           +KAL Y   + G++HRDVKP N+++D E   ++L D+G++      K          +  
Sbjct: 135 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 104 PERIEPPNPQKPDYDIRADVWSLG 127
           PE +        DYD   D+WSLG
Sbjct: 194 PELL----VDLQDYDYSLDMWSLG 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 21/102 (20%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--------------- 91
            + YL  +  +IHRD+   N L+ E  N+ + DFG++  +VD K                
Sbjct: 120 GMAYL-HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 92  RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
           R    G   +MAPE I         YD + DV+S GI L E+
Sbjct: 179 RYTVVGNPYWMAPEMI-----NGRSYDEKVDVFSFGIVLCEI 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--RTKNA 96
           + T    K + YL  T   IHR++   NIL++    +K+ DFG++  L   K   + K  
Sbjct: 119 QYTSQICKGMEYLG-TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 177
Query: 97  GCA--AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           G +   + APE +      +  + + +DVWS G+ L EL T
Sbjct: 178 GESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELFT 213

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 158 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPV 216
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 217 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           ++HRD+KP NIL+   G +KL DFG++       A         Y APE +      +  
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL-----LQST 187
Query: 117 YDIRADVWSLGITLVEL 133
           Y    D+WS+G    E+
Sbjct: 188 YATPVDMWSVGCIFAEM 204

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K + YL++   ++HRD+   N+L+    ++K+ DFG++ RL+D      +A     
Sbjct: 126 MQIAKGMSYLEDVR-LVHRDLAARNVLVKSPNHVKITDFGLA-RLLDIDETEYHADGGKV 183
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I      +  +  ++DVWS G+T+ EL T G  PY
Sbjct: 184 PIKWMALESI-----LRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D    T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 41  TLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC 98
           T    + + YL  +   IHRD+   N+L+ E   +++ DFG++  +  +D   +T N   
Sbjct: 163 TYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 99  -AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MAPE +         Y  ++DVWS G+ + E+ T G  PY
Sbjct: 222 PVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 12/112 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   N+L+D     K+ DFG+S  L D    A T   G     + 
Sbjct: 163 GMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT 221
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCKCDFEVLSRV 153
           APE I         +   +DVWS G+ + E LA GE PY +   + +V+S V
Sbjct: 222 APEAIAFRT-----FSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSV 267

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 23/158 (14%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALH----------YLKETHGVIHR 60
           +I MELMA     L   L  + P P     +L+ +  LH          YL+E H  IHR
Sbjct: 124 FILMELMAG--GDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYLEENH-FIHR 179
Query: 61  DVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPD 116
           D+   N LL   G     K+ DFG++ R +   +  +  GCA  M P +  PP    +  
Sbjct: 180 DIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPVKWMPPEAFMEGI 236
Query: 117 YDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 237 FTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 273

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 33/125 (26%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDE-------------------------RGNIK 76
           +  +KAL+YL++   + H D+KP NILLD+                            IK
Sbjct: 144 IEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 77  LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           L DFG +    D      N     Y APE I         +D+ +D+WS G  L EL TG
Sbjct: 203 LIDFGCATFKSDYHGSIINT--RQYRAPEVI-----LNLGWDVSSDMWSFGCVLAELYTG 255
Query: 137 EFPYK 141
              ++
Sbjct: 256 SLLFR 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 12/112 (10%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   N+L+D     K+ DFG+S  L D    A T   G     + 
Sbjct: 163 GMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKDCKCDFEVLSRV 153
           APE I         +   +DVWS G+ + E LA GE PY +   + +V+S V
Sbjct: 222 APEAIAFRT-----FSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSV 267

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 34/155 (21%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           K  +++I +E+  +   +L K   + + E     I  + +    ++ E+ G+IHRD+KP+
Sbjct: 103 KFDELYIVLEIADSDLKKLFKT-PIFLTEQHVKTILYNLLLGEKFIHES-GIIHRDLKPA 160
Query: 66  NILLDERGNIKLCDFGISGRLVDS---------------------------KARTKNAGC 98
           N LL++  ++K+CDFG++ R ++S                           K  T +   
Sbjct: 161 NCLLNQDCSVKICDFGLA-RTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVT 219
Query: 99  AAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
             Y APE I      + +Y    D+WS G    EL
Sbjct: 220 RWYRAPELI----LLQENYTNSIDIWSTGCIFAEL 250

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           ++HRD+KP NIL+   G +KL DFG++       A         Y APE +      +  
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL-----LQST 187
Query: 117 YDIRADVWSLGITLVEL 133
           Y    D+WS+G    E+
Sbjct: 188 YATPVDMWSVGCIFAEM 204

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 10/99 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYM 102
           + + YL E   ++HRD+   NIL+ E   +K+ DFG+S  + +  +  K +       +M
Sbjct: 161 QGMQYLAEM-SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM 219
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           A E +         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 220 AIESL-----FDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 23/158 (14%)
Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALH----------YLKETHGVIHR 60
           +I MELMA     L   L  + P P     +L+ +  LH          YL+E H  IHR
Sbjct: 109 FILMELMAG--GDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYLEENH-FIHR 164
Query: 61  DVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPD 116
           D+   N LL   G     K+ DFG++ R +   +  +  GCA  M P +  PP    +  
Sbjct: 165 DIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPVKWMPPEAFMEGI 221
Query: 117 YDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 222 FTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 258

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 10/99 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYM 102
           + + YL E   ++HRD+   NIL+ E   +K+ DFG+S  + +  +  K +       +M
Sbjct: 161 QGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM 219
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           A E +         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 220 AIESL-----FDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 67/139 (48%), Gaps = 14/139 (10%)
Query: 12  ICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG-VIHRDVKPSNIL 68
           + ME +     + RLL + H  +   +  ++ L     + Y++  +  ++HRD++  NI 
Sbjct: 98  MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 69  L---DERGNI--KLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L   DE   +  K+ DF +S + V S +     G   +MAPE I     ++  Y  +AD 
Sbjct: 157 LQSLDENAPVCAKVADFSLSQQSVHSVSGL--LGNFQWMAPETI---GAEEESYTEKADT 211
Query: 124 WSLGITLVELATGEFPYKD 142
           +S  + L  + TGE P+ +
Sbjct: 212 YSFAMILYTILTGEGPFDE 230

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           ++HRD+KP NIL+   G +KL DFG++       A         Y APE +      +  
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL-----LQST 187
Query: 117 YDIRADVWSLGITLVEL 133
           Y    D+WS+G    E+
Sbjct: 188 YATPVDMWSVGCIFAEM 204

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 147 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 205
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 206 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 158 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 216
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 217 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 17/91 (18%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-AAYMAPE----RIEPP 110
           IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N      +MAPE    RI   
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--- 269
Query: 111 NPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                 Y  ++DVWS G+ L E+ T G  PY
Sbjct: 270 ------YTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 143 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 202 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 150 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 208
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 209 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 17/91 (18%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-AAYMAPE----RIEPP 110
           IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N      +MAPE    RI   
Sbjct: 165 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--- 221
Query: 111 NPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
                 Y  ++DVWS G+ L E+ T G  PY
Sbjct: 222 ------YTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 158 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 216
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 217 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43  STVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL--VDSKARTKNAGC-A 99
              + + YL  +   IHRD+   N+L+ E   +K+ DFG++  +  +D   +T N     
Sbjct: 158 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 216
Query: 100 AYMAPE----RIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +MAPE    RI         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 217 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQ 113
           + HRD K  N+LL       L DFG++ R    K         G   YMAPE +E     
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 203
Query: 114 KPDYDIRADVWSLGITLVELAT 135
           + D  +R D++++G+ L EL +
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVS 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 10/99 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYM 102
           + + YL E   ++HRD+   NIL+ E   +K+ DFG+S  + +  +  K +       +M
Sbjct: 161 QGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM 219
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           A E +         Y  ++DVWS G+ L E+ T G  PY
Sbjct: 220 AIESL-----FDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 9/123 (7%)
Query: 36  ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTK 94
           I        +K L +   +  V+HRD+KP N+L++  G +KL DFG++    +  +  + 
Sbjct: 102 IVKSFLFQLLKGLGFC-HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE---FPYKDCKCDFEVLS 151
                 Y  P+ +         Y    D+WS G    ELA      FP  D     + + 
Sbjct: 161 EVVTLWYRPPDVLFGAKL----YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIF 216
Query: 152 RVL 154
           R+L
Sbjct: 217 RLL 219

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 10/94 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAY 101
           + + YL   H  IHRD+   N+LLD    +K+ DFG++  + +     + R        +
Sbjct: 145 EGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
            APE +     ++  +   +DVWS G+TL EL T
Sbjct: 204 YAPECL-----KEYKFYYASDVWSFGVTLYELLT 232

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/123 (22%), Positives = 59/123 (47%), Gaps = 17/123 (13%)
Query: 42  LSTVKALHYLKET---------HGVIHRDVKPSNILLDER--GNIKLCDFGISGRLVDSK 90
           +S  + ++Y+++          H ++H D+KP NI+ + +   ++K+ DFG++ +L   +
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVL 150
                   A + APE ++     +       D+W++G+    L +G  P+   + D E L
Sbjct: 206 IVKVTTATAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETL 259
Query: 151 SRV 153
             V
Sbjct: 260 QNV 262

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 39/189 (20%)
Query: 1   MSPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLK-ETHG 56
           M+ +   + +W+      M + +D L     ++  + + C +I LS    L +L  E  G
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 57  ------VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTK-------NAGCAAYMA 103
                 + HRD+K  NIL+ + G   + D G++  ++ S++  +         G   YMA
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 104 PERI-EPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP--- 159
           PE + E       D   R D+W+ G+ L E+A              V + ++ D  P   
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR-----------MVSNGIVEDYKPPFY 263
Query: 160 -CLPNDPLF 167
             +PNDP F
Sbjct: 264 DVVPNDPSF 272

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 39/189 (20%)
Query: 1   MSPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLK-ETHG 56
           M+ +   + +W+      M + +D L     ++  + + C +I LS    L +L  E  G
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 57  ------VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTK-------NAGCAAYMA 103
                 + HRD+K  NIL+ + G   + D G++  ++ S++  +         G   YMA
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 104 PERI-EPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP--- 159
           PE + E       D   R D+W+ G+ L E+A              V + ++ D  P   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR-----------MVSNGIVEDYKPPFY 234
Query: 160 -CLPNDPLF 167
             +PNDP F
Sbjct: 235 DVVPNDPSF 243

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 58/137 (42%), Gaps = 26/137 (18%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKE---------THGVIHRDVKPSNILLDE 71
           F R   R+  + P       TLST   LH+  +         +   IHRDV   N+LL  
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199
Query: 72  RGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
               K+ DFG+       S  +V   AR        +MAPE I         Y +++DVW
Sbjct: 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLP----VKWMAPESIF-----DCVYTVQSDVW 250
Query: 125 SLGITLVEL-ATGEFPY 140
           S GI L E+ + G  PY
Sbjct: 251 SYGILLWEIFSLGLNPY 267

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 39/189 (20%)
Query: 1   MSPQSKESDVWICMEL--MATCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLK-ETHG 56
           M+ +   + +W+      M + +D L     ++  + + C +I LS    L +L  E  G
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 57  ------VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTK-------NAGCAAYMA 103
                 + HRD+K  NIL+ + G   + D G++  ++ S++  +         G   YMA
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 104 PERI-EPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP--- 159
           PE + E       D   R D+W+ G+ L E+A              V + ++ D  P   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR-----------MVSNGIVEDYKPPFY 234
Query: 160 -CLPNDPLF 167
             +PNDP F
Sbjct: 235 DVVPNDPSF 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEP 109
           YL   H  +HRD+   N L+ E   +K+ DFG+S R V S    +  G    M P R  P
Sbjct: 143 YLASQH-FVHRDLATRNCLVGENLLVKIGDFGMS-RDVYSTDYYRVGGHT--MLPIRWMP 198
Query: 110 PNP-QKPDYDIRADVWSLGITLVELAT-GEFPY 140
           P       +   +DVWSLG+ L E+ T G+ P+
Sbjct: 199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL +  G +HRD+   NIL++     K+ DFG+S R+++             +    
Sbjct: 157 GMRYLADM-GYVHRDLAARNILVNSNLVCKVSDFGLS-RVIEDDPEAVYTTTGGKIPVRW 214
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPYKD 142
             P   Q   +   +DVWS GI + E ++ GE PY D
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 169 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 224
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 273

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 146 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 201
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 250

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 169 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 224
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 273

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 171 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 226
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 275

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 155 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 210
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 259

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +      +  GCA  M P 
Sbjct: 195 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRAGYYRKGGCA--MLPV 250
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 299

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 161 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 216
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 265

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 29/141 (20%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILL---------------DERG----NIKLCD 79
           K+     K++++L  ++ + H D+KP NIL                DER     +IK+ D
Sbjct: 122 KMAYQICKSVNFL-HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 80  FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG--E 137
           FG +    D +  +       Y APE I      +P      DVWS+G  L+E   G   
Sbjct: 181 FGSAT--YDDEHHSTLVSTRHYRAPEVILALGWSQP-----CDVWSIGCILIEYYLGFTV 233
Query: 138 FPYKDCKCDFEVLSRVLNDAP 158
           FP  D K    ++ R+L   P
Sbjct: 234 FPTHDSKEHLAMMERILGPLP 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 181 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 236
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 285

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 36/157 (22%)
Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           K  ++++ +E+  + F +L  R  V + E     +  + +  + Y+  + G++HRD+KP+
Sbjct: 128 KFDELYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYV-HSAGILHRDLKPA 185
Query: 66  NILLDERGNIKLCDFGISGRLVD-----------------------------SKARTKNA 96
           N L+++  ++K+CDFG++ R VD                              +  T + 
Sbjct: 186 NCLVNQDCSVKVCDFGLA-RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
Query: 97  GCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL 133
               Y APE I      + +Y    DVWS+G    EL
Sbjct: 245 VTRWYRAPELI----LLQENYTEAIDVWSIGCIFAEL 277

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 3/98 (3%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL + +  +HRD+   NIL++     K+ DFG+S  L D  +            P R
Sbjct: 147 GMKYLADMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 205
Query: 107 IEPPNP-QKPDYDIRADVWSLGITLVE-LATGEFPYKD 142
              P   Q   +   +DVWS GI + E ++ GE PY D
Sbjct: 206 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 155 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 210
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 259

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +      +  GCA  M P 
Sbjct: 172 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRAGYYRKGGCA--MLPV 227
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 276

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA  M P 
Sbjct: 154 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA--MLPV 209
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 258

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 149 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 208 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 134 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 193 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 128 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 187 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 126 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 185 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 124 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 183 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 127 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 186 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 126 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 185 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 127 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 186 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 124 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 183 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 131 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 190 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 124 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 183 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 131 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 190 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 130 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 189 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 127 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 186 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 125 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 184 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 127 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 186 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 131 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 190 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 158 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 217 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 124 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 183 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 124 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 183 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 125 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 184 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 118 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 177 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 42/95 (44%), Gaps = 12/95 (12%)
Query: 56  GVIHRDVKPSNILLDERGNIKLCDFGISGRLV-----DSKARTKNAGCA-----AYMAPE 105
           G  HRD+KP+NILL + G   L D G   +         +A T     A     +Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
                +      D R DVWSLG  L  +  GE PY
Sbjct: 214 LFSVQS--HCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 15/139 (10%)
Query: 12  ICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
           + ME + + C    L+R    +        +    K + YL  +   +HRD+   NIL++
Sbjct: 90  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVE 148
Query: 71  ERGNIKLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
              ++K+ DFG++  L   K     R        + APE +         +  ++DVWS 
Sbjct: 149 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS-----DNIFSRQSDVWSF 203
Query: 127 GITLVELATGEFPYKDCKC 145
           G+ L EL    F Y D  C
Sbjct: 204 GVVLYEL----FTYCDKSC 218

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 10/94 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAY 101
           + + YL   H  IHR++   N+LLD    +K+ DFG++  + +     + R        +
Sbjct: 128 EGMAYLHSQH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
            APE +     ++  +   +DVWS G+TL EL T
Sbjct: 187 YAPECL-----KEYKFYYASDVWSFGVTLYELLT 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 12/115 (10%)
Query: 30  VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 89
           +S  E +C  I       + YL E    +HRD+   N L+ E   +K+ DFG+S  +  +
Sbjct: 171 LSCAEQLC--IARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 90  ---KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVEL-ATGEFPY 140
              KA   +A    +M PE I         Y   +DVW+ G+ L E+ + G  PY
Sbjct: 228 DYYKADGNDAIPIRWMPPESI-----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 13/116 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YM 102
            + YL   +  +HRD+   NIL++     K+ DFG+S  L D    T           + 
Sbjct: 159 GMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA 157
           APE I         +   +DVWS GI + E+ T GE PY +   + EV+ + +ND 
Sbjct: 218 APEAI-----SYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVM-KAINDG 266

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 14/104 (13%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----ARTKNAGCAAY 101
           K + YL  +   +HRD+   NIL++   ++K+ DFG++  L   K     R        +
Sbjct: 126 KGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC 145
            APE +         +  ++DVWS G+ L EL    F Y D  C
Sbjct: 185 YAPESLS-----DNIFSRQSDVWSFGVVLYEL----FTYCDKSC 219

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----ARTK 94
           K  +   K + YL  +   +HRD+   N+L++    +K+ DFG++  +   K     +  
Sbjct: 130 KYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDD 188
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                 + APE +      +  + I +DVWS G+TL EL T
Sbjct: 189 RDSPVFWYAPECL-----MQSKFYIASDVWSFGVTLHELLT 224

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 14/104 (13%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----ARTKNAGCAAY 101
           K + YL  +   +HRD+   NIL++   ++K+ DFG++  L   K     R        +
Sbjct: 138 KGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC 145
            APE +         +  ++DVWS G+ L EL    F Y D  C
Sbjct: 197 YAPESLS-----DNIFSRQSDVWSFGVVLYEL----FTYCDKSC 231

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 29/141 (20%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILL---------------DERG----NIKLCD 79
           K+     K++++L  ++ + H D+KP NIL                DER     +IK+ D
Sbjct: 122 KMAYQICKSVNFL-HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 80  FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG--E 137
           FG +    D +  +       Y APE I      +P      DVWS+G  L+E   G   
Sbjct: 181 FGSAT--YDDEHHSTLVXXRHYRAPEVILALGWSQP-----CDVWSIGCILIEYYLGFTV 233
Query: 138 FPYKDCKCDFEVLSRVLNDAP 158
           FP  D K    ++ R+L   P
Sbjct: 234 FPTHDSKEHLAMMERILGPLP 254

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 14/104 (13%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----ARTKNAGCAAY 101
           K + YL  +   +HRD+   NIL++   ++K+ DFG++  L   K     R        +
Sbjct: 122 KGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC 145
            APE +         +  ++DVWS G+ L EL    F Y D  C
Sbjct: 181 YAPESLS-----DNIFSRQSDVWSFGVVLYEL----FTYCDKSC 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----ARTK 94
           K  +   K + YL  +   +HRD+   N+L++    +K+ DFG++  +   K     +  
Sbjct: 118 KYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDD 176
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
                 + APE +      +  + I +DVWS G+TL EL T
Sbjct: 177 RDSPVFWYAPECL-----MQSKFYIASDVWSFGVTLHELLT 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 10/94 (10%)
Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KARTKNAGCAAY 101
           + + YL   H  IHR++   N+LLD    +K+ DFG++  + +     + R        +
Sbjct: 128 EGMAYLHAQH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
            APE +     ++  +   +DVWS G+TL EL T
Sbjct: 187 YAPECL-----KEYKFYYASDVWSFGVTLYELLT 215

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 16/110 (14%)
Query: 42  LSTVKALHYLKET---------HGVIHRDVKPSNILLD-ERGN-IKLCDFGISGRLVDSK 90
           +S  +A+ Y+++          +  +H D+KP NI+   +R N +KL DFG++  L   +
Sbjct: 146 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           +     G A + APE  E     KP      D+WS+G+    L +G  P+
Sbjct: 206 SVKVTTGTAEFAAPEVAE----GKP-VGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 16/110 (14%)
Query: 42  LSTVKALHYLKET---------HGVIHRDVKPSNILLD-ERGN-IKLCDFGISGRLVDSK 90
           +S  +A+ Y+++          +  +H D+KP NI+   +R N +KL DFG++  L   +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 91  ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           +     G A + APE  E     KP      D+WS+G+    L +G  P+
Sbjct: 312 SVKVTTGTAEFAAPEVAE----GKP-VGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 49  HYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAYMAPE 105
            YL+E H  IHRD+   N LL   G     K+ DFG++  +  + +  +  GCA  M P 
Sbjct: 155 QYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA-SYYRKGGCA--MLPV 210
Query: 106 RIEPPNP-QKPDYDIRADVWSLGITLVEL-ATGEFPYKDCKCDFEVLSRV 153
           +  PP    +  +  + D WS G+ L E+ + G  PY   K + EVL  V
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 259

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YM 102
            + YL  +H V+H+D+   N+L+ ++ N+K+ D G+  R V +    K  G +     +M
Sbjct: 157 GMEYLS-SHHVVHKDLATRNVLVYDKLNVKISDLGLF-REVYAADYYKLLGNSLLPIRWM 214
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           APE I         + I +D+WS G+ L E  + G  PY
Sbjct: 215 APEAI-----MYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 10/126 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL   +  +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    
Sbjct: 144 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK--GGKGLLPVRW 200
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCL 161
           + P + +   +   +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNC 259
Query: 162 PNDPLF 167
           P D LF
Sbjct: 260 P-DMLF 264

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YM 102
            + YL  +H V+H+D+   N+L+ ++ N+K+ D G+  R V +    K  G +     +M
Sbjct: 140 GMEYLS-SHHVVHKDLATRNVLVYDKLNVKISDLGLF-REVYAADYYKLLGNSLLPIRWM 197
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           APE I         + I +D+WS G+ L E  + G  PY
Sbjct: 198 APEAI-----MYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG   +L+ ++ +  +A     
Sbjct: 126 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKV 183
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 184 PIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 52/123 (42%), Gaps = 9/123 (7%)
Query: 36  ICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTK 94
           I        +K L +   +  V+HRD+KP N+L++  G +KL +FG++    +  +  + 
Sbjct: 102 IVKSFLFQLLKGLGFC-HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE---FPYKDCKCDFEVLS 151
                 Y  P+ +         Y    D+WS G    ELA      FP  D     + + 
Sbjct: 161 EVVTLWYRPPDVLFGAKL----YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 152 RVL 154
           R+L
Sbjct: 217 RLL 219

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL   +  +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    
Sbjct: 135 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK--GGKGLLPVRW 191
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYK 141
           + P + +   +   +DVWS G+ L E+AT  E PY+
Sbjct: 192 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG   +L+ ++ +  +A     
Sbjct: 126 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKV 183
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 184 PIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG   +L+ ++ +  +A     
Sbjct: 131 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKV 188
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 189 PIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG   +L+ ++ +  +A     
Sbjct: 128 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKV 185
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 186 PIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG   +L+ ++ +  +A     
Sbjct: 124 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKV 181
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 182 PIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA-- 99
           +   K ++YL E   ++HRD+   N+L+    ++K+ DFG   +L+ ++ +  +A     
Sbjct: 126 VQIAKGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKV 183
Query: 100 --AYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
              +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 184 PIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 19/143 (13%)
Query: 11  WICMELMATCFDRLLKR---LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
           +I +EL A      +++    H+ +      + T S +  LH L     ++HRD+KP NI
Sbjct: 94  YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNI 149
Query: 68  LL---DERGNIK--LCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYD 118
           L+   +  G IK  + DFG+  +L   +     R+   G   ++APE +     + P Y 
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 119 IRADVWSLG-ITLVELATGEFPY 140
           +  D++S G +    ++ G  P+
Sbjct: 210 V--DIFSAGCVFYYVISEGSHPF 230

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 10/126 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL   +  +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    
Sbjct: 144 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRW 200
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCL 161
           + P + +   +   +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNC 259
Query: 162 PNDPLF 167
           P D LF
Sbjct: 260 P-DMLF 264

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 25/150 (16%)
Query: 5   SKESDVWICMELMATC-FDRLLK----RLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +++  ++I MEL+    F   L+    RL V     + G         + YL E+   IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYL-ESKCCIH 236
Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD--- 116
           RD+   N L+ E+  +K+ DFG+S        R +  G  A     R  P     P+   
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMS--------REEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 117 ---YDIRADVWSLGITLVE-LATGEFPYKD 142
              Y   +DVWS GI L E  + G  PY +
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPN 318

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 57/137 (41%), Gaps = 26/137 (18%)
Query: 21  FDRLLKRLHVSVPEPICGKITLSTVKALHYLKE---------THGVIHRDVKPSNILLDE 71
           F R   R+  + P       T ST   LH+  +         +   IHRDV   N+LL  
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199
Query: 72  RGNIKLCDFGI-------SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
               K+ DFG+       S  +V   AR        +MAPE I         Y +++DVW
Sbjct: 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLP----VKWMAPESIF-----DCVYTVQSDVW 250
Query: 125 SLGITLVEL-ATGEFPY 140
           S GI L E+ + G  PY
Sbjct: 251 SYGILLWEIFSLGLNPY 267

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    + P + +   +
Sbjct: 182 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVF 239
Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPNDPLF 167
              +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   P D LF
Sbjct: 240 TTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCP-DMLF 292

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    + P + +   +
Sbjct: 150 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVF 207
Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPNDPLF 167
              +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   P D LF
Sbjct: 208 TTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCP-DMLF 260

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 10/126 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL   +  +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    
Sbjct: 141 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRW 197
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCL 161
           + P + +   +   +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   
Sbjct: 198 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNC 256
Query: 162 PNDPLF 167
           P D LF
Sbjct: 257 P-DMLF 261

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA- 100
           +   + ++YL E   ++HRD+   N+L+    ++K+ DFG++  L   +      G    
Sbjct: 121 VQIAEGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 101 --YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
             +MA E I         Y  ++DVWS G+T+ EL T G  PY
Sbjct: 180 IKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 136 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
           APE I         +   +DVWS GI + E+ + GE PY
Sbjct: 195 APEAI-----AFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 130 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 189 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 130 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 189 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 10/126 (7%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            + YL   +  +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    
Sbjct: 137 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRW 193
Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCL 161
           + P + +   +   +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNC 252
Query: 162 PNDPLF 167
           P D LF
Sbjct: 253 P-DMLF 257

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 159 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 218 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKARTKNAGC--AAYM 102
            + YL +  G +HRD+   NIL++     K+ DFG+S  L D    A T   G     + 
Sbjct: 147 GMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVE-LATGEFPY 140
           +PE I         +   +DVWS GI L E ++ GE PY
Sbjct: 206 SPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    + P + +   +
Sbjct: 153 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVF 210
Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPNDPLF 167
              +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   P D LF
Sbjct: 211 TTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCP-DMLF 263
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	296
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-87
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-86
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-85
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-85
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-66
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-40
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-40
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-40
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-39
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-38
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-38
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-29
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-29
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-29
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-27
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-14
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-14
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-13
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-13
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-13
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-13
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-13
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-12
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-12
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-11
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-11
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-11
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-10
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-10
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-10
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-10
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-10
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-09
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  261 bits (670), Expect = 5e-87
 Identities = 116/162 (71%), Positives = 137/162 (84%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
             +DV+I MELM TC ++L KR+   +PE I GK+T++ VKAL+YLKE HGVIHRDVKPS
Sbjct: 95  TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NILLDERG IKLCDFGISGRLVD KA+ ++AGCAAYMAPERI+PP+P KPDYDIRADVWS
Sbjct: 155 NILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF 167
           LGI+LVELATG+FPYK+CK DFEVL++VL + PP LP    F
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  259 bits (663), Expect = 3e-86
 Identities = 89/205 (43%), Positives = 118/205 (57%), Gaps = 17/205 (8%)

Query: 6   KESDVWICMELMATCFDRLLKRLHV---SVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +E DVWICMELM T  D+  K++     ++PE I GKI +S VKAL +L     VIHRDV
Sbjct: 77  REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSN+L++  G +K+CDFGISG LVD  A+  +AGC  YMAPERI  P   +  Y +++D
Sbjct: 137 KPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN-PELNQKGYSVKSD 195

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND---PLFGRTIKASIAKD- 178
           +WSLGIT++ELA   FPY      F+ L +V+ +  P LP D     F       + K+ 
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNS 255

Query: 179 NGRST-------EFIRKRSYEDKST 196
             R T        F     +E K T
Sbjct: 256 KERPTYPELMQHPFFTL--HESKGT 278

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  258 bits (660), Expect = 2e-85
 Identities = 97/164 (59%), Positives = 121/164 (73%), Gaps = 5/164 (3%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVS----VPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +E D WICMELM+T FD+  K ++      +PE I GKITL+TVKAL++LKE   +IHRD
Sbjct: 92  REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 151

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +KPSNILLD  GNIKLCDFGISG+LVDS A+T++AGC  YMAPERI+ P+  +  YD+R+
Sbjct: 152 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID-PSASRQGYDVRS 210

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           DVWSLGITL ELATG FPY      F+ L++V+   PP L N  
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  210 bits (537), Expect = 2e-66
 Identities = 75/244 (30%), Positives = 121/244 (49%), Gaps = 62/244 (25%)

Query: 6   KESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            + ++ ICME M     D++LK+    +PE I GK++++ +K L YL+E H ++HRDVKP
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           SNIL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+W
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIW 214

Query: 125 SLGITLVELATGEFPYKDCKCD-------------------------------------- 146
           S+G++LVE+A G +P                                             
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274

Query: 147 ---FEVLSRVLNDAPPCLPND---PLFGRTIKASIAKD-NGRST-------EFIRKRSYE 192
              FE+L  ++N+ PP LP+      F   +   + K+   R+         FI++   +
Sbjct: 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR--SD 332

Query: 193 DKST 196
            +  
Sbjct: 333 AEEV 336

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  142 bits (359), Expect = 6e-40
 Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 15/172 (8%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
            ++++W+    MA  +  D +       + E     I    +KAL Y+    G +HR VK
Sbjct: 97  ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVK 155

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY--------MAPERIEPPNPQKP 115
            S+IL+   G + L     +  ++    R +               ++PE ++       
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG-- 213

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLF 167
            YD ++D++S+GIT  ELA G  P+KD     ++L   LN   PCL +    
Sbjct: 214 -YDAKSDIYSVGITACELANGHVPFKDMP-ATQMLLEKLNGTVPCLLDTSTI 263

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  140 bits (355), Expect = 8e-40
 Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 4/144 (2%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +P   +  +W+ ME     +  D +      ++ E     I    ++ L +L + H VIH
Sbjct: 94  NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIH 152

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYD 118
           RD+K  N+LL E   +KL DFG+S +L  +  R     G   +MAPE I         YD
Sbjct: 153 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212

Query: 119 IRADVWSLGITLVELATGEFPYKD 142
            ++D+WSLGIT +E+A G  P  D
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCD 236

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  139 bits (353), Expect = 9e-40
 Identities = 60/185 (32%), Positives = 89/185 (48%), Gaps = 28/185 (15%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSV-------PEPICGKITLSTVKALHYLKETHG 56
            + ++W+ M+L++  +  D ++K +            E     I    ++ L YL + +G
Sbjct: 84  VKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NG 141

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA------GCAAYMAPERIEPP 110
            IHRDVK  NILL E G++++ DFG+S  L      T+N       G   +MAPE +E  
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME-- 199

Query: 111 NPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFE---VLSRVLNDAPPCLPNDPLF 167
             Q   YD +AD+WS GIT +ELATG  PY      +    VL   L + PP L      
Sbjct: 200 --QVRGYDFKADIWSFGITAIELATGAAPY----HKYPPMKVLMLTLQNDPPSLETGVQD 253

Query: 168 GRTIK 172
              +K
Sbjct: 254 KEMLK 258

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  138 bits (351), Expect = 2e-39
 Identities = 44/140 (31%), Positives = 74/140 (52%), Gaps = 5/140 (3%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
            +  +WI +E          ++  L   + EP    +    ++AL++L     +IHRD+K
Sbjct: 87  HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLK 144

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
             N+L+   G+I+L DFG+S + + +   R    G   +MAPE +     +   YD +AD
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 204

Query: 123 VWSLGITLVELATGEFPYKD 142
           +WSLGITL+E+A  E P+ +
Sbjct: 205 IWSLGITLIEMAQIEPPHHE 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  137 bits (346), Expect = 1e-38
 Identities = 60/165 (36%), Positives = 88/165 (53%), Gaps = 19/165 (11%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           K++ +WI ME +   +  D LL+     + E     I    +K L YL      IHRD+K
Sbjct: 91  KDTKLWIIMEYLGGGSALD-LLE--PGPLDETQIATILREILKGLDYLHS-EKKIHRDIK 146

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            +N+LL E G +KL DFG++G+L D++  R    G   +MAPE I     ++  YD +AD
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDSKAD 201

Query: 123 VWSLGITLVELATGEFPYKDCKCDFE---VLSRVLNDAPPCLPND 164
           +WSLGIT +ELA GE P+     +     VL  +  + PP L  +
Sbjct: 202 IWSLGITAIELARGEPPH----SELHPMKVLFLIPKNNPPTLEGN 242

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  135 bits (343), Expect = 3e-38
 Identities = 57/140 (40%), Positives = 81/140 (57%), Gaps = 10/140 (7%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           K +D+WI ME     +  D +++  + ++ E     I  ST+K L YL      IHRD+K
Sbjct: 95  KNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYL-HFMRKIHRDIK 152

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
             NILL+  G+ KL DFG++G+L D+ A R    G   +MAPE I     Q+  Y+  AD
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-----QEIGYNCVAD 207

Query: 123 VWSLGITLVELATGEFPYKD 142
           +WSLGIT +E+A G+ PY D
Sbjct: 208 IWSLGITAIEMAEGKPPYAD 227

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  133 bits (337), Expect = 6e-37
 Identities = 51/138 (36%), Positives = 72/138 (52%), Gaps = 8/138 (5%)

Query: 6   KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +E   W+ ME    +  D LL+     + E     +T   ++ L YL  +H +IHRDVK 
Sbjct: 125 REHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKA 182

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            NILL E G +KL DFG +  +  + A +   G   +MAPE I      +  YD + DVW
Sbjct: 183 GNILLSEPGLVKLGDFGSASIM--APANSF-VGTPYWMAPEVIL--AMDEGQYDGKVDVW 237

Query: 125 SLGITLVELATGEFPYKD 142
           SLGIT +ELA  + P  +
Sbjct: 238 SLGITCIELAERKPPLFN 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (322), Expect = 3e-35
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 12/167 (7%)

Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVP--EPICGKITLSTVKALHYLKETHGVIHR 60
           S+   + I ME +   +    LL+     +   E   G  T   ++ L YL + + ++HR
Sbjct: 89  SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHR 146

Query: 61  DVKPSNILLDER-GNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYD 118
           D+K  N+L++   G +K+ DFG S RL      T+   G   YMAPE I   +     Y 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII---DKGPRGYG 203

Query: 119 IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPND 164
             AD+WSLG T++E+ATG+ P+ +       + +V      P +P  
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES 250

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (321), Expect = 4e-35
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 8/143 (5%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           S +SK   ++I ME     T    + KR    + + +  ++     K + Y+     +I+
Sbjct: 87  SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS-KKLIN 145

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
           RD+KPSNI L +   +K+ DFG+   L +   RT++ G   YM+PE+I      +  Y  
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS----SQD-YGK 200

Query: 120 RADVWSLGITLVELATGEFPYKD 142
             D+++LG+ L EL        +
Sbjct: 201 EVDLYALGLILAELLHVCDTAFE 223

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (320), Expect = 6e-35
 Identities = 43/140 (30%), Positives = 73/140 (52%), Gaps = 12/140 (8%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
              ++W+ ME +A  +  D + +     + E     +    ++AL +L  ++ VIHRD+K
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFL-HSNQVIHRDIK 143

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
             NILL   G++KL DFG   ++   ++ R+   G   +MAPE +      +  Y  + D
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAYGPKVD 198

Query: 123 VWSLGITLVELATGEFPYKD 142
           +WSLGI  +E+  GE PY +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLN 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  126 bits (318), Expect = 2e-34
 Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 12/140 (8%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
              ++W+ ME +      D ++    V + E     +  + ++AL YL    GVIHRD+K
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVS--QVRLNEEQIATVCEAVLQALAYL-HAQGVIHRDIK 168

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
             +ILL   G +KL DFG   ++      R    G   +MAPE I      +  Y    D
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-----SRSLYATEVD 223

Query: 123 VWSLGITLVELATGEFPYKD 142
           +WSLGI ++E+  GE PY  
Sbjct: 224 IWSLGIMVIEMVDGEPPYFS 243

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  125 bits (315), Expect = 6e-34
 Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 18/167 (10%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +   V I MEL+   +    L+K+    +PE          ++ L YL     ++H DVK
Sbjct: 121 EGPWVNIFMELLEGGSLGQ-LIKQ-MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVK 177

Query: 64  PSNILLDERGN-IKLCDFGISGRLVDSKARTKNAGCAA------YMAPERIEPPNPQKPD 116
             N+LL   G+   LCDFG +  L                    +MAPE +      KP 
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM----GKP- 232

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
            D + D+WS    ++ +  G  P+        +  ++ ++ PP    
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREI 278

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (313), Expect = 9e-34
 Identities = 43/137 (31%), Positives = 64/137 (46%), Gaps = 7/137 (5%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           +   +++  EL      +  +    S+PE         T+ AL +L    G++H DVKP+
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPA 186

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           NI L  RG  KL DFG+   L  + A     G   YMAPE ++        Y   ADV+S
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS------YGTAADVFS 240

Query: 126 LGITLVELATGEFPYKD 142
           LG+T++E+A        
Sbjct: 241 LGLTILEVACNMELPHG 257

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (309), Expect = 2e-33
 Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 12/161 (7%)

Query: 12  ICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
           I  +          L              I   T + + YL     +IHRD+K +NI L 
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL-HAKSIIHRDLKSNNIFLH 154

Query: 71  ERGNIKLCDFGISG---RLVDSKARTKNAGCAAYMAPE--RIEPPNPQKPDYDIRADVWS 125
           E   +K+ DFG++    R   S    + +G   +MAPE  R++  NP    Y  ++DV++
Sbjct: 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP----YSFQSDVYA 210

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVL-NDAPPCLPNDP 165
            GI L EL TG+ PY +     +++  V      P L    
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  119 bits (301), Expect = 3e-32
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 24/200 (12%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYL-KETHGVIHRDV 62
            +  + +  ELM   T     LKR    +   +        +K L +L   T  +IHRD+
Sbjct: 100 GKKCIVLVTELMTSGTLKT-YLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157

Query: 63  KPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           K  NI +    G++K+ D G++     S A+    G   +MAPE  E        YD   
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYEE------KYDESV 210

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN---DPLFGRTIKASIAKD 178
           DV++ G+ ++E+AT E+PY +C+   ++  RV +   P   +    P     I+  I ++
Sbjct: 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 270

Query: 179 -NGRST-------EFIRKRS 190
            + R +        F ++ +
Sbjct: 271 KDERYSIKDLLNHAFFQEET 290

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  120 bits (302), Expect = 3e-32
 Identities = 42/181 (23%), Positives = 77/181 (42%), Gaps = 26/181 (14%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +   K+S ++I ME     T +D +         +    ++    ++AL Y+    G+IH
Sbjct: 82  TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQILEALSYIHS-QGIIH 139

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKA---------------RTKNAGCAAYMAP 104
           RD+KP NI +DE  N+K+ DFG++  +  S                  T   G A Y+A 
Sbjct: 140 RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           E ++        Y+ + D++SLGI   E+        +      +L ++ + +    P+ 
Sbjct: 200 EVLD----GTGHYNEKIDMYSLGIIFFEMIYPFSTGME---RVNILKKLRSVSIEFPPDF 252

Query: 165 P 165
            
Sbjct: 253 D 253

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (299), Expect = 3e-31
 Identities = 29/141 (20%), Positives = 52/141 (36%), Gaps = 9/141 (6%)

Query: 10  VWICMELMATCFDRLLKRL------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
            +     M +      + L      H S+      ++TL  ++ L  L   +G++H  ++
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLR 238

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA--YMAPERIEPPNPQKPDYDIRA 121
           P +I+LD+RG + L  F    R   S       G A     A   +              
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298

Query: 122 DVWSLGITLVELATGEFPYKD 142
           D W+LG+ +  +   + P  D
Sbjct: 299 DTWTLGLAIYWIWCADLPNTD 319

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (295), Expect = 4e-31
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 14/166 (8%)

Query: 6   KESDVWICMELMA--TCFDRL--LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +++++ I +EL         +   K+    +PE    K  +    AL ++     V+HRD
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRD 161

Query: 62  VKPSNILLDERGNIKLCDFGISGRLV--DSKARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
           +KP+N+ +   G +KL D G+        + A +   G   YM+PERI     +   Y+ 
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH----ENG-YNF 215

Query: 120 RADVWSLGITLVELATGEFPYKDCKCD-FEVLSRVLNDAPPCLPND 164
           ++D+WSLG  L E+A  + P+   K + + +  ++     P LP+D
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (290), Expect = 4e-30
 Identities = 28/145 (19%), Positives = 55/145 (37%), Gaps = 16/145 (11%)

Query: 10  VWICMELMATCFDRLLKRL------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
            +     M +      + L      H S+      ++TL  ++ L  L   +G++H  ++
Sbjct: 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL-HHYGLVHTYLR 233

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPN------PQKPDY 117
           P +I+LD+RG + L  F      V   AR  ++    +  PE             ++   
Sbjct: 234 PVDIVLDQRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290

Query: 118 DIRADVWSLGITLVELATGEFPYKD 142
               D W+LG+ +  +   + P   
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITK 315

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (287), Expect = 5e-30
 Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 16/158 (10%)

Query: 1   MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYL-------K 52
           M+ +   + +W+             L+    ++    C +I LS    L +L       +
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGIS-----GRLVDSKARTKNAGCAAYMAPERI 107
               + HRD+K  NIL+ + G   + D G++                  G   YMAPE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 108 E-PPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK 144
           +        D   R D+W+ G+ L E+A         +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  114 bits (288), Expect = 7e-30
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 10/161 (6%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +   ++I M+       F R+  +  V   E       +    AL ++ +   ++HRD+K
Sbjct: 94  ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIK 152

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTK-NAGCAAYMAPERIEPPNPQKPDYDIRAD 122
             NI L + G ++L DFGI+  L  +    +   G   Y++PE  E     KP Y+ ++D
Sbjct: 153 SQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE----NKP-YNNKSD 207

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN 163
           +W+LG  L EL T +  ++       ++ ++++ + P +  
Sbjct: 208 IWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPPVSL 247

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  113 bits (285), Expect = 9e-30
 Identities = 40/144 (27%), Positives = 75/144 (52%), Gaps = 12/144 (8%)

Query: 5   SKESDVWICMELMA--TCFDRLLKR-LHVSVPEPICGKITLSTVKALHYL-KETHGVIHR 60
           ++  ++ I  E ++  + +  L K      + E     +     K ++YL      ++HR
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDS--KARTKNAGCAAYMAPERIEPPNPQKPDYD 118
           ++K  N+L+D++  +K+CDFG+S RL  S   +    AG   +MAPE +      +P  +
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAAGTPEWMAPEVLR----DEP-SN 217

Query: 119 IRADVWSLGITLVELATGEFPYKD 142
            ++DV+S G+ L ELAT + P+ +
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGN 241

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  114 bits (286), Expect = 1e-29
 Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 13/167 (7%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  +++ ME      +  LK+   S+          + ++A+H + + HG++H D+KP+N
Sbjct: 81  DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPAN 138

Query: 67  ILLDERGNIKLCDFGISGRLVD---SKARTKNAGCAAYMAPERIE------PPNPQKPDY 117
            L+ + G +KL DFGI+ ++     S  +    G   YM PE I+           K   
Sbjct: 139 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197

Query: 118 DIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPN 163
             ++DVWSLG  L  +  G+ P++        L  +++ +     P+
Sbjct: 198 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  111 bits (279), Expect = 5e-29
 Identities = 31/139 (22%), Positives = 57/139 (41%), Gaps = 12/139 (8%)

Query: 11  WICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYL-KETHGVIHRDVKPSNIL 68
            + ME +        L      +   +  ++ L     + Y+  +   ++HRD++  NI 
Sbjct: 97  RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156

Query: 69  LDERG-----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           L           K+ DFG+S +       +   G   +MAPE I     ++  Y  +AD 
Sbjct: 157 LQSLDENAPVCAKVADFGLS-QQSVHSV-SGLLGNFQWMAPETI---GAEEESYTEKADT 211

Query: 124 WSLGITLVELATGEFPYKD 142
           +S  + L  + TGE P+ +
Sbjct: 212 YSFAMILYTILTGEGPFDE 230

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  111 bits (280), Expect = 5e-29
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 14/160 (8%)

Query: 12  ICMELMA--TCFDRLLK-RLHVSVPEPICGKITLSTVKALHYL--KETHGVIHRDVKPSN 66
           + ME     + ++ L                  L   + + YL   +   +IHRD+KP N
Sbjct: 76  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135

Query: 67  ILLDERGN-IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           +LL   G  +K+CDFG +   + +   T N G AA+MAPE  E        Y  + DV+S
Sbjct: 136 LLLVAGGTVLKICDFGTA-CDIQTHM-TNNKGSAAWMAPEVFE----GSN-YSEKCDVFS 188

Query: 126 LGITLVELATGEFPYKDCKC-DFEVLSRVLNDAPPCLPND 164
            GI L E+ T   P+ +     F ++  V N   P L  +
Sbjct: 189 WGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  111 bits (279), Expect = 6e-29
 Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 13/169 (7%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  +++ ME      +  LK+   S+          + ++A+H + + HG++H D+KP+N
Sbjct: 100 DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPAN 157

Query: 67  ILLDERGNIKLCDFGISGRLVD---SKARTKNAGCAAYMAPERIE------PPNPQKPDY 117
            L+ + G +KL DFGI+ ++     S  +    G   YM PE I+           K   
Sbjct: 158 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216

Query: 118 DIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
             ++DVWSLG  L  +  G+ P++        L  +++ +     P+ P
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  110 bits (277), Expect = 7e-29
 Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 23/172 (13%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYL--KETHGVIHRD 61
           KE ++ + ME          L  +    +P  I     +   + ++YL  +    +IHRD
Sbjct: 77  KEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133

Query: 62  VKPSNILLDERG--------NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQ 113
           +K SNIL+ ++          +K+ DFG++ R      +   AG  A+MAPE I      
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMAPEVIR----A 188

Query: 114 KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVL-NDAPPCLPND 164
              +   +DVWS G+ L EL TGE P++       V   V  N     +P+ 
Sbjct: 189 SM-FSKGSDVWSYGVLLWELLTGEVPFRGIDG-LAVAYGVAMNKLALPIPST 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  110 bits (277), Expect = 8e-29
 Identities = 28/159 (17%), Positives = 58/159 (36%), Gaps = 15/159 (9%)

Query: 12  ICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYL-KETHGVIHRDVKPSNIL 68
           +    M   + ++ L +  +  V +    K  L   + + +L      +    +   +++
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145

Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           +DE    ++    +      S          A++APE ++     +      AD+WS  +
Sbjct: 146 IDEDMTARISMADVK----FSFQSPGRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAV 199

Query: 129 TLVELATGEFPYKDCKCDFEVLSRVLN-----DAPPCLP 162
            L EL T E P+ D     E+  +V         PP + 
Sbjct: 200 LLWELVTREVPFADLSN-MEIGMKVALEGLRPTIPPGIS 237

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  110 bits (276), Expect = 2e-28
 Identities = 33/149 (22%), Positives = 60/149 (40%), Gaps = 15/149 (10%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
               + I   L    T +  +++   + +      +I    VK + YL    G++H+D+K
Sbjct: 100 SPPHLAIITSLCKGRTLYS-VVRDAKIVLDVNKTRQIAQEIVKGMGYL-HAKGILHKDLK 157

Query: 64  PSNILLDERGNIKLCDFGIS------GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD- 116
             N+  D  G + + DFG+                    G   ++APE I   +P   + 
Sbjct: 158 SKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216

Query: 117 ---YDIRADVWSLGITLVELATGEFPYKD 142
              +   +DV++LG    EL   E+P+K 
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWPFKT 245

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (279), Expect = 2e-28
 Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 13/169 (7%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  +++ ME      +  LK+   S+          + ++A+H + + HG++H D+KP+N
Sbjct: 128 DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPAN 185

Query: 67  ILLDERGNIKLCDFGISGRLVD---SKARTKNAGCAAYMAPERIE------PPNPQKPDY 117
            L+ + G +KL DFGI+ ++     S  +    G   YM PE I+           K   
Sbjct: 186 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244

Query: 118 DIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPPCLPNDP 165
             ++DVWSLG  L  +  G+ P++        L  +++ +     P+ P
Sbjct: 245 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  110 bits (275), Expect = 6e-28
 Identities = 19/157 (12%), Positives = 47/157 (29%), Gaps = 12/157 (7%)

Query: 9   DVWICMELMATCFDRLLKRLHVSVPEP------ICGKITLSTVKALHYLKETHGVIHRDV 62
           +  + M   +   + L   L                 +T   ++    L ++ G++H   
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL-QSKGLVHGHF 220

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            P N+ +   G + L D     +         ++    Y   E +         +    +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREFLN---ASTATFTHALN 275

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
            W LG+++  +     P+       +   +  +   P
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  106 bits (268), Expect = 1e-27
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 11/143 (7%)

Query: 26  KRLHVSVPEPICGKITLSTVKALHYL----KETHGVIHRDVKPSNILLDERGNIKLCDFG 81
            +    + E    ++      AL          H V+HRD+KP+N+ LD + N+KL DFG
Sbjct: 102 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161

Query: 82  ISGRLVDSKARTK-NAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           ++  L    +  K   G   YM+PE++     +   Y+ ++D+WSLG  L EL     P+
Sbjct: 162 LARILNHDTSFAKTFVGTPYYMSPEQMN----RMS-YNEKSDIWSLGCLLYELCALMPPF 216

Query: 141 KDCKCDFEVLSRVLNDAPPCLPN 163
                  E+  ++       +P 
Sbjct: 217 TA-FSQKELAGKIREGKFRRIPY 238

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 2e-27
 Identities = 30/182 (16%), Positives = 65/182 (35%), Gaps = 35/182 (19%)

Query: 6   KESDVWICMELMA--TCFDRLLKRLHV--SVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           ++  + I  E     +  D + +   +     E     + L   + L Y+     ++H D
Sbjct: 82  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMD 140

Query: 62  VKPSNILLDERGNI-------------------KLCDFGISGRLVDSKARTKNAGCAAYM 102
           +KPSNI +                         K+ D G   R+   +      G + ++
Sbjct: 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFL 197

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP 162
           A E ++    +   +  +AD+++L +T+V  A  E   +    + +    +     P +P
Sbjct: 198 ANEVLQ----ENYTHLPKADIFALALTVVCAAGAEPLPR----NGDQWHEIRQGRLPRIP 249

Query: 163 ND 164
             
Sbjct: 250 QV 251

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  107 bits (270), Expect = 2e-27
 Identities = 31/158 (19%), Positives = 59/158 (37%), Gaps = 16/158 (10%)

Query: 1   MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYL-------K 52
           +      + +++  +          LK   +     +  K+  S+V  L +L       +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML--KLAYSSVSGLCHLHTEIFSTQ 158

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-----ARTKNAGCAAYMAPERI 107
               + HRD+K  NIL+ + G   + D G++ + +              G   YM PE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 108 E-PPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK 144
           +   N       I AD++S G+ L E+A         +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (271), Expect = 2e-27
 Identities = 41/144 (28%), Positives = 63/144 (43%), Gaps = 12/144 (8%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVS------VPEPICGKITLSTVKALHYLKETHGVI 58
             +V+I  E M   +          +       +P  +   I  S + +  Y+     + 
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD 118
           HRDVKPSNIL+D+ G +KL DFG S  +VD K +  + G   +M PE       +     
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFS---NESSYNG 230

Query: 119 IRADVWSLGITLVELATGEFPYKD 142
            + D+WSLGI L  +     P+  
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSL 254

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (267), Expect = 2e-27
 Identities = 41/138 (29%), Positives = 59/138 (42%), Gaps = 11/138 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            + V++ +E     T +  L K       E            AL Y      VIHRD+KP
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCHS-KRVIHRDIKP 137

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+LL   G +K+ DFG S     S+      G   Y+ PE IE        +D + D+W
Sbjct: 138 ENLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIE-----GRMHDEKVDLW 191

Query: 125 SLGITLVELATGEFPYKD 142
           SLG+   E   G+ P++ 
Sbjct: 192 SLGVLCYEFLVGKPPFEA 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  106 bits (266), Expect = 5e-27
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 20/174 (11%)

Query: 5   SKESDVWICMELMATC-----FDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVI 58
           +      + ME    C     +  L +  +   +PE     +    V  +++L+E +G++
Sbjct: 79  TTTRHKVLIMEF---CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIV 134

Query: 59  HRDVKPSNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPE---RIEPPN 111
           HR++KP NI+     D +   KL DFG +  L D +      G   Y+ P+   R     
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194

Query: 112 PQKPDYDIRADVWSLGITLVELATGEFPYKDC---KCDFEVLSRVLNDAPPCLP 162
             +  Y    D+WS+G+T    ATG  P++     + + EV+ +++   P    
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (264), Expect = 1e-26
 Identities = 37/160 (23%), Positives = 59/160 (36%), Gaps = 17/160 (10%)

Query: 10  VWICMELMA--TCFDRLLKRL--HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
            W+ +      T ++ + +       + E     + L   + L  +    G  HRD+KP+
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPT 163

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNA----------GCAAYMAPERIEPPNPQKP 115
           NILL + G   L D G   +       ++ A             +Y APE          
Sbjct: 164 NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS--VQSHC 221

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
             D R DVWSLG  L  +  GE PY       + ++  + 
Sbjct: 222 VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (266), Expect = 2e-26
 Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 16/170 (9%)

Query: 7   ESDVWICMELMATC---FDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGVIHRDV 62
                + ME    C   +  L +  +   +PE     +    V  +++L+E +G++HR++
Sbjct: 81  TRHKVLIMEF-CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNI 138

Query: 63  KPSNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPE---RIEPPNPQKP 115
           KP NI+     D +   KL DFG +  L D +      G   Y+ P+   R       + 
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198

Query: 116 DYDIRADVWSLGITLVELATGEFPYKDC---KCDFEVLSRVLNDAPPCLP 162
            Y    D+WS+G+T    ATG  P++     + + EV+ +++   P    
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  103 bits (259), Expect = 4e-26
 Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 22/154 (14%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
            K+  +    E +       ++K +    P              + YL  +  +IHRD+ 
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL-HSMNIIHRDLN 135

Query: 64  PSNILLDERGNIKLCDFGIS---------------GRLVDSKARTKNAGCAAYMAPERIE 108
             N L+ E  N+ + DFG++                +  D K R    G   +MAPE I 
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195

Query: 109 PPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
                +  YD + DV+S GI L E+        D
Sbjct: 196 ----GRS-YDEKVDVFSFGIVLCEIIGRVNADPD 224

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (258), Expect = 7e-26
 Identities = 45/155 (29%), Positives = 64/155 (41%), Gaps = 18/155 (11%)

Query: 11  WICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           ++ M L+        L ++  ++ P  +   I      AL       G  HRDVKP NIL
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAV--AIVRQIGSALDAAHA-AGATHRDVKPENIL 166

Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNA---GCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           +       L DFGI+      +  T+     G   YMAPER       +     RAD+++
Sbjct: 167 VSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAPERF-----SESHATYRADIYA 220

Query: 126 LGITLVELATGEFPYKDCKCD-FEVLSRVLNDAPP 159
           L   L E  TG  PY+    D   V+   +N A P
Sbjct: 221 LTCVLYECLTGSPPYQG---DQLSVMGAHINQAIP 252

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  102 bits (257), Expect = 7e-26
 Identities = 38/151 (25%), Positives = 63/151 (41%), Gaps = 22/151 (14%)

Query: 1   MSPQSKESDVWICMELMA--TCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGV 57
           + P S +  ++I M+L       D +  R  +      +C  I L   +A+ +L    G+
Sbjct: 81  LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGL 139

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-------------YMAP 104
           +HRD+KPSNI       +K+ DFG+   +   +                       YM+P
Sbjct: 140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELAT 135
           E+I         Y  + D++SLG+ L EL  
Sbjct: 200 EQIH----GNS-YSHKVDIFSLGLILFELLY 225

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  102 bits (255), Expect = 3e-25
 Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 16/158 (10%)

Query: 1   MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYL-------K 52
                  + +W+  +          L R  V+V   I  K+ LST   L +L       +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQ 163

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-----ARTKNAGCAAYMAPERI 107
               + HRD+K  NIL+ + G   + D G++ R   +      A     G   YMAPE +
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 108 E-PPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK 144
           +   N +  +   RAD++++G+   E+A         +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  100 bits (252), Expect = 3e-25
 Identities = 40/140 (28%), Positives = 58/140 (41%), Gaps = 15/140 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
              +++ +E       +  L K  R      E            ALHY  E   VIHRD+
Sbjct: 86  RKRIYLMLEFAPRGELYKELQKHGRF----DEQRSATFMEELADALHYCHE-RKVIHRDI 140

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KP N+L+  +G +K+ DFG S      + RT   G   Y+ PE IE        +D + D
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMIE-----GKTHDEKVD 194

Query: 123 VWSLGITLVELATGEFPYKD 142
           +W  G+   E   G  P+  
Sbjct: 195 LWCAGVLCYEFLVGMPPFDS 214

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  103 bits (259), Expect = 4e-25
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 15/154 (9%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           + + ++ ME       FD ++ R+  +  E     I    +  + YL + H ++HRD+KP
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFN--EVDAAVIIKQVLSGVTYLHK-HNIVHRDLKP 164

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   ++   IK+ DFG+S    + K   +  G A Y+APE +      +  YD + 
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL------RKKYDEKC 218

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           DVWS+G+ L  L  G  P+   + D E+L +V  
Sbjct: 219 DVWSIGVILFILLAGYPPFGG-QTDQEILRKVEK 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  101 bits (253), Expect = 4e-25
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 15/153 (9%)

Query: 1   MSPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYL-------- 51
               S + D+W+             LK     V       I  +  + L YL        
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLK 145

Query: 52  -KETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR---TKNAGCAAYMAPERI 107
                 + HRD+K  N+LL       + DFG++ +    K+        G   YMAPE +
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205

Query: 108 EPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           E     + D  +R D++++G+ L ELA+     
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 43/127 (33%), Positives = 68/127 (53%), Gaps = 6/127 (4%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +  ++  +LM     FD L +++ +S  E    KI  + ++ +  L +   ++HRD+KP
Sbjct: 96  NTFFFLVFDLMKKGELFDYLTEKVTLS--EKETRKIMRALLEVICALHK-LNIVHRDLKP 152

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE-PPNPQKPDYDIRADV 123
            NILLD+  NIKL DFG S +L   +   +  G  +Y+APE IE   N   P Y    D+
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212

Query: 124 WSLGITL 130
           WS G+ +
Sbjct: 213 WSTGVIM 219

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  101 bits (254), Expect = 1e-24
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 15/154 (9%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +   ++  E+      FD ++ R   S  E    +I    +  + Y+ + + ++HRD+KP
Sbjct: 98  KGYFYLVGEVYTGGELFDEIISRKRFS--EVDAARIIRQVLSGITYMHK-NKIVHRDLKP 154

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL    +  NI++ DFG+S     SK      G A Y+APE +         YD + 
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL------HGTYDEKC 208

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           DVWS G+ L  L +G  P+     ++++L +V  
Sbjct: 209 DVWSTGVILYILLSGCPPFNG-ANEYDILKKVEK 241

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (252), Expect = 3e-24
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 21/157 (13%)

Query: 7   ESDVWICMELMATC-----FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
            S  +I  EL         FD ++KR   S  E    +I       + Y+ + H ++HRD
Sbjct: 93  SSSFYIVGEL---YTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMHK-HNIVHRD 146

Query: 62  VKPSNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD 118
           +KP NILL   ++  +IK+ DFG+S     +       G A Y+APE +      +  YD
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL------RGTYD 200

Query: 119 IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
            + DVWS G+ L  L +G  P+   K ++++L RV  
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVET 236

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.0 bits (245), Expect = 3e-24
 Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 10/139 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            + V++ +E+         L  R+     E          +  + YL   HG++HRD+  
Sbjct: 83  SNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHS-HGILHRDLTL 140

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNA-GCAAYMAPERIEPPNPQKPDYDIRADV 123
           SN+LL    NIK+ DFG++ +L     +     G   Y++PE        +  + + +DV
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT-----RSAHGLESDV 195

Query: 124 WSLGITLVELATGEFPYKD 142
           WSLG     L  G  P+  
Sbjct: 196 WSLGCMFYTLLIGRPPFDT 214

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 41/94 (43%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
           AL YL+    +IHRD+KP NILLDE G++ + DF I+  L      T  AG   YMAPE 
Sbjct: 127 ALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185

Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
                     Y    D WSLG+T  EL  G  PY
Sbjct: 186 FSSRKG--AGYSFAVDWWSLGVTAYELLRGRRPY 217

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.0 bits (244), Expect = 7e-24
 Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 22/152 (14%)

Query: 1   MSPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEP-ICGKITLSTVKALHYLKETHGV 57
           + P S +  ++I M+L       D + +R  +   E  +C  I +   +A+ +L    G+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGL 185

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-------------RTKNAGCAAYMAP 104
           +HRD+KPSNI       +K+ DFG+   +   +               T   G   YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATG 136
           E+I        +Y  + D++SLG+ L EL   
Sbjct: 246 EQI-----HGNNYSHKVDIFSLGLILFELLYS 272

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 30/147 (20%), Positives = 57/147 (38%), Gaps = 15/147 (10%)

Query: 7   ESDVWICMELM-ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
               +I +EL  AT  + + ++   +        +   T   L +L     ++HRD+KP 
Sbjct: 90  RQFQYIAIELCAATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPH 147

Query: 66  NILLDERGN-----IKLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPD 116
           NIL+            + DFG+  +L   +     R+   G   ++APE +     +   
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN-- 205

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKD 142
                D++S G     + + G  P+  
Sbjct: 206 PTYTVDIFSAGCVFYYVISEGSHPFGK 232

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 21/157 (13%)

Query: 7   ESDVWICMELMATC-----FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +   ++  E          F++++ R      E     I    +  + YL + H ++HRD
Sbjct: 118 KKYFYLVTEF---YEGGELFEQIINRHKFD--ECDAANIMKQILSGICYLHK-HNIVHRD 171

Query: 62  VKPSNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD 118
           +KP NILL   +   NIK+ DFG+S             G A Y+APE +      K  Y+
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL------KKKYN 225

Query: 119 IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
            + DVWS G+ +  L  G  P+   + D +++ +V  
Sbjct: 226 EKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEK 261

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 98.6 bits (245), Expect = 3e-23
 Identities = 41/148 (27%), Positives = 61/148 (41%), Gaps = 12/148 (8%)

Query: 1   MSPQSKESDVWICMELMA--TCFDRLLKRLHVS-VPEPICGKITLSTVKALHYLKETHGV 57
           +   +      + ME          L +  +   + E     +      AL YL E + +
Sbjct: 84  LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-NRI 142

Query: 58  IHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           IHRD+KP NI+L    +R   K+ D G +  L   +  T+  G   Y+APE +E    QK
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE----QK 198

Query: 115 PDYDIRADVWSLGITLVELATGEFPYKD 142
             Y +  D WS G    E  TG  P+  
Sbjct: 199 K-YTVTVDYWSFGTLAFECITGFRPFLP 225

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 96.0 bits (239), Expect = 4e-23
 Identities = 39/162 (24%), Positives = 62/162 (38%), Gaps = 25/162 (15%)

Query: 2   SPQSKESDVWICMELMATC----FDRLLKR-LHVSVPEPICGKI---TLSTVKALHYLKE 53
             +  ++     + L   C     + L K      +      KI   T   V+ +H  K 
Sbjct: 98  GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP 157

Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA-------------GCAA 100
              +IHRD+K  N+LL  +G IKLCDFG +  +      + +A                 
Sbjct: 158 P--IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215

Query: 101 YMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           Y  PE I+           + D+W+LG  L  L   + P++D
Sbjct: 216 YRTPEIIDL--YSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 96.3 bits (240), Expect = 5e-23
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 6/127 (4%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            S +++  +LM     FD L +++ +S  E     I  S ++A+ +L   + ++HRD+KP
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALS--EKETRSIMRSLLEAVSFLHA-NNIVHRDLKP 228

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEP-PNPQKPDYDIRADV 123
            NILLD+   I+L DFG S  L   +   +  G   Y+APE ++   +   P Y    D+
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288

Query: 124 WSLGITL 130
           W+ G+ L
Sbjct: 289 WACGVIL 295

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 97.6 bits (243), Expect = 6e-23
 Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 33/179 (18%)

Query: 7   ESDVWICMELM--ATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +   +I ME +   +      ++L   V E I     L  + AL YL    G+++ D+KP
Sbjct: 156 DPVGYIVMEYVGGQSLKRSKGQKL--PVAEAI--AYLLEILPALSYLHS-IGLVYNDLKP 210

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNA-----GCAAYMAPERIEPPNPQKPDYDI 119
            NI+L E   +KL D G             N+     G   + APE +       P   +
Sbjct: 211 ENIMLTEEQ-LKLIDLGA--------VSRINSFGYLYGTPGFQAPEIVR----TGP--TV 255

Query: 120 RADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKD 178
             D++++G TL  L                    L +  P L     +GR ++ +I  D
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNG------RYVDGLPEDDPVLKTYDSYGRLLRRAIDPD 308

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 94.6 bits (236), Expect = 9e-23
 Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 14/135 (10%)

Query: 12  ICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           + ME +   T  + +     +SV   I    T   +  + +  +   ++HRD+KP NIL+
Sbjct: 88  LVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQILDGIKHAHD-MRIVHRDIKPQNILI 144

Query: 70  DERGNIKLCDFGISGRLVDSKARTKNA---GCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           D    +K+ DFGI+ + +   + T+     G   Y +PE+      +    D   D++S+
Sbjct: 145 DSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSPEQA-----KGEATDECTDIYSI 198

Query: 127 GITLVELATGEFPYK 141
           GI L E+  GE P+ 
Sbjct: 199 GIVLYEMLVGEPPFN 213

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 1e-22
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 6/100 (6%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           +K + YL     +IHRD+KPSN+L+ E G+IK+ DFG+S     S A   N  G  A+MA
Sbjct: 147 IKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMA 205

Query: 104 PERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
           PE +   +  +  +     DVW++G+TL     G+ P+ D
Sbjct: 206 PESL---SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 11/139 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
              V++ +EL    +  +   +R  ++  EP         V    YL   + VIHRD+K 
Sbjct: 87  NDFVFVVLELCRRRSLLELHKRRKALT--EPEARYYLRQIVLGCQYLHR-NRVIHRDLKL 143

Query: 65  SNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
            N+ L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DV
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFEVDV 198

Query: 124 WSLGITLVELATGEFPYKD 142
           WS+G  +  L  G+ P++ 
Sbjct: 199 WSIGCIMYTLLVGKPPFET 217

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 3/100 (3%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-DSKARTKNA-GCAAYM 102
           V A+  + +    +HRD+KP NIL+D  G+I+L DFG   +L+ D   ++  A G   Y+
Sbjct: 185 VIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           +PE ++     K  Y    D WSLG+ + E+  GE P+  
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 12/134 (8%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +    +  + I ME M     F R+ +R   +  E    +I      A+ +L   H + H
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAH 151

Query: 60  RDVKPSNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           RDVKP N+L    ++   +KL DFG +     +  +T       Y+APE + P       
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK----- 205

Query: 117 YDIRADVWSLGITL 130
           YD   D+WSLG+ +
Sbjct: 206 YDKSCDMWSLGVIM 219

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
             D +I +ELM     FD+++    +   E  C       + A+ YL E +G+IHRD+KP
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLK--EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 267

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV--SVGTAGYNRAV 325

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           D WSLG+ L    +G  P+ + +    +  ++ +
Sbjct: 326 DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 40/137 (29%), Positives = 61/137 (44%), Gaps = 16/137 (11%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E   ++  E M   +    + KR H +  E     +      AL +L    G+ HRD+KP
Sbjct: 83  EDRFYLVFEKMRGGSILSHIHKRRHFN--ELEASVVVQDVASALDFLHN-KGIAHRDLKP 139

Query: 65  SNILL---DERGNIKLCDFGIS--------GRLVDSKARTKNAGCAAYMAPERIEPPNPQ 113
            NIL    ++   +K+CDF +            + +       G A YMAPE +E  + +
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199

Query: 114 KPDYDIRADVWSLGITL 130
              YD R D+WSLG+ L
Sbjct: 200 ASIYDKRCDLWSLGVIL 216

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 92.8 bits (231), Expect = 6e-22
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 11/139 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
              V++ +EL    +  +   +R  ++  EP         V    YL   + VIHRD+K 
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALT--EPEARYYLRQIVLGCQYLHR-NRVIHRDLKL 169

Query: 65  SNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
            N+ L+E   +K+ DFG++ ++  D + +    G   Y+APE +      K  +    DV
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFEVDV 224

Query: 124 WSLGITLVELATGEFPYKD 142
           WS+G  +  L  G+ P++ 
Sbjct: 225 WSIGCIMYTLLVGKPPFET 243

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA---GCAAY 101
           V AL YL    G+IHRD+KP NILL+E  +I++ DFG +  L     + +     G A Y
Sbjct: 140 VSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 102 MAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           ++PE +      +      +D+W+LG  + +L  G  P++ 
Sbjct: 199 VSPELL-----TEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 90.7 bits (226), Expect = 1e-21
 Identities = 44/187 (23%), Positives = 73/187 (39%), Gaps = 25/187 (13%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +D+++ MEL      F+R++ +      E    +I    + A+ Y  +   V HRD+KP
Sbjct: 78  NTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVLSAVAYCHK-LNVAHRDLKP 134

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N L         +KL DFG++ R    K      G   Y++P+ +E        Y    
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL------YGPEC 188

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGR 181
           D WS G+ +  L  G  P+     D EV+ ++        P        +    A+    
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIRE-GTFTFPEKDW--LNVSPQ-AES--- 240

Query: 182 STEFIRK 188
               IR+
Sbjct: 241 ---LIRR 244

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 38/133 (28%), Positives = 56/133 (42%), Gaps = 11/133 (8%)

Query: 3   PQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
             +    + I ME +     F R+  R   +  E    +I  S  +A+ YL     + HR
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHR 185

Query: 61  DVKPSNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           DVKP N+L         +KL DFG +       + T       Y+APE + P       Y
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-----Y 240

Query: 118 DIRADVWSLGITL 130
           D   D+WSLG+ +
Sbjct: 241 DKSCDMWSLGVIM 253

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 36/103 (34%), Positives = 52/103 (50%), Gaps = 5/103 (4%)

Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VDSKARTKNA-GCAAY 101
            V A+  +    G +HRD+KP NILLD  G+I+L DFG   +L  D   R+  A G   Y
Sbjct: 171 IVMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 102 MAPE--RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           ++PE  +     P    Y    D W+LG+   E+  G+ P+  
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 11/123 (8%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            L ++     V++RD+KP+NILLDE G++++ D G++      K      G   YMAPE 
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 361

Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD--FEVLSRVLNDA---PPCL 161
           ++    +   YD  AD +SLG  L +L  G  P++  K     E+    L  A   P   
Sbjct: 362 LQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417

Query: 162 PND 164
             +
Sbjct: 418 SPE 420

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 4/100 (4%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA--YM 102
           V AL  +    G IHRDVKP N+LLD+ G++KL DFG   ++        +       Y+
Sbjct: 178 VLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           +PE ++        Y    D WS+G+ L E+  G+ P+  
Sbjct: 237 SPEVLK-SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.4 bits (225), Expect = 3e-21
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 16/137 (11%)

Query: 12  ICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
           I ME +   T  D +     ++    I  ++     +AL++  + +G+IHRDVKP+NI++
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQ-NGIIHRDVKPANIMI 149

Query: 70  DERGNIKLCDFGISGRLVDSKARTKNA-----GCAAYMAPERIEPPNPQKPDYDIRADVW 124
                +K+ DFGI+ R +     +        G A Y++PE+      +    D R+DV+
Sbjct: 150 SATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSDVY 203

Query: 125 SLGITLVELATGEFPYK 141
           SLG  L E+ TGE P+ 
Sbjct: 204 SLGCVLYEVLTGEPPFT 220

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.0 bits (224), Expect = 3e-21
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 15/154 (9%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            S  +I  EL      FD ++KR   S  E    +I       + Y+ + H ++HRD+KP
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMHK-HNIVHRDLKP 149

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            NILL   ++  +IK+ DFG+S     +       G A Y+APE +         YD + 
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT------YDEKC 203

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           DVWS G+ L  L +G  P+   K ++++L RV  
Sbjct: 204 DVWSAGVILYILLSGTPPFYG-KNEYDILKRVET 236

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.9 bits (226), Expect = 3e-21
 Identities = 42/140 (30%), Positives = 61/140 (43%), Gaps = 12/140 (8%)

Query: 7   ESDVWICMELMATC---FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +    + ME   +    F  + +  H  + EP+   I    V A+ YL     +IHRD+K
Sbjct: 101 QGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYL-RLKDIIHRDIK 157

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD-IRAD 122
             NI++ E   IKL DFG +  L   K      G   Y APE +         Y     +
Sbjct: 158 DENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL-----MGNPYRGPELE 212

Query: 123 VWSLGITLVELATGEFPYKD 142
           +WSLG+TL  L   E P+ +
Sbjct: 213 MWSLGVTLYTLVFEENPFCE 232

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 12/154 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            S++ + +E  A    F   L  L   V E    ++    ++ ++YL + + ++H D+KP
Sbjct: 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKP 159

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            NILL      G+IK+ DFG+S ++  +    +  G   Y+APE +       P      
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN----YDP-ITTAT 214

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           D+W++GI    L T   P+   + + E    +  
Sbjct: 215 DMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQ 247

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.0 bits (226), Expect = 3e-21
 Identities = 47/162 (29%), Positives = 65/162 (40%), Gaps = 22/162 (13%)

Query: 34  EPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSKA 91
           E +   I      ALHYL    G+ HRD+KP N L   ++   IKL DFG+S        
Sbjct: 167 EKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225

Query: 92  R-----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD 146
                 T  AG   ++APE +   N     Y  + D WS G+ L  L  G  P+     D
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVL---NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG-VND 281

Query: 147 FEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK 188
            + +S+VLN    C  N       +    A+D       +  
Sbjct: 282 ADTISQVLN-KKLCFENPNY--NVLSPL-ARD------LLSN 313

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.0 bits (224), Expect = 4e-21
 Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 32/192 (16%)

Query: 7   ESDVWICMELMATC-----FDRLLKRLHV--SVPEPICGKITLSTVKALHYLKETHGVIH 59
             +++I ME    C      +R++       ++ E    ++    + AL Y      V+H
Sbjct: 92  YHNMYIVMET---CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVH 147

Query: 60  RDVKPSNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           +D+KP NIL         IK+ DFG++      +  T  AG A YMAPE        K D
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF------KRD 201

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIA 176
              + D+WS G+ +  L TG  P+       EV  +      P    +    R +    A
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATY-KEPNYAVEC---RPLTPQ-A 255

Query: 177 KDNGRSTEFIRK 188
            D       +++
Sbjct: 256 VD------LLKQ 261

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.4 bits (225), Expect = 5e-21
 Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 14/132 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVP--EPICGKITLSTVKALHYLKETHGVIHRDV 62
           +  +++  E M        ++KR        E +        ++AL Y  + + +IHRDV
Sbjct: 98  DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDV 156

Query: 63  KPSNILL---DERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYD 118
           KP  +LL   +    +KL  FG++ +L +S        G   +MAPE +     ++  Y 
Sbjct: 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV-----KREPYG 211

Query: 119 IRADVWSLGITL 130
              DVW  G+ L
Sbjct: 212 KPVDVWGCGVIL 223

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.0 bits (224), Expect = 5e-21
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 7   ESDVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
             D +I +ELM     FD+++    +   E  C       + A+ YL E +G+IHRD+KP
Sbjct: 86  AEDYYIVLELMEGGELFDKVVGNKRLK--EATCKLYFYQMLLAVQYLHE-NGIIHRDLKP 142

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL   +E   IK+ DFG S  L ++       G   Y+APE +   +     Y+   
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV--SVGTAGYNRAV 200

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           D WSLG+ L    +G  P+ + +    +  ++ +
Sbjct: 201 DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.3 bits (222), Expect = 7e-21
 Identities = 41/141 (29%), Positives = 60/141 (42%), Gaps = 14/141 (9%)

Query: 7   ESDVWICMELMATC---FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +    + +E        FD + +     + E          V A+ +   + GV+HRD+K
Sbjct: 110 QEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHC-HSRGVVHRDIK 166

Query: 64  PSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD-IRA 121
             NIL+D  RG  KL DFG    L D        G   Y  PE I      +  Y  + A
Sbjct: 167 DENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI-----SRHQYHALPA 220

Query: 122 DVWSLGITLVELATGEFPYKD 142
            VWSLGI L ++  G+ P++ 
Sbjct: 221 TVWSLGILLYDMVCGDIPFER 241

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 13/129 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ES  ++  +L+     F+ ++ R   S  E          ++++ Y    +G++HR++KP
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREFYS--EADASHCIQQILESIAYCHS-NGIVHRNLKP 133

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL    +   +KL DFG++  + DS+A    AG   Y++PE ++     K  Y    
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK-----KDPYSKPV 188

Query: 122 DVWSLGITL 130
           D+W+ G+ L
Sbjct: 189 DIWACGVIL 197

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 43/122 (35%), Positives = 65/122 (53%), Gaps = 11/122 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL +L    G+I+RD+KP NILLDE G+IKL DFG+S   +D + +  +  G   YMAPE
Sbjct: 138 ALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---PPCLP 162
            +      +  +   AD WS G+ + E+ TG  P++      E ++ +L      P  L 
Sbjct: 197 VV-----NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAKLGMPQFLS 250

Query: 163 ND 164
            +
Sbjct: 251 PE 252

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 13/129 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ES  ++  +L+     F+ ++ R   S  E          ++++ Y    +G++HR++KP
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFYS--EADASHCIQQILESIAYCHS-NGIVHRNLKP 156

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+LL    +   +KL DFG++  + DS+A    AG   Y++PE +     +K  Y    
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-----KKDPYSKPV 211

Query: 122 DVWSLGITL 130
           D+W+ G+ L
Sbjct: 212 DIWACGVIL 220

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 14/141 (9%)

Query: 7   ESDVWICMELMATC---FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
                + +E        FD + +    ++ E +        ++A+ +     GV+HRD+K
Sbjct: 120 PDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHC-HNCGVLHRDIK 176

Query: 64  PSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD-IRA 121
             NIL+D  RG +KL DFG    L D+       G   Y  PE I     +   Y    A
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWI-----RYHRYHGRSA 230

Query: 122 DVWSLGITLVELATGEFPYKD 142
            VWSLGI L ++  G+ P++ 
Sbjct: 231 AVWSLGILLYDMVCGDIPFEH 251

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 38/116 (32%), Positives = 62/116 (53%), Gaps = 10/116 (8%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
            L +L +   +I+RD+KP N+LLD+ GN+++ D G++  L   + +TK  AG   +MAPE
Sbjct: 301 GLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLNDAP 158
            +        +YD   D ++LG+TL E+     P++         E+  RVL  A 
Sbjct: 360 LL-----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 88.7 bits (220), Expect = 4e-20
 Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 38/209 (18%)

Query: 7   ESDVWICMELM-ATCFDRLLKR-----LHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           +  ++I +EL      D +  +           E     +       + +L     +IHR
Sbjct: 81  DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHR 139

Query: 61  DVKPSNILLD-------------ERGNIKLCDFGISGRLVDSKARTKN-----AGCAAYM 102
           D+KP NIL+              E   I + DFG+  +L   ++  +      +G + + 
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWR 199

Query: 103 APERIEPPNPQKPD--YDIRADVWSLG-ITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
           APE +E  N  +         D++S+G +    L+ G+ P+ D    +   S ++     
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD---KYSRESNIIRGIFS 256

Query: 160 CLPNDPLFGRTIKASIAKDNGRSTEFIRK 188
                 L  R++ A  A D       I +
Sbjct: 257 LDEMKCLHDRSLIAE-ATD------LISQ 278

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 87.6 bits (218), Expect = 4e-20
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 7/97 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL +L +  G+I+RD+KP NI+L+ +G++KL DFG+    +     T    G   YMAPE
Sbjct: 133 ALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
            +      +  ++   D WSLG  + ++ TG  P+  
Sbjct: 192 IL-----MRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.3 bits (217), Expect = 5e-20
 Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 14/130 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +   ++ MEL+     F+R+ K+ H S  E     I    V A+ ++ +  GV+HRD+KP
Sbjct: 78  QLHTFLVMELLNGGELFERIKKKKHFS--ETEASYIMRKLVSAVSHMHD-VGVVHRDLKP 134

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKAR-TKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            N+L    ++   IK+ DFG +                  Y APE +      +  YD  
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN-----QNGYDES 189

Query: 121 ADVWSLGITL 130
            D+WSLG+ L
Sbjct: 190 CDLWSLGVIL 199

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.9 bits (216), Expect = 6e-20
 Identities = 36/129 (27%), Positives = 65/129 (50%), Gaps = 14/129 (10%)

Query: 7   ESDVWICMELMATC--FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +  ++ M+L++    FDR+L+R   +  E     +    + A+ YL E +G++HRD+KP
Sbjct: 78  TTHYYLVMQLVSGGELFDRILERGVYT--EKDASLVIQQVLSAVKYLHE-NGIVHRDLKP 134

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+L    +E   I + DFG+S ++  +   +   G   Y+APE +      +  Y    
Sbjct: 135 ENLLYLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYVAPEVLA-----QKPYSKAV 188

Query: 122 DVWSLGITL 130
           D WS+G+  
Sbjct: 189 DCWSIGVIT 197

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.4 bits (217), Expect = 6e-20
 Identities = 44/139 (31%), Positives = 60/139 (43%), Gaps = 11/139 (7%)

Query: 7   ESDVWICMELMAT--CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E  +++ ME  +    FD L+   H  + E          V A+ Y  +   ++HRD+K 
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKA 142

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD-IRADV 123
            N+LLD   NIK+ DFG S             G   Y APE       Q   YD    DV
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF-----QGKKYDGPEVDV 197

Query: 124 WSLGITLVELATGEFPYKD 142
           WSLG+ L  L +G  P+  
Sbjct: 198 WSLGVILYTLVSGSLPFDG 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.0 bits (216), Expect = 7e-20
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
              V++  ELM      D++L++   S  E     +  +  K + YL    GV+HRD+KP
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKFFS--EREASAVLFTITKTVEYLHA-QGVVHRDLKP 144

Query: 65  SNILL----DERGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
           SNIL         +I++CDFG + +L  ++         A ++APE +E     +  YD 
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE-----RQGYDA 199

Query: 120 RADVWSLGITL 130
             D+WSLG+ L
Sbjct: 200 ACDIWSLGVLL 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.9 bits (218), Expect = 7e-20
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 8/119 (6%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+A
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP 162
           PE +E       DY    D W LG+ + E+  G  P+ +   + ++   +L +     P
Sbjct: 318 PEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-EIRFP 369

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.7 bits (213), Expect = 8e-20
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 10/102 (9%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART---KNAGCAAY 101
           +  + YL    G+ HRD+KP N+LLDER N+K+ DFG++     +       K  G   Y
Sbjct: 115 MAGVVYL-HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 102 MAPERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
           +APE +     ++ ++     DVWS GI L  +  GE P+  
Sbjct: 174 VAPELL-----KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 13/154 (8%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +++ + +EL+     FDR++++ + S  E          ++A+ YL E +G++HRD+KP
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYS--ERDAADAVKQILEAVAYLHE-NGIVHRDLKP 176

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+L         +K+ DFG+S  +          G   Y APE +     +   Y    
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL-----RGCAYGPEV 231

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           D+WS+GI    L  G  P+ D + D  +  R+LN
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 86.2 bits (214), Expect = 1e-19
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 15/155 (9%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +DV + +EL++    FD L ++  +S  E          +  ++YL     + H D+KP
Sbjct: 87  RTDVVLILELVSGGELFDFLAQKESLS--EEEATSFIKQILDGVNYLHT-KKIAHFDLKP 143

Query: 65  SNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            NI+L        +IKL DFG++  + D        G   ++APE +      +P   + 
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN----YEP-LGLE 198

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           AD+WS+G+    L +G  P+       E L+ + +
Sbjct: 199 ADMWSIGVITYILLSGASPFLG-DTKQETLANITS 232

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 33/128 (25%), Positives = 63/128 (49%), Gaps = 14/128 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++DV + +EL+A    FD L ++  ++  E    +     +  ++YL     + H D+KP
Sbjct: 86  KTDVILILELVAGGELFDFLAEKESLT--EEEATEFLKQILNGVYYLHS-LQIAHFDLKP 142

Query: 65  SNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            NI+L      +  IK+ DFG++ ++          G   ++APE +      +P   + 
Sbjct: 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN----YEP-LGLE 197

Query: 121 ADVWSLGI 128
           AD+WS+G+
Sbjct: 198 ADMWSIGV 205

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 33/130 (25%), Positives = 64/130 (49%), Gaps = 14/130 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           E   ++  +L+     F+ ++ R + S  E          ++A+ +  +  GV+HR++KP
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCIQQILEAVLHCHQ-MGVVHRNLKP 138

Query: 65  SNILL---DERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            N+LL    +   +KL DFG++  +  + +A    AG   Y++PE +     +K  Y   
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-----RKDPYGKP 193

Query: 121 ADVWSLGITL 130
            D+W+ G+ L
Sbjct: 194 VDLWACGVIL 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 14/128 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++DV + +EL++    FD L ++  ++  E    +     +  +HYL     + H D+KP
Sbjct: 80  KTDVVLILELVSGGELFDFLAEKESLT--EDEATQFLKQILDGVHYLHS-KRIAHFDLKP 136

Query: 65  SNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            NI+L         IKL DFGI+ ++          G   ++APE +      +P   + 
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN----YEP-LGLE 191

Query: 121 ADVWSLGI 128
           AD+WS+G+
Sbjct: 192 ADMWSIGV 199

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 37/126 (29%), Positives = 57/126 (45%), Gaps = 10/126 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKART---KNAGCAAY 101
           +  + YL    G+ HRD+KP N+LLDER N+K+ DFG++     +       K  G   Y
Sbjct: 115 MAGVVYL-HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 102 MAPERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC 160
           +APE +     ++ ++     DVWS GI L  +  GE P+       +  S         
Sbjct: 174 VAPELL-----KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 161 LPNDPL 166
            P   +
Sbjct: 229 NPWKKI 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 23/148 (15%), Positives = 51/148 (34%), Gaps = 25/148 (16%)

Query: 12  ICMELMA--TCFDRLLKRLHVS---VPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  EL +  T  + +    +     +P+ +     +  +  +  + +   +IH D+KP N
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDN 202

Query: 67  ILL-----------DERGNIKLCDFGIS---GRLVDSKARTKNAGCAAYMAPERIEPPNP 112
            +L           D    + L D G S            T     + +   E +     
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS---- 258

Query: 113 QKPDYDIRADVWSLGITLVELATGEFPY 140
            KP ++ + D + +  T+  +  G +  
Sbjct: 259 NKP-WNYQIDYFGVAATVYCMLFGTYMK 285

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 11/103 (10%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS----GRLVDSKARTKNAGCAA 100
           +  L YL  + G++H+D+KP N+LL   G +K+   G++        D   RT + G  A
Sbjct: 119 IDGLEYL-HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPA 176

Query: 101 YMAPERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
           +  PE     N     +   + D+WS G+TL  + TG +P++ 
Sbjct: 177 FQPPEIA---NGLDT-FSGFKVDIWSAGVTLYNITTGLYPFEG 215

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 85.3 bits (211), Expect = 4e-19
 Identities = 32/158 (20%), Positives = 54/158 (34%), Gaps = 26/158 (16%)

Query: 1   MSPQSKESDVWICMELMATCFDR--LLKRLHV-SVPEPICGKITLSTVKALHYL------ 51
                   +  + ME          L K L + +       ++  S  + L YL      
Sbjct: 78  RVTADGRMEYLLVMEYYP----NGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 52  --KETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR---------TKNAGCAA 100
                  + HRD+   N+L+   G   + DFG+S RL  ++               G   
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193

Query: 101 YMAPERIE--PPNPQKPDYDIRADVWSLGITLVELATG 136
           YMAPE +E             + D+++LG+   E+   
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 9/117 (7%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL YL     V++RD+K  N++LD+ G+IK+ DFG+    +   A  K   G   Y+APE
Sbjct: 117 ALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP 162
            +     +  DY    D W LG+ + E+  G  P+ +   +  +   +L +     P
Sbjct: 176 VL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILME-EIRFP 225

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAP 104
           AL +L +  G+I+RD+K  NILLD  G++ L DFG+S   V  +       C    YMAP
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           + +         +D   D WSLG+ + EL TG  P+
Sbjct: 230 DIVR---GGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL YL     +++RD+KP NILLD +G+I L DFG+    ++  + T    G   Y+APE
Sbjct: 151 ALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---PPCLP 162
            +      K  YD   D W LG  L E+  G  P+       E+   +LN      P + 
Sbjct: 210 VL-----HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNKPLQLKPNIT 263

Query: 163 ND 164
           N 
Sbjct: 264 NS 265

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 10/119 (8%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER 106
            L  L     +++RD+KP NILLD+ G+I++ D G++  + + +      G   YMAPE 
Sbjct: 298 GLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356

Query: 107 IEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF---EVLSRVLNDAPPCLP 162
           +     +   Y    D W+LG  L E+  G+ P++  K      EV   V    P    
Sbjct: 357 V-----KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS 409

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.1 bits (211), Expect = 4e-19
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 14/128 (10%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +DV + +EL++    FD L ++  +S  E          +  ++YL     + H D+KP
Sbjct: 87  RTDVVLILELVSGGELFDFLAQKESLS--EEEATSFIKQILDGVNYLHT-KKIAHFDLKP 143

Query: 65  SNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            NI+L        +IKL DFG++  + D        G   ++APE +      +P   + 
Sbjct: 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN----YEP-LGLE 198

Query: 121 ADVWSLGI 128
           AD+WS+G+
Sbjct: 199 ADMWSIGV 206

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.6 bits (210), Expect = 5e-19
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 11/122 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
            L +L+   G+I+RD+K  N++LD  G+IK+ DFG+    +     TK   G   Y+APE
Sbjct: 133 GLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---PPCLP 162
            I         Y    D W+ G+ L E+  G+ P++    D E+   ++      P  + 
Sbjct: 192 II-----AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSMS 245

Query: 163 ND 164
            +
Sbjct: 246 KE 247

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 40/122 (32%), Positives = 62/122 (50%), Gaps = 11/122 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL +L +  G+I+RD+K  N+LLD  G+ KL DFG+    + +   T    G   Y+APE
Sbjct: 136 ALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---PPCLP 162
            +     Q+  Y    D W++G+ L E+  G  P++    D ++   +LND    P  L 
Sbjct: 195 IL-----QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILNDEVVYPTWLH 248

Query: 163 ND 164
            D
Sbjct: 249 ED 250

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 18/130 (13%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    +     T    G   Y+APE
Sbjct: 122 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF--------EVLSRVLNDA 157
            +     +  DY    D W+LG+ + E+  G  P+                +   +L   
Sbjct: 181 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235

Query: 158 ---PPCLPND 164
              P  L   
Sbjct: 236 IRIPRSLSVK 245

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 10/99 (10%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMA 103
           V    YL     +I+RD+KP N+L+D++G I++ DFG + R+     RT    G    +A
Sbjct: 151 VLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALA 206

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
           PE I         Y+   D W+LG+ + E+A G  P+  
Sbjct: 207 PEII-----LSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 18/130 (13%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL+YL E  G+I+RD+K  N+LLD  G+IKL D+G+    +     T    G   Y+APE
Sbjct: 165 ALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF--------EVLSRVLNDA 157
            +     +  DY    D W+LG+ + E+  G  P+                +   +L   
Sbjct: 224 IL-----RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

Query: 158 ---PPCLPND 164
              P  L   
Sbjct: 279 IRIPRSLSVK 288

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 11/122 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
            L +L    G+++RD+K  NILLD+ G+IK+ DFG+    +   A+T    G   Y+APE
Sbjct: 130 GLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---PPCLP 162
            +         Y+   D WS G+ L E+  G+ P+     + E+   +  D    P  L 
Sbjct: 189 IL-----LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRMDNPFYPRWLE 242

Query: 163 ND 164
            +
Sbjct: 243 KE 244

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 34/153 (22%), Positives = 71/153 (46%), Gaps = 12/153 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           + ++ + +E ++    FDR+    +  + E           + L ++ E H ++H D+KP
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKP 177

Query: 65  SNILLDERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            NI+ + +    +K+ DFG++ +L   +        A + APE ++    ++P      D
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD----REP-VGFYTD 232

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           +W++G+    L +G  P+   + D E L  V  
Sbjct: 233 MWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKR 264

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.5 bits (202), Expect = 5e-18
 Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 11/126 (8%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
             ++ +  E ++    F+R+       + E           +AL +L   H + H D++P
Sbjct: 73  MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRP 130

Query: 65  SNILLDERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            NI+   R +  IK+ +FG + +L              Y APE  +             D
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ----HDV-VSTATD 185

Query: 123 VWSLGI 128
           +WSLG 
Sbjct: 186 MWSLGT 191

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.4 bits (202), Expect = 6e-18
 Identities = 37/97 (38%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
           AL YL     +I+RD+KP NILLD+ G+IK+ DFG +  + D    T    G   Y+APE
Sbjct: 118 ALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPE 173

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKD 142
            +         Y+   D WS GI + E+  G  P+ D
Sbjct: 174 VV-----STKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 80.7 bits (200), Expect = 8e-18
 Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 22/107 (20%)

Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN--- 95
           KI       +++L E H  IHRD+K +NILLDE    K+ DFG++ R  +  A+T     
Sbjct: 137 KIAQGAANGINFLHENH-HIHRDIKSANILLDEAFTAKISDFGLA-RASEKFAQTVMTSR 194

Query: 96  -AGCAAYMAPERIEPPNPQKPDY-----DIRADVWSLGITLVELATG 136
             G  AYMAPE                   ++D++S G+ L+E+ TG
Sbjct: 195 IVGTTAYMAPE-----------ALRGEITPKSDIYSFGVVLLEIITG 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 79.9 bits (198), Expect = 1e-17
 Identities = 36/99 (36%), Positives = 49/99 (49%), Gaps = 7/99 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           + A+ Y    H V+HRD+KP N+LLD   N K+ DFG+S  + D +    + G   Y AP
Sbjct: 121 LSAVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179

Query: 105 ERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
           E I         Y     D+WS G+ L  L  G  P+ D
Sbjct: 180 EVI-----SGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 11/122 (9%)

Query: 47  ALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPE 105
            L +L+   G+I+RD+K  N++LD  G+IK+ DFG+    +     TK   G   Y+APE
Sbjct: 454 GLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA---PPCLP 162
            I         Y    D W+ G+ L E+  G+ P++    D E+   ++      P  + 
Sbjct: 513 II-----AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSMS 566

Query: 163 ND 164
            +
Sbjct: 567 KE 568

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 12/153 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++D+ + ME +     FDR++   + ++ E           + + ++ +   ++H D+KP
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQ-MYILHLDLKP 215

Query: 65  SNILLDERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            NIL   R    IK+ DFG++ R    +    N G   ++APE +              D
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN----YDF-VSFPTD 270

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           +WS+G+    L +G  P+     D E L+ +L 
Sbjct: 271 MWSVGVIAYMLLSGLSPFLG-DNDAETLNNILA 302

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 10/92 (10%)

Query: 55  HGVIHRDVKPSNILLDE--RGNIKLCDFGISGRLV-DSKARTKNAGCAAYMAPERIEPPN 111
             + HRD+K  N LLD      +K+CDFG S   V  S+ ++   G  AY+APE +    
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL---- 189

Query: 112 PQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
             + +YD   ADVWS G+TL  +  G +P++D
Sbjct: 190 -LRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 36/108 (33%), Positives = 49/108 (45%), Gaps = 23/108 (21%)

Query: 39  KITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR----TK 94
           +I +   + LHYL     +IHRDVK  NILLDE    K+ DFGIS +      +    T 
Sbjct: 143 EICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLSTV 200

Query: 95  NAGCAAYMAPERIEPPNPQKPDYDIR------ADVWSLGITLVELATG 136
             G   Y+ PE           Y I+      +DV+S G+ L E+   
Sbjct: 201 VKGTLGYIDPE-----------YFIKGRLTEKSDVYSFGVVLFEVLCA 237

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 7/99 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           + A+ Y    H ++HRD+KP N+LLD+  N+K+ DFG+S  + D      + G   Y AP
Sbjct: 118 ICAIEYC-HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176

Query: 105 ERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
           E I         Y     DVWS GI L  +  G  P+ D
Sbjct: 177 EVI-----NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.8 bits (195), Expect = 5e-17
 Identities = 42/149 (28%), Positives = 59/149 (39%), Gaps = 34/149 (22%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  + +  E         L R    VPE +   IT  T++A+++  + H  IHRDVKP N
Sbjct: 74  KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPEN 132

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPE-----RIEPPNP 112
           IL+ +   IKLCDFG         AR                 Y +PE            
Sbjct: 133 ILITKHSVIKLCDFGF--------ARLLTGPSDYYDDEVATRWYRSPELLVGDT------ 178

Query: 113 QKPDYDIRADVWSLGITLVELATGE--FP 139
               Y    DVW++G    EL +G   +P
Sbjct: 179 ---QYGPPVDVWAIGCVFAELLSGVPLWP 204

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.9 bits (195), Expect = 7e-17
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 13/149 (8%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--G 56
                + +   +++  ELM T   +++    + +            +  LH L   H  G
Sbjct: 98  FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAG 154

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           V+HRD+ P NILL +  +I +CDF ++        +T       Y APE +         
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK----G 210

Query: 117 YDIRADVWSLGITLVELATGE--FPYKDC 143
           +    D+WS G  + E+   +  F     
Sbjct: 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTF 239

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 25/201 (12%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++++ +  E M+    F+++    H  + E    +      K L ++ E +  +H D+KP
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKP 283

Query: 65  SNILLDERG--NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            NI+   +    +KL DFG++  L   ++     G A + APE  E     KP      D
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE----GKP-VGYYTD 338

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRS 182
           +WS+G+    L +G  P+   + D E L  V +     + +       I     KD    
Sbjct: 339 MWSVGVLSYILLSGLSPFGG-ENDDETLRNVKS-CDWNMDDSAF--SGISED-GKD---- 389

Query: 183 TEFIRK---RSYEDKSTCYEC 200
             FIRK        + T ++ 
Sbjct: 390 --FIRKLLLADPNTRMTIHQA 408

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 21/154 (13%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--G 56
           +   + E   DV+I  +LM T   +LLK  H+S  + IC       ++ L Y+   H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHIC-YFLYQILRGLKYI---HSAN 148

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA--GCAA---YMAPERIEPPN 111
           V+HRD+KPSN+LL+   ++K+CDFG++ R+ D             A   Y APE +    
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207

Query: 112 PQKPDYDIRADVWSLGITLVELATGE--FPYKDC 143
                Y    D+WS+G  L E+ +    FP K  
Sbjct: 208 ----GYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 28/161 (17%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--G 56
             P S E+  +V+I  ELM T   R++    +S  + I       T++A+  L   H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLS-DDHIQ-YFIYQTLRAVKVL---HGSN 132

Query: 57  VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA------------YMAP 104
           VIHRD+KPSN+L++   ++K+CDFG++ R++D  A   +                 Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLA-RIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191

Query: 105 ERIEPPNPQKPDYDIRADVWSLGITLVELATGE--FPYKDC 143
           E +      K  Y    DVWS G  L EL      FP +D 
Sbjct: 192 EVML--TSAK--YSRAMDVWSCGCILAELFLRRPIFPGRDY 228

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 23/142 (16%)

Query: 9   DVWICMELMATCFDRLLK----RLHVSVPEPICGKITLSTVKALHYLKETH--GVIHRDV 62
           DV+I MELM     ++++       +S        +    +  + +L   H  G+IHRD+
Sbjct: 104 DVYIVMELMDANLCQVIQMELDHERMSY-------LLYQMLCGIKHL---HSAGIIHRDL 153

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           KPSNI++     +K+ DFG++     S   T       Y APE I         Y    D
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVD 208

Query: 123 VWSLGITLVELATGE--FPYKD 142
           +WS+G  + E+  G   FP  D
Sbjct: 209 IWSVGCIMGEMIKGGVLFPGTD 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 36/148 (24%)

Query: 9   DVWICMELMATCFDRLLK-RL---HVSVPEPICGKITLSTVKALHYLKETH--GVIHRDV 62
           D ++ M  M T   +++  +     +         +    +K L Y+   H  GV+HRD+
Sbjct: 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQY-------LVYQMLKGLKYI---HSAGVVHRDL 152

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYM------APERIEPPNPQKPD 116
           KP N+ ++E   +K+ DFG+        AR  +A    Y+      APE I         
Sbjct: 153 KPGNLAVNEDCELKILDFGL--------ARHADAEMTGYVVTRWYRAPEVILSWM----H 200

Query: 117 YDIRADVWSLGITLVELATGE--FPYKD 142
           Y+   D+WS+G  + E+ TG+  F  KD
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKD 228

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 7/99 (7%)

Query: 45  VKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAP 104
           +  + Y    H V+HRD+KP N+LLD   N K+ DFG+S  + D +    + G   Y AP
Sbjct: 126 LSGVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184

Query: 105 ERIEPPNPQKPDYD-IRADVWSLGITLVELATGEFPYKD 142
           E I         Y     D+WS G+ L  L  G  P+ D
Sbjct: 185 EVI-----SGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 39/150 (26%), Positives = 58/150 (38%), Gaps = 34/150 (22%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           K+   ++  E +       L+     +   +  K     +  + +    H +IHRD+KP 
Sbjct: 95  KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPE 153

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPE-----RIEPPN 111
           NIL+ + G +KLCDFG         ART  A             Y APE           
Sbjct: 154 NILVSQSGVVKLCDFGF--------ARTLAAPGEVYDDEVATRWYRAPELLVGDV----- 200

Query: 112 PQKPDYDIRADVWSLGITLVELATGE--FP 139
                Y    DVW++G  + E+  GE  FP
Sbjct: 201 ----KYGKAVDVWAIGCLVTEMFMGEPLFP 226

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 34/133 (25%), Positives = 48/133 (36%), Gaps = 32/133 (24%)

Query: 3   PQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
             +    + I ME +     F R+  R   +  E    +I  S  +A+ YL     + HR
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHR 141

Query: 61  DVKPSNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDY 117
           DVKP N+L         +KL DFG                     A E           Y
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGF--------------------AKETT------GEKY 175

Query: 118 DIRADVWSLGITL 130
           D   D+WSLG+ +
Sbjct: 176 DKSCDMWSLGVIM 188

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 23/153 (15%)

Query: 2   SPQSKESDVWICMELMATCFDRLLKRLHVS---VPEPICGKITLSTVKALHYLKETHGVI 58
              S+   + + ME +     ++LK    S   +P  +         +A+ ++  + G+ 
Sbjct: 105 VNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGIC 163

Query: 59  HRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYM------APERIEPPN 111
           HRD+KP N+L++ +   +KLCDFG + +L+ S+         AY+      APE +    
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV------AYICSRFYRAPELMLGAT 217

Query: 112 PQKPDYDIRADVWSLGITLVELATGE--FPYKD 142
               +Y    D+WS+G    EL  G+  F  + 
Sbjct: 218 ----EYTPSIDLWSIGCVFGELILGKPLFSGET 246

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.8 bits (189), Expect = 6e-16
 Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 19/140 (13%)

Query: 9   DVWICMELMATCFDRL----LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           DV++ MELM     ++    L    +S        +    +  + +L  + G+IHRD+KP
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSY-------LLYQMLCGIKHL-HSAGIIHRDLKP 192

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           SNI++     +K+ DFG++     S   T       Y APE I         Y    D+W
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-----YKENVDIW 247

Query: 125 SLGITLVELATGE--FPYKD 142
           S+G  + E+   +  FP +D
Sbjct: 248 SVGCIMGEMVRHKILFPGRD 267

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 27/144 (18%)

Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--GVIHRDVKPSN 66
           D ++ M  M T   +L+K   +   E     +    +K L Y+   H  G+IHRD+KP N
Sbjct: 104 DFYLVMPFMGTDLGKLMKHEKLG--EDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGN 158

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYM------APERIEPPNPQKPDYDIR 120
           + ++E   +K+ DFG+        AR  ++    Y+      APE I         Y   
Sbjct: 159 LAVNEDCELKILDFGL--------ARQADSEMTGYVVTRWYRAPEVIL----NWMRYTQT 206

Query: 121 ADVWSLGITLVELATGE--FPYKD 142
            D+WS+G  + E+ TG+  F   D
Sbjct: 207 VDIWSVGCIMAEMITGKTLFKGSD 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 29/153 (18%)

Query: 2   SPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--GV 57
             +S E   DV++   LM    + ++K   ++  +     +    ++ L Y+   H   +
Sbjct: 99  PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHVQFLIYQILRGLKYI---HSADI 153

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYM------APERIEPPN 111
           IHRD+KPSN+ ++E   +K+ DFG+        AR        Y+      APE +    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGL--------ARHTADEMTGYVATRWYRAPEIMLNWM 205

Query: 112 PQKPDYDIRADVWSLGITLVELATGE--FPYKD 142
                Y+   D+WS+G  + EL TG   FP  D
Sbjct: 206 ----HYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 23/117 (19%)

Query: 39  KITLSTVKALHYLKETHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RT 93
           +I L + + L YL +     +IHRDVK +NILLDE     + DFG++ +L+D K     T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTT 193

Query: 94  KNAGCAAYMAPERIEPPNPQKPDYDIR------ADVWSLGITLVELATGEFPYKDCK 144
              G   ++APE           Y          DV+  G+ L+EL TG+  +   +
Sbjct: 194 AVRGTIGHIAPE-----------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 18/139 (12%)

Query: 12  ICM--ELMATCFDRLLKR-LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           + M  E++      L+K+  H  +P     +I+   +  L Y+    G+IH D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164

Query: 69  LDE------RGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           ++          IK+ D G +    D            Y +PE +         +   AD
Sbjct: 165 MEIVDSPENLIQIKIADLG-NACWYDEHYTNSIQTR-EYRSPEVL-----LGAPWGCGAD 217

Query: 123 VWSLGITLVELATGE--FP 139
           +WS    + EL TG+  F 
Sbjct: 218 IWSTACLIFELITGDFLFE 236

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 32/175 (18%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETHGVI 58
            S V +  +LM   F  LL  +           I    +        K ++YL E   ++
Sbjct: 88  TSTVQLITQLMP--FGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYL-EDRRLV 139

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA----AYMAPERIEPPNPQK 114
           HRD+   N+L+    ++K+ DFG++ +L+ ++ +  +A        +MA E I     + 
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMALESI---LHRI 195

Query: 115 PDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
             Y  ++DVWS G+T+ EL T G  PY       E+ S +        PP    D
Sbjct: 196 --YTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTID 247

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 20/156 (12%), Positives = 39/156 (25%), Gaps = 38/156 (24%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVKPS 65
            +   +  E +       L+ +  + P P+   +   S   A        GV      PS
Sbjct: 103 RAGGLVVAEWIR---GGSLQEVADTSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPS 158

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
            + +   G++ L                        M               + + D+  
Sbjct: 159 RVRVSIDGDVVLAYPA-------------------TMPDA------------NPQDDIRG 187

Query: 126 LGITLVELATGEFPYKDCKCD--FEVLSRVLNDAPP 159
           +G +L  L    +P  +           R     P 
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI 223

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 18/168 (10%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +++  ++I MEL+    F   L+     +      ++       + YL E+   IHRD+ 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL-ESKCCIHRDLA 240

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPERIEPPNPQKPDYDI 119
             N L+ E+  +K+ DFG+S R         + G         APE +         Y  
Sbjct: 241 ARNCLVTEKNVLKISDFGMS-REEADGVYAASGGLRQVPVKWTAPEAL-----NYGRYSS 294

Query: 120 RADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLP 162
            +DVWS GI L E  + G  PY +   + +    V        P   P
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLS-NQQTREFVEKGGRLPCPELCP 341

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 26/148 (17%)

Query: 1   MSPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           +      +   +   +  T F +L + L     +          +KAL Y   + G++HR
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTL----TDYDIRFYMYEILKALDYC-HSMGIMHR 154

Query: 61  DVKPSNILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAA--------YMAPERIEPPN 111
           DVKP N+++D E   ++L D+G+        A   + G           +  PE +    
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGL--------AEFYHPGQEYNVRVASRYFKGPELL---- 202

Query: 112 PQKPDYDIRADVWSLGITLVELATGEFP 139
                YD   D+WSLG  L  +   + P
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 41/180 (22%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLK------RLHVSVPEPICGKITLSTVKALHYLK 52
           + P       +++I +E+  +   +L K        H+         I  + +   +++ 
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT-------ILYNLLLGENFI- 145

Query: 53  ETH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPP 110
             H  G+IHRD+KP+N LL++  ++K+CDFG++ R ++S+  T                 
Sbjct: 146 --HESGIIHRDLKPANCLLNQDCSVKVCDFGLA-RTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 111 NPQK--------------------PDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVL 150
           N +K                     +Y    D+WS G    EL      + +   +   L
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 37/162 (22%)

Query: 9   DVWICMELMATCFDRL-----LKRLHVSVPEPICGKITLSTVKALHYLKETH--GVIHRD 61
           DV++  + M T    +     L+ +H          +    +K + YL   H  G++HRD
Sbjct: 85  DVYLVFDYMETDLHAVIRANILEPVHKQY-------VVYQLIKVIKYL---HSGGLLHRD 134

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDI-- 119
           +KPSNILL+   ++K+ DFG+S   V+ +  T N   +     E  +   P   DY    
Sbjct: 135 MKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194

Query: 120 --RA--------------DVWSLGITLVELATGE--FPYKDC 143
             RA              D+WSLG  L E+  G+  FP    
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 41/221 (18%), Positives = 81/221 (36%), Gaps = 47/221 (21%)

Query: 1   MSPQSKES--DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
           + P+  E   ++++ +E+  + F +L +   V + E     +  + +  + Y+  + G++
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYV-HSAGIL 178

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYD 118
           HRD+KP+N L+++  ++K+CDFG++ R VD      +    +    +      P   +  
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLA-RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237

Query: 119 I-----------RA--------------DVWSLGITLVELATGEFPYKDCKCDFEVLSRV 153
                       RA              DVWS+G    EL                L+ +
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL----------------LNMI 281

Query: 154 LNDAPPCLPNDPLF-GRTIKASIAKDNGRSTEFIRKRSYED 193
             +        PLF G +           +      R   D
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 73.0 bits (180), Expect = 5e-15
 Identities = 33/149 (22%), Positives = 59/149 (39%), Gaps = 34/149 (22%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           E  + +  E M     ++L      + +          ++ + +  + H ++HRD+KP N
Sbjct: 91  ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQN 149

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPE-----RIEPPNP 112
           +L++  G +KL DFG+        AR       +         Y AP+     +      
Sbjct: 150 LLINSDGALKLADFGL--------ARAFGIPVRSYTHEVVTLWYRAPDVLMGSK------ 195

Query: 113 QKPDYDIRADVWSLGITLVELATGE--FP 139
               Y    D+WS+G    E+ TG+  FP
Sbjct: 196 ---KYSTSVDIWSIGCIFAEMITGKPLFP 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 72.5 bits (179), Expect = 6e-15
 Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  + +  E +     +LL      +         L  +  + Y  +   V+HRD+KP N
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQN 130

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPERIEPPNPQKPDY 117
           +L++  G +K+ DFG+        AR                 Y AP+ +         Y
Sbjct: 131 LLINREGELKIADFGL--------ARAFGIPVRKYTHEIVTLWYRAPDVLM----GSKKY 178

Query: 118 DIRADVWSLGITLVELATGE--FP 139
               D+WS+G    E+  G   FP
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFP 202

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 71.8 bits (177), Expect = 8e-15
 Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 13/154 (8%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
            +++ + +  E M   C    L+             + L   + + YL E   VIHRD+ 
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDLA 131

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---YMAPERIEPPNPQKPDYDIR 120
             N L+ E   IK+ DFG++ R V     T + G      + +PE     +  +  Y  +
Sbjct: 132 ARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVF---SFSR--YSSK 185

Query: 121 ADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           +DVWS G+ + E+ + G+ PY++   + EV+  +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDI 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 18/152 (11%)

Query: 10  VWICMELMATC--FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI 67
             + ME+         L +  HV     I  ++       + YL E    +HRD+   N+
Sbjct: 92  WMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYL-EESNFVHRDLAARNV 148

Query: 68  LLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQKPDYDIRAD 122
           LL  +   K+ DFG+S + + +      A         + APE I   N  K  +  ++D
Sbjct: 149 LLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPECI---NYYK--FSSKSD 202

Query: 123 VWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           VWS G+ + E  + G+ PY+  K   EV + +
Sbjct: 203 VWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML 233

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 17/164 (10%)

Query: 10  VWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
            WI MEL         L+R   S+        +L   KA+ YL E+   +HRD+   NIL
Sbjct: 87  TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESINCVHRDIAVRNIL 145

Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDIRADVWS 125
           +     +KL DFG+S R ++ +   K +       +M+PE I   N ++  +   +DVW 
Sbjct: 146 VASPECVKLGDFGLS-RYIEDEDYYKASVTRLPIKWMSPESI---NFRR--FTTASDVWM 199

Query: 126 LGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
             + + E+ + G+ P+   + + +V+  +        P   P  
Sbjct: 200 FAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRLPKPDLCPPV 242

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.4 bits (176), Expect = 1e-14
 Identities = 30/143 (20%), Positives = 49/143 (34%), Gaps = 22/143 (15%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  + +  E       +     +  +   I        +K L +      V+HRD+KP N
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQN 131

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPERIEPPNPQKPDY 117
           +L++  G +KL +FG+        AR                 Y  P+ +         Y
Sbjct: 132 LLINRNGELKLANFGL--------ARAFGIPVRCYSAEVVTLWYRPPDVLF----GAKLY 179

Query: 118 DIRADVWSLGITLVELATGEFPY 140
               D+WS G    ELA    P 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 36/175 (20%)

Query: 10  VWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETHGVIHR 60
           + +  EL        LL RL         G   L T+        + + YL E+   IHR
Sbjct: 95  MKMVTELAPLGS---LLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYL-ESKRFIHR 145

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQKP 115
           D+   N+LL  R  +K+ DFG+  R +                  + APE +     +  
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLM-RALPQNDDHYVMQEHRKVPFAWCAPESL---KTRT- 200

Query: 116 DYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND-----APPCLPND 164
            +   +D W  G+TL E+ T G+ P+       ++L ++  +      P   P D
Sbjct: 201 -FSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERLPRPEDCPQD 253

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 22/172 (12%)

Query: 5   SKESDVWICMELMAT-CFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           ++E   +I  E M        L+   R  VS    +   +      A+ YL E    IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYL-EKKNFIHR 135

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---YMAPERIEPPNPQKPDY 117
           D+   N L+ E   +K+ DFG+S RL+     T +AG      + APE +      K  +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL---AYNK--F 189

Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
            I++DVW+ G+ L E+AT G  PY       +V   +      + P   P  
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 42/180 (23%), Positives = 65/180 (36%), Gaps = 32/180 (17%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
               +  +  E +     D  LK+    +      ++      A+H+L E + +IH +V 
Sbjct: 82  VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-EENTLIHGNVC 140

Query: 64  PSNILLDERGN--------IKLCDFGISGRLVDS----KARTKNAGCAAYMAPERIEPPN 111
             NILL    +        IKL D GIS   V      + R        ++ PE IE  N
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERIP------WVPPECIE--N 191

Query: 112 PQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLND---APPCLPNDPLF 167
           P+    ++  D WS G TL E+ + G+ P          L    +      P      L 
Sbjct: 192 PKN--LNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYEDRHQLPAPK--AAELA 246

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 37/149 (24%), Positives = 57/149 (38%), Gaps = 34/149 (22%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           E  + +  E +     + L      +            ++ L Y      V+HRD+KP N
Sbjct: 72  EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQN 130

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPE-----RIEPPNP 112
           +L++ERG +KL DFG+        AR K+              Y  P+            
Sbjct: 131 LLINERGELKLADFGL--------ARAKSIPTKTYDNEVVTLWYRPPDILLGST------ 176

Query: 113 QKPDYDIRADVWSLGITLVELATGE--FP 139
              DY  + D+W +G    E+ATG   FP
Sbjct: 177 ---DYSTQIDMWGVGCIFYEMATGRPLFP 202

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 70.7 bits (174), Expect = 3e-14
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 34/149 (22%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +S++ +  + M T  + ++K   + +         L T++ L YL + H ++HRD+KP+N
Sbjct: 84  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNN 142

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPE-----RIEPPNP 112
           +LLDE G +KL DFG+        A++  +   A         Y APE     R      
Sbjct: 143 LLLDENGVLKLADFGL--------AKSFGSPNRAYTHQVVTRWYRAPELLFGAR------ 188

Query: 113 QKPDYDIRADVWSLGITLVELATGE--FP 139
               Y +  D+W++G  L EL       P
Sbjct: 189 ---MYGVGVDMWAVGCILAELLLRVPFLP 214

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 39/156 (25%), Positives = 62/156 (39%), Gaps = 16/156 (10%)

Query: 5   SKESDVWICMELMAT-CFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           ++E   +I  E M        L+   R  VS    +   +      A+ YL E    IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYL-EKKNFIHR 342

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY--MAPERIEPPNPQKPDYD 118
           ++   N L+ E   +K+ DFG+S  +                  APE +         + 
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFS 397

Query: 119 IRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           I++DVW+ G+ L E+AT G  PY       +V   +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELL 432

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 26/170 (15%)

Query: 7   ESDVWICMELMA-TCFDRLLK---RLHVSVPE--PICGKITLSTVKALHYLKETHGVIHR 60
           E  ++I  E M+       LK     ++ +P+   +  +I       + Y+ E    +HR
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA----SGMAYV-ERMNYVHR 304

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDY 117
           D++ +NIL+ E    K+ DFG++ RL++    T   G      + APE           +
Sbjct: 305 DLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAA-----LYGRF 358

Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLP 162
            I++DVWS GI L EL T G  PY     + EVL +V        PP  P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECP 407

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 17/167 (10%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ VWI MEL         L+    S+              AL YL E+   +HRD+   
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKRFVHRDIAAR 520

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRAD 122
           N+L+     +KL DFG+S R ++     K +       +MAPE I         +   +D
Sbjct: 521 NVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESI-----NFRRFTSASD 574

Query: 123 VWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
           VW  G+ + E+   G  P++  K + +V+ R+ N      PP  P  
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNCPPT 620

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 27/155 (17%)

Query: 2   SPQSKESDVWICMELMATCFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVI 58
             +  E  + + +E +     R  +   +L  ++P  +        +++L Y+  + G+ 
Sbjct: 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGIC 163

Query: 59  HRDVKPSNILLDER-GNIKLCDFGISGRLVDSKARTKNAGCAA--------YMAPERIEP 109
           HRD+KP N+LLD   G +KL DFG         A+   AG           Y APE I  
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGS--------AKILIAGEPNVSYICSRYYRAPELIF- 214

Query: 110 PNPQKPDYDIRADVWSLGITLVELATGE--FPYKD 142
                 +Y    D+WS G  + EL  G+  FP + 
Sbjct: 215 ---GATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 70.0 bits (172), Expect = 4e-14
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 19/153 (12%)

Query: 10  VWICMELMAT-CFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           + + ME+       + L   R  + V      ++       + YL E    +HRD+   N
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMGMKYL-EEKNFVHRDLAARN 140

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQKPDYDIRA 121
           +LL  R   K+ DFG+S + + +      A  A      + APE I   N +K  +  R+
Sbjct: 141 VLLVNRHYAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPECI---NFRK--FSSRS 194

Query: 122 DVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           DVWS G+T+ E  + G+ PYK  K   EV++ +
Sbjct: 195 DVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFI 226

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 69.9 bits (172), Expect = 4e-14
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 21/169 (12%)

Query: 5   SKESDVWICMELMAT-CFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           SKE  ++I  E ++  C    L+     +   + +  ++     + + +L E+H  IHRD
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGMAFL-ESHQFIHRD 129

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---YMAPERIEPPNPQKPDYD 118
           +   N L+D    +K+ DFG++ R V       + G      + APE     +  K  Y 
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMT-RYVLDDQYVSSVGTKFPVKWSAPEVF---HYFK--YS 183

Query: 119 IRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLP 162
            ++DVW+ GI + E+ + G+ PY     + EV+ +V        P    
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLAS 231

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 16/151 (10%)

Query: 10  VWICMELMATC----FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++I  E MA      F +  +     +P+ I    +    + + ++ E    IHRD++ +
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFI-EQRNYIHRDLRAA 313

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY--MAPERIEPPNPQKPDYDIRADV 123
           NIL+      K+ DFG++  + D++   +          APE I   N     + I++DV
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI---NFGS--FTIKSDV 368

Query: 124 WSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           WS GI L+E+ T G  PY     + EV+  +
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMS-NPEVIRAL 398

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 69.6 bits (171), Expect = 5e-14
 Identities = 38/156 (24%), Positives = 75/156 (48%), Gaps = 17/156 (10%)

Query: 5   SKESDVWICMELMAT-CFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           +K+  ++I  E MA  C    L+  R      + +  ++     +A+ YL E+   +HRD
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCKDVCEAMEYL-ESKQFLHRD 145

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYD 118
           +   N L++++G +K+ DFG+S R V     T + G      +  PE +      K  + 
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVL---MYSK--FS 199

Query: 119 IRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
            ++D+W+ G+ + E+ + G+ PY+    + E    +
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHI 234

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 5e-14
 Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 20/145 (13%)

Query: 8   SDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETH--GVIHRDVKPS 65
           + V+I  E M T    +L++  +   E          ++ L Y+   H   V+HRD+KP+
Sbjct: 95  NSVYIVQEYMETDLANVLEQGPLL--EEHARLFMYQLLRGLKYI---HSANVLHRDLKPA 149

Query: 66  NILLDERG-NIKLCDFGISGRLVDSKARTKNA--GCAA---YMAPERIEPPNPQKPDYDI 119
           N+ ++     +K+ DFG++ R++D     K           Y +P  +  PN    +Y  
Sbjct: 150 NLFINTEDLVLKIGDFGLA-RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN----NYTK 204

Query: 120 RADVWSLGITLVELATGE--FPYKD 142
             D+W+ G    E+ TG+  F    
Sbjct: 205 AIDMWAAGCIFAEMLTGKTLFAGAH 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 70.4 bits (173), Expect = 6e-14
 Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 23/142 (16%)

Query: 14  MELMATCFDRLLK---RLHVSVPEPICGKITLSTVKALHYL-KETHGVIHRDVKPSNILL 69
           ME +     R  +   R  V+ P  +        ++++  L   +  V HRD+KP N+L+
Sbjct: 105 MEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164

Query: 70  DER-GNIKLCDFGISGRLVDSKARTKNAGCAAYM------APERIEPPNPQKPDYDIRAD 122
           +E  G +KLCDFG + +L  S+         AY+      APE I         Y    D
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEPNV------AYICSRYYRAPELIF----GNQHYTTAVD 214

Query: 123 VWSLGITLVELATGE--FPYKD 142
           +WS+G    E+  GE  F   +
Sbjct: 215 IWSVGCIFAEMMLGEPIFRGDN 236

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 69.6 bits (171), Expect = 8e-14
 Identities = 38/126 (30%), Positives = 54/126 (42%), Gaps = 20/126 (15%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPE 105
           +L  +   IHRD+   NILL      K+CDFG++ R + + +     G A      MAPE
Sbjct: 160 FL-ASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIKNDSNYVVKGNARLPVKWMAPE 217

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAP 158
            I        +  Y   +DVWS GI L EL + G  PY     D +    +       +P
Sbjct: 218 SIF-------NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270

Query: 159 PCLPND 164
              P +
Sbjct: 271 EHAPAE 276

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 69.7 bits (171), Expect = 8e-14
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 32/175 (18%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETHGVI 58
            S V +  +LM   F  LL  +           I    +        K ++YL E   ++
Sbjct: 88  TSTVQLITQLMP--FGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYL-EDRRLV 139

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA----AYMAPERIEPPNPQK 114
           HRD+   N+L+    ++K+ DFG++ +L+ ++ +  +A        +MA E I     + 
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMALESI---LHRI 195

Query: 115 PDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
             Y  ++DVWS G+T+ EL T G  PY       E+ S +        PP    D
Sbjct: 196 --YTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTID 247

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 41/155 (26%), Positives = 61/155 (39%), Gaps = 27/155 (17%)

Query: 2   SPQSKESDVWICMELMATCFDRLLKRLHVS---VPEPICGKITLSTVKALHYLKETHGVI 58
             +  E  + + ++ +     R+ +    +   +P            ++L Y+  + G+ 
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGIC 178

Query: 59  HRDVKPSNILLDER-GNIKLCDFGISGRLVDSKARTKNAGCAA--------YMAPERIEP 109
           HRD+KP N+LLD     +KLCDFG         A+    G           Y APE I  
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVSYICSRYYRAPELIF- 229

Query: 110 PNPQKPDYDIRADVWSLGITLVELATGE--FPYKD 142
                 DY    DVWS G  L EL  G+  FP   
Sbjct: 230 ---GATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 22/168 (13%)

Query: 7   ESDVWICMELMA-TCFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           E  ++I  E M+       LK     ++ +P+ +   +       + Y+ E    +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYV-ERMNYVHRDL 389

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---AYMAPERIEPPNPQKPDYDI 119
           + +NIL+ E    K+ DFG++ RL++    T   G      + APE           + I
Sbjct: 390 RAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAA-----LYGRFTI 443

Query: 120 RADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLP 162
           ++DVWS GI L EL T G  PY     + EVL +V        PP  P
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECP 490

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 29/158 (18%)

Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETHGVIHRD 61
           + + ME+       L K L          +I +S V          + YL E    +HR+
Sbjct: 410 LMLVMEMA--GGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYL-EEKNFVHRN 461

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQKPD 116
           +   N+LL  R   K+ DFG+S + + +      A  A      + APE I   N +K  
Sbjct: 462 LAARNVLLVNRHYAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPECI---NFRK-- 515

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           +  R+DVWS G+T+ E  + G+ PYK  K   EV++ +
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFI 552

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 21/156 (13%)

Query: 7   ESDVWICMELMAT-CFDRLLK--RLHVSVPEPI--CGKITLSTVKALHYLKETHGVIHRD 61
           E+ VWI MEL         L+  +  + +   I    ++      AL YL E+   +HRD
Sbjct: 87  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL----STALAYL-ESKRFVHRD 141

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYD 118
           +   N+L+     +KL DFG+S R ++     K +       +MAPE I   N ++  + 
Sbjct: 142 IAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESI---NFRR--FT 195

Query: 119 IRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
             +DVW  G+ + E+   G  P++  K + +V+ R+
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRI 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 19/158 (12%)

Query: 5   SKESDVWICMELMAT-CFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRD 61
           ++     I  E M     D  L+      ++ + +   +       + YL    G +HRD
Sbjct: 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV--GMLRGVGAGMRYL-SDLGYVHRD 176

Query: 62  VKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQKPD 116
           +   N+L+D     K+ DFG+S R+++                 + APE I     +   
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLS-RVLEDDPDAAYTTTGGKIPIRWTAPEAI---AFRT-- 230

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           +   +DVWS G+ + E+   GE PY +   + +V+S V
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSV 267

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 43/158 (27%), Positives = 65/158 (41%), Gaps = 47/158 (29%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGK-ITLSTVK--------ALHYLKETHGV 57
           E+ + +  E M    D  LK+   S       + + L+ VK         L +  E + +
Sbjct: 75  ENKLTLVFEFM----DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKI 129

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---------YMAPE--- 105
           +HRD+KP N+L+++RG +KL DFG+        AR                 Y AP+   
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGL--------ARAFGIPVNTFSSEVVTLWYRAPDVLM 181

Query: 106 --RIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
             R          Y    D+WS G  L E+ TG+  FP
Sbjct: 182 GSR---------TYSTSIDIWSCGCILAEMITGKPLFP 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 39/127 (30%), Positives = 58/127 (45%), Gaps = 14/127 (11%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---YM 102
           K + +L  +   IHRD+   NILL E+  +K+CDFG++  +       +         +M
Sbjct: 204 KGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 103 APERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DA 157
           APE I         Y I++DVWS G+ L E+ + G  PY   K D E   R+       A
Sbjct: 263 APETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317

Query: 158 PPCLPND 164
           P     +
Sbjct: 318 PDYTTPE 324

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 34/135 (25%)

Query: 23  RLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGI 82
            LL  + V        ++    +  L+Y+   + ++HRD+K +N+L+   G +KL DFG+
Sbjct: 112 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGL 170

Query: 83  SGRLVDSKARTKNAGCAAYMAPERIEPPN------------P----QKPDYDIRADVWSL 126
                   AR       A+   +  +P              P     + DY    D+W  
Sbjct: 171 --------AR-------AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215

Query: 127 GITLVELATGE--FP 139
           G  + E+ T      
Sbjct: 216 GCIMAEMWTRSPIMQ 230

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 68.1 bits (167), Expect = 2e-13
 Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 32/175 (18%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETHGVI 58
            S + +  + +      LL  +         G +    +        K ++YL E HG++
Sbjct: 86  GSSLQLVTQYL--PLGSLLDHVRQH-----RGALGPQLLLNWGVQIAKGMYYL-EEHGMV 137

Query: 59  HRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPERIEPPNPQK 114
           HR++   N+LL     +++ DFG++  L+    +      A      MA E I   +  K
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVA-DLLPPDDKQLLYSEAKTPIKWMALESI---HFGK 193

Query: 115 PDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
             Y  ++DVWS G+T+ EL T G  PY   +   EV   +        P     D
Sbjct: 194 --YTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTID 245

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 41/160 (25%), Positives = 61/160 (38%), Gaps = 35/160 (21%)

Query: 4   QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVK--------ALHYLKETH 55
              +  VW+  +        ++K    S       ++    VK         +HYL   +
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-N 147

Query: 56  GVIHRDVKPSNILL----DERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPE- 105
            V+HRD+KP+NIL+     ERG +K+ D G   RL +S  +             Y APE 
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSPLKPLADLDPVVVTFWYRAPEL 206

Query: 106 ----RIEPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
               R          Y    D+W++G    EL T E  F 
Sbjct: 207 LLGAR---------HYTKAIDIWAIGCIFAELLTSEPIFH 237

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 67.6 bits (166), Expect = 4e-13
 Identities = 43/154 (27%), Positives = 62/154 (40%), Gaps = 35/154 (22%)

Query: 2   SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVK--------ALHYLKE 53
           S   +E+ + +  E +    D+ L      VPEP    +   T+K         L +L  
Sbjct: 86  SRTDRETKLTLVFEHV----DQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHS 138

Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-TKNAGCAAYMAPE-----RI 107
            H V+HRD+KP NIL+   G IKL DFG+  R+   +   T       Y APE       
Sbjct: 139 -HRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAPEVLLQSS- 195

Query: 108 EPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
                    Y    D+WS+G    E+   +  F 
Sbjct: 196 ---------YATPVDLWSVGCIFAEMFRRKPLFR 220

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 67.2 bits (165), Expect = 4e-13
 Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 35/154 (22%)

Query: 2   SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVK--------ALHYLKE 53
           S   +E  V +  E +    D+ L+      P P    +   T+K         L +L  
Sbjct: 86  SRTDREIKVTLVFEHV----DQDLRTYLDKAPPP---GLPAETIKDLMRQFLRGLDFLHA 138

Query: 54  THGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR-TKNAGCAAYMAPE-----RI 107
            + ++HRD+KP NIL+   G +KL DFG+  R+   +   T       Y APE       
Sbjct: 139 -NCIVHRDLKPENILVTSGGTVKLADFGL-ARIYSYQMALTPVVVTLWYRAPEVLLQST- 195

Query: 108 EPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
                    Y    D+WS+G    E+   +  F 
Sbjct: 196 ---------YATPVDMWSVGCIFAEMFRRKPLFC 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 67.2 bits (165), Expect = 4e-13
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 18/152 (11%)

Query: 10  VWICMELMAT-CFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++I  E M        LK    + +++ + +   +     + + ++ E    IHRD++ +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLL--DMAAQIAEGMAFI-EERNYIHRDLRAA 138

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGC---AAYMAPERIEPPNPQKPDYDIRAD 122
           NIL+ +  + K+ DFG++ RL++    T   G      + APE I   N     + I++D
Sbjct: 139 NILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAI---NYGT--FTIKSD 192

Query: 123 VWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
           VWS GI L E+ T G  PY     + EV+  +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMT-NPEVIQNL 223

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 33/125 (26%), Positives = 53/125 (42%), Gaps = 18/125 (14%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA---YMAPER 106
           +L E    +HRD+   N+L+     +K+CDFG++  ++                +MAPE 
Sbjct: 187 FL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245

Query: 107 IEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPP 159
           +        +  Y I++DVWS GI L E+ + G  PY     D      + N    D P 
Sbjct: 246 LF-------EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF 298

Query: 160 CLPND 164
               +
Sbjct: 299 YATEE 303

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 52/222 (23%), Positives = 78/222 (35%), Gaps = 55/222 (24%)

Query: 39  KITLSTVKALHYLKETH-GVIHRDVKPSNILL--DERGNIKLCDFG------------IS 83
           K       AL +L      +IH D+KP NILL   +R  IK+ DFG            I 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220

Query: 84  GRLVDSKARTKNAGCAAYMAPERI-EPPNPQKPDYDIRADVWSLGITLVELATGE--FPY 140
            R               Y +PE +   P      YD+  D+WSLG  LVE+ TGE  F  
Sbjct: 221 SRF--------------YRSPEVLLGMP------YDLAIDMWSLGCILVEMHTGEPLFS- 259

Query: 141 KDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKR---SYEDKSTC 197
                + + +++++           + G    A I     ++ +F  K    ++  K T 
Sbjct: 260 --GANEVDQMNKIVE----------VLGI-PPAHILDQAPKARKFFEKLPDGTWNLKKTK 306

Query: 198 YECGAEGHLSYACPQNILGIREPPPKKEKKRKKKQFGDDPQA 239
                          NILG+    P   +  +      D   
Sbjct: 307 DGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 43/146 (29%), Positives = 59/146 (40%), Gaps = 39/146 (26%)

Query: 12  ICMELMATCFDRLLKRLH-VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
           +  EL++     L+K+        P+  K   S ++ L  L + + +IH D+KP NILL 
Sbjct: 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLK 234

Query: 71  E--RGNIKLCDFG------------ISGRLVDSKARTKNAGCAAYMAPERI-EPPNPQKP 115
           +  R  IK+ DFG            I  R               Y APE I         
Sbjct: 235 QQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--------------YRAPEVILGAR----- 275

Query: 116 DYDIRADVWSLGITLVELATGE--FP 139
            Y +  D+WSLG  L EL TG    P
Sbjct: 276 -YGMPIDMWSLGCILAELLTGYPLLP 300

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 43/130 (33%), Positives = 61/130 (46%), Gaps = 20/130 (15%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----Y 101
           K + +L  +   IHRD+   NILL E+  +K+CDFG++ R +         G A     +
Sbjct: 159 KGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPDYVRKGDARLPLKW 216

Query: 102 MAPERIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN--- 155
           MAPE I        D  Y I++DVWS G+ L E+ + G  PY   K D E   R+     
Sbjct: 217 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269

Query: 156 -DAPPCLPND 164
             AP     +
Sbjct: 270 MRAPDYTTPE 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 23/160 (14%)

Query: 5   SKESDVWICMELMAT-CFDRLLK--RLHVSVPEPI--CGKITLSTVKALHYLKETHGVIH 59
           +K   V I  E M     D  L+      +V + +     I       + YL    G +H
Sbjct: 116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA----SGMKYL-SDMGYVH 170

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQK 114
           RD+   NIL++     K+ DFG+  R+++                 + +PE I     +K
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLG-RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRK 226

Query: 115 PDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
             +   +DVWS GI L E+ + GE PY +   + +V+  V
Sbjct: 227 --FTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAV 263

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 23/160 (14%)

Query: 5   SKESDVWICMELMAT-CFDRLLK----RLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           SK   + I  E M     D+ L+       V     +   I       + YL      +H
Sbjct: 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA----AGMKYL-ANMNYVH 170

Query: 60  RDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA-----YMAPERIEPPNPQK 114
           RD+   NIL++     K+ DFG+S R+++                 + APE I   + +K
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEATYTTSGGKIPIRWTAPEAI---SYRK 226

Query: 115 PDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
             +   +DVWS GI + E+ T GE PY +   + EV+  +
Sbjct: 227 --FTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAI 263

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 65.8 bits (161), Expect = 1e-12
 Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 31/181 (17%)

Query: 3   PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKET 54
            + +     + +  M      L   L  S        + L T+          + YL  +
Sbjct: 99  AKGRLPIPMVILPFMK--HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL-SS 155

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPERIEPP 110
              IHRD+   N +L E   + + DFG+S R + S    +    +      +A E +   
Sbjct: 156 RNFIHRDLAARNCMLAEDMTVCVADFGLS-RKIYSGDYYRQGCASKLPVKWLALESLA-- 212

Query: 111 NPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPN 163
                D  Y + +DVW+ G+T+ E+ T G+ PY   +   E+ + ++       PP    
Sbjct: 213 -----DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYLIGGNRLKQPPECME 266

Query: 164 D 164
           +
Sbjct: 267 E 267

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 64.6 bits (158), Expect = 3e-12
 Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 23/158 (14%)

Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKETHGVIHRDV 62
            + +  M   +  L   L  S  E     I L T+          + YL      +HRD+
Sbjct: 117 MVILPFMK--YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL-SNRNFLHRDL 173

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPERIEPPNPQKPDYD 118
              N +L +   + + DFG+S + + S    +    A     ++A E +         Y 
Sbjct: 174 AARNCMLRDDMTVCVADFGLS-KKIYSGDYYRQGRIAKMPVKWIAIESL-----ADRVYT 227

Query: 119 IRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN 155
            ++DVW+ G+T+ E+AT G  PY   +   E+   +L+
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLH 264

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 63.4 bits (155), Expect = 8e-12
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 28/168 (16%)

Query: 10  VWICMELMAT-CFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++I  E MA       L+   R  +     +  K +L   +A+ YL E +  +HRD+   
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYL-EGNNFVHRDLAAR 146

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPERIEPPNPQKPDYDIRA 121
           N+L+ E    K+ DFG++     ++   K            APE +     +K  +  ++
Sbjct: 147 NVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEAL---REKK--FSTKS 195

Query: 122 DVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
           DVWS GI L E+ + G  PY       +V+ RV      DAP   P  
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPA 242

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 63.4 bits (155), Expect = 9e-12
 Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 20/126 (15%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPE 105
           +L  +   IHRDV   N+LL      K+ DFG++ R + + +     G A      MAPE
Sbjct: 179 FL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARLPVKWMAPE 236

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAP 158
            I        D  Y +++DVWS GI L E+ + G  PY     + +    V +      P
Sbjct: 237 SIF-------DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289

Query: 159 PCLPND 164
              P +
Sbjct: 290 AFAPKN 295

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 36/186 (19%)

Query: 5   SKESDVWICMELMA----TCFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLK 52
           S+     + MELM       +  L          P+    +LS +          + YL 
Sbjct: 98  SQGQPTLVIMELMTRGDLKSY--LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL- 154

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPERIE 108
             +  +HRD+   N ++ E   +K+ DFG++ R +      +  G       +M+PE ++
Sbjct: 155 NANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLK 213

Query: 109 PPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCL 161
                  D  +   +DVWS G+ L E+AT  E PY+    + +VL  V+     D P   
Sbjct: 214 -------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVMEGGLLDKPDNC 265

Query: 162 PNDPLF 167
           P D LF
Sbjct: 266 P-DMLF 270

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.0 bits (154), Expect = 1e-11
 Identities = 27/132 (20%), Positives = 43/132 (32%), Gaps = 47/132 (35%)

Query: 37  CGKITLSTVK--------ALHYLKETHGVIHRDVKPSNILLD-----ERGNIKLCDFGIS 83
              +++  +K         +++       +HRD+KP N+LL      E   +K+ DFG+ 
Sbjct: 126 NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL- 183

Query: 84  GRLVDSKARTKNAGCAA---------YMAPE-----RIEPPNPQKPDYDIRADVWSLGIT 129
                  AR                 Y  PE     R          Y    D+WS+   
Sbjct: 184 -------ARAFGIPIRQFTHEIITLWYRPPEILLGSR---------HYSTSVDIWSIACI 227

Query: 130 LVELATGE--FP 139
             E+      FP
Sbjct: 228 WAEMLMKTPLFP 239

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 20/165 (12%)

Query: 9   DVWICMELMAT-CFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            ++I  E MA       L+   R  +     +  K +L   +A+ YL E +  +HRD+  
Sbjct: 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYL-EGNNFVHRDLAA 317

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+L+ E    K+ DFG++     ++   K      + APE +     ++  +  ++DVW
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEAL-----REKKFSTKSDVW 370

Query: 125 SLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
           S GI L E+ + G  PY       +V+ RV      DAP   P  
Sbjct: 371 SFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPA 414

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 20/172 (11%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
             E    + +  M      + ++    +          L   + + YL      +HRD+ 
Sbjct: 93  PPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-AEQKFVHRDLA 151

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKA--RTKNAGCAAY----MAPERIEPPNPQKPDY 117
             N +LDE   +K+ DFG++ R +  +     +    A       A E +     Q   +
Sbjct: 152 ARNCMLDESFTVKVADFGLA-RDILDREYYSVQQHRHARLPVKWTALESL-----QTYRF 205

Query: 118 DIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
             ++DVWS G+ L EL T G  PY+     F++   +        P   P+ 
Sbjct: 206 TTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQPEYCPDS 256

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 61.1 bits (149), Expect = 5e-11
 Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 24/173 (13%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICG---KITLSTVKALHYLKETHGVIHRDV 62
            E    + +  M      L   +      P         L   K + YL  +   +HRD+
Sbjct: 98  SEGSPLVVLPYMK--HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDL 154

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA------YMAPERIEPPNPQKPD 116
              N +LDE+  +K+ DFG++ R +  K                +MA E +     Q   
Sbjct: 155 AARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESL-----QTQK 208

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
           +  ++DVWS G+ L EL T G  PY D    F++   +L       P   P+ 
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDP 260

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 61.1 bits (149), Expect = 6e-11
 Identities = 37/165 (22%), Positives = 58/165 (35%), Gaps = 58/165 (35%)

Query: 12  ICM--ELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           IC+  EL+    +D + +   +        K+     K++++L   + + H D+KP NIL
Sbjct: 92  ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENIL 150

Query: 69  LDE-------------------RGNIKLCDFG------------ISGRLVDSKARTKNAG 97
             +                     +IK+ DFG            +S R            
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH----------- 199

Query: 98  CAAYMAPERI-EPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
              Y APE I          +    DVWS+G  L+E   G   FP
Sbjct: 200 ---YRAPEVILALG------WSQPCDVWSIGCILIEYYLGFTVFP 235

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 61.2 bits (149), Expect = 6e-11
 Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 30/152 (19%)

Query: 4   QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTV--------KALHYLKET 54
                 + + ME + + C    L+R H         ++  S +        K + YL  +
Sbjct: 95  GPGRQSLRLVMEYLPSGCLRDFLQR-H-------RARLDASRLLLYSSQICKGMEYL-GS 145

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-----KARTKNAGCAAYMAPERIEP 109
              +HRD+   NIL++   ++K+ DFG++ +L+         R        + APE +  
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESL-- 202

Query: 110 PNPQKPDYDIRADVWSLGITLVELAT-GEFPY 140
            +     +  ++DVWS G+ L EL T  +   
Sbjct: 203 -SDNI--FSRQSDVWSFGVVLYELFTYCDKSC 231

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 38/180 (21%), Positives = 62/180 (34%), Gaps = 59/180 (32%)

Query: 12  ICM--ELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           ICM  E++     + + +  +  +P P   KI    ++ L YL     +IH D+KP NIL
Sbjct: 120 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

Query: 69  L-------------------------------------------------DERGNIKLCD 79
           L                                                  E+  +K+ D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 80  FGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFP 139
            G +  +   K  T++     Y + E +         Y+  AD+WS      ELATG++ 
Sbjct: 240 LGNACWV--HKHFTEDIQTRQYRSLEVLI-----GSGYNTPADIWSTACMAFELATGDYL 292

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 37/165 (22%), Positives = 54/165 (32%), Gaps = 58/165 (35%)

Query: 12  ICM--ELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           +C+  EL+    F+ L +      P P    +      AL +L E + + H D+KP NIL
Sbjct: 97  MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENIL 155

Query: 69  LDE-------------------RGNIKLCDFG------------ISGRLVDSKARTKNAG 97
                                   +I++ DFG            ++ R            
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH----------- 204

Query: 98  CAAYMAPERI-EPPNPQKPDYDIRADVWSLGITLVELATGE--FP 139
              Y  PE I E        +    DVWS+G  L E   G   F 
Sbjct: 205 ---YRPPEVILELG------WAQPCDVWSIGCILFEYYRGFTLFQ 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 60.3 bits (147), Expect = 1e-10
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 21/126 (16%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPE 105
           YL  +H V+H+D+   N+L+ ++ N+K+ D G+  R V +    K  G +      MAPE
Sbjct: 143 YL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLF-REVYAADYYKLLGNSLLPIRWMAPE 200

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAP 158
            I           + I +D+WS G+ L E+ + G  PY     + +V+  + N      P
Sbjct: 201 AIM-------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVVEMIRNRQVLPCP 252

Query: 159 PCLPND 164
              P  
Sbjct: 253 DDCPAW 258

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 24/173 (13%)

Query: 6   KESDVWICMELMAT-CFDRLLK--RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
            E    + +  M        ++    + +V + I     L   K + +L  +   +HRD+
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKFL-ASKKFVHRDL 218

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCAA----YMAPERIEPPNPQKPD 116
              N +LDE+  +K+ DFG++ R +  K      N   A     +MA E +     Q   
Sbjct: 219 AARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMALESL-----QTQK 272

Query: 117 YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAPPCLPND 164
           +  ++DVWS G+ L EL T G  PY D    F++   +L       P   P+ 
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDP 324

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 35/140 (25%), Positives = 59/140 (42%), Gaps = 19/140 (13%)

Query: 4   QSKESDVWICMELMAT-CFDRLLKRLHVSVPE--PICGKITLSTVKALHYLKETHGVIHR 60
            +  + + + ME +        L R  + + +      +I     + + YL      IHR
Sbjct: 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI----CEGMAYL-HAQHYIHR 158

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDS-----KARTKNAGCAAYMAPERIEPPNPQKP 115
           D+   N+LLD    +K+ DFG++ + V       + R        + APE +      K 
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPECL---KEYK- 213

Query: 116 DYDIRADVWSLGITLVELAT 135
            +   +DVWS G+TL EL T
Sbjct: 214 -FYYASDVWSFGVTLYELLT 232

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 17/111 (15%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPE 105
           YL      +HRD+   N L+ +   +K+ DFG+S R + S    +  G       +M PE
Sbjct: 173 YL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS-RDIYSTDYYRVGGRTMLPIRWMPPE 230

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV 153
            I           +   +DVWS G+ L E+ T G+ P+     + E +  +
Sbjct: 231 SIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-NTEAIDCI 273

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 40/174 (22%), Positives = 62/174 (35%), Gaps = 64/174 (36%)

Query: 12  ICM--ELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           +C+  E +    ++ + +  +            +  +KAL+YL++   + H D+KP NIL
Sbjct: 111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENIL 169

Query: 69  LDE-------------------------RGNIKLCDFG------------ISGRLVDSKA 91
           LD+                            IKL DFG            I+ R      
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ----- 224

Query: 92  RTKNAGCAAYMAPERI-EPPNPQKPDYDIRADVWSLGITLVELATGE--FPYKD 142
                    Y APE I          +D+ +D+WS G  L EL TG   F   +
Sbjct: 225 ---------YRAPEVILNLG------WDVSSDMWSFGCVLAELYTGSLLFRTHE 263

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 16/98 (16%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPE 105
           YL  +   IHRD+   N+L+ E   +K+ DFG++ R +++    K           MAPE
Sbjct: 172 YL-ASQKCIHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKKTTNGRLPVKWMAPE 229

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
            +        D  Y  ++DVWS G+ + E+ T G  PY
Sbjct: 230 ALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 58.8 bits (143), Expect = 3e-10
 Identities = 38/159 (23%), Positives = 61/159 (38%), Gaps = 32/159 (20%)

Query: 5   SKESDVWICMELMAT-CFDRLLKR-----LHVSVPEPICGKITLSTVKALH--------- 49
                + +  E M     ++ L+      + +   +P   K  L   + LH         
Sbjct: 87  GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 146

Query: 50  -YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAP 104
            YL  +   +HRD+   N L+     +K+ DFG+S R V S    +  G        M P
Sbjct: 147 VYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMS-RDVYSTDYYRVGGHTMLPIRWMPP 204

Query: 105 ERIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
           E I           +   +DVWS G+ L E+ T G+ P+
Sbjct: 205 ESIM-------YRKFTTESDVWSFGVILWEIFTYGKQPW 236

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 16/98 (16%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPE 105
           YL  +   IHRD+   N+L+ E   +K+ DFG++ R +++    K          +MAPE
Sbjct: 218 YL-ASQKCIHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKKTTNGRLPVKWMAPE 275

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
            +        D  Y  ++DVWS G+ + E+ T G  PY
Sbjct: 276 ALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 32/98 (32%), Positives = 46/98 (46%), Gaps = 16/98 (16%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAY----MAPE 105
           YL  +   IHRD+   N+L+ E   +K+ DFG++ R +      K           MAPE
Sbjct: 206 YL-ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-RDIHHIDYYKKTTNGRLPVKWMAPE 263

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
            +        D  Y  ++DVWS G+ L E+ T G  PY
Sbjct: 264 ALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 16/102 (15%)

Query: 46  KALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----Y 101
           + + YL     ++HRD+   NIL+ E   +K+ DFG+S R V  +              +
Sbjct: 161 QGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFGLS-RDVYEEDSYVKRSQGRIPVKW 218

Query: 102 MAPERIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
           MA E +        D  Y  ++DVWS G+ L E+ T G  PY
Sbjct: 219 MAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 57.7 bits (140), Expect = 8e-10
 Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 13/138 (9%)

Query: 4   QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
            +   ++ + ME +        L++    +      + T    K + YL  T   IHRD+
Sbjct: 82  SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-GTKRYIHRDL 140

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDS-----KARTKNAGCAAYMAPERIEPPNPQKPDY 117
              NIL++    +K+ DFG++ +++       K +        + APE +      K  +
Sbjct: 141 ATRNILVENENRVKIGDFGLT-KVLPQDKEFFKVKEPGESPIFWYAPESL---TESK--F 194

Query: 118 DIRADVWSLGITLVELAT 135
            + +DVWS G+ L EL T
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 57.7 bits (140), Expect = 8e-10
 Identities = 34/126 (26%), Positives = 51/126 (40%), Gaps = 24/126 (19%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNA------GCAAYMA 103
           YL      IHRD+   NIL+ E    K+ DFG+S R  +   +               MA
Sbjct: 157 YL-SQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMGRLPVRW-----MA 209

Query: 104 PERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLN----DAP 158
            E +   N     Y   +DVWS G+ L E+ + G  PY    C  E+  ++      + P
Sbjct: 210 IESL---NYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLEKP 263

Query: 159 PCLPND 164
               ++
Sbjct: 264 LNCDDE 269

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 13/138 (9%)

Query: 4   QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
            +   ++ + ME +        L++    +      + T    K + YL  T   IHRD+
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-GTKRYIHRDL 171

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDS-----KARTKNAGCAAYMAPERIEPPNPQKPDY 117
              NIL++    +K+ DFG++ +++       K +        + APE +      K  +
Sbjct: 172 ATRNILVENENRVKIGDFGLT-KVLPQDKEYYKVKEPGESPIFWYAPESL---TESK--F 225

Query: 118 DIRADVWSLGITLVELAT 135
            + +DVWS G+ L EL T
Sbjct: 226 SVASDVWSFGVVLYELFT 243

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 31/138 (22%), Positives = 61/138 (44%), Gaps = 13/138 (9%)

Query: 4   QSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           +   + + + ME + +      L +    +      K  +   K + YL  +   +HRD+
Sbjct: 94  EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL-GSRQYVHRDL 152

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDS-----KARTKNAGCAAYMAPERIEPPNPQKPDY 117
              N+L++    +K+ DFG++ + +++       +        + APE +      K  +
Sbjct: 153 AARNVLVESEHQVKIGDFGLT-KAIETDKEYYTVKDDRDSPVFWYAPECL---MQSK--F 206

Query: 118 DIRADVWSLGITLVELAT 135
            I +DVWS G+TL EL T
Sbjct: 207 YIASDVWSFGVTLHELLT 224

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 41/153 (26%), Positives = 60/153 (39%), Gaps = 26/153 (16%)

Query: 5   SKESDVWICMELMAT-CFDRLLK--RLHVSVPEPICGK----ITLSTVKALHYLKETHGV 57
            +    +I MELMA       L+  R   S P  +       +         YL E +  
Sbjct: 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-EENHF 161

Query: 58  IHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAY----MAPERIEPP 110
           IHRD+   N LL   G     K+ DFG++ R +   +  +  GCA      M PE     
Sbjct: 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCAMLPVKWMPPEAFM-- 218

Query: 111 NPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
                +  +  + D WS G+ L E+ + G  PY
Sbjct: 219 -----EGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 16/98 (16%)

Query: 50  YLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAA----YMAPE 105
           YL      +HRD+   N L+ E   +K+ DFG+S R + S    K  G  A    +M PE
Sbjct: 189 YL-SERKFVHRDLATRNCLVGENMVVKIADFGLS-RNIYSADYYKADGNDAIPIRWMPPE 246

Query: 106 RIEPPNPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
            I           Y   +DVW+ G+ L E+ + G  PY
Sbjct: 247 SIF-------YNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 41/153 (26%), Positives = 59/153 (38%), Gaps = 26/153 (16%)

Query: 5   SKESDVWICMELMAT-CFDRLLK--RLHVSVPEPICGKITLSTV----KALHYLKETHGV 57
            +    +I +ELMA       L+  R   S P  +     L           YL E +  
Sbjct: 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-EENHF 202

Query: 58  IHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKARTKNAGCAAY----MAPERIEPP 110
           IHRD+   N LL   G     K+ DFG++ R +      +  GCA      M PE     
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRAGYYRKGGCAMLPVKWMPPEAFM-- 259

Query: 111 NPQKPD--YDIRADVWSLGITLVELAT-GEFPY 140
                +  +  + D WS G+ L E+ + G  PY
Sbjct: 260 -----EGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 29/136 (21%), Positives = 48/136 (35%), Gaps = 40/136 (29%)

Query: 37  CGKITLSTV--------KALHYLKETHGVIHRDVKPSNILLD--ERGNIKLCDFGISGRL 86
            G    STV          L Y+ E +  +H D+K +N+LL       + L D+G+S R 
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 87  VDS------KARTKNA--GCAAYM--------APERIEPPNPQKPDYDIRADVWSLGITL 130
             +      +   +    G   +         A  R             R+DV  LG  +
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR-------------RSDVEILGYCM 250

Query: 131 VELATGEFPYKDCKCD 146
           +    G+ P++    D
Sbjct: 251 LRWLCGKLPWEQNLKD 266

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 23/123 (18%), Positives = 48/123 (39%), Gaps = 35/123 (28%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSK--------A 91
           L  ++ LH     +  +H +V   NI +  +++  + L  +G + R   S         +
Sbjct: 169 LDALEFLHE----NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224

Query: 92  RTKNAGCAAYM--------APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
           R+ + G   ++         P R             R+D+ SLG  +++   G  P+ +C
Sbjct: 225 RSPHEGDLEFISMDLHKGCGPSR-------------RSDLQSLGYCMLKWLYGFLPWTNC 271

Query: 144 KCD 146
             +
Sbjct: 272 LPN 274

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 26/119 (21%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKART----- 93
           +S ++ +H        IHRDVKP N L+        + + DFG++ +  D++        
Sbjct: 115 ISRIEYIHS----KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 94  --KN-AGCAAYM---APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD 146
             KN  G A Y        IE           R D+ SLG  L+    G  P++  K  
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSR--------RDDLESLGYVLMYFNLGSLPWQGLKAA 221

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 27/123 (21%), Positives = 48/123 (39%), Gaps = 35/123 (28%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDER--GNIKLCDFGISGRLVDSKA-------- 91
           L  ++ +H     H  +H D+K SN+LL+ +    + L D+G++ R              
Sbjct: 162 LDILEYIHE----HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 92  RTKNAGCAAYM--------APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDC 143
           +  + G   +         AP R             R D+  LG  +++  TG  P++D 
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSR-------------RGDLEILGYCMIQWLTGHLPWEDN 264

Query: 144 KCD 146
             D
Sbjct: 265 LKD 267

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 28/121 (23%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILL----DERGN-IKLCDFGISGRLVDSKART--- 93
           L+ V+++H       +++RD+KP N L+     +  N I + DFG+     D   +    
Sbjct: 116 LARVQSIHE----KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171

Query: 94  ----KN-AGCAAYM---APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC 145
               KN +G A YM        E    Q      R D+ +LG   +    G  P++  K 
Sbjct: 172 YREKKNLSGTARYMSINTHLGRE----QSR----RDDLEALGHVFMYFLRGSLPWQGLKA 223

Query: 146 D 146
            
Sbjct: 224 A 224

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 28/121 (23%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGN-----IKLCDFGISGRLVDSKART--- 93
           +S ++ +H       +I+RDVKP N L+   GN     I + DF ++   +D + +    
Sbjct: 115 ISRMEYVHS----KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170

Query: 94  ----KN-AGCAAYM---APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC 145
               K+  G A YM        E    Q      R D+ +LG   +    G  P++  K 
Sbjct: 171 YREHKSLTGTARYMSINTHLGKE----QSR----RDDLEALGHMFMYFLRGSLPWQGLKA 222

Query: 146 D 146
           D
Sbjct: 223 D 223

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 26/119 (21%)

Query: 42  LSTVKALHYLKETHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKART----- 93
           ++ V+ +H        +HRD+KP N L+        + + DFG++ +  D+         
Sbjct: 113 INRVEFVHS----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168

Query: 94  --KN-AGCAAYM---APERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD 146
             KN  G A Y        IE    Q      R D+ SLG  L+    G  P++  K  
Sbjct: 169 ENKNLTGTARYASVNTHLGIE----QSR----RDDLESLGYVLMYFLRGSLPWQGLKAG 219

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.3 bits (114), Expect = 1e-06
 Identities = 20/116 (17%), Positives = 35/116 (30%), Gaps = 13/116 (11%)

Query: 6   KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           K+  ++I +E      D L +             I      +L   + +    HRD+   
Sbjct: 133 KDDQLFIVLEFEFGGID-LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 66  NILLDERGNIKLCD--------FGISGRLVD----SKARTKNAGCAAYMAPERIEP 109
           N+LL +    KL              G  V     + +R +  G   +      E 
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 2e-06
 Identities = 48/398 (12%), Positives = 86/398 (21%), Gaps = 159/398 (39%)

Query: 1   MSPQSKES-DVWICMELMATCFDRL------LKRLHVSVPEPI----------------- 36
           MSP   E     +   +     DRL        + +VS  +P                  
Sbjct: 95  MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 37  ------CGKITLSTVKAL-------------HYLK-----ETHGVI-------HRDVKPS 65
                  GK  +  +                 +L          V+       ++     
Sbjct: 155 IDGVLGSGKTWV-ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
               D   NIKL       R+   +A  +       +       P        +  +V +
Sbjct: 214 TSRSDHSSNIKL-------RIHSIQAELRR-----LLK----SKPYEN--CLLVLLNVQN 255

Query: 126 LGI---------TLV------------ELATGEFPYKDCKCDF------EVLSRVLNDAP 158
                        L+               T                   +L + L+  P
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 159 PCLPN-----DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQN 213
             LP      +P     I  SI        +  +  + +  +T  E       S     N
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATW-DNWKHVNCDKLTTIIE------SSL----N 364

Query: 214 ILGIREPPPKKEKKRKKKQFG---DDPQASSKTLYQDLGSDSEVEDQSSHPAGGKIFRTH 270
           +L   EP    E ++   +           +  L                     +    
Sbjct: 365 VL---EPA---EYRKMFDRLSVFPPSAHIPTILL--------------------SLIWFD 398

Query: 271 DLSEEEEDVEPDCETLSAA-------------IQLDVK 295
            +  +   V       S               I L++K
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	296
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-33
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-32
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-32
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-32
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-30
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-29
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-29
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-28
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-26
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-26
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-26
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-26
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-26
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-24
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-24
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-23
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-23
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-23
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-23
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-23
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-23
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-23
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-22
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-22
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-22
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-22
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-22
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-21
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-21
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-21
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-21
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-21
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-21
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-21
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-19
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-19
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-17
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-17
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-17
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-10

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-38
 Identities = 58/173 (33%), Positives = 89/173 (51%), Gaps = 4/173 (2%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+++WI +E  A    D ++  L   + E     +   T+ AL+YL + + +IHRD+K  
Sbjct: 81  ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAG 139

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NIL    G+IKL DFG+S +   +  R  +  G   +MAPE +     +   YD +ADVW
Sbjct: 140 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           SLGITL+E+A  E P+ +      VL ++    PP L     +    K  + K
Sbjct: 200 SLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 5e-38
 Identities = 66/187 (35%), Positives = 102/187 (54%), Gaps = 8/187 (4%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           + ++ ICME M       + +    +PE I GK++++ +K L YL+E H ++HRDVKPSN
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           IL++ RG IKLCDFG+SG+L+DS A +   G  +YM+PER+     Q   Y +++D+WS+
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERL-----QGTHYSVQSDIWSM 189

Query: 127 GITLVELATGEFPY--KDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTE 184
           G++LVE+A G +P    D K    +    +       P  P       +S   D+     
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249

Query: 185 FIRKRSY 191
                 Y
Sbjct: 250 IFELLDY 256

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-33
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 9/167 (5%)

Query: 2   SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYL-KETHGVIHR 60
           S    +  + +  ELM +   +   +    +   +        +K L +L   T  +IHR
Sbjct: 79  STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138

Query: 61  DVKPSNILL-DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDI 119
           D+K  NI +    G++K+ D G++  L  +       G   +MAPE  E        YD 
Sbjct: 139 DLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMYEEK------YDE 191

Query: 120 RADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPL 166
             DV++ G+ ++E+AT E+PY +C+   ++  RV +   P   +   
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-32
 Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 8/164 (4%)

Query: 7   ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
              + I  +    +     L  +           I   T + + YL     +IHRD+K +
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL-HAKSIIHRDLKSN 133

Query: 66  NILLDERGNIKLCDFGIS---GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           NI L E   +K+ DFG++    R   S    + +G   +MAPE I   +     Y  ++D
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP--YSFQSD 191

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLND-APPCLPNDP 165
           V++ GI L EL TG+ PY +     +++  V      P L    
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (299), Expect = 3e-32
 Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 7/160 (4%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           E   W+ ME        LL+     + E     +T   ++ L YL   H +IHRDVK  N
Sbjct: 87  EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGN 145

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILL E G +KL DFG +  +  +       G   +MAPE I   +  +  YD + DVWSL
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQ--YDGKVDVWSL 200

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPL 166
           GIT +ELA  + P  +       L  +  +  P L +   
Sbjct: 201 GITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHW 239

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 6e-32
 Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 15/168 (8%)

Query: 6   KESDVWICMELMA--TCFDRLLK--RLHVSVPEPICGKITLSTVKALHYL----KETHGV 57
             + ++I ME          + K  +    + E    ++      AL          H V
Sbjct: 76  TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135

Query: 58  IHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGC-AAYMAPERIEPPNPQKPD 116
           +HRD+KP+N+ LD + N+KL DFG++  L    +  K       YM+PE++      +  
Sbjct: 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-----NRMS 190

Query: 117 YDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           Y+ ++D+WSLG  L EL     P+       E+  ++       +P  
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYR 237

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  117 bits (294), Expect = 7e-32
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 7/162 (4%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
            +  ++  +LM     FD L ++  V++ E    KI  + ++ +  L +   ++HRD+KP
Sbjct: 82  NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK-LNIVHRDLKP 138

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE-PPNPQKPDYDIRADV 123
            NILLD+  NIKL DFG S +L   +   +  G  +Y+APE IE   N   P Y    D+
Sbjct: 139 ENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 198

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           WS G+ +  L  G  P+   +    +L  +++        + 
Sbjct: 199 WSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEW 239

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-30
 Identities = 41/173 (23%), Positives = 63/173 (36%), Gaps = 9/173 (5%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
            + V++ +E           +      E            AL Y      VIHRD+KP N
Sbjct: 78  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPEN 136

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           +LL   G +K+ DFG S     S+  T   G   Y+ PE I     +   +D + D+WSL
Sbjct: 137 LLLGSAGELKIADFGWSVHAPSSRRTTL-CGTLDYLPPEMI-----EGRMHDEKVDLWSL 190

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN-DPLFGRTIKASIAKD 178
           G+   E   G+ P++      E   R+                  I   +  +
Sbjct: 191 GVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-29
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 9/174 (5%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
            +  ++ +E  +           + +PEP   +     +  + YL    G+ HRD+KP N
Sbjct: 75  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPEN 133

Query: 67  ILLDERGNIKLCDFGISGRLV---DSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           +LLDER N+K+ DFG++         +   K  G   Y+APE ++    ++  +    DV
Sbjct: 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK----RREFHAEPVDV 189

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           WS GI L  +  GE    D   D         +    L           A + K
Sbjct: 190 WSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-29
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 13/174 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
             ++W+ ME +A  +  D + +       E     +    ++AL +L   + VIHRD+K 
Sbjct: 89  GDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHS-NQVIHRDIKS 144

Query: 65  SNILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
            NILL   G++KL DFG   ++  +   R+   G   +MAPE +      +  Y  + D+
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-----TRKAYGPKVDI 199

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAK 177
           WSLGI  +E+  GE PY +       L  +  +  P L N        +  + +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 8e-29
 Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 10/160 (6%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +  ++I  E MA  +  D L  R    +      K +L   +A+ YL+  +  +HRD+  
Sbjct: 73  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 131

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
            N+L+ E    K+ DFG++     S  +        + APE +     ++  +  ++DVW
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEAL-----REKKFSTKSDVW 184

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           S GI L E+ +            +V+ RV        P+ 
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  107 bits (269), Expect = 8e-28
 Identities = 35/162 (21%), Positives = 65/162 (40%), Gaps = 10/162 (6%)

Query: 7   ESDVWICMELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++++ +  E M+       +   H  + E    +      K L ++ E +  +H D+KP 
Sbjct: 95  DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPE 153

Query: 66  NILL--DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           NI+        +KL DFG++  L   ++     G A + APE       +        D+
Sbjct: 154 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-----EGKPVGYYTDM 208

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           WS+G+    L +G  P+   + D E L  V +       +  
Sbjct: 209 WSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAF 249

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-26
 Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 10/162 (6%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +  ++I  E M   +  D L     + +       +     + + +++E    IHRD++ 
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRA 137

Query: 65  SNILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           +NIL+ +  + K+ DFG++  + D++  AR        + APE I         + I++D
Sbjct: 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSD 192

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           VWS GI L E+ T          + EV+  +        P++
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 10/156 (6%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  ++  +            R   S  E      T   V AL YL    G+IHRD+KP N
Sbjct: 80  DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPEN 138

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTK---NAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           ILL+E  +I++ DFG +  L     + +     G A Y++PE +      +      +D+
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-----TEKSACKSSDL 193

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP 159
           W+LG  + +L  G  P++    ++ +  +++     
Sbjct: 194 WALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLEYD 228

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  103 bits (258), Expect = 3e-26
 Identities = 33/163 (20%), Positives = 69/163 (42%), Gaps = 12/163 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           + ++ + +E ++    FDR+       + E           + L ++ E H ++H D+KP
Sbjct: 98  KYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKP 155

Query: 65  SNILLD--ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
            NI+ +  +  ++K+ DFG++ +L   +        A + APE +      +       D
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-----DREPVGFYTD 210

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           +W++G+    L +G  P+   + D E L  V         +  
Sbjct: 211 MWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAF 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (256), Expect = 4e-26
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 10/173 (5%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
              +++ M+ +       L R     P P+          AL YL     +I+RD+KP N
Sbjct: 76  AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPEN 134

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLD+ G+IK+ DFG +  + D        G   Y+APE +         Y+   D WS 
Sbjct: 135 ILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVV-----STKPYNKSIDWWSF 187

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN-DPLFGRTIKASIAKD 178
           GI + E+  G  P+ D     +   ++LN      P  +      +   I +D
Sbjct: 188 GILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 6e-26
 Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 10/160 (6%)

Query: 9   DVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
            ++I  E M+  +  D L       +  P    +       + Y+ E    +HRD++ +N
Sbjct: 85  PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAAN 143

Query: 67  ILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           IL+ E    K+ DFG++  + D++  AR        + APE           + I++DVW
Sbjct: 144 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVW 198

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           S GI L EL T          + EVL +V        P +
Sbjct: 199 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 9e-26
 Identities = 34/161 (21%), Positives = 65/161 (40%), Gaps = 9/161 (5%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           ++ + +  E M   C    L+             + L   + + YL+E   VIHRD+   
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAAR 130

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKN--AGCAAYMAPERIEPPNPQKPDYDIRADV 123
           N L+ E   IK+ DFG++  ++D +  +         + +PE           Y  ++DV
Sbjct: 131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-----SFSRYSSKSDV 185

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           WS G+ + E+ +      + + + EV+  +        P  
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 226

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  102 bits (254), Expect = 1e-25
 Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 7/159 (4%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
              +   ++LM           H    E          +  L ++     V++RD+KP+N
Sbjct: 79  PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPAN 137

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           ILLDE G++++ D G++      K    + G   YMAPE ++    +   YD  AD +SL
Sbjct: 138 ILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQ----KGVAYDSSADWFSL 192

Query: 127 GITLVELATGEFPYKDCKC-DFEVLSRVLNDAPPCLPND 164
           G  L +L  G  P++  K  D   + R+       LP+ 
Sbjct: 193 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 5e-25
 Identities = 37/176 (21%), Positives = 71/176 (40%), Gaps = 13/176 (7%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           + +++  ME +        +       +            +  L +L    G+++RD+K 
Sbjct: 75  KENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT--FYAAEIILGLQFLHS-KGIVYRDLKL 131

Query: 65  SNILLDERGNIKLCDFGISGRLVDSKAR-TKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
            NILLD+ G+IK+ DFG+    +   A+     G   Y+APE +         Y+   D 
Sbjct: 132 DNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL-----LGQKYNHSVDW 186

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN-DPLFGRTIKASIAKD 178
           WS G+ L E+  G+ P+   + + E+   +  D P      +      +     ++
Sbjct: 187 WSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-24
 Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 7/150 (4%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +S++ +  + M T  + ++K   + +         L T++ L YL + H ++HRD+KP+N
Sbjct: 72  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNN 130

Query: 67  ILLDERGNIKLCDFGISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           +LLDE G +KL DFG++       +A T       Y APE +         Y +  D+W+
Sbjct: 131 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM----YGVGVDMWA 186

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           +G  L EL            D + L+R+  
Sbjct: 187 VGCILAELLLRVPFLPG-DSDLDQLTRIFE 215

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 2e-24
 Identities = 41/146 (28%), Positives = 61/146 (41%), Gaps = 11/146 (7%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIH 59
           +  +    + I ME +     F R+  R   +  E    +I  S  +A+ YL     + H
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAH 134

Query: 60  RDVKPSNILLD---ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPD 116
           RDVKP N+L         +KL DFG +       + T       Y+APE + P       
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK----- 189

Query: 117 YDIRADVWSLGITLVELATGEFPYKD 142
           YD   D+WSLG+ +  L  G  P+  
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYS 215

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 97.6 bits (242), Expect = 3e-24
 Identities = 25/173 (14%), Positives = 52/173 (30%), Gaps = 21/173 (12%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
                + ++L+    + LL                   +  +  + E   +++RD+KP N
Sbjct: 73  GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDN 131

Query: 67  ILLDE-----RGNIKLCDFGISGRLVDSKARTKN--------AGCAAYMAPERIEPPNPQ 113
            L+          I + DFG+     D   +           +G A YM+          
Sbjct: 132 FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH-----L 186

Query: 114 KPDYDIRADVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPPCLPND 164
             +   R D+ +LG   +    G   +       + +   R+          +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 3e-24
 Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 10/162 (6%)

Query: 7   ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
             ++ +  E ++       +      + E           +AL +L   H + H D++P 
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPE 131

Query: 66  NILLDERGN--IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADV 123
           NI+   R +  IK+ +FG + +L              Y APE       Q        D+
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-----VHQHDVVSTATDM 186

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           WSLG  +  L +G  P+   + + +++  ++N          
Sbjct: 187 WSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAF 227

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 1e-23
 Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 13/165 (7%)

Query: 6   KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           +   + + ME+       + L      +P     ++       + YL E    +HRD+  
Sbjct: 79  QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHRDLAA 137

Query: 65  SNILLDERGNIKLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            N+LL  R   K+ DFG+S  L        AR+       + APE I         +  R
Sbjct: 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSR 192

Query: 121 ADVWSLGITLVE-LATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +DVWS G+T+ E L+ G+ PYK  K   EV++ +        P +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPE 236

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 2e-23
 Identities = 36/154 (23%), Positives = 63/154 (40%), Gaps = 18/154 (11%)

Query: 2   SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYL-------K 52
                 + +W+  +     + FD L +    +V      K+ LST   L +L       +
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 53  ETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-----SKARTKNAGCAAYMAPERI 107
               + HRD+K  NIL+ + G   + D G++ R          A     G   YMAPE +
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 108 EP-PNPQKPDYDIRADVWSLGITLVELATGEFPY 140
           +   N +  +   RAD++++G+   E+A      
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 2e-23
 Identities = 38/138 (27%), Positives = 58/138 (42%), Gaps = 8/138 (5%)

Query: 7   ESDVWICMELMATCFDRL-LKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
                + +E      D         ++ E +        ++A+ +     GV+HRD+K  
Sbjct: 81  PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDE 139

Query: 66  NILLD-ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           NIL+D  RG +KL DFG    L+     T   G   Y  PE I         +   A VW
Sbjct: 140 NILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIRY----HRYHGRSAAVW 194

Query: 125 SLGITLVELATGEFPYKD 142
           SLGI L ++  G+ P++ 
Sbjct: 195 SLGILLYDMVCGDIPFEH 212

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 95.2 bits (236), Expect = 2e-23
 Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 5/163 (3%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K + V I  E M     D  L++            +       + YL      +HRD+ 
Sbjct: 97  TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-ADMNYVHRDLA 155

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPER-IEPPNPQKPDYDIRAD 122
             NIL++     K+ DFG+S  L D  +            P R   P   Q   +   +D
Sbjct: 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD 215

Query: 123 VWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           VWS GI + E+ + GE PY D   + +V++ +  D     P D
Sbjct: 216 VWSYGIVMWEVMSYGERPYWDMT-NQDVINAIEQDYRLPPPMD 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 94.7 bits (235), Expect = 3e-23
 Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 14/164 (8%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
              +++ M+L++    FDR++++      E    ++    + A+ YL +   ++HRD+KP
Sbjct: 79  GGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG-IVHRDLKP 135

Query: 65  SNILL---DERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
            N+L    DE   I + DFG+S         +   G   Y+APE +      +  Y    
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL-----AQKPYSKAV 190

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           D WS+G+    L  G  P+ D + D ++  ++L           
Sbjct: 191 DCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYW 233

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 3e-23
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 8/155 (5%)

Query: 2   SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHR 60
           S   +E+ + +  E +       L K     VP      +    ++ L +L   H V+HR
Sbjct: 82  SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHR 140

Query: 61  DVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
           D+KP NIL+   G IKL DFG++       A T       Y APE +      +  Y   
Sbjct: 141 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL-----LQSSYATP 195

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
            D+WS+G    E+   +  ++    D + L ++L+
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRG-SSDVDQLGKILD 229

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 94.0 bits (233), Expect = 4e-23
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 11/160 (6%)

Query: 10  VWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILL 69
            +I ME +     R +      +      ++     +AL++  + +G+IHRDVKP+NI++
Sbjct: 86  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMI 144

Query: 70  DERGNIKLCDFGISGRLVDSKARTKNA----GCAAYMAPERIEPPNPQKPDYDIRADVWS 125
                +K+ DFGI+  + DS           G A Y++PE+      +    D R+DV+S
Sbjct: 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSDVYS 199

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           LG  L E+ TGE P+        V  + + + P       
Sbjct: 200 LGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARH 238

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 4e-23
 Identities = 34/159 (21%), Positives = 62/159 (38%), Gaps = 2/159 (1%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPI-CGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E    + +  M     R   R     P         L   K + +   +   +HRD+   
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF-LASKKFVHRDLAAR 159

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           N +LDE+  +K+ DFG++  + D +  + +    A +  + +   + Q   +  ++DVWS
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
            G+ L EL T   P       F++   +L       P  
Sbjct: 220 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.6 bits (232), Expect = 6e-23
 Identities = 38/161 (23%), Positives = 64/161 (39%), Gaps = 12/161 (7%)

Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
              + ME+          + +  V +    ++       + YL E    +HRD+   N+L
Sbjct: 81  SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESNFVHRDLAARNVL 139

Query: 69  LDERGNIKLCDFGISGRLVDS----KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L  +   K+ DFG+S  L       KA+T       + APE I         +  ++DVW
Sbjct: 140 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVW 194

Query: 125 SLGITLVE-LATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           S G+ + E  + G+ PY+  K   EV + +        P  
Sbjct: 195 SFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAG 234

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.4 bits (229), Expect = 1e-22
 Identities = 34/164 (20%), Positives = 74/164 (45%), Gaps = 11/164 (6%)

Query: 5   SKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           +K+  ++I  E MA  C    L+ +          ++     +A+ YL E+   +HRD+ 
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDLA 127

Query: 64  PSNILLDERGNIKLCDFGISGRLVDSKAR--TKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
             N L++++G +K+ DFG+S  ++D +      +     +  PE +         +  ++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL-----MYSKFSSKS 182

Query: 122 DVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           D+W+ G+ + E+ + G+ PY+    + E    +        P+ 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHL 225

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.4 bits (231), Expect = 1e-22
 Identities = 35/164 (21%), Positives = 57/164 (34%), Gaps = 9/164 (5%)

Query: 4   QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
                 V        +   R+       +       I       + YL E    +HRD+ 
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLA 167

Query: 64  PSNILLDERGNIKLCDFGISGRLVDS---KARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
             N L+ E   +K+ DFG+S  +  +   KA   +A    +M PE I         Y   
Sbjct: 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-----FYNRYTTE 222

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +DVW+ G+ L E+ +            EV+  V +      P +
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 92.9 bits (230), Expect = 1e-22
 Identities = 38/164 (23%), Positives = 63/164 (38%), Gaps = 10/164 (6%)

Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDV 62
           ++E   +I  E M      D L +     V   +   +      A+ YL++    IHRD+
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDL 141

Query: 63  KPSNILLDERGNIKLCDFGISGRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
              N L+ E   +K+ DFG+S  +      A         + APE +         + I+
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIK 196

Query: 121 ADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           +DVW+ G+ L E+AT            +V   +  D     P  
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 2e-22
 Identities = 29/149 (19%), Positives = 51/149 (34%), Gaps = 4/149 (2%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  + +  E       +     +  +   I        +K L +   +  V+HRD+KP N
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQN 131

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           +L++  G +KL +FG++                 +  P            Y    D+WS 
Sbjct: 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP---PDVLFGAKLYSTSIDMWSA 188

Query: 127 GITLVELATGEFPYKDCKCDFEVLSRVLN 155
           G    ELA    P        + L R+  
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFR 217

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.5 bits (229), Expect = 3e-22
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 10/153 (6%)

Query: 7   ESDVWICMELMATCFDRLLK---RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVK 63
           E  + + ++ +     R+ +   R   ++P            ++L Y+    G+ HRD+K
Sbjct: 91  EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIK 149

Query: 64  PSNILLDERGNI-KLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           P N+LLD    + KLCDFG + +LV  +          Y APE I        DY    D
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF----GATDYTSSID 205

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           VWS G  L EL  G+  +       + L  ++ 
Sbjct: 206 VWSAGCVLAELLLGQPIFPG-DSGVDQLVEIIK 237

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 3e-22
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 10/178 (5%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           E+ + + ++ +                E          V AL +L +  G+I+RD+K  N
Sbjct: 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLEN 159

Query: 67  ILLDERGNIKLCDFGISGRLVD--SKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           ILLD  G++ L DFG+S   V   ++      G   YMAP+ +         +D   D W
Sbjct: 160 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR---GGDSGHDKAVDWW 216

Query: 125 SLGITLVELATGEFPYKDCKCD---FEVLSRVLNDAPPCLPN-DPLFGRTIKASIAKD 178
           SLG+ + EL TG  P+          E+  R+L   PP       L    I+  + KD
Sbjct: 217 SLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 4e-22
 Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 12/169 (7%)

Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV++   LM     +LLK  H+              ++ L Y+     V+HRD+KPSN+L
Sbjct: 85  DVYLVTHLMGADLYKLLKTQHL--SNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 141

Query: 69  LDERGNIKLCDFGISGRLVDSKAR----TKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           L+   ++K+CDFG++             T+      Y APE +         Y    D+W
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM----LNSKGYTKSIDIW 197

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKA 173
           S+G  L E+ +    +   K   + L+ +L         D      +KA
Sbjct: 198 SVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 5e-22
 Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 9/174 (5%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
              +   ME                  E          V AL YL     V++RD+K  N
Sbjct: 77  HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLEN 135

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           ++LD+ G+IK+ DFG+    +   A  K   G   Y+APE +     +  DY    D W 
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVDWWG 190

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN-DPLFGRTIKASIAKD 178
           LG+ + E+  G  P+ + +    +   +L +         P     +   + KD
Sbjct: 191 LGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 5e-22
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 8/151 (5%)

Query: 7   ESDVWICMELMATCFDRLLK-RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ +++  E +     + +       +P P+        ++ L +    H V+HRD+KP 
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQ 131

Query: 66  NILLDERGNIKLCDFGISGRL-VDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
           N+L++  G IKL DFG++    V  +  T       Y APE +         Y    D+W
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----GCKYYSTAVDIW 187

Query: 125 SLGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           SLG    E+ T    +     + + L R+  
Sbjct: 188 SLGCIFAEMVTRRALFPG-DSEIDQLFRIFR 217

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 1e-21
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 9/161 (5%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
           E+ VWI MEL         L+    S+              AL YL+     +HRD+   
Sbjct: 79  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAAR 137

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTKNAGC--AAYMAPERIEPPNPQKPDYDIRADV 123
           N+L+     +KL DFG+S  + DS     + G     +MAPE I         +   +DV
Sbjct: 138 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-----NFRRFTSASDV 192

Query: 124 WSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           W  G+ + E+            + +V+ R+ N     +P +
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 3e-21
 Identities = 31/160 (19%), Positives = 63/160 (39%), Gaps = 12/160 (7%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  +++  +        LL  + V        ++    +  L+Y+   + ++HRD+K +N
Sbjct: 89  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAAN 147

Query: 67  ILLDERGNIKLCDFGISGRLVDSKA-----RTKNAGCAAYMAPERIEPPNPQKPDYDIRA 121
           +L+   G +KL DFG++     +K       T       Y  PE +      + DY    
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL----GERDYGPPI 203

Query: 122 DVWSLGITLVELATGE--FPYKDCKCDFEVLSRVLNDAPP 159
           D+W  G  + E+ T          +    ++S++     P
Sbjct: 204 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 4e-21
 Identities = 33/174 (18%), Positives = 58/174 (33%), Gaps = 22/174 (12%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHV--------------SVPEPICGKITLSTVKALHY 50
              +++ +E        D L K   +              ++             + + Y
Sbjct: 83  RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142

Query: 51  LKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPP 110
           L +    IHRD+   NIL+ E    K+ DFG+S        +T       +MA E +   
Sbjct: 143 LSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--- 198

Query: 111 NPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
                 Y   +DVWS G+ L E+ +            E+  ++        P +
Sbjct: 199 --NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 4e-21
 Identities = 36/163 (22%), Positives = 55/163 (33%), Gaps = 11/163 (6%)

Query: 7   ESDVWICMELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
              + I  E M     D+ L+             +       + Y       +HRD+   
Sbjct: 81  YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY-LANMNYVHRDLAAR 139

Query: 66  NILLDERGNIKLCDFGISGRLVDSKARTK----NAGCAAYMAPERIEPPNPQKPDYDIRA 121
           NIL++     K+ DFG+S  L D    T           + APE I             +
Sbjct: 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS-----AS 194

Query: 122 DVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           DVWS GI + E+ T          + EV+  + +      P D
Sbjct: 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 88.0 bits (217), Expect = 6e-21
 Identities = 30/150 (20%), Positives = 59/150 (39%), Gaps = 7/150 (4%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           +  + +  E +     +LL      +         L  +  + Y  +   V+HRD+KP N
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQN 130

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKN-AGCAAYMAPERIEPPNPQKPDYDIRADVWS 125
           +L++  G +K+ DFG++        +  +      Y AP+ +         Y    D+WS
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM----GSKKYSTTIDIWS 186

Query: 126 LGITLVELATGEFPYKDCKCDFEVLSRVLN 155
           +G    E+  G   +     + + L R+  
Sbjct: 187 VGCIFAEMVNGTPLFPG-VSEADQLMRIFR 215

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 7e-21
 Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 10/162 (6%)

Query: 7   ESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS 65
            S V +  +LM   C    ++    ++         +   K ++YL+    ++HRD+   
Sbjct: 82  TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAAR 140

Query: 66  NILLDERGNIKLCDFGISGRLVDSKAR---TKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           N+L+    ++K+ DFG++  L   +             +MA E I         Y  ++D
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-----LHRIYTHQSD 195

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           VWS G+T+ EL T      D     E+ S +        P  
Sbjct: 196 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (218), Expect = 7e-21
 Identities = 37/163 (22%), Positives = 66/163 (40%), Gaps = 11/163 (6%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
           ++DV + +EL+A            S+ E    +     +  ++YL     + H D+KP N
Sbjct: 85  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPEN 143

Query: 67  ILLDERG----NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRAD 122
           I+L +R      IK+ DFG++ ++          G   ++APE +           + AD
Sbjct: 144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-----NYEPLGLEAD 198

Query: 123 VWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
           +WS+G+    L +G  P+       E L+ V            
Sbjct: 199 MWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYF 240

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 7e-21
 Identities = 34/185 (18%), Positives = 61/185 (32%), Gaps = 33/185 (17%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHV---------------------SVPEPICGKITLS 43
              +++  E        + L  +                         +           
Sbjct: 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172

Query: 44  TVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCA---A 100
             K + +L+     +HRD+   N+L+     +K+CDFG++  ++                
Sbjct: 173 VAKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 231

Query: 101 YMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP 159
           +MAPE +      +  Y I++DVWS GI L E+ + G  PY     D      + N    
Sbjct: 232 WMAPESL-----FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 286

Query: 160 CLPND 164
             P  
Sbjct: 287 DQPFY 291

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 84.5 bits (208), Expect = 2e-19
 Identities = 31/141 (21%), Positives = 59/141 (41%), Gaps = 6/141 (4%)

Query: 16  LMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN- 74
           +     +   K+L+ ++ +          +KAL Y     G++HRDVKP N+++D     
Sbjct: 110 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRK 168

Query: 75  IKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELA 134
           ++L D+G++      +          +  PE           YD   D+WSLG  L  + 
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPE----LLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 135 TGEFPYKDCKCDFEVLSRVLN 155
             + P+     +++ L R+  
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAK 245

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.5 bits (208), Expect = 2e-19
 Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 12/171 (7%)

Query: 11  WICMELMATCFDRLLKRLH--VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
            + M +       +   L       EP         V    YL     +I+RD+KP N+L
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLL 173

Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           +D++G I++ DFG + R+          G    +APE I         Y+   D W+LG+
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEII-----LSKGYNKAVDWWALGV 226

Query: 129 TLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPN-DPLFGRTIKASIAKD 178
            + E+A G  P+       ++  ++++       +        ++  +  D
Sbjct: 227 LIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 83.7 bits (206), Expect = 2e-19
 Identities = 28/172 (16%), Positives = 52/172 (30%), Gaps = 18/172 (10%)

Query: 5   SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
           ++     + MEL+    + L               +    +  + Y+      IHRDVKP
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKP 131

Query: 65  SNIL---LDERGNIKLCDFGISGRLVDSKA--------RTKNAGCAAYMAPERIEPPNPQ 113
            N L     +   + + DFG++ +  D++              G A Y +          
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH-----L 186

Query: 114 KPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDP 165
             +   R D+ SLG  L+    G               +    +   +    
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYERISEKKMSTPI 237

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (205), Expect = 3e-19
 Identities = 35/160 (21%), Positives = 64/160 (40%), Gaps = 15/160 (9%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP 64
              + +  EL    +  DRL K            +  +   + + YL+     IHRD+  
Sbjct: 82  TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAA 139

Query: 65  SNILLDERGNIKLCDFGISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIR 120
            N+LL  R  +K+ DFG+   L  +      +       A+ APE +     +   +   
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL-----KTRTFSHA 194

Query: 121 ADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP 159
           +D W  G+TL E+ T G+ P+       ++L ++  +   
Sbjct: 195 SDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGER 233

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 2e-18
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 9/135 (6%)

Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           D ++ M  M T   +L+K  H  + E     +    +K L Y+    G+IHRD+KP N+ 
Sbjct: 97  DFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLA 153

Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           ++E   +K+ DFG++ R  DS+  T       Y APE I         Y    D+WS+G 
Sbjct: 154 VNEDCELKILDFGLA-RQADSE-MTGYVVTRWYRAPEVIL----NWMRYTQTVDIWSVGC 207

Query: 129 TLVELATGEFPYKDC 143
            + E+ TG+  +K  
Sbjct: 208 IMAEMITGKTLFKGS 222

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 2e-17
 Identities = 37/136 (27%), Positives = 56/136 (41%), Gaps = 10/136 (7%)

Query: 33  PEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAR 92
                   +    K + +L      IHRD+   NILL E+  +K+CDFG++  +      
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 93  TKN---AGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG-EFPYKDCKCDFE 148
            +         +MAPE I         Y I++DVWS G+ L E+ +    PY   K D E
Sbjct: 191 VRKGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 149 VLSRVLNDAPPCLPND 164
              R+        P+ 
Sbjct: 246 FCRRLKEGTRMRAPDY 261

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 3e-17
 Identities = 34/170 (20%), Positives = 66/170 (38%), Gaps = 13/170 (7%)

Query: 5   SKESDVWICMELMA--------TCFDRLLKRLHVSVPEPI--CGKITLSTVKALHYLKET 54
           S+     + MELM               +    V  P  +    ++       + YL   
Sbjct: 93  SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA- 151

Query: 55  HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQK 114
           +  +HRD+   N ++ E   +K+ DFG++  + ++    K  G    +    + P + + 
Sbjct: 152 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKD 209

Query: 115 PDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
             +   +DVWS G+ L E+AT          + +VL  V+       P++
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 259

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 78.5 bits (192), Expect = 3e-17
 Identities = 31/137 (22%), Positives = 55/137 (40%), Gaps = 13/137 (9%)

Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
            +   L       + K  H  +P     +I+   +  L Y+    G+IH D+KP N+L++
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160

Query: 71  ERG------NIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVW 124
                     IK+ D G +    +    +       Y +PE +         +   AD+W
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREYRSPEVL-----LGAPWGCGADIW 213

Query: 125 SLGITLVELATGEFPYK 141
           S    + EL TG+F ++
Sbjct: 214 STACLIFELITGDFLFE 230

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (189), Expect = 7e-17
 Identities = 29/176 (16%), Positives = 56/176 (31%), Gaps = 21/176 (11%)

Query: 7   ESDVWICMELMA--TCFDRLLKRLH----------------VSVPEPICGKITLSTVKAL 48
                +  E        + L ++                  +++        +    K +
Sbjct: 99  GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158

Query: 49  HYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIE 108
            +L      IHRD+   NILL      K+CDFG++  + +             +  + + 
Sbjct: 159 AFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA--RLPVKWMA 215

Query: 109 PPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
           P +     Y   +DVWS GI L EL +                +++ +    L  +
Sbjct: 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 271

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 1e-16
 Identities = 32/179 (17%), Positives = 62/179 (34%), Gaps = 25/179 (13%)

Query: 5   SKESDVWICMELMA--TCFDRLLKRLHVSV--------------PEPICGKITLSTVKAL 48
           +++  +++ +E  +     + L  R    +                           + +
Sbjct: 89  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148

Query: 49  HYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKARTK---NAGCAAYMAPE 105
            YL      IHRD+   N+L+ E   +K+ DFG++  +       K         +MAPE
Sbjct: 149 EYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207

Query: 106 RIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPND 164
            +         Y  ++DVWS G+ L E+ T            E+   +        P++
Sbjct: 208 AL-----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 261

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 2e-16
 Identities = 38/216 (17%), Positives = 78/216 (36%), Gaps = 10/216 (4%)

Query: 9   DVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNIL 68
           DV++ MELM     ++++             +    +  + +L     +IHRD+KPSNI+
Sbjct: 96  DVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIV 151

Query: 69  LDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGI 128
           +     +K+ DFG++     S   T       Y APE I         Y    D+WS+G 
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGC 206

Query: 129 TLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRK 188
            + E+   +  +   +   +  ++V+       P      +    +  ++  +       
Sbjct: 207 IMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265

Query: 189 RSYEDKSTCYECGAEGHLSYACPQNILGIREPPPKK 224
           + + D     +       +      +  +    P K
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 2e-12
 Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 9/136 (6%)

Query: 7   ESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN 66
            +DV++   LM    + ++K   +   +     +    ++ L Y+     +IHRD+KPSN
Sbjct: 95  FNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSN 151

Query: 67  ILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSL 126
           + ++E   +K+ DFG++         T       Y APE +         Y+   D+WS+
Sbjct: 152 LAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIM----LNWMHYNQTVDIWSV 205

Query: 127 GITLVELATGEFPYKD 142
           G  + EL TG   +  
Sbjct: 206 GCIMAELLTGRTLFPG 221

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 56.7 bits (136), Expect = 2e-10
 Identities = 19/122 (15%), Positives = 40/122 (32%), Gaps = 16/122 (13%)

Query: 11  WICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD 70
            + MEL+              V      ++    ++ +       G++H D+   N+L+ 
Sbjct: 86  AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS 137

Query: 71  ERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITL 130
           E G I + DF  S  + +   R         +  +           Y    D+ S    +
Sbjct: 138 EEG-IWIIDFPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDRI 189

Query: 131 VE 132
           ++
Sbjct: 190 LQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	296
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.98
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.98
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.43
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.08
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.69
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.54
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	80.64

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=299.75  Aligned_cols=197  Identities=30%  Similarity=0.485  Sum_probs=170.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|||||||. |+|.+++.+....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DF  154 (288)
T d2jfla1          76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADF  154 (288)
T ss_dssp             EEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEec
Confidence            35678899999999999 59999987767789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++...... .......||+.|+|||++.+.......|+.++|||||||++|+|++|..||.+ ....+.+.++.++.++
T Consensus       155 G~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~-~~~~~~~~~i~~~~~~  233 (288)
T d2jfla1         155 GVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPP  233 (288)
T ss_dssp             TTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT-SCGGGHHHHHHHSCCC
T ss_pred             hhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC
Confidence            999765433 22345689999999999976544455789999999999999999999999988 4556777888888877


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .++....+|+++++||.+||..||+        +|.++.+++.|+|+..
T Consensus       234 ~~~~~~~~s~~~~~li~~~L~~dp~--------~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKKCLEKNVD--------ARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSSTT--------TSCCHHHHTTSGGGCC
T ss_pred             CCCccccCCHHHHHHHHHHccCChh--------HCcCHHHHhcCcccCC
Confidence            7776667999999999999999998        6677888889888753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-42  Score=297.22  Aligned_cols=193  Identities=26%  Similarity=0.474  Sum_probs=166.1

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++++|||||||+| +|.+++.+  ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          84 DSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccc
Confidence            357788999999999995 99998874  579999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |++..+... .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ ......+..+.....+
T Consensus       161 G~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~~~~~~~~  234 (293)
T d1yhwa1         161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP  234 (293)
T ss_dssp             TTCEECCSTTCCBCCCCSCGGGCCHHHHSS-----SCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHHCSC
T ss_pred             hhheeeccccccccccccCCCccChhhhcC-----CCCCchhceehHhHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCC
Confidence            999876543 33445579999999999954     3688999999999999999999999988 4555666677776666


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCC
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACP  211 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~  211 (296)
                      .++....+|+.+++||.+||..||.        +|.++.+++.|+|++...+
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~--------~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVE--------KRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTT--------TSCCHHHHTTCGGGGGCCC
T ss_pred             CCCCcccCCHHHHHHHHHHccCChh--------HCcCHHHHhcCHhhCCCCC
Confidence            6666667999999999999999998        6678888999999876543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=288.37  Aligned_cols=187  Identities=25%  Similarity=0.359  Sum_probs=159.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|||||||+ |+|.+++.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          73 GYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeeccc
Confidence            35778899999999999 599999986 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++...... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+ ....+.+.++.++. +.
T Consensus       151 G~a~~~~~~-~~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~-~~  222 (263)
T d2j4za1         151 GWSVHAPSS-RRTTLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVE-FT  222 (263)
T ss_dssp             CSCSCCCCC-CCEETTEEGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTC-CC
T ss_pred             ceeeecCCC-cccccCCCCcccCHHHHcC-----CCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC-CC
Confidence            999765443 2334579999999999954     3688999999999999999999999987 45556666666654 34


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +|..  +|+++++||.+||..||+        +|.++.+++.|+|+..
T Consensus       223 ~p~~--~s~~~~~li~~~L~~dp~--------~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 FPDF--VTEGARDLISRLLKHNPS--------QRPMLREVLEHPWITA  260 (263)
T ss_dssp             CCTT--SCHHHHHHHHHHTCSSGG--------GSCCHHHHHTCHHHHH
T ss_pred             CCcc--CCHHHHHHHHHHccCCHh--------HCcCHHHHHcCcCcCC
Confidence            4443  799999999999999998        6667788888887643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=289.70  Aligned_cols=194  Identities=22%  Similarity=0.343  Sum_probs=162.0

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|||||||+ |+|.+++.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          75 FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEeccc
Confidence            35778899999999999 599999877 5789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |+++.+....   ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ .+..+.+.++.++.
T Consensus       153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~  226 (288)
T d1uu3a_         153 GTAKVLSPESKQARANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLE  226 (288)
T ss_dssp             TTCEECC----------CCCCGGGCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTC
T ss_pred             ccceecccCCcccccccccCCccccCceeecc-----CCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCC
Confidence            9998765332   2334579999999999953     3688999999999999999999999998 56667777777765


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      . .+|.  .+++++++||.+||..||.  .|++.+++.....+..|+|++-
T Consensus       227 ~-~~p~--~~s~~~~~li~~~L~~dP~--~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         227 Y-DFPE--KFFPKARDLVEKLLVLDAT--KRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             C-CCCT--TCCHHHHHHHHTTSCSSGG--GSTTSGGGTCHHHHHTSGGGTT
T ss_pred             C-CCCc--cCCHHHHHHHHHHccCCHh--HCcCHHHHcCCHHHHcCCccCC
Confidence            3 4443  3899999999999999998  5556777777777788887654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=289.76  Aligned_cols=192  Identities=23%  Similarity=0.332  Sum_probs=157.1

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|||||||. |+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus        70 ~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DF  147 (271)
T d1nvra_          70 GHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDF  147 (271)
T ss_dssp             EEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             eeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccc
Confidence            35678899999999999 599999965 6789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC---ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDS---KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |+++.....   .......||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||............+... 
T Consensus       148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-  222 (271)
T d1nvra_         148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRR----EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-  222 (271)
T ss_dssp             TTCEECEETTEECCBCCCCSCGGGSCTHHHHCS----SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-
T ss_pred             hhheeeccCCccccccceeeCcCccCHhHhcCC----CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-
Confidence            999876433   223445799999999999532    134678999999999999999999998754443444344333 


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ....+....+|+++.+||.+||..||+        +|.++.+++.++|+..
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~--------~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         223 KTYLNPWKKIDSAPLALLHKILVENPS--------ARITIPDIKKDRWYNK  265 (271)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTT--------TSCCHHHHTTCTTTTC
T ss_pred             CCCCCccccCCHHHHHHHHHHcCCChh--------HCcCHHHHhcCHhhCc
Confidence            333344455899999999999999998        7777888899988754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=285.43  Aligned_cols=184  Identities=22%  Similarity=0.366  Sum_probs=146.1

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCcEEECCCCCEE
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL---HVSVPEPICGKITLSTVKALHYLKETHG-----VIHRDVKPSNILLDERGNIK   76 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~-----ivH~dlkp~Nil~~~~~~~k   76 (296)
                      .++.+|||||||+ |+|.+++.+.   +..+++..++.++.||+.||.|||++ |     |+||||||+|||++.++.+|
T Consensus        76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTSCEE
T ss_pred             CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            3567999999999 5999998653   57899999999999999999999995 5     99999999999999999999


Q ss_pred             EeccCCcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc
Q psy3686          77 LCDFGISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN  155 (296)
Q Consensus        77 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~  155 (296)
                      |+|||+++.+.... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+ ....+...++..
T Consensus       155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~  228 (269)
T d2java1         155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIRE  228 (269)
T ss_dssp             ECCHHHHHHC-----------CCCSCCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHH
T ss_pred             EeeccceeecccCCCccccCCCCcccCCHHHHcC-----CCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHc
Confidence            99999998765432 3344689999999999953     3789999999999999999999999987 456677778888


Q ss_pred             cCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         156 DAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       156 ~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      +..+.++..  +|+++.+||.+||..||.        .|.++.+++.++|+
T Consensus       229 ~~~~~~~~~--~s~~l~~li~~~L~~dp~--------~Rps~~ell~hp~i  269 (269)
T d2java1         229 GKFRRIPYR--YSDELNEIITRMLNLKDY--------HRPSVEEILENPLI  269 (269)
T ss_dssp             TCCCCCCTT--SCHHHHHHHHHHTCSSGG--------GSCCHHHHHTSTTC
T ss_pred             CCCCCCCcc--cCHHHHHHHHHHcCCChh--------HCcCHHHHHhCCcC
Confidence            877666553  899999999999999998        55667777777763

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-40  Score=289.22  Aligned_cols=191  Identities=22%  Similarity=0.351  Sum_probs=149.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEC---CCCCEEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD---ERGNIKL   77 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~---~~~~~kl   77 (296)
                      ++|.+++.+|||||||+ |+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||+.   .++.+||
T Consensus        74 ~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          74 DIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEE
Confidence            35778899999999999 599999976 6789999999999999999999999 5999999999999995   4789999


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      +|||+++............||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ ....+....+.++.
T Consensus       152 ~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~  225 (307)
T d1a06a_         152 SDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAE  225 (307)
T ss_dssp             CCC------------------CTTSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTC
T ss_pred             eccceeEEccCCCeeeeeeeCccccCcHHHcC-----CCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccC
Confidence            99999987665555556689999999999954     3688999999999999999999999988 45566777777665


Q ss_pred             CC-CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 PP-CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ~p-~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .. ..+....+|+++.+||.+||..||+        +|.++.+++.|+|++.
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~--------~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPE--------KRFTCEQALQHPWIAG  269 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGG--------GSCCHHHHHHSTTTTS
T ss_pred             CCCCCccccCCCHHHHHHHHHHccCCHh--------HCcCHHHHhcCHhhCC
Confidence            43 2233345899999999999999998        6667888899988753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-40  Score=288.21  Aligned_cols=190  Identities=28%  Similarity=0.412  Sum_probs=160.4

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|||||||.| +|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          82 GCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             EEEEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeec
Confidence            356788999999999995 77655544 6789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |++......   ....||+.|+|||++.+.  ....|+.++|||||||++|+|++|..||.+ ....+.+.++..+..+.
T Consensus       160 G~a~~~~~~---~~~~GT~~Y~APE~~~~~--~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~~~~~~~  233 (309)
T d1u5ra_         160 GSASIMAPA---NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPA  233 (309)
T ss_dssp             TTCBSSSSB---CCCCSCGGGCCHHHHTTT--TSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCC
T ss_pred             ccccccCCC---CccccCccccCHHHHhcc--CCCCcCchhhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCC
Confidence            999765432   345799999999999653  233688999999999999999999999988 45567777777777666


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +... .+|+.+++||.+||..||+        +|.++.+++.|+|+..
T Consensus       234 ~~~~-~~s~~~~~li~~~L~~dP~--------~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         234 LQSG-HWSEYFRNFVDSCLQKIPQ--------DRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             CSCT-TSCHHHHHHHHHHTCSSGG--------GSCCHHHHTTCHHHHS
T ss_pred             CCCC-CCCHHHHHHHHHHCcCChh--------HCcCHHHHHhCHHhcC
Confidence            5543 3899999999999999998        6667788888887754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=292.77  Aligned_cols=191  Identities=36%  Similarity=0.713  Sum_probs=156.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++++|||||||. |+|.+++.+ .+.+++..++.++.||+.||.|||+++||+||||||+|||++.++.+||+||
T Consensus        71 ~~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          71 GAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             EEEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeC
Confidence            45778899999999999 499999987 5689999999999999999999997568999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcH-------------
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDF-------------  147 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-------------  147 (296)
                      |+|...... ......||+.|+|||++.+     ..|+.++||||+||++|+|++|+.||.+.....             
T Consensus       150 Gla~~~~~~-~~~~~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  223 (322)
T d1s9ja_         150 GVSGQLIDS-MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA  223 (322)
T ss_dssp             CCCHHHHHH-TC---CCSSCCCCHHHHHC-----SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred             CCccccCCC-ccccccCCccccCchHHcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence            999865432 2334589999999999954     378999999999999999999999997643321             


Q ss_pred             ----------------------------HHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         148 ----------------------------EVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       148 ----------------------------~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                                                  +....+....+|.++... +|.++++||.+||..||.        +|.++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~--------~R~ta~e  294 (322)
T d1s9ja_         224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV-FSLEFQDFVNKCLIKNPA--------ERADLKQ  294 (322)
T ss_dssp             ----------------------CCCCHHHHHHHHHTSCCCCCCBTT-BCHHHHHHHHHHTCSSTT--------TSCCHHH
T ss_pred             ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcccc-CCHHHHHHHHHHcCCChh--------HCcCHHH
Confidence                                        112223333444444433 799999999999999998        7778899


Q ss_pred             cccCCcccc
Q psy3686         200 CGAEGHLSY  208 (296)
Q Consensus       200 ~~~~~~~~~  208 (296)
                      +++|+|++.
T Consensus       295 ~L~Hpf~~~  303 (322)
T d1s9ja_         295 LMVHAFIKR  303 (322)
T ss_dssp             HHTSHHHHH
T ss_pred             HhhCHhhCc
Confidence            999988754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-40  Score=280.44  Aligned_cols=182  Identities=25%  Similarity=0.420  Sum_probs=151.8

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEC-CCCCEEEeccCC
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHG--VIHRDVKPSNILLD-ERGNIKLCDFGI   82 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~   82 (296)
                      ++.+|||||||+ |+|.+++.+ ...+++..++.++.||+.||+|||+ +|  |+||||||+|||++ .++.+||+|||+
T Consensus        84 ~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          84 KKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            567899999999 599999977 5689999999999999999999999 48  99999999999996 478999999999


Q ss_pred             cccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          83 SGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      ++..... ......||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+..........+..+..|.. 
T Consensus       162 a~~~~~~-~~~~~~GT~~Y~aPE~~~~------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~-  233 (270)
T d1t4ha_         162 ATLKRAS-FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-  233 (270)
T ss_dssp             GGGCCTT-SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG-
T ss_pred             ceeccCC-ccCCcccCccccCHHHhCC------CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc-
Confidence            9754332 3345589999999999842      5889999999999999999999999886666666666666544322 


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHL  206 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~  206 (296)
                      .+..+++++++||.+||..||+        +|.++.+++.|+|+
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~--------~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         234 FDKVAIPEVKEIIEGCIRQNKD--------ERYSIKDLLNHAFF  269 (270)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGG--------GSCCHHHHHTSGGG
T ss_pred             cCccCCHHHHHHHHHHccCCHh--------HCcCHHHHhCCccc
Confidence            2223789999999999999998        66677888888775

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.4e-40  Score=290.36  Aligned_cols=192  Identities=18%  Similarity=0.254  Sum_probs=163.8

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEC--CCCCEEEe
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLD--ERGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~--~~~~~kl~   78 (296)
                      ++|.+++.+|||||||+ |+|.+++.....++++..++.++.||+.||.|||+ +||+||||||+|||++  .++.+||+
T Consensus        93 ~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_          93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             EEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEe
Confidence            35778999999999999 59999887656789999999999999999999999 5999999999999997  57899999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++..+..........+|+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ ....+.+..+..+..
T Consensus       172 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~  245 (352)
T d1koba_         172 DFGLATKLNPDEIVKVTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDW  245 (352)
T ss_dssp             CCTTCEECCTTSCEEEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCC
T ss_pred             ecccceecCCCCceeeccCcccccCHHHHcC-----CCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC
Confidence            9999988776655566689999999999954     3689999999999999999999999988 456677777777654


Q ss_pred             CCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +.. .....+|+++++||.+||..||.        +|.++.+++.|+|+.-
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~--------~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPR--------KRLTVHDALEHPWLKG  288 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGG--------GSCCHHHHHTSTTTSS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChh--------HCcCHHHHhcCHhhCC
Confidence            322 23345899999999999999998        6677888888888753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-40  Score=287.84  Aligned_cols=192  Identities=23%  Similarity=0.337  Sum_probs=159.8

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|||||||. |+|.+++.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||
T Consensus        73 ~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          73 AFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecc
Confidence            5778899999999999 599999987 6789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      +++..... ......+||+.|+|||++.+     ..|+.++|||||||++|+|++|..||.+ .+..+....+..+. +.
T Consensus       151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-----~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~-~~  223 (337)
T d1o6la_         151 LCKEGISDGATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE-IR  223 (337)
T ss_dssp             TCBCSCCTTCCBCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC-CC
T ss_pred             cccccccCCcccccceeCHHHhhhhhccC-----CCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC-CC
Confidence            99875443 34455689999999999954     3789999999999999999999999998 45556666666655 44


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +|..  +|+++++||.+||.+||..|....   ...+.+++.|+|+..
T Consensus       224 ~p~~--~s~~~~dli~~~L~~dP~~R~~~~---~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         224 FPRT--LSPEAKSLLAGLLKKDPKQRLGGG---PSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CCTT--SCHHHHHHHHHHTCSSTTTSTTCS---TTTHHHHHTSGGGTT
T ss_pred             CCcc--CCHHHHHHHHhhccCCchhhcccc---cccHHHHHcCccccc
Confidence            5543  899999999999999998444321   123566777877643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-40  Score=282.00  Aligned_cols=190  Identities=24%  Similarity=0.343  Sum_probs=148.4

Q ss_pred             ccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           5 SKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         5 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      ..++.+|||||||+ |+|.+++......+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          73 STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             ECSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             EeccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccce
Confidence            45567899999999 59999998767789999999999999999999999 59999999999999999999999999999


Q ss_pred             ccccCC---ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-C
Q psy3686          84 GRLVDS---KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-P  159 (296)
Q Consensus        84 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-p  159 (296)
                      ......   .......||+.|+|||++.+.  ....++.++|||||||++|+|++|+.||.+..........+.++.. |
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p  229 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQ--DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP  229 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTC--SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcc--cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            765432   223345789999999999653  2335889999999999999999999999985554445445544432 2


Q ss_pred             CCC-CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         160 CLP-NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       160 ~~~-~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                      .++ ....+++.+.+||.+||..+|+  .|+++.++...++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~--~RPt~~~il~~Le  268 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRD--ERPLFPQILASIE  268 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGG--GSCCHHHHHHHHH
T ss_pred             cchhccccchHHHHHHHHHHcCCCHh--HCcCHHHHHHHHH
Confidence            222 2234899999999999999998  3445555554443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.8e-40  Score=289.99  Aligned_cols=193  Identities=21%  Similarity=0.236  Sum_probs=163.4

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC--CCCEEEe
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE--RGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~--~~~~kl~   78 (296)
                      +.|.+++.+|||||||+ |+|.+++....+.+++..++.++.||+.||.|||+ +||+||||||+|||++.  ++.+||+
T Consensus        90 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2          90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEe
Confidence            35678899999999999 59999997656789999999999999999999999 59999999999999964  5789999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++..+..........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ .+..+.+..+..+..
T Consensus       169 DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~  242 (350)
T d1koaa2         169 DFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDW  242 (350)
T ss_dssp             CCTTCEECCTTSCEEEECSCTTTCCHHHHHT-----CCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC
T ss_pred             ecchheecccccccceecCcccccCHHHHcC-----CCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC
Confidence            9999988776666666789999999999954     3688999999999999999999999987 566677777776553


Q ss_pred             CCC-CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         159 PCL-PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       159 p~~-~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      ... .....+|+.+++||.+||..||+        +|.++.+++.|+|+...
T Consensus       243 ~~~~~~~~~~s~~~~~li~~~L~~dP~--------~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         243 NMDDSAFSGISEDGKDFIRKLLLADPN--------TRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             CSCCGGGGGCCHHHHHHHHHHCCSSGG--------GSCCHHHHHHSTTTSCT
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChh--------HCcCHHHHhcCcccCCC
Confidence            222 22245899999999999999998        66678888889887544

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-39  Score=280.49  Aligned_cols=195  Identities=26%  Similarity=0.383  Sum_probs=164.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++++|||||||+ |+|.+++.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEccc
Confidence            35778999999999998 599999977 5689999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNP-QKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-  158 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-  158 (296)
                      |++.............||..|+|||.+.+... ....++.++||||+||++|+|++|+.||.+ .........+..+.. 
T Consensus       155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~  233 (277)
T d1phka_         155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQ  233 (277)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC
T ss_pred             hheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCC
Confidence            99988766555566689999999999853211 233578899999999999999999999998 456667777776653 


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +..+....+|+++++||.+||..+|.        +|.++.+++.++|++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~~p~--------~R~s~~eil~h~~~~  274 (277)
T d1phka_         234 FGSPEWDDYSDTVKDLVSRFLVVQPQ--------KRYTAEEALAHPFFQ  274 (277)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGG--------GSCCHHHHTTSGGGC
T ss_pred             CCCcccccCCHHHHHHHHHHccCChh--------HCcCHHHHHcCHHHH
Confidence            23334446899999999999999998        666778888888764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=282.12  Aligned_cols=196  Identities=21%  Similarity=0.270  Sum_probs=161.9

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC----CEE
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG----NIK   76 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~----~~k   76 (296)
                      ++|.+++.+|||||||. |+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++    .+|
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEEEECCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceE
Confidence            45788999999999999 599999987 5689999999999999999999999 5999999999999998776    599


Q ss_pred             EeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc
Q psy3686          77 LCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        77 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      |+|||++.............+++.|+|||++.+     ..++.++|||||||++|+|++|..||.+ ....+.+..+..+
T Consensus       158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~  231 (293)
T d1jksa_         158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAV  231 (293)
T ss_dssp             ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTT
T ss_pred             ecchhhhhhcCCCccccccCCCCcccCHHHHcC-----CCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhc
Confidence            999999988766555566689999999999953     3688999999999999999999999998 5666777777766


Q ss_pred             CCCCCC-CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccCCCC
Q psy3686         157 APPCLP-NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYACPQN  213 (296)
Q Consensus       157 ~~p~~~-~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (296)
                      .....+ ....+|+.+++||.+||..||+        +|.++.+++.++|++..-.+.
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~--------~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         232 NYEFEDEYFSNTSALAKDFIRRLLVKDPK--------KRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHTTSCSSGG--------GSCCHHHHHHSTTTCC-----
T ss_pred             CCCCCchhcCCCCHHHHHHHHHHccCChh--------HCcCHHHHhcCcccCCCChhH
Confidence            543221 1234799999999999999998        666778888898886543333

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-39  Score=288.91  Aligned_cols=194  Identities=24%  Similarity=0.332  Sum_probs=154.1

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+++.+|||||||. |+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeec
Confidence            4678899999999999 599999987 5789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-cHHHHHHHHccCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC-DFEVLSRVLNDAPPC  160 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-~~~~~~~i~~~~~p~  160 (296)
                      ++..+.... .....||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+... ....+.+......+.
T Consensus       153 la~~~~~~~-~~~~~GT~~y~APE~~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~  227 (364)
T d1omwa3         153 LACDFSKKK-PHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE  227 (364)
T ss_dssp             TCEECSSSC-CCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC
T ss_pred             eeeecCCCc-ccccccccccchhHHhhc----CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence            998765433 334589999999999852    23688999999999999999999999987432 222222232333333


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ++.  .+|+++++||.+||..||+.|+...   ...+.+++.|+|+.-
T Consensus       228 ~~~--~~s~~~~~li~~~L~~dP~~R~t~~---~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         228 LPD--SFSPELRSLLEGLLQRDVNRRLGCL---GRGAQEVKESPFFRS  270 (364)
T ss_dssp             CCS--SSCHHHHHHHHHHTCSSTTTSTTTS---SSTHHHHHTSGGGTT
T ss_pred             CCC--CCCHHHHHHHHHHcccCHHHhCCCc---ccCHHHHHcCccccC
Confidence            433  4899999999999999998333321   112567778887643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-39  Score=280.83  Aligned_cols=192  Identities=24%  Similarity=0.434  Sum_probs=161.2

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|+|||||.| +|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+||
T Consensus        71 ~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          71 GTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eeEeeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecC
Confidence            357788999999999995 99998876 7789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCC
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPC  160 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~  160 (296)
                      |+++.....  .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+ .+..+.+.++.++.. .
T Consensus       149 G~a~~~~~~--~~~~~Gt~~Y~APE~l~~-----~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~-~  219 (316)
T d1fota_         149 GFAKYVPDV--TYTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL-R  219 (316)
T ss_dssp             SSCEECSSC--BCCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC-C
T ss_pred             ccceEeccc--cccccCcccccCHHHHcC-----CCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC-C
Confidence            999876433  334589999999999954     3688999999999999999999999988 566677777877654 3


Q ss_pred             CCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         161 LPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       161 ~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +|.  .+|++++++|.+||.+||..|..   ..+.++.+++.|+|++-.
T Consensus       220 ~p~--~~s~~~~~li~~~L~~dp~~R~~---~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         220 FPP--FFNEDVKDLLSRLITRDLSQRLG---NLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CCT--TSCHHHHHHHHHHTCSCTTTCTT---SSTTTTHHHHTSGGGSSC
T ss_pred             CCC--CCCHHHHHHHHHHhhhCHHhccc---cchhhHHHHHcCcccccC
Confidence            333  37999999999999999984432   123467778888887543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=279.53  Aligned_cols=187  Identities=22%  Similarity=0.363  Sum_probs=157.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.|.+++.+|||||||. |+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        70 ~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          70 CTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCCceecccc
Confidence            35778899999999999 599999976 6789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      |+++..... .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+ ....+.+.++..+. +
T Consensus       148 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~-~  220 (320)
T d1xjda_         148 GMCKENMLGDAKTNTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN-P  220 (320)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC-C
T ss_pred             chhhhcccccccccccCCCCCcCCHHHHcC-----CCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC-C
Confidence            999866533 33444589999999999954     3788999999999999999999999988 45666677776654 4


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchh-hcccCCccc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCY-ECGAEGHLS  207 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~-~~~~~~~~~  207 (296)
                      .+|..  +|+.+.+||.+||..||+        +|.++. +++.|+|+.
T Consensus       221 ~~p~~--~s~~~~dli~~~L~~dP~--------~R~s~~~~l~~hpff~  259 (320)
T d1xjda_         221 FYPRW--LEKEAKDLLVKLFVREPE--------KRLGVRGDIRQHPLFR  259 (320)
T ss_dssp             CCCTT--SCHHHHHHHHHHSCSSGG--------GSBTTBSCGGGSGGGT
T ss_pred             CCCcc--CCHHHHHHHHHhcccCCC--------CCcCHHHHHHhCchhc
Confidence            55543  799999999999999998        333432 466777764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-39  Score=284.55  Aligned_cols=187  Identities=20%  Similarity=0.306  Sum_probs=150.2

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCce
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLH----------------------VSVPEPICGKITLSTVKALHYLKETHGVI   58 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~iv   58 (296)
                      +.+.+++.+|||||||+ |+|.+++....                      ..+++..++.++.||+.||+|||+ +||+
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~Ii  186 (325)
T d1rjba_         108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCV  186 (325)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCee
Confidence            35678889999999999 59999997642                      358999999999999999999999 5999


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy3686          59 HRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT  135 (296)
Q Consensus        59 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~  135 (296)
                      ||||||+|||++.++.+||+|||+++.......   .....+|+.|+|||++.     ...++.++|||||||++|+|++
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHTT
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-----CCCCCcceeccchhHHHHHHHh
Confidence            999999999999999999999999976554322   23346789999999984     3478999999999999999998


Q ss_pred             -CCCCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchh
Q psy3686         136 -GEFPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCY  198 (296)
Q Consensus       136 -g~~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~  198 (296)
                       |..||.+..........+..+..+..|..  +|+.+++||.+||..+|+  .|++++++...+
T Consensus       262 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~--~~~~l~~li~~cl~~dP~--~RPt~~ei~~~L  321 (325)
T d1rjba_         262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSR--KRPSFPNLTSFL  321 (325)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHTTCCCCCCTT--CCHHHHHHHHHHTCSSGG--GSCCHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCCCCCCc--CCHHHHHHHHHHcCCChh--HCcCHHHHHHHH
Confidence             89999985555444444445544445443  799999999999999998  344555554444

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-39  Score=277.65  Aligned_cols=179  Identities=24%  Similarity=0.338  Sum_probs=151.0

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ..+.+|||||||+ |+|.+++......+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus        79 ~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          79 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhh
Confidence            3456899999999 59999987666789999999999999999999999 599999999999999999999999999998


Q ss_pred             cccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      .+....    ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+. ...++...+.++..+
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~  231 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM  231 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC
T ss_pred             cccccccccccccccccCccccChHHHh-----CCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC
Confidence            765432    122346789999999994     3378999999999999999998 99999984 456777888888877


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      .+|..  +|+++.+||.+||..+|+.|  +++.++.
T Consensus       232 ~~p~~--~~~~l~~li~~cl~~~p~~R--Ps~~~i~  263 (285)
T d1u59a_         232 ECPPE--CPPELYALMSDCWIYKWEDR--PDFLTVE  263 (285)
T ss_dssp             CCCTT--CCHHHHHHHHHTTCSSGGGS--CCHHHHH
T ss_pred             CCCCc--CCHHHHHHHHHHcCCCHhHC--cCHHHHH
Confidence            77654  89999999999999999844  3444443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-39  Score=279.77  Aligned_cols=185  Identities=23%  Similarity=0.318  Sum_probs=144.6

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|||||||+ |+|.+++......+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus        94 g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_          94 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCc
Confidence            35677889999999999 59999998767789999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCccc------cccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHH
Q psy3686          81 GISGRLVDSKAR------TKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRV  153 (296)
Q Consensus        81 g~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i  153 (296)
                      |+++........      ....+++.|+|||.+.     ...++.++|||||||++|+|++ |..||.+ ....+++..+
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i  246 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-----YRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAI  246 (299)
T ss_dssp             -----------------------CGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHH
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHh-----cCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence            999876533211      1235688999999994     3478999999999999999998 8999988 4556777777


Q ss_pred             HccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         154 LNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       154 ~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                      ..+..+..+..  ++..+.+||.+||..+|+.|  +++.++...
T Consensus       247 ~~~~~~~~~~~--~~~~l~~li~~cl~~~P~~R--Ps~~ei~~~  286 (299)
T d1jpaa_         247 EQDYRLPPPMD--CPSALHQLMLDCWQKDRNHR--PKFGQIVNT  286 (299)
T ss_dssp             HTTCCCCCCTT--CCHHHHHHHHHHTCSSTTTS--CCHHHHHHH
T ss_pred             HcCCCCCCCcc--chHHHHHHHHHHcCCCHhHC--cCHHHHHHH
Confidence            77765555443  89999999999999999844  355554443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-38  Score=279.79  Aligned_cols=190  Identities=23%  Similarity=0.354  Sum_probs=159.4

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+.+.+|+||||+. |+|..++.+ .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||
T Consensus       109 ~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         109 SFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeece
Confidence            4678899999999999 599999977 5689999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      +++.....  .....||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ ......+.++..+.. .+
T Consensus       187 ~a~~~~~~--~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~-~~  257 (350)
T d1rdqe_         187 FAKRVKGR--TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RF  257 (350)
T ss_dssp             TCEECSSC--BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC-CC
T ss_pred             eeeecccc--cccccCccccCCHHHHcC-----CCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC-CC
Confidence            99876533  334589999999999954     3688999999999999999999999988 566677777777654 33


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +.  .+|+++.+||++||..||..|..   ..+.++.+++.|+|++-
T Consensus       258 p~--~~s~~~~~li~~~L~~dP~kR~~---~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         258 PS--HFSSDLKDLLRNLLQVDLTKRFG---NLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CT--TCCHHHHHHHHHHSCSCTTTCTT---SSTTTTHHHHTSGGGTT
T ss_pred             Cc--cCCHHHHHHHHHHhhhCHHhccc---cccccHHHHHcCccccC
Confidence            33  38999999999999999984432   12346777888887643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=272.30  Aligned_cols=184  Identities=21%  Similarity=0.334  Sum_probs=143.8

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|||||||. |+|.+++......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus        67 g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DF  145 (263)
T d1sm2a_          67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDF  145 (263)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred             ceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCCCeEeccc
Confidence            34667889999999999 69999998767889999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG-EFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g-~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |+++.......  .....+|+.|+|||++.+     ..++.++|||||||++|+|+++ .+||.. ....+.+..+..+.
T Consensus       146 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~  219 (263)
T d1sm2a_         146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGF  219 (263)
T ss_dssp             C------------------CTTSCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHHHTC
T ss_pred             chheeccCCCceeecceecCcccCChHHhcC-----CCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHHhcC
Confidence            99977654322  223468899999999953     3789999999999999999995 555554 56667777887777


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      .+..|..  +++.+.+||.+||..||+.|  +++.++..
T Consensus       220 ~~~~p~~--~~~~l~~li~~cl~~~p~~R--ps~~~il~  254 (263)
T d1sm2a_         220 RLYKPRL--ASTHVYQIMNHCWKERPEDR--PAFSRLLR  254 (263)
T ss_dssp             CCCCCTT--SCHHHHHHHHHHTCSSGGGS--CCHHHHHH
T ss_pred             CCCCccc--cCHHHHHHHHHHccCCHhHC--cCHHHHHH
Confidence            6666654  79999999999999999843  44544433

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=274.19  Aligned_cols=177  Identities=22%  Similarity=0.323  Sum_probs=147.3

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ..+.+|||||||+ |+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~  155 (277)
T d1xbba_          78 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSK  155 (277)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ccCCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhh
Confidence            3456799999999 599999976 6789999999999999999999999 599999999999999999999999999998


Q ss_pred             cccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      ......    ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+ ....++...+.++..+
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~  229 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECIN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM  229 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC
T ss_pred             hccccccccccccccCCCceecCchhhc-----CCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence            654332    122346889999999994     3368899999999999999998 8999998 4556777777777777


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      .+|..  +|+++.+||.+||..||+.|  +++.++
T Consensus       230 ~~p~~--~~~~~~~li~~cl~~dp~~R--Ps~~~i  260 (277)
T d1xbba_         230 GCPAG--CPREMYDLMNLCWTYDVENR--PGFAAV  260 (277)
T ss_dssp             CCCTT--CCHHHHHHHHHHTCSSTTTS--CCHHHH
T ss_pred             CCCcc--cCHHHHHHHHHHcCCCHhHC--cCHHHH
Confidence            66654  89999999999999999844  344443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-38  Score=272.81  Aligned_cols=193  Identities=25%  Similarity=0.362  Sum_probs=155.8

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.|.+++++|||||||.|.+...+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        67 ~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          67 DAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             EEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCc
Confidence            3577889999999999975555555557789999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--AP  158 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~  158 (296)
                      ++....... ......+|+.|+|||++..    ...++.++|||||||++|+|++|..||.+ ....+.+.++.+.  .+
T Consensus       146 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~-~~~~~~l~~i~~~~~~~  220 (299)
T d1ua2a_         146 LAKSFGSPNRAYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPG-DSDLDQLTRIFETLGTP  220 (299)
T ss_dssp             GGSTTTSCCCCCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHHHCCC
T ss_pred             cccccCCCcccccceecChhhccHHHHcc----CCCCChhhhhhhcchHHHHHHhCcCCCCC-CCHHHHHHHHHHhcCCC
Confidence            997765433 3334578999999999853    23678999999999999999999999988 4555666655431  11


Q ss_pred             CC-----------------CCC------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PC-----------------LPN------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~-----------------~~~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      +.                 .+.      ...+++++.+||.+||..||+        +|.++.+++.|+|+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~--------~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC--------ARITATQALKMKYFSN  285 (299)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT--------TSCCHHHHHTSGGGTS
T ss_pred             ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChh--------hCcCHHHHhCCHhhCC
Confidence            00                 000      123688999999999999998        7778889999998753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=278.25  Aligned_cols=191  Identities=17%  Similarity=0.233  Sum_probs=160.5

Q ss_pred             CCCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC--CCEEEe
Q psy3686           2 SPQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER--GNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~--~~~kl~   78 (296)
                      +.|.+++++|||||||.| +|.+++...+..+++..++.++.||+.||.|||+ +||+||||||+|||++.+  +.+||+
T Consensus        68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             EEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEc
Confidence            357789999999999995 9999997756689999999999999999999999 599999999999999854  589999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++.............+++.|+|||.+.     ...++.++|||||||++|+|++|..||.+ ....+.+.++.++..
T Consensus       147 DFG~~~~~~~~~~~~~~~~t~~y~ape~~~-----~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~  220 (321)
T d1tkia_         147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQ-----HDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEY  220 (321)
T ss_dssp             CCTTCEECCTTCEEEEEESCGGGSCHHHHT-----TCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC
T ss_pred             ccchhhccccCCcccccccccccccchhcc-----CCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC
Confidence            999998776555555568899999999994     34788999999999999999999999998 566677777777654


Q ss_pred             CCCC-CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLP-NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~-~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      .... ....+|+++++||.+||..||.        +|.++.+++.|+|+.
T Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~--------~R~s~~eil~hp~~~  262 (321)
T d1tkia_         221 TFDEEAFKEISIEAMDFVDRLLVKERK--------SRMTASEALQHPWLK  262 (321)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGG--------GSCCHHHHHHSHHHH
T ss_pred             CCChhhccCCCHHHHHHHHHHccCChh--------HCcCHHHHhcCHhhc
Confidence            2211 1234799999999999999998        666777888888764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-38  Score=273.54  Aligned_cols=185  Identities=20%  Similarity=0.248  Sum_probs=150.3

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      +++.+++.+|||||||+ |+|.+++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCCcEEEcc
Confidence            35678889999999999 6999998764 5689999999999999999999999 5999999999999999999999999


Q ss_pred             cCCcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccC
Q psy3686          80 FGISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        80 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      ||+++.......  .....+++.|+|||++.+     ..++.++|||||||++|+|++|..||............+..+.
T Consensus       159 FG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~  233 (287)
T d1opja_         159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY  233 (287)
T ss_dssp             CCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccceeecCCCCceeeccccccccccChHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC
Confidence            999987654322  223357889999999843     3789999999999999999997777665455555555566665


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      .+..+..  +|+.+.+||.+||..||+.|  +++.++..
T Consensus       234 ~~~~~~~--~~~~l~~li~~cl~~dP~~R--ps~~ei~~  268 (287)
T d1opja_         234 RMERPEG--CPEKVYELMRACWQWNPSDR--PSFAEIHQ  268 (287)
T ss_dssp             CCCCCTT--CCHHHHHHHHHHTCSSGGGS--CCHHHHHH
T ss_pred             CCCCCcc--chHHHHHHHHHHcCCCHhHC--cCHHHHHH
Confidence            5555543  89999999999999999833  34554433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=265.19  Aligned_cols=182  Identities=18%  Similarity=0.352  Sum_probs=153.7

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +.+.+++.+|+||||+. |+|..++......+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+||
T Consensus        66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~Df  144 (258)
T d1k2pa_          66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDF  144 (258)
T ss_dssp             EEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCCcEEECcc
Confidence            34677889999999998 69999988777889999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCcc--ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC
Q psy3686          81 GISGRLVDSKA--RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA  157 (296)
Q Consensus        81 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~  157 (296)
                      |++........  .....+|+.|+|||++.+     ..++.++|||||||++|+|+| |+.||.+. ...++...+.++.
T Consensus       145 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~  218 (258)
T d1k2pa_         145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGL  218 (258)
T ss_dssp             SSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTC
T ss_pred             hhheeccCCCceeecccCCCCCcCCcHHhcC-----CCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCC
Confidence            99976654322  223468899999999953     378999999999999999998 89999984 5667777888776


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDK  194 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~  194 (296)
                      .+..|..  +++.+.+||.+||..+|+.||  +++++
T Consensus       219 ~~~~p~~--~~~~l~~li~~cl~~dP~~RP--t~~ei  251 (258)
T d1k2pa_         219 RLYRPHL--ASEKVYTIMYSCWHEKADERP--TFKIL  251 (258)
T ss_dssp             CCCCCTT--CCHHHHHHHHHTTCSSGGGSC--CHHHH
T ss_pred             CCCCccc--ccHHHHHHHHHHccCCHhHCc--CHHHH
Confidence            6666554  799999999999999998443  44443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-38  Score=277.01  Aligned_cols=186  Identities=24%  Similarity=0.321  Sum_probs=149.4

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC---CCCEEEeccC
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---RGNIKLCDFG   81 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~---~~~~kl~dfg   81 (296)
                      ++.+|||||||+ |+|.+++.+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.   .+.+||+|||
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccc
Confidence            578999999998 5999999864 3579999999999999999999999 59999999999999975   4679999999


Q ss_pred             CcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHH---HccCC
Q psy3686          82 ISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRV---LNDAP  158 (296)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i---~~~~~  158 (296)
                      +++............||+.|+|||++.+     ..|+.++|||||||++|+|++|..||.+.... .....+   .....
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQ  233 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCG-----GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCS
T ss_pred             eeeeccCCCccccccCCcccCCcHHHcC-----CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-HHHHHHHHHHhcCC
Confidence            9987766666666789999999999953     36899999999999999999999999873322 222222   12222


Q ss_pred             CCCCCC--cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 PCLPND--PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p~~~~~--~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      ..+|..  ..+|+++++||.+||..||+        .|.++.+++.++|+.
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~--------~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPT--------QRMTITEFMNHPWIM  276 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTT--------TSCCHHHHHHSHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChh--------HCcCHHHHHcCHHhh
Confidence            233322  34899999999999999998        666677888887764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-38  Score=269.78  Aligned_cols=180  Identities=21%  Similarity=0.302  Sum_probs=147.8

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .++.+|||||||+ |+|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             CSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccce
Confidence            4567899999999 6999977543 3469999999999999999999999 59999999999999999999999999999


Q ss_pred             ccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          84 GRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        84 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      +......  ......+++.|+|||++.     ...++.++|||||||++|+|+||..|+.......+.+..+..+..+..
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~  231 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR  231 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             EEccCCccccccccCCcccccChHHHh-----CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            8765432  233447889999999994     336889999999999999999966555544667777888888776666


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      |..  +++.+.+||.+||..+|+.|  +++.++.
T Consensus       232 p~~--~~~~l~~li~~cl~~~P~~R--pt~~ei~  261 (272)
T d1qpca_         232 PDN--CPEELYQLMRLCWKERPEDR--PTFDYLR  261 (272)
T ss_dssp             CTT--CCHHHHHHHHHHTCSSGGGS--CCHHHHH
T ss_pred             ccc--ChHHHHHHHHHHcCCCHhHC--cCHHHHH
Confidence            654  89999999999999999833  3444443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-38  Score=271.64  Aligned_cols=184  Identities=21%  Similarity=0.311  Sum_probs=144.0

Q ss_pred             CccCCeEEEEecCcc-ccHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q psy3686           4 QSKESDVWICMELMA-TCFDRLLKRL---------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNI   67 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~-gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Ni   67 (296)
                      +.+++.+|+|||||+ |+|.+++...               ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NI  165 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  165 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccce
Confidence            345667999999999 6999999753               2358999999999999999999999 5999999999999


Q ss_pred             EECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q psy3686          68 LLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG-EFPYKDC  143 (296)
Q Consensus        68 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g-~~Pf~~~  143 (296)
                      |++.++.+||+|||+++......   ......||+.|+|||++.+     ..++.++|||||||++|+|++| ..||.+.
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999997654332   2334578999999999953     3789999999999999999986 5688876


Q ss_pred             CCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         144 KCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       144 ~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                      .........+..+..+..+..  +++++.++|.+||..||+.|  +++.++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~R--pt~~eil~~  290 (299)
T d1ywna1         241 KIDEEFCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQR--PTFSELVEH  290 (299)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTT--CCHHHHHHHHHHTCSSGGGS--CCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCcc--CCHHHHHHHHHHcCCChhHC--cCHHHHHHH
Confidence            666666666677776666654  79999999999999999833  344444433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=267.31  Aligned_cols=185  Identities=22%  Similarity=0.233  Sum_probs=146.9

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      +++.+++.+|+|||||. |+|.+++......+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus        76 g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DF  154 (283)
T d1mqba_          76 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDF  154 (283)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEccc
Confidence            34567889999999999 59999888777889999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc
Q psy3686          81 GISGRLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND  156 (296)
Q Consensus        81 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~  156 (296)
                      |+++......    ......+|+.|+|||++.     ...++.++|||||||++|+|++|..||.......+.+..+..+
T Consensus       155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~  229 (283)
T d1mqba_         155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  229 (283)
T ss_dssp             CC-----------------CCCGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             chhhcccCCCccceEeccCCCCccccCHHHHc-----cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence            9998764332    222346789999999994     3478999999999999999999766665546666777777777


Q ss_pred             CCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         157 APPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       157 ~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      ..+..+..  ++..+.+||.+||..+|+.||  ++.++..
T Consensus       230 ~~~~~~~~--~~~~l~~li~~cl~~~p~~RP--t~~eil~  265 (283)
T d1mqba_         230 FRLPTPMD--CPSAIYQLMMQCWQQERARRP--KFADIVS  265 (283)
T ss_dssp             CCCCCCTT--CBHHHHHHHHHHTCSSTTTSC--CHHHHHH
T ss_pred             CCCCCchh--hHHHHHHHHHHHCcCCHhHCc--CHHHHHH
Confidence            76666554  799999999999999998443  4444433

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-37  Score=264.89  Aligned_cols=172  Identities=27%  Similarity=0.450  Sum_probs=136.8

Q ss_pred             CeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcccc
Q psy3686           8 SDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRL   86 (296)
Q Consensus         8 ~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~   86 (296)
                      ..+|||||||+| +|.+++.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++|+|||.+...
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhh
Confidence            358999999995 99999876 5789999999999999999999999 59999999999999999999999999988655


Q ss_pred             cCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC-CCC
Q psy3686          87 VDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP-PCL  161 (296)
Q Consensus        87 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~-p~~  161 (296)
                      ....    ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+ ....+.+.+++...+ +..
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPS  235 (277)
T ss_dssp             C----------------TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCCCCGG
T ss_pred             ccccccccccccccCcccccCHHHHcC-----CCCCcceecccchHHHHHHHhCCCCCCC-cCHHHHHHHHHhcCCCCCc
Confidence            4322    2334578999999999954     3688999999999999999999999988 455566666655443 222


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      .....+|+.+.+||.+||.+||+.|+
T Consensus       236 ~~~~~~s~~l~~li~~~L~~dp~~R~  261 (277)
T d1o6ya_         236 ARHEGLSADLDAVVLKALAKNPENRY  261 (277)
T ss_dssp             GTSSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hhccCCCHHHHHHHHHHccCCHhHCH
Confidence            33445899999999999999998443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=266.50  Aligned_cols=180  Identities=25%  Similarity=0.377  Sum_probs=141.3

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .++.+|||||||. |+|.+++......+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus        78 ~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          78 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             ecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhhe
Confidence            4578999999999 59999988777889999999999999999999999 599999999999999999999999999998


Q ss_pred             cccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          85 RLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        85 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ......  ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+ ....+....+..+..+.+
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~-----~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~~  230 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLPM  230 (273)
T ss_dssp             --------------CCGGGCCHHHHH-----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCCC
T ss_pred             eccCCcceeccceecCcccchhhHhc-----cCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCCC
Confidence            765332  223346789999999994     3478899999999999999998 8999987 455677778888776666


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      +..  +|+.+.+||.+||..||+.|  +++.++..
T Consensus       231 ~~~--~~~~~~~li~~cl~~dp~~R--ps~~ei~~  261 (273)
T d1mp8a_         231 PPN--CPPTLYSLMTKCWAYDPSRR--PRFTELKA  261 (273)
T ss_dssp             CTT--CCHHHHHHHHHHTCSSGGGS--CCHHHHHH
T ss_pred             CCC--CCHHHHHHHHHHcCCCHhHC--cCHHHHHH
Confidence            544  89999999999999999843  34444433

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=263.67  Aligned_cols=188  Identities=23%  Similarity=0.321  Sum_probs=153.2

Q ss_pred             cCCeEEEEecCcccc-HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMATC-FDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~gs-L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+..+|++||||.|. +..........+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            456899999999974 444444446789999999999999999999999 599999999999999999999999999998


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--CCC---
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--APP---  159 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~~p---  159 (296)
                      ............||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+ ....+.+..+...  .+.   
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~-----~~y~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFRG-SSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhcccccCCCcccChhhcCcchhcC-----CCCChhehhhchHHHHHHHHHCCCCCCC-CCHHHHHHHHHHhhCCCchhc
Confidence            7665556666789999999999953     3789999999999999999999999988 4555555555431  100   


Q ss_pred             -------------------CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         160 -------------------CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       160 -------------------~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                         .......+++.+.+||.+||..||+        +|.++.+++.|+|++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~--------~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA--------KRISAYSALSHPYFQD  298 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT--------TSCCHHHHHTSGGGTT
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh--------HCcCHHHHhcChhhcC
Confidence                               0001123789999999999999998        7778889999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-37  Score=261.90  Aligned_cols=182  Identities=23%  Similarity=0.324  Sum_probs=149.1

Q ss_pred             CCCccCCeEEEEecCcc--ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-CCCEEEe
Q psy3686           2 SPQSKESDVWICMELMA--TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-RGNIKLC   78 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~--gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-~~~~kl~   78 (296)
                      ++|.+++.+|+||||+.  +++.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          76 DWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence            35778899999999997  388888876 5789999999999999999999999 59999999999999985 4789999


Q ss_pred             ccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC
Q psy3686          79 DFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP  158 (296)
Q Consensus        79 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~  158 (296)
                      |||++...... ......||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||...       ..+.++..
T Consensus       154 DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~----~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~i~~~~~  221 (273)
T d1xwsa_         154 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH----RYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQV  221 (273)
T ss_dssp             CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHS----CBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHCCC
T ss_pred             ccccceecccc-cccccccCCCcCCHHHHcCC----CCCCcccccccceeeehhHhhCCCCCCCc-------hHHhhccc
Confidence            99999765433 33456899999999998532    23467899999999999999999999862       12334332


Q ss_pred             CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                       .++.  .+|+++++||.+||..||+        +|.++.+++.++|++.
T Consensus       222 -~~~~--~~s~~~~~li~~~L~~dp~--------~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         222 -FFRQ--RVSSECQHLIRWCLALRPS--------DRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             -CCSS--CCCHHHHHHHHHHTCSSGG--------GSCCHHHHHTSGGGSS
T ss_pred             -CCCC--CCCHHHHHHHHHHccCCHh--------HCcCHHHHhcCHhhCC
Confidence             3333  3899999999999999998        6667888888888753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=263.42  Aligned_cols=183  Identities=19%  Similarity=0.286  Sum_probs=151.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLH---------------VSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSN   66 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~N   66 (296)
                      .+.+++.+|+|||||. |+|.+++....               ..+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N  165 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  165 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence            4667889999999999 69999997542               458999999999999999999999 599999999999


Q ss_pred             EEECCCCCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3686          67 ILLDERGNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKD  142 (296)
Q Consensus        67 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~  142 (296)
                      ||++.++.+||+|||++........   .....+++.|+|||.+.     ...|+.++|||||||++|+|++ |..||.+
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-----~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-----CCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            9999999999999999986654322   23347888999999994     3478999999999999999998 7888887


Q ss_pred             CCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         143 CKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       143 ~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                       .....++..+..+..+..|..  +++.+.+||.+||+.+|+.|  +++.++.+
T Consensus       241 -~~~~~~~~~i~~~~~~~~p~~--~~~~l~~li~~cl~~dP~~R--ps~~eil~  289 (299)
T d1fgka_         241 -VPVEELFKLLKEGHRMDKPSN--CTNELYMMMRDCWHAVPSQR--PTFKQLVE  289 (299)
T ss_dssp             -CCHHHHHHHHHTTCCCCCCSS--CCHHHHHHHHHHTCSSGGGS--CCHHHHHH
T ss_pred             -CCHHHHHHHHHcCCCCCCCcc--chHHHHHHHHHHccCCHhHC--cCHHHHHH
Confidence             455566677777776666654  89999999999999999833  34444433

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-36  Score=260.49  Aligned_cols=194  Identities=21%  Similarity=0.390  Sum_probs=155.3

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEecc
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDF   80 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~df   80 (296)
                      ++|.+++.+|||||||.|++..++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DF  146 (298)
T d1gz8a_          68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADF  146 (298)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECST
T ss_pred             cccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccC
Confidence            457788999999999998766666443 6679999999999999999999999 59999999999999999999999999


Q ss_pred             CCcccccCC-ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHcc--C
Q psy3686          81 GISGRLVDS-KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLND--A  157 (296)
Q Consensus        81 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~--~  157 (296)
                      |++...... .......+|+.|+|||.+..    ...++.++|||||||++|+|++|+.||.+ .+....+.++.+.  .
T Consensus       147 G~a~~~~~~~~~~~~~~gt~~y~apE~~~~----~~~~~~~~DiwSlGvily~m~~G~~Pf~~-~~~~~~~~~i~~~~~~  221 (298)
T d1gz8a_         147 GLARAFGVPVRTYTHEVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPG-DSEIDQLFRIFRTLGT  221 (298)
T ss_dssp             THHHHHCCCSBCTTCCBCCCTTCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCC
T ss_pred             CcceeccCCcccceeecccceeeehhhhcc----ccCCCccccccccchhhhHHhhCCCCCCC-CCHHHHHHHHHHhcCC
Confidence            999776543 33445589999999999853    23567899999999999999999999987 4444555554331  1


Q ss_pred             CCC---------------CCC---------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 PPC---------------LPN---------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ~p~---------------~~~---------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                      +..               ++.         ...+|.++++||.+||..||.        +|.++.+++.|+|++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~--------~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN--------KRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTT--------TSCCHHHHHTSGGGTTC
T ss_pred             CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChh--------HCcCHHHHhCCHhhccC
Confidence            110               000         123678999999999999998        77788889999887543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-36  Score=261.16  Aligned_cols=180  Identities=24%  Similarity=0.298  Sum_probs=142.5

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      .++.+|+|||||. |+|..++... ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++
T Consensus        82 ~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          82 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             CSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             ecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCCcEEEcccchh
Confidence            3456899999999 5898887654 4679999999999999999999999 59999999999999999999999999999


Q ss_pred             ccccCCc--cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          84 GRLVDSK--ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        84 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      +......  ......+++.|+|||.+.     ...++.++|||||||++|+|++|..||.......+.+..+.++..+..
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~  235 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  235 (285)
T ss_dssp             C--------------CCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             hhccCCCceeeccccccccccChHHHh-----CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            7654332  223346889999999994     347889999999999999999976666555677777877877766555


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      +.  .++..+++||.+||..||+.|  ++++++.
T Consensus       236 ~~--~~~~~l~~li~~cl~~dP~~R--ps~~~i~  265 (285)
T d1fmka3         236 PP--ECPESLHDLMCQCWRKEPEER--PTFEYLQ  265 (285)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGS--CCHHHHH
T ss_pred             Cc--ccCHHHHHHHHHHcccCHhHC--cCHHHHH
Confidence            54  389999999999999999833  4455543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-36  Score=264.78  Aligned_cols=185  Identities=18%  Similarity=0.250  Sum_probs=152.7

Q ss_pred             CCCccCCeEEEEecCcc-ccHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q psy3686           2 SPQSKESDVWICMELMA-TCFDRLLKRL---------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPS   65 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~   65 (296)
                      +++.+++.+|||||||+ |+|.+++...               ...+++..++.++.||+.||.|||+ +||+||||||+
T Consensus        78 ~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~  156 (309)
T d1fvra_          78 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAAR  156 (309)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGG
T ss_pred             EEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccc
Confidence            35678899999999999 5999999753               3679999999999999999999999 59999999999


Q ss_pred             cEEECCCCCEEEeccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCC
Q psy3686          66 NILLDERGNIKLCDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGE-FPYKDCK  144 (296)
Q Consensus        66 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~-~Pf~~~~  144 (296)
                      |||++.++.+||+|||++.............+|..|+|||.+.     ...++.++|||||||++|+|++|. .||.+ .
T Consensus       157 NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~  230 (309)
T d1fvra_         157 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-M  230 (309)
T ss_dssp             GEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTT-C
T ss_pred             eEEEcCCCceEEccccccccccccccccceecCCcccchHHhc-----cCCCCccceeehhHHHHHHHHhcCCCCCCC-C
Confidence            9999999999999999997665544444557899999999994     347899999999999999999965 56766 5


Q ss_pred             CcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccch
Q psy3686         145 CDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTC  197 (296)
Q Consensus       145 ~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~  197 (296)
                      ...+....+.++..+..+..  +++.+++||.+||..||+  .|+++.++...
T Consensus       231 ~~~~~~~~i~~~~~~~~~~~--~~~~~~~li~~cl~~dP~--~RPs~~eil~~  279 (309)
T d1fvra_         231 TCAELYEKLPQGYRLEKPLN--CDDEVYDLMRQCWREKPY--ERPSFAQILVS  279 (309)
T ss_dssp             CHHHHHHHGGGTCCCCCCTT--BCHHHHHHHHHHTCSSGG--GSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCcc--CCHHHHHHHHHHcCCChh--HCcCHHHHHHH
Confidence            66677778888777666654  899999999999999998  33455555444

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-35  Score=260.48  Aligned_cols=191  Identities=24%  Similarity=0.352  Sum_probs=151.8

Q ss_pred             ccCCeEEEEecCccccHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEecc
Q psy3686           5 SKESDVWICMELMATCFDRLLKR---LHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCDF   80 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~df   80 (296)
                      .+..++|||||||+|++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecc
Confidence            34567899999999765555432   26689999999999999999999999 5999999999999999775 8999999


Q ss_pred             CCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cC-
Q psy3686          81 GISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DA-  157 (296)
Q Consensus        81 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~-  157 (296)
                      |++.............++..|+|||.+.+    ...++.++||||+||++|+|++|..||... ...+.+..+.+  +. 
T Consensus       168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DIwSlG~il~el~~g~~pf~~~-~~~~~l~~i~~~~g~~  242 (350)
T d1q5ka_         168 GSAKQLVRGEPNVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGD-SGVDQLVEIIKVLGTP  242 (350)
T ss_dssp             TTCEECCTTSCCCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCC
T ss_pred             cchhhccCCcccccccccccccChHHhhc----ccCCCcceeecccceEEEehhhCCCCCCCC-CHHHHHHHHHHHhCCC
Confidence            99987766665666789999999998853    336889999999999999999999999873 44444444432  11 


Q ss_pred             ----------------CCCCC-------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         158 ----------------PPCLP-------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       158 ----------------~p~~~-------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                      .+...       ....+++++.+||.+||..||+        +|.++.+++.|+|+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~--------~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT--------ARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGG--------GSCCHHHHHTSGGGGGG
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChh--------HCcCHHHHhcCHhhccc
Confidence                            01110       1124789999999999999998        77778888999887543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-36  Score=257.99  Aligned_cols=178  Identities=20%  Similarity=0.295  Sum_probs=144.2

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ++.+++|||||. |+|.+++......+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          82 TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhhh
Confidence            457899999999 69999888777889999999999999999999999 5999999999999999999999999999987


Q ss_pred             ccCCcc----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccC-CC
Q psy3686          86 LVDSKA----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDA-PP  159 (296)
Q Consensus        86 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~-~p  159 (296)
                      ......    .....++..|+|||++.     ...++.++|||||||++|+|++ |..||.+ .+..+....+.+.. .+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~  234 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERL  234 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHh-----CCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCC
Confidence            644322    22335778999999995     3378899999999999999998 8999988 45556666665543 33


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      ..+  ..+|+.+.+||.+||..||+.|  +++.++.
T Consensus       235 ~~~--~~~~~~l~~li~~cl~~dp~~R--Pt~~ei~  266 (273)
T d1u46a_         235 PRP--EDCPQDIYNVMVQCWAHKPEDR--PTFVALR  266 (273)
T ss_dssp             CCC--TTCCHHHHHHHHHHTCSSGGGS--CCHHHHH
T ss_pred             CCc--ccccHHHHHHHHHHcCCChhHC--cCHHHHH
Confidence            333  3489999999999999999844  4555543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-36  Score=262.45  Aligned_cols=179  Identities=22%  Similarity=0.291  Sum_probs=144.6

Q ss_pred             CCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           7 ESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         7 ~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ++..++|||++. |+|.+++......+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          82 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             cCCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCCCeEeecccccee
Confidence            345677777777 69999988878899999999999999999999999 5999999999999999999999999999987


Q ss_pred             ccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCC
Q psy3686          86 LVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCL  161 (296)
Q Consensus        86 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~  161 (296)
                      ......   .....+|+.|+|||++.+     ..++.++|||||||++|+|+| |..||.+ ....++...+..+..+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~~  234 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLPQ  234 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCCC
T ss_pred             cccccccccccccccCccccChHHHhc-----CCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCCC
Confidence            654322   223367899999999953     378999999999999999998 8899987 344556666777766655


Q ss_pred             CCCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         162 PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       162 ~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      |..  +++.+.+||.+||..+|..|  +++.++..
T Consensus       235 p~~--~~~~~~~li~~cl~~dP~~R--Ps~~eil~  265 (317)
T d1xkka_         235 PPI--CTIDVYMIMVKCWMIDADSR--PKFRELII  265 (317)
T ss_dssp             CTT--BCHHHHHHHHHHTCSSGGGS--CCHHHHHH
T ss_pred             Ccc--cCHHHHHHHHHhCCCChhhC--cCHHHHHH
Confidence            543  89999999999999999833  44444433

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-35  Score=254.91  Aligned_cols=192  Identities=18%  Similarity=0.297  Sum_probs=150.9

Q ss_pred             CCCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           2 SPQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         2 ~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      +.|.+++.+|+|||++.|++...+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        67 ~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             EEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             eecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccc
Confidence            3577889999999999986666666657889999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCcc-ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC
Q psy3686          82 ISGRLVDSKA-RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP  158 (296)
Q Consensus        82 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~  158 (296)
                      .+........ .....+++.|+|||.+.+    ...++.++|||||||++|+|++|+.||.+. ...+.+.++..  +.+
T Consensus       146 ~a~~~~~~~~~~~~~~~~~~y~~pE~~~~----~~~~~~~~DiwslGv~l~el~~G~~pf~~~-~~~~~~~~i~~~~~~~  220 (286)
T d1ob3a_         146 LARAFGIPVRKYTHEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLMRIFRILGTP  220 (286)
T ss_dssp             HHHHHCC---------CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCC
T ss_pred             cceecccCccccceecccchhhhHHHHhC----CCCCCcceeehhcCcHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCC
Confidence            9987654432 233468899999999963    336789999999999999999999999873 44455554432  110


Q ss_pred             C--CC----------------------CCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         159 P--CL----------------------PNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       159 p--~~----------------------~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                      +  .+                      .....+++.+.+||++||..||+        +|.++.+++.|+|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~--------~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN--------QRITAKQALEHAYFK  285 (286)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT--------TSCCHHHHHTSGGGG
T ss_pred             ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChh--------HCcCHHHHhcCcccC
Confidence            0  00                      01123689999999999999998        677788888888764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-36  Score=259.98  Aligned_cols=182  Identities=21%  Similarity=0.271  Sum_probs=149.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCce
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-----------------------HVSVPEPICGKITLSTVKALHYLKETHGVI   58 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~iv   58 (296)
                      ++.+.+.+++||||+. |+|.+++...                       ...+++..++.++.||+.||+|||+ +|++
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iv  162 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFV  162 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCC
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeE
Confidence            4567889999999999 6999999753                       2348999999999999999999999 5999


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy3686          59 HRDVKPSNILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT  135 (296)
Q Consensus        59 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~  135 (296)
                      ||||||+|||++.++.+||+|||+++......   ......+++.|+|||.+.     ...++.++|||||||++|+|++
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-----cCCCChhhhhccchhhHHHHHc
Confidence            99999999999999999999999997654332   223446888999999995     3478999999999999999999


Q ss_pred             CC-CCCCCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         136 GE-FPYKDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       136 g~-~Pf~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      |. .||.+ ....+....+..+..+..|..  +++++.+||.+||..+|+.|  +++.++.
T Consensus       238 ~~~~p~~~-~~~~e~~~~v~~~~~~~~p~~--~~~~~~~li~~cl~~~P~~R--Pt~~ev~  293 (301)
T d1lufa_         238 YGLQPYYG-MAHEEVIYYVRDGNILACPEN--CPLELYNLMRLCWSKLPADR--PSFCSIH  293 (301)
T ss_dssp             TTCCTTTT-SCHHHHHHHHHTTCCCCCCTT--CCHHHHHHHHHHTCSSGGGS--CCHHHHH
T ss_pred             cCCCCCCC-CCHHHHHHHHHcCCCCCCCcc--chHHHHHHHHHHcCCChhHC--cCHHHHH
Confidence            85 56776 567778888888877766654  79999999999999999844  3454443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=260.45  Aligned_cols=196  Identities=24%  Similarity=0.291  Sum_probs=152.6

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .+.+...+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeccCCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCCCEEEeecc
Confidence            4678889999999999 599999987 5688999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCC--ccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CcHHHHHHHHccC
Q psy3686          82 ISGRLVDS--KARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCK--CDFEVLSRVLNDA  157 (296)
Q Consensus        82 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~--~~~~~~~~i~~~~  157 (296)
                      ++..+...  .......+++.|++||.+.+.   ...++.++|||||||++|+|++|..||.+..  .....+.......
T Consensus       175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~---~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         175 LSKEFVADETERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             chhhhcccccccccccccccccchhHHhhcC---CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            99766433  223445789999999999642   2357789999999999999999999997642  2223333333233


Q ss_pred             CCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         158 PPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       158 ~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      .+.++.  .+|+.+.+||.+||..||..|+...   ..++.+++.|+|++.
T Consensus       252 ~~~~~~--~~s~~~~~li~~~l~~dP~~R~s~~---~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         252 EPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCG---PRDADEIKEHLFFQK  297 (322)
T ss_dssp             CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSS---TTTHHHHHTSGGGTT
T ss_pred             CCCCcc--cCCHHHHHHHHHHcccCHHHcCCCC---cccHHHHHcCHhhcC
Confidence            344444  3899999999999999998443321   123566778888753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-36  Score=253.89  Aligned_cols=178  Identities=22%  Similarity=0.361  Sum_probs=141.0

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRL-HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~   83 (296)
                      +++.+||||||++ |+|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             cCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCCCEeecccccc
Confidence            3467899999998 6999999754 3469999999999999999999999 59999999999999999999999999999


Q ss_pred             ccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcHHHHHHHHccCCCCCC
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPYKDCKCDFEVLSRVLNDAPPCLP  162 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~i~~~~~p~~~  162 (296)
                      +.....  .....++..|+|||.+.+     ..++.++|||||||++|+|++ |..||.. ....++...+.++..+.++
T Consensus       151 ~~~~~~--~~~~~~~~~y~aPE~l~~-----~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~~~  222 (262)
T d1byga_         151 KEASST--QDTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMDAP  222 (262)
T ss_dssp             -------------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCCCC
T ss_pred             eecCCC--CccccccccCCChHHHhC-----CCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCCCC
Confidence            765433  233467889999999943     378999999999999999998 7888877 4555677777777777776


Q ss_pred             CCcchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         163 NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       163 ~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                      ..  +++.+.+||.+||..||..  |+++.++.+
T Consensus       223 ~~--~~~~~~~li~~cl~~dP~~--Rps~~~l~~  252 (262)
T d1byga_         223 DG--CPPAVYEVMKNCWHLDAAM--RPSFLQLRE  252 (262)
T ss_dssp             TT--CCHHHHHHHHHHTCSSGGG--SCCHHHHHH
T ss_pred             cc--CCHHHHHHHHHHcccCHhH--CcCHHHHHH
Confidence            64  7999999999999999983  344545443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=258.05  Aligned_cols=184  Identities=20%  Similarity=0.296  Sum_probs=149.8

Q ss_pred             cCCeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           6 KESDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         6 ~~~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .++.+|+|||||. |+|.+++......+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~  178 (311)
T d1r0pa_         100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLAR  178 (311)
T ss_dssp             TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred             cCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchh
Confidence            4678999999999 59999998777788999999999999999999999 599999999999999999999999999998


Q ss_pred             cccCCcc-----ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCCC
Q psy3686          85 RLVDSKA-----RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAPP  159 (296)
Q Consensus        85 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~p  159 (296)
                      .......     .....+|..|+|||.+.     ...++.++||||||+++|+|++|..||.......+....+..+..+
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~  253 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL  253 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC
T ss_pred             hccccccccceecccccccccccChHHHh-----cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            6543321     22246789999999984     3478999999999999999999888887755666677778888777


Q ss_pred             CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhh
Q psy3686         160 CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYE  199 (296)
Q Consensus       160 ~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~  199 (296)
                      ..|..  +++.+.+||.+||..||+  .|+++.++...++
T Consensus       254 ~~p~~--~~~~l~~li~~cl~~dP~--~RPs~~ei~~~L~  289 (311)
T d1r0pa_         254 LQPEY--CPDPLYEVMLKCWHPKAE--MRPSFSELVSRIS  289 (311)
T ss_dssp             CCCTT--CCHHHHHHHHHHTCSSGG--GSCCHHHHHHHHH
T ss_pred             CCccc--CcHHHHHHHHHHcCCCHh--HCcCHHHHHHHHH
Confidence            76654  799999999999999998  4455555554443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-34  Score=253.28  Aligned_cols=185  Identities=25%  Similarity=0.366  Sum_probs=149.0

Q ss_pred             cCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccc
Q psy3686           6 KESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGR   85 (296)
Q Consensus         6 ~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~   85 (296)
                      ...++|||||||+++|..+++.  ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus        94 ~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          94 DFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             TCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcccccccccccccceec
Confidence            3447899999998899998874  689999999999999999999999 5999999999999999999999999999977


Q ss_pred             ccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC-----
Q psy3686          86 LVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP-----  158 (296)
Q Consensus        86 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~-----  158 (296)
                      ....  .....+|+.|+|||++.+    ...++.++||||+||++|+|++|..||.+. .....+..+..  +.+     
T Consensus       171 ~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         171 ADSE--MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGS-DHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCHHHH
T ss_pred             cCCc--cccccccccccCHHHHcC----CCCCCccchhhcchHHHHHHHHCcCCCCCC-ChHHHHHHHHhccCCCcHHHH
Confidence            6433  344578999999999853    235788999999999999999999999884 33333333222  110     


Q ss_pred             ---------------CCCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         159 ---------------PCLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       159 ---------------p~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                                     +...      ....+++.+.+||.+||..||.        .|.++.+++.|+|+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~--------~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE--------QRVTAGEALAHPYFES  306 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT--------TSCCHHHHHHSGGGTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChh--------HCcCHHHHhcChhhCc
Confidence                           0111      1123689999999999999998        7778889999988754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=254.49  Aligned_cols=183  Identities=21%  Similarity=0.288  Sum_probs=146.2

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh-----------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL-----------------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKP   64 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~-----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp   64 (296)
                      .+.+++.+|||||||+ |+|.+++...                 ...+++..+..++.||+.||+|||+ +|++||||||
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp  173 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAA  173 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccc
Confidence            4567788999999999 5999999763                 2369999999999999999999999 5999999999


Q ss_pred             CcEEECCCCCEEEeccCCcccccCCc---cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3686          65 SNILLDERGNIKLCDFGISGRLVDSK---ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELAT-GEFPY  140 (296)
Q Consensus        65 ~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf  140 (296)
                      +||+++.++.++++|||.++......   ......+|+.|+|||.+.     ...++.++|||||||++|+|++ |.+||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-----CCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            99999999999999999998765332   223347899999999994     3478999999999999999999 66666


Q ss_pred             CCCCCcHHHHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCcc
Q psy3686         141 KDCKCDFEVLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKS  195 (296)
Q Consensus       141 ~~~~~~~~~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~  195 (296)
                      ............+..+..+..+..  ++..+.+||.+||..||+.|  +++.++.
T Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~--~~~~l~~Li~~cl~~dP~~R--Ps~~~il  299 (311)
T d1t46a_         249 PGMPVDSKFYKMIKEGFRMLSPEH--APAEMYDIMKTCWDADPLKR--PTFKQIV  299 (311)
T ss_dssp             TTCCSSHHHHHHHHHTCCCCCCTT--SCHHHHHHHHHHTCSSGGGS--CCHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCCCCccc--ccHHHHHHHHHHcCCChhHC--cCHHHHH
Confidence            664444444444455555555543  79999999999999999833  4444443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-34  Score=250.12  Aligned_cols=190  Identities=17%  Similarity=0.244  Sum_probs=146.8

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ..++.+|+|||||.+.+..........+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCCcEEeeecceee
Confidence            4467899999999976666665557889999999999999999999999 599999999999999999999999999997


Q ss_pred             cccCCc-----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc---c
Q psy3686          85 RLVDSK-----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---D  156 (296)
Q Consensus        85 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~---~  156 (296)
                      ......     ......+|+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+ .........+..   .
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~~~~k~DiwSlGvil~el~~g~~pf~~-~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQLCGS  240 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcC----CCCCCcHHHcccCCceeeeHhhCCCCCCC-CCHHHHHHHHHHhcCC
Confidence            654321     2233478999999999863    23688999999999999999999999987 344444444332   1


Q ss_pred             CCCCCCCC--------------------------cchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         157 APPCLPND--------------------------PLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       157 ~~p~~~~~--------------------------~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                      ..+.....                          ...++.+.+||.+||..||+        .|.++.+++.|+|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~--------~R~sa~elL~Hpff~~  310 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA--------QRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT--------TSCCHHHHHHSGGGSS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh--------HCcCHHHHHcChhhcc
Confidence            11111000                          01267888999999999998        8888999999998753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-34  Score=250.71  Aligned_cols=187  Identities=23%  Similarity=0.336  Sum_probs=146.5

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .....+||+|++++|+|.+++..  ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            34456788888887899999975  579999999999999999999999 599999999999999999999999999997


Q ss_pred             cccCCc----cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc-cCCC
Q psy3686          85 RLVDSK----ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN-DAPP  159 (296)
Q Consensus        85 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~-~~~p  159 (296)
                      ......    ......+++.|+|||++..    ...++.++||||+||++|+|++|+.||.+.. .......... ...+
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~eml~g~~pf~~~~-~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-YLDQLNHILGILGSP  232 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTT----BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSC
T ss_pred             eccCCCccceeeccccccceechHHHhhc----CCCCCchhhhhccCceehHHhhCCCCCCCCC-HHHHHHHHhhhccCC
Confidence            654332    2334578999999999853    2367889999999999999999999998743 2222222211 0000


Q ss_pred             ---------------------CCC------CCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccc
Q psy3686         160 ---------------------CLP------NDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLS  207 (296)
Q Consensus       160 ---------------------~~~------~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~  207 (296)
                                           ...      ....+++.+.+||.+||..||.        .|.++.++++++|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~--------~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH--------KRIEVEQALAHPYLE  299 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTT--------TSCCHHHHHTSGGGT
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChh--------HCcCHHHHhcCHhhc
Confidence                                 000      1123688999999999999998        777888888888764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-34  Score=250.42  Aligned_cols=185  Identities=21%  Similarity=0.303  Sum_probs=152.1

Q ss_pred             CCccCCeEEEEecCcc-ccHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCC
Q psy3686           3 PQSKESDVWICMELMA-TCFDRLLKRL---------HVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDER   72 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~-gsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~   72 (296)
                      .+..++.+++|||||. |+|.+++...         ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTT
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCC
Confidence            4567788999999999 6999998754         2457999999999999999999999 599999999999999999


Q ss_pred             CCEEEeccCCcccccCCcc---ccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCcHH
Q psy3686          73 GNIKLCDFGISGRLVDSKA---RTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATG-EFPYKDCKCDFE  148 (296)
Q Consensus        73 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g-~~Pf~~~~~~~~  148 (296)
                      +++||+|||+++.......   .....+++.|+|||.+.     ...++.++|||||||++|+|++| ..||.+ ....+
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-----~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~  243 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQ  243 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHc-----cCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHH
Confidence            9999999999976644322   23346889999999994     34788899999999999999997 477776 56677


Q ss_pred             HHHHHHccCCCCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchh
Q psy3686         149 VLSRVLNDAPPCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCY  198 (296)
Q Consensus       149 ~~~~i~~~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~  198 (296)
                      .+..+.++..+..+..  +++.+.++|.+||+.+|+.|  +++.++...+
T Consensus       244 ~~~~i~~~~~~~~p~~--~~~~l~~li~~cl~~~P~~R--Ps~~~il~~L  289 (308)
T d1p4oa_         244 VLRFVMEGGLLDKPDN--CPDMLFELMRMCWQYNPKMR--PSFLEIISSI  289 (308)
T ss_dssp             HHHHHHTTCCCCCCTT--CCHHHHHHHHHHTCSSGGGS--CCHHHHHHHH
T ss_pred             HHHHHHhCCCCCCccc--chHHHHHHHHHHcCCChhHC--cCHHHHHHHH
Confidence            7888888777666554  79999999999999999844  4555554443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-34  Score=250.96  Aligned_cols=175  Identities=18%  Similarity=0.253  Sum_probs=137.7

Q ss_pred             CccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC---CCCEEEecc
Q psy3686           4 QSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE---RGNIKLCDF   80 (296)
Q Consensus         4 ~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~---~~~~kl~df   80 (296)
                      +.+++.+|+||||++|+|...+......+++..+..++.|++.||+|||+ +||+||||||+|||++.   +..++|+||
T Consensus        72 ~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeecc
Confidence            46778899999999998888887778899999999999999999999999 59999999999999864   457999999


Q ss_pred             CCcccccCCc--------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHH--H
Q psy3686          81 GISGRLVDSK--------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEV--L  150 (296)
Q Consensus        81 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~  150 (296)
                      |+++.+....        ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.........  .
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-----BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhC-----CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence            9998765432        1234479999999999954     36899999999999999999999999874332211  1


Q ss_pred             HHHHc----cCCCCCCCCcchhHHHHHHHHhccCCChHHH
Q psy3686         151 SRVLN----DAPPCLPNDPLFGRTIKASIAKDNGRSTEFI  186 (296)
Q Consensus       151 ~~i~~----~~~p~~~~~~~~s~~l~~li~~cl~~~P~~r  186 (296)
                      .+...    ...+.+.  ..+|+++.+||.+||..+|+.|
T Consensus       226 ~~~~~~~~~~~~~~~~--~~~p~~~~~li~~cl~~~p~~R  263 (299)
T d1ckia_         226 ERISEKKMSTPIEVLC--KGYPSEFATYLNFCRSLRFDDK  263 (299)
T ss_dssp             HHHHHHHHHSCHHHHT--TTSCHHHHHHHHHHHHSCTTCC
T ss_pred             HHhhcccCCCChhHhc--cCCCHHHHHHHHHHccCChhHC
Confidence            11111    1111122  2379999999999999999844

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-34  Score=248.63  Aligned_cols=177  Identities=16%  Similarity=0.223  Sum_probs=141.4

Q ss_pred             CCccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECC-----CCCEEE
Q psy3686           3 PQSKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDE-----RGNIKL   77 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~-----~~~~kl   77 (296)
                      ++.+++..|+||||++|+|.+++......++...+..++.|++.||+|||+ +||+||||||+|||++.     .+.+||
T Consensus        69 ~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEE
Confidence            456788999999999999999998877789999999999999999999999 59999999999999964     578999


Q ss_pred             eccCCcccccCCc--------cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--cH
Q psy3686          78 CDFGISGRLVDSK--------ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKC--DF  147 (296)
Q Consensus        78 ~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~--~~  147 (296)
                      +|||+++.+....        ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+...  ..
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~  222 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK  222 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-----CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH
Confidence            9999998764321        2233479999999999954     3689999999999999999999999986432  22


Q ss_pred             HHHHHHHccC----CCCCCCCcchhHHHHHHHHhccCCChHHHh
Q psy3686         148 EVLSRVLNDA----PPCLPNDPLFGRTIKASIAKDNGRSTEFIR  187 (296)
Q Consensus       148 ~~~~~i~~~~----~p~~~~~~~~s~~l~~li~~cl~~~P~~r~  187 (296)
                      ....++....    .+.+.  ..+|+++.++|..||..+|+.||
T Consensus       223 ~~~~~i~~~~~~~~~~~l~--~~~p~~l~~ii~~~~~~~~~~rP  264 (293)
T d1csna_         223 QKYERIGEKKQSTPLRELC--AGFPEEFYKYMHYARNLAFDATP  264 (293)
T ss_dssp             HHHHHHHHHHHHSCHHHHT--TTSCHHHHHHHHHHHHCCTTCCC
T ss_pred             HHHHHHHhccCCCChHHhc--CCCCHHHHHHHHHHhcCCcccCc
Confidence            2333332211    11111  23789999999999999998433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-33  Score=247.80  Aligned_cols=186  Identities=20%  Similarity=0.283  Sum_probs=148.2

Q ss_pred             cCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCC-CEEEeccCCc
Q psy3686           6 KESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERG-NIKLCDFGIS   83 (296)
Q Consensus         6 ~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~   83 (296)
                      ....+|+|||||.+ +|..+.    ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccc
Confidence            45679999999995 876653    579999999999999999999999 5999999999999998765 5899999999


Q ss_pred             ccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--c-----
Q psy3686          84 GRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--D-----  156 (296)
Q Consensus        84 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~-----  156 (296)
                      .............+|+.|+|||.+.+.    ..++.++||||+||++|+|++|..||............+..  +     
T Consensus       178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         178 EFYHPGQEYNVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             eeccCCCcccccccCccccCcccccCC----CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            877666666667899999999998642    35788999999999999999999999875544433322211  0     


Q ss_pred             ------CC---------------------CCCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccc
Q psy3686         157 ------AP---------------------PCLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSY  208 (296)
Q Consensus       157 ------~~---------------------p~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~  208 (296)
                            ..                     +..+....+++++.+||++||..||.        +|.++.++++|+|+.-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~--------~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ--------SRLTAREAMEHPYFYT  324 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGG--------GSCCHHHHHTSGGGTT
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChh--------HCcCHHHHhcCcccCC
Confidence                  00                     00111234789999999999999998        6778889999988754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-33  Score=238.62  Aligned_cols=194  Identities=19%  Similarity=0.259  Sum_probs=155.2

Q ss_pred             CCccCCeEEEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccC
Q psy3686           3 PQSKESDVWICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFG   81 (296)
Q Consensus         3 ~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg   81 (296)
                      .|.+...+++||+++.| +|..++.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~~~~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          69 VLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             EEECSSEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccccccceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCCceeeeecc
Confidence            46788899999999996 76666654 7899999999999999999999999 599999999999999999999999999


Q ss_pred             CcccccCCc-cccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc--cCC
Q psy3686          82 ISGRLVDSK-ARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN--DAP  158 (296)
Q Consensus        82 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~--~~~  158 (296)
                      .+....... ......++..|+|||.+..    ...++.++|||||||++|+|++|..||....+..+.+.++..  +.+
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         147 LARAFGIPVRCYSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             TCEECCSCCSCCCSCCSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhhcccCCCccceeeccccchhhhhHhcc----CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence            998765443 2333467788999999863    224688999999999999999999998765665555555432  111


Q ss_pred             C------------------------CCCCCcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCcccccC
Q psy3686         159 P------------------------CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYAC  210 (296)
Q Consensus       159 p------------------------~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~~  210 (296)
                      .                        .......+++.+.+||.+||..||.        +|.++.+++.|+|++-.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~--------~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV--------QRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG--------GSCCHHHHTTSGGGSSCS
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChh--------HCcCHHHHhcChhhcCCC
Confidence            0                        0001134689999999999999998        777888999999886554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-33  Score=248.93  Aligned_cols=186  Identities=21%  Similarity=0.325  Sum_probs=141.3

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+.+++|+|||||.|+|.+.+   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++++|||++.
T Consensus        92 ~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccccccceeeechhhhh
Confidence            456899999999998777766   4679999999999999999999999 599999999999999999999999999988


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHc---------
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLN---------  155 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~---------  155 (296)
                      ............+|+.|+|||++.+     ..++.++||||+||++|+|++|+.||.+. +......++..         
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~DiwSlG~~l~ell~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -------------CCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccccccccccccccChhhhcC-----CCCCCCcccccccchHHHHhhCCCCCCCC-CHHHHHHHHHHhccCCCHHH
Confidence            7766666666689999999999954     37889999999999999999999999873 33333333321         


Q ss_pred             -------------cCCCCC-------------CC----CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCc
Q psy3686         156 -------------DAPPCL-------------PN----DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGH  205 (296)
Q Consensus       156 -------------~~~p~~-------------~~----~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~  205 (296)
                                   ...+..             +.    ...+|+++.+||++||..||+        +|.++.++++|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~--------~R~ta~elL~Hpw  313 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA--------KRISVDDALQHPY  313 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT--------TSCCHHHHHTSTT
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh--------HCcCHHHHhcCcc
Confidence                         110000             00    012578899999999999998        8889999999999


Q ss_pred             ccc
Q psy3686         206 LSY  208 (296)
Q Consensus       206 ~~~  208 (296)
                      ++.
T Consensus       314 ~~~  316 (355)
T d2b1pa1         314 INV  316 (355)
T ss_dssp             TGG
T ss_pred             cCC
Confidence            865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.3e-32  Score=243.43  Aligned_cols=187  Identities=22%  Similarity=0.323  Sum_probs=143.5

Q ss_pred             ccCCeEEEEecCccccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686           5 SKESDVWICMELMATCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus         5 ~~~~~~~lv~E~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .+.+.+|++|++++|+|.+++.  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||.+.
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccccccccccchhc
Confidence            3445566666666679999996  4689999999999999999999999 599999999999999999999999999986


Q ss_pred             cccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHccCC------
Q psy3686          85 RLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCDFEVLSRVLNDAP------  158 (296)
Q Consensus        85 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~i~~~~~------  158 (296)
                      ....  ......++..|+|||.+.+    ...++.++|||||||++|+|++|..||.+. +.......+.....      
T Consensus       170 ~~~~--~~~~~~g~~~y~apE~~~~----~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         170 HTDD--EMTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             CCTG--GGSSSCHHHHTSCHHHHTT----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHH
T ss_pred             ccCc--ccccccccccccCchhhcC----CccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHH
Confidence            5532  2334578899999998753    235688999999999999999999999883 44444444432110      


Q ss_pred             ----------------CCCCC------CcchhHHHHHHHHhccCCChHHHhhhccCCccchhhcccCCccccc
Q psy3686         159 ----------------PCLPN------DPLFGRTIKASIAKDNGRSTEFIRKRSYEDKSTCYECGAEGHLSYA  209 (296)
Q Consensus       159 ----------------p~~~~------~~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~~~~~~~~~~~~~~  209 (296)
                                      +..+.      ...+++.+++||.+||..||.        +|.++.+++.|+|++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~--------~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD--------KRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG--------GSCCHHHHHTSGGGTTT
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh--------hCcCHHHHhcCHhhCCC
Confidence                            01111      123689999999999999998        77788999999987643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.1e-33  Score=242.18  Aligned_cols=185  Identities=22%  Similarity=0.267  Sum_probs=137.0

Q ss_pred             CeEEEEecCcc-ccHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------hCCceeCCCCCCcEEECCCCCEEEec
Q psy3686           8 SDVWICMELMA-TCFDRLLKRLHVSVPEPICGKITLSTVKALHYLKE-------THGVIHRDVKPSNILLDERGNIKLCD   79 (296)
Q Consensus         8 ~~~~lv~E~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-------~~~ivH~dlkp~Nil~~~~~~~kl~d   79 (296)
                      ..+|||||||. |+|.+++++  ..+++..++.++.|++.||.|||+       ..||+||||||+||||+.++.+||+|
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            36899999998 699999985  579999999999999999999996       24899999999999999999999999


Q ss_pred             cCCcccccCCc-----cccccccCcCCCCccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------
Q psy3686          80 FGISGRLVDSK-----ARTKNAGCAAYMAPERIEPPNPQ-KPDYDIRADVWSLGITLVELATGEFPYKDCK---------  144 (296)
Q Consensus        80 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~---------  144 (296)
                      ||++.......     ......||+.|+|||++.+.... ...++.++|||||||++|+|++|..||....         
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            99998765432     22345799999999998653211 1135778999999999999999988764311         


Q ss_pred             ----CcHHHHHHHHc--cCCCCCCCC---cchhHHHHHHHHhccCCChHHHhhhccCCccc
Q psy3686         145 ----CDFEVLSRVLN--DAPPCLPND---PLFGRTIKASIAKDNGRSTEFIRKRSYEDKST  196 (296)
Q Consensus       145 ----~~~~~~~~i~~--~~~p~~~~~---~~~s~~l~~li~~cl~~~P~~r~~~~~~~~~~  196 (296)
                          ...........  +..|.++..   ......+.+||.+||..||+  .|+++.++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~--~Rps~~ei~~  290 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA--ARLTALRIKK  290 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGG--GSCCHHHHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHh--HCcCHHHHHH
Confidence                12233333322  223444332   22446799999999999998  4445554433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=2.9e-27  Score=209.81  Aligned_cols=188  Identities=19%  Similarity=0.282  Sum_probs=136.8

Q ss_pred             CCeEEEEecCcc--ccHHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCC------EEE
Q psy3686           7 ESDVWICMELMA--TCFDRLLK-RLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGN------IKL   77 (296)
Q Consensus         7 ~~~~~lv~E~~~--gsL~~~l~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~------~kl   77 (296)
                      ....++||.++.  ++...... .....+++..++.++.||+.||.|||+.+||+||||||+|||++.++.      +++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence            455666666665  34444333 336789999999999999999999998559999999999999976653      899


Q ss_pred             eccCCcccccCCccccccccCcCCCCccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----HHHHHH
Q psy3686          78 CDFGISGRLVDSKARTKNAGCAAYMAPERIEPPNPQKPDYDIRADVWSLGITLVELATGEFPYKDCKCD-----FEVLSR  152 (296)
Q Consensus        78 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~  152 (296)
                      +|||.+.....  ......+++.|+|||++.+     ..++.++||||+||++++|++|+.||......     ...+..
T Consensus       174 ~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         174 ADLGNACWYDE--HYTNSIQTREYRSPEVLLG-----APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             CCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-----CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeccccccccc--ccccccccccccChhhccc-----cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            99999876543  2344579999999999853     36889999999999999999999999753211     111111


Q ss_pred             HHc--cCC------------------------C-------------CCCCCcchhHHHHHHHHhccCCChHHHhhhccCC
Q psy3686         153 VLN--DAP------------------------P-------------CLPNDPLFGRTIKASIAKDNGRSTEFIRKRSYED  193 (296)
Q Consensus       153 i~~--~~~------------------------p-------------~~~~~~~~s~~l~~li~~cl~~~P~~r~~~~~~~  193 (296)
                      ...  +..                        .             ........++.+.+||.+||..||.        +
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~--------~  318 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR--------K  318 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT--------T
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh--------H
Confidence            110  100                        0             0111223678999999999999998        7


Q ss_pred             ccchhhcccCCccccc
Q psy3686         194 KSTCYECGAEGHLSYA  209 (296)
Q Consensus       194 ~~~~~~~~~~~~~~~~  209 (296)
                      |.++.++++|+|++..
T Consensus       319 Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CBCHHHHHTCGGGTTC
T ss_pred             CcCHHHHhcCcccCCC
Confidence            7788999999998744

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.43  E-value=4e-14  Score=113.17  Aligned_cols=67  Identities=22%  Similarity=0.294  Sum_probs=56.5

Q ss_pred             EEEecCccc-cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEECCCCCEEEeccCCccccc
Q psy3686          11 WICMELMAT-CFDRLLKRLHVSVPEPICGKITLSTVKALHYLKETHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV   87 (296)
Q Consensus        11 ~lv~E~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~   87 (296)
                      ++||||+++ .+        ..++...+..++.|++.+|.|||+ +||+||||||+|||++.++ ++|+|||.+....
T Consensus        86 ~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~  153 (191)
T d1zara2          86 AVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG  153 (191)
T ss_dssp             EEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETTE-EEECCCTTCEETT
T ss_pred             EEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCCC-EEEEECCCcccCC
Confidence            699999996 43        234556677899999999999999 5999999999999998654 8999999987654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.08  E-value=0.00017  Score=58.38  Aligned_cols=28  Identities=32%  Similarity=0.458  Sum_probs=24.3

Q ss_pred             ceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          57 VIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        57 ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            6899999999999876666799998774

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.00  E-value=0.0027  Score=54.63  Aligned_cols=28  Identities=25%  Similarity=0.325  Sum_probs=24.4

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      .++|||+++.|||++.++ ++|+||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            489999999999998765 8999998774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.69  E-value=0.0044  Score=51.29  Aligned_cols=29  Identities=31%  Similarity=0.377  Sum_probs=26.3

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      |+||+|+.++||+++.+...-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            79999999999999988777899999773

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.72  E-value=0.019  Score=45.41  Aligned_cols=28  Identities=29%  Similarity=0.351  Sum_probs=24.6

Q ss_pred             ceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          57 VIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        57 ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999887667899998763

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.54  E-value=0.18  Score=41.37  Aligned_cols=27  Identities=26%  Similarity=0.355  Sum_probs=22.5

Q ss_pred             CceeCCCCCCcEEECCCCCEEEeccCCcc
Q psy3686          56 GVIHRDVKPSNILLDERGNIKLCDFGISG   84 (296)
Q Consensus        56 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~   84 (296)
                      ++||+|+.+.|||++. + ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            6899999999999964 3 4589998774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=80.64  E-value=0.32  Score=40.99  Aligned_cols=15  Identities=40%  Similarity=0.656  Sum_probs=13.2

Q ss_pred             ceeCCCCCCcEEECC
Q psy3686          57 VIHRDVKPSNILLDE   71 (296)
Q Consensus        57 ivH~dlkp~Nil~~~   71 (296)
                      ++|+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            689999999999854